data_1tvc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tvc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.47 ' CB ' ' CG ' ' A' ' 105' ' ' LYS . 83.8 p -110.36 150.88 28.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.863 0.364 . . . . 0.0 111.038 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -131.46 162.67 29.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.547 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.587 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 8.3 mt-10 -110.8 129.97 55.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.814 0.34 . . . . 0.0 111.03 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.591 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . . . -127.77 135.15 49.73 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.976 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.526 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 14.9 tp10 -93.64 122.62 36.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.394 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.515 HG11 ' CD2' ' A' ' 31' ' ' LEU . 32.6 m -71.25 104.34 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.481 ' HA ' HG22 ' A' ' 98' ' ' VAL . 2.6 p -122.51 -34.47 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.433 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -87.5 -130.61 3.2 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.306 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.593 ' CD2' ' CG2' ' A' ' 27' ' ' VAL . 0.1 OUTLIER 87.87 71.63 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.436 0.636 . . . . 0.0 110.291 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -108.91 146.54 33.61 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.818 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -88.54 114.3 25.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 28' ' ' GLN . 1.7 m -95.04 -27.53 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.54 0.686 . . . . 0.0 109.692 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.519 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 11.7 m -138.51 172.13 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.297 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 t -51.64 -56.85 11.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.977 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.506 ' CA ' ' O ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -118.48 43.03 2.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.708 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.519 ' CB ' ' HB2' ' A' ' 23' ' ' SER . 0.2 OUTLIER -147.2 140.39 25.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.317 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.593 ' CG2' ' CD2' ' A' ' 19' ' ' LEU . 1.4 p -141.02 146.44 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.097 0.475 . . . . 0.0 112.236 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.526 ' N ' HG22 ' A' ' 27' ' ' VAL . 6.4 tt0 -110.0 103.02 11.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.568 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.616 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -94.02 125.3 38.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.494 -178.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.562 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -112.61 116.29 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.074 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.541 ' HB3' ' CB ' ' A' ' 14' ' ' ALA . 2.2 mt -121.73 132.81 54.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 111.539 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.454 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 38.4 mt-30 -145.81 109.29 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.393 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' CA ' ' A' ' 14' ' ' ALA . 12.2 tptt -149.22 -0.32 0.5 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.469 ' HG3' ' HB2' ' A' ' 13' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.139 0.495 . . . . 0.0 112.077 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.361 0.6 . . . . 0.0 111.797 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.49 ' CA ' ' HA ' ' A' ' 70' ' ' PRO . 1.5 ttpm? -163.07 26.65 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.967 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.631 ' CG ' ' CG ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER 76.55 96.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.584 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -108.75 165.79 12.03 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.437 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.59 59.12 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.713 2.275 . . . . 0.0 111.858 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 58.48 61.68 7.12 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.66 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.484 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 1.2 mm-40 -35.44 146.21 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.664 0.232 . . . . 0.0 110.493 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.66 ' CD2' ' CD2' ' A' ' 108' ' ' LEU . 2.6 t80 -152.69 139.34 18.8 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.667 0.27 . . . . 0.0 111.696 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.579 ' O ' ' CE1' ' A' ' 50' ' ' PHE . 3.8 mtt -139.94 -162.68 1.38 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.852 0.358 . . . . 0.0 111.922 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 3.4 t0 -134.96 123.3 23.14 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.534 ' CD1' HD12 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.56 157.71 43.32 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.598 ' HA ' ' HB3' ' A' ' 61' ' ' SER . 0.0 OUTLIER -108.72 149.6 28.77 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.094 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.67 ' CG2' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -34.49 -70.95 0.11 Allowed Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.249 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.67 ' HD3' ' CG2' ' A' ' 55' ' ' ILE . 51.3 Cg_endo -103.98 14.45 0.24 Allowed 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 123.39 2.727 . . . . 0.0 111.941 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 98.52 0.34 58.01 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.663 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.569 ' CG2' ' HD2' ' A' ' 56' ' ' PRO . 13.0 p -40.69 -103.18 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.852 0.461 . . . . 0.0 111.596 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.533 ' N ' HG22 ' A' ' 54' ' ' THR . 1.3 m-20 160.23 36.16 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.009 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 60' ' ' VAL . 6.1 t -152.32 27.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.958 0.408 . . . . 0.0 110.888 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.598 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 36.8 t -97.46 -101.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.631 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 170.64 -176.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.102 0.477 . . . . 0.0 111.36 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 2.4 m -99.19 142.56 30.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.689 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.532 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 1.8 t80 -141.36 131.4 24.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 19.7 m -79.28 108.89 9.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.62 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.544 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 72.9 Cg_endo -91.61 165.11 3.45 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.921 2.414 . . . . 0.0 112.189 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.17 135.55 25.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.867 0.365 . . . . 0.0 111.647 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -105.35 -69.76 0.81 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.999 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.589 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 1.4 mt 138.3 160.27 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.468 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.574 ' HD3' ' CG ' ' A' ' 45' ' ' PHE . 20.2 Cg_endo -60.93 87.75 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 121.973 1.782 . . . . 0.0 111.341 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -168.08 117.65 0.65 Allowed Pre-proline 0 N--CA 1.457 -0.102 0 CA-C-O 120.807 0.337 . . . . 0.0 110.891 -179.206 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.13 89.95 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.429 2.086 . . . . 0.0 111.861 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -158.09 -82.87 0.05 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.853 0.359 . . . . 0.0 110.094 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.11 96.41 0.28 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.788 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 37.4 mtm180 -151.87 106.33 3.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.463 0.173 . . . . 0.0 110.925 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.548 ' C ' ' CD1' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -97.79 130.92 44.7 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.852 0.358 . . . . 0.0 110.446 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.483 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 3.1 mt-10 -129.16 117.88 21.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.319 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.616 ' CE2' ' HB3' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -109.99 146.94 34.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.144 0.497 . . . . 0.0 111.715 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.575 ' CD2' ' CG2' ' A' ' 128' ' ' THR . 7.5 mt -111.17 84.53 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.032 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.611 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -91.79 129.53 42.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.873 -178.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.43 95.91 5.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.164 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.531 ' HB ' ' CB ' ' A' ' 89' ' ' SER . 7.4 m -98.15 141.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.765 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.509 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -121.35 112.92 32.59 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.587 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 85' ' ' GLU . 82.5 Cg_exo -44.17 122.01 3.39 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.649 2.233 . . . . 0.0 112.181 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 84' ' ' PRO . 17.6 tp10 84.47 5.29 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.46 ' HA3' HD13 ' A' ' 83' ' ' LEU . . . -74.08 -130.99 0.2 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.459 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -125.25 -26.03 3.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.602 0.239 . . . . 0.0 111.484 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 2.4 t80 -106.12 -31.26 8.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.544 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.531 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 1.0 OUTLIER -70.89 -34.17 71.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.685 0.279 . . . . 0.0 111.698 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 67.2 m-20 -74.91 -40.35 60.92 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.517 0.675 . . . . 0.0 109.752 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.593 ' CD2' HG23 ' A' ' 55' ' ' ILE . 2.6 t80 -73.67 -24.48 59.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.508 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.533 ' O ' ' CB ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -68.08 -41.08 82.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.801 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -16.64 27.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.596 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 44.2 m-20 -101.22 -7.28 23.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.452 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.415 ' HB2' ' CD1' ' A' ' 91' ' ' TYR . 0.9 OUTLIER -151.56 13.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 92' ' ' LEU . . . -139.79 26.24 2.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.97 0.415 . . . . 0.0 111.156 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.468 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -56.81 -171.98 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.01 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.563 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -88.13 2.03 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.714 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.35 58.06 0.41 Allowed Glycine 0 C--N 1.321 -0.286 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.203 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -162.09 -178.85 6.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.027 0.442 . . . . 0.0 111.413 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 101' ' ' VAL . 3.5 p -129.06 131.54 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.489 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.534 HD12 ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.73 123.71 31.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.708 0.29 . . . . 0.0 110.781 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.481 ' CA ' ' O ' ' A' ' 12' ' ' PHE . 3.6 m -95.5 131.65 41.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.762 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.581 HG13 ' CD1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -99.82 134.61 38.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -130.15 113.78 14.91 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.37 -178.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 169.6 70.05 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.54 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.37 60.74 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.555 2.17 . . . . 0.0 110.308 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.66 ' CD2' ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -133.77 170.36 15.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.019 -177.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.49 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -117.01 173.54 14.75 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.094 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.459 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 8.3 p -112.6 112.1 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.324 0.583 . . . . 0.0 110.548 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.5 120.89 39.7 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.569 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.12 -37.93 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.651 ' HA ' ' CG ' ' A' ' 215' ' ' TYR . 0.2 OUTLIER -126.04 120.02 29.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.72 179.352 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.646 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 2.7 tptt -130.38 108.61 10.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.449 ' HB3' ' HE1' ' A' ' 140' ' ' MET . 0.0 OUTLIER -78.68 140.56 38.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.667 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -89.38 13.45 13.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.815 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.58 -76.05 0.28 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.504 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.83 89.81 2.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.855 0.36 . . . . 0.0 110.293 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.515 ' O ' ' NE ' ' A' ' 121' ' ' ARG . . . -168.57 144.27 2.94 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.21 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 25.9 Cg_endo -62.16 105.0 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.697 2.265 . . . . 0.0 111.944 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -117.37 143.84 45.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.249 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CE2' ' CD ' ' A' ' 150' ' ' ARG . 14.6 m-85 -119.59 127.18 52.72 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.734 0.302 . . . . 0.0 111.131 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.578 ' CD1' ' HB2' ' A' ' 215' ' ' TYR . 1.3 t80 -117.48 106.73 13.48 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.594 ' CG1' ' CD2' ' A' ' 216' ' ' LEU . 4.5 p -98.73 110.96 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.371 0.605 . . . . 0.0 111.809 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -102.96 133.63 47.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.527 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 246' ' ' LEU . . . -105.62 103.17 2.1 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.497 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.566 ' HA2' ' CG1' ' A' ' 155' ' ' VAL . . . 118.22 -154.52 16.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.834 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.575 ' CG2' ' CD2' ' A' ' 79' ' ' LEU . 18.8 m -107.88 -11.89 15.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.805 0.336 . . . . 0.0 111.111 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.638 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -66.92 9.72 0.91 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.545 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 131' ' ' ALA . 0.3 OUTLIER -78.05 4.15 13.06 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.581 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -47.34 -44.54 52.32 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.098 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 5.9 Cg_exo -73.32 -30.73 9.99 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.836 2.357 . . . . 0.0 110.104 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.53 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 17.7 t -65.79 -49.49 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.921 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 138' ' ' ARG . 19.0 m -64.54 -33.28 62.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.541 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -64.5 -50.65 66.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.235 179.254 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -31.82 71.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.885 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 133' ' ' VAL . 74.7 t -59.85 -52.9 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.46 ' HA ' ' OE1' ' A' ' 141' ' ' GLN . 0.8 OUTLIER -60.76 -31.38 70.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.622 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.631 ' CG ' ' CG ' ' A' ' 45' ' ' PHE . 31.7 mt-30 -63.0 -38.55 91.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.264 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.514 ' CE ' HG21 ' A' ' 149' ' ' THR . 2.5 ptm -67.91 -42.76 80.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.268 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.513 ' N ' ' HG2' ' A' ' 140' ' ' MET . 21.4 mt-30 -68.5 -42.83 78.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.116 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -12.37 60.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.788 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.476 ' HB2' ' O ' ' A' ' 139' ' ' GLN . 0.8 OUTLIER -80.54 -84.34 0.1 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.455 0.645 . . . . 0.0 111.164 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.498 ' C ' ' CD ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -156.6 23.66 0.34 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.678 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 140' ' ' MET . . . -112.66 49.69 0.38 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.356 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.498 ' CD ' ' C ' ' A' ' 144' ' ' THR . 52.6 Cg_endo -69.31 -3.6 12.03 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.579 2.186 . . . . 0.0 111.922 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -69.97 -159.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.256 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.544 ' CB ' ' HB2' ' A' ' 176' ' ' ASN . 1.0 OUTLIER -73.03 105.28 4.43 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.62 0.724 . . . . 0.0 111.515 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.5 OUTLIER -110.04 115.21 29.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.237 178.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.633 ' CD ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -106.34 138.56 42.29 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.745 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.491 ' C ' ' CD1' ' A' ' 151' ' ' ILE . 0.1 OUTLIER -133.52 134.95 56.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.026 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.578 ' CD1' ' CB ' ' A' ' 180' ' ' LYS . 21.8 m-30 -109.51 123.24 49.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.071 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.472 ' HB2' HD22 ' A' ' 167' ' ' LEU . 7.2 t80 -119.87 131.01 55.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.775 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.606 ' CA ' ' HB2' ' A' ' 182' ' ' CYS . . . -158.49 158.6 29.43 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 119.492 -1.337 . . . . 0.0 113.775 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.575 ' CG2' HD23 ' A' ' 161' ' ' LEU . 11.8 m -164.15 -116.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.605 ' CB ' ' N ' ' A' ' 188' ' ' GLY . 0.6 OUTLIER -119.91 -164.27 1.06 Allowed 'General case' 0 C--N 1.343 0.285 0 O-C-N 122.459 -0.151 . . . . 0.0 110.895 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.604 ' O ' ' CB ' ' A' ' 158' ' ' GLU . 65.3 p -25.95 -41.38 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.456 0.302 . . . . 0.0 111.515 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.604 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.8 OUTLIER 107.82 -43.27 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.617 0 O-C-N 123.967 0.792 . . . . 0.0 112.402 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 157' ' ' THR . 80.3 Cg_exo -46.2 -22.02 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.199 1.933 . . . . 0.0 112.335 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -98.4 -13.96 20.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.764 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.575 HD23 ' CG2' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -110.58 -165.69 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.756 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 0.1 OUTLIER 178.26 -154.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.903 0.382 . . . . 0.0 111.349 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.522 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 77.13 16.12 1.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.097 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -70.27 -39.17 76.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.246 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.572 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 0.6 OUTLIER -73.68 -27.45 61.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.097 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.459 ' O ' ' OG ' ' A' ' 169' ' ' SER . 3.5 mm-40 -64.79 -49.61 70.02 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -76.21 -31.13 58.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 164' ' ' ILE . 7.7 mttt -62.74 -36.67 83.77 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 166' ' ' GLU . 15.0 p -66.96 -32.95 74.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -63.01 -41.57 99.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.486 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 0.6 OUTLIER -68.91 -36.45 78.04 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.913 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -76.21 -25.05 54.72 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.348 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 169' ' ' SER . 37.4 t -61.48 -71.06 0.16 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.707 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.537 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -179.92 -153.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.133 0.492 . . . . 0.0 112.083 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER 42.59 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.577 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.56 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.0 OUTLIER -13.45 73.69 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 124.433 1.083 . . . . 0.0 111.736 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 175' ' ' ARG . 0.3 OUTLIER -94.65 148.53 22.17 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.201 -178.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.522 ' OG1' ' CZ ' ' A' ' 150' ' ' ARG . 6.8 m -137.18 115.33 11.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.03 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.463 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 7.3 p -101.22 127.77 54.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.161 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.578 ' CB ' ' CD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -95.84 135.52 37.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.539 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -101.0 104.97 16.15 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.354 0.597 . . . . 0.0 110.899 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.606 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 34.5 m -88.67 -160.76 0.68 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.108 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.656 ' N ' ' O ' ' A' ' 193' ' ' GLU . 40.6 t 56.23 146.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.765 0.793 . . . . 0.0 111.815 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.718 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.3 -63.4 0.76 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.751 -178.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.545 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 1.1 t60 -168.65 51.47 0.2 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.541 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.563 ' O ' ' CB ' ' A' ' 187' ' ' SER . 62.6 Cg_endo -88.01 -101.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.054 2.503 . . . . 0.0 112.793 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 0.4 OUTLIER 153.23 -8.01 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.605 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 130.34 12.11 2.35 Favored Glycine 0 C--N 1.322 -0.214 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.728 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.54 63.39 1.55 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.525 ' N ' ' OG ' ' A' ' 248' ' ' SER . 7.5 t-105 -125.86 117.53 23.54 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.21 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.404 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 10.0 mm-40 -92.01 104.18 16.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.543 ' HA2' ' CA ' ' A' ' 251' ' ' ALA . . . 142.06 -120.05 1.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.438 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -167.09 -85.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 0.0 OUTLIER -85.82 126.78 34.29 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.636 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -25.99 106.74 0.01 OUTLIER Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.085 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 2.2 m 146.25 166.01 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 114.961 -0.619 . . . . 0.0 110.896 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 196' ' ' SER . 83.5 Cg_endo -81.93 44.33 1.7 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.899 2.399 . . . . 0.0 112.566 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.572 ' CG1' ' CB ' ' A' ' 251' ' ' ALA . 0.1 OUTLIER 65.81 17.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.297 0.57 . . . . 0.0 110.754 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.443 ' OD2' ' HG2' ' A' ' 197' ' ' PRO . 1.0 OUTLIER -58.41 -36.77 74.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.442 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.88 -43.68 94.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.685 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.535 ' O ' ' CD2' ' A' ' 205' ' ' LEU . 0.1 OUTLIER -65.8 -31.38 72.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.927 0.394 . . . . 0.0 110.527 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.525 ' O ' ' HG ' ' A' ' 205' ' ' LEU . 5.7 mtm180 -58.83 -42.13 88.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.5 0.666 . . . . 0.0 110.178 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.84 -32.71 65.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.088 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -58.79 -43.2 90.41 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -60.79 -46.06 91.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.0 -24.22 66.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.352 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 208' ' ' SER . 16.4 t -92.11 -87.96 0.21 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.885 0.374 . . . . 0.0 111.18 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 1.9 p 163.28 103.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 1.2 m-20 156.69 57.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.52 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 147.4 105.37 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.397 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.574 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 56.3 t30 177.27 -56.01 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.208 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 9.6 Cg_endo -52.82 -55.69 3.51 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.953 1.769 . . . . 0.0 110.667 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.516 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -133.47 109.45 9.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.979 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.529 ' HB ' ' CG2' ' A' ' 240' ' ' VAL . 0.9 OUTLIER -121.12 125.56 74.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.651 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -117.39 126.21 52.29 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.49 0.662 . . . . 0.0 110.163 -178.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.594 ' CD2' ' CG1' ' A' ' 124' ' ' VAL . 34.0 mt -122.73 118.78 28.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.042 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . 0.577 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -123.42 132.31 53.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.107 178.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 245' ' ' PHE . . . 136.32 -154.78 22.16 Favored Glycine 0 C--O 1.224 -0.475 0 C-N-CA 120.333 -0.936 . . . . 0.0 112.859 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.556 ' HG3' ' HA ' ' A' ' 248' ' ' SER . 11.8 Cg_endo -53.79 161.21 4.78 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.005 2.47 . . . . 0.0 112.648 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.422 ' O ' HG21 ' A' ' 223' ' ' ILE . 50.5 Cg_endo -69.28 -8.97 25.03 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.611 2.208 . . . . 0.0 111.572 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.48 -49.17 52.94 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.282 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.566 ' CA ' ' OXT' ' A' ' 251' ' ' ALA . 0.0 OUTLIER -55.7 -25.71 41.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.541 HG13 ' CB ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -76.59 -42.54 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.487 178.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.488 ' N ' HG21 ' A' ' 223' ' ' ILE . 38.1 m-20 -74.67 -47.57 31.04 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.561 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -76.41 -48.99 17.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 222' ' ' MET . . . -59.5 -37.79 79.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.76 0.314 . . . . 0.0 110.594 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 37.9 t -69.64 -31.22 69.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.946 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 232' ' ' SER . 4.8 mt-10 -70.95 -45.13 64.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.738 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.561 ' CD2' ' O ' ' A' ' 225' ' ' ALA . 0.0 OUTLIER -60.67 -37.38 81.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.178 0.513 . . . . 0.0 110.702 -179.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.543 ' HA ' ' CG2' ' A' ' 235' ' ' ILE . 12.5 t -65.24 -45.63 93.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.393 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.8 -30.16 61.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.035 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 228' ' ' GLU . 0.6 OUTLIER -75.37 -44.16 46.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.391 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.466 ' NE ' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -79.65 -70.57 0.5 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.008 0.432 . . . . 0.0 111.11 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 154.9 -31.42 0.67 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.8 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.546 ' CG2' ' O ' ' A' ' 235' ' ' ILE . 0.0 OUTLIER -26.33 84.59 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 123.064 0.545 . . . . 0.0 112.423 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.539 ' N ' ' O ' ' A' ' 234' ' ' GLY . 5.8 Cg_exo -76.37 114.35 3.87 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 123.427 2.751 . . . . 0.0 112.232 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -106.22 161.08 14.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.931 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -117.51 -45.96 2.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.736 0.303 . . . . 0.0 110.91 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 19.3 mm-40 -105.87 40.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.354 0.597 . . . . 0.0 110.281 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.568 ' CG1' ' CZ ' ' A' ' 242' ' ' PHE . 2.3 t -92.04 134.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.928 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.36 145.67 30.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.248 -178.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.568 ' CZ ' ' CG1' ' A' ' 240' ' ' VAL . 1.5 m-85 -131.64 144.24 50.89 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.721 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . 0.521 ' O ' ' CE ' ' A' ' 222' ' ' MET . 21.2 tt0 -132.72 148.72 52.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -111.19 106.48 15.51 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.661 ' CE1' ' CD2' ' A' ' 246' ' ' LEU . 0.0 OUTLIER -137.0 145.28 43.93 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.557 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.661 ' CD2' ' CE1' ' A' ' 245' ' ' PHE . 0.2 OUTLIER 51.59 171.52 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . 0.555 ' CD ' ' HB2' ' A' ' 246' ' ' LEU . 32.2 Cg_exo -60.36 -138.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.914 3.076 . . . . 0.0 113.054 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.556 ' HA ' ' HG3' ' A' ' 219' ' ' PRO . 1.0 OUTLIER -72.75 161.15 31.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.808 0.337 . . . . 0.0 111.847 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.459 ' C ' ' HA3' ' A' ' 126' ' ' GLY . . . 143.41 -20.75 2.24 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.609 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.554 ' CB ' ' HD2' ' A' ' 219' ' ' PRO . . . -105.78 153.43 21.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.903 0.383 . . . . 0.0 111.785 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.572 ' CB ' ' CG1' ' A' ' 198' ' ' ILE . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.037 -0.982 . . . . 0.0 112.614 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 105' ' ' LYS . . . . . . . . 0 N--CA 1.449 -0.454 0 CA-C-O 121.062 0.257 . . . . 0.0 112.6 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.474 ' HB2' ' HB2' ' A' ' 105' ' ' LYS . 3.6 p -112.61 150.99 30.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.583 -0.308 . . . . 0.0 110.711 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -132.41 165.63 23.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.034 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.582 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 3.3 mt-10 -113.53 129.89 56.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.989 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 31' ' ' LEU . . . -125.86 150.68 47.69 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 1.9 pt-20 -102.11 112.19 24.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.825 0.345 . . . . 0.0 110.303 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 100' ' ' GLN . 11.4 t -71.36 105.67 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.012 0.434 . . . . 0.0 110.715 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 7.7 p -120.21 19.53 6.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.98 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -132.8 -124.75 2.57 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.558 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.56 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 74.71 95.31 0.07 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.861 0.839 . . . . 0.0 109.586 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -142.33 139.35 31.76 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.808 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.546 ' CZ2' ' HG3' ' A' ' 93' ' ' ARG . 22.3 m0 -89.47 113.31 24.65 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 23' ' ' SER . 1.5 m -86.6 -33.25 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-O 121.928 0.871 . . . . 0.0 109.265 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 160' ' ' GLU . 0.4 OUTLIER -129.85 -174.19 3.24 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.411 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.43 ' HB3' ' HG3' ' A' ' 160' ' ' GLU . 9.8 t -60.06 -40.66 90.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.433 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 8.9 m-80 -133.66 40.84 3.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.197 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 23' ' ' SER . 17.7 m -133.92 123.42 24.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.542 ' CG2' HD13 ' A' ' 19' ' ' LEU . 6.6 p -136.72 132.63 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 111.747 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 3.1 tt0 -119.98 134.58 55.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.577 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.741 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -130.68 142.61 50.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.406 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.571 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -113.04 116.93 30.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.591 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.59 HD12 ' CE1' ' A' ' 29' ' ' PHE . 38.8 mt -101.57 142.93 32.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 1.3 mt-30 -146.79 134.18 20.75 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.635 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . 2.7 tmtp? -178.14 -70.67 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.413 ' HG2' ' HD3' ' A' ' 33' ' ' LYS . 8.2 mtp180 . . . . . 0 C--N 1.322 -0.616 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.645 ' N ' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.257 0.551 . . . . 0.0 110.311 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.424 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -146.69 -142.2 0.12 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.962 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.01 81.24 2.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.165 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.5 mp0 -113.21 165.31 13.52 Favored Pre-proline 0 C--N 1.332 -0.194 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.522 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 14.6 Cg_endo -57.57 72.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.422 2.082 . . . . 0.0 111.484 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 41.96 73.94 0.19 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.324 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -28.28 145.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.512 0.196 . . . . 0.0 110.979 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.617 ' CD2' HD21 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -143.7 142.27 30.89 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.722 0.296 . . . . 0.0 111.724 -178.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.581 ' O ' ' CE1' ' A' ' 50' ' ' PHE . 3.7 mtt -141.38 -155.59 0.6 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 105' ' ' LYS . 19.9 t70 -136.5 119.11 15.98 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.575 ' CD1' ' CD1' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.81 157.21 42.66 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.637 HG23 ' N ' ' A' ' 61' ' ' SER . 0.2 OUTLIER -95.7 154.48 17.2 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.875 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.713 ' CG2' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -31.49 -66.08 0.19 Allowed Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 123.309 0.381 . . . . 0.0 110.701 -179.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.713 ' HD3' ' CG2' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -112.36 8.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.834 3.022 . . . . 0.0 111.704 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 101.08 -6.26 56.42 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.64 -177.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.585 HG21 ' CD ' ' A' ' 56' ' ' PRO . 69.0 p -23.02 -87.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.269 0.628 . . . . 0.0 111.703 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.486 ' O ' HG11 ' A' ' 60' ' ' VAL . 4.8 m-20 -151.64 42.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.105 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.574 ' N ' ' OG1' ' A' ' 54' ' ' THR . 0.4 OUTLIER 80.96 125.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.874 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.637 ' N ' HG23 ' A' ' 54' ' ' THR . 27.0 t -111.23 -57.73 2.2 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.692 0.758 . . . . 0.0 110.005 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -179.9 -177.92 0.41 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.175 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -88.62 129.65 35.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.144 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.491 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 2.1 t80 -140.65 125.76 18.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.949 0.404 . . . . 0.0 110.778 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 32.0 t -75.33 106.27 2.75 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.674 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.556 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 11.1 Cg_endo -91.24 154.33 3.75 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.439 2.759 . . . . 0.0 111.1 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 132' ' ' PRO . . . -144.38 128.91 18.05 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 69' ' ' LEU . 12.0 t-20 -108.94 -67.79 0.96 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.554 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER 142.28 151.11 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 O-C-N 123.825 0.703 . . . . 0.0 109.977 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.55 ' CD ' ' HG ' ' A' ' 69' ' ' LEU . 12.0 Cg_endo -55.56 108.0 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 121.732 1.621 . . . . 0.0 109.962 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.645 ' O ' ' N ' ' A' ' 43' ' ' VAL . 6.8 p30 178.0 -168.19 0.04 OUTLIER Pre-proline 0 C--O 1.217 -0.657 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.831 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 71' ' ' ASN . 53.2 Cg_exo -53.19 -21.86 18.12 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.842 1.695 . . . . 0.0 113.295 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.626 ' CA ' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER 79.81 70.02 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 177.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -141.61 28.1 2.32 Favored Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.143 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 59.8 mtm-85 -152.86 93.59 1.77 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.073 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 8.5 mt -91.08 143.18 26.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -127.47 111.21 13.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.0 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.741 ' CD2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -108.7 142.35 39.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.776 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.489 ' N ' ' OH ' ' A' ' 64' ' ' TYR . 9.2 mt -126.36 80.6 1.94 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.143 0.497 . . . . 0.0 109.768 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.617 ' HB ' ' CE2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -92.56 122.07 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.171 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.442 ' NH1' HD12 ' A' ' 161' ' ' LEU . 0.4 OUTLIER -79.55 95.77 5.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.438 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.53 ' CG1' HG12 ' A' ' 27' ' ' VAL . 2.4 m -90.59 141.22 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.983 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.476 ' HA ' ' OD1' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -87.25 167.51 21.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.591 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 83' ' ' LEU . 30.4 Cg_endo -63.8 77.7 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.593 2.195 . . . . 0.0 112.251 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.42 61.47 3.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.462 ' HA3' HD12 ' A' ' 83' ' ' LEU . . . -109.88 -39.71 1.53 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.731 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.81 -63.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 111.383 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.556 ' CE1' HD12 ' A' ' 80' ' ' ILE . 6.1 t80 -71.74 -39.76 69.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.004 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -69.04 -24.02 64.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.923 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 2.3 m-20 -76.11 -37.77 57.69 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.812 0.815 . . . . 0.0 109.214 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.488 ' CE1' HG23 ' A' ' 58' ' ' THR . 0.1 OUTLIER -73.19 -28.8 62.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.304 -1.317 . . . . 0.0 110.777 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.483 ' HA ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -68.41 -43.24 77.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.302 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.546 ' HG3' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -90.58 -23.75 20.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.753 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 20.2 m120 -87.26 -15.25 38.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.576 0.227 . . . . 0.0 111.325 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.509 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 1.5 t70 -127.92 -23.68 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 55' ' ' ILE . . . -118.13 36.87 4.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.954 0.407 . . . . 0.0 111.078 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -70.58 -41.21 72.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.545 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 100' ' ' GLN . 2.2 t -121.8 90.45 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.203 0.525 . . . . 0.0 111.834 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.516 ' CA ' ' O ' ' A' ' 16' ' ' VAL . . . 8.77 56.7 0.01 OUTLIER Glycine 0 N--CA 1.459 0.181 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.153 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 98' ' ' VAL . 3.6 mt-30 -68.92 -179.27 1.42 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.715 0.293 . . . . 0.0 110.852 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.0 p -92.94 133.42 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.824 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.575 ' CD1' ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.74 120.81 25.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.798 0.332 . . . . 0.0 110.453 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -89.66 136.5 33.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.182 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.561 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 1.4 m -111.11 127.55 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -129.75 117.53 20.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.497 -178.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.534 ' CA ' ' HB3' ' A' ' 51' ' ' MET . . . 164.64 71.44 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.751 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.41 58.93 1.03 Allowed 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.159 1.906 . . . . 0.0 110.228 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.617 HD21 ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -129.36 169.87 14.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.031 -178.128 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.521 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -116.17 173.25 14.62 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.49 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 47' ' ' PRO . 2.5 p -121.25 111.75 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.325 0.583 . . . . 0.0 110.587 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -81.14 114.25 19.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.406 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 215' ' ' TYR . . . -179.0 -48.18 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.596 ' HA ' ' HB3' ' A' ' 215' ' ' TYR . 1.1 pp -124.4 118.06 25.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.212 0.53 . . . . 0.0 110.867 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.627 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -139.46 114.13 9.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.04 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -89.59 138.25 31.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.47 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -91.34 13.66 16.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.025 0.44 . . . . 0.0 110.839 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.46 -73.8 0.43 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.461 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.528 ' HA ' ' CB ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -129.83 89.56 2.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.846 0.355 . . . . 0.0 110.409 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -164.09 155.85 14.31 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.406 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 10.2 Cg_exo -71.36 107.65 2.19 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.077 2.518 . . . . 0.0 111.747 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.505 ' NH1' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -136.82 138.1 40.45 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.226 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.669 ' CE2' ' CD ' ' A' ' 150' ' ' ARG . 1.9 m-85 -107.62 127.29 53.52 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.141 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 113' ' ' LEU . 1.1 m-85 -106.73 104.34 14.0 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.544 ' HA ' ' HB2' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -99.1 111.18 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.344 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -110.14 133.73 52.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.285 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -109.63 102.63 1.62 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.674 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.57 ' HA2' ' CG1' ' A' ' 155' ' ' VAL . . . 122.58 -152.79 16.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.992 -1.099 . . . . 0.0 112.349 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.506 ' C ' ' H ' ' A' ' 130' ' ' LEU . 2.9 m -111.55 -16.32 13.3 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.247 0.546 . . . . 0.0 110.51 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.621 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -65.58 11.21 0.4 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.857 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 128' ' ' THR . 0.4 OUTLIER -74.99 4.34 6.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.52 0.328 . . . . 0.0 110.191 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.585 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -45.32 -41.93 17.29 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.29 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 7.3 Cg_exo -72.36 -31.08 11.94 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.39 2.06 . . . . 0.0 109.936 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 217' ' ' CYS . 5.9 t -66.85 -44.31 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.41 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 131' ' ' ALA . 10.5 m -70.59 -30.4 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.893 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.37 -51.31 63.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.3 tpt -64.19 -45.45 88.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.169 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 133' ' ' VAL . 42.6 t -61.82 -30.52 48.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.227 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -38.0 87.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.336 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -42.18 98.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.395 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.623 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 4.7 tpp -68.66 -34.77 76.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.503 0.668 . . . . 0.0 110.732 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.513 ' HG2' HD22 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -77.77 -30.74 51.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.519 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -70.47 -44.5 67.63 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.653 ' CE2' ' CB ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -79.04 -21.14 47.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.432 0.634 . . . . 0.0 109.828 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.487 ' O ' ' O ' ' A' ' 145' ' ' ALA . 1.1 p 54.17 26.64 6.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.917 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.653 ' CB ' ' CE2' ' A' ' 143' ' ' TRP . . . -37.27 161.11 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.775 0.322 . . . . 0.0 110.586 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 145' ' ' ALA . 57.7 Cg_endo -72.44 5.36 2.83 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 122.662 2.241 . . . . 0.0 112.9 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.528 ' CB ' ' HA ' ' A' ' 118' ' ' MET . 19.0 p-10 -86.2 136.8 33.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 111.85 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 0.9 OUTLIER -73.62 113.69 11.03 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.753 0.787 . . . . 0.0 111.012 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 53.8 m -107.96 115.09 29.5 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.539 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.669 ' CD ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -103.4 140.91 36.83 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.266 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.502 ' C ' ' CD1' ' A' ' 151' ' ' ILE . 0.1 OUTLIER -134.54 133.96 54.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.162 0.506 . . . . 0.0 110.816 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.544 ' HB2' ' HA ' ' A' ' 124' ' ' VAL . 19.1 m-30 -114.05 110.66 20.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.497 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 154' ' ' GLY . 1.0 OUTLIER -116.45 133.42 56.04 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 122.091 -0.38 . . . . 0.0 111.064 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.617 ' CA ' ' HB2' ' A' ' 182' ' ' CYS . . . -158.73 158.79 29.68 Favored Glycine 0 CA--C 1.502 -0.748 0 C-N-CA 119.366 -1.397 . . . . 0.0 113.649 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.57 ' CG1' ' HA2' ' A' ' 127' ' ' GLY . 2.5 m -168.76 -108.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.603 ' CB ' ' N ' ' A' ' 188' ' ' GLY . 0.4 OUTLIER -122.19 -169.71 1.94 Allowed 'General case' 0 C--N 1.344 0.331 0 CA-C-O 120.773 0.32 . . . . 0.0 111.517 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.56 ' O ' ' CB ' ' A' ' 158' ' ' GLU . 76.9 p -29.51 -63.38 0.12 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.488 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.56 ' CB ' ' O ' ' A' ' 157' ' ' THR . 4.4 mm-40 153.32 -53.54 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.194 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 79.0 Cg_exo -37.65 -27.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.955 2.437 . . . . 0.0 112.732 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -86.41 -30.56 22.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.897 0.379 . . . . 0.0 110.976 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -108.86 -174.66 2.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.268 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.53 ' O ' ' CB ' ' A' ' 163' ' ' TYR . 0.3 OUTLIER -171.05 -167.12 0.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.302 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.53 ' CB ' ' O ' ' A' ' 162' ' ' PHE . 0.2 OUTLIER 85.57 13.17 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.823 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.463 ' CG2' ' N ' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -65.45 -49.59 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.293 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.463 ' N ' ' CG2' ' A' ' 164' ' ' ILE . 0.7 OUTLIER -69.27 -33.37 73.12 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.271 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.438 ' CD ' ' CE1' ' A' ' 163' ' ' TYR . 1.6 mt-10 -72.42 -36.14 68.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.467 ' HA ' ' HB2' ' A' ' 170' ' ' LEU . 0.0 OUTLIER -60.89 -32.07 71.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.05 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 171' ' ' GLU . 4.5 mtpt -63.14 -49.04 75.92 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 6.8 m -61.83 -31.54 71.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.513 HD22 ' HG2' ' A' ' 141' ' ' GLN . 0.8 OUTLIER -62.86 -34.6 77.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.544 ' HA ' ' CD1' ' A' ' 177' ' ' LEU . 40.6 mt-10 -63.86 -42.08 97.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.28 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 -78.21 -33.62 49.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.603 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 144' ' ' THR . 0.3 OUTLIER -50.27 -46.29 55.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.639 -179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.53 ' HB2' ' CD2' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -77.15 -163.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.176 0.512 . . . . 0.0 111.602 -179.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER -105.08 -62.38 1.35 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.351 -179.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.462 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.0 OUTLIER -130.28 64.02 1.54 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.795 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' A' ' 149' ' ' THR . 0.7 OUTLIER -105.1 154.25 20.41 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.032 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.502 ' N ' HD11 ' A' ' 177' ' ' LEU . 9.1 m -136.72 117.37 13.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.578 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.448 HG11 ' OE2' ' A' ' 171' ' ' GLU . 7.6 p -95.43 135.33 29.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.671 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 1.9 tppt? -97.95 135.95 38.94 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.852 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 194' ' ' GLN . . . -102.11 105.34 16.04 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 121.517 0.675 . . . . 0.0 111.751 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.617 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 34.7 m -87.35 -159.15 0.49 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.645 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.575 ' N ' ' O ' ' A' ' 193' ' ' GLU . 28.4 t 55.93 148.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.64 0.733 . . . . 0.0 111.77 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.723 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -136.37 -62.55 0.66 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.197 -178.024 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.578 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 3.7 t60 -166.86 51.43 0.22 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.724 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.621 ' O ' ' CB ' ' A' ' 187' ' ' SER . 98.5 Cg_endo -88.97 -98.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.044 2.496 . . . . 0.0 112.704 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.621 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 13.6 t 143.11 2.28 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.603 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 123.73 12.29 4.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.453 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.27 62.72 1.58 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 249' ' ' GLY . 8.3 t-105 -130.83 120.6 23.93 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.249 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 250' ' ' ALA . 0.0 OUTLIER -98.96 104.45 16.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.341 178.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.577 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 145.18 -117.75 1.04 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.506 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 183' ' ' VAL . 18.7 mt-10 -165.04 -98.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -87.41 126.85 35.13 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . 2.46 108.92 0.0 OUTLIER Glycine 0 C--N 1.339 0.7 0 O-C-N 124.061 0.851 . . . . 0.0 113.726 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 5.9 m 96.83 156.21 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.286 0 CA-C-O 121.06 0.457 . . . . 0.0 111.086 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 196' ' ' SER . 58.0 Cg_exo -35.75 -69.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.349 2.699 . . . . 0.0 113.638 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.662 ' CG2' ' O ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER 173.36 35.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 122.093 0.949 . . . . 0.0 110.636 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.486 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 0.9 OUTLIER -57.61 -37.19 72.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.859 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.81 -32.81 70.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.316 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.55 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -69.54 -32.13 70.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 110.489 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.486 ' HG3' ' HA ' ' A' ' 199' ' ' ASP . 2.8 mtt180 -59.86 -52.25 66.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.533 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.11 -40.93 86.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.566 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.456 ' HA ' ' HB2' ' A' ' 207' ' ' SER . 11.3 m-20 -60.18 -28.49 67.99 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 230' ' ' VAL . 0.1 OUTLIER -61.79 -47.99 82.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.25 178.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -14.38 59.69 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.016 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.456 ' HB2' ' HA ' ' A' ' 204' ' ' ASP . 3.8 m -91.98 -76.59 0.45 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.803 0.335 . . . . 0.0 111.497 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.548 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 17.3 p 168.97 102.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.677 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.595 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 5.0 m-20 153.32 86.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.696 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 101.6 109.79 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.527 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.4 t-20 -175.26 -58.51 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.437 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 11.7 Cg_endo -57.23 -83.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.043 1.829 . . . . 0.0 110.676 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.536 ' HA ' ' CG2' ' A' ' 240' ' ' VAL . 0.0 OUTLIER -114.38 111.59 21.7 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.552 ' CD1' ' HA ' ' A' ' 210' ' ' ALA . 0.8 OUTLIER -109.5 126.48 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.689 ' CE1' ' CD2' ' A' ' 241' ' ' PHE . 2.7 m-85 -116.72 134.2 55.1 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.77 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.539 ' CD2' ' HB ' ' A' ' 124' ' ' VAL . 1.5 mt -134.45 115.58 14.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.791 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . 0.528 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 42.3 t -123.48 107.54 11.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.851 0.357 . . . . 0.0 110.476 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.613 ' CA ' ' CD2' ' A' ' 245' ' ' PHE . . . 114.14 -36.92 3.77 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.769 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 218' ' ' GLY . 45.0 Cg_endo -92.82 79.99 0.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.812 2.341 . . . . 0.0 113.956 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.57 ' CD ' ' O ' ' A' ' 218' ' ' GLY . 9.2 Cg_endo -51.59 -66.8 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.452 2.101 . . . . 0.0 111.074 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.459 ' N ' ' HB3' ' A' ' 250' ' ' ALA . . . -54.09 -48.77 61.91 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.012 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.546 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -55.22 -24.73 28.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 243' ' ' GLU . 0.1 OUTLIER -74.56 -37.07 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.111 177.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 221' ' ' GLY . 7.2 m-20 -71.85 -46.43 58.0 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.813 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.528 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -67.59 -33.14 74.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.503 ' O ' ' HG ' ' A' ' 229' ' ' LEU . . . -60.13 -39.43 86.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.361 0.6 . . . . 0.0 110.055 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.451 ' HB2' ' OE1' ' A' ' 239' ' ' GLN . 31.5 t -70.49 -31.8 69.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.784 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -44.02 92.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.638 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' A' ' 225' ' ' ALA . 0.0 OUTLIER -59.74 -37.59 79.38 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.077 0.465 . . . . 0.0 110.636 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 238' ' ' GLU . 3.0 t -62.46 -46.45 96.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.424 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -74.56 -30.28 61.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.783 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 51.5 m -74.11 -42.05 60.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.303 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.481 ' HD2' ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER -85.11 -74.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.236 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 158.75 -56.58 0.35 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.07 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 238' ' ' GLU . 2.2 pp -39.36 98.69 0.18 Allowed Pre-proline 0 N--CA 1.453 -0.288 0 CA-C-O 121.255 0.55 . . . . 0.0 111.221 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.505 ' O ' ' ND2' ' A' ' 211' ' ' ASN . 57.7 Cg_endo -70.33 164.43 35.12 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 123.404 2.736 . . . . 0.0 112.646 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 211' ' ' ASN . . . 76.3 9.42 85.75 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.642 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.565 ' HB2' ' CD1' ' A' ' 235' ' ' ILE . 8.7 tp10 -71.53 1.02 7.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.68 0.276 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.535 ' O ' ' O ' ' A' ' 214' ' ' ILE . 39.3 mt-30 -101.95 -76.98 0.56 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.369 0.604 . . . . 0.0 109.874 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.586 HG12 ' CG ' ' A' ' 241' ' ' PHE . 4.0 t 65.06 -83.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.46 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.689 ' CD2' ' CE1' ' A' ' 215' ' ' TYR . 9.5 m-85 -115.64 127.82 55.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.894 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.425 ' CB ' HD12 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -132.57 132.84 42.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.438 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . 0.513 ' N ' HD12 ' A' ' 223' ' ' ILE . 11.0 tp10 -132.56 149.04 52.38 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.281 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 220' ' ' PRO . 0.9 OUTLIER -127.74 106.23 8.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.621 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -138.58 146.11 41.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.342 179.134 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.568 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 5.7 mt 64.71 167.63 0.11 Allowed Pre-proline 0 N--CA 1.471 0.588 0 O-C-N 121.886 -0.509 . . . . 0.0 111.925 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . 0.552 ' CD ' HD22 ' A' ' 246' ' ' LEU . 38.6 Cg_endo -88.6 -107.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.764 2.976 . . . . 0.0 112.422 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 247' ' ' PRO . 30.7 m -36.4 136.49 0.33 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 110.959 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 190' ' ' TRP . . . 125.84 -15.87 6.97 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.548 ' O ' ' CB ' ' A' ' 191' ' ' GLU . . . -106.38 119.36 39.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.81 -0.695 . . . . 0.0 111.364 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.577 ' N ' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 CA-C-O 121.077 0.265 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -118.91 152.82 35.62 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.818 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -132.45 165.19 24.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.93 0.395 . . . . 0.0 110.947 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.582 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -104.84 123.99 48.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.635 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.546 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . . . -121.44 154.2 36.87 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.52 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -118.99 116.56 26.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 98' ' ' VAL . 17.3 m -71.16 125.66 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.454 . . . . 0.0 111.194 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.531 ' HA ' ' CG1' ' A' ' 98' ' ' VAL . 8.7 p -144.56 16.31 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.367 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -140.97 -135.38 3.17 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.691 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER 92.17 70.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.196 0.522 . . . . 0.0 110.494 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -111.8 147.88 34.75 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.677 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -89.31 114.37 25.75 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 m -89.37 -29.19 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.523 0.677 . . . . 0.0 109.718 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.511 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 20.9 m -137.11 177.18 8.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.435 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.45 ' OG ' ' OD1' ' A' ' 25' ' ' ASN . 2.9 t -51.88 -58.37 6.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.894 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 2.5 m-20 -117.55 44.85 2.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.441 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.524 HG23 ' NE ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -146.06 137.29 24.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.602 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.588 ' CG2' ' CD2' ' A' ' 19' ' ' LEU . 1.5 p -140.34 143.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.595 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.499 ' N ' HG23 ' A' ' 27' ' ' VAL . 8.4 tt0 -115.42 103.14 10.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.213 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.603 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.6 OUTLIER -91.4 121.24 32.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.676 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -102.37 116.02 31.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.375 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 mt -111.9 133.78 53.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.466 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 46.8 mt-30 -142.79 129.49 20.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.589 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -152.38 -97.48 0.05 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.163 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.455 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 2.8 mmp_? . . . . . 0 C--N 1.329 -0.31 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 120.807 0.337 . . . . 0.0 111.279 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.678 ' N ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -166.69 22.57 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.006 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.522 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -103.94 -169.38 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.265 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.51 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 20.5 mm-40 -107.55 130.28 23.05 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.905 0.383 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.488 ' HB2' ' HB2' ' A' ' 136' ' ' MET . 99.8 Cg_exo -41.75 -23.01 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.618 2.212 . . . . 0.0 112.219 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . -51.83 -34.35 37.12 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.961 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.492 ' NE2' ' O ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -68.44 158.91 32.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.904 0.383 . . . . 0.0 110.909 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.592 ' CE2' ' O ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -125.79 164.06 21.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.445 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.537 ' CA ' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -114.84 143.33 45.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.978 0.418 . . . . 0.0 111.902 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.528 ' HA ' ' CB ' ' A' ' 63' ' ' SER . 14.1 t70 -98.95 107.8 20.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.563 HD13 ' CG2' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -148.96 157.08 43.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.361 -178.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.535 ' HA ' ' CB ' ' A' ' 61' ' ' SER . 0.2 OUTLIER -93.42 151.52 19.69 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.68 ' CG2' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -32.72 -66.06 0.21 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.519 -178.445 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.68 ' HD3' ' CG2' ' A' ' 55' ' ' ILE . 7.5 Cg_endo -106.32 4.19 0.2 Allowed 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 123.424 2.75 . . . . 0.0 111.486 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 106.95 -3.02 35.61 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.261 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.558 HG22 ' CD ' ' A' ' 56' ' ' PRO . 31.4 p -24.52 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.178 0.513 . . . . 0.0 111.744 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.509 ' N ' ' OG1' ' A' ' 58' ' ' THR . 19.8 p-10 -178.06 -28.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.77 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 60' ' ' VAL . 6.2 p -147.58 109.28 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.682 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.535 ' CB ' ' HA ' ' A' ' 54' ' ' THR . 0.3 OUTLIER -143.15 -76.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.793 179.288 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER 170.49 155.22 0.06 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.47 . . . . 0.0 111.901 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.528 ' CB ' ' HA ' ' A' ' 52' ' ' ASP . 46.6 p -89.54 131.82 35.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.382 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.547 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -120.78 119.62 33.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.404 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.53 ' CA ' ' HB3' ' A' ' 50' ' ' PHE . 60.7 p -60.41 102.68 0.32 Allowed Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 64' ' ' TYR . 92.6 Cg_endo -102.9 -178.42 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.276 2.651 . . . . 0.0 113.563 -178.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 76' ' ' LEU . . . -87.21 167.37 14.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.649 ' HB3' ' HA ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER 89.63 117.55 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -177.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.678 ' O ' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -167.47 -65.59 0.01 OUTLIER Pre-proline 0 C--O 1.215 -0.734 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.543 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 69' ' ' LEU . 66.4 Cg_endo -99.07 75.26 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.379 2.053 . . . . 0.0 113.244 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.485 ' O ' HG22 ' A' ' 43' ' ' VAL . 0.5 OUTLIER 178.9 125.33 0.21 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.718 0.294 . . . . 0.0 110.48 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.26 56.98 0.23 Allowed 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.313 2.009 . . . . 0.0 111.675 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HG3' ' OD1' ' A' ' 71' ' ' ASN . 2.4 mt-10 -135.93 -81.44 0.4 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.017 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.77 15.25 2.66 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.854 -1.165 . . . . 0.0 114.255 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -61.96 85.25 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.284 0.542 . . . . 0.0 110.257 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.649 ' HA ' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -96.18 128.76 43.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.599 0.714 . . . . 0.0 111.197 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.427 ' HG3' ' HB3' ' A' ' 67' ' ' ALA . 7.7 mt-10 -132.72 141.4 48.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.625 -1.171 . . . . 0.0 111.251 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.603 ' CE2' ' HB3' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -133.4 133.09 41.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.222 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.547 ' N ' ' OH ' ' A' ' 64' ' ' TYR . 9.1 mt -106.78 85.6 2.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.189 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.601 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -90.48 116.57 32.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.945 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.524 ' NE ' HG23 ' A' ' 26' ' ' THR . 0.1 OUTLIER -78.12 96.07 5.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.408 0.623 . . . . 0.0 110.19 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.523 ' CG2' ' HB3' ' A' ' 89' ' ' SER . 2.5 m -89.07 141.47 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.84 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 85' ' ' GLU . 3.9 pp -74.46 169.73 18.25 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.845 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.465 ' CD ' ' HB2' ' A' ' 83' ' ' LEU . 34.5 Cg_exo -61.22 63.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.804 2.336 . . . . 0.0 112.192 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER 51.15 107.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.55 -35.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.573 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.429 ' HB2' HD23 ' A' ' 83' ' ' LEU . 2.1 mpt_? -133.26 -81.58 0.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.752 0.311 . . . . 0.0 111.175 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -74.03 -45.17 51.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.203 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.523 ' HB3' ' CG2' ' A' ' 82' ' ' VAL . 3.3 p -67.94 -23.33 65.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.513 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -75.66 -46.07 33.5 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.486 0.66 . . . . 0.0 109.493 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.441 ' C ' HD11 ' A' ' 55' ' ' ILE . 7.8 t80 -73.35 -23.28 60.2 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.52 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.548 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -65.75 -49.37 68.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.275 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.89 -19.0 21.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.662 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 1.5 m-20 -94.38 -2.37 52.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.399 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.69 30.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.651 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.548 ' CB ' ' HA ' ' A' ' 92' ' ' LEU . . . -151.03 25.95 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -170.02 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.87 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 17' ' ' VAL . 1.5 t -97.9 -137.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.551 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 98' ' ' VAL . . . 31.7 53.92 0.35 Allowed Glycine 0 CA--C 1.516 0.128 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.021 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.445 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -159.68 -170.96 3.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 111.197 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 14' ' ' ALA . 2.3 t -129.04 143.61 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.882 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.559 ' CD1' HD13 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -128.81 153.75 47.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.016 0.436 . . . . 0.0 111.541 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.457 ' O ' HD12 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -99.14 119.17 37.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.587 178.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.563 ' CG2' HD13 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -113.89 143.0 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.18 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.537 ' O ' ' CA ' ' A' ' 51' ' ' MET . 5.1 mtpt -128.7 168.25 16.07 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.502 ' N ' ' HD3' ' A' ' 107' ' ' PRO . . . -153.38 49.66 0.51 Allowed Glycine 0 C--N 1.313 -0.708 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.628 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 106' ' ' GLY . 91.5 Cg_endo -86.17 27.4 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.722 2.281 . . . . 0.0 111.403 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -88.27 172.96 9.05 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 122.108 0.956 . . . . 0.0 113.01 -178.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.592 ' O ' ' CE2' ' A' ' 50' ' ' PHE . . . -110.27 174.04 17.07 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.574 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.45 107.56 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 117.911 0.856 . . . . 0.0 110.801 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 4.3 m-85 -123.11 114.84 20.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.525 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . 136.63 -82.88 0.27 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.633 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.589 ' HB3' ' CE2' ' A' ' 123' ' ' PHE . 0.4 OUTLIER -95.53 117.97 31.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.19 0.519 . . . . 0.0 111.206 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -138.49 113.09 8.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.033 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.458 ' OE1' ' CE2' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -106.52 140.54 39.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.12 12.0 30.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.115 0.483 . . . . 0.0 110.946 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 129.18 -90.77 0.31 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.919 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.456 ' HA ' ' OD1' ' A' ' 147' ' ' ASN . 19.6 ptt? -130.52 90.98 3.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.77 0.319 . . . . 0.0 110.835 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.518 ' HB1' ' CZ ' ' A' ' 121' ' ' ARG . . . -149.29 147.29 23.03 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.984 0.421 . . . . 0.0 111.285 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 36.4 Cg_endo -65.38 110.2 1.54 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.842 2.361 . . . . 0.0 112.071 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.546 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -136.71 146.77 46.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.884 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.627 ' CE2' ' CD ' ' A' ' 150' ' ' ARG . 0.6 OUTLIER -115.08 122.2 45.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.58 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.636 ' CE2' ' CG1' ' A' ' 133' ' ' VAL . 1.0 OUTLIER -106.44 108.08 19.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.144 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.588 ' CB ' ' HB2' ' A' ' 152' ' ' TYR . 10.0 p -98.41 111.63 28.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.571 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -101.28 132.69 46.68 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.419 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.99 103.07 1.2 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.542 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.592 ' HA2' ' CG1' ' A' ' 155' ' ' VAL . . . 115.99 -154.88 16.6 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.134 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.535 HG23 ' CB ' ' A' ' 79' ' ' LEU . 14.5 m -105.66 -9.59 17.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.205 0.526 . . . . 0.0 110.54 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.581 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -64.66 10.01 0.36 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.537 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -81.22 5.55 16.68 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.82 0.31 . . . . 0.0 110.632 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.529 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -47.03 -46.71 54.62 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.306 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 90.0 Cg_endo -79.72 -29.92 2.61 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.653 2.235 . . . . 0.0 111.053 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.636 ' CG1' ' CE2' ' A' ' 123' ' ' PHE . 20.9 t -63.11 -52.4 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.566 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.407 HG13 ' HG ' ' A' ' 130' ' ' LEU . 2.0 m -61.78 -36.56 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.659 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 139' ' ' GLN . 18.6 m -62.08 -50.35 72.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.333 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.514 ' CB ' HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -62.56 -36.17 81.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.469 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 133' ' ' VAL . 17.7 t -66.97 -53.45 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.302 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.489 ' CG ' HD22 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -63.63 -31.83 73.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.708 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -67.47 -37.34 82.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.026 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.469 ' O ' ' N ' ' A' ' 145' ' ' ALA . 3.0 ptm -63.43 -43.38 97.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.525 ' HG2' ' CG ' ' A' ' 174' ' ' MET . 2.0 mt-30 -73.06 -34.86 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.4 ' OE1' ' O ' ' A' ' 138' ' ' ARG . 1.5 mp0 -79.62 -12.84 59.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.913 0.387 . . . . 0.0 110.672 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.478 ' HB2' ' O ' ' A' ' 139' ' ' GLN . 2.8 m95 -92.23 -85.33 0.25 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.443 0.64 . . . . 0.0 111.264 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 144' ' ' THR . 0.2 OUTLIER -154.81 20.34 0.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.242 -178.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.555 ' N ' ' CD ' ' A' ' 146' ' ' PRO . . . -125.3 44.87 1.21 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.343 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 145' ' ' ALA . 73.1 Cg_endo -76.16 5.75 4.35 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.606 2.204 . . . . 0.0 112.005 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.482 ' C ' ' ND2' ' A' ' 176' ' ' ASN . 8.4 p-10 -58.46 -159.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.149 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 40.9 mt-10 -74.55 104.63 5.32 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.408 0.623 . . . . 0.0 111.273 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 2.8 m -119.06 117.92 30.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.095 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.627 ' CD ' ' CE2' ' A' ' 122' ' ' TYR . 1.8 mmt180 -101.52 146.15 28.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.992 0.425 . . . . 0.0 110.369 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.445 HD13 HG22 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -133.47 134.11 57.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.811 -178.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.588 ' HB2' ' CB ' ' A' ' 124' ' ' VAL . 18.2 m-30 -112.91 110.47 20.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.238 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 182' ' ' CYS . 3.4 t80 -112.99 126.72 55.81 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.484 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.67 ' HA2' ' HB2' ' A' ' 182' ' ' CYS . . . -155.58 151.89 23.41 Favored Glycine 0 CA--C 1.499 -0.939 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.105 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.592 ' CG1' ' HA2' ' A' ' 127' ' ' GLY . 3.8 m -164.64 -111.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.6 ' CB ' ' N ' ' A' ' 188' ' ' GLY . 19.9 p30 -105.85 -168.05 1.39 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.369 0.604 . . . . 0.0 112.182 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.586 ' O ' ' CB ' ' A' ' 158' ' ' GLU . 34.1 p -33.96 -32.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.83 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.586 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.9 tt0 105.46 -52.09 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.974 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.491 ' HD2' ' OG1' ' A' ' 157' ' ' THR . 86.3 Cg_exo -48.26 -21.57 3.14 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 121.994 1.796 . . . . 0.0 112.003 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -87.29 -30.75 20.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.491 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.539 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -89.23 -160.51 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.396 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 38.0 p90 177.14 -176.59 0.15 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.0 0.429 . . . . 0.0 111.501 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.46 ' O ' ' HB2' ' A' ' 167' ' ' LEU . 0.2 OUTLIER 79.84 2.46 2.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.336 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -71.28 -45.42 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.817 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.579 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 6.8 m-20 -67.16 -35.02 78.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.24 0.543 . . . . 0.0 110.172 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -72.28 -37.03 69.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -61.05 -32.15 71.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.015 179.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.473 ' HG3' ' HA ' ' A' ' 165' ' ' ASP . 8.1 mttt -65.9 -39.3 90.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 m -62.88 -32.0 73.16 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.315 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.489 HD22 ' CG ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -63.8 -36.89 85.38 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 177' ' ' LEU . 2.3 mm-40 -67.53 -37.66 83.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.224 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -78.76 -32.27 46.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.235 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.434 ' OG ' ' HA ' ' A' ' 170' ' ' LEU . 58.4 p -75.01 -16.17 60.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.006 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.525 ' CG ' ' HG2' ' A' ' 141' ' ' GLN . 0.7 OUTLIER -94.95 -168.93 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.178 0.513 . . . . 0.0 111.643 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.493 ' CB ' ' O ' ' A' ' 146' ' ' PRO . 0.7 OUTLIER -81.76 -63.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.331 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.49 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.0 OUTLIER -141.9 70.11 1.33 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.943 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 149' ' ' THR . 7.3 mp -98.68 151.75 20.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.827 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.466 ' CB ' ' HD3' ' A' ' 150' ' ' ARG . 4.8 m -136.83 115.01 11.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.822 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.411 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 7.7 p -92.85 134.97 29.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.505 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.475 ' HB3' ' HA ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -99.1 136.44 39.06 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.588 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -96.55 105.44 17.54 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.851 0.834 . . . . 0.0 111.04 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.67 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 92.3 m -95.1 -167.96 1.72 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.16 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 156' ' ' ASN . 6.2 t 56.07 148.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.785 0.802 . . . . 0.0 111.186 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.75 -49.78 0.53 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.409 -1.268 . . . . 0.0 108.238 -177.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.584 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 12.1 t-80 178.55 57.04 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.498 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 187' ' ' SER . 33.5 Cg_endo -94.02 -93.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.538 2.825 . . . . 0.0 112.886 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 27.4 t 137.22 20.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.6 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 96.79 11.05 54.55 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.585 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.434 ' C ' ' HA ' ' A' ' 251' ' ' ALA . 0.4 OUTLIER -136.96 63.31 1.57 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.553 ' O ' ' O ' ' A' ' 249' ' ' GLY . 4.9 t-105 -125.44 123.19 38.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.448 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.565 ' N ' ' CB ' ' A' ' 251' ' ' ALA . 2.5 mt-10 -84.33 105.36 15.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.51 ' C ' ' CG ' ' A' ' 193' ' ' GLU . . . 131.42 -111.15 1.05 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.092 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.548 ' CB ' ' SG ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -167.51 -71.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.585 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -102.33 150.67 23.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.176 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.645 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -37.46 107.29 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.74 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.623 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 48.0 m 127.66 143.77 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 123.658 0.783 . . . . 0.0 110.169 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 199' ' ' ASP . 27.5 Cg_endo -62.32 56.83 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.797 2.331 . . . . 0.0 112.752 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.588 ' CD1' ' CB ' ' A' ' 201' ' ' LEU . 0.5 OUTLIER 37.17 26.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.574 0.702 . . . . 0.0 111.961 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.542 ' HA ' ' CD ' ' A' ' 202' ' ' ARG . 5.1 m-20 -57.67 -34.77 69.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.126 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.83 89.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.543 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.588 ' CB ' ' CD1' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -69.21 -30.86 69.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.172 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.577 ' O ' ' HG ' ' A' ' 205' ' ' LEU . 11.0 mtp-105 -58.46 -48.57 80.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.513 0.673 . . . . 0.0 110.645 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.525 ' HA ' ' NH1' ' A' ' 233' ' ' ARG . 2.1 mt-10 -71.41 -33.66 69.65 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.318 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -59.87 -39.07 84.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.609 -0.436 . . . . 0.0 109.937 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -61.18 -49.61 76.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -64.53 -21.63 66.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.816 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.8 -85.27 0.2 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.751 0.31 . . . . 0.0 111.202 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 2.2 p 174.03 99.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.719 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 7.9 m-20 154.18 42.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.15 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 150.05 104.35 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.539 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.568 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 14.5 t-20 177.87 -57.32 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.06 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 8.4 Cg_endo -51.75 -55.79 3.59 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.17 1.913 . . . . 0.0 110.984 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -133.32 109.37 9.33 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.524 ' HB ' ' CG2' ' A' ' 240' ' ' VAL . 1.0 OUTLIER -116.45 125.82 73.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.568 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.4 m-85 -117.52 126.47 52.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.484 0.659 . . . . 0.0 110.533 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.54 ' CD2' ' CG1' ' A' ' 124' ' ' VAL . 0.7 OUTLIER -125.66 117.22 23.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.163 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . 0.509 ' SG ' ' CG2' ' A' ' 133' ' ' VAL . 48.8 t -124.53 107.8 11.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.978 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.579 ' HA2' ' CD2' ' A' ' 245' ' ' PHE . . . 168.57 -175.81 43.06 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.005 -1.093 . . . . 0.0 113.187 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.53 ' HB2' ' CB ' ' A' ' 250' ' ' ALA . 5.4 Cg_exo -38.18 168.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.773 2.982 . . . . 0.0 112.904 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 73.3 Cg_endo -75.52 -28.12 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.888 2.392 . . . . 0.0 111.84 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 224' ' ' ASP . . . -81.75 -46.55 6.71 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.23 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.439 ' HE3' ' CD2' ' A' ' 216' ' ' LEU . 1.3 tmt? -57.07 -35.49 69.43 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.533 ' CD1' ' HB3' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -76.97 -34.53 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.985 178.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.471 ' HB2' ' HA2' ' A' ' 221' ' ' GLY . 0.2 OUTLIER -67.59 -46.81 71.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.161 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -61.42 -47.05 87.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.808 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.486 ' O ' ' HG ' ' A' ' 229' ' ' LEU . . . -68.28 -31.21 70.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.675 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.435 ' HA ' HG21 ' A' ' 230' ' ' VAL . 49.6 t -70.32 -31.8 69.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.165 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.84 -44.37 85.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.867 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.557 ' CD1' ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -60.49 -39.88 89.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.793 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.528 ' CG1' ' HG3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -66.05 -41.6 89.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 -179.219 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -72.9 -30.0 63.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.151 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.42 -29.83 19.92 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.558 ' CD ' ' O ' ' A' ' 202' ' ' ARG . 1.4 mmp_? -72.91 -66.83 0.62 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.874 0.368 . . . . 0.0 111.415 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.491 ' C ' ' HD2' ' A' ' 236' ' ' PRO . . . 122.09 9.67 6.62 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.795 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.665 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 1.0 OUTLIER -83.3 -19.18 0.26 Allowed Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 235' ' ' ILE . 66.1 Cg_exo -39.99 117.23 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.68 1.587 . . . . 0.0 112.382 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -96.49 -116.79 3.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.753 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -129.53 -32.8 1.92 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.585 0.231 . . . . 0.0 111.401 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.577 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 9.7 mm-40 -99.87 30.74 3.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.008 0.433 . . . . 0.0 111.147 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.524 ' CG2' ' HB ' ' A' ' 214' ' ' ILE . 1.7 t -94.52 131.87 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.041 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.645 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.66 151.4 37.19 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.65 151.27 51.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.097 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . 0.527 ' O ' ' CD1' ' A' ' 223' ' ' ILE . 8.8 tm-20 -132.47 149.4 52.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.269 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -117.85 107.35 14.01 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 111.674 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.581 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -136.48 148.14 47.53 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.147 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.514 HD21 ' N ' ' A' ' 247' ' ' PRO . 3.0 tt -15.72 139.99 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . 0.57 ' O ' ' CB ' ' A' ' 248' ' ' SER . 77.7 Cg_exo -50.8 -149.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.885 3.057 . . . . 0.0 113.565 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 247' ' ' PRO . 7.4 m 97.01 -19.43 0.05 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.907 0.86 . . . . 0.0 109.871 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 190' ' ' TRP . . . -122.15 -18.5 3.44 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.085 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.53 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . . . -109.08 151.67 26.09 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.606 0.762 . . . . 0.0 110.339 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.565 ' CB ' ' N ' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.07 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 CA-C-O 121.084 0.269 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -111.47 158.49 19.07 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.922 0.391 . . . . 0.0 111.055 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 34' ' ' ARG . 1.9 t80 -128.55 165.24 21.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.957 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.446 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -110.46 129.63 55.73 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.084 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -137.8 154.62 49.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.864 0.364 . . . . 0.0 111.153 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -103.52 121.38 42.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.455 HG12 ' HA2' ' A' ' 99' ' ' GLY . 24.3 t -72.1 136.03 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 10.5 p -162.2 24.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.264 0.554 . . . . 0.0 109.711 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.596 ' O ' ' CE1' ' A' ' 29' ' ' PHE . . . -153.05 122.2 1.26 Allowed Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.85 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.607 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -170.85 90.44 0.14 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.665 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -140.39 144.04 36.0 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.7 178.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . 10.1 m0 -89.94 112.6 24.03 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.579 -0.849 . . . . 0.0 108.87 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 26' ' ' THR . 0.7 OUTLIER -71.41 -19.02 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.639 0.733 . . . . 0.0 109.122 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.497 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 37.9 m -153.17 -175.24 5.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.074 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.3 m -52.2 -57.86 8.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.113 0.483 . . . . 0.0 110.917 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -118.79 47.26 1.68 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.14 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -143.28 128.59 18.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.754 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.529 HG13 ' CD1' ' A' ' 92' ' ' LEU . 2.5 p -131.0 133.83 62.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.301 0.572 . . . . 0.0 112.476 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -100.62 131.36 46.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.792 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.667 ' CD2' ' CZ ' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -126.02 128.42 47.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.917 -178.326 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.602 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -121.35 115.77 23.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.213 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.597 ' CD1' ' CD2' ' A' ' 102' ' ' LEU . 2.8 mt -115.28 148.73 38.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.455 . . . . 0.0 111.753 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -124.01 108.32 12.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.523 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -105.35 -165.43 1.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.048 -179.091 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.832 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.548 HG21 ' N ' ' A' ' 69' ' ' LEU . 21.9 m . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 121.258 0.551 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -155.77 23.12 0.39 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.803 -178.015 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.643 ' O ' ' CG ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER 99.07 92.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.583 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -115.2 125.4 28.94 Favored Pre-proline 0 N--CA 1.453 -0.317 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.937 178.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.447 ' C ' ' O ' ' A' ' 46' ' ' GLU . 53.5 Cg_exo -28.13 84.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.055 2.503 . . . . 0.0 112.739 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.635 ' N ' ' CD2' ' A' ' 111' ' ' PHE . . . 40.56 75.97 0.1 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.612 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.428 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 1.6 tm0? -69.74 109.7 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 111.021 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.639 ' CD1' ' CB ' ' A' ' 65' ' ' SER . 1.5 m-30 -109.97 164.15 12.88 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.549 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 106' ' ' GLY . 5.2 mmt -135.74 -171.48 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.418 0.628 . . . . 0.0 112.414 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 105' ' ' LYS . 9.3 t0 -131.79 102.5 5.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.665 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.516 ' CD1' HD13 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -134.58 157.93 45.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.451 0.643 . . . . 0.0 112.228 -177.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.567 ' HA ' ' CB ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -109.19 151.2 26.8 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.968 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.685 ' CG2' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -30.45 -69.62 0.1 Allowed Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.224 0.327 . . . . 0.0 110.897 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.685 ' HD3' ' CG2' ' A' ' 55' ' ' ILE . 59.9 Cg_endo -104.69 7.64 0.28 Allowed 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.451 2.767 . . . . 0.0 111.735 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.41 18.56 14.28 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.093 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.567 ' CG2' ' HD2' ' A' ' 56' ' ' PRO . 6.8 p -63.65 -110.51 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.128 -0.536 . . . . 0.0 111.4 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.551 ' N ' HG23 ' A' ' 54' ' ' THR . 0.3 OUTLIER 175.45 28.5 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.488 ' CG1' ' O ' ' A' ' 60' ' ' VAL . 48.3 t -140.83 31.94 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.712 0.291 . . . . 0.0 111.289 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.567 ' CB ' ' HA ' ' A' ' 54' ' ' THR . 34.0 t -103.5 -103.23 0.29 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.681 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 61' ' ' SER . 8.6 mtt180 166.99 -179.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.088 0.471 . . . . 0.0 111.569 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 2.7 t -88.76 143.01 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.591 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.641 ' CE2' ' CG2' ' A' ' 80' ' ' ILE . 1.9 t80 -141.25 130.29 23.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.639 ' CB ' ' CD1' ' A' ' 50' ' ' PHE . 22.4 p -75.9 105.63 2.34 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 64' ' ' TYR . 72.4 Cg_endo -99.45 -169.92 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.905 2.403 . . . . 0.0 113.348 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.636 ' O ' ' CB ' ' A' ' 68' ' ' ASN . . . -86.15 176.77 7.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.636 ' CB ' ' O ' ' A' ' 67' ' ' ALA . 3.2 t30 106.61 123.71 0.01 OUTLIER 'General case' 0 C--N 1.343 0.31 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.613 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -170.96 -84.32 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 122.139 -0.351 . . . . 0.0 110.615 -178.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 69' ' ' LEU . 55.3 Cg_endo -85.81 72.57 4.07 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 120.384 1.173 . . . . 0.0 112.397 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -164.51 139.09 4.4 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.586 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.513 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 60.3 Cg_endo -91.15 53.57 0.91 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.665 2.243 . . . . 0.0 116.234 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 72' ' ' PRO . 61.6 mt-10 -158.66 -106.91 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.269 0.94 . . . . 0.0 112.558 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.57 78.0 0.17 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.46 81.92 1.95 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.159 0.98 . . . . 0.0 111.332 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -97.48 132.14 43.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.51 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 1.3 tt0 -129.99 111.69 12.77 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.443 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.667 ' CZ ' ' CD2' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -104.78 137.18 42.96 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.226 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.523 ' N ' ' OH ' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -122.53 75.41 1.25 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.918 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.641 ' CG2' ' CE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -92.61 130.4 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.121 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.518 ' NH1' ' CD2' ' A' ' 246' ' ' LEU . 0.3 OUTLIER -78.11 102.7 7.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.178 -178.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.579 ' CG2' ' CB ' ' A' ' 89' ' ' SER . 3.5 m -102.02 138.22 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.313 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 89' ' ' SER . 5.4 mt -68.99 129.01 92.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.738 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.23 110.14 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.666 2.244 . . . . 0.0 111.938 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.525 ' N ' ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER 47.25 43.73 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.422 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.54 -68.88 0.58 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.956 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -137.24 -68.2 0.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.268 . . . . 0.0 111.663 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -76.98 -33.57 57.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.714 0.292 . . . . 0.0 111.515 -179.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.579 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 0.5 OUTLIER -78.84 -20.74 48.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.404 -179.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.414 ' O ' ' CG ' ' A' ' 94' ' ' ASN . 0.7 OUTLIER -75.68 -46.66 30.03 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.692 0.758 . . . . 0.0 109.069 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.539 ' O ' ' CD1' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -74.62 -24.52 58.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.498 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.535 ' CD2' HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.78 -49.4 73.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.001 -179.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -89.05 -16.95 30.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.447 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.414 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 73.8 m-20 -95.04 -9.32 34.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.286 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.435 ' OD2' ' HG3' ' A' ' 56' ' ' PRO . 0.3 OUTLIER -135.13 2.99 3.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.383 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 92' ' ' LEU . . . -139.16 28.91 2.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.825 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -77.53 -49.58 14.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.467 -179.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.573 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.3 OUTLIER -74.95 3.2 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.142 0.496 . . . . 0.0 111.796 -179.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 100' ' ' GLN . . . 54.12 36.92 57.67 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.415 -0.897 . . . . 0.0 111.722 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.538 ' HG3' ' CG1' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -52.8 -160.41 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.943 0.401 . . . . 0.0 111.065 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.65 143.14 12.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.775 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.597 ' CD2' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -128.91 132.95 47.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.468 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 6.8 m -92.02 123.1 35.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.088 0.471 . . . . 0.0 111.063 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 12' ' ' PHE . 2.0 m -96.8 127.85 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -127.0 170.17 12.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.557 -178.214 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 51' ' ' MET . . . 69.59 83.88 0.17 Allowed Glycine 0 C--N 1.312 -0.795 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.05 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.22 54.03 4.49 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.427 2.084 . . . . 0.0 110.053 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.595 ' HG ' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -97.42 166.52 11.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.134 -177.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.595 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -156.9 129.32 2.37 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.485 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.481 ' O ' ' CE2' ' A' ' 50' ' ' PHE . 10.7 p -158.25 113.51 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.865 0.364 . . . . 0.0 110.769 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.635 ' CD2' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -119.24 150.26 40.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.681 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -95.09 9.41 70.12 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.696 ' HA ' ' CG ' ' A' ' 215' ' ' TYR . 3.7 pp -116.09 119.4 35.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.278 0.561 . . . . 0.0 110.848 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.647 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.5 OUTLIER -137.5 112.92 9.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.485 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 121' ' ' ARG . 0.1 OUTLIER -87.2 140.54 29.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.54 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -94.12 14.29 20.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.2 -74.68 0.22 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.765 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -129.59 89.96 2.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.941 0.401 . . . . 0.0 110.461 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 121' ' ' ARG . . . -164.37 144.73 6.4 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.363 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 43.8 Cg_endo -67.98 116.93 4.56 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.765 2.31 . . . . 0.0 111.905 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.1 OUTLIER -130.96 158.53 40.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.647 ' CE2' ' CD ' ' A' ' 150' ' ' ARG . 3.5 m-85 -126.68 130.53 50.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.079 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -106.46 103.71 13.23 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.59 ' CG1' ' CD2' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -101.01 111.09 29.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.275 0.56 . . . . 0.0 110.843 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -114.47 133.08 56.02 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.898 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -105.82 102.7 2.01 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.841 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.561 ' HA2' ' CG1' ' A' ' 155' ' ' VAL . . . 124.08 -164.32 17.41 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.417 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.502 ' C ' ' H ' ' A' ' 130' ' ' LEU . 5.4 m -106.4 -10.39 16.34 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.45 0.643 . . . . 0.0 110.746 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.615 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -68.01 10.63 1.17 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.459 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.522 HD23 ' N ' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -75.75 5.14 6.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 122.894 0.478 . . . . 0.0 110.283 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.597 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -44.98 -41.24 12.36 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.197 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 3.7 Cg_exo -73.53 -31.39 8.91 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.49 2.127 . . . . 0.0 110.063 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 217' ' ' CYS . 21.4 t -64.86 -42.7 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.614 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 131' ' ' ALA . 10.6 m -70.15 -29.78 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.533 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.534 ' HB3' ' CD1' ' A' ' 69' ' ' LEU . 16.7 m -66.49 -53.09 39.09 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.48 ' CG ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -60.5 -42.4 96.3 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.511 0.672 . . . . 0.0 109.215 178.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.555 ' O ' ' CG ' ' A' ' 141' ' ' GLN . 26.8 t -62.35 -32.39 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.927 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 135' ' ' SER . 5.3 mtm180 -59.6 -32.12 70.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.198 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.567 ' OE1' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -68.4 -43.03 78.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.09 178.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.626 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -71.5 -34.96 70.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.507 0.67 . . . . 0.0 111.047 179.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.555 ' CG ' ' O ' ' A' ' 137' ' ' VAL . 0.4 OUTLIER -78.05 -30.45 49.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.239 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 138' ' ' ARG . 3.4 mm-40 -69.8 -44.99 68.93 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.653 ' CZ2' ' CB ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -79.24 -21.14 46.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.436 0.636 . . . . 0.0 109.736 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 145' ' ' ALA . 0.6 OUTLIER 52.74 28.03 5.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.735 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.653 ' CB ' ' CZ2' ' A' ' 143' ' ' TRP . . . -33.09 153.95 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.946 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.445 ' HA ' ' HG3' ' A' ' 175' ' ' ARG . 41.8 Cg_endo -67.63 -3.58 10.52 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.667 2.245 . . . . 0.0 112.71 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.571 ' ND2' ' NH2' ' A' ' 121' ' ' ARG . 40.3 t30 -76.37 144.12 40.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 111.567 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 1.2 mt-10 -73.59 111.41 8.71 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.624 0.726 . . . . 0.0 111.072 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 1.1 m -108.5 115.38 29.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.892 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.647 ' CD ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -106.6 141.49 37.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.455 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.492 ' C ' ' CD1' ' A' ' 151' ' ' ILE . 0.1 OUTLIER -133.59 129.33 55.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.262 0.554 . . . . 0.0 111.032 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.575 ' CD1' ' HB2' ' A' ' 180' ' ' LYS . 22.0 m-30 -108.33 115.06 29.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.47 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.466 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 37.2 t80 -120.15 132.02 55.24 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.396 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.625 ' CA ' ' HB2' ' A' ' 182' ' ' CYS . . . -155.06 160.67 29.9 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 119.511 -1.328 . . . . 0.0 113.288 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.568 ' CG1' ' O ' ' A' ' 154' ' ' GLY . 1.2 m -170.73 -106.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.596 ' CB ' ' N ' ' A' ' 188' ' ' GLY . 0.3 OUTLIER -126.17 -169.59 2.04 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 120.663 0.268 . . . . 0.0 111.287 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.57 HG22 ' N ' ' A' ' 187' ' ' SER . 72.0 p -28.29 -62.67 0.1 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.655 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.563 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.2 OUTLIER 153.1 -54.05 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.495 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 40.7 Cg_exo -31.28 -31.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.155 2.57 . . . . 0.0 112.96 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.2 mm-40 -85.44 -60.11 2.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.016 0.436 . . . . 0.0 110.636 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.567 ' CD1' ' CG2' ' A' ' 155' ' ' VAL . 0.4 OUTLIER -67.3 -174.68 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.394 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 163' ' ' TYR . 0.8 OUTLIER 175.27 176.11 0.2 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.86 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 162' ' ' PHE . 0.3 OUTLIER 87.66 6.75 0.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.313 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -71.39 -45.51 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.771 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.584 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 3.5 m-20 -66.0 -35.7 81.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.243 0.544 . . . . 0.0 110.107 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.454 ' O ' ' OG ' ' A' ' 169' ' ' SER . 0.9 OUTLIER -72.38 -36.22 68.66 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -61.61 -31.83 71.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.095 179.007 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 165' ' ' ASP . 24.2 mttt -62.92 -48.54 78.5 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 166' ' ' GLU . 3.9 p -61.8 -31.41 71.62 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.549 ' CD2' ' HB3' ' A' ' 141' ' ' GLN . 1.1 mt -63.57 -37.41 87.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.528 ' HA ' ' CD2' ' A' ' 177' ' ' LEU . 4.4 mm-40 -68.43 -36.07 78.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.922 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -34.53 59.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.143 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.1 t -53.7 -49.17 68.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.521 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.531 ' CG ' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -69.31 -154.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 111.588 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.445 ' HG3' ' HA ' ' A' ' 146' ' ' PRO . 0.3 OUTLIER -106.49 -54.26 2.5 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.718 -179.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -132.35 69.91 1.47 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.112 0.482 . . . . 0.0 110.706 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 149' ' ' THR . 3.6 mp -98.81 150.47 21.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.888 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.513 ' OG1' ' CZ ' ' A' ' 150' ' ' ARG . 2.4 m -137.48 115.41 11.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.718 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.458 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 2.6 p -101.15 134.65 40.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.776 0.322 . . . . 0.0 111.352 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.575 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -101.69 135.28 43.49 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.562 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -100.82 105.51 16.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.491 0.663 . . . . 0.0 111.824 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.625 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 29.6 m -88.53 -161.93 0.79 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.181 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.574 HG22 ' CA ' ' A' ' 156' ' ' ASN . 14.9 t 54.73 147.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-O 121.703 0.763 . . . . 0.0 111.812 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.24 -60.78 0.61 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.188 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.586 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 1.9 t-80 -164.99 51.26 0.25 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.789 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 187' ' ' SER . 86.3 Cg_endo -90.3 -98.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.21 2.607 . . . . 0.0 112.542 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 21.7 t 137.85 6.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.596 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 120.64 12.19 6.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.259 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.16 62.62 1.59 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.441 ' O ' ' N ' ' A' ' 249' ' ' GLY . 8.5 t-105 -132.08 121.31 23.61 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.305 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 250' ' ' ALA . 3.9 mt-10 -95.92 104.71 16.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.52 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.559 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 140.82 -117.02 1.2 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.696 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.575 ' C ' ' HB3' ' A' ' 182' ' ' CYS . 13.6 mt-10 -162.98 -95.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.514 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -86.73 139.34 30.83 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.641 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -21.37 107.08 0.01 OUTLIER Glycine 0 C--N 1.334 0.448 0 O-C-N 123.688 0.618 . . . . 0.0 113.096 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.614 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 67.1 m 120.65 154.45 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 123.481 0.712 . . . . 0.0 110.701 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.65 -75.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 123.234 2.623 . . . . 0.0 112.728 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.645 ' CG2' ' O ' ' A' ' 198' ' ' ILE . 0.2 OUTLIER 174.88 32.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.985 0.897 . . . . 0.0 110.732 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.473 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 35.9 m-20 -58.61 -37.27 75.49 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.191 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.46 73.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.548 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 0.2 OUTLIER -69.32 -34.04 74.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.873 0.368 . . . . 0.0 110.904 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.539 ' HB3' ' NE ' ' A' ' 233' ' ' ARG . 5.9 mtm180 -59.84 -52.15 66.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -41.87 96.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.814 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.2 -29.16 68.53 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.596 ' CD2' ' CD1' ' A' ' 235' ' ' ILE . 0.0 OUTLIER -62.67 -43.96 97.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.337 178.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.44 -18.07 57.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.538 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 208' ' ' SER . 59.4 m -75.79 -80.45 0.09 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.93 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 207' ' ' SER . 0.4 OUTLIER 164.99 34.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.449 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.554 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 2.0 m-20 -137.85 52.29 1.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.697 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 151.5 102.01 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.208 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.557 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 13.5 t30 174.04 -56.78 0.0 OUTLIER Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.143 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 18.8 Cg_endo -59.53 -58.04 0.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.294 1.996 . . . . 0.0 111.207 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.523 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -133.14 109.23 9.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.309 178.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.533 HD12 ' CB ' ' A' ' 210' ' ' ALA . 0.5 OUTLIER -121.63 125.76 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.696 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -120.62 127.1 51.78 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.388 0.613 . . . . 0.0 111.063 -178.414 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.59 ' CD2' ' CG1' ' A' ' 124' ' ' VAL . 3.4 mt -125.71 116.45 21.66 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.284 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . 0.536 ' HB2' ' CG2' ' A' ' 133' ' ' VAL . 38.9 m -124.8 107.09 10.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.077 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.621 ' N ' ' CD ' ' A' ' 219' ' ' PRO . . . 110.44 -28.13 10.58 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.93 -1.128 . . . . 0.0 114.075 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 218' ' ' GLY . 46.3 Cg_endo -89.76 83.17 0.53 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.238 1.958 . . . . 0.0 114.72 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.573 ' CD ' ' O ' ' A' ' 218' ' ' GLY . 11.9 Cg_endo -53.48 -71.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 111.301 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 224' ' ' ASP . . . -54.2 -48.62 62.94 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.427 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.563 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -54.77 -24.08 20.89 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -72.76 -36.81 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.942 178.132 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 221' ' ' GLY . 65.6 m-20 -73.45 -47.04 44.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.003 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -69.72 -37.02 76.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.641 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 222' ' ' MET . . . -59.4 -38.5 80.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.385 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 31.7 m -69.91 -31.19 68.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.572 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -44.5 82.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.811 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.514 ' CD2' ' O ' ' A' ' 225' ' ' ALA . 0.0 OUTLIER -60.76 -37.14 80.83 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.013 0.435 . . . . 0.0 110.664 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.554 ' HA ' ' CD2' ' A' ' 205' ' ' LEU . 3.6 t -66.23 -45.62 89.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.392 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -72.75 -30.02 63.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 6.2 m -76.98 -44.15 32.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.539 ' NE ' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -68.21 -75.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.166 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.475 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 137.8 -36.13 1.97 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.255 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.596 ' CD1' ' CD2' ' A' ' 205' ' ' LEU . 1.6 pp -35.84 95.29 0.09 OUTLIER Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 111.005 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 18.7 Cg_endo -59.86 115.33 2.55 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.757 2.305 . . . . 0.0 112.185 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -93.85 173.72 33.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.437 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -143.71 -41.92 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 110.91 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.582 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 43.7 mm-40 -107.5 37.78 2.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.501 ' CG2' ' HB ' ' A' ' 214' ' ' ILE . 2.1 t -92.84 132.45 37.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.647 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -144.72 144.5 31.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.42 -178.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -130.75 140.93 50.35 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . 0.503 ' OE2' ' CA ' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -132.79 149.12 52.31 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.75 178.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 220' ' ' PRO . 1.0 OUTLIER -127.22 108.09 10.57 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.615 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.4 OUTLIER -138.22 144.32 40.57 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.538 178.364 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.613 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 0.1 OUTLIER 68.31 148.55 0.12 Allowed Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 121.917 -0.49 . . . . 0.0 111.379 -179.101 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . 0.559 ' HD2' ' CD2' ' A' ' 246' ' ' LEU . 97.7 Cg_endo -73.28 -104.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.959 2.439 . . . . 0.0 112.371 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 247' ' ' PRO . 52.8 p -37.66 134.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.183 0.516 . . . . 0.0 110.912 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 127.71 -15.69 6.27 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.554 ' O ' ' CB ' ' A' ' 191' ' ' GLU . . . -106.53 120.55 42.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.709 -0.745 . . . . 0.0 111.541 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.559 ' N ' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.066 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 CA-C-O 121.022 0.234 . . . . 0.0 112.81 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.559 ' CB ' ' HB3' ' A' ' 105' ' ' LYS . 0.8 OUTLIER -115.03 149.34 37.62 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.693 -0.253 . . . . 0.0 111.022 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.654 ' CE2' ' CG2' ' A' ' 104' ' ' VAL . 0.9 OUTLIER -134.05 165.54 24.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -113.31 135.29 54.0 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.992 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -134.53 150.35 50.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.755 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 1.1 pt-20 -96.5 116.63 29.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 110.754 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 102' ' ' LEU . 2.9 m -75.34 135.34 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.284 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 7.4 p -149.4 20.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.168 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -106.63 -129.82 6.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.028 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.546 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 74.9 80.39 0.11 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.831 -0.685 . . . . 0.0 110.445 -178.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -123.25 139.45 54.04 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.079 178.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 7.9 m0 -90.1 113.49 25.24 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.164 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 m -96.26 -26.99 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.516 ' HB2' ' HB ' ' A' ' 26' ' ' THR . 8.2 m -143.43 171.09 14.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.244 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.46 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -52.88 -53.83 43.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.116 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -119.46 45.47 2.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.58 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 23' ' ' SER . 0.3 OUTLIER -148.06 140.36 24.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.426 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.531 HG12 ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -140.89 141.28 31.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.26 0.552 . . . . 0.0 112.036 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.463 ' HB2' ' CD2' ' A' ' 79' ' ' LEU . 17.0 tt0 -121.44 110.52 16.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.895 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.703 ' CD2' ' CD1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -118.74 140.52 49.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 111.446 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.569 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -117.13 143.66 45.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.347 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.563 ' CD2' ' CE1' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -122.14 154.91 36.78 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.17 0.509 . . . . 0.0 111.954 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -116.13 104.81 11.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.491 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.643 ' CG ' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -60.63 -171.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.459 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? . . . . . 0 CA--C 1.544 0.714 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.698 -179.328 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.595 ' CG2' ' ND2' ' A' ' 68' ' ' ASN . 18.8 m . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 121.281 0.563 . . . . 0.0 112.441 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.685 ' HA ' ' CA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.32 41.37 1.09 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.282 178.123 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.6 ' CZ ' ' O ' ' A' ' 132' ' ' PRO . 83.9 t80 71.66 143.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.064 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.594 ' O ' ' CE2' ' A' ' 45' ' ' PHE . 4.9 mt-10 -112.91 161.88 24.5 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.743 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' GLY . 5.1 Cg_endo -47.44 80.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.717 2.278 . . . . 0.0 112.326 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 34.85 41.2 0.24 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.862 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.49 ' O ' ' CB ' ' A' ' 65' ' ' SER . 4.8 mt-30 -53.46 161.04 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.67 0.235 . . . . 0.0 110.442 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.683 ' CE1' ' CB ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -152.82 160.47 43.09 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.964 0.411 . . . . 0.0 111.703 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.627 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -138.73 -172.35 3.29 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.389 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -112.7 108.79 17.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -149.64 155.92 41.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.601 HG23 ' N ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -106.9 155.3 19.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.792 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.714 ' CG2' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -29.89 -68.62 0.11 Allowed Pre-proline 0 CA--C 1.54 0.58 0 O-C-N 123.393 0.433 . . . . 0.0 110.666 -179.171 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.714 ' HD3' ' CG2' ' A' ' 55' ' ' ILE . 6.3 Cg_endo -107.89 3.69 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.434 2.756 . . . . 0.0 111.807 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 107.23 -4.35 35.42 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.132 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.572 HG23 ' CD ' ' A' ' 56' ' ' PRO . 70.5 p -25.52 -89.76 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.975 0.51 . . . . 0.0 111.864 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.49 ' O ' HG12 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -147.2 43.11 1.12 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.578 ' N ' ' OG1' ' A' ' 54' ' ' THR . 0.4 OUTLIER 79.25 125.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.676 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.601 ' N ' HG23 ' A' ' 54' ' ' THR . 4.1 m -101.44 -54.32 2.79 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.372 0.606 . . . . 0.0 110.493 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 175.2 -155.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.438 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.683 ' CB ' ' CE1' ' A' ' 50' ' ' PHE . 3.6 p -105.73 119.36 38.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.898 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.48 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 4.2 t80 -140.72 124.51 17.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.119 0.485 . . . . 0.0 112.086 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 1.3 t -80.85 108.25 9.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.063 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.484 ' HD2' ' O ' ' A' ' 49' ' ' GLN . 87.9 Cg_endo -83.61 159.41 14.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.795 2.33 . . . . 0.0 111.667 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.588 ' HB2' ' CD1' ' A' ' 45' ' ' PHE . . . -119.48 129.51 54.76 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.603 ' O ' ' CB ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -82.21 -75.31 0.31 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.328 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.603 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 10.8 tp 101.53 141.38 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.22 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.685 ' CA ' ' HA ' ' A' ' 44' ' ' LYS . 5.5 Cg_exo -36.25 86.31 0.01 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 123.001 2.467 . . . . 0.0 112.0 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -162.67 117.96 1.2 Allowed Pre-proline 0 CA--C 1.518 -0.251 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.086 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.56 38.55 0.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.484 2.123 . . . . 0.0 112.379 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.06 -51.47 1.21 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 71' ' ' ASN . . . 127.34 107.95 1.48 Allowed Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.81 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 5.9 mtt180 -139.53 93.55 2.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.517 0.199 . . . . 0.0 110.506 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.555 ' C ' ' CD1' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -95.88 131.55 42.1 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.351 0.596 . . . . 0.0 111.368 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.444 ' N ' HD13 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.9 150.74 30.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.138 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.703 ' CD1' ' CD2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -135.29 129.99 34.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.367 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.475 ' O ' ' OH ' ' A' ' 64' ' ' TYR . 2.7 mt -135.6 103.37 5.42 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-O 120.846 0.355 . . . . 0.0 110.355 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.655 ' CD1' ' CZ ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -115.04 127.33 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.194 -178.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.519 ' HG3' ' CD1' ' A' ' 246' ' ' LEU . 1.8 mmt180 -79.69 95.57 5.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.595 ' CG2' ' CB ' ' A' ' 89' ' ' SER . 3.0 m -90.56 142.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.114 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.456 ' HG ' ' HD2' ' A' ' 84' ' ' PRO . 0.5 OUTLIER -88.15 151.35 48.96 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.612 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.456 ' HD2' ' HG ' ' A' ' 83' ' ' LEU . 55.3 Cg_endo -69.87 -8.46 23.66 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.753 2.302 . . . . 0.0 112.392 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -70.51 -25.87 63.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.506 ' CA ' ' HB2' ' A' ' 90' ' ' ASP . . . 115.43 -4.06 21.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.569 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 86' ' ' GLY . 9.3 mmm180 -36.63 -73.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 110.792 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -116.92 -21.88 8.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.595 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 1.3 p -65.75 -36.79 84.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.206 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.506 ' HB2' ' CA ' ' A' ' 86' ' ' GLY . 2.1 m-20 -75.09 -33.47 61.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.364 0.602 . . . . 0.0 109.868 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.634 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 2.0 t80 -73.34 -31.59 64.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.702 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.532 ' HA ' ' CD1' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -68.73 -39.36 80.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.203 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.08 -19.88 21.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 9.0 m-20 -97.48 -10.97 24.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.43 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.53 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -124.73 -12.3 7.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.452 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 92' ' ' LEU . . . -132.56 33.2 3.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.028 0.442 . . . . 0.0 110.909 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -52.88 61.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.682 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -89.32 -135.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 120.737 0.303 . . . . 0.0 111.129 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 100' ' ' GLN . . . -120.97 28.07 6.24 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.995 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.485 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 17.2 mp0 -39.26 163.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 110.911 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 14' ' ' ALA . 4.8 p -92.83 139.77 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.953 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.552 ' CD1' ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.67 125.33 35.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -92.38 134.55 34.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.97 0.414 . . . . 0.0 111.086 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.654 ' CG2' ' CE2' ' A' ' 12' ' ' PHE . 1.9 m -112.91 129.37 68.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.445 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.559 ' HB3' ' CB ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -130.55 112.97 13.67 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.759 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 151.56 73.66 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.022 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.94 53.97 4.37 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.496 2.131 . . . . 0.0 110.924 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.595 HD22 ' CD2' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -102.17 166.61 10.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.781 -178.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.551 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -108.75 172.7 16.84 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.492 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 4.4 p -152.18 113.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.201 0.524 . . . . 0.0 111.205 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 241' ' ' PHE . 13.0 m-30 -71.01 114.74 9.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.419 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -149.99 -46.46 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.593 ' HA ' ' CG ' ' A' ' 215' ' ' TYR . 2.0 pt? -146.43 119.59 8.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.937 0.399 . . . . 0.0 110.488 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -137.9 112.83 9.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.853 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -78.95 140.2 38.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.287 179.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.43 ' HD3' ' HG3' ' A' ' 239' ' ' GLN . 17.2 ttp180 -98.37 11.7 37.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.185 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.478 ' C ' ' NH2' ' A' ' 121' ' ' ARG . . . 107.27 -78.08 0.24 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.693 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.442 ' HA ' ' HB3' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -129.91 89.83 2.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.844 0.354 . . . . 0.0 110.577 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 121' ' ' ARG . . . -166.86 151.93 7.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 33.0 Cg_endo -64.47 116.73 3.93 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.652 2.235 . . . . 0.0 111.606 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.575 ' CB ' ' CE2' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -124.76 128.24 48.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.081 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.636 ' CD2' ' CE1' ' A' ' 152' ' ' TYR . 2.5 m-30 -106.65 115.84 30.9 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.656 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -119.66 111.01 17.51 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.258 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.576 ' CG1' ' CD2' ' A' ' 216' ' ' LEU . 7.4 p -109.15 111.06 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.206 0.527 . . . . 0.0 110.978 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -103.7 133.58 48.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.951 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.551 ' HA3' ' N ' ' A' ' 250' ' ' ALA . . . -109.59 103.61 1.77 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.944 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.535 ' HA2' ' CG1' ' A' ' 155' ' ' VAL . . . 123.55 -158.91 18.21 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 119.782 -1.199 . . . . 0.0 112.757 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 130' ' ' LEU . 3.2 m -110.09 -14.41 14.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.675 0.274 . . . . 0.0 111.409 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.608 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -67.67 9.36 1.35 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.355 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.573 HD12 ' CE1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -77.99 3.88 13.59 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 122.491 0.316 . . . . 0.0 110.192 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.582 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -46.52 -43.34 36.5 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 120.516 -0.473 . . . . 0.0 109.998 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.6 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 2.8 Cg_exo -73.82 -35.35 4.51 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.529 2.152 . . . . 0.0 109.718 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.656 ' CG1' ' CE1' ' A' ' 123' ' ' PHE . 15.8 t -63.36 -42.88 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.208 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 131' ' ' ALA . 20.8 m -70.48 -29.74 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.414 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.466 ' HB3' ' CG ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -63.21 -52.7 61.23 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -46.44 89.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.477 0.656 . . . . 0.0 109.628 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.622 ' CG2' ' CE2' ' A' ' 123' ' ' PHE . 0.9 OUTLIER -59.53 -33.42 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.623 178.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -34.19 71.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.224 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.436 ' CD ' ' HG3' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -65.3 -42.45 93.05 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.601 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.7 OUTLIER -70.49 -34.01 71.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.661 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.557 ' CG ' ' O ' ' A' ' 137' ' ' VAL . 0.6 OUTLIER -77.06 -30.61 55.66 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.287 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -70.55 -44.82 66.66 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.658 ' CZ2' ' CB ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -80.66 -20.56 42.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.411 0.624 . . . . 0.0 110.192 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.514 ' O ' ' CG ' ' A' ' 175' ' ' ARG . 0.1 OUTLIER 51.21 28.75 4.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.656 178.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.658 ' CB ' ' CZ2' ' A' ' 143' ' ' TRP . . . -31.17 150.56 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 111.1 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.42 -9.19 6.37 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.877 2.385 . . . . 0.0 113.083 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.442 ' HB3' ' HA ' ' A' ' 118' ' ' MET . 8.4 p-10 -76.35 143.34 40.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.128 0.49 . . . . 0.0 111.861 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 9.1 mt-10 -73.75 127.38 32.65 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.827 0.822 . . . . 0.0 110.88 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 26.1 m -118.27 121.67 41.02 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.477 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.611 ' HB2' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.46 134.77 44.05 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.062 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.624 HD13 ' CD2' ' A' ' 123' ' ' PHE . 0.5 OUTLIER -113.88 130.81 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.957 -179.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.636 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 45.4 m-85 -123.76 109.28 13.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.034 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CE1' HD12 ' A' ' 130' ' ' LEU . 4.4 t80 -122.15 132.26 54.37 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.397 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.651 ' HA2' ' HB2' ' A' ' 182' ' ' CYS . . . -160.85 153.63 24.51 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 119.697 -1.239 . . . . 0.0 113.723 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.56 ' CG2' ' CD2' ' A' ' 161' ' ' LEU . 2.4 m -167.58 -105.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.618 ' CB ' ' N ' ' A' ' 188' ' ' GLY . 4.0 p30 -108.3 174.39 5.9 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.936 0.398 . . . . 0.0 111.738 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.55 ' O ' ' CB ' ' A' ' 158' ' ' GLU . 0.5 OUTLIER -34.28 -41.81 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.401 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.0 OUTLIER 153.85 -41.53 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.241 0 O-C-N 123.307 0.379 . . . . 0.0 111.88 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 62.4 Cg_exo -40.1 -30.23 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.458 2.105 . . . . 0.0 112.707 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.494 ' CB ' ' ND2' ' A' ' 156' ' ' ASN . 1.2 mp0 -103.61 -13.93 16.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.701 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.56 ' CD1' ' CZ ' ' A' ' 153' ' ' PHE . 10.9 tp -94.75 171.85 8.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.846 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 1.1 p90 176.28 -163.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.977 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.6 OUTLIER 72.05 9.22 6.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.393 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.56 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -57.62 -41.65 79.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 109.986 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.56 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 16.8 m-20 -64.24 -27.76 69.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.873 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -71.57 -47.49 54.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.88 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.54 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -62.95 -31.28 72.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.088 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -60.7 -45.93 92.34 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.6 m -61.76 -31.76 71.97 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.543 ' CD1' ' OE1' ' A' ' 141' ' ' GLN . 1.0 OUTLIER -62.75 -38.02 88.89 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.466 ' HA ' HD13 ' A' ' 177' ' ' LEU . 30.8 mt-10 -66.68 -36.22 82.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.309 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -78.65 -35.93 44.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.31 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.461 ' O ' ' C ' ' A' ' 174' ' ' MET . 0.5 OUTLIER -87.77 -79.14 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.684 0.278 . . . . 0.0 111.606 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.55 ' CG ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -23.69 126.5 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.458 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 144' ' ' THR . 1.7 mmp_? -38.41 -91.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.427 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.443 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -119.0 61.3 0.8 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.27 0.557 . . . . 0.0 109.894 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.593 ' CD2' ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -103.58 157.77 16.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.622 -179.094 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.593 ' N ' ' CD2' ' A' ' 177' ' ' LEU . 3.7 m -137.1 123.13 20.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.932 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.5 ' HA ' HG23 ' A' ' 151' ' ' ILE . 64.2 t -89.18 136.57 23.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.638 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.473 ' HG2' ' CD2' ' A' ' 152' ' ' TYR . 17.8 tptt -102.63 130.31 49.48 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.642 0.258 . . . . 0.0 110.582 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' NE2' ' A' ' 194' ' ' GLN . . . -97.51 104.93 17.0 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.74 0.781 . . . . 0.0 110.798 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.651 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 97.6 m -91.16 -168.54 2.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.11 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 156' ' ' ASN . 19.4 t 56.47 148.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.913 0.864 . . . . 0.0 111.407 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.98 -69.27 0.54 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.979 -178.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.606 ' N ' ' CD ' ' A' ' 186' ' ' PRO . 0.2 OUTLIER -155.89 34.93 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.584 178.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.633 ' O ' ' CB ' ' A' ' 187' ' ' SER . 83.3 Cg_endo -73.47 -100.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.502 2.135 . . . . 0.0 112.791 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.633 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 27.4 t 137.69 30.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.972 0.509 . . . . 0.0 111.707 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.618 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 94.06 12.57 56.28 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.3 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.07 63.4 1.57 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.496 ' O ' ' HB3' ' A' ' 248' ' ' SER . 4.0 t-105 -132.25 113.7 13.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.723 -177.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.444 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 1.3 mt-10 -84.34 103.66 13.71 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.597 ' HA2' ' CB ' ' A' ' 251' ' ' ALA . . . 146.05 -122.09 1.59 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.056 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.565 ' CB ' ' SG ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -159.21 -79.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.577 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -100.88 148.59 24.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.07 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.651 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -40.49 105.92 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.674 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 3.5 m 148.71 172.72 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 111.264 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.526 ' CD ' ' HB3' ' A' ' 196' ' ' SER . 2.6 Cg_exo -75.86 -70.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.994 2.462 . . . . 0.0 112.606 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.667 ' CG2' ' O ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER 169.13 37.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-O 122.372 1.082 . . . . 0.0 110.136 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 199' ' ' ASP . 0.5 OUTLIER -72.57 -34.24 67.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.054 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -57.81 -45.49 86.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.586 ' CD2' HD12 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -71.39 -29.73 65.28 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.175 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.537 ' CG ' HD12 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -58.06 -52.89 63.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.786 -178.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.23 -43.17 64.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.334 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.61 -29.2 67.83 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.539 ' CG ' HG12 ' A' ' 235' ' ' ILE . 0.5 OUTLIER -63.31 -48.69 76.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.422 ' CD ' ' NH2' ' A' ' 233' ' ' ARG . 3.4 mt-10 -67.73 -26.93 66.39 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.666 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 208' ' ' SER . 69.9 m -75.32 -82.5 0.07 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.893 0.377 . . . . 0.0 110.789 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 209' ' ' ASP . 0.1 OUTLIER 166.08 90.31 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.691 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 0.2 OUTLIER 164.23 53.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.837 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 151.94 99.92 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.189 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.578 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 13.5 t30 172.65 -56.54 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.981 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 12.9 Cg_endo -56.63 -50.97 10.17 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.412 2.075 . . . . 0.0 111.025 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -132.67 109.06 9.44 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.536 ' HB ' ' CG2' ' A' ' 240' ' ' VAL . 1.0 OUTLIER -122.11 125.08 72.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.593 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.3 m-85 -118.75 126.71 52.49 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.397 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.576 ' CD2' ' CG1' ' A' ' 124' ' ' VAL . 20.5 mt -125.16 118.81 26.9 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.829 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 250' ' ' ALA . 0.0 OUTLIER -122.87 131.66 53.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.658 178.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.6 ' O ' ' N ' ' A' ' 245' ' ' PHE . . . 144.08 -151.46 23.44 Favored Glycine 0 C--O 1.224 -0.511 0 C-N-CA 120.058 -1.067 . . . . 0.0 113.075 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 247' ' ' PRO . 56.7 Cg_endo -70.73 166.61 28.23 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.65 2.233 . . . . 0.0 112.459 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.454 ' O ' HG22 ' A' ' 223' ' ' ILE . 27.7 Cg_exo -61.1 -9.07 11.34 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.77 2.313 . . . . 0.0 112.189 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -69.32 -54.83 11.65 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.959 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.58 ' CE ' ' N ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -55.51 -25.66 38.5 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -77.07 -42.41 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.376 178.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -75.58 -48.68 21.26 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 229' ' ' LEU . . . -77.44 -48.37 17.33 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 222' ' ' MET . . . -66.36 -39.49 89.17 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.559 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 223' ' ' ILE . 49.9 t -65.32 -45.83 82.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.543 0.211 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 232' ' ' SER . 0.8 OUTLIER -66.87 -36.3 82.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.302 0.573 . . . . 0.0 109.701 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.571 ' CD1' ' CG2' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -60.15 -56.36 22.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.349 179.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.525 ' CG1' HD13 ' A' ' 235' ' ' ILE . 94.7 t -72.53 -42.57 63.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.242 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 227' ' ' CYS . 30.7 mtp180 -62.38 -30.17 71.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.427 . . . . 0.0 110.074 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 228' ' ' GLU . 21.5 m -91.41 -27.11 18.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.516 ' NE ' ' O ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -57.57 -67.98 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.1 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 146.78 -54.12 0.54 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.852 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.539 ' O ' ' CD1' ' A' ' 235' ' ' ILE . 2.1 pp -34.03 95.21 0.08 OUTLIER Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 121.151 0.5 . . . . 0.0 111.556 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.441 ' N ' ' O ' ' A' ' 234' ' ' GLY . 32.7 Cg_endo -64.48 118.16 5.15 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.855 2.37 . . . . 0.0 112.257 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.464 ' CA ' ' OD1' ' A' ' 211' ' ' ASN . . . -108.97 154.94 16.3 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.56 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -117.95 -37.26 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.738 0.304 . . . . 0.0 110.866 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.572 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 70.5 mm-40 -102.17 35.66 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.22 0.534 . . . . 0.0 110.359 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 214' ' ' ILE . 1.8 t -89.65 128.83 41.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.365 0.602 . . . . 0.0 110.873 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.645 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.73 142.56 27.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.86 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.539 ' HB2' ' CD1' ' A' ' 223' ' ' ILE . 0.7 OUTLIER -131.32 141.1 49.88 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.912 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 216' ' ' LEU . 7.2 pt-20 -132.12 148.46 52.48 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.243 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 4.5 ptmm? -116.35 105.83 12.96 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.608 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -137.02 144.46 43.25 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.309 178.237 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.568 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 5.1 mt 62.43 155.73 0.12 Allowed Pre-proline 0 N--CA 1.467 0.405 0 CA-C-O 121.131 0.491 . . . . 0.0 111.993 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . 0.568 ' CD ' HD22 ' A' ' 246' ' ' LEU . 22.5 Cg_exo -65.1 -141.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.628 2.886 . . . . 0.0 112.363 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 190' ' ' TRP . 0.4 OUTLIER -52.98 151.95 4.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.144 0.497 . . . . 0.0 111.391 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 152.45 -51.61 0.49 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.818 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.572 ' O ' ' CB ' ' A' ' 251' ' ' ALA . . . -108.19 142.03 39.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.533 -0.334 . . . . 0.0 111.272 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.597 ' CB ' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.837 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.392 0 CA-C-O 120.99 0.217 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.526 ' HB2' ' CG ' ' A' ' 105' ' ' LYS . 2.3 t -102.74 151.52 22.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.672 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.592 ' CE1' ' O ' ' A' ' 13' ' ' GLU . 5.0 t80 -132.1 152.76 51.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.695 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.592 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -111.13 126.11 54.49 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 110.826 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.573 ' HB1' ' CE2' ' A' ' 12' ' ' PHE . . . -131.18 154.12 48.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.154 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.538 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 19.8 tt0 -98.86 124.89 44.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.018 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 100' ' ' GLN . 6.4 m -70.69 115.71 10.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 110.561 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.05 14.91 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.047 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 29' ' ' PHE . . . -150.34 117.63 0.86 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.064 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.607 ' CD2' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -155.74 52.82 0.58 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.654 -0.773 . . . . 0.0 109.996 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.558 ' ND2' ' C ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -95.6 150.72 20.03 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.679 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 7.8 m95 -88.86 112.39 23.2 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 2.6 m -76.92 -23.13 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.569 0.7 . . . . 0.0 109.74 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.491 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 38.8 m -150.5 -175.27 5.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.3 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.97 -57.02 9.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.632 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -121.92 49.25 1.58 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.724 179.308 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -147.56 141.12 25.48 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.473 -179.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.607 HG23 ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -140.8 148.26 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.162 -178.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -108.74 129.23 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.554 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.655 ' CB ' ' CZ ' ' A' ' 78' ' ' PHE . 0.3 OUTLIER -124.37 121.83 36.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.622 -178.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -112.3 115.5 28.87 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.6 HD21 ' CE1' ' A' ' 29' ' ' PHE . 3.2 mt -120.64 133.74 55.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.261 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.447 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 29.6 mt-30 -145.64 110.18 5.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.601 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.538 ' HB2' ' N ' ' A' ' 15' ' ' GLU . 8.1 tmtm? -156.43 6.28 0.18 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.534 ' CD ' ' HB2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.158 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.332 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.838 ' HA ' ' N ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER . . . . . 0 C--O 1.21 -0.986 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 10.4 ttmt -13.85 74.0 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.854 0.861 . . . . 0.0 112.886 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.596 ' N ' ' O ' ' A' ' 43' ' ' VAL . 55.4 t80 -99.19 -103.59 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.655 0.264 . . . . 0.0 110.868 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.5 OUTLIER -113.42 155.76 44.23 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 120.771 0.319 . . . . 0.0 110.703 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.526 ' HD2' ' CG2' ' A' ' 110' ' ' VAL . 72.8 Cg_exo -49.53 80.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.665 2.243 . . . . 0.0 112.231 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 49.09 63.47 3.93 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.762 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.512 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -48.45 -179.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.576 -0.157 . . . . 0.0 110.576 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.664 ' CD1' ' CB ' ' A' ' 65' ' ' SER . 0.2 OUTLIER -131.95 163.21 28.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.947 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.535 ' O ' ' CB ' ' A' ' 63' ' ' SER . 2.6 mmt -129.9 -168.41 1.95 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.942 0.401 . . . . 0.0 111.703 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -138.47 96.34 3.15 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.799 ' HB2' ' CA ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -132.82 158.18 43.14 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.764 -177.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.566 ' HA ' ' CB ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -106.85 151.13 25.62 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.983 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.01 ' CA ' ' O ' ' A' ' 103' ' ' SER 10.821 1.9 mp -53.53 102.83 0.33 Allowed Pre-proline 2 N--CA 7.684 311.237 3 C-N-CA 11.143 -44.223 . . . . 0.0 17.059 -71.011 . . . . . . . . 5 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' A' ' 55' ' ' ILE . 7.2 Cg_endo -95.54 4.88 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 1 CA-C-N 103.419 -4.886 . . . . 0.0 111.153 72.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 105.82 2.43 39.77 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.494 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.543 HG23 ' CG ' ' A' ' 56' ' ' PRO . 27.0 p -46.43 -105.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.582 0.229 . . . . 0.0 111.345 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.546 ' CA ' HG23 ' A' ' 54' ' ' THR . 6.0 p-10 172.33 29.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.5 ' CG1' ' O ' ' A' ' 60' ' ' VAL . 58.3 t -137.99 34.47 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.733 0.302 . . . . 0.0 111.223 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.566 ' CB ' ' HA ' ' A' ' 54' ' ' THR . 38.8 t -107.82 -104.77 0.35 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.738 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 162.94 -173.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.095 0.474 . . . . 0.0 111.501 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -88.97 135.05 33.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.21 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.59 ' CE1' ' HB2' ' A' ' 78' ' ' PHE . 1.7 t80 -134.16 126.03 29.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.747 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.664 ' CB ' ' CD1' ' A' ' 50' ' ' PHE . 91.6 p -64.77 106.67 1.05 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.569 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.53 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 90.5 Cg_endo -92.15 171.03 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.639 2.226 . . . . 0.0 112.72 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.555 ' O ' ' HB3' ' A' ' 68' ' ' ASN . . . -87.2 159.36 18.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.513 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 75' ' ' ARG . 9.2 t30 82.17 138.74 0.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 124.167 0.917 . . . . 0.0 110.371 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.596 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER 151.64 -46.58 0.0 OUTLIER Pre-proline 0 CA--C 1.512 -0.512 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.611 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 97.6 Cg_endo -92.74 55.15 0.53 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.167 2.578 . . . . 0.0 111.609 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.567 ' N ' ' N ' ' A' ' 44' ' ' LYS . 4.6 p30 158.16 109.17 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.413 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.838 ' N ' ' HA ' ' A' ' 43' ' ' VAL . 6.2 Cg_endo -48.18 106.15 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.274 2.649 . . . . 0.0 113.88 -177.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -158.71 -74.73 0.08 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.803 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.44 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . 105.36 72.56 0.86 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.011 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 9.7 mtm180 -151.98 109.25 3.57 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.556 ' C ' ' CD1' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -93.88 128.03 39.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.622 -178.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.528 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 56.0 mt-10 -130.26 115.75 17.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.236 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.686 ' CD1' ' CG2' ' A' ' 80' ' ' ILE . 1.6 p90 -121.5 135.04 55.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.865 0.364 . . . . 0.0 110.996 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 0.6 OUTLIER -114.78 82.17 1.68 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.979 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.686 ' CG2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -92.14 129.2 43.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.108 -179.161 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -77.52 110.13 12.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.233 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.57 ' CG2' ' CB ' ' A' ' 89' ' ' SER . 4.4 m -102.5 127.81 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.293 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.522 HD22 ' CD ' ' A' ' 84' ' ' PRO . 13.5 mt -42.66 166.56 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.522 ' CD ' HD22 ' A' ' 83' ' ' LEU . 74.7 Cg_exo -49.77 -50.01 14.37 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.654 2.236 . . . . 0.0 112.391 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 175.83 67.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 87' ' ' ARG . . . 176.27 64.25 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.575 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 164.07 -93.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.676 0.274 . . . . 0.0 111.005 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.599 ' CE1' ' CG1' ' A' ' 55' ' ' ILE . 1.1 t80 -94.99 -29.96 14.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.343 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.57 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 4.8 p -81.36 -27.14 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.862 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -75.8 -43.44 46.21 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.571 0.701 . . . . 0.0 109.822 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -72.89 -25.29 61.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 96' ' ' ALA . 0.7 OUTLIER -68.46 -47.49 67.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.282 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.446 ' O ' ' CD ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -90.2 -25.61 20.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 12.5 m120 -96.9 2.29 51.5 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.166 -0.213 . . . . 0.0 111.343 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.59 19.72 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 55' ' ' ILE . . . -146.96 27.68 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.671 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 96' ' ' ALA . 39.7 mmm-85 -45.39 173.36 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.114 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.531 HG13 ' CG2' ' A' ' 16' ' ' VAL . 0.5 OUTLIER -95.31 -144.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.44 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.37 -44.9 1.99 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.986 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.551 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 9.3 pt20 -83.52 -158.52 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.282 0.563 . . . . 0.0 112.372 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.519 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 5.3 p -125.13 144.19 36.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.483 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.581 ' CD2' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -129.32 136.1 49.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.711 0.291 . . . . 0.0 110.638 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 1.01 ' O ' ' CA ' ' A' ' 55' ' ' ILE . 16.1 t -102.67 127.22 49.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.03 0.443 . . . . 0.0 111.066 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.873 ' HA ' ' CA ' ' A' ' 55' ' ' ILE . 2.0 m -101.37 122.61 53.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.722 ' H ' ' CA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -130.18 113.01 13.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.624 -178.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.519 ' HA3' ' N ' ' A' ' 52' ' ' ASP . . . -173.56 85.14 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.972 -1.108 . . . . 0.0 113.779 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.01 64.37 1.36 Allowed 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.353 2.036 . . . . 0.0 110.786 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.44 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -88.47 173.75 8.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.231 -178.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.573 ' O ' ' CE2' ' A' ' 50' ' ' PHE . . . -108.54 174.51 18.79 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.282 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.526 ' CG2' ' HD2' ' A' ' 47' ' ' PRO . 18.7 m -107.46 109.2 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 121.605 0.717 . . . . 0.0 110.516 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 1.3 m-85 -121.54 132.82 54.92 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.26 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 215' ' ' TYR . . . 124.43 -86.98 0.37 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.012 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.584 ' HB3' ' CE2' ' A' ' 123' ' ' PHE . 0.4 OUTLIER -81.75 118.36 22.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.935 0.397 . . . . 0.0 110.001 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.641 ' CB ' ' CD2' ' A' ' 241' ' ' PHE . 0.9 OUTLIER -137.5 114.63 10.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.959 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.21 129.54 53.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.205 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.05 14.28 24.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.956 0.408 . . . . 0.0 111.114 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.26 -66.23 1.81 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.527 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.496 ' HA ' ' HB2' ' A' ' 147' ' ' ASN . 17.3 ttm -128.82 89.05 2.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.896 0.379 . . . . 0.0 110.376 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -167.15 142.92 3.5 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.597 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 97.1 Cg_endo -78.28 108.81 2.55 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 123.148 2.565 . . . . 0.0 112.219 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.543 ' CB ' ' CE2' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -136.99 153.03 50.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.949 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.597 ' CD2' ' OH ' ' A' ' 152' ' ' TYR . 2.1 m-85 -120.64 123.03 41.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.022 0.439 . . . . 0.0 110.985 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.643 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 45.6 t80 -108.23 111.3 23.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.181 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.541 ' HA ' ' HB2' ' A' ' 152' ' ' TYR . 3.2 p -98.15 112.25 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 121.473 0.654 . . . . 0.0 111.914 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -118.23 132.22 56.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.815 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.551 ' O ' ' CD2' ' A' ' 246' ' ' LEU . . . -123.98 101.97 0.7 Allowed Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.433 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.602 ' N ' HG11 ' A' ' 155' ' ' VAL . . . 142.1 -152.01 23.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.006 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.51 HG23 ' CB ' ' A' ' 79' ' ' LEU . 32.1 m -119.39 -15.82 9.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.056 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.534 ' C ' ' CZ ' ' A' ' 245' ' ' PHE . . . -66.65 9.37 0.9 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.8 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.551 ' CD1' ' CE1' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -80.4 4.72 17.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 120.875 0.369 . . . . 0.0 110.01 179.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.567 ' N ' ' HD2' ' A' ' 132' ' ' PRO . . . -46.8 -52.5 31.77 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.516 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 131' ' ' ALA . 39.8 Cg_endo -65.68 -30.83 50.43 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.915 1.743 . . . . 0.0 109.946 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 123' ' ' PHE . 41.6 t -67.27 -45.75 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.403 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.529 ' CG1' ' HG ' ' A' ' 130' ' ' LEU . 15.5 m -70.6 -29.81 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.012 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.21 -52.56 58.21 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 109.991 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.562 ' CE ' ' CE ' ' A' ' 140' ' ' MET . 7.8 tpt -62.29 -44.12 97.25 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.312 0.577 . . . . 0.0 109.504 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.509 ' CG2' ' O ' ' A' ' 133' ' ' VAL . 61.5 t -61.61 -30.21 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.079 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -36.29 80.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.412 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -42.83 87.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 110.236 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.646 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 2.4 tpp -70.56 -33.26 70.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.002 0.906 . . . . 0.0 110.103 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.542 ' CG ' ' HB3' ' A' ' 170' ' ' LEU . 0.0 OUTLIER -77.32 -29.81 53.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.307 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -71.7 -45.11 62.89 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.649 ' CE2' ' CB ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -77.25 -22.41 52.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.389 0.614 . . . . 0.0 109.798 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 145' ' ' ALA . 1.2 p 58.4 26.3 13.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.229 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.649 ' CB ' ' CE2' ' A' ' 143' ' ' TRP . . . -37.01 160.4 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.541 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.64 14.15 1.05 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.12 2.547 . . . . 0.0 113.328 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 118' ' ' MET . 2.1 p-10 -83.14 132.3 35.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.99 0.424 . . . . 0.0 111.779 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.491 ' CB ' ' HB2' ' A' ' 176' ' ' ASN . 1.0 OUTLIER -73.94 105.12 5.05 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.626 0.727 . . . . 0.0 111.08 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 2.7 m -113.48 115.5 28.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.109 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.594 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -105.66 139.81 39.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.094 0.473 . . . . 0.0 110.157 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.464 HD12 ' O ' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -133.98 126.93 51.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.51 -178.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.597 ' OH ' ' CD2' ' A' ' 122' ' ' TYR . 17.3 m-85 -103.15 108.7 19.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.551 ' CE1' ' CD1' ' A' ' 130' ' ' LEU . 31.9 t80 -125.92 156.36 39.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.64 ' HA3' ' HB2' ' A' ' 182' ' ' CYS . . . 153.87 -172.62 32.57 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.711 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.602 HG11 ' N ' ' A' ' 127' ' ' GLY . 22.4 m -161.97 -124.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.563 ' CA ' HG23 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -108.67 160.14 16.18 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 117.484 0.129 . . . . 0.0 110.978 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.551 ' HA ' ' CG1' ' A' ' 183' ' ' VAL . 0.1 OUTLIER -4.69 -65.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.66 0.784 . . . . 0.0 112.315 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 156' ' ' ASN . 1.4 mt-10 165.67 59.14 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.229 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 160' ' ' GLU . 26.5 Cg_exo -61.2 -16.45 46.49 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.736 1.624 . . . . 0.0 109.491 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.496 ' O ' ' O ' ' A' ' 161' ' ' LEU . 1.3 tp10 174.26 -58.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.779 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.566 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 3.5 tp 41.63 -177.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.306 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.566 ' CG ' ' O ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER 154.56 179.95 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.701 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.577 ' CE1' ' HG2' ' A' ' 166' ' ' GLU . 0.0 OUTLIER 83.01 3.41 1.0 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.695 179.323 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.578 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -56.84 -41.21 75.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.578 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 0.6 OUTLIER -64.9 -27.6 68.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.831 178.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.577 ' HG2' ' CE1' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -71.54 -46.61 59.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.955 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.546 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -59.72 -30.09 68.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.515 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.438 ' HE3' HG12 ' A' ' 164' ' ' ILE . 11.9 mttt -75.83 -24.47 55.85 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.443 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.5 OUTLIER -72.72 -32.75 65.96 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.745 178.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -66.89 -48.09 69.8 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.163 176.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.435 ' OE2' HG13 ' A' ' 179' ' ' VAL . 1.2 mm-40 -56.97 -39.61 74.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.284 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -29.32 40.22 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.532 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 174' ' ' MET . 49.5 m -79.63 -72.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.531 ' HG2' ' CD1' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -52.42 -163.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.182 0.515 . . . . 0.0 111.76 -178.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -114.24 -42.34 3.36 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.604 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.491 ' HB2' ' CB ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -132.21 64.02 1.61 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.077 -179.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.543 ' HA ' ' O ' ' A' ' 149' ' ' THR . 3.2 mp -102.69 152.74 20.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.262 0.554 . . . . 0.0 111.388 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.463 ' HB ' ' CD ' ' A' ' 150' ' ' ARG . 27.3 m -136.51 114.82 11.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.899 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.501 ' CG2' ' HB2' ' A' ' 167' ' ' LEU . 8.9 p -99.63 135.27 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.431 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.74 135.62 53.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.027 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.513 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -104.38 106.76 17.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.213 0.53 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.64 ' HB2' ' HA3' ' A' ' 154' ' ' GLY . 31.3 m -80.07 -163.7 0.58 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.334 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.563 HG23 ' CA ' ' A' ' 156' ' ' ASN . 24.1 t 66.72 149.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 122.365 1.078 . . . . 0.0 113.639 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.695 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -139.09 -84.17 0.26 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.846 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.655 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 0.2 OUTLIER -140.78 29.27 0.11 Allowed Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.43 176.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.655 ' HD3' ' N ' ' A' ' 185' ' ' HIS . 52.3 Cg_exo -53.88 -138.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 122.209 1.939 . . . . 0.0 113.714 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.546 ' HA ' ' CG2' ' A' ' 157' ' ' THR . 47.0 t 173.24 35.59 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.402 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.444 ' HA2' ' CG ' ' A' ' 156' ' ' ASN . . . 86.52 16.18 62.56 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.145 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.51 64.76 1.45 Allowed 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' A' ' 249' ' ' GLY . 13.3 t-105 -133.37 127.39 33.37 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.687 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.502 ' HG2' ' CG ' ' A' ' 219' ' ' PRO . 1.2 mt-10 -113.98 105.74 13.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.717 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.535 ' CA ' ' HB2' ' A' ' 251' ' ' ALA . . . 148.44 -108.6 0.42 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.351 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.554 ' HA ' ' HB3' ' A' ' 182' ' ' CYS . 16.4 mt-10 -168.89 -95.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.513 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 64.5 mt-30 -86.95 133.95 33.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.598 ' HA2' ' CD1' ' A' ' 184' ' ' TRP . . . -22.24 106.82 0.01 OUTLIER Glycine 0 C--N 1.333 0.406 0 O-C-N 123.717 0.635 . . . . 0.0 113.214 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 5.9 m 140.11 158.98 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 O-C-N 124.245 0.615 . . . . 0.0 110.539 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.468 ' O ' ' HB ' ' A' ' 198' ' ' ILE . 49.4 Cg_exo -54.08 -70.44 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.445 2.097 . . . . 0.0 112.077 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.639 ' CG2' ' O ' ' A' ' 198' ' ' ILE . 0.3 OUTLIER 169.65 29.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 121.665 0.745 . . . . 0.0 111.111 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.507 ' OD1' ' NH2' ' A' ' 202' ' ' ARG . 1.4 m-20 -64.11 -36.81 85.25 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.312 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.33 -37.53 78.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.545 ' O ' ' CD2' ' A' ' 205' ' ' LEU . 0.1 OUTLIER -69.42 -35.22 75.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.812 0.339 . . . . 0.0 110.978 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.539 ' O ' ' HG ' ' A' ' 205' ' ' LEU . 26.8 mtt180 -59.37 -49.96 75.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.421 0.629 . . . . 0.0 111.246 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -31.94 71.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.63 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.451 ' OD1' ' OD2' ' A' ' 209' ' ' ASP . 0.5 OUTLIER -58.56 -43.23 89.29 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.287 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -61.24 -48.24 82.36 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.468 ' HG3' ' HG2' ' A' ' 233' ' ' ARG . 2.4 mt-10 -62.25 -22.15 65.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.706 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.65 -86.8 0.28 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.823 0.344 . . . . 0.0 111.623 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 0.0 OUTLIER 179.37 97.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.806 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 3.9 p30 152.55 87.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.537 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 96.37 106.09 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.547 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 t30 -172.39 -58.82 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.737 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 10.0 Cg_endo -52.72 -64.47 0.18 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.218 1.945 . . . . 0.0 110.895 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.526 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.4 OUTLIER -125.34 110.19 13.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.371 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.557 ' O ' ' O ' ' A' ' 239' ' ' GLN . 1.0 OUTLIER -107.45 125.71 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 114' ' ' LYS . 2.3 m-85 -116.13 129.68 56.44 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.5 ' HB2' ' CE ' ' A' ' 222' ' ' MET . 0.6 OUTLIER -139.86 123.42 17.23 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -178.055 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 123' ' ' PHE . 2.5 m -123.75 110.37 14.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.71 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 245' ' ' PHE . . . -176.98 -156.85 16.73 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.678 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.502 ' CG ' ' HG2' ' A' ' 191' ' ' GLU . 37.3 Cg_endo -65.79 175.61 4.35 Favored 'Trans proline' 0 N--CA 1.466 -0.11 0 C-N-CA 122.326 2.017 . . . . 0.0 111.687 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 219' ' ' PRO . 26.2 Cg_endo -62.53 -8.84 13.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.457 2.105 . . . . 0.0 112.136 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -83.15 -40.36 9.3 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 120.734 -0.745 . . . . 0.0 113.127 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.551 ' HA ' ' CA ' ' A' ' 251' ' ' ALA . 0.0 OUTLIER -56.38 -33.85 66.12 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.527 ' CB ' ' HE1' ' A' ' 222' ' ' MET . 0.0 OUTLIER -77.6 -36.81 23.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.896 178.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.416 ' OD1' HG22 ' A' ' 223' ' ' ILE . 16.0 m-20 -73.94 -47.67 35.98 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -73.22 -48.68 33.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.531 ' O ' ' CG2' ' A' ' 230' ' ' VAL . . . -60.85 -34.07 74.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.823 0.344 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 223' ' ' ILE . 8.0 m -70.0 -32.28 70.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.029 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -71.09 -45.32 63.93 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.568 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 225' ' ' ALA . 0.0 OUTLIER -62.43 -46.21 89.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.112 0.482 . . . . 0.0 110.799 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.551 ' CG1' ' HA ' ' A' ' 238' ' ' GLU . 13.0 t -60.01 -45.58 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.106 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -67.55 -29.82 69.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.187 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -31.37 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.945 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -84.22 -83.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.135 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 235' ' ' ILE . . . 140.87 -23.68 2.61 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.33 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 236' ' ' PRO . 1.4 pp -31.51 105.17 0.23 Allowed Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-O 121.128 0.489 . . . . 0.0 111.681 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.486 ' O ' ' OD1' ' A' ' 211' ' ' ASN . 79.0 Cg_exo -33.15 158.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.605 2.87 . . . . 0.0 112.542 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 238' ' ' GLU . . . 68.84 6.08 49.65 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.693 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.551 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 2.9 mp0 29.12 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.841 0.353 . . . . 0.0 111.253 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.557 ' O ' ' O ' ' A' ' 214' ' ' ILE . 7.5 mt-30 -122.68 -2.62 8.83 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.658 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.644 ' CG1' ' CD2' ' A' ' 241' ' ' PHE . 2.3 t 52.25 -82.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.153 0.501 . . . . 0.0 111.344 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.644 ' CD2' ' CG1' ' A' ' 240' ' ' VAL . 10.1 m-85 -119.28 125.4 49.01 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.26 129.62 37.89 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.874 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 216' ' ' LEU . 0.0 OUTLIER -132.21 148.26 52.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.048 178.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -125.37 106.55 9.91 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.612 ' C ' ' CD1' ' A' ' 245' ' ' PHE . 0.2 OUTLIER -136.94 144.9 43.67 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 178.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.61 ' HB3' ' CD1' ' A' ' 245' ' ' PHE . 0.4 OUTLIER 83.29 160.8 0.12 Allowed Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.429 0.691 . . . . 0.0 112.775 179.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -61.66 -138.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.67 2.913 . . . . 0.0 111.741 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.444 ' HB2' ' C ' ' A' ' 190' ' ' TRP . 10.1 p -72.84 145.84 46.67 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.298 0.571 . . . . 0.0 110.858 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 190' ' ' TRP . . . 167.98 -53.99 0.22 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.539 ' CB ' ' HB2' ' A' ' 222' ' ' MET . . . -107.69 149.12 28.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.54 -0.33 . . . . 0.0 110.49 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.551 ' CA ' ' HA ' ' A' ' 222' ' ' MET . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.173 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 m -96.29 150.6 20.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.889 0.376 . . . . 0.0 111.07 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.592 ' CE1' ' O ' ' A' ' 13' ' ' GLU . 2.6 t80 -132.09 149.02 52.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.939 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.592 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 3.9 mt-10 -108.79 119.81 40.63 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.873 0.368 . . . . 0.0 111.02 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.529 ' HB3' ' CD1' ' A' ' 102' ' ' LEU . . . -119.74 131.78 55.46 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.965 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.533 ' CB ' ' HB2' ' A' ' 33' ' ' LYS . 1.2 tt0 -92.71 137.57 32.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.117 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.581 ' CG1' ' HA ' ' A' ' 98' ' ' VAL . 10.9 t -71.28 124.55 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.75 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.504 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 7.6 p -154.36 22.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.126 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.456 ' HA3' ' HG ' ' A' ' 30' ' ' LEU . . . -150.55 -139.77 3.09 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.548 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.596 ' CD2' ' CG2' ' A' ' 27' ' ' VAL . 0.1 OUTLIER 82.57 62.71 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.174 0.512 . . . . 0.0 110.471 -179.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -101.69 148.96 24.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.589 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 12.2 m95 -89.16 114.63 25.94 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 m -95.04 -27.6 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 121.529 0.681 . . . . 0.0 109.301 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.516 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 13.8 m -143.9 173.68 11.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.348 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -54.27 -58.07 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.958 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 0.3 OUTLIER -112.69 39.23 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.801 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.52 ' CG2' HG21 ' A' ' 128' ' ' THR . 0.2 OUTLIER -145.92 135.53 23.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.522 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.596 ' CG2' ' CD2' ' A' ' 19' ' ' LEU . 1.5 p -140.6 147.19 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.084 0.469 . . . . 0.0 112.019 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.474 ' N ' HG23 ' A' ' 27' ' ' VAL . 1.9 tt0 -116.57 122.17 43.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.981 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.612 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -114.09 121.35 43.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.797 0.332 . . . . 0.0 111.726 -178.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.578 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -108.62 116.37 31.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.883 179.046 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.531 HD22 ' CD2' ' A' ' 102' ' ' LEU . 2.3 mt -122.63 133.15 54.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.048 0.452 . . . . 0.0 111.746 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -145.05 131.37 19.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.079 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.533 ' HB2' ' CB ' ' A' ' 15' ' ' GLU . 7.2 tptm -164.74 -33.38 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.515 HG21 ' ND2' ' A' ' 68' ' ' ASN . 0.3 OUTLIER . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 121.435 0.636 . . . . 0.0 111.849 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.525 ' HE3' ' CE1' ' A' ' 45' ' ' PHE . 4.8 tttp -154.72 -142.03 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.733 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.525 ' CE1' ' HE3' ' A' ' 44' ' ' LYS . 22.2 p90 -122.06 78.11 1.45 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.376 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 48' ' ' GLY . 28.1 mm-40 -113.04 166.55 10.86 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HB3' ' O ' ' A' ' 113' ' ' LEU . 32.1 Cg_exo -58.05 65.98 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.389 2.06 . . . . 0.0 111.616 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 40.39 62.46 1.57 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.223 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.487 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -30.32 148.98 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.716 0.258 . . . . 0.0 110.844 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.694 ' CD1' ' CB ' ' A' ' 65' ' ' SER . 5.3 m-85 -116.16 163.17 16.36 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.533 ' O ' ' CB ' ' A' ' 63' ' ' SER . 4.7 mtt -131.41 162.56 29.89 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.962 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 105' ' ' LYS . 4.4 t0 -125.31 102.46 7.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.842 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.533 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -150.07 156.95 42.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.595 HG21 ' N ' ' A' ' 61' ' ' SER . 0.2 OUTLIER -85.63 154.69 21.52 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.313 178.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.648 ' HB ' ' HD3' ' A' ' 56' ' ' PRO . 1.3 mt -30.4 -71.91 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 123.411 0.444 . . . . 0.0 109.906 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.648 ' HD3' ' HB ' ' A' ' 55' ' ' ILE . 9.3 Cg_endo -99.82 4.47 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.568 2.179 . . . . 0.0 111.583 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 101.41 -3.05 54.0 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.832 -178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.538 HG21 ' CG ' ' A' ' 56' ' ' PRO . 64.9 p -27.81 -87.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 122.841 0.456 . . . . 0.0 112.084 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 60' ' ' VAL . 43.9 p-10 -150.45 40.02 0.75 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.563 ' N ' HG23 ' A' ' 54' ' ' THR . 0.3 OUTLIER 90.68 121.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 178.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.595 ' N ' HG21 ' A' ' 54' ' ' THR . 40.3 t -120.72 -66.95 1.01 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.708 0.766 . . . . 0.0 109.931 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -170.41 157.94 6.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.227 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -88.73 120.7 30.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.669 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.527 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 3.0 t80 -111.7 121.18 44.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.901 0.381 . . . . 0.0 111.608 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.694 ' CB ' ' CD1' ' A' ' 50' ' ' PHE . 82.4 p -55.56 98.69 0.17 Allowed Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.732 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.563 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 2.1 Cg_endo -82.94 155.34 15.13 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.83 2.353 . . . . 0.0 111.54 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 132' ' ' PRO . . . -144.65 130.65 19.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.571 ' O ' ' CB ' ' A' ' 69' ' ' LEU . 10.0 t-20 -115.88 -63.62 1.43 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.764 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.571 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 0.6 OUTLIER 144.42 154.44 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.936 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 44' ' ' LYS . 18.0 Cg_endo -59.63 96.89 0.1 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.283 1.989 . . . . 0.0 111.225 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -179.2 138.06 0.33 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.058 0.456 . . . . 0.0 111.519 -179.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.07 79.63 3.07 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.377 . . . . 0.0 111.998 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.461 ' OE1' ' NH1' ' A' ' 75' ' ' ARG . 39.3 mt-10 -144.23 -72.84 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.961 0.41 . . . . 0.0 110.008 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.484 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . 122.83 97.08 1.33 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.335 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 85.0 mtm-85 -162.33 83.66 0.55 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 122.633 0.373 . . . . 0.0 110.888 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.533 ' CD1' ' HB2' ' A' ' 66' ' ' PRO . 30.0 mt -96.91 145.94 25.42 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.61 0.719 . . . . 0.0 112.496 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 5.9 pt-20 -131.24 141.89 50.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.433 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.649 ' CE1' ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -115.95 133.76 55.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.013 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.527 ' N ' ' OH ' ' A' ' 64' ' ' TYR . 0.9 OUTLIER -101.58 82.31 2.28 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.649 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -91.22 118.01 35.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.854 -178.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.456 ' HG2' HG21 ' A' ' 128' ' ' THR . 0.0 OUTLIER -78.33 95.99 5.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.584 ' CG1' ' CG2' ' A' ' 80' ' ' ILE . 2.3 m -94.0 142.12 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.999 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.506 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -68.14 172.63 4.05 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.799 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 83' ' ' LEU . 44.6 Cg_endo -68.68 58.39 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 0.0 112.149 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 84' ' ' PRO . 0.6 OUTLIER 67.48 72.58 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 87' ' ' ARG . . . 173.12 66.58 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.691 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 163.09 -90.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 111.132 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.533 ' O ' ' CD1' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -108.6 -27.19 10.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.26 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.554 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -60.1 -32.99 71.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 111.185 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 0.8 OUTLIER -75.93 -32.0 59.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.386 0.612 . . . . 0.0 110.842 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.403 ' O ' ' HB3' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -68.94 -51.26 41.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.878 -178.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.554 ' CD1' ' HA ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -71.59 -30.75 66.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -31.04 18.07 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.662 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 2.1 t-20 -95.87 -11.29 26.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.7 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 91' ' ' TYR . 2.2 t70 -135.58 -15.28 1.87 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.545 ' CB ' ' HB3' ' A' ' 56' ' ' PRO . . . -119.43 29.02 7.85 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.993 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 96' ' ' ALA . 1.1 mmt180 -56.58 -163.37 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.581 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 0.2 OUTLIER -86.74 -153.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-O 121.195 0.522 . . . . 0.0 110.65 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.41 -47.26 1.38 Allowed Glycine 0 C--N 1.316 -0.548 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.469 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.55 179.45 5.0 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 14' ' ' ALA . 99.6 t -121.85 145.23 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.259 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.531 ' CD2' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.6 120.36 40.74 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 108.57 13.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.533 ' HB ' ' CB ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -108.49 165.43 4.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.066 0.46 . . . . 0.0 112.079 -177.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.63 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -132.24 112.49 12.29 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 51' ' ' MET . . . -103.54 44.97 1.38 Allowed Glycine 0 CA--C 1.519 0.321 0 C-N-CA 119.533 -1.318 . . . . 0.0 115.74 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.49 ' CD ' ' C ' ' A' ' 105' ' ' LYS . 82.5 Cg_endo -81.83 38.81 0.78 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.173 1.915 . . . . 0.0 111.481 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.533 HD22 ' CB ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -88.33 173.19 8.89 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.813 0.816 . . . . 0.0 112.761 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.01 173.42 19.41 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.477 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 47' ' ' PRO . 9.3 m -108.63 107.16 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 117.925 0.862 . . . . 0.0 110.923 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 0.3 OUTLIER -123.74 122.53 38.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.476 178.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 215' ' ' TYR . . . 123.35 -84.78 0.37 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.283 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.577 ' HB2' ' CE2' ' A' ' 123' ' ' PHE . 7.7 tp -75.88 117.87 18.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.057 0.456 . . . . 0.0 110.073 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.616 ' O ' ' CZ ' ' A' ' 215' ' ' TYR . 0.1 OUTLIER -138.7 127.3 23.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.605 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 121' ' ' ARG . 2.2 pp20? -112.45 134.56 53.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.624 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -110.32 6.35 22.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.974 0.416 . . . . 0.0 111.197 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.81 -75.73 0.4 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.532 ' HA ' ' CB ' ' A' ' 147' ' ' ASN . 3.7 mpp? -129.91 89.33 2.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.887 0.375 . . . . 0.0 110.524 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.478 ' O ' ' HD3' ' A' ' 121' ' ' ARG . . . -158.36 144.2 12.41 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.243 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.86 94.67 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.599 2.2 . . . . 0.0 111.613 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -127.81 150.45 49.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.257 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.698 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -124.17 144.39 49.95 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.923 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 113' ' ' LEU . 1.9 t80 -128.35 115.36 18.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.746 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.583 ' HB ' ' CD1' ' A' ' 152' ' ' TYR . 8.0 p -98.82 111.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.101 0.477 . . . . 0.0 111.33 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 153' ' ' PHE . . . -111.31 132.84 54.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.784 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.437 ' HA3' ' C ' ' A' ' 249' ' ' GLY . . . -129.18 104.34 0.64 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.412 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.459 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 134.64 -166.13 24.33 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.033 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.52 HG21 ' CG2' ' A' ' 26' ' ' THR . 0.7 OUTLIER -98.84 -28.15 13.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.118 0.485 . . . . 0.0 110.56 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.58 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -65.5 8.24 0.8 Allowed Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.764 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.6 ' CD1' ' CD1' ' A' ' 153' ' ' PHE . 0.4 OUTLIER -79.23 4.51 14.75 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.582 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -46.9 -44.57 47.26 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.904 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 8.9 Cg_exo -69.48 -30.89 22.86 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.425 2.084 . . . . 0.0 109.748 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.542 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 13.7 t -68.12 -53.08 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.576 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.465 ' CG1' ' HG ' ' A' ' 130' ' ' LEU . 29.1 m -66.57 -30.47 49.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.625 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.3 OUTLIER -61.16 -50.73 71.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.183 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.444 ' HE1' ' HG2' ' A' ' 115' ' ' GLU . 0.5 OUTLIER -66.93 -43.03 84.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.791 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 133' ' ' VAL . 13.5 t -59.81 -37.59 72.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 134' ' ' VAL . 3.2 mtm-85 -69.43 -31.03 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.1 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 135' ' ' SER . 43.7 mt-30 -63.15 -43.03 99.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.259 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.472 ' O ' ' HB3' ' A' ' 145' ' ' ALA . 3.9 ptp -71.38 -48.87 47.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.189 0.519 . . . . 0.0 110.6 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.529 ' NE2' ' CD2' ' A' ' 177' ' ' LEU . 0.7 OUTLIER -58.2 -30.99 66.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.716 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 138' ' ' ARG . 1.3 mt-10 -82.16 -37.31 26.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.266 0.555 . . . . 0.0 110.085 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.53 ' O ' ' CG2' ' A' ' 144' ' ' THR . 0.0 OUTLIER -67.59 -9.65 44.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.651 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 143' ' ' TRP . 1.6 p 87.55 10.45 0.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.766 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.497 ' N ' ' CD1' ' A' ' 143' ' ' TRP . . . -38.79 98.42 0.17 Allowed Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.737 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.495 ' HA ' ' HB2' ' A' ' 175' ' ' ARG . 81.0 Cg_endo -78.12 8.41 3.54 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.906 2.404 . . . . 0.0 112.679 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.532 ' CB ' ' HA ' ' A' ' 118' ' ' MET . 14.7 p-10 -78.58 150.3 32.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.944 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 176' ' ' ASN . 0.2 OUTLIER -74.18 104.77 5.09 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.49 0.662 . . . . 0.0 110.99 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.476 ' O ' ' CB ' ' A' ' 177' ' ' LEU . 0.7 OUTLIER -123.01 117.21 24.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.936 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.659 ' CB ' ' CD2' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -102.71 141.55 35.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.509 ' CD1' ' O ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -134.27 126.23 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.698 ' CE1' ' HB3' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -102.89 108.1 19.17 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.6 ' CD1' ' CD1' ' A' ' 130' ' ' LEU . 7.1 t80 -124.91 153.96 41.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.852 0.358 . . . . 0.0 111.949 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.617 ' HA3' ' HB2' ' A' ' 182' ' ' CYS . . . 150.07 -168.21 30.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.711 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.544 HG22 ' CD1' ' A' ' 161' ' ' LEU . 16.4 m -163.52 -120.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.624 ' O ' ' CG2' ' A' ' 183' ' ' VAL . 2.4 p-10 -103.93 -166.01 1.21 Allowed 'General case' 0 C--N 1.35 0.613 0 C-N-CA 122.371 0.268 . . . . 0.0 111.122 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.585 ' CG2' ' HA ' ' A' ' 187' ' ' SER . 0.1 OUTLIER -28.03 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.608 0.242 . . . . 0.0 111.415 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 156' ' ' ASN . 39.6 mt-10 93.35 41.0 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.684 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 37.7 Cg_endo -66.85 -26.09 44.91 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 C-N-CA 122.137 1.891 . . . . 0.0 110.626 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -130.58 20.8 5.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.208 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.544 ' CD1' HG22 ' A' ' 155' ' ' VAL . 9.9 tp -88.57 165.31 14.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.063 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.473 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 0.9 OUTLIER 176.26 -160.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.998 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.3 OUTLIER 72.85 26.63 2.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.243 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -69.8 -35.87 67.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.912 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.574 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 9.2 m-20 -62.29 -28.47 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.299 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.466 ' O ' ' CD2' ' A' ' 170' ' ' LEU . 2.3 mm-40 -72.08 -47.46 51.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.705 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -64.22 -30.25 71.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.763 178.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 172' ' ' ARG . 4.8 mtmm -72.55 -24.8 61.17 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -35.82 71.17 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.415 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.521 HD21 ' N ' ' A' ' 170' ' ' LEU . 0.0 OUTLIER -67.64 -48.52 66.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.476 ' O ' ' SD ' ' A' ' 174' ' ' MET . 3.3 mt-10 -57.65 -32.15 67.0 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.864 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 168' ' ' LYS . 1.1 mtt-85 -79.56 -41.69 26.68 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 174' ' ' MET . 6.4 t -93.1 -50.67 5.4 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.537 ' CG ' ' HB2' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -35.62 167.19 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.966 0.889 . . . . 0.0 112.892 -178.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.495 ' HB2' ' HA ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -99.75 -71.92 0.68 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.473 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -124.63 56.31 1.3 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.787 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.537 ' HB2' ' CG ' ' A' ' 174' ' ' MET . 5.8 mp -114.47 154.69 27.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.397 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.454 ' OG1' ' HG3' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -136.06 117.79 15.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.464 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.454 ' HB ' ' OE2' ' A' ' 171' ' ' GLU . 91.0 t -89.66 134.32 29.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.6 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.528 ' CB ' ' HA ' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -104.13 135.72 45.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.013 0.435 . . . . 0.0 111.676 -179.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -103.14 107.05 17.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.905 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.673 ' HB3' ' HA ' ' A' ' 193' ' ' GLU . 38.1 m -79.91 -168.26 1.55 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.311 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.624 ' CG2' ' O ' ' A' ' 156' ' ' ASN . 52.5 t 70.07 148.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.875 0.845 . . . . 0.0 112.835 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.714 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.53 -53.3 0.6 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.586 -177.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.542 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 4.7 p-80 167.77 62.2 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 113.623 -1.626 . . . . 0.0 108.696 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.626 ' O ' ' CB ' ' A' ' 187' ' ' SER . 67.0 Cg_endo -95.65 -96.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.797 2.998 . . . . 0.0 114.305 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.626 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 28.6 t 136.78 78.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.985 0.514 . . . . 0.0 110.34 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.44 ' HA2' ' CG ' ' A' ' 156' ' ' ASN . . . 41.65 23.13 0.11 Allowed Glycine 0 C--N 1.329 0.148 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.066 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 187' ' ' SER . 0.2 OUTLIER -139.23 62.05 1.54 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.541 ' NE1' ' O ' ' A' ' 193' ' ' GLU . 19.4 t-105 -135.24 129.12 33.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.521 ' C ' ' CB ' ' A' ' 251' ' ' ALA . 1.6 mp0 -113.83 104.87 12.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.376 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.526 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 147.0 -113.07 0.63 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.272 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.673 ' HA ' ' HB3' ' A' ' 182' ' ' CYS . 80.8 mt-10 -161.42 -118.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.578 ' O ' ' O ' ' A' ' 195' ' ' GLY . 2.1 tt0 -87.75 117.74 26.79 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 194' ' ' GLN . . . 31.74 104.31 0.01 OUTLIER Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.348 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.538 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 5.86 66.68 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.2 0.6 . . . . 0.0 112.435 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.488 ' HG3' ' O ' ' A' ' 194' ' ' GLN . 22.2 Cg_endo -97.12 22.6 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.28 2.653 . . . . 0.0 113.872 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 251' ' ' ALA . 0.2 OUTLIER -87.92 -9.44 10.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.469 -179.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.16 -36.99 83.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -61.03 -29.58 69.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.334 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -64.04 -39.64 94.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.938 0.399 . . . . 0.0 110.13 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.535 ' O ' ' HG ' ' A' ' 205' ' ' LEU . 12.9 mtt180 -58.88 -48.37 81.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.514 0.673 . . . . 0.0 110.259 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.29 -32.04 68.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.013 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.76 -42.65 89.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -60.47 -48.05 83.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.408 ' OE1' ' HG3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -61.31 -21.05 63.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.019 178.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.0 t -86.31 -90.5 0.11 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.773 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 173.65 33.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.473 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 0.0 OUTLIER -145.09 58.46 1.29 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . 0.571 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 148.87 101.02 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.23 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.557 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 19.1 t30 173.84 -56.91 0.0 OUTLIER Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.175 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 12.3 Cg_endo -57.25 -53.74 4.43 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.265 1.977 . . . . 0.0 111.144 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.536 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -133.0 108.59 8.99 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.508 0.671 . . . . 0.0 109.319 178.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.53 ' C ' ' CD1' ' A' ' 215' ' ' TYR . 0.8 OUTLIER -123.51 131.04 73.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.128 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.616 ' CZ ' ' O ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -127.89 131.96 49.38 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.302 0.572 . . . . 0.0 110.679 -178.509 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.53 ' HB3' ' CG1' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -142.53 119.49 11.3 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.787 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . 0.507 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.5 OUTLIER -122.45 109.15 14.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.871 179.467 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 245' ' ' PHE . . . -178.57 -147.52 7.08 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.618 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.461 ' HB2' ' HD2' ' A' ' 220' ' ' PRO . 58.7 Cg_endo -72.48 174.5 11.52 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.504 2.136 . . . . 0.0 111.918 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 219' ' ' PRO . 26.8 Cg_endo -62.05 -8.66 12.48 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.551 2.167 . . . . 0.0 112.215 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -72.0 -54.16 8.51 Favored Glycine 0 C--O 1.224 -0.483 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.893 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.596 ' HA ' ' HA ' ' A' ' 251' ' ' ALA . 1.1 tpp -55.31 -27.96 50.42 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.538 ' O ' ' CB ' ' A' ' 227' ' ' CYS . 0.0 OUTLIER -77.17 -41.56 30.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.404 178.276 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -75.37 -49.22 19.71 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.552 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -77.13 -49.53 15.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 222' ' ' MET . . . -62.63 -35.62 80.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.948 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 223' ' ' ILE . 52.3 t -70.19 -31.96 69.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 110.306 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.5 -44.95 81.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.552 ' CD2' ' O ' ' A' ' 225' ' ' ALA . 0.0 OUTLIER -61.02 -38.96 87.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.979 0.419 . . . . 0.0 111.011 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 226' ' ' ALA . 2.3 t -64.45 -45.29 96.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.288 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.5 ' CZ ' ' SG ' ' A' ' 227' ' ' CYS . 19.0 mtt180 -74.22 -29.97 61.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.871 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 2.7 m -75.43 -44.41 44.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.469 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.528 ' NE ' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -68.4 -45.01 73.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.191 -179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 235' ' ' ILE . . . 109.18 -31.01 8.02 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.983 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.52 HG12 ' CB ' ' A' ' 205' ' ' LEU . 1.2 pp -34.27 95.99 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-O 120.829 0.347 . . . . 0.0 111.4 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.407 ' N ' ' O ' ' A' ' 234' ' ' GLY . 11.6 Cg_endo -55.25 112.5 1.06 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.744 2.296 . . . . 0.0 111.877 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -93.75 116.59 5.25 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.699 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -88.35 -46.77 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 110.67 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.592 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 6.0 mt-30 -110.31 37.56 2.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.082 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.533 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 1.5 t -89.89 129.41 40.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.178 0.513 . . . . 0.0 110.348 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.592 ' CE2' ' O ' ' A' ' 239' ' ' GLN . 0.8 OUTLIER -146.11 135.1 22.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.451 -178.179 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.07 140.93 50.12 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.56 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 8.0 tp10 -131.42 148.66 52.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.108 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -111.51 106.73 15.69 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.589 ' CD1' ' HB2' ' A' ' 246' ' ' LEU . 0.1 OUTLIER -136.16 143.97 44.75 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.052 178.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.589 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 3.2 mt 59.42 151.12 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-O 120.95 0.405 . . . . 0.0 111.337 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . 0.558 ' CD ' HD23 ' A' ' 246' ' ' LEU . 24.9 Cg_exo -64.05 -141.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.128 2.552 . . . . 0.0 112.056 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 190' ' ' TRP . 0.5 OUTLIER -43.14 148.64 0.26 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.274 0.559 . . . . 0.0 111.662 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 157.56 -66.88 0.29 Allowed Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.207 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.465 ' HB2' ' HA3' ' A' ' 218' ' ' GLY . . . -106.82 137.11 45.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.274 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.596 ' HA ' ' HA ' ' A' ' 222' ' ' MET . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.699 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.41 0 CA-C-O 121.141 0.301 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -125.22 150.04 47.39 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.927 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.648 ' CZ ' ' CG1' ' A' ' 104' ' ' VAL . 1.5 p90 -133.79 166.73 21.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.789 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -103.77 137.33 41.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.249 0.547 . . . . 0.0 111.388 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 31' ' ' LEU . . . -130.65 140.16 50.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.592 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . 2.3 tp10 -93.41 119.03 32.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.225 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.518 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 9.9 m -71.34 107.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 6.7 p -129.3 20.19 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.807 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -133.0 -128.73 2.92 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.639 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.579 HD21 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER 74.74 95.84 0.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.808 0.813 . . . . 0.0 109.407 -178.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -142.19 137.76 31.04 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.607 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -88.5 112.49 23.04 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 m -90.27 -30.65 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.712 0.768 . . . . 0.0 109.32 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.517 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 19.0 m -137.3 175.04 9.96 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.626 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.7 t -51.09 -53.41 34.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.071 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 0.8 OUTLIER -123.27 52.52 1.38 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.026 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.517 ' CB ' ' HB2' ' A' ' 23' ' ' SER . 0.2 OUTLIER -150.73 137.18 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.846 -179.489 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.525 HG12 ' CG1' ' A' ' 82' ' ' VAL . 2.0 p -141.27 147.15 22.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.119 0.485 . . . . 0.0 112.007 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.462 ' HG3' ' HG ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -119.98 113.63 20.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.154 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CB ' ' CZ ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -111.95 121.08 44.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.364 -179.259 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.561 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -102.67 119.49 38.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.329 179.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.612 ' CD1' ' CD2' ' A' ' 102' ' ' LEU . 1.2 mt -122.89 136.25 54.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 0.0 112.06 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 1.7 mt-30 -144.65 135.49 24.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.376 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER 166.21 -23.48 0.0 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.903 0.383 . . . . 0.0 111.962 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.601 ' HB3' ' CD1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.183 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 71' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.013 0.435 . . . . 0.0 110.774 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -153.92 22.67 0.51 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.756 -178.318 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.594 ' CE1' ' HA ' ' A' ' 136' ' ' MET . 0.0 OUTLIER 58.21 127.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.538 -179.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.562 ' O ' ' N ' ' A' ' 48' ' ' GLY . 32.0 mt-10 -113.28 145.27 32.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.513 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 80.6 Cg_exo -45.11 81.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.63 2.22 . . . . 0.0 112.36 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 38.9 46.77 2.35 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.335 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.475 ' HA ' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -71.88 151.18 43.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.622 0.249 . . . . 0.0 110.698 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.632 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -133.31 163.21 29.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.96 0.409 . . . . 0.0 111.392 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.546 ' O ' ' CB ' ' A' ' 63' ' ' SER . 1.7 mtt -131.74 -167.82 1.93 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.699 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' A' ' 105' ' ' LYS . 7.9 t0 -133.39 115.32 14.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.969 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.584 ' CD1' ' CG2' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -149.6 157.39 43.21 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.618 ' HA ' ' HB3' ' A' ' 61' ' ' SER . 0.0 OUTLIER -109.97 150.87 27.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.737 179.319 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.619 ' HB ' ' HD3' ' A' ' 56' ' ' PRO . 1.5 mt -32.85 -77.12 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 55' ' ' ILE . 4.1 Cg_endo -96.01 9.31 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.199 1.932 . . . . 0.0 111.582 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 102.37 1.67 50.65 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.669 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.534 ' CG2' ' HG2' ' A' ' 56' ' ' PRO . 29.8 p -46.58 -104.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.661 0.267 . . . . 0.0 111.302 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.549 ' CA ' HG22 ' A' ' 54' ' ' THR . 1.3 m-20 169.24 30.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.726 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.409 ' H ' ' CG2' ' A' ' 54' ' ' THR . 0.6 OUTLIER -140.89 34.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.684 0.278 . . . . 0.0 111.111 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.618 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 28.2 t -108.63 -104.17 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.901 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.455 ' CG ' ' O ' ' A' ' 61' ' ' SER . 0.3 OUTLIER 172.44 -169.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 111.019 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 51' ' ' MET . 1.8 m -101.89 145.07 29.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.86 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 78' ' ' PHE . 2.4 t80 -143.51 130.3 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.608 ' OG ' ' CD2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -59.84 105.49 0.57 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.454 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.578 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 57.6 Cg_endo -90.34 131.93 1.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.648 2.232 . . . . 0.0 111.482 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -144.28 138.61 28.07 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.571 ' N ' ' OD1' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -113.21 -67.69 0.98 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.551 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER 151.03 150.5 0.0 OUTLIER Pre-proline 0 CA--C 1.521 -0.166 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.998 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 12.6 Cg_endo -56.75 96.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.719 1.613 . . . . 0.0 111.37 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.549 ' ND2' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER 177.21 166.48 0.49 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-O 121.362 0.601 . . . . 0.0 112.053 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 71' ' ' ASN . 88.7 Cg_endo -90.5 73.64 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.347 2.698 . . . . 0.0 112.543 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 3.2 tp10 -129.19 -16.68 3.96 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.464 ' HA2' ' CG1' ' A' ' 43' ' ' VAL . . . 42.46 78.78 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.23 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -155.96 112.85 3.18 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 120.738 0.304 . . . . 0.0 110.313 -178.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.547 ' C ' ' CD1' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -95.23 130.65 41.89 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.062 0.458 . . . . 0.0 110.275 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 67' ' ' ALA . 16.9 pt-20 -127.54 125.49 40.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.123 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.686 ' CD1' ' CG2' ' A' ' 80' ' ' ILE . 2.0 p90 -118.93 144.15 46.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.343 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.54 ' N ' ' OH ' ' A' ' 64' ' ' TYR . 2.7 mt -112.6 74.97 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.73 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.686 ' CG2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -91.85 127.08 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.456 0.646 . . . . 0.0 111.085 -179.073 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 0.7 OUTLIER -78.59 105.98 10.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.194 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.525 ' CG1' HG12 ' A' ' 27' ' ' VAL . 2.6 m -96.17 122.45 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.206 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.525 ' CD1' ' HG3' ' A' ' 87' ' ' ARG . 16.2 mt -41.28 168.52 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.98 0.419 . . . . 0.0 111.178 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 52.8 Cg_exo -54.53 -49.66 16.09 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.703 2.269 . . . . 0.0 112.361 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 84' ' ' PRO . 2.5 mt-10 176.29 61.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 87' ' ' ARG . . . -175.86 57.72 0.11 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.749 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.525 ' HG3' ' CD1' ' A' ' 83' ' ' LEU . 0.1 OUTLIER 170.34 -95.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.597 0.237 . . . . 0.0 111.135 179.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.554 ' CE1' HD13 ' A' ' 80' ' ' ILE . 2.8 t80 -93.64 -27.01 16.82 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 111.195 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 80.4 p -73.16 -20.39 60.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 5.0 m-20 -74.22 -40.21 62.59 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.56 ' CD1' HD12 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -73.16 -21.14 60.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.867 178.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.562 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -65.76 -47.59 74.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.602 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -16.6 24.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.591 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 1.9 t-20 -99.82 1.71 43.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.561 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -171.1 22.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 92' ' ' LEU . . . -138.56 28.39 2.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.235 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -51.51 -166.92 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.715 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.431 ' O ' HG11 ' A' ' 98' ' ' VAL . 2.1 t -125.21 95.96 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-O 121.463 0.649 . . . . 0.0 110.717 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 158.16 34.2 0.02 OUTLIER Glycine 0 C--N 1.316 -0.561 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.735 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.459 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -144.63 174.93 10.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.959 0.409 . . . . 0.0 111.198 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 102' ' ' LEU . 11.5 p -105.59 143.74 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.466 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.612 ' CD2' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -120.28 140.9 50.54 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.797 0.332 . . . . 0.0 110.986 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.3 m -100.34 115.2 29.41 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.648 ' CG1' ' CZ ' ' A' ' 12' ' ' PHE . 1.1 t -105.26 133.72 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.626 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -130.56 110.67 11.6 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.019 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.535 ' CA ' ' HA ' ' A' ' 51' ' ' MET . . . -123.75 84.08 0.36 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 119.597 -1.287 . . . . 0.0 114.924 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -91.72 30.05 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.126 2.551 . . . . 0.0 110.417 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -88.07 173.04 9.09 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.842 -178.252 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -114.59 174.71 15.62 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.317 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.513 ' CG1' ' O ' ' A' ' 47' ' ' PRO . 35.9 m -107.62 107.45 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 117.91 0.855 . . . . 0.0 110.936 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.45 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 55.5 m-85 -123.0 114.75 20.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.548 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 215' ' ' TYR . . . 142.85 -88.92 0.17 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.366 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -82.86 116.4 22.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 110.565 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.652 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.1 OUTLIER -139.19 110.6 7.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.514 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.519 ' HB2' ' NH1' ' A' ' 121' ' ' ARG . 2.0 tt0 -95.21 138.63 32.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.67 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -103.06 9.53 38.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.453 . . . . 0.0 111.071 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.88 -79.02 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.559 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.47 ' HA ' ' HB3' ' A' ' 147' ' ' ASN . 5.9 mtp -130.18 90.14 2.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.87 0.367 . . . . 0.0 110.44 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 121' ' ' ARG . . . -159.53 146.04 12.34 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.435 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.466 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 42.7 Cg_endo -67.35 102.43 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.696 2.264 . . . . 0.0 111.24 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.525 ' HB2' ' CE2' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -124.1 147.01 48.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.353 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.647 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 3.3 m-85 -110.19 122.3 47.3 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 113' ' ' LEU . 2.3 t80 -123.46 126.61 47.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.671 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.674 ' HB ' ' CD2' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -131.34 145.24 35.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.049 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -116.95 133.68 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.288 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -102.49 103.8 2.5 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.939 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.543 ' HA2' HG11 ' A' ' 155' ' ' VAL . . . 105.41 -161.81 14.56 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.875 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.499 ' C ' ' H ' ' A' ' 130' ' ' LEU . 19.4 m -96.14 -10.4 28.3 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 110.791 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.643 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -67.25 11.34 0.75 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.393 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.524 ' HG ' ' CG1' ' A' ' 134' ' ' VAL . 0.8 OUTLIER -73.01 3.08 5.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 122.662 0.385 . . . . 0.0 110.279 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.601 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -45.96 -40.95 18.27 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.27 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 2.9 Cg_endo -78.46 -31.02 2.88 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.821 2.347 . . . . 0.0 110.279 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.571 HG12 ' CE2' ' A' ' 123' ' ' PHE . 24.6 t -65.14 -43.82 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.828 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.524 ' CG1' ' HG ' ' A' ' 130' ' ' LEU . 33.8 m -70.26 -31.26 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.704 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.413 ' N ' HG22 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -63.77 -51.09 66.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.256 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.594 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -62.42 -46.91 86.45 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.172 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 133' ' ' VAL . 23.6 t -60.1 -30.63 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.108 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -62.77 -36.52 83.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.438 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.579 ' HG3' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -63.93 -42.65 97.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.448 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.635 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -64.52 -34.25 77.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.771 0.796 . . . . 0.0 110.173 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.533 ' OE1' ' CD2' ' A' ' 170' ' ' LEU . 0.1 OUTLIER -79.36 -30.12 42.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.603 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -44.83 79.02 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.728 0.299 . . . . 0.0 111.356 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.651 ' CE2' ' CB ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -82.46 -19.94 37.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.582 0.706 . . . . 0.0 109.718 179.026 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.501 ' O ' ' O ' ' A' ' 145' ' ' ALA . 5.1 m 51.61 29.45 5.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.268 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.651 ' CB ' ' CE2' ' A' ' 143' ' ' TRP . . . -37.22 162.3 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.824 0.345 . . . . 0.0 110.568 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.511 ' HA ' ' NE ' ' A' ' 175' ' ' ARG . 74.6 Cg_endo -78.79 13.32 1.96 Allowed 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.741 2.294 . . . . 0.0 112.955 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.471 ' C ' ' ND2' ' A' ' 176' ' ' ASN . 31.6 p-10 -91.35 136.71 32.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.153 0.502 . . . . 0.0 111.989 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.466 ' HG3' ' HB3' ' A' ' 120' ' ' PRO . 3.6 pm0 -73.84 119.67 18.37 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.66 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 41.9 m -115.55 124.53 51.24 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.671 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.625 ' NE ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.4 131.17 47.63 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.845 178.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 151' ' ' ILE . 0.2 OUTLIER -127.19 109.08 19.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.43 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.674 ' CD2' ' HB ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -121.31 110.04 15.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.457 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.578 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -122.22 147.3 46.36 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.394 -178.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.647 ' CA ' ' HB2' ' A' ' 182' ' ' CYS . . . -148.82 171.4 29.13 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.606 -1.283 . . . . 0.0 114.224 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.555 ' CG1' ' O ' ' A' ' 154' ' ' GLY . 3.0 m -167.72 -111.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.589 ' CB ' ' N ' ' A' ' 188' ' ' GLY . 0.4 OUTLIER -124.36 -170.32 2.12 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 120.709 0.29 . . . . 0.0 111.414 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.564 HG23 ' N ' ' A' ' 187' ' ' SER . 49.5 p -27.04 -64.47 0.08 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.705 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.9 mt-10 152.26 -50.75 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.312 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 85.9 Cg_exo -38.85 -26.84 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.745 2.297 . . . . 0.0 112.511 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.456 ' O ' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -87.93 -30.87 19.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.025 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.533 ' CD2' HG21 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -105.07 -172.5 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.0 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.465 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 0.5 OUTLIER 176.71 -155.56 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.071 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.553 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 77.4 9.58 2.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.632 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.583 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -57.74 -44.33 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 110.162 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.583 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 2.4 m-20 -62.43 -28.09 69.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.111 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 1.8 mt-10 -71.72 -47.41 54.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.837 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.578 HD13 ' CZ ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -62.34 -30.64 71.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.98 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 171' ' ' GLU . 13.2 mttm -60.41 -47.72 84.87 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -31.66 72.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.533 ' CD2' ' OE1' ' A' ' 141' ' ' GLN . 0.5 OUTLIER -65.15 -35.62 81.68 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.533 ' CG ' HG23 ' A' ' 179' ' ' VAL . 0.9 OUTLIER -62.96 -41.64 99.59 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.967 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.54 -37.65 59.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.397 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.5 t -65.34 -14.79 61.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.478 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.593 ' CG ' ' HB3' ' A' ' 177' ' ' LEU . 2.2 tpt -94.3 178.63 5.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.203 0.525 . . . . 0.0 111.311 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.511 ' NE ' ' HA ' ' A' ' 146' ' ' PRO . 6.0 tpp180 -96.18 -71.61 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.119 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.471 ' ND2' ' C ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -128.04 63.16 1.41 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.671 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.593 ' HB3' ' CG ' ' A' ' 174' ' ' MET . 0.0 OUTLIER -109.49 160.3 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.255 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.562 ' N ' ' CD2' ' A' ' 177' ' ' LEU . 1.8 m -137.55 121.95 18.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.117 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.533 HG23 ' CG ' ' A' ' 171' ' ' GLU . 53.7 t -90.06 135.71 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.167 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.519 ' CB ' ' HB3' ' A' ' 152' ' ' TYR . 3.2 tptp -108.47 130.27 55.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.687 0.28 . . . . 0.0 110.882 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.54 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -99.78 104.61 16.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 111.038 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.647 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 63.1 m -80.43 -157.87 0.17 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.956 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.574 HG23 ' CA ' ' A' ' 156' ' ' ASN . 22.5 t 57.66 143.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.485 0.66 . . . . 0.0 111.166 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.737 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -130.16 -59.82 1.03 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.916 -178.005 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.564 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 0.1 OUTLIER -168.06 51.84 0.22 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.692 178.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.624 ' O ' ' CB ' ' A' ' 187' ' ' SER . 96.2 Cg_endo -89.87 -98.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.967 2.445 . . . . 0.0 112.876 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.624 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 23.6 t 139.6 3.41 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.454 0.471 . . . . 0.0 112.199 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.589 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 124.22 11.47 4.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.539 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.31 62.4 1.59 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.569 ' CE3' ' N ' ' A' ' 191' ' ' GLU . 4.5 t-105 -129.86 116.25 18.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.387 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.569 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 0.9 OUTLIER -91.52 103.83 16.39 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.528 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 143.06 -123.82 2.2 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.344 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.607 ' C ' ' HB3' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -163.1 -93.92 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.592 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -87.56 120.72 29.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 194' ' ' GLN . . . 5.14 107.3 0.0 OUTLIER Glycine 0 C--N 1.35 1.321 0 O-C-N 123.735 0.647 . . . . 0.0 112.748 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER 11.98 -73.11 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.7 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 196' ' ' SER . 75.3 Cg_exo -22.67 68.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.845 3.697 . . . . 0.0 114.535 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.692 ' N ' ' O ' ' A' ' 196' ' ' SER . 0.3 OUTLIER -88.28 14.49 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.416 0.627 . . . . 0.0 110.311 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.459 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 0.2 OUTLIER -59.43 -36.24 75.53 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.911 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -58.72 -31.37 68.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.673 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.517 ' O ' ' CD2' ' A' ' 205' ' ' LEU . 0.2 OUTLIER -69.27 -34.15 74.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.154 0.502 . . . . 0.0 110.27 179.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.546 ' O ' ' HG ' ' A' ' 205' ' ' LEU . 46.8 mtt180 -60.1 -45.72 92.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.325 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.74 -32.78 71.51 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.946 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 207' ' ' SER . 88.6 m-20 -58.95 -43.76 91.31 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.019 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -60.59 -45.86 92.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -62.15 -25.6 67.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.487 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 208' ' ' SER . 1.1 t -70.81 -86.71 0.02 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.157 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.41 ' N ' ' OG ' ' A' ' 207' ' ' SER . 0.5 OUTLIER 178.31 30.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.517 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 1.8 m-20 -148.87 60.98 1.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.779 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 155.96 97.22 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.655 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.552 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 17.6 t30 174.39 -56.53 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.992 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 27.5 Cg_endo -62.08 -50.49 4.86 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.477 2.118 . . . . 0.0 111.208 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.533 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -132.44 109.97 10.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.181 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.527 ' HB ' ' CG2' ' A' ' 240' ' ' VAL . 0.9 OUTLIER -123.26 125.42 71.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -123.06 127.5 48.84 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.76 0.791 . . . . 0.0 112.007 -177.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 223' ' ' ILE . 0.9 OUTLIER -134.97 115.36 13.46 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.716 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . 0.496 ' C ' ' CD ' ' A' ' 219' ' ' PRO . 1.8 t -124.64 112.81 17.22 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.55 ' N ' ' CD ' ' A' ' 219' ' ' PRO . . . 112.83 -40.08 2.65 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.285 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.551 ' HB2' ' CB ' ' A' ' 222' ' ' MET . 55.7 Cg_endo -91.84 83.9 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.618 2.212 . . . . 0.0 113.562 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.569 ' N ' ' HB2' ' A' ' 250' ' ' ALA . 9.9 Cg_endo -52.03 -70.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.689 2.26 . . . . 0.0 111.587 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.449 ' N ' ' HB2' ' A' ' 250' ' ' ALA . . . -53.35 -48.17 60.46 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.836 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.551 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.2 OUTLIER -55.66 -25.14 37.88 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -75.84 -37.45 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.387 178.382 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -70.35 -46.67 63.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.849 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.564 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -70.18 -47.62 60.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.281 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 222' ' ' MET . . . -59.73 -39.97 86.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.329 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.482 ' HA ' HG21 ' A' ' 230' ' ' VAL . 13.3 t -70.28 -31.92 69.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.16 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -44.65 77.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.831 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.564 ' CD2' ' O ' ' A' ' 225' ' ' ALA . 0.0 OUTLIER -60.52 -35.93 77.16 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.108 0.48 . . . . 0.0 110.453 179.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 226' ' ' ALA . 2.8 t -65.68 -44.89 93.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.035 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.5 mtt85 -73.48 -30.3 63.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.0 -44.08 32.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.48 ' HD3' ' O ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -55.99 -59.69 4.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.989 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 137.65 -50.9 0.8 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.214 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.513 HD11 ' CB ' ' A' ' 205' ' ' LEU . 0.7 OUTLIER -34.99 94.84 0.08 OUTLIER Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.128 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 28.1 Cg_endo -62.7 127.47 20.71 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.825 2.35 . . . . 0.0 112.225 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -95.31 -175.33 37.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.687 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -157.47 -40.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 110.622 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.576 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 8.3 mm-40 -110.73 42.38 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.336 0.589 . . . . 0.0 110.48 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 214' ' ' ILE . 2.4 t -91.64 137.52 21.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.652 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -141.69 140.73 33.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.159 -178.301 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.549 ' CB ' HG12 ' A' ' 223' ' ' ILE . 5.6 p90 -131.14 139.27 49.77 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.296 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . 0.521 ' N ' HD13 ' A' ' 223' ' ' ILE . 0.8 OUTLIER -131.79 148.74 52.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.036 179.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 220' ' ' PRO . 1.9 mptt -124.03 105.71 9.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.643 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.2 OUTLIER -138.02 145.84 42.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 178.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.572 HD21 ' CD ' ' A' ' 247' ' ' PRO . 5.2 mt 67.83 163.99 0.13 Allowed Pre-proline 0 N--CA 1.468 0.461 0 CA-C-O 120.81 0.338 . . . . 0.0 111.294 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . 0.572 ' CD ' HD21 ' A' ' 246' ' ' LEU . 54.9 Cg_endo -86.41 -103.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.284 2.656 . . . . 0.0 112.111 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 247' ' ' PRO . 32.3 m -37.93 137.29 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.013 0.435 . . . . 0.0 110.547 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 124.76 -15.38 7.5 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.569 ' HB2' ' N ' ' A' ' 220' ' ' PRO . . . -107.49 110.76 22.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.957 -0.621 . . . . 0.0 111.515 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.528 ' N ' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.108 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' C ' ' HG3' ' A' ' 105' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.349 0 CA-C-O 121.081 0.267 . . . . 0.0 112.637 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.531 ' CB ' ' HB2' ' A' ' 105' ' ' LYS . 25.4 t -123.48 150.04 44.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.845 0.355 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.577 ' CD2' HG22 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -133.01 165.37 24.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.15 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.515 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 2.0 mp0 -105.98 133.08 51.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.134 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.574 ' HB1' ' CZ ' ' A' ' 12' ' ' PHE . . . -123.23 144.29 49.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.727 0.299 . . . . 0.0 111.012 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 32' ' ' GLN . 1.2 pt-20 -93.58 120.75 34.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.811 0.338 . . . . 0.0 110.123 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.539 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 3.9 m -71.67 105.74 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.252 0.549 . . . . 0.0 111.06 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.93 -33.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.018 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -79.18 -129.02 0.61 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.03 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.606 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 71.39 95.53 0.07 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.978 0.894 . . . . 0.0 109.747 -179.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -142.32 143.22 32.67 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.858 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.524 ' NE1' ' HD3' ' A' ' 93' ' ' ARG . 3.3 m0 -88.43 113.16 23.74 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 m -92.05 -29.9 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-O 121.747 0.784 . . . . 0.0 108.963 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.512 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 12.0 m -137.6 173.83 11.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.471 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.523 ' CB ' ' HG2' ' A' ' 160' ' ' GLU . 18.6 t -53.51 -53.34 52.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.095 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 82' ' ' VAL . 98.6 m-20 -119.19 47.6 1.65 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.397 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.61 ' CG2' ' CG2' ' A' ' 128' ' ' THR . 0.2 OUTLIER -149.02 140.97 23.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.735 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.518 ' CG1' HG23 ' A' ' 80' ' ' ILE . 1.4 p -140.34 147.4 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.144 0.497 . . . . 0.0 112.087 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.8 105.26 13.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.932 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.598 ' CE2' HD21 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -100.07 128.69 46.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.882 -178.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.507 HD13 ' N ' ' A' ' 30' ' ' LEU . 6.9 mp -118.35 116.86 27.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.899 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.556 ' CD2' ' CE1' ' A' ' 29' ' ' PHE . 5.1 mt -114.03 133.84 55.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.029 0.442 . . . . 0.0 112.054 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.516 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -144.27 136.71 26.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.648 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.483 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -170.43 -94.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.707 0.289 . . . . 0.0 111.586 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.523 0 CA-C-O 121.118 0.485 . . . . 0.0 110.185 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.524 ' CG1' ' OD1' ' A' ' 68' ' ' ASN . 0.6 OUTLIER . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 121.356 0.598 . . . . 0.0 111.66 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.529 ' HG2' ' CD1' ' A' ' 45' ' ' PHE . 5.9 ttpt -148.57 -141.63 0.11 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.689 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.529 ' CD1' ' HG2' ' A' ' 44' ' ' LYS . 48.6 p90 -95.06 56.46 1.94 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.282 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.6 OUTLIER -114.21 127.61 26.65 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.442 ' HD2' ' OE1' ' A' ' 46' ' ' GLU . 63.3 Cg_exo -32.01 84.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.842 2.361 . . . . 0.0 112.111 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 33.32 73.06 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.889 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.499 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.8 OUTLIER -32.66 154.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.906 0.353 . . . . 0.0 110.851 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.671 ' CD2' ' CB ' ' A' ' 65' ' ' SER . 1.3 m-85 -122.92 163.23 20.74 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.561 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -133.06 162.82 30.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.47 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 105' ' ' LYS . 2.8 t0 -122.66 109.29 14.09 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 110.249 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.636 ' CD1' ' CD1' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.16 158.9 44.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.53 0.681 . . . . 0.0 112.225 -178.351 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.651 ' HA ' ' HB3' ' A' ' 61' ' ' SER . 0.0 OUTLIER -103.09 151.0 23.06 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.455 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.703 ' CG2' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -32.32 -68.62 0.15 Allowed Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.72 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.703 ' HD3' ' CG2' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -103.89 2.27 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.926 2.417 . . . . 0.0 111.144 177.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 109.9 -0.07 30.26 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.084 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.547 HG21 ' CD ' ' A' ' 56' ' ' PRO . 30.4 p -31.16 -98.47 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.515 0.326 . . . . 0.0 111.449 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.554 ' N ' HG22 ' A' ' 54' ' ' THR . 10.1 p-10 160.5 31.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.71 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 59' ' ' ASP . 2.7 t -158.8 40.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.044 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.651 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 45.4 t -107.66 -103.34 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 4.7 mtm180 172.77 -174.36 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.99 0.424 . . . . 0.0 111.037 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -105.33 123.95 48.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.636 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 78' ' ' PHE . 1.2 t80 -107.36 126.14 52.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.819 0.343 . . . . 0.0 110.633 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.671 ' CB ' ' CD2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -63.78 104.94 0.57 Allowed Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.791 -179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.573 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 7.2 Cg_exo -73.25 152.74 50.52 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.528 2.152 . . . . 0.0 110.861 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 132' ' ' PRO . . . -121.4 128.53 52.3 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.569 ' O ' ' CB ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -135.71 -81.11 0.41 Allowed 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.631 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.569 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER 146.59 171.65 0.0 OUTLIER Pre-proline 0 C--N 1.339 0.134 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.156 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 69' ' ' LEU . 29.4 Cg_endo -63.63 88.26 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 121.654 1.569 . . . . 0.0 111.858 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.559 ' ND2' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -170.41 139.29 1.42 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 111.173 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -86.8 67.13 4.48 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.942 2.428 . . . . 0.0 114.541 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.497 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 37.2 mp0 -136.77 -116.26 0.17 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.69 71.61 0.17 Allowed Glycine 0 CA--C 1.543 1.829 0 N-CA-C 116.114 1.206 . . . . 0.0 116.114 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -121.72 82.0 1.89 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.275 1.537 . . . . 0.0 110.296 178.345 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.554 ' C ' ' CD1' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -97.17 129.3 44.55 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.333 0.587 . . . . 0.0 111.447 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 3.5 mt-10 -130.77 121.17 24.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.739 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.605 ' CE1' ' HB ' ' A' ' 80' ' ' ILE . 1.3 p90 -114.86 140.55 48.87 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.968 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.535 ' CD2' ' HB2' ' A' ' 131' ' ' ALA . 0.7 OUTLIER -102.44 84.1 2.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.605 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -90.37 139.94 16.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.728 -177.395 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.524 ' NE ' ' HD3' ' A' ' 247' ' ' PRO . 0.0 OUTLIER -78.05 112.03 14.56 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.517 ' CG2' HG11 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -105.9 138.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.783 -178.277 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 85' ' ' GLU . 9.0 mt -101.4 158.55 31.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.768 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 83' ' ' LEU . 26.2 Cg_endo -62.06 67.71 0.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.673 2.249 . . . . 0.0 112.023 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 83' ' ' LEU . 29.2 mm-40 75.63 53.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.647 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.14 -97.19 1.35 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.665 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -125.57 -48.46 1.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.67 0.271 . . . . 0.0 111.157 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.571 ' CZ ' ' HA ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -85.52 -32.95 21.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 0.0 110.859 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.564 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 3.3 p -70.01 -20.58 63.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.28 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 9.9 m-20 -77.25 -34.12 55.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.31 0.576 . . . . 0.0 110.867 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.599 ' CE1' ' HA ' ' A' ' 56' ' ' PRO . 35.0 t80 -73.51 -51.41 17.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.93 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.564 ' CD1' ' HA ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -70.97 -29.63 65.68 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.074 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.524 ' HD3' ' NE1' ' A' ' 21' ' ' TRP . 8.4 mtm180 -90.55 -27.46 19.13 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.81 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 1.9 t-20 -102.56 -5.45 23.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.702 0.287 . . . . 0.0 110.845 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 91' ' ' TYR . 2.9 t70 -130.22 -23.47 2.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 92' ' ' LEU . . . -96.51 28.67 3.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.15 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 7.2 mmm180 -97.03 -47.4 5.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.045 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.537 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.6 OUTLIER -72.95 -1.17 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.864 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.475 ' HA2' HG23 ' A' ' 16' ' ' VAL . . . 77.05 20.41 75.82 Favored Glycine 0 C--N 1.32 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.047 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.528 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 25.0 mt-30 -47.96 179.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 111.186 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.439 ' CG1' ' O ' ' A' ' 14' ' ' ALA . 2.1 t -109.54 139.77 31.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.977 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.636 ' CD1' ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -130.09 126.21 37.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.298 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 12' ' ' PHE . 1.5 t -94.78 140.47 29.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 111.915 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.577 HG22 ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -115.91 142.22 30.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.901 178.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 25.6 ttpp -131.63 113.23 13.36 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.192 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 50' ' ' PHE . . . 162.49 98.38 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 118.921 -1.609 . . . . 0.0 114.592 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -92.9 29.95 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.414 2.743 . . . . 0.0 110.014 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.566 ' HG ' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -88.61 166.74 13.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.466 -177.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.566 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -146.07 171.78 26.89 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.354 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.594 HG13 ' CZ ' ' A' ' 50' ' ' PHE . 3.5 p -158.05 121.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.222 0.534 . . . . 0.0 111.067 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -70.1 135.93 49.72 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.508 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -146.66 -41.09 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.644 ' HA ' ' CG ' ' A' ' 215' ' ' TYR . 1.4 pt? -133.27 119.51 19.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.166 0.508 . . . . 0.0 110.432 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.651 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.4 OUTLIER -137.93 114.79 10.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.452 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.463 ' HA ' ' OH ' ' A' ' 215' ' ' TYR . 7.5 pm0 -83.62 140.62 32.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.693 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.41 15.01 5.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.746 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.82 -78.06 0.25 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.9 mtt -130.04 89.92 2.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.85 0.357 . . . . 0.0 110.153 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.46 ' O ' ' HD3' ' A' ' 121' ' ' ARG . . . -165.6 150.84 8.03 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.455 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 47.6 Cg_endo -68.75 104.83 1.21 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.806 2.337 . . . . 0.0 112.078 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -120.81 146.66 46.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.692 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.657 ' CZ ' ' CD ' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -115.52 141.05 48.58 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.168 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.574 ' CD2' HD11 ' A' ' 113' ' ' LEU . 1.1 t80 -122.42 117.16 25.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.866 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.615 ' HB ' ' CE1' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -106.2 113.29 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.365 0.602 . . . . 0.0 111.943 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -100.83 133.12 45.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.201 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -112.47 103.62 1.48 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.643 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.561 ' HA2' ' CG1' ' A' ' 155' ' ' VAL . . . 106.31 -156.57 16.24 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.621 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.61 ' CG2' ' CG2' ' A' ' 26' ' ' THR . 8.6 m -100.35 -17.01 17.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.955 0.407 . . . . 0.0 111.132 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.591 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -63.71 10.1 0.23 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.098 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' A' ' 128' ' ' THR . 0.4 OUTLIER -77.86 3.62 13.95 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.895 0.348 . . . . 0.0 110.08 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.592 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -46.75 -43.96 42.25 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.966 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 2.8 Cg_exo -74.02 -30.74 8.68 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.933 2.422 . . . . 0.0 110.399 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.57 ' CG1' ' CE2' ' A' ' 123' ' ' PHE . 10.7 t -64.64 -46.82 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.601 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 131' ' ' ALA . 19.3 m -66.86 -30.75 50.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.21 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -66.72 -50.82 61.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.859 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.439 ' O ' ' HB2' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -63.88 -39.07 93.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.029 178.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.7 t -62.61 -44.8 99.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.333 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -60.9 -31.04 70.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.229 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 143' ' ' TRP . 75.2 mt-30 -63.47 -41.74 98.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.485 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.459 ' HE3' ' HG3' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -57.68 -51.98 67.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.687 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.53 ' HG2' ' CG ' ' A' ' 174' ' ' MET . 1.7 mp0 -69.23 -33.46 73.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.701 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -80.89 -12.25 59.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.983 0.42 . . . . 0.0 111.012 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.476 ' C ' ' CG2' ' A' ' 144' ' ' THR . 3.8 m95 -89.21 -85.05 0.21 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.303 0.573 . . . . 0.0 111.554 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.51 ' O ' ' OG1' ' A' ' 144' ' ' THR . 0.6 OUTLIER -174.69 26.52 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.652 -178.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.458 ' CB ' ' HE2' ' A' ' 140' ' ' MET . . . -111.81 54.39 0.42 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.388 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.526 ' O ' ' CB ' ' A' ' 175' ' ' ARG . 57.7 Cg_endo -70.75 -1.56 9.48 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.663 2.242 . . . . 0.0 112.132 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.501 ' C ' ' ND2' ' A' ' 176' ' ' ASN . 0.7 OUTLIER -50.43 -169.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 1.2 mt-10 -71.87 105.2 3.72 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.586 0.707 . . . . 0.0 110.294 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 98.8 m -117.43 117.38 29.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.595 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.657 ' CD ' ' CZ ' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -102.73 135.72 43.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.091 0.472 . . . . 0.0 110.493 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 151' ' ' ILE . 0.3 OUTLIER -133.19 109.72 14.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.033 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.643 ' CZ ' ' HB3' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -107.1 109.27 21.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.543 ' CZ ' HD21 ' A' ' 161' ' ' LEU . 2.1 t80 -111.91 145.39 39.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.586 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.601 ' CA ' ' HB2' ' A' ' 182' ' ' CYS . . . -162.0 167.01 36.52 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.63 -1.748 . . . . 0.0 114.717 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.565 ' CG1' ' O ' ' A' ' 154' ' ' GLY . 17.0 m -164.95 -119.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.471 -0.865 . . . . 0.0 110.998 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.613 ' CB ' ' N ' ' A' ' 188' ' ' GLY . 1.4 p30 -112.55 -171.38 1.85 Allowed 'General case' 0 C--N 1.343 0.284 0 O-C-N 122.243 -0.285 . . . . 0.0 111.118 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.546 ' CG2' ' HA ' ' A' ' 187' ' ' SER . 0.2 OUTLIER -32.01 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.768 0.318 . . . . 0.0 111.071 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 19.5 mt-10 89.05 39.1 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.305 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 24.8 Cg_endo -62.22 -25.97 77.25 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 C-N-CA 122.296 1.997 . . . . 0.0 110.698 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.523 ' HG2' ' CB ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -121.73 -28.15 4.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.045 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.543 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 5.3 tp -40.41 165.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.783 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER 177.38 -153.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.926 0.393 . . . . 0.0 111.079 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.524 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 72.33 7.68 5.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.361 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -59.72 -41.81 86.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.561 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 18.5 m-20 -61.88 -27.84 69.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.179 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.51 ' HG3' ' CD1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -72.33 -41.85 66.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.994 179.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -71.5 -31.53 67.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.075 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.492 ' HD3' ' HA ' ' A' ' 165' ' ' ASP . 14.1 mtpp -61.3 -46.36 90.65 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 6.0 m -63.0 -31.87 73.11 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.476 HD23 ' OE1' ' A' ' 141' ' ' GLN . 1.0 OUTLIER -62.9 -36.67 84.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.346 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.527 ' HG2' ' CD1' ' A' ' 177' ' ' LEU . 3.6 mt-10 -63.04 -41.0 99.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.203 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -33.98 47.73 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.09 -6.59 53.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.022 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.53 ' CG ' ' HG2' ' A' ' 141' ' ' GLN . 0.0 OUTLIER -106.29 -168.64 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.032 0.444 . . . . 0.0 111.242 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' A' ' 146' ' ' PRO . 6.9 ttt-85 -103.26 -64.43 1.08 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.901 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.501 ' ND2' ' C ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -139.91 66.37 1.4 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.431 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.533 ' C ' ' CD1' ' A' ' 177' ' ' LEU . 0.6 OUTLIER -106.65 153.68 22.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.6 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.457 ' HB ' ' HG3' ' A' ' 150' ' ' ARG . 40.9 m -136.08 115.12 12.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.278 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 151' ' ' ILE . 8.8 p -89.66 135.1 26.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.658 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.38 133.92 47.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.101 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.551 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -98.66 104.26 16.28 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.463 0.649 . . . . 0.0 110.541 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.601 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 95.6 m -80.71 -167.44 1.38 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.186 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.587 ' CG2' ' O ' ' A' ' 156' ' ' ASN . 77.2 t 64.33 148.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.689 0.757 . . . . 0.0 111.822 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.717 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.45 -61.12 0.82 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.288 -178.267 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.523 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 2.6 m170 -174.95 53.38 0.12 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.728 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 187' ' ' SER . 91.3 Cg_endo -86.88 -98.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.922 2.414 . . . . 0.0 112.632 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 0.4 OUTLIER 156.35 -0.63 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.613 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 124.04 11.18 4.89 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.356 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.8 63.26 1.55 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.507 ' CE3' ' N ' ' A' ' 191' ' ' GLU . 1.8 t-105 -127.46 108.81 11.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.455 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.507 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 0.2 OUTLIER -98.55 104.86 16.94 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.56 178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 193' ' ' GLU . . . 164.84 -76.28 0.15 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.734 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.573 ' CB ' ' O ' ' A' ' 192' ' ' GLY . 1.1 mt-10 148.03 -100.14 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.551 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 0.0 OUTLIER -87.09 131.91 33.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.656 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -31.02 105.28 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 C-N-CA 119.888 -1.148 . . . . 0.0 111.962 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.525 ' CB ' ' CD ' ' A' ' 197' ' ' PRO . 0.3 OUTLIER 162.57 -178.44 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.305 -0.447 . . . . 0.0 111.301 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.525 ' CD ' ' CB ' ' A' ' 196' ' ' SER . 69.7 Cg_endo -91.3 -1.15 4.73 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.168 2.579 . . . . 0.0 114.05 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.645 ' CG2' ' O ' ' A' ' 198' ' ' ILE . 0.2 OUTLIER 75.64 33.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.669 1.223 . . . . 0.0 109.522 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.498 ' OD1' ' NE ' ' A' ' 202' ' ' ARG . 0.2 OUTLIER -78.29 -33.54 49.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.579 -1.192 . . . . 0.0 112.492 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -56.61 -44.78 81.49 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.604 ' CD2' ' O ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -65.79 -31.2 72.03 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.399 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.528 ' CD ' HD21 ' A' ' 229' ' ' LEU . 18.6 mtm180 -57.71 -48.71 78.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.429 0.633 . . . . 0.0 110.265 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.19 -32.66 67.01 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.313 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -59.4 -40.92 88.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.571 ' CB ' ' CD1' ' A' ' 235' ' ' ILE . 0.0 OUTLIER -60.69 -47.75 84.85 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -20.67 66.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.946 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.97 12.35 27.1 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.677 0.275 . . . . 0.0 111.425 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 0.7 OUTLIER 72.24 100.11 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.87 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 0.9 OUTLIER 155.47 86.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 96.32 102.17 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.281 0.562 . . . . 0.0 110.381 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.597 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 4.5 t-20 174.45 -55.53 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.888 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 10.0 Cg_endo -51.01 -48.0 23.04 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.199 1.933 . . . . 0.0 110.58 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.68 108.41 8.52 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.492 ' C ' ' CD1' ' A' ' 215' ' ' TYR . 1.0 OUTLIER -121.26 125.43 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.644 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -121.03 127.16 51.47 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.804 -178.409 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.527 ' CD2' ' CG1' ' A' ' 124' ' ' VAL . 3.0 mt -138.44 115.88 11.23 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.622 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . 0.531 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 1.0 OUTLIER -125.84 119.66 28.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.582 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.579 ' HA2' ' CG ' ' A' ' 245' ' ' PHE . . . 115.29 -48.8 0.9 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.779 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.56 ' HB3' ' CB ' ' A' ' 250' ' ' ALA . 97.8 Cg_endo -80.51 110.01 2.37 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.424 2.083 . . . . 0.0 113.549 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.479 ' HA ' ' CB ' ' A' ' 244' ' ' LYS . 16.0 Cg_exo -66.72 -45.35 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.718 2.279 . . . . 0.0 110.825 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.49 -38.35 90.65 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.589 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.605 ' CA ' ' HA ' ' A' ' 251' ' ' ALA . 3.6 tpt -56.08 -25.27 44.7 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.551 HG13 ' CB ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -69.09 -45.49 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.12 178.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -75.04 -47.78 27.25 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.531 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.557 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -77.34 -50.24 13.24 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 222' ' ' MET . . . -59.84 -40.1 87.38 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.436 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 223' ' ' ILE . 42.5 t -69.95 -30.86 68.33 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 232' ' ' SER . 3.5 mm-40 -69.61 -44.62 70.31 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.578 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.557 ' CD2' ' O ' ' A' ' 225' ' ' ALA . 0.0 OUTLIER -60.06 -37.92 81.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.002 0.429 . . . . 0.0 110.658 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 226' ' ' ALA . 2.3 t -64.19 -45.34 96.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.181 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -30.19 61.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.059 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.506 ' OG ' ' NH1' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -75.48 -46.22 33.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.181 0.515 . . . . 0.0 111.258 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.52 ' CG ' HD13 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -58.91 -51.1 71.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.026 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 125.34 -52.48 0.8 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.098 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.571 ' CD1' ' CB ' ' A' ' 205' ' ' LEU . 0.9 OUTLIER -36.04 95.73 0.1 OUTLIER Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 121.08 0.467 . . . . 0.0 111.128 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 31.8 Cg_endo -64.16 119.61 6.7 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.897 2.398 . . . . 0.0 112.47 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -90.75 176.71 41.38 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.45 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.7 -40.25 0.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 0.0 111.081 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.581 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 21.0 mm100 -105.64 36.03 2.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.017 0.437 . . . . 0.0 110.67 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.528 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 2.1 t -89.19 136.5 23.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.322 0.582 . . . . 0.0 111.062 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.651 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.6 OUTLIER -144.92 138.02 26.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.94 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.551 ' CB ' HG13 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -129.52 130.39 45.73 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.081 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . 0.501 ' CA ' HD11 ' A' ' 223' ' ' ILE . 0.3 OUTLIER -132.65 149.39 52.3 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.543 179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.479 ' CB ' ' HA ' ' A' ' 220' ' ' PRO . 1.7 ptmm? -129.08 115.0 17.07 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.591 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.5 OUTLIER -137.42 146.86 44.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.171 179.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.576 ' HG ' ' CD1' ' A' ' 245' ' ' PHE . 0.2 OUTLIER 57.61 174.3 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.477 0 C-N-CA 122.922 0.489 . . . . 0.0 111.731 -178.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . 0.544 ' N ' HD13 ' A' ' 246' ' ' LEU . 75.9 Cg_exo -52.78 -141.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.371 2.714 . . . . 0.0 113.643 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 190' ' ' TRP . 2.4 p -81.4 177.25 9.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.485 0.66 . . . . 0.0 112.085 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 163.2 -71.0 0.21 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.578 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 219' ' ' PRO . . . -107.74 149.64 27.92 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.605 ' HA ' ' CA ' ' A' ' 222' ' ' MET . . . . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.46 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.519 ' CB ' ' HB2' ' A' ' 105' ' ' LYS . 83.9 p -95.71 153.87 17.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.821 0.343 . . . . 0.0 110.892 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.61 ' CE1' ' O ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -132.05 156.88 45.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.916 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.61 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 1.6 mt-10 -106.04 121.79 44.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.589 ' CA ' ' HB2' ' A' ' 33' ' ' LYS . . . -126.73 127.69 45.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.183 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 32' ' ' GLN . 4.2 tp10 -93.41 128.08 39.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.899 0.38 . . . . 0.0 110.697 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 100' ' ' GLN . 28.0 m -71.88 106.14 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.091 0.472 . . . . 0.0 111.096 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 2.4 p -127.2 2.31 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.314 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -120.14 -128.86 3.71 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.526 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.59 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER 82.49 58.77 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.329 0.585 . . . . 0.0 110.063 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -95.63 145.42 25.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.669 -179.521 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -88.69 113.86 24.69 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.488 HG12 ' ND2' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -97.3 -27.59 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.53 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 13.2 m -141.44 173.62 11.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.133 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.4 ' CB ' ' HG2' ' A' ' 160' ' ' GLU . 14.9 t -52.19 -57.06 10.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.692 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.519 ' CA ' ' O ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -118.07 44.45 2.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.553 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.533 ' CG2' ' HG2' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -148.34 138.66 22.66 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.311 0.577 . . . . 0.0 110.886 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.59 HG21 ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -141.34 148.35 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.138 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -114.55 103.54 11.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.367 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CB ' ' CZ ' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -99.26 127.51 45.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.886 -178.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.582 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -113.28 116.65 30.07 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.468 ' HB3' ' CB ' ' A' ' 14' ' ' ALA . 4.6 mt -112.37 131.57 55.47 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.025 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -144.77 109.86 5.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.72 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.589 ' HB2' ' CA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -114.92 -49.17 2.81 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.684 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.57 ' O ' ' O ' ' A' ' 69' ' ' LEU . 20.4 m . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 119.716 -0.183 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.671 ' HA ' ' N ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -112.76 84.02 1.91 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.131 0.973 . . . . 0.0 111.14 178.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.598 ' O ' ' CG ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER 7.06 61.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.171 0.919 . . . . 0.0 112.572 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -84.92 160.94 54.43 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.816 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 37.1 Cg_exo -57.99 68.53 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.589 2.193 . . . . 0.0 111.837 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 59.39 37.74 92.43 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.003 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 65' ' ' SER . 4.8 tt0 -52.95 158.12 1.51 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.064 0.432 . . . . 0.0 110.077 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.67 ' CD2' ' CD2' ' A' ' 108' ' ' LEU . 28.7 p90 -151.96 163.47 39.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.508 ' O ' ' HA ' ' A' ' 63' ' ' SER . 2.0 mmt -121.14 175.36 6.14 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.705 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.54 108.09 15.07 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.549 ' CB ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -150.49 156.69 41.92 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.588 HG23 ' N ' ' A' ' 61' ' ' SER . 0.2 OUTLIER -96.6 154.15 17.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.602 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.714 ' CG2' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -29.45 -68.14 0.12 Allowed Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 123.443 0.464 . . . . 0.0 110.601 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.714 ' HD3' ' CG2' ' A' ' 55' ' ' ILE . 4.4 Cg_endo -110.05 6.26 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.719 2.946 . . . . 0.0 111.733 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 104.51 -5.88 44.76 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.019 -178.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.583 HG23 ' CD ' ' A' ' 56' ' ' PRO . 67.6 p -24.34 -88.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.127 0.571 . . . . 0.0 111.814 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -154.12 42.84 0.53 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.551 ' N ' ' OG1' ' A' ' 54' ' ' THR . 0.3 OUTLIER 88.19 125.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.588 ' N ' HG23 ' A' ' 54' ' ' THR . 28.8 t -117.41 -72.42 0.69 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.502 0.668 . . . . 0.0 110.268 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.63 171.14 10.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.597 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.648 ' CB ' ' CE1' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -101.54 118.96 38.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.903 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.526 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 1.6 t80 -118.57 127.34 53.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.994 0.426 . . . . 0.0 111.94 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.587 ' HA ' ' CB ' ' A' ' 50' ' ' PHE . 92.4 p -72.18 109.54 6.04 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.741 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.532 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 88.6 Cg_endo -85.67 169.65 9.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.956 2.438 . . . . 0.0 112.694 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.4 130.53 19.55 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.964 0.412 . . . . 0.0 111.655 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -129.68 -56.09 1.14 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.555 0.693 . . . . 0.0 109.844 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 43' ' ' VAL . 0.4 OUTLIER 164.61 -164.93 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 96.6 Cg_endo -91.31 63.16 1.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.102 1.201 . . . . 0.0 112.372 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.671 ' N ' ' HA ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -174.46 109.74 0.29 Allowed Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.491 ' HG3' ' HB2' ' A' ' 44' ' ' LYS . 4.1 Cg_exo -74.17 40.85 0.62 Allowed 'Trans proline' 0 CA--C 1.515 -0.429 0 C-N-CA 122.336 2.024 . . . . 0.0 112.409 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -138.14 6.79 2.62 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.579 178.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.29 -116.05 1.74 Allowed Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.912 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.534 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -152.34 119.49 5.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.875 -0.662 . . . . 0.0 110.012 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.541 ' CD2' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -96.8 148.33 23.03 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 122.22 1.009 . . . . 0.0 113.169 -178.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.507 ' CB ' HD13 ' A' ' 30' ' ' LEU . 1.8 pt-20 -131.07 150.56 52.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.972 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.621 ' CZ ' ' CB ' ' A' ' 29' ' ' PHE . 1.9 p90 -126.37 139.8 52.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.938 0.399 . . . . 0.0 111.549 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.526 ' N ' ' OH ' ' A' ' 64' ' ' TYR . 1.3 mt -104.4 91.56 3.95 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.499 ' CG2' ' CG1' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -92.36 118.61 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.197 -178.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.533 ' HG2' ' CG2' ' A' ' 26' ' ' THR . 0.8 OUTLIER -79.34 96.25 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.978 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.588 ' CG2' ' CB ' ' A' ' 89' ' ' SER . 2.9 m -92.69 141.5 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.006 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.514 ' HG ' ' CD ' ' A' ' 84' ' ' PRO . 1.1 mp -60.73 -179.97 0.21 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.747 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 85' ' ' GLU . 37.4 Cg_exo -56.8 -32.35 91.38 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.593 2.195 . . . . 0.0 112.182 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER 157.94 100.7 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.831 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 155.04 -16.91 0.53 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.645 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.467 ' HB2' ' HB2' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -102.72 -98.19 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.881 -0.188 . . . . 0.0 110.975 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -97.07 -30.17 13.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.717 0.294 . . . . 0.0 111.204 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.588 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 0.8 OUTLIER -60.47 -27.31 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.99 0.424 . . . . 0.0 110.921 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -76.24 -32.47 58.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.555 0.693 . . . . 0.0 109.819 179.469 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.575 ' CG ' HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -73.43 -45.31 55.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.129 -179.137 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.544 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -67.73 -34.72 77.4 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -29.68 15.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 2.4 t-20 -95.2 -5.14 44.56 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.384 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.49 15.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.544 ' CB ' ' HA ' ' A' ' 92' ' ' LEU . . . -153.61 30.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.668 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -47.49 -102.1 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.44 ' O ' HG11 ' A' ' 98' ' ' VAL . 2.5 t -148.01 103.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.115 0.484 . . . . 0.0 110.98 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 150.7 -12.65 0.87 Allowed Glycine 0 C--N 1.32 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.021 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.522 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 27.1 mp0 -91.29 162.46 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 111.133 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.459 HG11 ' HG2' ' A' ' 33' ' ' LYS . 40.9 t -129.62 142.22 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.581 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.542 ' CD1' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -118.94 153.4 34.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.089 0.471 . . . . 0.0 111.415 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.6 t -105.95 97.56 7.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.549 ' HA ' ' CB ' ' A' ' 53' ' ' LEU . 2.0 m -90.88 118.54 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.519 ' HB2' ' CB ' ' A' ' 11' ' ' SER . 3.7 tttt -129.52 123.08 30.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.496 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 161.79 65.66 0.02 OUTLIER Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.732 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.44 57.4 1.33 Allowed 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.422 2.081 . . . . 0.0 110.883 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.67 ' CD2' ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -100.55 170.03 8.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.864 -178.543 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.624 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -118.83 172.09 14.41 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -157.13 115.33 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.564 0.682 . . . . 0.0 111.683 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -69.67 113.81 7.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.539 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -147.02 -40.5 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.628 ' HA ' ' CG ' ' A' ' 215' ' ' TYR . 0.9 OUTLIER -146.14 119.14 8.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.431 178.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.652 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.1 OUTLIER -138.28 117.48 12.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.294 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -92.29 140.62 29.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.435 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -90.05 15.89 9.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.018 0.437 . . . . 0.0 110.98 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.46 -77.39 0.23 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.69 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.56 89.87 2.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.939 0.4 . . . . 0.0 110.37 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -163.59 149.94 9.97 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.16 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.471 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 32.2 Cg_endo -64.24 115.22 3.03 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.569 2.179 . . . . 0.0 111.69 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.581 ' CZ ' ' CG2' ' A' ' 149' ' ' THR . 0.0 OUTLIER -124.77 146.31 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.393 -179.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.635 ' CD2' ' CB ' ' A' ' 150' ' ' ARG . 39.5 m-85 -126.09 122.78 36.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 110.63 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.635 ' CZ ' ' CG2' ' A' ' 133' ' ' VAL . 0.9 OUTLIER -111.93 106.05 14.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.418 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.576 ' HA ' ' HB2' ' A' ' 152' ' ' TYR . 6.9 p -99.11 111.0 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 121.233 0.539 . . . . 0.0 111.125 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -109.79 133.68 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.143 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.428 ' C ' ' HA3' ' A' ' 249' ' ' GLY . . . -107.82 103.08 1.86 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.047 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.543 ' CA ' HG12 ' A' ' 155' ' ' VAL . . . 118.86 -167.94 13.2 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.372 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 79' ' ' LEU . 6.1 m -91.74 -13.42 31.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.024 0.44 . . . . 0.0 110.847 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.574 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -64.72 10.02 0.36 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 116.111 -0.495 . . . . 0.0 113.409 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.475 ' H ' ' C ' ' A' ' 128' ' ' THR . 0.4 OUTLIER -79.97 3.68 19.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 117.177 0.489 . . . . 0.0 110.033 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.584 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -47.55 -43.43 49.41 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.917 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 6.7 Cg_exo -71.35 -30.87 14.93 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.525 2.15 . . . . 0.0 109.655 177.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.635 ' CG2' ' CZ ' ' A' ' 123' ' ' PHE . 17.9 t -66.07 -44.33 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.208 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 131' ' ' ALA . 14.4 m -70.44 -29.91 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.532 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.14 -52.69 57.88 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.476 ' HB3' HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -62.13 -44.95 95.5 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.389 0.614 . . . . 0.0 109.46 178.312 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.468 HG12 ' NE2' ' A' ' 141' ' ' GLN . 5.3 t -60.17 -30.16 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.846 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.82 -37.99 83.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.254 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.552 ' OE1' ' CE2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -63.61 -42.66 98.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.065 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.611 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.6 OUTLIER -70.05 -33.31 71.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.664 0.745 . . . . 0.0 110.366 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.551 ' CG ' ' CD2' ' A' ' 170' ' ' LEU . 0.0 OUTLIER -76.4 -30.38 57.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.51 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -73.11 -44.67 60.01 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.658 ' CE2' ' CB ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -78.14 -21.26 50.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.335 0.588 . . . . 0.0 110.115 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER 53.57 27.84 7.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.761 178.472 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.658 ' CB ' ' CE2' ' A' ' 143' ' ' TRP . . . -36.6 160.32 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 0.0 110.693 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 145' ' ' ALA . 60.2 Cg_endo -73.23 4.27 3.96 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.691 2.26 . . . . 0.0 112.728 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 148' ' ' GLU . 10.8 t30 -81.48 135.83 35.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.984 0.421 . . . . 0.0 111.522 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.543 ' CB ' ' HB2' ' A' ' 176' ' ' ASN . 4.6 pt-20 -73.78 112.7 10.14 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.437 0.637 . . . . 0.0 110.957 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.581 ' CG2' ' CZ ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -111.74 116.35 30.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.052 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.635 ' CB ' ' CD2' ' A' ' 122' ' ' TYR . 0.8 OUTLIER -107.12 142.82 36.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.76 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.489 ' C ' ' CD1' ' A' ' 151' ' ' ILE . 0.1 OUTLIER -134.05 136.2 53.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.152 0.501 . . . . 0.0 110.697 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.625 ' CD1' ' CG ' ' A' ' 180' ' ' LYS . 18.2 m-30 -110.5 112.02 23.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.881 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.485 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 8.6 t80 -113.9 130.34 56.51 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 122.199 -0.313 . . . . 0.0 111.364 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.625 ' HA2' ' HB2' ' A' ' 182' ' ' CYS . . . -154.12 161.19 29.89 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 119.535 -1.316 . . . . 0.0 113.865 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.543 HG12 ' CA ' ' A' ' 127' ' ' GLY . 21.0 m -164.05 -122.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.379 -0.411 . . . . 0.0 111.265 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.618 ' CB ' ' N ' ' A' ' 188' ' ' GLY . 44.7 p-10 -103.45 -174.34 2.52 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 120.557 0.218 . . . . 0.0 110.783 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.544 ' CA ' ' HD2' ' A' ' 186' ' ' PRO . 0.5 OUTLIER -42.95 -25.31 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.323 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.668 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 40.1 mt-10 94.16 22.41 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.711 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 77.9 Cg_exo -46.78 -23.82 2.65 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.28 1.32 . . . . 0.0 111.252 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -131.59 -28.85 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.674 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.541 ' CD1' HG22 ' A' ' 155' ' ' VAL . 13.3 tp -35.76 158.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.71 -157.99 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.542 ' CE1' ' HG2' ' A' ' 166' ' ' GLU . 0.1 OUTLIER 74.15 27.61 1.52 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.1 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -70.23 -39.07 76.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.071 0.462 . . . . 0.0 110.306 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.577 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 0.2 OUTLIER -73.7 -27.2 61.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.825 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.542 ' HG2' ' CE1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -64.17 -49.16 73.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 -179.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -75.19 -30.84 60.77 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 164' ' ' ILE . 1.8 mttm -61.64 -41.26 97.25 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.16 -32.4 73.01 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.59 ' O ' ' HB3' ' A' ' 174' ' ' MET . 0.3 OUTLIER -61.72 -48.58 80.08 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.099 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.468 ' O ' ' SD ' ' A' ' 174' ' ' MET . 36.2 mt-10 -56.58 -32.65 65.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.89 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -39.94 30.85 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 m -112.13 28.8 8.44 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.59 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 0.0 OUTLIER -113.65 167.05 10.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.164 0.507 . . . . 0.0 111.615 179.365 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -84.85 -80.05 0.21 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.373 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.543 ' HB2' ' CB ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -130.61 63.48 1.57 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.245 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.531 ' CB ' ' O ' ' A' ' 149' ' ' THR . 4.5 mp -112.27 149.65 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.077 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.466 ' HB ' ' HG2' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -137.08 126.9 25.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.283 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 151' ' ' ILE . 72.6 t -100.99 135.8 35.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.314 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.625 ' CG ' ' CD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -99.79 136.69 39.34 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.196 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -98.22 105.89 18.1 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.68 0.752 . . . . 0.0 111.389 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . 0.625 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 64.4 m -86.06 -164.75 1.08 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.358 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 157' ' ' THR . 37.3 t 54.17 147.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 122.151 0.977 . . . . 0.0 112.646 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.729 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -137.18 -62.94 0.61 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.523 -1.672 . . . . 0.0 108.484 -178.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.518 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 50.8 m-70 -167.64 49.45 0.18 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.698 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.574 ' O ' ' CB ' ' A' ' 187' ' ' SER . 40.7 Cg_endo -85.95 -104.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.384 2.723 . . . . 0.0 112.895 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 9.6 t 150.81 21.78 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.618 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 97.84 10.4 52.62 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.636 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 251' ' ' ALA . 0.4 OUTLIER -138.07 63.88 1.52 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 178.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' TRP . . . . . 0.523 ' O ' ' O ' ' A' ' 249' ' ' GLY . 5.6 t-105 -122.81 123.63 41.46 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.778 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.51 ' HG3' ' HA ' ' A' ' 251' ' ' ALA . 0.3 OUTLIER -83.84 105.57 14.84 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.856 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.501 ' C ' ' CG ' ' A' ' 193' ' ' GLU . . . 127.33 -108.8 1.0 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.256 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.557 ' C ' ' HB3' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -168.9 -74.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.559 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -99.35 153.31 19.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 179.466 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.639 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -28.22 108.95 0.02 OUTLIER Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.465 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 8.2 m 95.4 155.61 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.268 -0.466 . . . . 0.0 110.418 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.471 ' O ' ' C ' ' A' ' 198' ' ' ILE . 32.5 Cg_exo -59.79 58.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.998 2.466 . . . . 0.0 112.634 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.638 ' CG1' ' HB2' ' A' ' 201' ' ' LEU . 0.1 OUTLIER 30.16 92.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 122.031 0.92 . . . . 0.0 110.066 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.89 -33.69 59.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.534 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -57.73 -31.56 66.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.638 ' HB2' ' CG1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -69.52 -41.76 75.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.806 0.336 . . . . 0.0 110.672 -178.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.497 ' O ' ' HG ' ' A' ' 205' ' ' LEU . 13.6 mtm180 -57.19 -49.23 76.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.367 0.603 . . . . 0.0 110.257 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -71.78 -32.66 67.89 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.575 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 210' ' ' ALA . 1.5 m-20 -59.44 -41.68 90.19 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.554 ' CD2' ' O ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -60.73 -47.13 87.69 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -65.15 -19.06 65.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.674 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 208' ' ' SER . 16.2 t -90.8 -79.53 0.36 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.457 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 207' ' ' SER . 3.0 t 155.59 -11.68 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.87 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.586 ' O ' ' CE1' ' A' ' 122' ' ' TYR . 6.8 m-20 -88.97 40.07 0.96 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.212 0.529 . . . . 0.0 110.412 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 204' ' ' ASP . . . 161.96 99.75 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.78 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.601 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 6.0 t30 173.25 -55.42 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.215 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 1.5 Cg_endo -45.81 -55.24 3.75 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.272 1.981 . . . . 0.0 110.889 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.03 108.85 9.13 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.515 ' HB ' ' CG2' ' A' ' 240' ' ' VAL . 0.9 OUTLIER -117.5 124.71 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.628 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -113.18 127.3 56.14 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.551 -178.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.565 ' CD1' ' CG1' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -131.94 123.61 27.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.71 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . 0.554 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -122.71 107.27 11.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.8 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 244' ' ' LYS . . . 176.22 166.14 33.06 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.571 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.579 ' CB ' ' CD ' ' A' ' 220' ' ' PRO . 24.3 Cg_exo -55.45 -170.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.721 2.281 . . . . 0.0 112.594 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 219' ' ' PRO . 23.6 Cg_exo -64.72 -19.69 64.68 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 123.192 2.595 . . . . 0.0 113.002 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -83.09 -54.61 3.14 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.839 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' MET . . . . . 0.527 ' CE ' HG23 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -57.13 -34.39 68.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.124 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 242' ' ' PHE . 0.1 OUTLIER -76.66 -34.14 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.452 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 220' ' ' PRO . 12.3 m-20 -72.96 -47.0 49.25 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.851 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.538 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -61.43 -48.12 82.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.724 0.297 . . . . 0.0 111.74 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.467 ' O ' ' HG ' ' A' ' 229' ' ' LEU . . . -69.57 -34.87 74.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.566 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 223' ' ' ILE . 8.2 p -70.05 -31.93 69.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 110.263 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.99 -44.82 95.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.551 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 225' ' ' ALA . 0.0 OUTLIER -62.11 -39.62 93.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.093 0.473 . . . . 0.0 110.847 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.537 ' CG1' HG23 ' A' ' 235' ' ' ILE . 3.8 t -65.88 -45.68 90.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.456 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 23.5 mtt-85 -72.76 -30.25 63.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.782 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 33.3 m -69.08 -43.63 74.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.348 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 202' ' ' ARG . 1.0 OUTLIER -80.99 -74.35 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.967 0.413 . . . . 0.0 111.354 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 148.76 -18.64 1.26 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.865 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.537 HG23 ' CG1' ' A' ' 230' ' ' VAL . 0.0 OUTLIER -22.86 82.41 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.533 ' N ' ' O ' ' A' ' 234' ' ' GLY . 6.0 Cg_exo -75.82 113.05 3.64 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.156 2.571 . . . . 0.0 111.811 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -119.84 -174.54 15.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.827 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.2 -35.92 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.621 0.248 . . . . 0.0 111.277 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.59 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 5.7 mm-40 -101.81 32.52 3.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.493 . . . . 0.0 110.834 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.515 ' CG2' ' HB ' ' A' ' 214' ' ' ILE . 2.2 t -94.6 134.67 31.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.248 0.547 . . . . 0.0 110.451 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.652 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.24 149.36 33.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.947 -177.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.528 ' HB2' ' CD1' ' A' ' 223' ' ' ILE . 5.7 p90 -131.55 148.68 52.64 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.247 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . 0.505 ' N ' HD12 ' A' ' 223' ' ' ILE . 2.2 tt0 -132.8 148.81 52.32 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -106.61 111.43 23.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.328 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.574 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -136.97 147.64 46.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.548 ' CD2' ' HD2' ' A' ' 247' ' ' PRO . 0.4 OUTLIER -20.34 146.09 0.01 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' PRO . . . . . 0.554 ' O ' ' CB ' ' A' ' 248' ' ' SER . 71.9 Cg_exo -50.28 -155.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.69 2.927 . . . . 0.0 113.122 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 247' ' ' PRO . 5.6 m 92.72 -19.29 0.1 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.816 0.817 . . . . 0.0 110.428 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 190' ' ' TRP . . . -128.45 -24.14 1.16 Allowed Glycine 0 C--N 1.309 -0.921 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.569 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . . . -108.38 150.27 27.59 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 122.747 0.419 . . . . 0.0 110.52 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.51 ' HA ' ' HG3' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.229 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.865 0.364 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -74.62 177.68 5.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.3 mt -73.48 135.89 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.28 110.96 1.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.938 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -168.12 71.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.997 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.85 77.03 0.66 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.64 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -135.91 91.63 2.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.359 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.28 101.77 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.12 23.84 4.74 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.549 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.47 ' CB ' ' CG ' ' A' ' 105' ' ' LYS . 83.8 p -110.36 150.88 28.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.863 0.364 . . . . 0.0 111.038 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -131.46 162.67 29.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.547 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.587 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 8.3 mt-10 -110.8 129.97 55.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.814 0.34 . . . . 0.0 111.03 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.591 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . . . -127.77 135.15 49.73 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.976 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.526 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 14.9 tp10 -93.64 122.62 36.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.394 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.515 HG11 ' CD2' ' A' ' 31' ' ' LEU . 32.6 m -71.25 104.34 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.481 ' HA ' HG22 ' A' ' 98' ' ' VAL . 2.6 p -122.51 -34.47 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.433 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -87.5 -130.61 3.2 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.306 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.593 ' CD2' ' CG2' ' A' ' 27' ' ' VAL . 0.1 OUTLIER 87.87 71.63 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.436 0.636 . . . . 0.0 110.291 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -108.91 146.54 33.61 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.818 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -88.54 114.3 25.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 28' ' ' GLN . 1.7 m -95.04 -27.53 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.54 0.686 . . . . 0.0 109.692 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.519 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 11.7 m -138.51 172.13 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.297 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 t -51.64 -56.85 11.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.977 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.506 ' CA ' ' O ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -118.48 43.03 2.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.708 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.519 ' CB ' ' HB2' ' A' ' 23' ' ' SER . 0.2 OUTLIER -147.2 140.39 25.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.317 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.593 ' CG2' ' CD2' ' A' ' 19' ' ' LEU . 1.4 p -141.02 146.44 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.097 0.475 . . . . 0.0 112.236 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.526 ' N ' HG22 ' A' ' 27' ' ' VAL . 6.4 tt0 -110.0 103.02 11.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.568 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.616 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -94.02 125.3 38.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.494 -178.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.562 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -112.61 116.29 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.074 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.541 ' HB3' ' CB ' ' A' ' 14' ' ' ALA . 2.2 mt -121.73 132.81 54.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 111.539 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.49 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 38.4 mt-30 -145.81 109.29 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.393 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' CA ' ' A' ' 14' ' ' ALA . 12.2 tptt -149.22 -0.32 0.5 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.469 ' HG3' ' HB2' ' A' ' 13' ' ' GLU . 1.0 OUTLIER -168.39 168.04 5.94 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.139 0.495 . . . . 0.0 112.077 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 36' ' ' ASP . 36.7 Cg_exo -60.33 107.19 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.087 2.525 . . . . 0.0 111.863 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.567 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . 3.5 m-20 155.03 -34.68 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.645 0.735 . . . . 0.0 110.696 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.528 ' HG2' ' CB ' ' A' ' 76' ' ' LEU . 6.8 mt-10 -169.87 59.91 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.381 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.49 ' HB2' ' HA ' ' A' ' 32' ' ' GLN . 13.8 t -164.07 -65.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.983 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -153.91 -12.88 0.06 OUTLIER Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.428 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.521 ' HB2' ' CB ' ' A' ' 35' ' ' PRO . 18.1 m120 -121.92 13.49 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.889 0.844 . . . . 0.0 111.54 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.534 ' CB ' ' C ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -83.83 -34.79 24.6 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.804 0.812 . . . . 0.0 109.021 178.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 72' ' ' PRO . . . 57.49 96.3 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.423 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.527 HG12 ' CZ ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -96.31 160.98 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.361 0.6 . . . . 0.0 111.797 -179.131 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' CA ' ' HA ' ' A' ' 70' ' ' PRO . 1.5 ttpm? -163.07 26.65 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.967 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.631 ' CG ' ' CG ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER 76.55 96.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.584 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -108.75 165.79 12.03 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.437 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.59 59.12 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.713 2.275 . . . . 0.0 111.858 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 58.48 61.68 7.12 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.66 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.484 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 1.2 mm-40 -35.44 146.21 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.664 0.232 . . . . 0.0 110.493 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.769 ' CD2' HM72 ' A' ' 252' ' ' FDA . 2.6 t80 -152.69 139.34 18.8 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.667 0.27 . . . . 0.0 111.696 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.579 ' O ' ' CE1' ' A' ' 50' ' ' PHE . 3.8 mtt -139.94 -162.68 1.38 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.852 0.358 . . . . 0.0 111.922 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 3.4 t0 -134.96 123.3 23.14 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.534 ' CD1' HD12 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.56 157.71 43.32 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.598 ' HA ' ' HB3' ' A' ' 61' ' ' SER . 0.0 OUTLIER -108.72 149.6 28.77 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.094 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.67 ' CG2' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -34.49 -70.95 0.11 Allowed Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.249 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.67 ' HD3' ' CG2' ' A' ' 55' ' ' ILE . 51.3 Cg_endo -103.98 14.45 0.24 Allowed 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 123.39 2.727 . . . . 0.0 111.941 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 98.52 0.34 58.01 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.663 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.569 ' CG2' ' HD2' ' A' ' 56' ' ' PRO . 13.0 p -40.69 -103.18 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.852 0.461 . . . . 0.0 111.596 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.533 ' N ' HG22 ' A' ' 54' ' ' THR . 1.3 m-20 160.23 36.16 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.009 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 60' ' ' VAL . 6.1 t -152.32 27.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.958 0.408 . . . . 0.0 110.888 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.598 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 36.8 t -97.46 -101.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.631 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.612 ' HB3' HO2' ' A' ' 252' ' ' FDA . 0.0 OUTLIER 170.64 -176.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.102 0.477 . . . . 0.0 111.36 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 2.4 m -99.19 142.56 30.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.689 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.532 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 1.8 t80 -141.36 131.4 24.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 19.7 m -79.28 108.89 9.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.62 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.544 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 72.9 Cg_endo -91.61 165.11 3.45 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.921 2.414 . . . . 0.0 112.189 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.17 135.55 25.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.867 0.365 . . . . 0.0 111.647 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -105.35 -69.76 0.81 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.999 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.589 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 1.4 mt 138.3 160.27 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.468 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.574 ' HD3' ' CG ' ' A' ' 45' ' ' PHE . 20.2 Cg_endo -60.93 87.75 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 121.973 1.782 . . . . 0.0 111.341 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -168.08 117.65 0.65 Allowed Pre-proline 0 N--CA 1.457 -0.102 0 CA-C-O 120.807 0.337 . . . . 0.0 110.891 -179.206 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.509 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 42.3 Cg_endo -68.13 89.95 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.429 2.086 . . . . 0.0 111.861 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' O ' ' CA ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -158.09 -82.87 0.05 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.853 0.359 . . . . 0.0 110.094 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.473 ' O ' ' CA ' ' A' ' 38' ' ' CYS . . . 141.11 96.41 0.28 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.788 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 37.4 mtm180 -151.87 106.33 3.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.463 0.173 . . . . 0.0 110.925 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.548 ' C ' ' CD1' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -97.79 130.92 44.7 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.852 0.358 . . . . 0.0 110.446 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.483 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 3.1 mt-10 -129.16 117.88 21.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.319 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.616 ' CE2' ' HB3' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -109.99 146.94 34.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.144 0.497 . . . . 0.0 111.715 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.575 ' CD2' ' CG2' ' A' ' 128' ' ' THR . 7.5 mt -111.17 84.53 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.032 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.611 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -91.79 129.53 42.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.873 -178.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.65 ' CD ' ' N7A' ' A' ' 252' ' ' FDA . 0.0 OUTLIER -78.43 95.91 5.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.164 179.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.531 ' HB ' ' CB ' ' A' ' 89' ' ' SER . 7.4 m -98.15 141.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.765 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.509 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -121.35 112.92 32.59 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.587 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 85' ' ' GLU . 82.5 Cg_exo -44.17 122.01 3.39 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.649 2.233 . . . . 0.0 112.181 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 84' ' ' PRO . 17.6 tp10 84.47 5.29 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.46 ' HA3' HD13 ' A' ' 83' ' ' LEU . . . -74.08 -130.99 0.2 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.459 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -125.25 -26.03 3.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.602 0.239 . . . . 0.0 111.484 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 2.4 t80 -106.12 -31.26 8.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.544 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.531 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 1.0 OUTLIER -70.89 -34.17 71.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.685 0.279 . . . . 0.0 111.698 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 67.2 m-20 -74.91 -40.35 60.92 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.517 0.675 . . . . 0.0 109.752 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.593 ' CD2' HG23 ' A' ' 55' ' ' ILE . 2.6 t80 -73.67 -24.48 59.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.508 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.533 ' O ' ' CB ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -68.08 -41.08 82.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.801 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -16.64 27.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.596 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 44.2 m-20 -101.22 -7.28 23.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.452 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.415 ' HB2' ' CD1' ' A' ' 91' ' ' TYR . 0.9 OUTLIER -151.56 13.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 92' ' ' LEU . . . -139.79 26.24 2.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.97 0.415 . . . . 0.0 111.156 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.468 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -56.81 -171.98 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.01 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.563 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -88.13 2.03 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.714 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.35 58.06 0.41 Allowed Glycine 0 C--N 1.321 -0.286 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.203 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -162.09 -178.85 6.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.027 0.442 . . . . 0.0 111.413 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 101' ' ' VAL . 3.5 p -129.06 131.54 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.489 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.534 HD12 ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.73 123.71 31.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.708 0.29 . . . . 0.0 110.781 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.481 ' CA ' ' O ' ' A' ' 12' ' ' PHE . 3.6 m -95.5 131.65 41.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.762 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.581 HG13 ' CD1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -99.82 134.61 38.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -130.15 113.78 14.91 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.37 -178.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 169.6 70.05 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.54 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.37 60.74 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.555 2.17 . . . . 0.0 110.308 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.66 ' CD2' ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -133.77 170.36 15.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.019 -177.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.49 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -117.01 173.54 14.75 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.094 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.732 HG22 HM73 ' A' ' 252' ' ' FDA . 8.3 p -112.6 112.1 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.324 0.583 . . . . 0.0 110.548 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.5 120.89 39.7 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.569 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.12 -37.93 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.651 ' HA ' ' CG ' ' A' ' 215' ' ' TYR . 0.2 OUTLIER -126.04 120.02 29.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.72 179.352 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.646 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 2.7 tptt -130.38 108.61 10.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.449 ' HB3' ' HE1' ' A' ' 140' ' ' MET . 0.0 OUTLIER -78.68 140.56 38.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.667 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -89.38 13.45 13.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.815 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.58 -76.05 0.28 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.504 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.83 89.81 2.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.855 0.36 . . . . 0.0 110.293 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.515 ' O ' ' NE ' ' A' ' 121' ' ' ARG . . . -168.57 144.27 2.94 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.21 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 25.9 Cg_endo -62.16 105.0 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.697 2.265 . . . . 0.0 111.944 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -117.37 143.84 45.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.249 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CE2' ' CD ' ' A' ' 150' ' ' ARG . 14.6 m-85 -119.59 127.18 52.72 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.734 0.302 . . . . 0.0 111.131 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.578 ' CD1' ' HB2' ' A' ' 215' ' ' TYR . 1.3 t80 -117.48 106.73 13.48 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.594 ' CG1' ' CD2' ' A' ' 216' ' ' LEU . 4.5 p -98.73 110.96 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.371 0.605 . . . . 0.0 111.809 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -102.96 133.63 47.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.527 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 246' ' ' LEU . . . -105.62 103.17 2.1 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.497 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.566 ' HA2' ' CG1' ' A' ' 155' ' ' VAL . . . 118.22 -154.52 16.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.834 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.575 ' CG2' ' CD2' ' A' ' 79' ' ' LEU . 18.8 m -107.88 -11.89 15.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.805 0.336 . . . . 0.0 111.111 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.638 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -66.92 9.72 0.91 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.545 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 131' ' ' ALA . 0.3 OUTLIER -78.05 4.15 13.06 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.581 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -47.34 -44.54 52.32 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.098 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 5.9 Cg_exo -73.32 -30.73 9.99 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.836 2.357 . . . . 0.0 110.104 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.53 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 17.7 t -65.79 -49.49 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.921 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 138' ' ' ARG . 19.0 m -64.54 -33.28 62.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.541 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -64.5 -50.65 66.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.235 179.254 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -31.82 71.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.885 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 133' ' ' VAL . 74.7 t -59.85 -52.9 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.46 ' HA ' ' OE1' ' A' ' 141' ' ' GLN . 0.8 OUTLIER -60.76 -31.38 70.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.622 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.631 ' CG ' ' CG ' ' A' ' 45' ' ' PHE . 31.7 mt-30 -63.0 -38.55 91.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.264 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.514 ' CE ' HG21 ' A' ' 149' ' ' THR . 2.5 ptm -67.91 -42.76 80.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.268 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.513 ' N ' ' HG2' ' A' ' 140' ' ' MET . 21.4 mt-30 -68.5 -42.83 78.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.116 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -12.37 60.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.788 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.476 ' HB2' ' O ' ' A' ' 139' ' ' GLN . 0.8 OUTLIER -80.54 -84.34 0.1 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.455 0.645 . . . . 0.0 111.164 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.498 ' C ' ' CD ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -156.6 23.66 0.34 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.678 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 140' ' ' MET . . . -112.66 49.69 0.38 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.356 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.498 ' CD ' ' C ' ' A' ' 144' ' ' THR . 52.6 Cg_endo -69.31 -3.6 12.03 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.579 2.186 . . . . 0.0 111.922 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -69.97 -159.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.256 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.544 ' CB ' ' HB2' ' A' ' 176' ' ' ASN . 1.0 OUTLIER -73.03 105.28 4.43 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.62 0.724 . . . . 0.0 111.515 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.5 OUTLIER -110.04 115.21 29.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.237 178.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.633 ' CD ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -106.34 138.56 42.29 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.745 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.491 ' C ' ' CD1' ' A' ' 151' ' ' ILE . 0.1 OUTLIER -133.52 134.95 56.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.026 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.578 ' CD1' ' CB ' ' A' ' 180' ' ' LYS . 21.8 m-30 -109.51 123.24 49.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.071 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.472 ' HB2' HD22 ' A' ' 167' ' ' LEU . 7.2 t80 -119.87 131.01 55.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.775 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.606 ' CA ' ' HB2' ' A' ' 182' ' ' CYS . . . -158.49 158.6 29.43 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 119.492 -1.337 . . . . 0.0 113.775 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.575 ' CG2' HD23 ' A' ' 161' ' ' LEU . 11.8 m -164.15 -116.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.605 ' CB ' ' N ' ' A' ' 188' ' ' GLY . 0.6 OUTLIER -119.91 -164.27 1.06 Allowed 'General case' 0 C--N 1.343 0.285 0 O-C-N 122.459 -0.151 . . . . 0.0 110.895 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.604 ' O ' ' CB ' ' A' ' 158' ' ' GLU . 65.3 p -25.95 -41.38 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.456 0.302 . . . . 0.0 111.515 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.604 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.8 OUTLIER 107.82 -43.27 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.617 0 O-C-N 123.967 0.792 . . . . 0.0 112.402 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 157' ' ' THR . 80.3 Cg_exo -46.2 -22.02 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.199 1.933 . . . . 0.0 112.335 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -98.4 -13.96 20.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.764 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.575 HD23 ' CG2' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -110.58 -165.69 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.756 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 0.1 OUTLIER 178.26 -154.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.903 0.382 . . . . 0.0 111.349 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.522 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 77.13 16.12 1.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.097 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -70.27 -39.17 76.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.246 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.572 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 0.6 OUTLIER -73.68 -27.45 61.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.097 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.459 ' O ' ' OG ' ' A' ' 169' ' ' SER . 3.5 mm-40 -64.79 -49.61 70.02 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -76.21 -31.13 58.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 164' ' ' ILE . 7.7 mttt -62.74 -36.67 83.77 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 166' ' ' GLU . 15.0 p -66.96 -32.95 74.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -63.01 -41.57 99.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.486 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 0.6 OUTLIER -68.91 -36.45 78.04 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.913 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -76.21 -25.05 54.72 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.348 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 169' ' ' SER . 37.4 t -61.48 -71.06 0.16 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.707 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.537 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -179.92 -153.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.133 0.492 . . . . 0.0 112.083 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER 42.59 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.577 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.56 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.0 OUTLIER -13.45 73.69 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 124.433 1.083 . . . . 0.0 111.736 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 175' ' ' ARG . 0.3 OUTLIER -94.65 148.53 22.17 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.201 -178.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.522 ' OG1' ' CZ ' ' A' ' 150' ' ' ARG . 6.8 m -137.18 115.33 11.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.03 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.463 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 7.3 p -101.22 127.77 54.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.161 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.578 ' CB ' ' CD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -95.84 135.52 37.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.539 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -101.0 104.97 16.15 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.354 0.597 . . . . 0.0 110.899 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.606 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 34.5 m -88.67 -160.76 0.68 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.108 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.656 ' N ' ' O ' ' A' ' 193' ' ' GLU . 40.6 t 56.23 146.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.765 0.793 . . . . 0.0 111.815 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.718 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.3 -63.4 0.76 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.751 -178.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.545 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 1.1 t60 -168.65 51.47 0.2 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.541 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.563 ' O ' ' CB ' ' A' ' 187' ' ' SER . 62.6 Cg_endo -88.01 -101.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.054 2.503 . . . . 0.0 112.793 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 0.4 OUTLIER 153.23 -8.01 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.605 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 130.34 12.11 2.35 Favored Glycine 0 C--N 1.322 -0.214 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.728 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.54 63.39 1.55 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.525 ' N ' ' OG ' ' A' ' 248' ' ' SER . 7.5 t-105 -125.86 117.53 23.54 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.21 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.404 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 10.0 mm-40 -92.01 104.18 16.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.543 ' HA2' ' CA ' ' A' ' 251' ' ' ALA . . . 142.06 -120.05 1.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.438 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -167.09 -85.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 0.0 OUTLIER -85.82 126.78 34.29 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.636 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -25.99 106.74 0.01 OUTLIER Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.085 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 2.2 m 146.25 166.01 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 114.961 -0.619 . . . . 0.0 110.896 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 196' ' ' SER . 83.5 Cg_endo -81.93 44.33 1.7 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.899 2.399 . . . . 0.0 112.566 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.572 ' CG1' ' CB ' ' A' ' 251' ' ' ALA . 0.1 OUTLIER 65.81 17.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.297 0.57 . . . . 0.0 110.754 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.443 ' OD2' ' HG2' ' A' ' 197' ' ' PRO . 1.0 OUTLIER -58.41 -36.77 74.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.442 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.88 -43.68 94.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.685 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.535 ' O ' ' CD2' ' A' ' 205' ' ' LEU . 0.1 OUTLIER -65.8 -31.38 72.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.927 0.394 . . . . 0.0 110.527 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.525 ' O ' ' HG ' ' A' ' 205' ' ' LEU . 5.7 mtm180 -58.83 -42.13 88.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.5 0.666 . . . . 0.0 110.178 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.84 -32.71 65.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.088 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -58.79 -43.2 90.41 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -60.79 -46.06 91.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.0 -24.22 66.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.352 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 208' ' ' SER . 16.4 t -92.11 -87.96 0.21 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.885 0.374 . . . . 0.0 111.18 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 1.9 p 163.28 103.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 1.2 m-20 156.69 57.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.52 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 147.4 105.37 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.397 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.574 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 56.3 t30 177.27 -56.01 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.208 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 9.6 Cg_endo -52.82 -55.69 3.51 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.953 1.769 . . . . 0.0 110.667 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.516 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -133.47 109.45 9.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.979 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.529 ' HB ' ' CG2' ' A' ' 240' ' ' VAL . 0.9 OUTLIER -121.12 125.56 74.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.651 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -117.39 126.21 52.29 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.49 0.662 . . . . 0.0 110.163 -178.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.594 ' CD2' ' CG1' ' A' ' 124' ' ' VAL . 34.0 mt -122.73 118.78 28.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.042 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . 0.577 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -123.42 132.31 53.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.107 178.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 245' ' ' PHE . . . 136.32 -154.78 22.16 Favored Glycine 0 C--O 1.224 -0.475 0 C-N-CA 120.333 -0.936 . . . . 0.0 112.859 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.556 ' HG3' ' HA ' ' A' ' 248' ' ' SER . 11.8 Cg_endo -53.79 161.21 4.78 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.005 2.47 . . . . 0.0 112.648 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.422 ' O ' HG21 ' A' ' 223' ' ' ILE . 50.5 Cg_endo -69.28 -8.97 25.03 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.611 2.208 . . . . 0.0 111.572 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.48 -49.17 52.94 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.282 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.566 ' CA ' ' OXT' ' A' ' 251' ' ' ALA . 0.0 OUTLIER -55.7 -25.71 41.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.541 HG13 ' CB ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -76.59 -42.54 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.487 178.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.488 ' N ' HG21 ' A' ' 223' ' ' ILE . 38.1 m-20 -74.67 -47.57 31.04 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.561 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -76.41 -48.99 17.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 222' ' ' MET . . . -59.5 -37.79 79.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.76 0.314 . . . . 0.0 110.594 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 37.9 t -69.64 -31.22 69.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.946 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 232' ' ' SER . 4.8 mt-10 -70.95 -45.13 64.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.738 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.561 ' CD2' ' O ' ' A' ' 225' ' ' ALA . 0.0 OUTLIER -60.67 -37.38 81.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.178 0.513 . . . . 0.0 110.702 -179.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.543 ' HA ' ' CG2' ' A' ' 235' ' ' ILE . 12.5 t -65.24 -45.63 93.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.393 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.8 -30.16 61.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.035 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 228' ' ' GLU . 0.6 OUTLIER -75.37 -44.16 46.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.391 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.466 ' NE ' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -79.65 -70.57 0.5 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.008 0.432 . . . . 0.0 111.11 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 154.9 -31.42 0.67 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.8 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.546 ' CG2' ' O ' ' A' ' 235' ' ' ILE . 0.0 OUTLIER -26.33 84.59 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 123.064 0.545 . . . . 0.0 112.423 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.539 ' N ' ' O ' ' A' ' 234' ' ' GLY . 5.8 Cg_exo -76.37 114.35 3.87 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 123.427 2.751 . . . . 0.0 112.232 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -106.22 161.08 14.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.931 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -117.51 -45.96 2.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.736 0.303 . . . . 0.0 110.91 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 19.3 mm-40 -105.87 40.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.354 0.597 . . . . 0.0 110.281 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.568 ' CG1' ' CZ ' ' A' ' 242' ' ' PHE . 2.3 t -92.04 134.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.928 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.36 145.67 30.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.248 -178.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.568 ' CZ ' ' CG1' ' A' ' 240' ' ' VAL . 1.5 m-85 -131.64 144.24 50.89 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.721 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . 0.521 ' O ' ' CE ' ' A' ' 222' ' ' MET . 21.2 tt0 -132.72 148.72 52.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -111.19 106.48 15.51 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.661 ' CE1' ' CD2' ' A' ' 246' ' ' LEU . 0.0 OUTLIER -137.0 145.28 43.93 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.557 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.661 ' CD2' ' CE1' ' A' ' 245' ' ' PHE . 0.2 OUTLIER 51.59 171.52 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.555 ' CD ' ' HB2' ' A' ' 246' ' ' LEU . 32.2 Cg_exo -60.36 -138.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.914 3.076 . . . . 0.0 113.054 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.556 ' HA ' ' HG3' ' A' ' 219' ' ' PRO . 1.0 OUTLIER -72.75 161.15 31.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.808 0.337 . . . . 0.0 111.847 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.459 ' C ' ' HA3' ' A' ' 126' ' ' GLY . . . 143.41 -20.75 2.24 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.609 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.554 ' CB ' ' HD2' ' A' ' 219' ' ' PRO . . . -105.78 153.43 21.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.903 0.383 . . . . 0.0 111.785 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.572 ' CB ' ' CG1' ' A' ' 198' ' ' ILE . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.037 -0.982 . . . . 0.0 112.614 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' FDA . . . . . 0.921 ' N1 ' " H3'" ' A' ' 252' ' ' FDA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.776 0.322 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -116.59 -70.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.771 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.8 mt -114.9 82.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.988 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 t -94.36 33.87 1.35 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 70.53 46.87 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.78 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.79 159.0 7.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.607 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.74 155.59 48.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.0 110.735 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.13 100.6 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.003 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 105' ' ' LYS . . . -105.81 20.77 35.68 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.6 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.474 ' HB2' ' HB2' ' A' ' 105' ' ' LYS . 3.6 p -112.61 150.99 30.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.583 -0.308 . . . . 0.0 110.711 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -132.41 165.63 23.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.034 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.582 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 3.3 mt-10 -113.53 129.89 56.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.989 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 31' ' ' LEU . . . -125.86 150.68 47.69 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 1.9 pt-20 -102.11 112.19 24.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.825 0.345 . . . . 0.0 110.303 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 100' ' ' GLN . 11.4 t -71.36 105.67 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.012 0.434 . . . . 0.0 110.715 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 7.7 p -120.21 19.53 6.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.98 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -132.8 -124.75 2.57 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.558 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.56 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 74.71 95.31 0.07 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.861 0.839 . . . . 0.0 109.586 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -142.33 139.35 31.76 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.808 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.546 ' CZ2' ' HG3' ' A' ' 93' ' ' ARG . 22.3 m0 -89.47 113.31 24.65 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 23' ' ' SER . 1.5 m -86.6 -33.25 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-O 121.928 0.871 . . . . 0.0 109.265 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 160' ' ' GLU . 0.4 OUTLIER -129.85 -174.19 3.24 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.411 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.43 ' HB3' ' HG3' ' A' ' 160' ' ' GLU . 9.8 t -60.06 -40.66 90.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.433 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 8.9 m-80 -133.66 40.84 3.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.197 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 23' ' ' SER . 17.7 m -133.92 123.42 24.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.542 ' CG2' HD13 ' A' ' 19' ' ' LEU . 6.6 p -136.72 132.63 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 111.747 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 3.1 tt0 -119.98 134.58 55.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.577 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.741 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -130.68 142.61 50.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.406 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.571 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -113.04 116.93 30.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.591 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.59 HD12 ' CE1' ' A' ' 29' ' ' PHE . 38.8 mt -101.57 142.93 32.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 1.3 mt-30 -146.79 134.18 20.75 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.635 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . 2.7 tmtp? -178.14 -70.67 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.66 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 8.2 mtp180 -139.84 -163.4 0.06 OUTLIER Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.66 ' CD ' ' CB ' ' A' ' 34' ' ' ARG . 41.5 Cg_exo -40.9 108.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 122.74 2.294 . . . . 0.0 113.742 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 35' ' ' PRO . 21.3 m-20 144.68 -179.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.638 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.58 ' HB3' ' CB ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -70.68 60.73 0.23 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.553 ' CA ' ' HA2' ' A' ' 74' ' ' GLY . 67.7 m -159.19 -54.61 0.06 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.403 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.507 ' O ' ' NE ' ' A' ' 41' ' ' ARG . . . -87.34 26.44 7.06 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.446 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 73' ' ' GLU . 1.8 p-10 40.56 50.03 2.78 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.549 ' HG2' ' HA ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -86.16 -41.52 14.63 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.669 178.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 72' ' ' PRO . . . 154.87 109.59 0.34 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 119.776 -1.202 . . . . 0.0 116.063 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.645 ' N ' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -103.4 167.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 121.257 0.551 . . . . 0.0 110.311 176.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.424 ' C ' ' HB3' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -146.69 -142.2 0.12 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.962 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.01 81.24 2.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.165 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.5 mp0 -113.21 165.31 13.52 Favored Pre-proline 0 C--N 1.332 -0.194 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.522 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 14.6 Cg_endo -57.57 72.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.422 2.082 . . . . 0.0 111.484 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 41.96 73.94 0.19 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.324 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -28.28 145.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.512 0.196 . . . . 0.0 110.979 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.842 ' CE2' HM72 ' A' ' 252' ' ' FDA . 1.0 OUTLIER -143.7 142.27 30.89 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.722 0.296 . . . . 0.0 111.724 -178.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.581 ' O ' ' CE1' ' A' ' 50' ' ' PHE . 3.7 mtt -141.38 -155.59 0.6 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 105' ' ' LYS . 19.9 t70 -136.5 119.11 15.98 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.575 ' CD1' ' CD1' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.81 157.21 42.66 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.637 HG23 ' N ' ' A' ' 61' ' ' SER . 0.2 OUTLIER -95.7 154.48 17.2 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.875 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.713 ' CG2' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -31.49 -66.08 0.19 Allowed Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 123.309 0.381 . . . . 0.0 110.701 -179.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.713 ' HD3' ' CG2' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -112.36 8.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.834 3.022 . . . . 0.0 111.704 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 101.08 -6.26 56.42 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.64 -177.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.585 HG21 ' CD ' ' A' ' 56' ' ' PRO . 69.0 p -23.02 -87.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.269 0.628 . . . . 0.0 111.703 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.486 ' O ' HG11 ' A' ' 60' ' ' VAL . 4.8 m-20 -151.64 42.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.105 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.574 ' N ' ' OG1' ' A' ' 54' ' ' THR . 0.4 OUTLIER 80.96 125.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.874 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.637 ' N ' HG23 ' A' ' 54' ' ' THR . 27.0 t -111.23 -57.73 2.2 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.692 0.758 . . . . 0.0 110.005 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.455 ' HB3' HO2' ' A' ' 252' ' ' FDA . 0.1 OUTLIER -179.9 -177.92 0.41 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.175 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.688 ' HB2' HM82 ' A' ' 252' ' ' FDA . 0.7 OUTLIER -88.62 129.65 35.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.144 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.491 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 2.1 t80 -140.65 125.76 18.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.949 0.404 . . . . 0.0 110.778 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 32.0 t -75.33 106.27 2.75 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.674 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.556 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 11.1 Cg_endo -91.24 154.33 3.75 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.439 2.759 . . . . 0.0 111.1 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 132' ' ' PRO . . . -144.38 128.91 18.05 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 69' ' ' LEU . 12.0 t-20 -108.94 -67.79 0.96 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.554 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER 142.28 151.11 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 O-C-N 123.825 0.703 . . . . 0.0 109.977 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.55 ' CD ' ' HG ' ' A' ' 69' ' ' LEU . 12.0 Cg_endo -55.56 108.0 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 121.732 1.621 . . . . 0.0 109.962 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.645 ' O ' ' N ' ' A' ' 43' ' ' VAL . 6.8 p30 178.0 -168.19 0.04 OUTLIER Pre-proline 0 C--O 1.217 -0.657 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.831 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 71' ' ' ASN . 53.2 Cg_exo -53.19 -21.86 18.12 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.842 1.695 . . . . 0.0 113.295 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.626 ' CA ' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER 79.81 70.02 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 177.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 38' ' ' CYS . . . -141.61 28.1 2.32 Favored Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.143 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 59.8 mtm-85 -152.86 93.59 1.77 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.073 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 8.5 mt -91.08 143.18 26.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -127.47 111.21 13.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.0 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.741 ' CD2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -108.7 142.35 39.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.776 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.489 ' N ' ' OH ' ' A' ' 64' ' ' TYR . 9.2 mt -126.36 80.6 1.94 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.143 0.497 . . . . 0.0 109.768 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.617 ' HB ' ' CE2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -92.56 122.07 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.171 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.768 ' O ' H52A ' A' ' 252' ' ' FDA . 0.4 OUTLIER -79.55 95.77 5.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.438 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.53 ' CG1' HG12 ' A' ' 27' ' ' VAL . 2.4 m -90.59 141.22 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.983 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.576 ' CD2' ' H4B' ' A' ' 252' ' ' FDA . 0.2 OUTLIER -87.25 167.51 21.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.591 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 83' ' ' LEU . 30.4 Cg_endo -63.8 77.7 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.593 2.195 . . . . 0.0 112.251 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.42 61.47 3.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.462 ' HA3' HD12 ' A' ' 83' ' ' LEU . . . -109.88 -39.71 1.53 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.731 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.81 -63.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 111.383 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.556 ' CE1' HD12 ' A' ' 80' ' ' ILE . 6.1 t80 -71.74 -39.76 69.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.004 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -69.04 -24.02 64.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.923 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 2.3 m-20 -76.11 -37.77 57.69 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.812 0.815 . . . . 0.0 109.214 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.488 ' CE1' HG23 ' A' ' 58' ' ' THR . 0.1 OUTLIER -73.19 -28.8 62.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.304 -1.317 . . . . 0.0 110.777 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.483 ' HA ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -68.41 -43.24 77.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.302 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.546 ' HG3' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -90.58 -23.75 20.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.753 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 20.2 m120 -87.26 -15.25 38.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.576 0.227 . . . . 0.0 111.325 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.509 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 1.5 t70 -127.92 -23.68 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 55' ' ' ILE . . . -118.13 36.87 4.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.954 0.407 . . . . 0.0 111.078 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -70.58 -41.21 72.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.545 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 100' ' ' GLN . 2.2 t -121.8 90.45 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.203 0.525 . . . . 0.0 111.834 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.516 ' CA ' ' O ' ' A' ' 16' ' ' VAL . . . 8.77 56.7 0.01 OUTLIER Glycine 0 N--CA 1.459 0.181 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.153 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 98' ' ' VAL . 3.6 mt-30 -68.92 -179.27 1.42 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.715 0.293 . . . . 0.0 110.852 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.0 p -92.94 133.42 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.824 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.575 ' CD1' ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.74 120.81 25.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.798 0.332 . . . . 0.0 110.453 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -89.66 136.5 33.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.182 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.561 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 1.4 m -111.11 127.55 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -129.75 117.53 20.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.497 -178.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.534 ' CA ' ' HB3' ' A' ' 51' ' ' MET . . . 164.64 71.44 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.751 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.41 58.93 1.03 Allowed 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.159 1.906 . . . . 0.0 110.228 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.617 HD21 ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -129.36 169.87 14.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.031 -178.128 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.521 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -116.17 173.25 14.62 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.49 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 47' ' ' PRO . 2.5 p -121.25 111.75 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.325 0.583 . . . . 0.0 110.587 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -81.14 114.25 19.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.406 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 215' ' ' TYR . . . -179.0 -48.18 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.596 ' HA ' ' HB3' ' A' ' 215' ' ' TYR . 1.1 pp -124.4 118.06 25.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.212 0.53 . . . . 0.0 110.867 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.627 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -139.46 114.13 9.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.04 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -89.59 138.25 31.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.47 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -91.34 13.66 16.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.025 0.44 . . . . 0.0 110.839 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.46 -73.8 0.43 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.461 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.528 ' HA ' ' CB ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -129.83 89.56 2.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.846 0.355 . . . . 0.0 110.409 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -164.09 155.85 14.31 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.406 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 10.2 Cg_exo -71.36 107.65 2.19 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.077 2.518 . . . . 0.0 111.747 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.505 ' NH1' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -136.82 138.1 40.45 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.226 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.669 ' CE2' ' CD ' ' A' ' 150' ' ' ARG . 1.9 m-85 -107.62 127.29 53.52 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.141 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 113' ' ' LEU . 1.1 m-85 -106.73 104.34 14.0 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.544 ' HA ' ' HB2' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -99.1 111.18 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.344 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -110.14 133.73 52.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.285 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -109.63 102.63 1.62 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.674 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.57 ' HA2' ' CG1' ' A' ' 155' ' ' VAL . . . 122.58 -152.79 16.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.992 -1.099 . . . . 0.0 112.349 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.506 ' C ' ' H ' ' A' ' 130' ' ' LEU . 2.9 m -111.55 -16.32 13.3 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.247 0.546 . . . . 0.0 110.51 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.621 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -65.58 11.21 0.4 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.857 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 128' ' ' THR . 0.4 OUTLIER -74.99 4.34 6.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.52 0.328 . . . . 0.0 110.191 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.585 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -45.32 -41.93 17.29 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.29 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 7.3 Cg_exo -72.36 -31.08 11.94 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.39 2.06 . . . . 0.0 109.936 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 217' ' ' CYS . 5.9 t -66.85 -44.31 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.41 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 131' ' ' ALA . 10.5 m -70.59 -30.4 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.893 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.37 -51.31 63.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.3 tpt -64.19 -45.45 88.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.169 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 133' ' ' VAL . 42.6 t -61.82 -30.52 48.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.227 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -38.0 87.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.336 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -42.18 98.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.395 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.623 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 4.7 tpp -68.66 -34.77 76.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.503 0.668 . . . . 0.0 110.732 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.513 ' HG2' HD22 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -77.77 -30.74 51.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.519 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -70.47 -44.5 67.63 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.653 ' CE2' ' CB ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -79.04 -21.14 47.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.432 0.634 . . . . 0.0 109.828 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.487 ' O ' ' O ' ' A' ' 145' ' ' ALA . 1.1 p 54.17 26.64 6.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.917 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.653 ' CB ' ' CE2' ' A' ' 143' ' ' TRP . . . -37.27 161.11 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.775 0.322 . . . . 0.0 110.586 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 145' ' ' ALA . 57.7 Cg_endo -72.44 5.36 2.83 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 122.662 2.241 . . . . 0.0 112.9 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.528 ' CB ' ' HA ' ' A' ' 118' ' ' MET . 19.0 p-10 -86.2 136.8 33.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 111.85 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 0.9 OUTLIER -73.62 113.69 11.03 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.753 0.787 . . . . 0.0 111.012 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 53.8 m -107.96 115.09 29.5 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.539 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.669 ' CD ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -103.4 140.91 36.83 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.266 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.502 ' C ' ' CD1' ' A' ' 151' ' ' ILE . 0.1 OUTLIER -134.54 133.96 54.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.162 0.506 . . . . 0.0 110.816 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.544 ' HB2' ' HA ' ' A' ' 124' ' ' VAL . 19.1 m-30 -114.05 110.66 20.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.497 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 154' ' ' GLY . 1.0 OUTLIER -116.45 133.42 56.04 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 122.091 -0.38 . . . . 0.0 111.064 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.617 ' CA ' ' HB2' ' A' ' 182' ' ' CYS . . . -158.73 158.79 29.68 Favored Glycine 0 CA--C 1.502 -0.748 0 C-N-CA 119.366 -1.397 . . . . 0.0 113.649 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.57 ' CG1' ' HA2' ' A' ' 127' ' ' GLY . 2.5 m -168.76 -108.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.603 ' CB ' ' N ' ' A' ' 188' ' ' GLY . 0.4 OUTLIER -122.19 -169.71 1.94 Allowed 'General case' 0 C--N 1.344 0.331 0 CA-C-O 120.773 0.32 . . . . 0.0 111.517 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.56 ' O ' ' CB ' ' A' ' 158' ' ' GLU . 76.9 p -29.51 -63.38 0.12 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.488 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.56 ' CB ' ' O ' ' A' ' 157' ' ' THR . 4.4 mm-40 153.32 -53.54 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.194 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 79.0 Cg_exo -37.65 -27.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.955 2.437 . . . . 0.0 112.732 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -86.41 -30.56 22.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.897 0.379 . . . . 0.0 110.976 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -108.86 -174.66 2.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.268 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.53 ' O ' ' CB ' ' A' ' 163' ' ' TYR . 0.3 OUTLIER -171.05 -167.12 0.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.302 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.53 ' CB ' ' O ' ' A' ' 162' ' ' PHE . 0.2 OUTLIER 85.57 13.17 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.823 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.463 ' CG2' ' N ' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -65.45 -49.59 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.293 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.463 ' N ' ' CG2' ' A' ' 164' ' ' ILE . 0.7 OUTLIER -69.27 -33.37 73.12 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.271 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.438 ' CD ' ' CE1' ' A' ' 163' ' ' TYR . 1.6 mt-10 -72.42 -36.14 68.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.467 ' HA ' ' HB2' ' A' ' 170' ' ' LEU . 0.0 OUTLIER -60.89 -32.07 71.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.05 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 171' ' ' GLU . 4.5 mtpt -63.14 -49.04 75.92 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 6.8 m -61.83 -31.54 71.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.513 HD22 ' HG2' ' A' ' 141' ' ' GLN . 0.8 OUTLIER -62.86 -34.6 77.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.544 ' HA ' ' CD1' ' A' ' 177' ' ' LEU . 40.6 mt-10 -63.86 -42.08 97.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.28 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 -78.21 -33.62 49.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.603 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 144' ' ' THR . 0.3 OUTLIER -50.27 -46.29 55.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.639 -179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.53 ' HB2' ' CD2' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -77.15 -163.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.176 0.512 . . . . 0.0 111.602 -179.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER -105.08 -62.38 1.35 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.351 -179.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.462 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.0 OUTLIER -130.28 64.02 1.54 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.795 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' A' ' 149' ' ' THR . 0.7 OUTLIER -105.1 154.25 20.41 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.032 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.502 ' N ' HD11 ' A' ' 177' ' ' LEU . 9.1 m -136.72 117.37 13.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.578 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.448 HG11 ' OE2' ' A' ' 171' ' ' GLU . 7.6 p -95.43 135.33 29.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.671 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 1.9 tppt? -97.95 135.95 38.94 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.852 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 194' ' ' GLN . . . -102.11 105.34 16.04 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 121.517 0.675 . . . . 0.0 111.751 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.617 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 34.7 m -87.35 -159.15 0.49 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.645 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.575 ' N ' ' O ' ' A' ' 193' ' ' GLU . 28.4 t 55.93 148.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.64 0.733 . . . . 0.0 111.77 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.723 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -136.37 -62.55 0.66 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.197 -178.024 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.578 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 3.7 t60 -166.86 51.43 0.22 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.724 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.621 ' O ' ' CB ' ' A' ' 187' ' ' SER . 98.5 Cg_endo -88.97 -98.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.044 2.496 . . . . 0.0 112.704 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.621 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 13.6 t 143.11 2.28 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.603 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 123.73 12.29 4.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.453 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.27 62.72 1.58 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 249' ' ' GLY . 8.3 t-105 -130.83 120.6 23.93 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.249 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 250' ' ' ALA . 0.0 OUTLIER -98.96 104.45 16.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.341 178.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.577 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 145.18 -117.75 1.04 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.506 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 183' ' ' VAL . 18.7 mt-10 -165.04 -98.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -87.41 126.85 35.13 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . 2.46 108.92 0.0 OUTLIER Glycine 0 C--N 1.339 0.7 0 O-C-N 124.061 0.851 . . . . 0.0 113.726 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 5.9 m 96.83 156.21 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.286 0 CA-C-O 121.06 0.457 . . . . 0.0 111.086 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 196' ' ' SER . 58.0 Cg_exo -35.75 -69.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.349 2.699 . . . . 0.0 113.638 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.662 ' CG2' ' O ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER 173.36 35.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 122.093 0.949 . . . . 0.0 110.636 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.486 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 0.9 OUTLIER -57.61 -37.19 72.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.859 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.81 -32.81 70.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.316 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.55 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -69.54 -32.13 70.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 110.489 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.486 ' HG3' ' HA ' ' A' ' 199' ' ' ASP . 2.8 mtt180 -59.86 -52.25 66.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.533 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.11 -40.93 86.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.566 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.456 ' HA ' ' HB2' ' A' ' 207' ' ' SER . 11.3 m-20 -60.18 -28.49 67.99 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 230' ' ' VAL . 0.1 OUTLIER -61.79 -47.99 82.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.25 178.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -14.38 59.69 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.016 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.456 ' HB2' ' HA ' ' A' ' 204' ' ' ASP . 3.8 m -91.98 -76.59 0.45 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.803 0.335 . . . . 0.0 111.497 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.548 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 17.3 p 168.97 102.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.677 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.595 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 5.0 m-20 153.32 86.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.696 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 101.6 109.79 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.527 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.4 t-20 -175.26 -58.51 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.437 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 11.7 Cg_endo -57.23 -83.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.043 1.829 . . . . 0.0 110.676 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.536 ' HA ' ' CG2' ' A' ' 240' ' ' VAL . 0.0 OUTLIER -114.38 111.59 21.7 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.552 ' CD1' ' HA ' ' A' ' 210' ' ' ALA . 0.8 OUTLIER -109.5 126.48 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.689 ' CE1' ' CD2' ' A' ' 241' ' ' PHE . 2.7 m-85 -116.72 134.2 55.1 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.77 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.539 ' CD2' ' HB ' ' A' ' 124' ' ' VAL . 1.5 mt -134.45 115.58 14.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.791 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . 0.528 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 42.3 t -123.48 107.54 11.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.851 0.357 . . . . 0.0 110.476 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.613 ' CA ' ' CD2' ' A' ' 245' ' ' PHE . . . 114.14 -36.92 3.77 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.769 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 218' ' ' GLY . 45.0 Cg_endo -92.82 79.99 0.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.812 2.341 . . . . 0.0 113.956 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.57 ' CD ' ' O ' ' A' ' 218' ' ' GLY . 9.2 Cg_endo -51.59 -66.8 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.452 2.101 . . . . 0.0 111.074 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.459 ' N ' ' HB3' ' A' ' 250' ' ' ALA . . . -54.09 -48.77 61.91 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.012 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.546 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -55.22 -24.73 28.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 243' ' ' GLU . 0.1 OUTLIER -74.56 -37.07 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.111 177.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 221' ' ' GLY . 7.2 m-20 -71.85 -46.43 58.0 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.813 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.528 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -67.59 -33.14 74.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.503 ' O ' ' HG ' ' A' ' 229' ' ' LEU . . . -60.13 -39.43 86.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.361 0.6 . . . . 0.0 110.055 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.451 ' HB2' ' OE1' ' A' ' 239' ' ' GLN . 31.5 t -70.49 -31.8 69.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.784 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -44.02 92.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.638 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' A' ' 225' ' ' ALA . 0.0 OUTLIER -59.74 -37.59 79.38 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.077 0.465 . . . . 0.0 110.636 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 238' ' ' GLU . 3.0 t -62.46 -46.45 96.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.424 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -74.56 -30.28 61.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.783 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 51.5 m -74.11 -42.05 60.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.303 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.481 ' HD2' ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER -85.11 -74.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.236 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 158.75 -56.58 0.35 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.07 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 238' ' ' GLU . 2.2 pp -39.36 98.69 0.18 Allowed Pre-proline 0 N--CA 1.453 -0.288 0 CA-C-O 121.255 0.55 . . . . 0.0 111.221 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.505 ' O ' ' ND2' ' A' ' 211' ' ' ASN . 57.7 Cg_endo -70.33 164.43 35.12 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 123.404 2.736 . . . . 0.0 112.646 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 211' ' ' ASN . . . 76.3 9.42 85.75 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.642 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.565 ' HB2' ' CD1' ' A' ' 235' ' ' ILE . 8.7 tp10 -71.53 1.02 7.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.68 0.276 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.535 ' O ' ' O ' ' A' ' 214' ' ' ILE . 39.3 mt-30 -101.95 -76.98 0.56 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.369 0.604 . . . . 0.0 109.874 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.586 HG12 ' CG ' ' A' ' 241' ' ' PHE . 4.0 t 65.06 -83.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.46 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.689 ' CD2' ' CE1' ' A' ' 215' ' ' TYR . 9.5 m-85 -115.64 127.82 55.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.894 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.425 ' CB ' HD12 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -132.57 132.84 42.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.438 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . 0.542 ' OE2' HM71 ' A' ' 252' ' ' FDA . 11.0 tp10 -132.56 149.04 52.38 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.281 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 220' ' ' PRO . 0.9 OUTLIER -127.74 106.23 8.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.621 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -138.58 146.11 41.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.342 179.134 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.568 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 5.7 mt 64.71 167.63 0.11 Allowed Pre-proline 0 N--CA 1.471 0.588 0 O-C-N 121.886 -0.509 . . . . 0.0 111.925 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.552 ' CD ' HD22 ' A' ' 246' ' ' LEU . 38.6 Cg_endo -88.6 -107.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.764 2.976 . . . . 0.0 112.422 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 247' ' ' PRO . 30.7 m -36.4 136.49 0.33 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 110.959 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 190' ' ' TRP . . . 125.84 -15.87 6.97 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.548 ' O ' ' CB ' ' A' ' 191' ' ' GLU . . . -106.38 119.36 39.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.81 -0.695 . . . . 0.0 111.364 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.577 ' N ' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' FDA . . . . . 0.915 ' N1 ' " H3'" ' A' ' 252' ' ' FDA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.752 0.311 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -116.65 0.83 12.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.102 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.1 mm -79.14 104.9 7.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.867 0.365 . . . . 0.0 111.079 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.0 t -61.63 156.58 19.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -67.3 138.29 56.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.98 35.3 0.78 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.548 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.68 104.45 16.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.713 0.292 . . . . 0.0 110.821 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.11 100.41 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.075 0.464 . . . . 0.0 111.096 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.06 21.02 9.66 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.602 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -118.91 152.82 35.62 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.818 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -132.45 165.19 24.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.93 0.395 . . . . 0.0 110.947 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.582 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -104.84 123.99 48.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.635 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.546 ' HA ' ' CB ' ' A' ' 33' ' ' LYS . . . -121.44 154.2 36.87 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.52 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -118.99 116.56 26.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 98' ' ' VAL . 17.3 m -71.16 125.66 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.454 . . . . 0.0 111.194 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.531 ' HA ' ' CG1' ' A' ' 98' ' ' VAL . 8.7 p -144.56 16.31 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.367 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -140.97 -135.38 3.17 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.691 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER 92.17 70.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.196 0.522 . . . . 0.0 110.494 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -111.8 147.88 34.75 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.677 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -89.31 114.37 25.75 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 m -89.37 -29.19 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.523 0.677 . . . . 0.0 109.718 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.511 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 20.9 m -137.11 177.18 8.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.435 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.45 ' OG ' ' OD1' ' A' ' 25' ' ' ASN . 2.9 t -51.88 -58.37 6.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.894 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 2.5 m-20 -117.55 44.85 2.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.441 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.524 HG23 ' NE ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -146.06 137.29 24.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.602 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.588 ' CG2' ' CD2' ' A' ' 19' ' ' LEU . 1.5 p -140.34 143.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.595 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.499 ' N ' HG23 ' A' ' 27' ' ' VAL . 8.4 tt0 -115.42 103.14 10.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.213 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.603 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.6 OUTLIER -91.4 121.24 32.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.676 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -102.37 116.02 31.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.375 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 mt -111.9 133.78 53.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.466 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 46.8 mt-30 -142.79 129.49 20.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.589 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -152.38 -97.48 0.05 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.163 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.542 ' HB3' ' CB ' ' A' ' 41' ' ' ARG . 2.8 mmp_? -37.75 98.0 0.15 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 57.9 Cg_endo -71.76 90.43 0.72 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.16 2.573 . . . . 0.0 115.206 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.533 ' OD2' ' CA ' ' A' ' 42' ' ' GLY . 1.8 t70 -107.96 -36.62 6.3 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 122.343 1.068 . . . . 0.0 108.426 176.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -173.27 -39.57 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.24 -1.8 . . . . 0.0 108.146 178.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' CB ' ' N ' ' A' ' 75' ' ' ARG . 86.6 m -116.67 -52.96 2.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.14 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 34' ' ' ARG . . . 154.5 52.33 0.01 OUTLIER Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.471 -0.871 . . . . 0.0 114.114 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.612 ' CB ' ' CA ' ' A' ' 74' ' ' GLY . 26.1 t-20 -144.59 6.71 1.26 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.451 0.625 . . . . 0.0 112.488 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' CB ' ' HB3' ' A' ' 34' ' ' ARG . 0.0 OUTLIER 78.84 -5.81 1.98 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.533 ' CA ' ' OD2' ' A' ' 36' ' ' ASP . . . 117.12 101.6 2.18 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.752 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -94.39 163.93 2.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.807 0.337 . . . . 0.0 111.279 -179.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.678 ' N ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -166.69 22.57 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.006 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.522 ' O ' ' HB3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -103.94 -169.38 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.265 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.51 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 20.5 mm-40 -107.55 130.28 23.05 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.905 0.383 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.488 ' HB2' ' HB2' ' A' ' 136' ' ' MET . 99.8 Cg_exo -41.75 -23.01 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.618 2.212 . . . . 0.0 112.219 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . -51.83 -34.35 37.12 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.961 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.492 ' NE2' ' O ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -68.44 158.91 32.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.904 0.383 . . . . 0.0 110.909 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.883 ' CG ' HM73 ' A' ' 252' ' ' FDA . 0.0 OUTLIER -125.79 164.06 21.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.445 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.537 ' CA ' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -114.84 143.33 45.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.978 0.418 . . . . 0.0 111.902 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.528 ' HA ' ' CB ' ' A' ' 63' ' ' SER . 14.1 t70 -98.95 107.8 20.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.563 HD13 ' CG2' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -148.96 157.08 43.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.361 -178.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.535 ' HA ' ' CB ' ' A' ' 61' ' ' SER . 0.2 OUTLIER -93.42 151.52 19.69 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.68 ' CG2' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -32.72 -66.06 0.21 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.519 -178.445 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.68 ' HD3' ' CG2' ' A' ' 55' ' ' ILE . 7.5 Cg_endo -106.32 4.19 0.2 Allowed 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 123.424 2.75 . . . . 0.0 111.486 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 106.95 -3.02 35.61 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.261 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.558 HG22 ' CD ' ' A' ' 56' ' ' PRO . 31.4 p -24.52 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.178 0.513 . . . . 0.0 111.744 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.509 ' N ' ' OG1' ' A' ' 58' ' ' THR . 19.8 p-10 -178.06 -28.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.77 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 60' ' ' VAL . 6.2 p -147.58 109.28 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.682 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.535 ' CB ' ' HA ' ' A' ' 54' ' ' THR . 0.3 OUTLIER -143.15 -76.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.793 179.288 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.575 ' HG3' " H3'" ' A' ' 252' ' ' FDA . 0.4 OUTLIER 170.49 155.22 0.06 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.47 . . . . 0.0 111.901 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.528 ' CB ' ' HA ' ' A' ' 52' ' ' ASP . 46.6 p -89.54 131.82 35.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.382 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.547 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -120.78 119.62 33.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.404 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.58 ' HB3' ' H6 ' ' A' ' 252' ' ' FDA . 60.7 p -60.41 102.68 0.32 Allowed Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 64' ' ' TYR . 92.6 Cg_endo -102.9 -178.42 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.276 2.651 . . . . 0.0 113.563 -178.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 76' ' ' LEU . . . -87.21 167.37 14.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.649 ' HB3' ' HA ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER 89.63 117.55 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -177.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.678 ' O ' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -167.47 -65.59 0.01 OUTLIER Pre-proline 0 C--O 1.215 -0.734 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.543 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 69' ' ' LEU . 66.4 Cg_endo -99.07 75.26 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.379 2.053 . . . . 0.0 113.244 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.485 ' O ' HG22 ' A' ' 43' ' ' VAL . 0.5 OUTLIER 178.9 125.33 0.21 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.718 0.294 . . . . 0.0 110.48 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.495 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 30.8 Cg_endo -64.26 56.98 0.23 Allowed 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.313 2.009 . . . . 0.0 111.675 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.561 ' HB3' ' N ' ' A' ' 38' ' ' CYS . 2.4 mt-10 -135.93 -81.44 0.4 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.017 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.612 ' CA ' ' CB ' ' A' ' 40' ' ' ASN . . . 126.77 15.25 2.66 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.854 -1.165 . . . . 0.0 114.255 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.593 ' N ' ' CB ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -61.96 85.25 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.284 0.542 . . . . 0.0 110.257 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.649 ' HA ' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -96.18 128.76 43.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.599 0.714 . . . . 0.0 111.197 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.427 ' HG3' ' HB3' ' A' ' 67' ' ' ALA . 7.7 mt-10 -132.72 141.4 48.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.625 -1.171 . . . . 0.0 111.251 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.603 ' CE2' ' HB3' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -133.4 133.09 41.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.222 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.547 ' N ' ' OH ' ' A' ' 64' ' ' TYR . 9.1 mt -106.78 85.6 2.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.189 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.601 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -90.48 116.57 32.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.945 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.64 ' CD ' ' N7A' ' A' ' 252' ' ' FDA . 0.1 OUTLIER -78.12 96.07 5.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.408 0.623 . . . . 0.0 110.19 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.523 ' CG2' ' HB3' ' A' ' 89' ' ' SER . 2.5 m -89.07 141.47 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.84 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 85' ' ' GLU . 3.9 pp -74.46 169.73 18.25 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.845 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.465 ' CD ' ' HB2' ' A' ' 83' ' ' LEU . 34.5 Cg_exo -61.22 63.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.804 2.336 . . . . 0.0 112.192 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER 51.15 107.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.55 -35.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.573 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.429 ' HB2' HD23 ' A' ' 83' ' ' LEU . 2.1 mpt_? -133.26 -81.58 0.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.752 0.311 . . . . 0.0 111.175 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.598 ' CE2' H5'1 ' A' ' 252' ' ' FDA . 2.3 t80 -74.03 -45.17 51.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.203 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.523 ' HB3' ' CG2' ' A' ' 82' ' ' VAL . 3.3 p -67.94 -23.33 65.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.513 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -75.66 -46.07 33.5 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.486 0.66 . . . . 0.0 109.493 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.441 ' C ' HD11 ' A' ' 55' ' ' ILE . 7.8 t80 -73.35 -23.28 60.2 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.52 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.548 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -65.75 -49.37 68.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.275 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.89 -19.0 21.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.662 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 1.5 m-20 -94.38 -2.37 52.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.399 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.69 30.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.651 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.548 ' CB ' ' HA ' ' A' ' 92' ' ' LEU . . . -151.03 25.95 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -170.02 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.87 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 17' ' ' VAL . 1.5 t -97.9 -137.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.551 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 98' ' ' VAL . . . 31.7 53.92 0.35 Allowed Glycine 0 CA--C 1.516 0.128 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.021 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.445 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -159.68 -170.96 3.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 111.197 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 14' ' ' ALA . 2.3 t -129.04 143.61 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.882 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.559 ' CD1' HD13 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -128.81 153.75 47.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.016 0.436 . . . . 0.0 111.541 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.457 ' O ' HD12 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -99.14 119.17 37.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.587 178.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.563 ' CG2' HD13 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -113.89 143.0 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.18 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.537 ' O ' ' CA ' ' A' ' 51' ' ' MET . 5.1 mtpt -128.7 168.25 16.07 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.502 ' N ' ' HD3' ' A' ' 107' ' ' PRO . . . -153.38 49.66 0.51 Allowed Glycine 0 C--N 1.313 -0.708 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.628 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 106' ' ' GLY . 91.5 Cg_endo -86.17 27.4 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.722 2.281 . . . . 0.0 111.403 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -88.27 172.96 9.05 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 122.108 0.956 . . . . 0.0 113.01 -178.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.592 ' O ' ' CE2' ' A' ' 50' ' ' PHE . . . -110.27 174.04 17.07 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.574 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.45 107.56 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 117.911 0.856 . . . . 0.0 110.801 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 4.3 m-85 -123.11 114.84 20.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.525 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . 136.63 -82.88 0.27 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.633 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.589 ' HB3' ' CE2' ' A' ' 123' ' ' PHE . 0.4 OUTLIER -95.53 117.97 31.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.19 0.519 . . . . 0.0 111.206 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -138.49 113.09 8.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.033 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.458 ' OE1' ' CE2' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -106.52 140.54 39.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.12 12.0 30.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.115 0.483 . . . . 0.0 110.946 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 129.18 -90.77 0.31 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.919 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.456 ' HA ' ' OD1' ' A' ' 147' ' ' ASN . 19.6 ptt? -130.52 90.98 3.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.77 0.319 . . . . 0.0 110.835 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.518 ' HB1' ' CZ ' ' A' ' 121' ' ' ARG . . . -149.29 147.29 23.03 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.984 0.421 . . . . 0.0 111.285 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 36.4 Cg_endo -65.38 110.2 1.54 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.842 2.361 . . . . 0.0 112.071 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.546 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -136.71 146.77 46.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.884 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.627 ' CE2' ' CD ' ' A' ' 150' ' ' ARG . 0.6 OUTLIER -115.08 122.2 45.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.58 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.636 ' CE2' ' CG1' ' A' ' 133' ' ' VAL . 1.0 OUTLIER -106.44 108.08 19.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.144 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.588 ' CB ' ' HB2' ' A' ' 152' ' ' TYR . 10.0 p -98.41 111.63 28.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.571 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -101.28 132.69 46.68 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.419 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.99 103.07 1.2 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.542 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.592 ' HA2' ' CG1' ' A' ' 155' ' ' VAL . . . 115.99 -154.88 16.6 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.134 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.535 HG23 ' CB ' ' A' ' 79' ' ' LEU . 14.5 m -105.66 -9.59 17.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.205 0.526 . . . . 0.0 110.54 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.581 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -64.66 10.01 0.36 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.537 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -81.22 5.55 16.68 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.82 0.31 . . . . 0.0 110.632 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.529 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -47.03 -46.71 54.62 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.306 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 90.0 Cg_endo -79.72 -29.92 2.61 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.653 2.235 . . . . 0.0 111.053 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.636 ' CG1' ' CE2' ' A' ' 123' ' ' PHE . 20.9 t -63.11 -52.4 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.566 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.407 HG13 ' HG ' ' A' ' 130' ' ' LEU . 2.0 m -61.78 -36.56 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.659 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 139' ' ' GLN . 18.6 m -62.08 -50.35 72.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.333 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.514 ' CB ' HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -62.56 -36.17 81.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.469 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 133' ' ' VAL . 17.7 t -66.97 -53.45 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.302 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.489 ' CG ' HD22 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -63.63 -31.83 73.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.708 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -67.47 -37.34 82.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.026 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.469 ' O ' ' N ' ' A' ' 145' ' ' ALA . 3.0 ptm -63.43 -43.38 97.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.525 ' HG2' ' CG ' ' A' ' 174' ' ' MET . 2.0 mt-30 -73.06 -34.86 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.4 ' OE1' ' O ' ' A' ' 138' ' ' ARG . 1.5 mp0 -79.62 -12.84 59.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.913 0.387 . . . . 0.0 110.672 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.478 ' HB2' ' O ' ' A' ' 139' ' ' GLN . 2.8 m95 -92.23 -85.33 0.25 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.443 0.64 . . . . 0.0 111.264 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 144' ' ' THR . 0.2 OUTLIER -154.81 20.34 0.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.242 -178.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.555 ' N ' ' CD ' ' A' ' 146' ' ' PRO . . . -125.3 44.87 1.21 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.343 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 145' ' ' ALA . 73.1 Cg_endo -76.16 5.75 4.35 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.606 2.204 . . . . 0.0 112.005 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.482 ' C ' ' ND2' ' A' ' 176' ' ' ASN . 8.4 p-10 -58.46 -159.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.149 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 40.9 mt-10 -74.55 104.63 5.32 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.408 0.623 . . . . 0.0 111.273 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 2.8 m -119.06 117.92 30.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.095 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.627 ' CD ' ' CE2' ' A' ' 122' ' ' TYR . 1.8 mmt180 -101.52 146.15 28.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.992 0.425 . . . . 0.0 110.369 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.445 HD13 HG22 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -133.47 134.11 57.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.811 -178.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.588 ' HB2' ' CB ' ' A' ' 124' ' ' VAL . 18.2 m-30 -112.91 110.47 20.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.238 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 182' ' ' CYS . 3.4 t80 -112.99 126.72 55.81 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.484 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.67 ' HA2' ' HB2' ' A' ' 182' ' ' CYS . . . -155.58 151.89 23.41 Favored Glycine 0 CA--C 1.499 -0.939 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.105 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.592 ' CG1' ' HA2' ' A' ' 127' ' ' GLY . 3.8 m -164.64 -111.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.6 ' CB ' ' N ' ' A' ' 188' ' ' GLY . 19.9 p30 -105.85 -168.05 1.39 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.369 0.604 . . . . 0.0 112.182 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.586 ' O ' ' CB ' ' A' ' 158' ' ' GLU . 34.1 p -33.96 -32.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.83 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.586 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.9 tt0 105.46 -52.09 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.974 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.491 ' HD2' ' OG1' ' A' ' 157' ' ' THR . 86.3 Cg_exo -48.26 -21.57 3.14 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 121.994 1.796 . . . . 0.0 112.003 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -87.29 -30.75 20.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.491 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.539 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -89.23 -160.51 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.396 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 38.0 p90 177.14 -176.59 0.15 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.0 0.429 . . . . 0.0 111.501 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.46 ' O ' ' HB2' ' A' ' 167' ' ' LEU . 0.2 OUTLIER 79.84 2.46 2.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.336 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -71.28 -45.42 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.817 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.579 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 6.8 m-20 -67.16 -35.02 78.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.24 0.543 . . . . 0.0 110.172 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -72.28 -37.03 69.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -61.05 -32.15 71.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.015 179.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.473 ' HG3' ' HA ' ' A' ' 165' ' ' ASP . 8.1 mttt -65.9 -39.3 90.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 m -62.88 -32.0 73.16 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.315 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.489 HD22 ' CG ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -63.8 -36.89 85.38 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 177' ' ' LEU . 2.3 mm-40 -67.53 -37.66 83.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.224 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -78.76 -32.27 46.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.235 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.434 ' OG ' ' HA ' ' A' ' 170' ' ' LEU . 58.4 p -75.01 -16.17 60.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.006 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.525 ' CG ' ' HG2' ' A' ' 141' ' ' GLN . 0.7 OUTLIER -94.95 -168.93 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.178 0.513 . . . . 0.0 111.643 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.493 ' CB ' ' O ' ' A' ' 146' ' ' PRO . 0.7 OUTLIER -81.76 -63.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.331 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.49 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.0 OUTLIER -141.9 70.11 1.33 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.943 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 149' ' ' THR . 7.3 mp -98.68 151.75 20.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.827 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.466 ' CB ' ' HD3' ' A' ' 150' ' ' ARG . 4.8 m -136.83 115.01 11.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.822 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.411 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 7.7 p -92.85 134.97 29.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.505 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.475 ' HB3' ' HA ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -99.1 136.44 39.06 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.588 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -96.55 105.44 17.54 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.851 0.834 . . . . 0.0 111.04 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.67 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 92.3 m -95.1 -167.96 1.72 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.16 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 156' ' ' ASN . 6.2 t 56.07 148.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.785 0.802 . . . . 0.0 111.186 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.75 -49.78 0.53 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.409 -1.268 . . . . 0.0 108.238 -177.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.584 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 12.1 t-80 178.55 57.04 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.498 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 187' ' ' SER . 33.5 Cg_endo -94.02 -93.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.538 2.825 . . . . 0.0 112.886 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 27.4 t 137.22 20.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.6 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 96.79 11.05 54.55 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.585 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.434 ' C ' ' HA ' ' A' ' 251' ' ' ALA . 0.4 OUTLIER -136.96 63.31 1.57 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.553 ' O ' ' O ' ' A' ' 249' ' ' GLY . 4.9 t-105 -125.44 123.19 38.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.448 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.565 ' N ' ' CB ' ' A' ' 251' ' ' ALA . 2.5 mt-10 -84.33 105.36 15.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.51 ' C ' ' CG ' ' A' ' 193' ' ' GLU . . . 131.42 -111.15 1.05 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.092 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.548 ' CB ' ' SG ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -167.51 -71.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.585 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -102.33 150.67 23.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.176 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.645 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -37.46 107.29 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.74 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.623 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 48.0 m 127.66 143.77 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 123.658 0.783 . . . . 0.0 110.169 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 199' ' ' ASP . 27.5 Cg_endo -62.32 56.83 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.797 2.331 . . . . 0.0 112.752 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.588 ' CD1' ' CB ' ' A' ' 201' ' ' LEU . 0.5 OUTLIER 37.17 26.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.574 0.702 . . . . 0.0 111.961 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.542 ' HA ' ' CD ' ' A' ' 202' ' ' ARG . 5.1 m-20 -57.67 -34.77 69.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.126 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.83 89.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.543 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.588 ' CB ' ' CD1' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -69.21 -30.86 69.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.172 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.577 ' O ' ' HG ' ' A' ' 205' ' ' LEU . 11.0 mtp-105 -58.46 -48.57 80.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.513 0.673 . . . . 0.0 110.645 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.525 ' HA ' ' NH1' ' A' ' 233' ' ' ARG . 2.1 mt-10 -71.41 -33.66 69.65 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.318 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -59.87 -39.07 84.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.609 -0.436 . . . . 0.0 109.937 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -61.18 -49.61 76.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -64.53 -21.63 66.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.816 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.8 -85.27 0.2 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.751 0.31 . . . . 0.0 111.202 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 2.2 p 174.03 99.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.719 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 7.9 m-20 154.18 42.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.15 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 150.05 104.35 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.539 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.568 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 14.5 t-20 177.87 -57.32 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.06 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 8.4 Cg_endo -51.75 -55.79 3.59 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.17 1.913 . . . . 0.0 110.984 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -133.32 109.37 9.33 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.524 ' HB ' ' CG2' ' A' ' 240' ' ' VAL . 1.0 OUTLIER -116.45 125.82 73.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.568 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.4 m-85 -117.52 126.47 52.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.484 0.659 . . . . 0.0 110.533 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.54 ' CD2' ' CG1' ' A' ' 124' ' ' VAL . 0.7 OUTLIER -125.66 117.22 23.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.163 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . 0.509 ' SG ' ' CG2' ' A' ' 133' ' ' VAL . 48.8 t -124.53 107.8 11.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.978 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.579 ' HA2' ' CD2' ' A' ' 245' ' ' PHE . . . 168.57 -175.81 43.06 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.005 -1.093 . . . . 0.0 113.187 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.53 ' HB2' ' CB ' ' A' ' 250' ' ' ALA . 5.4 Cg_exo -38.18 168.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.773 2.982 . . . . 0.0 112.904 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 73.3 Cg_endo -75.52 -28.12 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.888 2.392 . . . . 0.0 111.84 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 224' ' ' ASP . . . -81.75 -46.55 6.71 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.23 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.439 ' HE3' ' CD2' ' A' ' 216' ' ' LEU . 1.3 tmt? -57.07 -35.49 69.43 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.533 ' CD1' ' HB3' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -76.97 -34.53 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.985 178.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.471 ' HB2' ' HA2' ' A' ' 221' ' ' GLY . 0.2 OUTLIER -67.59 -46.81 71.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.161 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -61.42 -47.05 87.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.808 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.486 ' O ' ' HG ' ' A' ' 229' ' ' LEU . . . -68.28 -31.21 70.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.675 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.435 ' HA ' HG21 ' A' ' 230' ' ' VAL . 49.6 t -70.32 -31.8 69.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.165 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.84 -44.37 85.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.867 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.557 ' CD1' ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -60.49 -39.88 89.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.793 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.528 ' CG1' ' HG3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -66.05 -41.6 89.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 -179.219 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -72.9 -30.0 63.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.151 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.42 -29.83 19.92 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.558 ' CD ' ' O ' ' A' ' 202' ' ' ARG . 1.4 mmp_? -72.91 -66.83 0.62 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.874 0.368 . . . . 0.0 111.415 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.491 ' C ' ' HD2' ' A' ' 236' ' ' PRO . . . 122.09 9.67 6.62 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.795 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.665 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 1.0 OUTLIER -83.3 -19.18 0.26 Allowed Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 235' ' ' ILE . 66.1 Cg_exo -39.99 117.23 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.68 1.587 . . . . 0.0 112.382 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -96.49 -116.79 3.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.753 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -129.53 -32.8 1.92 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.585 0.231 . . . . 0.0 111.401 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.577 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 9.7 mm-40 -99.87 30.74 3.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.008 0.433 . . . . 0.0 111.147 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.524 ' CG2' ' HB ' ' A' ' 214' ' ' ILE . 1.7 t -94.52 131.87 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.041 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.645 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.66 151.4 37.19 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.65 151.27 51.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.097 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . 0.527 ' O ' ' CD1' ' A' ' 223' ' ' ILE . 8.8 tm-20 -132.47 149.4 52.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.269 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -117.85 107.35 14.01 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 111.674 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.581 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -136.48 148.14 47.53 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.147 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.636 ' HB2' ' N1 ' ' A' ' 252' ' ' FDA . 3.0 tt -15.72 139.99 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.57 ' O ' ' CB ' ' A' ' 248' ' ' SER . 77.7 Cg_exo -50.8 -149.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.885 3.057 . . . . 0.0 113.565 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 247' ' ' PRO . 7.4 m 97.01 -19.43 0.05 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.907 0.86 . . . . 0.0 109.871 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 190' ' ' TRP . . . -122.15 -18.5 3.44 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.085 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.53 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . . . -109.08 151.67 26.09 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.606 0.762 . . . . 0.0 110.339 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.565 ' CB ' ' N ' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.07 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' FDA . . . . . 0.883 HM73 ' CG ' ' A' ' 50' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 81.9 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.42 -54.75 1.87 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.04 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.3 mt -116.33 117.13 54.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.468 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -154.85 57.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 5' ' ' SER . 2.2 m-85 179.23 91.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.43 -139.47 9.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.504 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -121.06 45.48 2.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 111.057 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.79 101.02 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.59 24.58 3.38 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.47 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -111.47 158.49 19.07 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.922 0.391 . . . . 0.0 111.055 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 34' ' ' ARG . 1.9 t80 -128.55 165.24 21.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.957 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.446 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -110.46 129.63 55.73 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.084 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -137.8 154.62 49.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.864 0.364 . . . . 0.0 111.153 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -103.52 121.38 42.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.455 HG12 ' HA2' ' A' ' 99' ' ' GLY . 24.3 t -72.1 136.03 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 10.5 p -162.2 24.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.264 0.554 . . . . 0.0 109.711 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.596 ' O ' ' CE1' ' A' ' 29' ' ' PHE . . . -153.05 122.2 1.26 Allowed Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.85 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.607 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -170.85 90.44 0.14 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.665 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -140.39 144.04 36.0 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.7 178.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 27' ' ' VAL . 10.1 m0 -89.94 112.6 24.03 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.579 -0.849 . . . . 0.0 108.87 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 26' ' ' THR . 0.7 OUTLIER -71.41 -19.02 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.639 0.733 . . . . 0.0 109.122 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.497 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 37.9 m -153.17 -175.24 5.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.074 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.3 m -52.2 -57.86 8.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.113 0.483 . . . . 0.0 110.917 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -118.79 47.26 1.68 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.14 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -143.28 128.59 18.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.754 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.529 HG13 ' CD1' ' A' ' 92' ' ' LEU . 2.5 p -131.0 133.83 62.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.301 0.572 . . . . 0.0 112.476 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -100.62 131.36 46.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.792 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.667 ' CD2' ' CZ ' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -126.02 128.42 47.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.917 -178.326 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.602 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -121.35 115.77 23.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.213 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.597 ' CD1' ' CD2' ' A' ' 102' ' ' LEU . 2.8 mt -115.28 148.73 38.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.455 . . . . 0.0 111.753 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -124.01 108.32 12.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.523 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -105.35 -165.43 1.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.048 -179.091 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.611 ' N ' ' HD2' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -28.81 -55.41 0.26 Allowed Pre-proline 0 N--CA 1.463 0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.832 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 34' ' ' ARG . 9.5 Cg_endo -52.95 -153.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.019 2.479 . . . . 0.0 111.972 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.594 ' CB ' ' HB3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -129.89 -156.51 0.76 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.402 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -93.04 67.81 4.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 111.644 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.597 ' CB ' ' HB2' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -161.28 -63.2 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 179.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.572 ' HA3' ' HB2' ' A' ' 71' ' ' ASN . . . -164.96 99.16 0.16 Allowed Glycine 0 C--N 1.344 1.003 0 C-N-CA 120.325 -0.94 . . . . 0.0 114.151 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.755 ' N ' ' HA2' ' A' ' 74' ' ' GLY . 18.0 t30 -14.81 138.3 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 124.499 1.12 . . . . 0.0 113.334 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.457 ' C ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER 31.5 35.51 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.584 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 72' ' ' PRO . . . 61.69 81.36 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.935 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.552 HG23 ' CA ' ' A' ' 39' ' ' GLY . 21.9 m -94.41 170.68 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.258 0.551 . . . . 0.0 111.459 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -155.77 23.12 0.39 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.803 -178.015 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.643 ' O ' ' CG ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER 99.07 92.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.583 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -115.2 125.4 28.94 Favored Pre-proline 0 N--CA 1.453 -0.317 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.937 178.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.447 ' C ' ' O ' ' A' ' 46' ' ' GLU . 53.5 Cg_exo -28.13 84.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.055 2.503 . . . . 0.0 112.739 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.635 ' N ' ' CD2' ' A' ' 111' ' ' PHE . . . 40.56 75.97 0.1 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.612 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.428 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 1.6 tm0? -69.74 109.7 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 111.021 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.686 ' CD2' HM72 ' A' ' 252' ' ' FDA . 1.5 m-30 -109.97 164.15 12.88 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.549 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 106' ' ' GLY . 5.2 mmt -135.74 -171.48 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.418 0.628 . . . . 0.0 112.414 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 105' ' ' LYS . 9.3 t0 -131.79 102.5 5.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.665 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.516 ' CD1' HD13 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -134.58 157.93 45.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.451 0.643 . . . . 0.0 112.228 -177.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.567 ' HA ' ' CB ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -109.19 151.2 26.8 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.968 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.685 ' CG2' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -30.45 -69.62 0.1 Allowed Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.224 0.327 . . . . 0.0 110.897 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.685 ' HD3' ' CG2' ' A' ' 55' ' ' ILE . 59.9 Cg_endo -104.69 7.64 0.28 Allowed 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.451 2.767 . . . . 0.0 111.735 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.41 18.56 14.28 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.093 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.567 ' CG2' ' HD2' ' A' ' 56' ' ' PRO . 6.8 p -63.65 -110.51 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.128 -0.536 . . . . 0.0 111.4 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.551 ' N ' HG23 ' A' ' 54' ' ' THR . 0.3 OUTLIER 175.45 28.5 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.488 ' CG1' ' O ' ' A' ' 60' ' ' VAL . 48.3 t -140.83 31.94 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.712 0.291 . . . . 0.0 111.289 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.567 ' CB ' ' HA ' ' A' ' 54' ' ' THR . 34.0 t -103.5 -103.23 0.29 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.681 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 61' ' ' SER . 8.6 mtt180 166.99 -179.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.088 0.471 . . . . 0.0 111.569 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 2.7 t -88.76 143.01 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.591 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.641 ' CE2' ' CG2' ' A' ' 80' ' ' ILE . 1.9 t80 -141.25 130.29 23.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.639 ' CB ' ' CD1' ' A' ' 50' ' ' PHE . 22.4 p -75.9 105.63 2.34 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 64' ' ' TYR . 72.4 Cg_endo -99.45 -169.92 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.905 2.403 . . . . 0.0 113.348 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.636 ' O ' ' CB ' ' A' ' 68' ' ' ASN . . . -86.15 176.77 7.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.636 ' CB ' ' O ' ' A' ' 67' ' ' ALA . 3.2 t30 106.61 123.71 0.01 OUTLIER 'General case' 0 C--N 1.343 0.31 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.613 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -170.96 -84.32 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 122.139 -0.351 . . . . 0.0 110.615 -178.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 69' ' ' LEU . 55.3 Cg_endo -85.81 72.57 4.07 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 120.384 1.173 . . . . 0.0 112.397 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.572 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -164.51 139.09 4.4 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.586 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.543 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 60.3 Cg_endo -91.15 53.57 0.91 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.665 2.243 . . . . 0.0 116.234 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.597 ' HB2' ' CB ' ' A' ' 38' ' ' CYS . 61.6 mt-10 -158.66 -106.91 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.269 0.94 . . . . 0.0 112.558 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.755 ' HA2' ' N ' ' A' ' 40' ' ' ASN . . . -160.57 78.0 0.17 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.591 ' CG ' ' N ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -123.46 81.92 1.95 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.159 0.98 . . . . 0.0 111.332 178.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -97.48 132.14 43.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.51 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 1.3 tt0 -129.99 111.69 12.77 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.443 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.667 ' CZ ' ' CD2' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -104.78 137.18 42.96 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.226 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.523 ' N ' ' OH ' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -122.53 75.41 1.25 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.918 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.641 ' CG2' ' CE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -92.61 130.4 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.121 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.79 ' O ' H52A ' A' ' 252' ' ' FDA . 0.3 OUTLIER -78.11 102.7 7.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.178 -178.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.579 ' CG2' ' CB ' ' A' ' 89' ' ' SER . 3.5 m -102.02 138.22 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.313 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.496 ' HG ' ' H4B' ' A' ' 252' ' ' FDA . 5.4 mt -68.99 129.01 92.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.738 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.23 110.14 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.666 2.244 . . . . 0.0 111.938 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.525 ' N ' ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER 47.25 43.73 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.422 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.54 -68.88 0.58 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.956 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -137.24 -68.2 0.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.268 . . . . 0.0 111.663 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -76.98 -33.57 57.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.714 0.292 . . . . 0.0 111.515 -179.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.579 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 0.5 OUTLIER -78.84 -20.74 48.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.404 -179.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.414 ' O ' ' CG ' ' A' ' 94' ' ' ASN . 0.7 OUTLIER -75.68 -46.66 30.03 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.692 0.758 . . . . 0.0 109.069 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.539 ' O ' ' CD1' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -74.62 -24.52 58.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.498 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.535 ' CD2' HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.78 -49.4 73.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.001 -179.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -89.05 -16.95 30.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.447 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.414 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 73.8 m-20 -95.04 -9.32 34.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.286 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.435 ' OD2' ' HG3' ' A' ' 56' ' ' PRO . 0.3 OUTLIER -135.13 2.99 3.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.383 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 92' ' ' LEU . . . -139.16 28.91 2.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.825 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -77.53 -49.58 14.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.467 -179.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.573 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.3 OUTLIER -74.95 3.2 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.142 0.496 . . . . 0.0 111.796 -179.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 100' ' ' GLN . . . 54.12 36.92 57.67 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.415 -0.897 . . . . 0.0 111.722 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.538 ' HG3' ' CG1' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -52.8 -160.41 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.943 0.401 . . . . 0.0 111.065 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.65 143.14 12.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.775 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.597 ' CD2' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -128.91 132.95 47.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.468 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 6.8 m -92.02 123.1 35.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.088 0.471 . . . . 0.0 111.063 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 12' ' ' PHE . 2.0 m -96.8 127.85 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -127.0 170.17 12.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.557 -178.214 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 51' ' ' MET . . . 69.59 83.88 0.17 Allowed Glycine 0 C--N 1.312 -0.795 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.05 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.22 54.03 4.49 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.427 2.084 . . . . 0.0 110.053 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.595 ' HG ' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -97.42 166.52 11.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.134 -177.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.595 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -156.9 129.32 2.37 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.485 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.481 ' O ' ' CE2' ' A' ' 50' ' ' PHE . 10.7 p -158.25 113.51 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.865 0.364 . . . . 0.0 110.769 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.635 ' CD2' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -119.24 150.26 40.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.681 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -95.09 9.41 70.12 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.696 ' HA ' ' CG ' ' A' ' 215' ' ' TYR . 3.7 pp -116.09 119.4 35.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.278 0.561 . . . . 0.0 110.848 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.647 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.5 OUTLIER -137.5 112.92 9.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.485 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 121' ' ' ARG . 0.1 OUTLIER -87.2 140.54 29.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.54 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -94.12 14.29 20.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.2 -74.68 0.22 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.765 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -129.59 89.96 2.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.941 0.401 . . . . 0.0 110.461 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 121' ' ' ARG . . . -164.37 144.73 6.4 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.363 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 43.8 Cg_endo -67.98 116.93 4.56 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.765 2.31 . . . . 0.0 111.905 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.1 OUTLIER -130.96 158.53 40.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.647 ' CE2' ' CD ' ' A' ' 150' ' ' ARG . 3.5 m-85 -126.68 130.53 50.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.079 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -106.46 103.71 13.23 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.59 ' CG1' ' CD2' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -101.01 111.09 29.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.275 0.56 . . . . 0.0 110.843 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -114.47 133.08 56.02 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.898 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -105.82 102.7 2.01 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.841 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.561 ' HA2' ' CG1' ' A' ' 155' ' ' VAL . . . 124.08 -164.32 17.41 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.417 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.502 ' C ' ' H ' ' A' ' 130' ' ' LEU . 5.4 m -106.4 -10.39 16.34 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.45 0.643 . . . . 0.0 110.746 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.615 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -68.01 10.63 1.17 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.459 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.522 HD23 ' N ' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -75.75 5.14 6.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 122.894 0.478 . . . . 0.0 110.283 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.597 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -44.98 -41.24 12.36 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.197 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 3.7 Cg_exo -73.53 -31.39 8.91 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.49 2.127 . . . . 0.0 110.063 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 217' ' ' CYS . 21.4 t -64.86 -42.7 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.614 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 131' ' ' ALA . 10.6 m -70.15 -29.78 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.533 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.534 ' HB3' ' CD1' ' A' ' 69' ' ' LEU . 16.7 m -66.49 -53.09 39.09 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.48 ' CG ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -60.5 -42.4 96.3 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.511 0.672 . . . . 0.0 109.215 178.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.555 ' O ' ' CG ' ' A' ' 141' ' ' GLN . 26.8 t -62.35 -32.39 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.927 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 135' ' ' SER . 5.3 mtm180 -59.6 -32.12 70.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.198 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.567 ' OE1' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -68.4 -43.03 78.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.09 178.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.626 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -71.5 -34.96 70.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.507 0.67 . . . . 0.0 111.047 179.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.555 ' CG ' ' O ' ' A' ' 137' ' ' VAL . 0.4 OUTLIER -78.05 -30.45 49.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.239 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 138' ' ' ARG . 3.4 mm-40 -69.8 -44.99 68.93 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.653 ' CZ2' ' CB ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -79.24 -21.14 46.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.436 0.636 . . . . 0.0 109.736 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 145' ' ' ALA . 0.6 OUTLIER 52.74 28.03 5.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.735 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.653 ' CB ' ' CZ2' ' A' ' 143' ' ' TRP . . . -33.09 153.95 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.946 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.445 ' HA ' ' HG3' ' A' ' 175' ' ' ARG . 41.8 Cg_endo -67.63 -3.58 10.52 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.667 2.245 . . . . 0.0 112.71 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.571 ' ND2' ' NH2' ' A' ' 121' ' ' ARG . 40.3 t30 -76.37 144.12 40.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 111.567 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 1.2 mt-10 -73.59 111.41 8.71 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.624 0.726 . . . . 0.0 111.072 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 1.1 m -108.5 115.38 29.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.892 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.647 ' CD ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -106.6 141.49 37.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.455 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.492 ' C ' ' CD1' ' A' ' 151' ' ' ILE . 0.1 OUTLIER -133.59 129.33 55.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.262 0.554 . . . . 0.0 111.032 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.575 ' CD1' ' HB2' ' A' ' 180' ' ' LYS . 22.0 m-30 -108.33 115.06 29.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.47 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.466 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 37.2 t80 -120.15 132.02 55.24 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.396 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.625 ' CA ' ' HB2' ' A' ' 182' ' ' CYS . . . -155.06 160.67 29.9 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 119.511 -1.328 . . . . 0.0 113.288 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.568 ' CG1' ' O ' ' A' ' 154' ' ' GLY . 1.2 m -170.73 -106.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.596 ' CB ' ' N ' ' A' ' 188' ' ' GLY . 0.3 OUTLIER -126.17 -169.59 2.04 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 120.663 0.268 . . . . 0.0 111.287 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.57 HG22 ' N ' ' A' ' 187' ' ' SER . 72.0 p -28.29 -62.67 0.1 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.655 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.563 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.2 OUTLIER 153.1 -54.05 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.495 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 40.7 Cg_exo -31.28 -31.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.155 2.57 . . . . 0.0 112.96 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.2 mm-40 -85.44 -60.11 2.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.016 0.436 . . . . 0.0 110.636 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.567 ' CD1' ' CG2' ' A' ' 155' ' ' VAL . 0.4 OUTLIER -67.3 -174.68 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.394 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 163' ' ' TYR . 0.8 OUTLIER 175.27 176.11 0.2 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.86 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 162' ' ' PHE . 0.3 OUTLIER 87.66 6.75 0.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.313 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -71.39 -45.51 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.771 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.584 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 3.5 m-20 -66.0 -35.7 81.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.243 0.544 . . . . 0.0 110.107 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.454 ' O ' ' OG ' ' A' ' 169' ' ' SER . 0.9 OUTLIER -72.38 -36.22 68.66 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -61.61 -31.83 71.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.095 179.007 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 165' ' ' ASP . 24.2 mttt -62.92 -48.54 78.5 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 166' ' ' GLU . 3.9 p -61.8 -31.41 71.62 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.549 ' CD2' ' HB3' ' A' ' 141' ' ' GLN . 1.1 mt -63.57 -37.41 87.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.528 ' HA ' ' CD2' ' A' ' 177' ' ' LEU . 4.4 mm-40 -68.43 -36.07 78.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.922 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -34.53 59.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.143 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.1 t -53.7 -49.17 68.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.521 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.531 ' CG ' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -69.31 -154.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 111.588 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.445 ' HG3' ' HA ' ' A' ' 146' ' ' PRO . 0.3 OUTLIER -106.49 -54.26 2.5 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.718 -179.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -132.35 69.91 1.47 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.112 0.482 . . . . 0.0 110.706 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 149' ' ' THR . 3.6 mp -98.81 150.47 21.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.888 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.513 ' OG1' ' CZ ' ' A' ' 150' ' ' ARG . 2.4 m -137.48 115.41 11.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.718 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.458 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 2.6 p -101.15 134.65 40.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.776 0.322 . . . . 0.0 111.352 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.575 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -101.69 135.28 43.49 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.562 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -100.82 105.51 16.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.491 0.663 . . . . 0.0 111.824 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.625 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 29.6 m -88.53 -161.93 0.79 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.181 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.574 HG22 ' CA ' ' A' ' 156' ' ' ASN . 14.9 t 54.73 147.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-O 121.703 0.763 . . . . 0.0 111.812 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.24 -60.78 0.61 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.188 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.586 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 1.9 t-80 -164.99 51.26 0.25 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.789 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 187' ' ' SER . 86.3 Cg_endo -90.3 -98.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.21 2.607 . . . . 0.0 112.542 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 21.7 t 137.85 6.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.596 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 120.64 12.19 6.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.259 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.16 62.62 1.59 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.441 ' O ' ' N ' ' A' ' 249' ' ' GLY . 8.5 t-105 -132.08 121.31 23.61 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.305 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 250' ' ' ALA . 3.9 mt-10 -95.92 104.71 16.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.52 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.559 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 140.82 -117.02 1.2 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.696 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.575 ' C ' ' HB3' ' A' ' 182' ' ' CYS . 13.6 mt-10 -162.98 -95.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.514 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -86.73 139.34 30.83 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.641 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -21.37 107.08 0.01 OUTLIER Glycine 0 C--N 1.334 0.448 0 O-C-N 123.688 0.618 . . . . 0.0 113.096 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.614 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 67.1 m 120.65 154.45 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 123.481 0.712 . . . . 0.0 110.701 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.65 -75.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 123.234 2.623 . . . . 0.0 112.728 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.645 ' CG2' ' O ' ' A' ' 198' ' ' ILE . 0.2 OUTLIER 174.88 32.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.985 0.897 . . . . 0.0 110.732 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.473 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 35.9 m-20 -58.61 -37.27 75.49 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.191 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.46 73.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.548 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 0.2 OUTLIER -69.32 -34.04 74.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.873 0.368 . . . . 0.0 110.904 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.539 ' HB3' ' NE ' ' A' ' 233' ' ' ARG . 5.9 mtm180 -59.84 -52.15 66.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -41.87 96.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.814 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.2 -29.16 68.53 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.596 ' CD2' ' CD1' ' A' ' 235' ' ' ILE . 0.0 OUTLIER -62.67 -43.96 97.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.337 178.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.44 -18.07 57.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.538 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 208' ' ' SER . 59.4 m -75.79 -80.45 0.09 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.93 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 207' ' ' SER . 0.4 OUTLIER 164.99 34.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.449 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.554 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 2.0 m-20 -137.85 52.29 1.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.697 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 151.5 102.01 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.208 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.557 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 13.5 t30 174.04 -56.78 0.0 OUTLIER Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.143 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 18.8 Cg_endo -59.53 -58.04 0.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.294 1.996 . . . . 0.0 111.207 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.523 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -133.14 109.23 9.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.309 178.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.533 HD12 ' CB ' ' A' ' 210' ' ' ALA . 0.5 OUTLIER -121.63 125.76 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.696 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -120.62 127.1 51.78 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.388 0.613 . . . . 0.0 111.063 -178.414 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.59 ' CD2' ' CG1' ' A' ' 124' ' ' VAL . 3.4 mt -125.71 116.45 21.66 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.284 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . 0.536 ' HB2' ' CG2' ' A' ' 133' ' ' VAL . 38.9 m -124.8 107.09 10.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.077 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.621 ' N ' ' CD ' ' A' ' 219' ' ' PRO . . . 110.44 -28.13 10.58 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.93 -1.128 . . . . 0.0 114.075 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 218' ' ' GLY . 46.3 Cg_endo -89.76 83.17 0.53 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.238 1.958 . . . . 0.0 114.72 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.573 ' CD ' ' O ' ' A' ' 218' ' ' GLY . 11.9 Cg_endo -53.48 -71.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 111.301 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 224' ' ' ASP . . . -54.2 -48.62 62.94 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.427 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.563 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -54.77 -24.08 20.89 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -72.76 -36.81 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.942 178.132 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 221' ' ' GLY . 65.6 m-20 -73.45 -47.04 44.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.003 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -69.72 -37.02 76.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.641 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 222' ' ' MET . . . -59.4 -38.5 80.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.385 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 31.7 m -69.91 -31.19 68.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.572 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -44.5 82.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.811 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.514 ' CD2' ' O ' ' A' ' 225' ' ' ALA . 0.0 OUTLIER -60.76 -37.14 80.83 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.013 0.435 . . . . 0.0 110.664 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.554 ' HA ' ' CD2' ' A' ' 205' ' ' LEU . 3.6 t -66.23 -45.62 89.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.392 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -72.75 -30.02 63.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 6.2 m -76.98 -44.15 32.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.539 ' NE ' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -68.21 -75.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.166 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.475 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 137.8 -36.13 1.97 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.255 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.596 ' CD1' ' CD2' ' A' ' 205' ' ' LEU . 1.6 pp -35.84 95.29 0.09 OUTLIER Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 111.005 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 18.7 Cg_endo -59.86 115.33 2.55 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.757 2.305 . . . . 0.0 112.185 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -93.85 173.72 33.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.437 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -143.71 -41.92 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 110.91 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.582 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 43.7 mm-40 -107.5 37.78 2.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.501 ' CG2' ' HB ' ' A' ' 214' ' ' ILE . 2.1 t -92.84 132.45 37.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.647 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -144.72 144.5 31.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.42 -178.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -130.75 140.93 50.35 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . 0.503 ' OE2' ' CA ' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -132.79 149.12 52.31 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.75 178.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 220' ' ' PRO . 1.0 OUTLIER -127.22 108.09 10.57 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.615 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.4 OUTLIER -138.22 144.32 40.57 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.538 178.364 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.613 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 0.1 OUTLIER 68.31 148.55 0.12 Allowed Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 121.917 -0.49 . . . . 0.0 111.379 -179.101 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.559 ' HD2' ' CD2' ' A' ' 246' ' ' LEU . 97.7 Cg_endo -73.28 -104.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.959 2.439 . . . . 0.0 112.371 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 247' ' ' PRO . 52.8 p -37.66 134.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.183 0.516 . . . . 0.0 110.912 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 127.71 -15.69 6.27 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.554 ' O ' ' CB ' ' A' ' 191' ' ' GLU . . . -106.53 120.55 42.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.709 -0.745 . . . . 0.0 111.541 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.559 ' N ' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.066 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' FDA . . . . . 0.79 H52A ' O ' ' A' ' 81' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.807 0.337 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -126.11 125.61 42.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.946 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 mt -124.82 133.75 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.063 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.57 -162.89 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -134.71 37.55 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.47 39.33 4.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.433 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -108.43 44.31 1.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.846 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 t -122.56 103.62 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.154 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.05 22.5 17.37 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.81 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.559 ' CB ' ' HB3' ' A' ' 105' ' ' LYS . 0.8 OUTLIER -115.03 149.34 37.62 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.693 -0.253 . . . . 0.0 111.022 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.654 ' CE2' ' CG2' ' A' ' 104' ' ' VAL . 0.9 OUTLIER -134.05 165.54 24.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -113.31 135.29 54.0 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.992 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -134.53 150.35 50.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.755 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 1.1 pt-20 -96.5 116.63 29.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 110.754 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 102' ' ' LEU . 2.9 m -75.34 135.34 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.284 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 7.4 p -149.4 20.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.168 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -106.63 -129.82 6.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.028 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.546 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 74.9 80.39 0.11 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.831 -0.685 . . . . 0.0 110.445 -178.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -123.25 139.45 54.04 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.079 178.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 7.9 m0 -90.1 113.49 25.24 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.164 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 m -96.26 -26.99 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.516 ' HB2' ' HB ' ' A' ' 26' ' ' THR . 8.2 m -143.43 171.09 14.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.244 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.46 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -52.88 -53.83 43.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.116 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -119.46 45.47 2.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.58 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 23' ' ' SER . 0.3 OUTLIER -148.06 140.36 24.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.426 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.531 HG12 ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -140.89 141.28 31.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.26 0.552 . . . . 0.0 112.036 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.463 ' HB2' ' CD2' ' A' ' 79' ' ' LEU . 17.0 tt0 -121.44 110.52 16.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.895 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.703 ' CD2' ' CD1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -118.74 140.52 49.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 111.446 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.569 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -117.13 143.66 45.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.347 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.563 ' CD2' ' CE1' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -122.14 154.91 36.78 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.17 0.509 . . . . 0.0 111.954 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 6.0 mt-30 -116.13 104.81 11.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.491 178.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.643 ' CG ' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -60.63 -171.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.459 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.644 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 1.9 mmp_? -55.57 -90.36 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.698 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.644 ' CD ' ' CB ' ' A' ' 34' ' ' ARG . 32.4 Cg_exo -45.67 -82.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.185 0 CA-C-N 120.474 1.205 . . . . 0.0 112.333 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -104.31 -164.31 1.04 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.767 0.712 . . . . 0.0 109.725 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.606 ' HB2' ' HA ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -54.55 -26.41 31.91 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.981 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' CB ' ' CA ' ' A' ' 74' ' ' GLY . 5.0 t -110.91 -6.1 14.76 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.684 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.545 ' CA ' ' HD2' ' A' ' 35' ' ' PRO . . . 78.92 68.77 1.46 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.805 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.573 ' N ' ' HB2' ' A' ' 35' ' ' PRO . 13.0 t30 61.89 12.95 5.15 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.206 0.527 . . . . 0.0 110.261 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.544 ' O ' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -73.84 -15.23 61.17 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.578 ' HA2' ' N ' ' A' ' 73' ' ' GLU . . . -2.19 75.28 0.0 OUTLIER Glycine 0 C--N 1.343 0.935 0 O-C-N 124.151 0.907 . . . . 0.0 114.41 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.595 ' CG2' ' ND2' ' A' ' 68' ' ' ASN . 18.8 m -134.0 164.39 34.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.281 0.563 . . . . 0.0 112.441 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.685 ' HA ' ' CA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.32 41.37 1.09 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.282 178.123 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.6 ' CZ ' ' O ' ' A' ' 132' ' ' PRO . 83.9 t80 71.66 143.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.064 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.594 ' O ' ' CE2' ' A' ' 45' ' ' PHE . 4.9 mt-10 -112.91 161.88 24.5 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.743 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' GLY . 5.1 Cg_endo -47.44 80.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.717 2.278 . . . . 0.0 112.326 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 34.85 41.2 0.24 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.862 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.49 ' O ' ' CB ' ' A' ' 65' ' ' SER . 4.8 mt-30 -53.46 161.04 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.67 0.235 . . . . 0.0 110.442 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.683 ' CE1' ' CB ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -152.82 160.47 43.09 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.964 0.411 . . . . 0.0 111.703 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.627 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -138.73 -172.35 3.29 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.389 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -112.7 108.79 17.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -149.64 155.92 41.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.601 HG23 ' N ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -106.9 155.3 19.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.792 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.714 ' CG2' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -29.89 -68.62 0.11 Allowed Pre-proline 0 CA--C 1.54 0.58 0 O-C-N 123.393 0.433 . . . . 0.0 110.666 -179.171 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.714 ' HD3' ' CG2' ' A' ' 55' ' ' ILE . 6.3 Cg_endo -107.89 3.69 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.434 2.756 . . . . 0.0 111.807 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 107.23 -4.35 35.42 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.132 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.572 HG23 ' CD ' ' A' ' 56' ' ' PRO . 70.5 p -25.52 -89.76 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.975 0.51 . . . . 0.0 111.864 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.49 ' O ' HG12 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -147.2 43.11 1.12 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.578 ' N ' ' OG1' ' A' ' 54' ' ' THR . 0.4 OUTLIER 79.25 125.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.676 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.601 ' N ' HG23 ' A' ' 54' ' ' THR . 4.1 m -101.44 -54.32 2.79 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.372 0.606 . . . . 0.0 110.493 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.434 ' HB3' " O4'" ' A' ' 252' ' ' FDA . 0.0 OUTLIER 175.2 -155.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.438 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.683 ' CB ' ' CE1' ' A' ' 50' ' ' PHE . 3.6 p -105.73 119.36 38.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.898 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.527 ' CE2' ' N3 ' ' A' ' 252' ' ' FDA . 4.2 t80 -140.72 124.51 17.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.119 0.485 . . . . 0.0 112.086 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.692 ' HB3' ' H6 ' ' A' ' 252' ' ' FDA . 1.3 t -80.85 108.25 9.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.063 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.484 ' HD2' ' O ' ' A' ' 49' ' ' GLN . 87.9 Cg_endo -83.61 159.41 14.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.795 2.33 . . . . 0.0 111.667 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.588 ' HB2' ' CD1' ' A' ' 45' ' ' PHE . . . -119.48 129.51 54.76 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.603 ' O ' ' CB ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -82.21 -75.31 0.31 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.328 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.603 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 10.8 tp 101.53 141.38 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.22 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.685 ' CA ' ' HA ' ' A' ' 44' ' ' LYS . 5.5 Cg_exo -36.25 86.31 0.01 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 123.001 2.467 . . . . 0.0 112.0 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -162.67 117.96 1.2 Allowed Pre-proline 0 CA--C 1.518 -0.251 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.086 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.537 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 88.7 Cg_endo -85.56 38.55 0.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.484 2.123 . . . . 0.0 112.379 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.578 ' N ' ' HA2' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -129.06 -51.47 1.21 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.594 ' O ' ' CB ' ' A' ' 37' ' ' GLU . . . 127.34 107.95 1.48 Allowed Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.81 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.606 ' HA ' ' HB2' ' A' ' 37' ' ' GLU . 5.9 mtt180 -139.53 93.55 2.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.517 0.199 . . . . 0.0 110.506 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.555 ' C ' ' CD1' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -95.88 131.55 42.1 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.351 0.596 . . . . 0.0 111.368 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.444 ' N ' HD13 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.9 150.74 30.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.138 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.703 ' CD1' ' CD2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -135.29 129.99 34.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.367 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.475 ' O ' ' OH ' ' A' ' 64' ' ' TYR . 2.7 mt -135.6 103.37 5.42 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-O 120.846 0.355 . . . . 0.0 110.355 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.655 ' CD1' ' CZ ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -115.04 127.33 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.194 -178.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.519 ' HG3' ' CD1' ' A' ' 246' ' ' LEU . 1.8 mmt180 -79.69 95.57 5.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.595 ' CG2' ' CB ' ' A' ' 89' ' ' SER . 3.0 m -90.56 142.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.114 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.791 HD12 ' H1B' ' A' ' 252' ' ' FDA . 0.5 OUTLIER -88.15 151.35 48.96 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.612 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.456 ' HD2' ' HG ' ' A' ' 83' ' ' LEU . 55.3 Cg_endo -69.87 -8.46 23.66 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.753 2.302 . . . . 0.0 112.392 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -70.51 -25.87 63.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.506 ' CA ' ' HB2' ' A' ' 90' ' ' ASP . . . 115.43 -4.06 21.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.569 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 86' ' ' GLY . 9.3 mmm180 -36.63 -73.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 110.792 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.493 ' CB ' ' O1A' ' A' ' 252' ' ' FDA . 13.4 t80 -116.92 -21.88 8.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.595 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 1.3 p -65.75 -36.79 84.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.206 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.506 ' HB2' ' CA ' ' A' ' 86' ' ' GLY . 2.1 m-20 -75.09 -33.47 61.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.364 0.602 . . . . 0.0 109.868 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.634 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 2.0 t80 -73.34 -31.59 64.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.702 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.532 ' HA ' ' CD1' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -68.73 -39.36 80.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.203 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.08 -19.88 21.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 9.0 m-20 -97.48 -10.97 24.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.43 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.53 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -124.73 -12.3 7.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.452 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 92' ' ' LEU . . . -132.56 33.2 3.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.028 0.442 . . . . 0.0 110.909 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -52.88 61.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.682 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -89.32 -135.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 120.737 0.303 . . . . 0.0 111.129 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 100' ' ' GLN . . . -120.97 28.07 6.24 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.995 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.485 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 17.2 mp0 -39.26 163.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 110.911 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 14' ' ' ALA . 4.8 p -92.83 139.77 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.953 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.552 ' CD1' ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.67 125.33 35.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -92.38 134.55 34.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.97 0.414 . . . . 0.0 111.086 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.654 ' CG2' ' CE2' ' A' ' 12' ' ' PHE . 1.9 m -112.91 129.37 68.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.445 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.559 ' HB3' ' CB ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -130.55 112.97 13.67 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.759 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 151.56 73.66 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.022 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.94 53.97 4.37 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.496 2.131 . . . . 0.0 110.924 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.595 HD22 ' CD2' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -102.17 166.61 10.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.781 -178.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.551 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -108.75 172.7 16.84 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.492 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.684 ' CG2' HM72 ' A' ' 252' ' ' FDA . 4.4 p -152.18 113.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.201 0.524 . . . . 0.0 111.205 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 241' ' ' PHE . 13.0 m-30 -71.01 114.74 9.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.419 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -149.99 -46.46 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.593 ' HA ' ' CG ' ' A' ' 215' ' ' TYR . 2.0 pt? -146.43 119.59 8.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.937 0.399 . . . . 0.0 110.488 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -137.9 112.83 9.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.853 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -78.95 140.2 38.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.287 179.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.43 ' HD3' ' HG3' ' A' ' 239' ' ' GLN . 17.2 ttp180 -98.37 11.7 37.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.185 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.478 ' C ' ' NH2' ' A' ' 121' ' ' ARG . . . 107.27 -78.08 0.24 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.693 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.442 ' HA ' ' HB3' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -129.91 89.83 2.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.844 0.354 . . . . 0.0 110.577 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 121' ' ' ARG . . . -166.86 151.93 7.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 33.0 Cg_endo -64.47 116.73 3.93 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.652 2.235 . . . . 0.0 111.606 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.575 ' CB ' ' CE2' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -124.76 128.24 48.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.081 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.636 ' CD2' ' CE1' ' A' ' 152' ' ' TYR . 2.5 m-30 -106.65 115.84 30.9 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.656 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -119.66 111.01 17.51 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.258 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.576 ' CG1' ' CD2' ' A' ' 216' ' ' LEU . 7.4 p -109.15 111.06 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.206 0.527 . . . . 0.0 110.978 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -103.7 133.58 48.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.951 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.551 ' HA3' ' N ' ' A' ' 250' ' ' ALA . . . -109.59 103.61 1.77 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.944 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.535 ' HA2' ' CG1' ' A' ' 155' ' ' VAL . . . 123.55 -158.91 18.21 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 119.782 -1.199 . . . . 0.0 112.757 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 130' ' ' LEU . 3.2 m -110.09 -14.41 14.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.675 0.274 . . . . 0.0 111.409 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.608 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -67.67 9.36 1.35 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.355 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.573 HD12 ' CE1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -77.99 3.88 13.59 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 122.491 0.316 . . . . 0.0 110.192 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.582 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -46.52 -43.34 36.5 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 120.516 -0.473 . . . . 0.0 109.998 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.6 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 2.8 Cg_exo -73.82 -35.35 4.51 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.529 2.152 . . . . 0.0 109.718 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.656 ' CG1' ' CE1' ' A' ' 123' ' ' PHE . 15.8 t -63.36 -42.88 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.208 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 131' ' ' ALA . 20.8 m -70.48 -29.74 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.414 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.466 ' HB3' ' CG ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -63.21 -52.7 61.23 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -46.44 89.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.477 0.656 . . . . 0.0 109.628 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.622 ' CG2' ' CE2' ' A' ' 123' ' ' PHE . 0.9 OUTLIER -59.53 -33.42 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.623 178.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -34.19 71.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.224 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.436 ' CD ' ' HG3' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -65.3 -42.45 93.05 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.601 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.7 OUTLIER -70.49 -34.01 71.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.661 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.557 ' CG ' ' O ' ' A' ' 137' ' ' VAL . 0.6 OUTLIER -77.06 -30.61 55.66 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.287 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -70.55 -44.82 66.66 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.658 ' CZ2' ' CB ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -80.66 -20.56 42.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.411 0.624 . . . . 0.0 110.192 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.514 ' O ' ' CG ' ' A' ' 175' ' ' ARG . 0.1 OUTLIER 51.21 28.75 4.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.656 178.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.658 ' CB ' ' CZ2' ' A' ' 143' ' ' TRP . . . -31.17 150.56 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 111.1 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.42 -9.19 6.37 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.877 2.385 . . . . 0.0 113.083 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.442 ' HB3' ' HA ' ' A' ' 118' ' ' MET . 8.4 p-10 -76.35 143.34 40.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.128 0.49 . . . . 0.0 111.861 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 9.1 mt-10 -73.75 127.38 32.65 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.827 0.822 . . . . 0.0 110.88 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 26.1 m -118.27 121.67 41.02 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.477 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.611 ' HB2' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.46 134.77 44.05 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.062 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.624 HD13 ' CD2' ' A' ' 123' ' ' PHE . 0.5 OUTLIER -113.88 130.81 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.957 -179.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.636 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 45.4 m-85 -123.76 109.28 13.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.034 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CE1' HD12 ' A' ' 130' ' ' LEU . 4.4 t80 -122.15 132.26 54.37 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.397 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.651 ' HA2' ' HB2' ' A' ' 182' ' ' CYS . . . -160.85 153.63 24.51 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 119.697 -1.239 . . . . 0.0 113.723 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.56 ' CG2' ' CD2' ' A' ' 161' ' ' LEU . 2.4 m -167.58 -105.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.618 ' CB ' ' N ' ' A' ' 188' ' ' GLY . 4.0 p30 -108.3 174.39 5.9 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.936 0.398 . . . . 0.0 111.738 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.55 ' O ' ' CB ' ' A' ' 158' ' ' GLU . 0.5 OUTLIER -34.28 -41.81 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.401 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.0 OUTLIER 153.85 -41.53 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.241 0 O-C-N 123.307 0.379 . . . . 0.0 111.88 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 62.4 Cg_exo -40.1 -30.23 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.458 2.105 . . . . 0.0 112.707 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.494 ' CB ' ' ND2' ' A' ' 156' ' ' ASN . 1.2 mp0 -103.61 -13.93 16.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.701 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.56 ' CD1' ' CZ ' ' A' ' 153' ' ' PHE . 10.9 tp -94.75 171.85 8.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.846 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 1.1 p90 176.28 -163.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.977 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.6 OUTLIER 72.05 9.22 6.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.393 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.56 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -57.62 -41.65 79.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 109.986 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.56 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 16.8 m-20 -64.24 -27.76 69.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.873 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -71.57 -47.49 54.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.88 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.54 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -62.95 -31.28 72.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.088 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -60.7 -45.93 92.34 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.6 m -61.76 -31.76 71.97 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.543 ' CD1' ' OE1' ' A' ' 141' ' ' GLN . 1.0 OUTLIER -62.75 -38.02 88.89 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.466 ' HA ' HD13 ' A' ' 177' ' ' LEU . 30.8 mt-10 -66.68 -36.22 82.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.309 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -78.65 -35.93 44.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.31 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.461 ' O ' ' C ' ' A' ' 174' ' ' MET . 0.5 OUTLIER -87.77 -79.14 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.684 0.278 . . . . 0.0 111.606 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.55 ' CG ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -23.69 126.5 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.458 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 144' ' ' THR . 1.7 mmp_? -38.41 -91.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.427 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.443 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -119.0 61.3 0.8 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.27 0.557 . . . . 0.0 109.894 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.593 ' CD2' ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -103.58 157.77 16.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.622 -179.094 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.593 ' N ' ' CD2' ' A' ' 177' ' ' LEU . 3.7 m -137.1 123.13 20.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.932 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.5 ' HA ' HG23 ' A' ' 151' ' ' ILE . 64.2 t -89.18 136.57 23.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.638 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.473 ' HG2' ' CD2' ' A' ' 152' ' ' TYR . 17.8 tptt -102.63 130.31 49.48 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.642 0.258 . . . . 0.0 110.582 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' NE2' ' A' ' 194' ' ' GLN . . . -97.51 104.93 17.0 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.74 0.781 . . . . 0.0 110.798 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.651 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 97.6 m -91.16 -168.54 2.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.11 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 156' ' ' ASN . 19.4 t 56.47 148.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.913 0.864 . . . . 0.0 111.407 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.98 -69.27 0.54 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.979 -178.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.606 ' N ' ' CD ' ' A' ' 186' ' ' PRO . 0.2 OUTLIER -155.89 34.93 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.584 178.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.633 ' O ' ' CB ' ' A' ' 187' ' ' SER . 83.3 Cg_endo -73.47 -100.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.502 2.135 . . . . 0.0 112.791 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.633 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 27.4 t 137.69 30.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.972 0.509 . . . . 0.0 111.707 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.618 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 94.06 12.57 56.28 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.3 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.07 63.4 1.57 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.496 ' O ' ' HB3' ' A' ' 248' ' ' SER . 4.0 t-105 -132.25 113.7 13.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.723 -177.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.444 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 1.3 mt-10 -84.34 103.66 13.71 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.597 ' HA2' ' CB ' ' A' ' 251' ' ' ALA . . . 146.05 -122.09 1.59 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.056 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.565 ' CB ' ' SG ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -159.21 -79.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.577 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -100.88 148.59 24.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.07 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.651 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -40.49 105.92 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.674 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 3.5 m 148.71 172.72 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 111.264 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.526 ' CD ' ' HB3' ' A' ' 196' ' ' SER . 2.6 Cg_exo -75.86 -70.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.994 2.462 . . . . 0.0 112.606 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.667 ' CG2' ' O ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER 169.13 37.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-O 122.372 1.082 . . . . 0.0 110.136 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 199' ' ' ASP . 0.5 OUTLIER -72.57 -34.24 67.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.054 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -57.81 -45.49 86.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.586 ' CD2' HD12 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -71.39 -29.73 65.28 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.175 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.537 ' CG ' HD12 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -58.06 -52.89 63.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.786 -178.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.23 -43.17 64.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.334 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.61 -29.2 67.83 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.539 ' CG ' HG12 ' A' ' 235' ' ' ILE . 0.5 OUTLIER -63.31 -48.69 76.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.422 ' CD ' ' NH2' ' A' ' 233' ' ' ARG . 3.4 mt-10 -67.73 -26.93 66.39 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.666 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 208' ' ' SER . 69.9 m -75.32 -82.5 0.07 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.893 0.377 . . . . 0.0 110.789 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 209' ' ' ASP . 0.1 OUTLIER 166.08 90.31 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.691 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 0.2 OUTLIER 164.23 53.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.837 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 151.94 99.92 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.189 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.578 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 13.5 t30 172.65 -56.54 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.981 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 12.9 Cg_endo -56.63 -50.97 10.17 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.412 2.075 . . . . 0.0 111.025 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -132.67 109.06 9.44 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.536 ' HB ' ' CG2' ' A' ' 240' ' ' VAL . 1.0 OUTLIER -122.11 125.08 72.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.593 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.3 m-85 -118.75 126.71 52.49 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.397 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.576 ' CD2' ' CG1' ' A' ' 124' ' ' VAL . 20.5 mt -125.16 118.81 26.9 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.829 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 250' ' ' ALA . 0.0 OUTLIER -122.87 131.66 53.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.658 178.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.6 ' O ' ' N ' ' A' ' 245' ' ' PHE . . . 144.08 -151.46 23.44 Favored Glycine 0 C--O 1.224 -0.511 0 C-N-CA 120.058 -1.067 . . . . 0.0 113.075 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 247' ' ' PRO . 56.7 Cg_endo -70.73 166.61 28.23 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.65 2.233 . . . . 0.0 112.459 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.454 ' O ' HG22 ' A' ' 223' ' ' ILE . 27.7 Cg_exo -61.1 -9.07 11.34 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.77 2.313 . . . . 0.0 112.189 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -69.32 -54.83 11.65 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.959 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.58 ' CE ' ' N ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -55.51 -25.66 38.5 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -77.07 -42.41 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.376 178.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -75.58 -48.68 21.26 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 229' ' ' LEU . . . -77.44 -48.37 17.33 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 222' ' ' MET . . . -66.36 -39.49 89.17 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.559 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 223' ' ' ILE . 49.9 t -65.32 -45.83 82.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.543 0.211 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 232' ' ' SER . 0.8 OUTLIER -66.87 -36.3 82.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.302 0.573 . . . . 0.0 109.701 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.571 ' CD1' ' CG2' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -60.15 -56.36 22.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.349 179.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.525 ' CG1' HD13 ' A' ' 235' ' ' ILE . 94.7 t -72.53 -42.57 63.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.242 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 227' ' ' CYS . 30.7 mtp180 -62.38 -30.17 71.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.427 . . . . 0.0 110.074 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 228' ' ' GLU . 21.5 m -91.41 -27.11 18.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.516 ' NE ' ' O ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -57.57 -67.98 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.1 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 146.78 -54.12 0.54 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.852 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.539 ' O ' ' CD1' ' A' ' 235' ' ' ILE . 2.1 pp -34.03 95.21 0.08 OUTLIER Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 121.151 0.5 . . . . 0.0 111.556 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.441 ' N ' ' O ' ' A' ' 234' ' ' GLY . 32.7 Cg_endo -64.48 118.16 5.15 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.855 2.37 . . . . 0.0 112.257 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.464 ' CA ' ' OD1' ' A' ' 211' ' ' ASN . . . -108.97 154.94 16.3 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.56 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -117.95 -37.26 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.738 0.304 . . . . 0.0 110.866 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.572 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 70.5 mm-40 -102.17 35.66 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.22 0.534 . . . . 0.0 110.359 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 214' ' ' ILE . 1.8 t -89.65 128.83 41.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.365 0.602 . . . . 0.0 110.873 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.645 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.73 142.56 27.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.86 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.539 ' HB2' ' CD1' ' A' ' 223' ' ' ILE . 0.7 OUTLIER -131.32 141.1 49.88 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.912 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 216' ' ' LEU . 7.2 pt-20 -132.12 148.46 52.48 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.243 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 4.5 ptmm? -116.35 105.83 12.96 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.608 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -137.02 144.46 43.25 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.309 178.237 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.568 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 5.1 mt 62.43 155.73 0.12 Allowed Pre-proline 0 N--CA 1.467 0.405 0 CA-C-O 121.131 0.491 . . . . 0.0 111.993 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.727 ' HG2' ' H3B' ' A' ' 252' ' ' FDA . 22.5 Cg_exo -65.1 -141.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.628 2.886 . . . . 0.0 112.363 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 190' ' ' TRP . 0.4 OUTLIER -52.98 151.95 4.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.144 0.497 . . . . 0.0 111.391 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 152.45 -51.61 0.49 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.818 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.572 ' O ' ' CB ' ' A' ' 251' ' ' ALA . . . -108.19 142.03 39.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.533 -0.334 . . . . 0.0 111.272 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.597 ' CB ' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.837 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' FDA . . . . . 0.791 ' H1B' HD12 ' A' ' 83' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.799 0.333 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -123.87 32.77 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.56 125.89 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.031 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.4 m 47.94 58.22 5.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.014 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.9 t80 72.86 132.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.53 40.51 1.65 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.514 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 47.66 47.35 17.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.831 0.348 . . . . 0.0 111.093 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.39 102.37 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.8 20.5 2.17 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.7 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.526 ' HB2' ' CG ' ' A' ' 105' ' ' LYS . 2.3 t -102.74 151.52 22.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.672 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.592 ' CE1' ' O ' ' A' ' 13' ' ' GLU . 5.0 t80 -132.1 152.76 51.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.695 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.592 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -111.13 126.11 54.49 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 110.826 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.573 ' HB1' ' CE2' ' A' ' 12' ' ' PHE . . . -131.18 154.12 48.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.154 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.538 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 19.8 tt0 -98.86 124.89 44.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.018 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 100' ' ' GLN . 6.4 m -70.69 115.71 10.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 110.561 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.05 14.91 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.047 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 29' ' ' PHE . . . -150.34 117.63 0.86 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.064 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.607 ' CD2' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -155.74 52.82 0.58 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.654 -0.773 . . . . 0.0 109.996 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.558 ' ND2' ' C ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -95.6 150.72 20.03 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.679 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 7.8 m95 -88.86 112.39 23.2 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 2.6 m -76.92 -23.13 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.569 0.7 . . . . 0.0 109.74 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.491 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 38.8 m -150.5 -175.27 5.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.3 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.97 -57.02 9.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.632 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -121.92 49.25 1.58 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.724 179.308 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -147.56 141.12 25.48 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.473 -179.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.607 HG23 ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -140.8 148.26 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.162 -178.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -108.74 129.23 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.554 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.655 ' CB ' ' CZ ' ' A' ' 78' ' ' PHE . 0.3 OUTLIER -124.37 121.83 36.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.622 -178.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -112.3 115.5 28.87 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.6 HD21 ' CE1' ' A' ' 29' ' ' PHE . 3.2 mt -120.64 133.74 55.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.261 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 38' ' ' CYS . 29.6 mt-30 -145.64 110.18 5.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.601 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.538 ' HB2' ' N ' ' A' ' 15' ' ' GLU . 8.1 tmtm? -156.43 6.28 0.18 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.534 ' CD ' ' HB2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -163.0 168.72 9.9 Favored Pre-proline 0 N--CA 1.462 0.158 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.332 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.504 ' C ' ' CB ' ' A' ' 41' ' ' ARG . 35.4 Cg_exo -59.91 78.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.899 2.399 . . . . 0.0 112.049 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.571 ' N ' ' HB3' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -170.08 -70.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.585 0.707 . . . . 0.0 110.106 179.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.535 ' HA ' ' HA2' ' A' ' 74' ' ' GLY . 0.4 OUTLIER -131.81 64.82 1.59 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.072 178.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.554 ' CA ' ' O ' ' A' ' 74' ' ' GLY . 17.4 t -161.48 -74.23 0.06 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 73' ' ' GLU . . . -81.37 -81.52 0.85 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.43 -177.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 6.7 t-20 -154.98 47.1 0.53 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.566 -0.317 . . . . 0.0 110.761 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.571 ' HB3' ' N ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER -107.19 -28.7 9.78 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.652 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.709 ' O ' ' O ' ' A' ' 71' ' ' ASN . . . -69.98 90.48 0.34 Allowed Glycine 0 CA--C 1.491 -1.44 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.426 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.838 ' HA ' ' N ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -122.85 142.48 39.23 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 10.4 ttmt -13.85 74.0 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.854 0.861 . . . . 0.0 112.886 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.596 ' N ' ' O ' ' A' ' 43' ' ' VAL . 55.4 t80 -99.19 -103.59 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.655 0.264 . . . . 0.0 110.868 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.5 OUTLIER -113.42 155.76 44.23 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 120.771 0.319 . . . . 0.0 110.703 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.526 ' HD2' ' CG2' ' A' ' 110' ' ' VAL . 72.8 Cg_exo -49.53 80.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.665 2.243 . . . . 0.0 112.231 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 49.09 63.47 3.93 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.762 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.512 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -48.45 -179.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.576 -0.157 . . . . 0.0 110.576 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.715 ' CD2' HM71 ' A' ' 252' ' ' FDA . 0.2 OUTLIER -131.95 163.21 28.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.947 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.535 ' O ' ' CB ' ' A' ' 63' ' ' SER . 2.6 mmt -129.9 -168.41 1.95 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.942 0.401 . . . . 0.0 111.703 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -138.47 96.34 3.15 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.799 ' HB2' ' CA ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -132.82 158.18 43.14 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.764 -177.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.566 ' HA ' ' CB ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -106.85 151.13 25.62 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.983 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.01 ' CA ' ' O ' ' A' ' 103' ' ' SER 10.821 1.9 mp -53.53 102.83 0.33 Allowed Pre-proline 2 N--CA 7.684 311.237 3 C-N-CA 11.143 -44.223 . . . . 0.0 17.059 -71.011 . . . . . . . . 5 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' A' ' 55' ' ' ILE . 7.2 Cg_endo -95.54 4.88 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 1 CA-C-N 103.419 -4.886 . . . . 0.0 111.153 72.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 105.82 2.43 39.77 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.494 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.543 HG23 ' CG ' ' A' ' 56' ' ' PRO . 27.0 p -46.43 -105.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.582 0.229 . . . . 0.0 111.345 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.546 ' CA ' HG23 ' A' ' 54' ' ' THR . 6.0 p-10 172.33 29.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.5 ' CG1' ' O ' ' A' ' 60' ' ' VAL . 58.3 t -137.99 34.47 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.733 0.302 . . . . 0.0 111.223 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.566 ' CB ' ' HA ' ' A' ' 54' ' ' THR . 38.8 t -107.82 -104.77 0.35 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.738 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 162.94 -173.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.095 0.474 . . . . 0.0 111.501 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -88.97 135.05 33.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.21 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.59 ' CE1' ' HB2' ' A' ' 78' ' ' PHE . 1.7 t80 -134.16 126.03 29.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.747 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.664 ' CB ' ' CD1' ' A' ' 50' ' ' PHE . 91.6 p -64.77 106.67 1.05 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.569 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.53 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 90.5 Cg_endo -92.15 171.03 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.639 2.226 . . . . 0.0 112.72 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.555 ' O ' ' HB3' ' A' ' 68' ' ' ASN . . . -87.2 159.36 18.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.513 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 75' ' ' ARG . 9.2 t30 82.17 138.74 0.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 124.167 0.917 . . . . 0.0 110.371 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.596 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER 151.64 -46.58 0.0 OUTLIER Pre-proline 0 CA--C 1.512 -0.512 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.611 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 97.6 Cg_endo -92.74 55.15 0.53 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.167 2.578 . . . . 0.0 111.609 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.709 ' O ' ' O ' ' A' ' 42' ' ' GLY . 4.6 p30 158.16 109.17 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.413 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.838 ' N ' ' HA ' ' A' ' 43' ' ' VAL . 6.2 Cg_endo -48.18 106.15 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.274 2.649 . . . . 0.0 113.88 -177.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 40' ' ' ASN . 10.8 mm-40 -158.71 -74.73 0.08 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.803 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.554 ' O ' ' CA ' ' A' ' 38' ' ' CYS . . . 105.36 72.56 0.86 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.011 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 9.7 mtm180 -151.98 109.25 3.57 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.556 ' C ' ' CD1' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -93.88 128.03 39.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.622 -178.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.528 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 56.0 mt-10 -130.26 115.75 17.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.236 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.686 ' CD1' ' CG2' ' A' ' 80' ' ' ILE . 1.6 p90 -121.5 135.04 55.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.865 0.364 . . . . 0.0 110.996 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 0.6 OUTLIER -114.78 82.17 1.68 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.979 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.686 ' CG2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -92.14 129.2 43.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.108 -179.161 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.668 ' NH1' H61A ' A' ' 252' ' ' FDA . 0.3 OUTLIER -77.52 110.13 12.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.233 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.57 ' CG2' ' CB ' ' A' ' 89' ' ' SER . 4.4 m -102.5 127.81 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.293 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.522 HD22 ' CD ' ' A' ' 84' ' ' PRO . 13.5 mt -42.66 166.56 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.522 ' CD ' HD22 ' A' ' 83' ' ' LEU . 74.7 Cg_exo -49.77 -50.01 14.37 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.654 2.236 . . . . 0.0 112.391 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 175.83 67.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 87' ' ' ARG . . . 176.27 64.25 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.575 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 164.07 -93.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.676 0.274 . . . . 0.0 111.005 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.599 ' CE1' ' CG1' ' A' ' 55' ' ' ILE . 1.1 t80 -94.99 -29.96 14.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.343 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.57 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 4.8 p -81.36 -27.14 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.862 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -75.8 -43.44 46.21 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.571 0.701 . . . . 0.0 109.822 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -72.89 -25.29 61.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 96' ' ' ALA . 0.7 OUTLIER -68.46 -47.49 67.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.282 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.446 ' O ' ' CD ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -90.2 -25.61 20.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 12.5 m120 -96.9 2.29 51.5 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.166 -0.213 . . . . 0.0 111.343 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.59 19.72 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 55' ' ' ILE . . . -146.96 27.68 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.671 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 96' ' ' ALA . 39.7 mmm-85 -45.39 173.36 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.114 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.531 HG13 ' CG2' ' A' ' 16' ' ' VAL . 0.5 OUTLIER -95.31 -144.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.44 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.37 -44.9 1.99 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.986 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.551 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 9.3 pt20 -83.52 -158.52 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.282 0.563 . . . . 0.0 112.372 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.519 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 5.3 p -125.13 144.19 36.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.483 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.581 ' CD2' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -129.32 136.1 49.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.711 0.291 . . . . 0.0 110.638 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 1.01 ' O ' ' CA ' ' A' ' 55' ' ' ILE . 16.1 t -102.67 127.22 49.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.03 0.443 . . . . 0.0 111.066 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.873 ' HA ' ' CA ' ' A' ' 55' ' ' ILE . 2.0 m -101.37 122.61 53.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.722 ' H ' ' CA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -130.18 113.01 13.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.624 -178.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.519 ' HA3' ' N ' ' A' ' 52' ' ' ASP . . . -173.56 85.14 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.972 -1.108 . . . . 0.0 113.779 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.01 64.37 1.36 Allowed 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.353 2.036 . . . . 0.0 110.786 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.44 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -88.47 173.75 8.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.231 -178.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.573 ' O ' ' CE2' ' A' ' 50' ' ' PHE . . . -108.54 174.51 18.79 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.282 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.526 ' CG2' ' HD2' ' A' ' 47' ' ' PRO . 18.7 m -107.46 109.2 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 121.605 0.717 . . . . 0.0 110.516 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 1.3 m-85 -121.54 132.82 54.92 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.26 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 215' ' ' TYR . . . 124.43 -86.98 0.37 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.012 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.584 ' HB3' ' CE2' ' A' ' 123' ' ' PHE . 0.4 OUTLIER -81.75 118.36 22.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.935 0.397 . . . . 0.0 110.001 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.641 ' CB ' ' CD2' ' A' ' 241' ' ' PHE . 0.9 OUTLIER -137.5 114.63 10.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.959 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.21 129.54 53.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.205 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.05 14.28 24.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.956 0.408 . . . . 0.0 111.114 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.26 -66.23 1.81 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.527 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.496 ' HA ' ' HB2' ' A' ' 147' ' ' ASN . 17.3 ttm -128.82 89.05 2.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.896 0.379 . . . . 0.0 110.376 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -167.15 142.92 3.5 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.597 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 97.1 Cg_endo -78.28 108.81 2.55 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 123.148 2.565 . . . . 0.0 112.219 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.543 ' CB ' ' CE2' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -136.99 153.03 50.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.949 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.597 ' CD2' ' OH ' ' A' ' 152' ' ' TYR . 2.1 m-85 -120.64 123.03 41.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.022 0.439 . . . . 0.0 110.985 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.643 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 45.6 t80 -108.23 111.3 23.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.181 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.541 ' HA ' ' HB2' ' A' ' 152' ' ' TYR . 3.2 p -98.15 112.25 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 121.473 0.654 . . . . 0.0 111.914 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -118.23 132.22 56.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.815 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.551 ' O ' ' CD2' ' A' ' 246' ' ' LEU . . . -123.98 101.97 0.7 Allowed Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.433 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.602 ' N ' HG11 ' A' ' 155' ' ' VAL . . . 142.1 -152.01 23.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.006 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.51 HG23 ' CB ' ' A' ' 79' ' ' LEU . 32.1 m -119.39 -15.82 9.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.056 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.695 ' HA3' ' HN3' ' A' ' 252' ' ' FDA . . . -66.65 9.37 0.9 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.8 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.551 ' CD1' ' CE1' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -80.4 4.72 17.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 120.875 0.369 . . . . 0.0 110.01 179.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.567 ' N ' ' HD2' ' A' ' 132' ' ' PRO . . . -46.8 -52.5 31.77 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.516 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 131' ' ' ALA . 39.8 Cg_endo -65.68 -30.83 50.43 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.915 1.743 . . . . 0.0 109.946 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 123' ' ' PHE . 41.6 t -67.27 -45.75 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.403 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.529 ' CG1' ' HG ' ' A' ' 130' ' ' LEU . 15.5 m -70.6 -29.81 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.012 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.21 -52.56 58.21 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 109.991 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.562 ' CE ' ' CE ' ' A' ' 140' ' ' MET . 7.8 tpt -62.29 -44.12 97.25 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.312 0.577 . . . . 0.0 109.504 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.509 ' CG2' ' O ' ' A' ' 133' ' ' VAL . 61.5 t -61.61 -30.21 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.079 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -36.29 80.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.412 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -42.83 87.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 110.236 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.646 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 2.4 tpp -70.56 -33.26 70.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.002 0.906 . . . . 0.0 110.103 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.542 ' CG ' ' HB3' ' A' ' 170' ' ' LEU . 0.0 OUTLIER -77.32 -29.81 53.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.307 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -71.7 -45.11 62.89 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.649 ' CE2' ' CB ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -77.25 -22.41 52.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.389 0.614 . . . . 0.0 109.798 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 145' ' ' ALA . 1.2 p 58.4 26.3 13.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.229 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.649 ' CB ' ' CE2' ' A' ' 143' ' ' TRP . . . -37.01 160.4 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.541 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.64 14.15 1.05 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.12 2.547 . . . . 0.0 113.328 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 118' ' ' MET . 2.1 p-10 -83.14 132.3 35.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.99 0.424 . . . . 0.0 111.779 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' CB ' ' HB2' ' A' ' 176' ' ' ASN . 1.0 OUTLIER -73.94 105.12 5.05 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.626 0.727 . . . . 0.0 111.08 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 2.7 m -113.48 115.5 28.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.109 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.594 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -105.66 139.81 39.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.094 0.473 . . . . 0.0 110.157 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.464 HD12 ' O ' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -133.98 126.93 51.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.51 -178.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.597 ' OH ' ' CD2' ' A' ' 122' ' ' TYR . 17.3 m-85 -103.15 108.7 19.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.551 ' CE1' ' CD1' ' A' ' 130' ' ' LEU . 31.9 t80 -125.92 156.36 39.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.64 ' HA3' ' HB2' ' A' ' 182' ' ' CYS . . . 153.87 -172.62 32.57 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.711 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.602 HG11 ' N ' ' A' ' 127' ' ' GLY . 22.4 m -161.97 -124.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.563 ' CA ' HG23 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -108.67 160.14 16.18 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 117.484 0.129 . . . . 0.0 110.978 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.551 ' HA ' ' CG1' ' A' ' 183' ' ' VAL . 0.1 OUTLIER -4.69 -65.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.66 0.784 . . . . 0.0 112.315 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 156' ' ' ASN . 1.4 mt-10 165.67 59.14 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.229 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.558 ' HG2' H62A ' A' ' 252' ' ' FDA . 26.5 Cg_exo -61.2 -16.45 46.49 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.736 1.624 . . . . 0.0 109.491 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.496 ' O ' ' O ' ' A' ' 161' ' ' LEU . 1.3 tp10 174.26 -58.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.779 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.566 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 3.5 tp 41.63 -177.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.306 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.566 ' CG ' ' O ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER 154.56 179.95 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.701 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.577 ' CE1' ' HG2' ' A' ' 166' ' ' GLU . 0.0 OUTLIER 83.01 3.41 1.0 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.695 179.323 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.578 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -56.84 -41.21 75.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.578 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 0.6 OUTLIER -64.9 -27.6 68.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.831 178.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.577 ' HG2' ' CE1' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -71.54 -46.61 59.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.955 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.546 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -59.72 -30.09 68.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.515 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.438 ' HE3' HG12 ' A' ' 164' ' ' ILE . 11.9 mttt -75.83 -24.47 55.85 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.443 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.5 OUTLIER -72.72 -32.75 65.96 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.745 178.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -66.89 -48.09 69.8 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.163 176.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.435 ' OE2' HG13 ' A' ' 179' ' ' VAL . 1.2 mm-40 -56.97 -39.61 74.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.284 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -29.32 40.22 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.532 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 174' ' ' MET . 49.5 m -79.63 -72.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.531 ' HG2' ' CD1' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -52.42 -163.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.182 0.515 . . . . 0.0 111.76 -178.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -114.24 -42.34 3.36 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.604 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.491 ' HB2' ' CB ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -132.21 64.02 1.61 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.077 -179.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.543 ' HA ' ' O ' ' A' ' 149' ' ' THR . 3.2 mp -102.69 152.74 20.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.262 0.554 . . . . 0.0 111.388 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.463 ' HB ' ' CD ' ' A' ' 150' ' ' ARG . 27.3 m -136.51 114.82 11.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.899 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.501 ' CG2' ' HB2' ' A' ' 167' ' ' LEU . 8.9 p -99.63 135.27 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.431 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.74 135.62 53.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.027 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.513 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -104.38 106.76 17.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.213 0.53 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.64 ' HB2' ' HA3' ' A' ' 154' ' ' GLY . 31.3 m -80.07 -163.7 0.58 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.334 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.563 HG23 ' CA ' ' A' ' 156' ' ' ASN . 24.1 t 66.72 149.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 122.365 1.078 . . . . 0.0 113.639 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.695 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -139.09 -84.17 0.26 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.846 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.655 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 0.2 OUTLIER -140.78 29.27 0.11 Allowed Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.43 176.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.655 ' HD3' ' N ' ' A' ' 185' ' ' HIS . 52.3 Cg_exo -53.88 -138.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 122.209 1.939 . . . . 0.0 113.714 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.546 ' HA ' ' CG2' ' A' ' 157' ' ' THR . 47.0 t 173.24 35.59 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.402 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.444 ' HA2' ' CG ' ' A' ' 156' ' ' ASN . . . 86.52 16.18 62.56 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.145 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.51 64.76 1.45 Allowed 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' A' ' 249' ' ' GLY . 13.3 t-105 -133.37 127.39 33.37 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.687 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.502 ' HG2' ' CG ' ' A' ' 219' ' ' PRO . 1.2 mt-10 -113.98 105.74 13.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.717 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.535 ' CA ' ' HB2' ' A' ' 251' ' ' ALA . . . 148.44 -108.6 0.42 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.351 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.554 ' HA ' ' HB3' ' A' ' 182' ' ' CYS . 16.4 mt-10 -168.89 -95.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.513 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 64.5 mt-30 -86.95 133.95 33.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.598 ' HA2' ' CD1' ' A' ' 184' ' ' TRP . . . -22.24 106.82 0.01 OUTLIER Glycine 0 C--N 1.333 0.406 0 O-C-N 123.717 0.635 . . . . 0.0 113.214 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 5.9 m 140.11 158.98 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 O-C-N 124.245 0.615 . . . . 0.0 110.539 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.468 ' O ' ' HB ' ' A' ' 198' ' ' ILE . 49.4 Cg_exo -54.08 -70.44 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.445 2.097 . . . . 0.0 112.077 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.639 ' CG2' ' O ' ' A' ' 198' ' ' ILE . 0.3 OUTLIER 169.65 29.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 121.665 0.745 . . . . 0.0 111.111 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.507 ' OD1' ' NH2' ' A' ' 202' ' ' ARG . 1.4 m-20 -64.11 -36.81 85.25 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.312 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.33 -37.53 78.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.545 ' O ' ' CD2' ' A' ' 205' ' ' LEU . 0.1 OUTLIER -69.42 -35.22 75.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.812 0.339 . . . . 0.0 110.978 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.539 ' O ' ' HG ' ' A' ' 205' ' ' LEU . 26.8 mtt180 -59.37 -49.96 75.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.421 0.629 . . . . 0.0 111.246 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -31.94 71.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.63 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.451 ' OD1' ' OD2' ' A' ' 209' ' ' ASP . 0.5 OUTLIER -58.56 -43.23 89.29 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.287 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -61.24 -48.24 82.36 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.468 ' HG3' ' HG2' ' A' ' 233' ' ' ARG . 2.4 mt-10 -62.25 -22.15 65.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.706 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.65 -86.8 0.28 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.823 0.344 . . . . 0.0 111.623 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 0.0 OUTLIER 179.37 97.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.806 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 3.9 p30 152.55 87.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.537 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 96.37 106.09 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.547 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 t30 -172.39 -58.82 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.737 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 10.0 Cg_endo -52.72 -64.47 0.18 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.218 1.945 . . . . 0.0 110.895 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.526 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.4 OUTLIER -125.34 110.19 13.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.371 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.557 ' O ' ' O ' ' A' ' 239' ' ' GLN . 1.0 OUTLIER -107.45 125.71 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 114' ' ' LYS . 2.3 m-85 -116.13 129.68 56.44 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.5 ' HB2' ' CE ' ' A' ' 222' ' ' MET . 0.6 OUTLIER -139.86 123.42 17.23 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -178.055 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 123' ' ' PHE . 2.5 m -123.75 110.37 14.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.71 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 245' ' ' PHE . . . -176.98 -156.85 16.73 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.678 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.502 ' CG ' ' HG2' ' A' ' 191' ' ' GLU . 37.3 Cg_endo -65.79 175.61 4.35 Favored 'Trans proline' 0 N--CA 1.466 -0.11 0 C-N-CA 122.326 2.017 . . . . 0.0 111.687 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 219' ' ' PRO . 26.2 Cg_endo -62.53 -8.84 13.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.457 2.105 . . . . 0.0 112.136 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -83.15 -40.36 9.3 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 120.734 -0.745 . . . . 0.0 113.127 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.551 ' HA ' ' CA ' ' A' ' 251' ' ' ALA . 0.0 OUTLIER -56.38 -33.85 66.12 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.527 ' CB ' ' HE1' ' A' ' 222' ' ' MET . 0.0 OUTLIER -77.6 -36.81 23.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.896 178.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.416 ' OD1' HG22 ' A' ' 223' ' ' ILE . 16.0 m-20 -73.94 -47.67 35.98 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -73.22 -48.68 33.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.531 ' O ' ' CG2' ' A' ' 230' ' ' VAL . . . -60.85 -34.07 74.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.823 0.344 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 223' ' ' ILE . 8.0 m -70.0 -32.28 70.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.029 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -71.09 -45.32 63.93 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.568 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 225' ' ' ALA . 0.0 OUTLIER -62.43 -46.21 89.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.112 0.482 . . . . 0.0 110.799 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.551 ' CG1' ' HA ' ' A' ' 238' ' ' GLU . 13.0 t -60.01 -45.58 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.106 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -67.55 -29.82 69.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.187 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -31.37 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.945 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -84.22 -83.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.135 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 235' ' ' ILE . . . 140.87 -23.68 2.61 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.33 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 236' ' ' PRO . 1.4 pp -31.51 105.17 0.23 Allowed Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-O 121.128 0.489 . . . . 0.0 111.681 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.486 ' O ' ' OD1' ' A' ' 211' ' ' ASN . 79.0 Cg_exo -33.15 158.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.605 2.87 . . . . 0.0 112.542 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 238' ' ' GLU . . . 68.84 6.08 49.65 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.693 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.551 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 2.9 mp0 29.12 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.841 0.353 . . . . 0.0 111.253 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.557 ' O ' ' O ' ' A' ' 214' ' ' ILE . 7.5 mt-30 -122.68 -2.62 8.83 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.658 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.644 ' CG1' ' CD2' ' A' ' 241' ' ' PHE . 2.3 t 52.25 -82.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.153 0.501 . . . . 0.0 111.344 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.644 ' CD2' ' CG1' ' A' ' 240' ' ' VAL . 10.1 m-85 -119.28 125.4 49.01 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.26 129.62 37.89 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.874 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 216' ' ' LEU . 0.0 OUTLIER -132.21 148.26 52.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.048 178.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -125.37 106.55 9.91 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.612 ' C ' ' CD1' ' A' ' 245' ' ' PHE . 0.2 OUTLIER -136.94 144.9 43.67 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 178.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.61 ' HB3' ' CD1' ' A' ' 245' ' ' PHE . 0.4 OUTLIER 83.29 160.8 0.12 Allowed Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.429 0.691 . . . . 0.0 112.775 179.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.813 ' HG2' ' H8A' ' A' ' 252' ' ' FDA . 37.3 Cg_exo -61.66 -138.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.67 2.913 . . . . 0.0 111.741 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.444 ' HB2' ' C ' ' A' ' 190' ' ' TRP . 10.1 p -72.84 145.84 46.67 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.298 0.571 . . . . 0.0 110.858 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 190' ' ' TRP . . . 167.98 -53.99 0.22 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.539 ' CB ' ' HB2' ' A' ' 222' ' ' MET . . . -107.69 149.12 28.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.54 -0.33 . . . . 0.0 110.49 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.551 ' CA ' ' HA ' ' A' ' 222' ' ' MET . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.173 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' FDA . . . . . 0.813 ' H8A' ' HG2' ' A' ' 247' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.818 0.342 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 177.05 -55.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.07 155.57 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.62 121.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.827 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -144.6 95.72 2.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.952 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.47 94.42 1.94 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.476 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -62.03 175.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.13 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.93 99.77 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.523 0.678 . . . . 0.0 111.111 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.13 22.09 31.1 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.457 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 m -96.29 150.6 20.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.889 0.376 . . . . 0.0 111.07 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.608 ' CD1' ' HB2' ' A' ' 36' ' ' ASP . 2.6 t80 -132.09 149.02 52.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.939 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.592 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 3.9 mt-10 -108.79 119.81 40.63 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.873 0.368 . . . . 0.0 111.02 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.529 ' HB3' ' CD1' ' A' ' 102' ' ' LEU . . . -119.74 131.78 55.46 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.965 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.533 ' CB ' ' HB2' ' A' ' 33' ' ' LYS . 1.2 tt0 -92.71 137.57 32.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.117 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.581 ' CG1' ' HA ' ' A' ' 98' ' ' VAL . 10.9 t -71.28 124.55 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.75 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.504 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 7.6 p -154.36 22.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.126 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.456 ' HA3' ' HG ' ' A' ' 30' ' ' LEU . . . -150.55 -139.77 3.09 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.548 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.596 ' CD2' ' CG2' ' A' ' 27' ' ' VAL . 0.1 OUTLIER 82.57 62.71 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.174 0.512 . . . . 0.0 110.471 -179.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -101.69 148.96 24.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.589 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 12.2 m95 -89.16 114.63 25.94 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 m -95.04 -27.6 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 121.529 0.681 . . . . 0.0 109.301 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.516 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 13.8 m -143.9 173.68 11.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.348 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -54.27 -58.07 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.958 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 0.3 OUTLIER -112.69 39.23 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.801 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.52 ' CG2' HG21 ' A' ' 128' ' ' THR . 0.2 OUTLIER -145.92 135.53 23.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.522 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.596 ' CG2' ' CD2' ' A' ' 19' ' ' LEU . 1.5 p -140.6 147.19 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.084 0.469 . . . . 0.0 112.019 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.474 ' N ' HG23 ' A' ' 27' ' ' VAL . 1.9 tt0 -116.57 122.17 43.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.981 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.612 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -114.09 121.35 43.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.797 0.332 . . . . 0.0 111.726 -178.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.578 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -108.62 116.37 31.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.883 179.046 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.531 HD22 ' CD2' ' A' ' 102' ' ' LEU . 2.3 mt -122.63 133.15 54.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.048 0.452 . . . . 0.0 111.746 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.52 ' CA ' ' HB2' ' A' ' 38' ' ' CYS . 0.5 OUTLIER -145.05 131.37 19.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.079 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.533 ' HB2' ' CB ' ' A' ' 15' ' ' GLU . 7.2 tptm -164.74 -33.38 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.488 ' HB3' ' HD2' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -147.08 177.22 1.84 Allowed Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.534 ' HG3' ' CB ' ' A' ' 40' ' ' ASN . 75.6 Cg_exo -49.18 106.59 0.12 Allowed 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.505 2.137 . . . . 0.0 111.987 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.608 ' HB2' ' CD1' ' A' ' 12' ' ' PHE . 1.5 m-20 157.37 -36.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.288 0.565 . . . . 0.0 111.475 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -169.93 51.28 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.193 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.529 ' N ' ' HA3' ' A' ' 74' ' ' GLY . 53.2 t -163.71 -58.2 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -137.75 -66.02 0.05 OUTLIER Glycine 0 CA--C 1.51 -0.263 0 C-N-CA 119.97 -1.109 . . . . 0.0 113.69 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.534 ' CB ' ' HG3' ' A' ' 35' ' ' PRO . 0.8 OUTLIER -88.08 18.82 3.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.87 0.367 . . . . 0.0 111.259 -179.229 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.601 ' HA ' ' N ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -56.45 -45.52 80.77 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.47 0.652 . . . . 0.0 109.624 178.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 72' ' ' PRO . . . 60.14 78.15 0.15 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.911 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.515 HG21 ' ND2' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -93.45 163.4 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.435 0.636 . . . . 0.0 111.849 -178.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.525 ' HE3' ' CE1' ' A' ' 45' ' ' PHE . 4.8 tttp -154.72 -142.03 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.733 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.525 ' CE1' ' HE3' ' A' ' 44' ' ' LYS . 22.2 p90 -122.06 78.11 1.45 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.376 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 48' ' ' GLY . 28.1 mm-40 -113.04 166.55 10.86 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HB3' ' O ' ' A' ' 113' ' ' LEU . 32.1 Cg_exo -58.05 65.98 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.389 2.06 . . . . 0.0 111.616 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 40.39 62.46 1.57 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.223 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.487 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -30.32 148.98 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.716 0.258 . . . . 0.0 110.844 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.694 ' CD1' ' CB ' ' A' ' 65' ' ' SER . 5.3 m-85 -116.16 163.17 16.36 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.533 ' O ' ' CB ' ' A' ' 63' ' ' SER . 4.7 mtt -131.41 162.56 29.89 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.962 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 105' ' ' LYS . 4.4 t0 -125.31 102.46 7.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.842 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.533 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -150.07 156.95 42.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.595 HG21 ' N ' ' A' ' 61' ' ' SER . 0.2 OUTLIER -85.63 154.69 21.52 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.313 178.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.648 ' HB ' ' HD3' ' A' ' 56' ' ' PRO . 1.3 mt -30.4 -71.91 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 123.411 0.444 . . . . 0.0 109.906 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.648 ' HD3' ' HB ' ' A' ' 55' ' ' ILE . 9.3 Cg_endo -99.82 4.47 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.568 2.179 . . . . 0.0 111.583 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 101.41 -3.05 54.0 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.832 -178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.538 HG21 ' CG ' ' A' ' 56' ' ' PRO . 64.9 p -27.81 -87.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 122.841 0.456 . . . . 0.0 112.084 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 60' ' ' VAL . 43.9 p-10 -150.45 40.02 0.75 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.563 ' N ' HG23 ' A' ' 54' ' ' THR . 0.3 OUTLIER 90.68 121.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 178.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.595 ' N ' HG21 ' A' ' 54' ' ' THR . 40.3 t -120.72 -66.95 1.01 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.708 0.766 . . . . 0.0 109.931 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.435 ' HG2' HO2' ' A' ' 252' ' ' FDA . 1.0 OUTLIER -170.41 157.94 6.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.227 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -88.73 120.7 30.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.669 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.527 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 3.0 t80 -111.7 121.18 44.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.901 0.381 . . . . 0.0 111.608 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.694 ' CB ' ' CD1' ' A' ' 50' ' ' PHE . 82.4 p -55.56 98.69 0.17 Allowed Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.732 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 2.1 Cg_endo -82.94 155.34 15.13 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.83 2.353 . . . . 0.0 111.54 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 132' ' ' PRO . . . -144.65 130.65 19.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.571 ' O ' ' CB ' ' A' ' 69' ' ' LEU . 10.0 t-20 -115.88 -63.62 1.43 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.764 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.571 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 0.6 OUTLIER 144.42 154.44 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.936 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 44' ' ' LYS . 18.0 Cg_endo -59.63 96.89 0.1 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.283 1.989 . . . . 0.0 111.225 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -179.2 138.06 0.33 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.058 0.456 . . . . 0.0 111.519 -179.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.45 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 85.5 Cg_endo -82.07 79.63 3.07 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.377 . . . . 0.0 111.998 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.529 ' O ' ' CA ' ' A' ' 39' ' ' GLY . 39.3 mt-10 -144.23 -72.84 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.961 0.41 . . . . 0.0 110.008 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.529 ' HA3' ' N ' ' A' ' 38' ' ' CYS . . . 122.83 97.08 1.33 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.335 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 85.0 mtm-85 -162.33 83.66 0.55 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 122.633 0.373 . . . . 0.0 110.888 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.533 ' CD1' ' HB2' ' A' ' 66' ' ' PRO . 30.0 mt -96.91 145.94 25.42 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.61 0.719 . . . . 0.0 112.496 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 5.9 pt-20 -131.24 141.89 50.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.433 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.649 ' CE1' ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -115.95 133.76 55.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.013 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.527 ' N ' ' OH ' ' A' ' 64' ' ' TYR . 0.9 OUTLIER -101.58 82.31 2.28 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.649 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -91.22 118.01 35.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.854 -178.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.677 ' O ' H52A ' A' ' 252' ' ' FDA . 0.0 OUTLIER -78.33 95.99 5.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.584 ' CG1' ' CG2' ' A' ' 80' ' ' ILE . 2.3 m -94.0 142.12 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.999 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.506 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -68.14 172.63 4.05 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.799 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 83' ' ' LEU . 44.6 Cg_endo -68.68 58.39 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 0.0 112.149 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 84' ' ' PRO . 0.6 OUTLIER 67.48 72.58 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 87' ' ' ARG . . . 173.12 66.58 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.691 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 163.09 -90.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 111.132 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.537 ' CG ' ' O2P' ' A' ' 252' ' ' FDA . 0.3 OUTLIER -108.6 -27.19 10.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.26 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.554 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -60.1 -32.99 71.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 111.185 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 0.8 OUTLIER -75.93 -32.0 59.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.386 0.612 . . . . 0.0 110.842 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.403 ' O ' ' HB3' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -68.94 -51.26 41.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.878 -178.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.554 ' CD1' ' HA ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -71.59 -30.75 66.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -31.04 18.07 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.662 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 2.1 t-20 -95.87 -11.29 26.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.7 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 91' ' ' TYR . 2.2 t70 -135.58 -15.28 1.87 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.545 ' CB ' ' HB3' ' A' ' 56' ' ' PRO . . . -119.43 29.02 7.85 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.993 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 96' ' ' ALA . 1.1 mmt180 -56.58 -163.37 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.581 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . 0.2 OUTLIER -86.74 -153.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-O 121.195 0.522 . . . . 0.0 110.65 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.41 -47.26 1.38 Allowed Glycine 0 C--N 1.316 -0.548 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.469 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.55 179.45 5.0 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 14' ' ' ALA . 99.6 t -121.85 145.23 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.259 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.531 ' CD2' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.6 120.36 40.74 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 108.57 13.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.533 ' HB ' ' CB ' ' A' ' 53' ' ' LEU . 0.8 OUTLIER -108.49 165.43 4.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.066 0.46 . . . . 0.0 112.079 -177.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.63 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -132.24 112.49 12.29 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 51' ' ' MET . . . -103.54 44.97 1.38 Allowed Glycine 0 CA--C 1.519 0.321 0 C-N-CA 119.533 -1.318 . . . . 0.0 115.74 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.49 ' CD ' ' C ' ' A' ' 105' ' ' LYS . 82.5 Cg_endo -81.83 38.81 0.78 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.173 1.915 . . . . 0.0 111.481 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.533 HD22 ' CB ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -88.33 173.19 8.89 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.813 0.816 . . . . 0.0 112.761 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.01 173.42 19.41 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.477 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 47' ' ' PRO . 9.3 m -108.63 107.16 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 117.925 0.862 . . . . 0.0 110.923 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 0.3 OUTLIER -123.74 122.53 38.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.476 178.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 215' ' ' TYR . . . 123.35 -84.78 0.37 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.283 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.577 ' HB2' ' CE2' ' A' ' 123' ' ' PHE . 7.7 tp -75.88 117.87 18.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.057 0.456 . . . . 0.0 110.073 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.616 ' O ' ' CZ ' ' A' ' 215' ' ' TYR . 0.1 OUTLIER -138.7 127.3 23.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.605 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 121' ' ' ARG . 2.2 pp20? -112.45 134.56 53.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.624 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -110.32 6.35 22.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.974 0.416 . . . . 0.0 111.197 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.81 -75.73 0.4 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.532 ' HA ' ' CB ' ' A' ' 147' ' ' ASN . 3.7 mpp? -129.91 89.33 2.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.887 0.375 . . . . 0.0 110.524 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.478 ' O ' ' HD3' ' A' ' 121' ' ' ARG . . . -158.36 144.2 12.41 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.243 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.86 94.67 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.599 2.2 . . . . 0.0 111.613 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -127.81 150.45 49.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.257 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.698 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -124.17 144.39 49.95 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.923 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 113' ' ' LEU . 1.9 t80 -128.35 115.36 18.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.746 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.583 ' HB ' ' CD1' ' A' ' 152' ' ' TYR . 8.0 p -98.82 111.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.101 0.477 . . . . 0.0 111.33 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 153' ' ' PHE . . . -111.31 132.84 54.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.784 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.437 ' HA3' ' C ' ' A' ' 249' ' ' GLY . . . -129.18 104.34 0.64 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.412 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.459 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 134.64 -166.13 24.33 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.033 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.52 HG21 ' CG2' ' A' ' 26' ' ' THR . 0.7 OUTLIER -98.84 -28.15 13.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.118 0.485 . . . . 0.0 110.56 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.602 ' HA3' ' HN3' ' A' ' 252' ' ' FDA . . . -65.5 8.24 0.8 Allowed Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.764 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.6 ' CD1' ' CD1' ' A' ' 153' ' ' PHE . 0.4 OUTLIER -79.23 4.51 14.75 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.582 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -46.9 -44.57 47.26 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.904 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 8.9 Cg_exo -69.48 -30.89 22.86 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.425 2.084 . . . . 0.0 109.748 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.542 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 13.7 t -68.12 -53.08 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.576 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.465 ' CG1' ' HG ' ' A' ' 130' ' ' LEU . 29.1 m -66.57 -30.47 49.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.625 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.3 OUTLIER -61.16 -50.73 71.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.183 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.444 ' HE1' ' HG2' ' A' ' 115' ' ' GLU . 0.5 OUTLIER -66.93 -43.03 84.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.791 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 133' ' ' VAL . 13.5 t -59.81 -37.59 72.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 134' ' ' VAL . 3.2 mtm-85 -69.43 -31.03 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.1 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 135' ' ' SER . 43.7 mt-30 -63.15 -43.03 99.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.259 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.472 ' O ' ' HB3' ' A' ' 145' ' ' ALA . 3.9 ptp -71.38 -48.87 47.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.189 0.519 . . . . 0.0 110.6 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.529 ' NE2' ' CD2' ' A' ' 177' ' ' LEU . 0.7 OUTLIER -58.2 -30.99 66.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.716 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 138' ' ' ARG . 1.3 mt-10 -82.16 -37.31 26.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.266 0.555 . . . . 0.0 110.085 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.53 ' O ' ' CG2' ' A' ' 144' ' ' THR . 0.0 OUTLIER -67.59 -9.65 44.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.651 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 143' ' ' TRP . 1.6 p 87.55 10.45 0.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.766 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.497 ' N ' ' CD1' ' A' ' 143' ' ' TRP . . . -38.79 98.42 0.17 Allowed Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.737 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.495 ' HA ' ' HB2' ' A' ' 175' ' ' ARG . 81.0 Cg_endo -78.12 8.41 3.54 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.906 2.404 . . . . 0.0 112.679 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.532 ' CB ' ' HA ' ' A' ' 118' ' ' MET . 14.7 p-10 -78.58 150.3 32.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.944 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 176' ' ' ASN . 0.2 OUTLIER -74.18 104.77 5.09 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.49 0.662 . . . . 0.0 110.99 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.476 ' O ' ' CB ' ' A' ' 177' ' ' LEU . 0.7 OUTLIER -123.01 117.21 24.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.936 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.659 ' CB ' ' CD2' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -102.71 141.55 35.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.509 ' CD1' ' O ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -134.27 126.23 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.698 ' CE1' ' HB3' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -102.89 108.1 19.17 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.6 ' CD1' ' CD1' ' A' ' 130' ' ' LEU . 7.1 t80 -124.91 153.96 41.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.852 0.358 . . . . 0.0 111.949 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.617 ' HA3' ' HB2' ' A' ' 182' ' ' CYS . . . 150.07 -168.21 30.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.711 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.544 HG22 ' CD1' ' A' ' 161' ' ' LEU . 16.4 m -163.52 -120.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.624 ' O ' ' CG2' ' A' ' 183' ' ' VAL . 2.4 p-10 -103.93 -166.01 1.21 Allowed 'General case' 0 C--N 1.35 0.613 0 C-N-CA 122.371 0.268 . . . . 0.0 111.122 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.585 ' CG2' ' HA ' ' A' ' 187' ' ' SER . 0.1 OUTLIER -28.03 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.608 0.242 . . . . 0.0 111.415 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 156' ' ' ASN . 39.6 mt-10 93.35 41.0 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.684 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 37.7 Cg_endo -66.85 -26.09 44.91 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 C-N-CA 122.137 1.891 . . . . 0.0 110.626 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -130.58 20.8 5.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.208 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.544 ' CD1' HG22 ' A' ' 155' ' ' VAL . 9.9 tp -88.57 165.31 14.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.063 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.473 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 0.9 OUTLIER 176.26 -160.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.998 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.3 OUTLIER 72.85 26.63 2.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.243 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -69.8 -35.87 67.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.912 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.574 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 9.2 m-20 -62.29 -28.47 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.299 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.466 ' O ' ' CD2' ' A' ' 170' ' ' LEU . 2.3 mm-40 -72.08 -47.46 51.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.705 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -64.22 -30.25 71.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.763 178.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 172' ' ' ARG . 4.8 mtmm -72.55 -24.8 61.17 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -35.82 71.17 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.415 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.521 HD21 ' N ' ' A' ' 170' ' ' LEU . 0.0 OUTLIER -67.64 -48.52 66.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.476 ' O ' ' SD ' ' A' ' 174' ' ' MET . 3.3 mt-10 -57.65 -32.15 67.0 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.864 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 168' ' ' LYS . 1.1 mtt-85 -79.56 -41.69 26.68 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 174' ' ' MET . 6.4 t -93.1 -50.67 5.4 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.537 ' CG ' ' HB2' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -35.62 167.19 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.966 0.889 . . . . 0.0 112.892 -178.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.495 ' HB2' ' HA ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -99.75 -71.92 0.68 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.473 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -124.63 56.31 1.3 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.787 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.537 ' HB2' ' CG ' ' A' ' 174' ' ' MET . 5.8 mp -114.47 154.69 27.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.397 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.454 ' OG1' ' HG3' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -136.06 117.79 15.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.464 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.454 ' HB ' ' OE2' ' A' ' 171' ' ' GLU . 91.0 t -89.66 134.32 29.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.6 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.528 ' CB ' ' HA ' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -104.13 135.72 45.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.013 0.435 . . . . 0.0 111.676 -179.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -103.14 107.05 17.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.905 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.673 ' HB3' ' HA ' ' A' ' 193' ' ' GLU . 38.1 m -79.91 -168.26 1.55 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.311 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.624 ' CG2' ' O ' ' A' ' 156' ' ' ASN . 52.5 t 70.07 148.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.875 0.845 . . . . 0.0 112.835 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.714 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.53 -53.3 0.6 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.586 -177.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.542 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 4.7 p-80 167.77 62.2 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 113.623 -1.626 . . . . 0.0 108.696 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.626 ' O ' ' CB ' ' A' ' 187' ' ' SER . 67.0 Cg_endo -95.65 -96.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.797 2.998 . . . . 0.0 114.305 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.626 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 28.6 t 136.78 78.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.985 0.514 . . . . 0.0 110.34 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.515 ' O ' ' H2A' ' A' ' 252' ' ' FDA . . . 41.65 23.13 0.11 Allowed Glycine 0 C--N 1.329 0.148 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.066 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 187' ' ' SER . 0.2 OUTLIER -139.23 62.05 1.54 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.541 ' NE1' ' O ' ' A' ' 193' ' ' GLU . 19.4 t-105 -135.24 129.12 33.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.521 ' C ' ' CB ' ' A' ' 251' ' ' ALA . 1.6 mp0 -113.83 104.87 12.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.376 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.526 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 147.0 -113.07 0.63 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.272 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.673 ' HA ' ' HB3' ' A' ' 182' ' ' CYS . 80.8 mt-10 -161.42 -118.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.578 ' O ' ' O ' ' A' ' 195' ' ' GLY . 2.1 tt0 -87.75 117.74 26.79 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 194' ' ' GLN . . . 31.74 104.31 0.01 OUTLIER Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.348 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.538 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 5.86 66.68 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.2 0.6 . . . . 0.0 112.435 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.488 ' HG3' ' O ' ' A' ' 194' ' ' GLN . 22.2 Cg_endo -97.12 22.6 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.28 2.653 . . . . 0.0 113.872 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 251' ' ' ALA . 0.2 OUTLIER -87.92 -9.44 10.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.469 -179.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.16 -36.99 83.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -61.03 -29.58 69.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.334 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -64.04 -39.64 94.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.938 0.399 . . . . 0.0 110.13 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.535 ' O ' ' HG ' ' A' ' 205' ' ' LEU . 12.9 mtt180 -58.88 -48.37 81.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.514 0.673 . . . . 0.0 110.259 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.29 -32.04 68.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.013 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.76 -42.65 89.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -60.47 -48.05 83.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.408 ' OE1' ' HG3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -61.31 -21.05 63.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.019 178.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.0 t -86.31 -90.5 0.11 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.773 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 173.65 33.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.473 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 0.0 OUTLIER -145.09 58.46 1.29 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . 0.571 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 148.87 101.02 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.23 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.557 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 19.1 t30 173.84 -56.91 0.0 OUTLIER Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.175 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 12.3 Cg_endo -57.25 -53.74 4.43 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.265 1.977 . . . . 0.0 111.144 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.536 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -133.0 108.59 8.99 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.508 0.671 . . . . 0.0 109.319 178.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.53 ' C ' ' CD1' ' A' ' 215' ' ' TYR . 0.8 OUTLIER -123.51 131.04 73.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.128 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.616 ' CZ ' ' O ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -127.89 131.96 49.38 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.302 0.572 . . . . 0.0 110.679 -178.509 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.53 ' HB3' ' CG1' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -142.53 119.49 11.3 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.787 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . 0.507 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.5 OUTLIER -122.45 109.15 14.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.871 179.467 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 245' ' ' PHE . . . -178.57 -147.52 7.08 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.618 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.461 ' HB2' ' HD2' ' A' ' 220' ' ' PRO . 58.7 Cg_endo -72.48 174.5 11.52 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.504 2.136 . . . . 0.0 111.918 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 219' ' ' PRO . 26.8 Cg_endo -62.05 -8.66 12.48 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.551 2.167 . . . . 0.0 112.215 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -72.0 -54.16 8.51 Favored Glycine 0 C--O 1.224 -0.483 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.893 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.596 ' HA ' ' HA ' ' A' ' 251' ' ' ALA . 1.1 tpp -55.31 -27.96 50.42 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.538 ' O ' ' CB ' ' A' ' 227' ' ' CYS . 0.0 OUTLIER -77.17 -41.56 30.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.404 178.276 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -75.37 -49.22 19.71 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.552 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -77.13 -49.53 15.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 222' ' ' MET . . . -62.63 -35.62 80.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.948 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 223' ' ' ILE . 52.3 t -70.19 -31.96 69.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 110.306 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.5 -44.95 81.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.552 ' CD2' ' O ' ' A' ' 225' ' ' ALA . 0.0 OUTLIER -61.02 -38.96 87.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.979 0.419 . . . . 0.0 111.011 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 226' ' ' ALA . 2.3 t -64.45 -45.29 96.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.288 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.5 ' CZ ' ' SG ' ' A' ' 227' ' ' CYS . 19.0 mtt180 -74.22 -29.97 61.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.871 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 2.7 m -75.43 -44.41 44.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.469 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.528 ' NE ' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -68.4 -45.01 73.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.191 -179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 235' ' ' ILE . . . 109.18 -31.01 8.02 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.983 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.52 HG12 ' CB ' ' A' ' 205' ' ' LEU . 1.2 pp -34.27 95.99 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-O 120.829 0.347 . . . . 0.0 111.4 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.407 ' N ' ' O ' ' A' ' 234' ' ' GLY . 11.6 Cg_endo -55.25 112.5 1.06 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.744 2.296 . . . . 0.0 111.877 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -93.75 116.59 5.25 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.699 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -88.35 -46.77 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 110.67 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.592 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 6.0 mt-30 -110.31 37.56 2.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.082 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.533 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 1.5 t -89.89 129.41 40.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.178 0.513 . . . . 0.0 110.348 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.592 ' CE2' ' O ' ' A' ' 239' ' ' GLN . 0.8 OUTLIER -146.11 135.1 22.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.451 -178.179 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.07 140.93 50.12 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.56 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 8.0 tp10 -131.42 148.66 52.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.108 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -111.51 106.73 15.69 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.589 ' CD1' ' HB2' ' A' ' 246' ' ' LEU . 0.1 OUTLIER -136.16 143.97 44.75 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.052 178.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.589 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 3.2 mt 59.42 151.12 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-O 120.95 0.405 . . . . 0.0 111.337 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.783 ' HG2' ' H3B' ' A' ' 252' ' ' FDA . 24.9 Cg_exo -64.05 -141.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.128 2.552 . . . . 0.0 112.056 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 190' ' ' TRP . 0.5 OUTLIER -43.14 148.64 0.26 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.274 0.559 . . . . 0.0 111.662 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 157.56 -66.88 0.29 Allowed Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.207 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.465 ' HB2' ' HA3' ' A' ' 218' ' ' GLY . . . -106.82 137.11 45.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.274 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.596 ' HA ' ' HA ' ' A' ' 222' ' ' MET . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.699 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' FDA . . . . . 0.783 ' H3B' ' HG2' ' A' ' 247' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.822 0.344 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.29 -70.44 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.9 mm 60.01 166.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 6' ' ' PHE . 11.7 p 171.64 118.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.843 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.428 ' CB ' ' O ' ' A' ' 5' ' ' SER . 1.0 OUTLIER 78.43 124.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.36 138.71 20.16 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.558 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -158.08 175.43 13.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.834 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.55 105.08 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 121.599 0.714 . . . . 0.0 111.137 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.47 18.6 5.73 Favored Glycine 0 C--N 1.315 -0.634 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.362 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -125.22 150.04 47.39 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.927 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.648 ' CZ ' ' CG1' ' A' ' 104' ' ' VAL . 1.5 p90 -133.79 166.73 21.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.789 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -103.77 137.33 41.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.249 0.547 . . . . 0.0 111.388 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 31' ' ' LEU . . . -130.65 140.16 50.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.592 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . 2.3 tp10 -93.41 119.03 32.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.225 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.518 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 9.9 m -71.34 107.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 6.7 p -129.3 20.19 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.807 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -133.0 -128.73 2.92 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.639 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.579 HD21 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER 74.74 95.84 0.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.808 0.813 . . . . 0.0 109.407 -178.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -142.19 137.76 31.04 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.607 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -88.5 112.49 23.04 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 m -90.27 -30.65 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.712 0.768 . . . . 0.0 109.32 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.517 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 19.0 m -137.3 175.04 9.96 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.626 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.7 t -51.09 -53.41 34.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.071 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 0.8 OUTLIER -123.27 52.52 1.38 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.026 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.517 ' CB ' ' HB2' ' A' ' 23' ' ' SER . 0.2 OUTLIER -150.73 137.18 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.846 -179.489 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.525 HG12 ' CG1' ' A' ' 82' ' ' VAL . 2.0 p -141.27 147.15 22.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.119 0.485 . . . . 0.0 112.007 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.462 ' HG3' ' HG ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -119.98 113.63 20.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.154 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CB ' ' CZ ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -111.95 121.08 44.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.364 -179.259 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.561 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -102.67 119.49 38.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.329 179.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.612 ' CD1' ' CD2' ' A' ' 102' ' ' LEU . 1.2 mt -122.89 136.25 54.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 0.0 112.06 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 1.7 mt-30 -144.65 135.49 24.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.376 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER 166.21 -23.48 0.0 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.903 0.383 . . . . 0.0 111.962 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.601 ' HB3' ' CD1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -75.66 161.68 75.25 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.183 -179.098 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.586 ' HA ' ' HB2' ' A' ' 40' ' ' ASN . 73.9 Cg_endo -95.77 77.6 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.889 3.059 . . . . 0.0 112.953 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.463 ' N ' ' HD2' ' A' ' 34' ' ' ARG . 0.1 OUTLIER 170.35 -159.61 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 121.091 0.472 . . . . 0.0 111.807 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.544 ' CB ' ' HA ' ' A' ' 43' ' ' VAL . 23.3 mp0 -76.87 65.71 2.62 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.452 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.545 ' N ' HG13 ' A' ' 43' ' ' VAL . 4.8 t -174.87 -31.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.5 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 74' ' ' GLY . . . -157.88 24.78 0.42 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.217 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.586 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 64.3 t30 -132.47 39.58 3.36 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 117.822 0.811 . . . . 0.0 112.408 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.531 ' O ' ' CA ' ' A' ' 72' ' ' PRO . 1.7 mpp_? 46.17 21.92 0.13 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.445 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.46 ' N ' ' C ' ' A' ' 40' ' ' ASN . . . -137.14 73.69 0.43 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.285 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.545 HG13 ' N ' ' A' ' 38' ' ' CYS . 1.0 OUTLIER -118.66 165.66 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.013 0.435 . . . . 0.0 110.774 179.318 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -153.92 22.67 0.51 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.756 -178.318 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.594 ' CE1' ' HA ' ' A' ' 136' ' ' MET . 0.0 OUTLIER 58.21 127.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.538 -179.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.562 ' O ' ' N ' ' A' ' 48' ' ' GLY . 32.0 mt-10 -113.28 145.27 32.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.513 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 80.6 Cg_exo -45.11 81.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.63 2.22 . . . . 0.0 112.36 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 38.9 46.77 2.35 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.335 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.475 ' HA ' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -71.88 151.18 43.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.622 0.249 . . . . 0.0 110.698 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.641 ' CD2' HM73 ' A' ' 252' ' ' FDA . 0.0 OUTLIER -133.31 163.21 29.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.96 0.409 . . . . 0.0 111.392 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.546 ' O ' ' CB ' ' A' ' 63' ' ' SER . 1.7 mtt -131.74 -167.82 1.93 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.699 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' A' ' 105' ' ' LYS . 7.9 t0 -133.39 115.32 14.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.969 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.584 ' CD1' ' CG2' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -149.6 157.39 43.21 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.618 ' HA ' ' HB3' ' A' ' 61' ' ' SER . 0.0 OUTLIER -109.97 150.87 27.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.737 179.319 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.619 ' HB ' ' HD3' ' A' ' 56' ' ' PRO . 1.5 mt -32.85 -77.12 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 55' ' ' ILE . 4.1 Cg_endo -96.01 9.31 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.199 1.932 . . . . 0.0 111.582 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 102.37 1.67 50.65 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.669 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.534 ' CG2' ' HG2' ' A' ' 56' ' ' PRO . 29.8 p -46.58 -104.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.661 0.267 . . . . 0.0 111.302 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.549 ' CA ' HG22 ' A' ' 54' ' ' THR . 1.3 m-20 169.24 30.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.726 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.409 ' H ' ' CG2' ' A' ' 54' ' ' THR . 0.6 OUTLIER -140.89 34.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.684 0.278 . . . . 0.0 111.111 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.618 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 28.2 t -108.63 -104.17 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.901 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.455 ' CG ' ' O ' ' A' ' 61' ' ' SER . 0.3 OUTLIER 172.44 -169.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 111.019 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 51' ' ' MET . 1.8 m -101.89 145.07 29.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.86 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 78' ' ' PHE . 2.4 t80 -143.51 130.3 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.608 ' OG ' ' CD2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -59.84 105.49 0.57 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.454 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.578 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 57.6 Cg_endo -90.34 131.93 1.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.648 2.232 . . . . 0.0 111.482 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -144.28 138.61 28.07 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.571 ' N ' ' OD1' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -113.21 -67.69 0.98 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.551 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER 151.03 150.5 0.0 OUTLIER Pre-proline 0 CA--C 1.521 -0.166 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.998 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 12.6 Cg_endo -56.75 96.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.719 1.613 . . . . 0.0 111.37 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.549 ' ND2' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER 177.21 166.48 0.49 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-O 121.362 0.601 . . . . 0.0 112.053 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.531 ' CA ' ' O ' ' A' ' 41' ' ' ARG . 88.7 Cg_endo -90.5 73.64 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.347 2.698 . . . . 0.0 112.543 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.526 ' CA ' ' HA ' ' A' ' 41' ' ' ARG . 3.2 tp10 -129.19 -16.68 3.96 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.529 ' O ' ' HA2' ' A' ' 39' ' ' GLY . . . 42.46 78.78 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.23 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -155.96 112.85 3.18 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 120.738 0.304 . . . . 0.0 110.313 -178.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.547 ' C ' ' CD1' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -95.23 130.65 41.89 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.062 0.458 . . . . 0.0 110.275 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 67' ' ' ALA . 16.9 pt-20 -127.54 125.49 40.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.123 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.686 ' CD1' ' CG2' ' A' ' 80' ' ' ILE . 2.0 p90 -118.93 144.15 46.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.343 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.54 ' N ' ' OH ' ' A' ' 64' ' ' TYR . 2.7 mt -112.6 74.97 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.73 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.686 ' CG2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -91.85 127.08 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.456 0.646 . . . . 0.0 111.085 -179.073 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.683 ' NH1' H61A ' A' ' 252' ' ' FDA . 0.7 OUTLIER -78.59 105.98 10.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.194 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.525 ' CG1' HG12 ' A' ' 27' ' ' VAL . 2.6 m -96.17 122.45 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.206 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.814 ' CD2' ' H4B' ' A' ' 252' ' ' FDA . 16.2 mt -41.28 168.52 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.98 0.419 . . . . 0.0 111.178 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 52.8 Cg_exo -54.53 -49.66 16.09 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.703 2.269 . . . . 0.0 112.361 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 84' ' ' PRO . 2.5 mt-10 176.29 61.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 87' ' ' ARG . . . -175.86 57.72 0.11 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.749 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.525 ' HG3' ' CD1' ' A' ' 83' ' ' LEU . 0.1 OUTLIER 170.34 -95.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.597 0.237 . . . . 0.0 111.135 179.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.554 ' CE1' HD13 ' A' ' 80' ' ' ILE . 2.8 t80 -93.64 -27.01 16.82 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 111.195 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 80.4 p -73.16 -20.39 60.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 5.0 m-20 -74.22 -40.21 62.59 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.56 ' CD1' HD12 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -73.16 -21.14 60.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.867 178.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.562 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -65.76 -47.59 74.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.602 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -16.6 24.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.591 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 1.9 t-20 -99.82 1.71 43.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.561 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -171.1 22.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 92' ' ' LEU . . . -138.56 28.39 2.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.235 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -51.51 -166.92 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.715 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.431 ' O ' HG11 ' A' ' 98' ' ' VAL . 2.1 t -125.21 95.96 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-O 121.463 0.649 . . . . 0.0 110.717 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 158.16 34.2 0.02 OUTLIER Glycine 0 C--N 1.316 -0.561 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.735 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.459 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -144.63 174.93 10.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.959 0.409 . . . . 0.0 111.198 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 102' ' ' LEU . 11.5 p -105.59 143.74 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.466 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.612 ' CD2' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -120.28 140.9 50.54 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.797 0.332 . . . . 0.0 110.986 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.3 m -100.34 115.2 29.41 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.648 ' CG1' ' CZ ' ' A' ' 12' ' ' PHE . 1.1 t -105.26 133.72 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.626 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -130.56 110.67 11.6 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.019 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.535 ' CA ' ' HA ' ' A' ' 51' ' ' MET . . . -123.75 84.08 0.36 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 119.597 -1.287 . . . . 0.0 114.924 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -91.72 30.05 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.126 2.551 . . . . 0.0 110.417 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -88.07 173.04 9.09 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.842 -178.252 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -114.59 174.71 15.62 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.317 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.513 ' CG1' ' O ' ' A' ' 47' ' ' PRO . 35.9 m -107.62 107.45 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 117.91 0.855 . . . . 0.0 110.936 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.45 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 55.5 m-85 -123.0 114.75 20.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.548 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 215' ' ' TYR . . . 142.85 -88.92 0.17 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.366 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -82.86 116.4 22.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 110.565 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.652 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.1 OUTLIER -139.19 110.6 7.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.514 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.519 ' HB2' ' NH1' ' A' ' 121' ' ' ARG . 2.0 tt0 -95.21 138.63 32.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.67 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -103.06 9.53 38.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.453 . . . . 0.0 111.071 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.88 -79.02 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.559 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.47 ' HA ' ' HB3' ' A' ' 147' ' ' ASN . 5.9 mtp -130.18 90.14 2.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.87 0.367 . . . . 0.0 110.44 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 121' ' ' ARG . . . -159.53 146.04 12.34 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.435 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.466 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 42.7 Cg_endo -67.35 102.43 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.696 2.264 . . . . 0.0 111.24 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.525 ' HB2' ' CE2' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -124.1 147.01 48.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.353 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.647 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 3.3 m-85 -110.19 122.3 47.3 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 113' ' ' LEU . 2.3 t80 -123.46 126.61 47.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.671 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.674 ' HB ' ' CD2' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -131.34 145.24 35.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.049 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -116.95 133.68 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.288 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -102.49 103.8 2.5 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.939 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.543 ' HA2' HG11 ' A' ' 155' ' ' VAL . . . 105.41 -161.81 14.56 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.875 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.499 ' C ' ' H ' ' A' ' 130' ' ' LEU . 19.4 m -96.14 -10.4 28.3 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 110.791 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.643 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -67.25 11.34 0.75 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.393 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.524 ' HG ' ' CG1' ' A' ' 134' ' ' VAL . 0.8 OUTLIER -73.01 3.08 5.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 122.662 0.385 . . . . 0.0 110.279 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.601 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -45.96 -40.95 18.27 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.27 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 2.9 Cg_endo -78.46 -31.02 2.88 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.821 2.347 . . . . 0.0 110.279 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.571 HG12 ' CE2' ' A' ' 123' ' ' PHE . 24.6 t -65.14 -43.82 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.828 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.524 ' CG1' ' HG ' ' A' ' 130' ' ' LEU . 33.8 m -70.26 -31.26 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.704 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.413 ' N ' HG22 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -63.77 -51.09 66.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.256 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.594 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -62.42 -46.91 86.45 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.172 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 133' ' ' VAL . 23.6 t -60.1 -30.63 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.108 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -62.77 -36.52 83.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.438 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.579 ' HG3' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -63.93 -42.65 97.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.448 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.635 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -64.52 -34.25 77.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.771 0.796 . . . . 0.0 110.173 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.533 ' OE1' ' CD2' ' A' ' 170' ' ' LEU . 0.1 OUTLIER -79.36 -30.12 42.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.603 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -44.83 79.02 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.728 0.299 . . . . 0.0 111.356 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.651 ' CE2' ' CB ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -82.46 -19.94 37.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.582 0.706 . . . . 0.0 109.718 179.026 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.501 ' O ' ' O ' ' A' ' 145' ' ' ALA . 5.1 m 51.61 29.45 5.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.268 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.651 ' CB ' ' CE2' ' A' ' 143' ' ' TRP . . . -37.22 162.3 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.824 0.345 . . . . 0.0 110.568 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.511 ' HA ' ' NE ' ' A' ' 175' ' ' ARG . 74.6 Cg_endo -78.79 13.32 1.96 Allowed 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.741 2.294 . . . . 0.0 112.955 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.471 ' C ' ' ND2' ' A' ' 176' ' ' ASN . 31.6 p-10 -91.35 136.71 32.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.153 0.502 . . . . 0.0 111.989 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.466 ' HG3' ' HB3' ' A' ' 120' ' ' PRO . 3.6 pm0 -73.84 119.67 18.37 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.66 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 41.9 m -115.55 124.53 51.24 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.671 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.625 ' NE ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.4 131.17 47.63 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.845 178.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 151' ' ' ILE . 0.2 OUTLIER -127.19 109.08 19.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.43 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.674 ' CD2' ' HB ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -121.31 110.04 15.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.457 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.578 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -122.22 147.3 46.36 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.394 -178.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.647 ' CA ' ' HB2' ' A' ' 182' ' ' CYS . . . -148.82 171.4 29.13 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.606 -1.283 . . . . 0.0 114.224 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.555 ' CG1' ' O ' ' A' ' 154' ' ' GLY . 3.0 m -167.72 -111.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.589 ' CB ' ' N ' ' A' ' 188' ' ' GLY . 0.4 OUTLIER -124.36 -170.32 2.12 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 120.709 0.29 . . . . 0.0 111.414 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.564 HG23 ' N ' ' A' ' 187' ' ' SER . 49.5 p -27.04 -64.47 0.08 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.705 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.9 mt-10 152.26 -50.75 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.312 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 85.9 Cg_exo -38.85 -26.84 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.745 2.297 . . . . 0.0 112.511 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.456 ' O ' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -87.93 -30.87 19.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.025 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.533 ' CD2' HG21 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -105.07 -172.5 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.0 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.465 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 0.5 OUTLIER 176.71 -155.56 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.071 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.553 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 77.4 9.58 2.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.632 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.583 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -57.74 -44.33 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 110.162 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.583 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 2.4 m-20 -62.43 -28.09 69.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.111 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 1.8 mt-10 -71.72 -47.41 54.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.837 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.578 HD13 ' CZ ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -62.34 -30.64 71.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.98 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 171' ' ' GLU . 13.2 mttm -60.41 -47.72 84.87 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -31.66 72.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.533 ' CD2' ' OE1' ' A' ' 141' ' ' GLN . 0.5 OUTLIER -65.15 -35.62 81.68 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.533 ' CG ' HG23 ' A' ' 179' ' ' VAL . 0.9 OUTLIER -62.96 -41.64 99.59 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.967 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.54 -37.65 59.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.397 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.5 t -65.34 -14.79 61.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.478 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.593 ' CG ' ' HB3' ' A' ' 177' ' ' LEU . 2.2 tpt -94.3 178.63 5.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.203 0.525 . . . . 0.0 111.311 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.511 ' NE ' ' HA ' ' A' ' 146' ' ' PRO . 6.0 tpp180 -96.18 -71.61 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.119 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.471 ' ND2' ' C ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -128.04 63.16 1.41 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.671 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.593 ' HB3' ' CG ' ' A' ' 174' ' ' MET . 0.0 OUTLIER -109.49 160.3 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.255 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.562 ' N ' ' CD2' ' A' ' 177' ' ' LEU . 1.8 m -137.55 121.95 18.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.117 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.533 HG23 ' CG ' ' A' ' 171' ' ' GLU . 53.7 t -90.06 135.71 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.167 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.519 ' CB ' ' HB3' ' A' ' 152' ' ' TYR . 3.2 tptp -108.47 130.27 55.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.687 0.28 . . . . 0.0 110.882 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.54 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -99.78 104.61 16.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 111.038 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.647 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 63.1 m -80.43 -157.87 0.17 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.956 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.574 HG23 ' CA ' ' A' ' 156' ' ' ASN . 22.5 t 57.66 143.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.485 0.66 . . . . 0.0 111.166 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.737 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -130.16 -59.82 1.03 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.916 -178.005 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.564 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 0.1 OUTLIER -168.06 51.84 0.22 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.692 178.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.624 ' O ' ' CB ' ' A' ' 187' ' ' SER . 96.2 Cg_endo -89.87 -98.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.967 2.445 . . . . 0.0 112.876 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.624 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 23.6 t 139.6 3.41 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.454 0.471 . . . . 0.0 112.199 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.602 ' HA3' ' N1A' ' A' ' 252' ' ' FDA . . . 124.22 11.47 4.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.539 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.31 62.4 1.59 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.569 ' CE3' ' N ' ' A' ' 191' ' ' GLU . 4.5 t-105 -129.86 116.25 18.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.387 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.569 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 0.9 OUTLIER -91.52 103.83 16.39 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.528 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 143.06 -123.82 2.2 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.344 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.607 ' C ' ' HB3' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -163.1 -93.92 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.592 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -87.56 120.72 29.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 194' ' ' GLN . . . 5.14 107.3 0.0 OUTLIER Glycine 0 C--N 1.35 1.321 0 O-C-N 123.735 0.647 . . . . 0.0 112.748 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER 11.98 -73.11 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.7 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 196' ' ' SER . 75.3 Cg_exo -22.67 68.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.845 3.697 . . . . 0.0 114.535 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.692 ' N ' ' O ' ' A' ' 196' ' ' SER . 0.3 OUTLIER -88.28 14.49 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.416 0.627 . . . . 0.0 110.311 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.459 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 0.2 OUTLIER -59.43 -36.24 75.53 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.911 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -58.72 -31.37 68.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.673 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.517 ' O ' ' CD2' ' A' ' 205' ' ' LEU . 0.2 OUTLIER -69.27 -34.15 74.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.154 0.502 . . . . 0.0 110.27 179.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.546 ' O ' ' HG ' ' A' ' 205' ' ' LEU . 46.8 mtt180 -60.1 -45.72 92.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.325 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.74 -32.78 71.51 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.946 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 207' ' ' SER . 88.6 m-20 -58.95 -43.76 91.31 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.019 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -60.59 -45.86 92.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -62.15 -25.6 67.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.487 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 208' ' ' SER . 1.1 t -70.81 -86.71 0.02 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.157 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.41 ' N ' ' OG ' ' A' ' 207' ' ' SER . 0.5 OUTLIER 178.31 30.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.517 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 1.8 m-20 -148.87 60.98 1.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.779 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 155.96 97.22 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.655 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.552 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 17.6 t30 174.39 -56.53 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.992 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 27.5 Cg_endo -62.08 -50.49 4.86 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.477 2.118 . . . . 0.0 111.208 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.533 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -132.44 109.97 10.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.181 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.527 ' HB ' ' CG2' ' A' ' 240' ' ' VAL . 0.9 OUTLIER -123.26 125.42 71.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -123.06 127.5 48.84 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.76 0.791 . . . . 0.0 112.007 -177.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 223' ' ' ILE . 0.9 OUTLIER -134.97 115.36 13.46 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.716 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . 0.496 ' C ' ' CD ' ' A' ' 219' ' ' PRO . 1.8 t -124.64 112.81 17.22 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.55 ' N ' ' CD ' ' A' ' 219' ' ' PRO . . . 112.83 -40.08 2.65 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.285 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.551 ' HB2' ' CB ' ' A' ' 222' ' ' MET . 55.7 Cg_endo -91.84 83.9 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.618 2.212 . . . . 0.0 113.562 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.569 ' N ' ' HB2' ' A' ' 250' ' ' ALA . 9.9 Cg_endo -52.03 -70.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.689 2.26 . . . . 0.0 111.587 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.449 ' N ' ' HB2' ' A' ' 250' ' ' ALA . . . -53.35 -48.17 60.46 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.836 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.551 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.2 OUTLIER -55.66 -25.14 37.88 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -75.84 -37.45 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.387 178.382 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -70.35 -46.67 63.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.849 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.564 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -70.18 -47.62 60.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.281 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 222' ' ' MET . . . -59.73 -39.97 86.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.329 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.482 ' HA ' HG21 ' A' ' 230' ' ' VAL . 13.3 t -70.28 -31.92 69.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.16 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -44.65 77.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.831 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.564 ' CD2' ' O ' ' A' ' 225' ' ' ALA . 0.0 OUTLIER -60.52 -35.93 77.16 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.108 0.48 . . . . 0.0 110.453 179.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 226' ' ' ALA . 2.8 t -65.68 -44.89 93.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.035 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.5 mtt85 -73.48 -30.3 63.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.0 -44.08 32.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.48 ' HD3' ' O ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -55.99 -59.69 4.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.989 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 137.65 -50.9 0.8 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.214 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.513 HD11 ' CB ' ' A' ' 205' ' ' LEU . 0.7 OUTLIER -34.99 94.84 0.08 OUTLIER Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.128 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 28.1 Cg_endo -62.7 127.47 20.71 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.825 2.35 . . . . 0.0 112.225 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -95.31 -175.33 37.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.687 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -157.47 -40.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 110.622 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.576 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 8.3 mm-40 -110.73 42.38 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.336 0.589 . . . . 0.0 110.48 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 214' ' ' ILE . 2.4 t -91.64 137.52 21.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.652 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -141.69 140.73 33.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.159 -178.301 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.549 ' CB ' HG12 ' A' ' 223' ' ' ILE . 5.6 p90 -131.14 139.27 49.77 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.296 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . 0.521 ' N ' HD13 ' A' ' 223' ' ' ILE . 0.8 OUTLIER -131.79 148.74 52.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.036 179.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 220' ' ' PRO . 1.9 mptt -124.03 105.71 9.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.643 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.2 OUTLIER -138.02 145.84 42.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 178.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.572 HD21 ' CD ' ' A' ' 247' ' ' PRO . 5.2 mt 67.83 163.99 0.13 Allowed Pre-proline 0 N--CA 1.468 0.461 0 CA-C-O 120.81 0.338 . . . . 0.0 111.294 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.572 ' CD ' HD21 ' A' ' 246' ' ' LEU . 54.9 Cg_endo -86.41 -103.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.284 2.656 . . . . 0.0 112.111 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 247' ' ' PRO . 32.3 m -37.93 137.29 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.013 0.435 . . . . 0.0 110.547 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 124.76 -15.38 7.5 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.569 ' HB2' ' N ' ' A' ' 220' ' ' PRO . . . -107.49 110.76 22.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.957 -0.621 . . . . 0.0 111.515 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.528 ' N ' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.108 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' FDA . . . . . 0.814 ' H4B' ' CD2' ' A' ' 83' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.3 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.828 0.346 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.97 16.31 5.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.809 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 tt -148.81 132.58 8.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.044 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.406 ' OG ' ' N ' ' A' ' 6' ' ' PHE . 29.4 t -56.86 -179.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.933 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' N ' ' OG ' ' A' ' 5' ' ' SER . 80.5 m-85 59.23 158.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.975 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.08 -81.35 1.2 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.57 26.57 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.921 0.391 . . . . 0.0 110.906 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.35 99.76 7.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.05 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' C ' ' HG3' ' A' ' 105' ' ' LYS . . . -157.17 20.29 0.41 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.637 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.531 ' CB ' ' HB2' ' A' ' 105' ' ' LYS . 25.4 t -123.48 150.04 44.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.845 0.355 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.577 ' CD2' HG22 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -133.01 165.37 24.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.15 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.515 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 2.0 mp0 -105.98 133.08 51.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.134 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.574 ' HB1' ' CZ ' ' A' ' 12' ' ' PHE . . . -123.23 144.29 49.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.727 0.299 . . . . 0.0 111.012 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 32' ' ' GLN . 1.2 pt-20 -93.58 120.75 34.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.811 0.338 . . . . 0.0 110.123 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.539 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 3.9 m -71.67 105.74 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.252 0.549 . . . . 0.0 111.06 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.93 -33.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.018 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -79.18 -129.02 0.61 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.03 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.606 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 71.39 95.53 0.07 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.978 0.894 . . . . 0.0 109.747 -179.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -142.32 143.22 32.67 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.858 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.524 ' NE1' ' HD3' ' A' ' 93' ' ' ARG . 3.3 m0 -88.43 113.16 23.74 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 m -92.05 -29.9 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-O 121.747 0.784 . . . . 0.0 108.963 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.512 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 12.0 m -137.6 173.83 11.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.471 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.523 ' CB ' ' HG2' ' A' ' 160' ' ' GLU . 18.6 t -53.51 -53.34 52.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.095 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 82' ' ' VAL . 98.6 m-20 -119.19 47.6 1.65 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.397 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.61 ' CG2' ' CG2' ' A' ' 128' ' ' THR . 0.2 OUTLIER -149.02 140.97 23.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.735 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.518 ' CG1' HG23 ' A' ' 80' ' ' ILE . 1.4 p -140.34 147.4 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.144 0.497 . . . . 0.0 112.087 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.8 105.26 13.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.932 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.598 ' CE2' HD21 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -100.07 128.69 46.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.882 -178.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.507 HD13 ' N ' ' A' ' 30' ' ' LEU . 6.9 mp -118.35 116.86 27.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.899 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.556 ' CD2' ' CE1' ' A' ' 29' ' ' PHE . 5.1 mt -114.03 133.84 55.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.029 0.442 . . . . 0.0 112.054 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.516 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -144.27 136.71 26.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.648 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.483 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -170.43 -94.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.707 0.289 . . . . 0.0 111.586 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.565 ' N ' ' CD ' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -48.01 -47.53 64.49 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 121.118 0.485 . . . . 0.0 110.185 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.608 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 91.2 Cg_endo -80.89 -142.1 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.015 2.477 . . . . 0.0 111.531 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 74' ' ' GLY . 0.2 OUTLIER -138.17 -162.64 1.33 Allowed 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.879 -0.513 . . . . 0.0 110.182 179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.504 ' C ' ' CG ' ' A' ' 75' ' ' ARG . 5.1 pt-20 -98.06 65.01 1.72 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.589 ' N ' ' CG ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -170.55 1.93 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -178.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.601 ' CA ' ' CG2' ' A' ' 43' ' ' VAL . . . 163.53 90.6 0.08 OUTLIER Glycine 0 C--O 1.218 -0.897 0 C-N-CA 118.544 -1.789 . . . . 0.0 115.127 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.582 ' CA ' ' HA2' ' A' ' 74' ' ' GLY . 60.5 t-20 -25.35 115.2 0.05 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 49.09 27.62 1.8 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.955 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . 76.01 86.38 0.34 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.698 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.601 ' CG2' ' CA ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -94.75 170.46 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.356 0.598 . . . . 0.0 111.66 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.529 ' HG2' ' CD1' ' A' ' 45' ' ' PHE . 5.9 ttpt -148.57 -141.63 0.11 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.689 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.529 ' CD1' ' HG2' ' A' ' 44' ' ' LYS . 48.6 p90 -95.06 56.46 1.94 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.282 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.6 OUTLIER -114.21 127.61 26.65 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.442 ' HD2' ' OE1' ' A' ' 46' ' ' GLU . 63.3 Cg_exo -32.01 84.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.842 2.361 . . . . 0.0 112.111 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 33.32 73.06 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.889 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.499 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.8 OUTLIER -32.66 154.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.906 0.353 . . . . 0.0 110.851 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.671 ' CD2' ' CB ' ' A' ' 65' ' ' SER . 1.3 m-85 -122.92 163.23 20.74 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.561 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -133.06 162.82 30.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.47 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 105' ' ' LYS . 2.8 t0 -122.66 109.29 14.09 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 110.249 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.636 ' CD1' ' CD1' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.16 158.9 44.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.53 0.681 . . . . 0.0 112.225 -178.351 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.651 ' HA ' ' HB3' ' A' ' 61' ' ' SER . 0.0 OUTLIER -103.09 151.0 23.06 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.455 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.703 ' CG2' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -32.32 -68.62 0.15 Allowed Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.72 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.703 ' HD3' ' CG2' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -103.89 2.27 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.926 2.417 . . . . 0.0 111.144 177.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 109.9 -0.07 30.26 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.084 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.547 HG21 ' CD ' ' A' ' 56' ' ' PRO . 30.4 p -31.16 -98.47 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.515 0.326 . . . . 0.0 111.449 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.554 ' N ' HG22 ' A' ' 54' ' ' THR . 10.1 p-10 160.5 31.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.71 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 59' ' ' ASP . 2.7 t -158.8 40.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.044 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.651 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 45.4 t -107.66 -103.34 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 4.7 mtm180 172.77 -174.36 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.99 0.424 . . . . 0.0 111.037 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -105.33 123.95 48.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.636 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 78' ' ' PHE . 1.2 t80 -107.36 126.14 52.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.819 0.343 . . . . 0.0 110.633 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.671 ' CB ' ' CD2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -63.78 104.94 0.57 Allowed Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.791 -179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.573 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 7.2 Cg_exo -73.25 152.74 50.52 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.528 2.152 . . . . 0.0 110.861 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 132' ' ' PRO . . . -121.4 128.53 52.3 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.569 ' O ' ' CB ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -135.71 -81.11 0.41 Allowed 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.631 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.569 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER 146.59 171.65 0.0 OUTLIER Pre-proline 0 C--N 1.339 0.134 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.156 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 69' ' ' LEU . 29.4 Cg_endo -63.63 88.26 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 121.654 1.569 . . . . 0.0 111.858 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.559 ' ND2' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -170.41 139.29 1.42 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 111.173 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.542 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 91.5 Cg_endo -86.8 67.13 4.48 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.942 2.428 . . . . 0.0 114.541 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 35' ' ' PRO . 37.2 mp0 -136.77 -116.26 0.17 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.607 ' HA3' ' HB2' ' A' ' 35' ' ' PRO . . . -166.69 71.61 0.17 Allowed Glycine 0 CA--C 1.543 1.829 0 N-CA-C 116.114 1.206 . . . . 0.0 116.114 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.589 ' CG ' ' N ' ' A' ' 38' ' ' CYS . 0.1 OUTLIER -121.72 82.0 1.89 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.275 1.537 . . . . 0.0 110.296 178.345 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.554 ' C ' ' CD1' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -97.17 129.3 44.55 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.333 0.587 . . . . 0.0 111.447 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 3.5 mt-10 -130.77 121.17 24.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.739 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.605 ' CE1' ' HB ' ' A' ' 80' ' ' ILE . 1.3 p90 -114.86 140.55 48.87 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.968 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.535 ' CD2' ' HB2' ' A' ' 131' ' ' ALA . 0.7 OUTLIER -102.44 84.1 2.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.605 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -90.37 139.94 16.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.728 -177.395 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.674 ' HB3' ' H8A' ' A' ' 252' ' ' FDA . 0.0 OUTLIER -78.05 112.03 14.56 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.517 ' CG2' HG11 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -105.9 138.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.783 -178.277 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.604 HD12 ' H4B' ' A' ' 252' ' ' FDA . 9.0 mt -101.4 158.55 31.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.768 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 83' ' ' LEU . 26.2 Cg_endo -62.06 67.71 0.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.673 2.249 . . . . 0.0 112.023 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 83' ' ' LEU . 29.2 mm-40 75.63 53.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.647 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.14 -97.19 1.35 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.665 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -125.57 -48.46 1.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.67 0.271 . . . . 0.0 111.157 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.571 ' CZ ' ' HA ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -85.52 -32.95 21.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 0.0 110.859 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.564 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 3.3 p -70.01 -20.58 63.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.28 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 9.9 m-20 -77.25 -34.12 55.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.31 0.576 . . . . 0.0 110.867 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.599 ' CE1' ' HA ' ' A' ' 56' ' ' PRO . 35.0 t80 -73.51 -51.41 17.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.93 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.564 ' CD1' ' HA ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -70.97 -29.63 65.68 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.074 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.524 ' HD3' ' NE1' ' A' ' 21' ' ' TRP . 8.4 mtm180 -90.55 -27.46 19.13 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.81 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 1.9 t-20 -102.56 -5.45 23.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.702 0.287 . . . . 0.0 110.845 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 91' ' ' TYR . 2.9 t70 -130.22 -23.47 2.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 92' ' ' LEU . . . -96.51 28.67 3.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.15 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 7.2 mmm180 -97.03 -47.4 5.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.045 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.537 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.6 OUTLIER -72.95 -1.17 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.864 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.475 ' HA2' HG23 ' A' ' 16' ' ' VAL . . . 77.05 20.41 75.82 Favored Glycine 0 C--N 1.32 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.047 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.528 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 25.0 mt-30 -47.96 179.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 111.186 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.439 ' CG1' ' O ' ' A' ' 14' ' ' ALA . 2.1 t -109.54 139.77 31.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.977 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.636 ' CD1' ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -130.09 126.21 37.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.298 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 12' ' ' PHE . 1.5 t -94.78 140.47 29.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 111.915 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.577 HG22 ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -115.91 142.22 30.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.901 178.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 25.6 ttpp -131.63 113.23 13.36 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.192 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 50' ' ' PHE . . . 162.49 98.38 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 118.921 -1.609 . . . . 0.0 114.592 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -92.9 29.95 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.414 2.743 . . . . 0.0 110.014 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.566 ' HG ' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -88.61 166.74 13.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.466 -177.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.566 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -146.07 171.78 26.89 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.354 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.594 HG13 ' CZ ' ' A' ' 50' ' ' PHE . 3.5 p -158.05 121.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.222 0.534 . . . . 0.0 111.067 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -70.1 135.93 49.72 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.508 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -146.66 -41.09 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.644 ' HA ' ' CG ' ' A' ' 215' ' ' TYR . 1.4 pt? -133.27 119.51 19.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.166 0.508 . . . . 0.0 110.432 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.651 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.4 OUTLIER -137.93 114.79 10.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.452 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.463 ' HA ' ' OH ' ' A' ' 215' ' ' TYR . 7.5 pm0 -83.62 140.62 32.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.693 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.41 15.01 5.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.746 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.82 -78.06 0.25 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.9 mtt -130.04 89.92 2.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.85 0.357 . . . . 0.0 110.153 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.46 ' O ' ' HD3' ' A' ' 121' ' ' ARG . . . -165.6 150.84 8.03 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.455 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 47.6 Cg_endo -68.75 104.83 1.21 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.806 2.337 . . . . 0.0 112.078 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -120.81 146.66 46.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.692 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.657 ' CZ ' ' CD ' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -115.52 141.05 48.58 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.168 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.574 ' CD2' HD11 ' A' ' 113' ' ' LEU . 1.1 t80 -122.42 117.16 25.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.866 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.615 ' HB ' ' CE1' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -106.2 113.29 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.365 0.602 . . . . 0.0 111.943 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -100.83 133.12 45.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.201 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -112.47 103.62 1.48 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.643 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.561 ' HA2' ' CG1' ' A' ' 155' ' ' VAL . . . 106.31 -156.57 16.24 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.621 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.61 ' CG2' ' CG2' ' A' ' 26' ' ' THR . 8.6 m -100.35 -17.01 17.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.955 0.407 . . . . 0.0 111.132 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.591 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -63.71 10.1 0.23 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.098 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' A' ' 128' ' ' THR . 0.4 OUTLIER -77.86 3.62 13.95 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.895 0.348 . . . . 0.0 110.08 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.592 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -46.75 -43.96 42.25 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.966 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 2.8 Cg_exo -74.02 -30.74 8.68 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.933 2.422 . . . . 0.0 110.399 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.57 ' CG1' ' CE2' ' A' ' 123' ' ' PHE . 10.7 t -64.64 -46.82 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.601 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 131' ' ' ALA . 19.3 m -66.86 -30.75 50.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.21 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -66.72 -50.82 61.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.859 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.439 ' O ' ' HB2' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -63.88 -39.07 93.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.029 178.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.7 t -62.61 -44.8 99.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.333 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -60.9 -31.04 70.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.229 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 143' ' ' TRP . 75.2 mt-30 -63.47 -41.74 98.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.485 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.459 ' HE3' ' HG3' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -57.68 -51.98 67.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.687 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.53 ' HG2' ' CG ' ' A' ' 174' ' ' MET . 1.7 mp0 -69.23 -33.46 73.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.701 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -80.89 -12.25 59.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.983 0.42 . . . . 0.0 111.012 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.476 ' C ' ' CG2' ' A' ' 144' ' ' THR . 3.8 m95 -89.21 -85.05 0.21 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.303 0.573 . . . . 0.0 111.554 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.51 ' O ' ' OG1' ' A' ' 144' ' ' THR . 0.6 OUTLIER -174.69 26.52 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.652 -178.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.458 ' CB ' ' HE2' ' A' ' 140' ' ' MET . . . -111.81 54.39 0.42 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.388 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.526 ' O ' ' CB ' ' A' ' 175' ' ' ARG . 57.7 Cg_endo -70.75 -1.56 9.48 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.663 2.242 . . . . 0.0 112.132 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.501 ' C ' ' ND2' ' A' ' 176' ' ' ASN . 0.7 OUTLIER -50.43 -169.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 1.2 mt-10 -71.87 105.2 3.72 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.586 0.707 . . . . 0.0 110.294 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 98.8 m -117.43 117.38 29.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.595 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.657 ' CD ' ' CZ ' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -102.73 135.72 43.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.091 0.472 . . . . 0.0 110.493 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 151' ' ' ILE . 0.3 OUTLIER -133.19 109.72 14.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.033 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.643 ' CZ ' ' HB3' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -107.1 109.27 21.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.543 ' CZ ' HD21 ' A' ' 161' ' ' LEU . 2.1 t80 -111.91 145.39 39.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.586 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.601 ' CA ' ' HB2' ' A' ' 182' ' ' CYS . . . -162.0 167.01 36.52 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.63 -1.748 . . . . 0.0 114.717 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.565 ' CG1' ' O ' ' A' ' 154' ' ' GLY . 17.0 m -164.95 -119.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.471 -0.865 . . . . 0.0 110.998 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.613 ' CB ' ' N ' ' A' ' 188' ' ' GLY . 1.4 p30 -112.55 -171.38 1.85 Allowed 'General case' 0 C--N 1.343 0.284 0 O-C-N 122.243 -0.285 . . . . 0.0 111.118 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.546 ' CG2' ' HA ' ' A' ' 187' ' ' SER . 0.2 OUTLIER -32.01 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.768 0.318 . . . . 0.0 111.071 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 19.5 mt-10 89.05 39.1 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.305 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 24.8 Cg_endo -62.22 -25.97 77.25 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 C-N-CA 122.296 1.997 . . . . 0.0 110.698 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.523 ' HG2' ' CB ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -121.73 -28.15 4.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.045 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.543 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 5.3 tp -40.41 165.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.783 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER 177.38 -153.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.926 0.393 . . . . 0.0 111.079 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.524 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 72.33 7.68 5.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.361 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -59.72 -41.81 86.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.561 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 18.5 m-20 -61.88 -27.84 69.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.179 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.51 ' HG3' ' CD1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -72.33 -41.85 66.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.994 179.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -71.5 -31.53 67.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.075 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.492 ' HD3' ' HA ' ' A' ' 165' ' ' ASP . 14.1 mtpp -61.3 -46.36 90.65 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 6.0 m -63.0 -31.87 73.11 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.476 HD23 ' OE1' ' A' ' 141' ' ' GLN . 1.0 OUTLIER -62.9 -36.67 84.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.346 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.527 ' HG2' ' CD1' ' A' ' 177' ' ' LEU . 3.6 mt-10 -63.04 -41.0 99.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.203 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -33.98 47.73 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.09 -6.59 53.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.022 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.53 ' CG ' ' HG2' ' A' ' 141' ' ' GLN . 0.0 OUTLIER -106.29 -168.64 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.032 0.444 . . . . 0.0 111.242 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' A' ' 146' ' ' PRO . 6.9 ttt-85 -103.26 -64.43 1.08 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.901 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.501 ' ND2' ' C ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -139.91 66.37 1.4 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.431 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.533 ' C ' ' CD1' ' A' ' 177' ' ' LEU . 0.6 OUTLIER -106.65 153.68 22.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.6 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.457 ' HB ' ' HG3' ' A' ' 150' ' ' ARG . 40.9 m -136.08 115.12 12.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.278 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 151' ' ' ILE . 8.8 p -89.66 135.1 26.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.658 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.38 133.92 47.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.101 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.551 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -98.66 104.26 16.28 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.463 0.649 . . . . 0.0 110.541 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.601 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 95.6 m -80.71 -167.44 1.38 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.186 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.587 ' CG2' ' O ' ' A' ' 156' ' ' ASN . 77.2 t 64.33 148.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.689 0.757 . . . . 0.0 111.822 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.717 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.45 -61.12 0.82 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.288 -178.267 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.523 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 2.6 m170 -174.95 53.38 0.12 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.728 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 187' ' ' SER . 91.3 Cg_endo -86.88 -98.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.922 2.414 . . . . 0.0 112.632 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 0.4 OUTLIER 156.35 -0.63 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.613 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 124.04 11.18 4.89 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.356 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.8 63.26 1.55 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.507 ' CE3' ' N ' ' A' ' 191' ' ' GLU . 1.8 t-105 -127.46 108.81 11.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.455 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.507 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 0.2 OUTLIER -98.55 104.86 16.94 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.56 178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 193' ' ' GLU . . . 164.84 -76.28 0.15 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.734 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.573 ' CB ' ' O ' ' A' ' 192' ' ' GLY . 1.1 mt-10 148.03 -100.14 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.551 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 0.0 OUTLIER -87.09 131.91 33.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.656 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -31.02 105.28 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 C-N-CA 119.888 -1.148 . . . . 0.0 111.962 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.525 ' CB ' ' CD ' ' A' ' 197' ' ' PRO . 0.3 OUTLIER 162.57 -178.44 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.305 -0.447 . . . . 0.0 111.301 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.525 ' CD ' ' CB ' ' A' ' 196' ' ' SER . 69.7 Cg_endo -91.3 -1.15 4.73 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.168 2.579 . . . . 0.0 114.05 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.645 ' CG2' ' O ' ' A' ' 198' ' ' ILE . 0.2 OUTLIER 75.64 33.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.669 1.223 . . . . 0.0 109.522 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.498 ' OD1' ' NE ' ' A' ' 202' ' ' ARG . 0.2 OUTLIER -78.29 -33.54 49.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.579 -1.192 . . . . 0.0 112.492 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -56.61 -44.78 81.49 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.604 ' CD2' ' O ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -65.79 -31.2 72.03 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.399 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.528 ' CD ' HD21 ' A' ' 229' ' ' LEU . 18.6 mtm180 -57.71 -48.71 78.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.429 0.633 . . . . 0.0 110.265 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.19 -32.66 67.01 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.313 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -59.4 -40.92 88.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.571 ' CB ' ' CD1' ' A' ' 235' ' ' ILE . 0.0 OUTLIER -60.69 -47.75 84.85 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -20.67 66.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.946 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.97 12.35 27.1 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.677 0.275 . . . . 0.0 111.425 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 0.7 OUTLIER 72.24 100.11 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.87 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 210' ' ' ALA . 0.9 OUTLIER 155.47 86.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . 96.32 102.17 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.281 0.562 . . . . 0.0 110.381 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.597 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 4.5 t-20 174.45 -55.53 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.888 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 10.0 Cg_endo -51.01 -48.0 23.04 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.199 1.933 . . . . 0.0 110.58 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.68 108.41 8.52 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.492 ' C ' ' CD1' ' A' ' 215' ' ' TYR . 1.0 OUTLIER -121.26 125.43 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.644 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -121.03 127.16 51.47 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.804 -178.409 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.527 ' CD2' ' CG1' ' A' ' 124' ' ' VAL . 3.0 mt -138.44 115.88 11.23 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.622 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . 0.531 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 1.0 OUTLIER -125.84 119.66 28.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.582 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.579 ' HA2' ' CG ' ' A' ' 245' ' ' PHE . . . 115.29 -48.8 0.9 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.779 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.56 ' HB3' ' CB ' ' A' ' 250' ' ' ALA . 97.8 Cg_endo -80.51 110.01 2.37 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.424 2.083 . . . . 0.0 113.549 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.479 ' HA ' ' CB ' ' A' ' 244' ' ' LYS . 16.0 Cg_exo -66.72 -45.35 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.718 2.279 . . . . 0.0 110.825 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.49 -38.35 90.65 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.589 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.605 ' CA ' ' HA ' ' A' ' 251' ' ' ALA . 3.6 tpt -56.08 -25.27 44.7 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.551 HG13 ' CB ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -69.09 -45.49 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.12 178.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -75.04 -47.78 27.25 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.531 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.557 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -77.34 -50.24 13.24 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 222' ' ' MET . . . -59.84 -40.1 87.38 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.436 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 223' ' ' ILE . 42.5 t -69.95 -30.86 68.33 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 232' ' ' SER . 3.5 mm-40 -69.61 -44.62 70.31 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.578 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.557 ' CD2' ' O ' ' A' ' 225' ' ' ALA . 0.0 OUTLIER -60.06 -37.92 81.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.002 0.429 . . . . 0.0 110.658 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 226' ' ' ALA . 2.3 t -64.19 -45.34 96.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.181 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -30.19 61.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.059 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.506 ' OG ' ' NH1' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -75.48 -46.22 33.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.181 0.515 . . . . 0.0 111.258 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.52 ' CG ' HD13 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -58.91 -51.1 71.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.026 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 125.34 -52.48 0.8 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.098 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.571 ' CD1' ' CB ' ' A' ' 205' ' ' LEU . 0.9 OUTLIER -36.04 95.73 0.1 OUTLIER Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 121.08 0.467 . . . . 0.0 111.128 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 31.8 Cg_endo -64.16 119.61 6.7 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.897 2.398 . . . . 0.0 112.47 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -90.75 176.71 41.38 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.45 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.7 -40.25 0.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 0.0 111.081 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.581 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 21.0 mm100 -105.64 36.03 2.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.017 0.437 . . . . 0.0 110.67 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.528 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 2.1 t -89.19 136.5 23.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.322 0.582 . . . . 0.0 111.062 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.651 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.6 OUTLIER -144.92 138.02 26.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.94 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.551 ' CB ' HG13 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -129.52 130.39 45.73 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.081 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . 0.501 ' CA ' HD11 ' A' ' 223' ' ' ILE . 0.3 OUTLIER -132.65 149.39 52.3 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.543 179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.479 ' CB ' ' HA ' ' A' ' 220' ' ' PRO . 1.7 ptmm? -129.08 115.0 17.07 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.591 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.5 OUTLIER -137.42 146.86 44.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.171 179.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.576 ' HG ' ' CD1' ' A' ' 245' ' ' PHE . 0.2 OUTLIER 57.61 174.3 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.477 0 C-N-CA 122.922 0.489 . . . . 0.0 111.731 -178.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.544 ' N ' HD13 ' A' ' 246' ' ' LEU . 75.9 Cg_exo -52.78 -141.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.371 2.714 . . . . 0.0 113.643 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 190' ' ' TRP . 2.4 p -81.4 177.25 9.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.485 0.66 . . . . 0.0 112.085 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 163.2 -71.0 0.21 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.578 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 219' ' ' PRO . . . -107.74 149.64 27.92 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.605 ' HA ' ' CA ' ' A' ' 222' ' ' MET . . . . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.46 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' FDA . . . . . 0.674 ' H8A' ' HB3' ' A' ' 81' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.782 0.325 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.46 ' O ' ' CD1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -141.87 144.58 33.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.797 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.46 ' CD1' ' O ' ' A' ' 3' ' ' ARG . 20.4 mm -149.82 46.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.198 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.13 173.75 8.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.782 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.45 147.64 30.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.976 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.96 -167.35 11.04 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.467 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.8 mp0 -66.14 128.61 36.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 110.947 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 t -121.99 101.14 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.102 0.477 . . . . 0.0 110.982 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.11 25.23 29.06 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.443 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.519 ' CB ' ' HB2' ' A' ' 105' ' ' LYS . 83.9 p -95.71 153.87 17.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.821 0.343 . . . . 0.0 110.892 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.611 ' CE1' ' HB2' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -132.05 156.88 45.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.916 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.61 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 1.6 mt-10 -106.04 121.79 44.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.589 ' CA ' ' HB2' ' A' ' 33' ' ' LYS . . . -126.73 127.69 45.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.183 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 32' ' ' GLN . 4.2 tp10 -93.41 128.08 39.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.899 0.38 . . . . 0.0 110.697 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 100' ' ' GLN . 28.0 m -71.88 106.14 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.091 0.472 . . . . 0.0 111.096 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 2.4 p -127.2 2.31 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.314 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -120.14 -128.86 3.71 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.526 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.59 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER 82.49 58.77 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.329 0.585 . . . . 0.0 110.063 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -95.63 145.42 25.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.669 -179.521 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -88.69 113.86 24.69 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG12 ' ND2' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -97.3 -27.59 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.53 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 13.2 m -141.44 173.62 11.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.133 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.4 ' CB ' ' HG2' ' A' ' 160' ' ' GLU . 14.9 t -52.19 -57.06 10.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.692 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.519 ' CA ' ' O ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -118.07 44.45 2.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.553 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.533 ' CG2' ' HG2' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -148.34 138.66 22.66 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.311 0.577 . . . . 0.0 110.886 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.59 HG21 ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -141.34 148.35 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.138 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -114.55 103.54 11.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.367 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CB ' ' CZ ' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -99.26 127.51 45.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.886 -178.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.582 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -113.28 116.65 30.07 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.547 ' O ' ' NH2' ' A' ' 41' ' ' ARG . 4.6 mt -112.37 131.57 55.47 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.025 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.538 ' HA ' ' CZ ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -144.77 109.86 5.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.72 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.589 ' HB2' ' CA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -114.92 -49.17 2.81 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.595 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -63.68 -164.68 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.595 ' CD ' ' CB ' ' A' ' 34' ' ' ARG . 88.1 Cg_exo -44.54 -74.46 0.04 OUTLIER 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 121.645 1.563 . . . . 0.0 113.546 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 38' ' ' CYS . 2.4 m-20 153.81 -169.83 0.0 OUTLIER 'General case' 0 C--N 1.345 0.372 0 CA-C-N 118.089 0.404 . . . . 0.0 110.784 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.579 ' CA ' ' HB3' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -58.0 59.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.592 0.558 . . . . 0.0 111.391 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.6 ' N ' ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER 166.56 -16.04 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 35' ' ' PRO . . . -103.87 -84.33 1.77 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 119.578 -1.296 . . . . 0.0 114.991 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 8.0 t-20 -157.47 88.26 0.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.612 ' CG ' ' O ' ' A' ' 74' ' ' GLY . 1.1 ptt85 -177.26 -29.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.612 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.561 ' C ' ' HA ' ' A' ' 72' ' ' PRO . . . -57.64 -166.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.689 -0.767 . . . . 0.0 114.293 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.57 ' O ' ' O ' ' A' ' 69' ' ' LEU . 20.4 m -134.4 167.4 26.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 C-N-CA 123.793 0.837 . . . . 0.0 111.029 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.671 ' HA ' ' N ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -112.76 84.02 1.91 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.131 0.973 . . . . 0.0 111.14 178.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.598 ' O ' ' CG ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER 7.06 61.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.171 0.919 . . . . 0.0 112.572 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -84.92 160.94 54.43 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.816 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 37.1 Cg_exo -57.99 68.53 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.589 2.193 . . . . 0.0 111.837 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 59.39 37.74 92.43 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.003 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 65' ' ' SER . 4.8 tt0 -52.95 158.12 1.51 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.064 0.432 . . . . 0.0 110.077 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.67 ' CD2' ' CD2' ' A' ' 108' ' ' LEU . 28.7 p90 -151.96 163.47 39.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.508 ' O ' ' HA ' ' A' ' 63' ' ' SER . 2.0 mmt -121.14 175.36 6.14 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.705 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.54 108.09 15.07 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.549 ' CB ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -150.49 156.69 41.92 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.588 HG23 ' N ' ' A' ' 61' ' ' SER . 0.2 OUTLIER -96.6 154.15 17.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.602 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.714 ' CG2' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -29.45 -68.14 0.12 Allowed Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 123.443 0.464 . . . . 0.0 110.601 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.714 ' HD3' ' CG2' ' A' ' 55' ' ' ILE . 4.4 Cg_endo -110.05 6.26 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.719 2.946 . . . . 0.0 111.733 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 104.51 -5.88 44.76 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.019 -178.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.583 HG23 ' CD ' ' A' ' 56' ' ' PRO . 67.6 p -24.34 -88.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.127 0.571 . . . . 0.0 111.814 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -154.12 42.84 0.53 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.551 ' N ' ' OG1' ' A' ' 54' ' ' THR . 0.3 OUTLIER 88.19 125.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.588 ' N ' HG23 ' A' ' 54' ' ' THR . 28.8 t -117.41 -72.42 0.69 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.502 0.668 . . . . 0.0 110.268 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.516 ' HB3' " H4'" ' A' ' 252' ' ' FDA . 0.0 OUTLIER -167.63 171.14 10.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.597 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.648 ' CB ' ' CE1' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -101.54 118.96 38.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.903 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.594 ' HB2' HO3' ' A' ' 252' ' ' FDA . 1.6 t80 -118.57 127.34 53.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.994 0.426 . . . . 0.0 111.94 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.587 ' HA ' ' CB ' ' A' ' 50' ' ' PHE . 92.4 p -72.18 109.54 6.04 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.741 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.532 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 88.6 Cg_endo -85.67 169.65 9.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.956 2.438 . . . . 0.0 112.694 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.4 130.53 19.55 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.964 0.412 . . . . 0.0 111.655 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -129.68 -56.09 1.14 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.555 0.693 . . . . 0.0 109.844 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 43' ' ' VAL . 0.4 OUTLIER 164.61 -164.93 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 96.6 Cg_endo -91.31 63.16 1.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.102 1.201 . . . . 0.0 112.372 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.671 ' N ' ' HA ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -174.46 109.74 0.29 Allowed Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.561 ' HA ' ' C ' ' A' ' 42' ' ' GLY . 4.1 Cg_exo -74.17 40.85 0.62 Allowed 'Trans proline' 0 CA--C 1.515 -0.429 0 C-N-CA 122.336 2.024 . . . . 0.0 112.409 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -138.14 6.79 2.62 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.579 178.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.612 ' O ' ' CG ' ' A' ' 41' ' ' ARG . . . -90.29 -116.05 1.74 Allowed Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.912 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.579 ' HB3' ' CA ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -152.34 119.49 5.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.875 -0.662 . . . . 0.0 110.012 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.541 ' CD2' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -96.8 148.33 23.03 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 122.22 1.009 . . . . 0.0 113.169 -178.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.507 ' CB ' HD13 ' A' ' 30' ' ' LEU . 1.8 pt-20 -131.07 150.56 52.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.972 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.621 ' CZ ' ' CB ' ' A' ' 29' ' ' PHE . 1.9 p90 -126.37 139.8 52.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.938 0.399 . . . . 0.0 111.549 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.526 ' N ' ' OH ' ' A' ' 64' ' ' TYR . 1.3 mt -104.4 91.56 3.95 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.499 ' CG2' ' CG1' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -92.36 118.61 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.197 -178.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.82 ' O ' H52A ' A' ' 252' ' ' FDA . 0.8 OUTLIER -79.34 96.25 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.978 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.588 ' CG2' ' CB ' ' A' ' 89' ' ' SER . 2.9 m -92.69 141.5 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.006 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.546 HD11 ' H1B' ' A' ' 252' ' ' FDA . 1.1 mp -60.73 -179.97 0.21 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.747 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 85' ' ' GLU . 37.4 Cg_exo -56.8 -32.35 91.38 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.593 2.195 . . . . 0.0 112.182 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER 157.94 100.7 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.831 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 155.04 -16.91 0.53 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.645 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.467 ' HB2' ' HB2' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -102.72 -98.19 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.881 -0.188 . . . . 0.0 110.975 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -97.07 -30.17 13.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.717 0.294 . . . . 0.0 111.204 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.588 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 0.8 OUTLIER -60.47 -27.31 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.99 0.424 . . . . 0.0 110.921 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -76.24 -32.47 58.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.555 0.693 . . . . 0.0 109.819 179.469 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.575 ' CG ' HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -73.43 -45.31 55.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.129 -179.137 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.544 ' HA ' ' CB ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -67.73 -34.72 77.4 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -29.68 15.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 2.4 t-20 -95.2 -5.14 44.56 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.384 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.49 15.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.544 ' CB ' ' HA ' ' A' ' 92' ' ' LEU . . . -153.61 30.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.668 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -47.49 -102.1 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.44 ' O ' HG11 ' A' ' 98' ' ' VAL . 2.5 t -148.01 103.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.115 0.484 . . . . 0.0 110.98 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 150.7 -12.65 0.87 Allowed Glycine 0 C--N 1.32 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.021 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.522 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 27.1 mp0 -91.29 162.46 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 111.133 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.459 HG11 ' HG2' ' A' ' 33' ' ' LYS . 40.9 t -129.62 142.22 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.581 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.542 ' CD1' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -118.94 153.4 34.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.089 0.471 . . . . 0.0 111.415 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.6 t -105.95 97.56 7.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.549 ' HA ' ' CB ' ' A' ' 53' ' ' LEU . 2.0 m -90.88 118.54 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.519 ' HB2' ' CB ' ' A' ' 11' ' ' SER . 3.7 tttt -129.52 123.08 30.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.496 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 161.79 65.66 0.02 OUTLIER Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.732 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.44 57.4 1.33 Allowed 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.422 2.081 . . . . 0.0 110.883 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.67 ' CD2' ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -100.55 170.03 8.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.864 -178.543 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.624 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -118.83 172.09 14.41 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -157.13 115.33 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.564 0.682 . . . . 0.0 111.683 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -69.67 113.81 7.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.539 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -147.02 -40.5 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.628 ' HA ' ' CG ' ' A' ' 215' ' ' TYR . 0.9 OUTLIER -146.14 119.14 8.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.431 178.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.652 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.1 OUTLIER -138.28 117.48 12.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.294 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -92.29 140.62 29.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.435 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -90.05 15.89 9.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.018 0.437 . . . . 0.0 110.98 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.46 -77.39 0.23 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.69 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.56 89.87 2.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.939 0.4 . . . . 0.0 110.37 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -163.59 149.94 9.97 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.16 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.471 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 32.2 Cg_endo -64.24 115.22 3.03 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.569 2.179 . . . . 0.0 111.69 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.581 ' CZ ' ' CG2' ' A' ' 149' ' ' THR . 0.0 OUTLIER -124.77 146.31 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.393 -179.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.635 ' CD2' ' CB ' ' A' ' 150' ' ' ARG . 39.5 m-85 -126.09 122.78 36.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 110.63 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.635 ' CZ ' ' CG2' ' A' ' 133' ' ' VAL . 0.9 OUTLIER -111.93 106.05 14.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.418 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.576 ' HA ' ' HB2' ' A' ' 152' ' ' TYR . 6.9 p -99.11 111.0 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 121.233 0.539 . . . . 0.0 111.125 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -109.79 133.68 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.143 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.428 ' C ' ' HA3' ' A' ' 249' ' ' GLY . . . -107.82 103.08 1.86 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.047 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.543 ' CA ' HG12 ' A' ' 155' ' ' VAL . . . 118.86 -167.94 13.2 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.372 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 79' ' ' LEU . 6.1 m -91.74 -13.42 31.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.024 0.44 . . . . 0.0 110.847 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.574 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -64.72 10.02 0.36 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 116.111 -0.495 . . . . 0.0 113.409 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.475 ' H ' ' C ' ' A' ' 128' ' ' THR . 0.4 OUTLIER -79.97 3.68 19.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 117.177 0.489 . . . . 0.0 110.033 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.584 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -47.55 -43.43 49.41 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.917 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 6.7 Cg_exo -71.35 -30.87 14.93 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.525 2.15 . . . . 0.0 109.655 177.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.635 ' CG2' ' CZ ' ' A' ' 123' ' ' PHE . 17.9 t -66.07 -44.33 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.208 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 131' ' ' ALA . 14.4 m -70.44 -29.91 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.532 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.14 -52.69 57.88 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.476 ' HB3' HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -62.13 -44.95 95.5 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.389 0.614 . . . . 0.0 109.46 178.312 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.468 HG12 ' NE2' ' A' ' 141' ' ' GLN . 5.3 t -60.17 -30.16 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.846 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.82 -37.99 83.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.254 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.552 ' OE1' ' CE2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -63.61 -42.66 98.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.065 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.611 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.6 OUTLIER -70.05 -33.31 71.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.664 0.745 . . . . 0.0 110.366 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.551 ' CG ' ' CD2' ' A' ' 170' ' ' LEU . 0.0 OUTLIER -76.4 -30.38 57.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.51 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -73.11 -44.67 60.01 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.658 ' CE2' ' CB ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -78.14 -21.26 50.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.335 0.588 . . . . 0.0 110.115 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER 53.57 27.84 7.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.761 178.472 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.658 ' CB ' ' CE2' ' A' ' 143' ' ' TRP . . . -36.6 160.32 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 0.0 110.693 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 145' ' ' ALA . 60.2 Cg_endo -73.23 4.27 3.96 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.691 2.26 . . . . 0.0 112.728 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 148' ' ' GLU . 10.8 t30 -81.48 135.83 35.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.984 0.421 . . . . 0.0 111.522 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.543 ' CB ' ' HB2' ' A' ' 176' ' ' ASN . 4.6 pt-20 -73.78 112.7 10.14 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.437 0.637 . . . . 0.0 110.957 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.581 ' CG2' ' CZ ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -111.74 116.35 30.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.052 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.635 ' CB ' ' CD2' ' A' ' 122' ' ' TYR . 0.8 OUTLIER -107.12 142.82 36.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.76 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.489 ' C ' ' CD1' ' A' ' 151' ' ' ILE . 0.1 OUTLIER -134.05 136.2 53.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.152 0.501 . . . . 0.0 110.697 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.625 ' CD1' ' CG ' ' A' ' 180' ' ' LYS . 18.2 m-30 -110.5 112.02 23.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.881 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.485 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 8.6 t80 -113.9 130.34 56.51 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 122.199 -0.313 . . . . 0.0 111.364 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.625 ' HA2' ' HB2' ' A' ' 182' ' ' CYS . . . -154.12 161.19 29.89 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 119.535 -1.316 . . . . 0.0 113.865 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.543 HG12 ' CA ' ' A' ' 127' ' ' GLY . 21.0 m -164.05 -122.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.379 -0.411 . . . . 0.0 111.265 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.635 ' ND2' H62A ' A' ' 252' ' ' FDA . 44.7 p-10 -103.45 -174.34 2.52 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 120.557 0.218 . . . . 0.0 110.783 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.544 ' CA ' ' HD2' ' A' ' 186' ' ' PRO . 0.5 OUTLIER -42.95 -25.31 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.323 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.668 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 40.1 mt-10 94.16 22.41 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.711 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 77.9 Cg_exo -46.78 -23.82 2.65 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.28 1.32 . . . . 0.0 111.252 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -131.59 -28.85 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.674 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.541 ' CD1' HG22 ' A' ' 155' ' ' VAL . 13.3 tp -35.76 158.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.71 -157.99 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.542 ' CE1' ' HG2' ' A' ' 166' ' ' GLU . 0.1 OUTLIER 74.15 27.61 1.52 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.1 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.577 ' CD1' ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -70.23 -39.07 76.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.071 0.462 . . . . 0.0 110.306 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.577 ' N ' ' CD1' ' A' ' 164' ' ' ILE . 0.2 OUTLIER -73.7 -27.2 61.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.825 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.542 ' HG2' ' CE1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -64.17 -49.16 73.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 -179.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -75.19 -30.84 60.77 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 164' ' ' ILE . 1.8 mttm -61.64 -41.26 97.25 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.16 -32.4 73.01 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.59 ' O ' ' HB3' ' A' ' 174' ' ' MET . 0.3 OUTLIER -61.72 -48.58 80.08 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.099 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.468 ' O ' ' SD ' ' A' ' 174' ' ' MET . 36.2 mt-10 -56.58 -32.65 65.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.89 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -39.94 30.85 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 m -112.13 28.8 8.44 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.59 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 0.0 OUTLIER -113.65 167.05 10.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.164 0.507 . . . . 0.0 111.615 179.365 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -84.85 -80.05 0.21 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.373 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.543 ' HB2' ' CB ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -130.61 63.48 1.57 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.245 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.531 ' CB ' ' O ' ' A' ' 149' ' ' THR . 4.5 mp -112.27 149.65 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.077 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.466 ' HB ' ' HG2' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -137.08 126.9 25.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.283 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 151' ' ' ILE . 72.6 t -100.99 135.8 35.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.314 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.625 ' CG ' ' CD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -99.79 136.69 39.34 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.196 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -98.22 105.89 18.1 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.68 0.752 . . . . 0.0 111.389 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . 0.625 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 64.4 m -86.06 -164.75 1.08 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.358 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 157' ' ' THR . 37.3 t 54.17 147.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 122.151 0.977 . . . . 0.0 112.646 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.729 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -137.18 -62.94 0.61 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.523 -1.672 . . . . 0.0 108.484 -178.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.518 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 50.8 m-70 -167.64 49.45 0.18 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.698 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.574 ' O ' ' CB ' ' A' ' 187' ' ' SER . 40.7 Cg_endo -85.95 -104.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.384 2.723 . . . . 0.0 112.895 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 9.6 t 150.81 21.78 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.618 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 97.84 10.4 52.62 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.636 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 251' ' ' ALA . 0.4 OUTLIER -138.07 63.88 1.52 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 178.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' TRP . . . . . 0.523 ' O ' ' O ' ' A' ' 249' ' ' GLY . 5.6 t-105 -122.81 123.63 41.46 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.778 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.51 ' HG3' ' HA ' ' A' ' 251' ' ' ALA . 0.3 OUTLIER -83.84 105.57 14.84 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.856 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.501 ' C ' ' CG ' ' A' ' 193' ' ' GLU . . . 127.33 -108.8 1.0 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.256 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.557 ' C ' ' HB3' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -168.9 -74.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.559 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -99.35 153.31 19.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 179.466 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.639 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -28.22 108.95 0.02 OUTLIER Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.465 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 8.2 m 95.4 155.61 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.268 -0.466 . . . . 0.0 110.418 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.471 ' O ' ' C ' ' A' ' 198' ' ' ILE . 32.5 Cg_exo -59.79 58.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.998 2.466 . . . . 0.0 112.634 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.638 ' CG1' ' HB2' ' A' ' 201' ' ' LEU . 0.1 OUTLIER 30.16 92.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 122.031 0.92 . . . . 0.0 110.066 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.89 -33.69 59.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.534 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -57.73 -31.56 66.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.638 ' HB2' ' CG1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -69.52 -41.76 75.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.806 0.336 . . . . 0.0 110.672 -178.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.497 ' O ' ' HG ' ' A' ' 205' ' ' LEU . 13.6 mtm180 -57.19 -49.23 76.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.367 0.603 . . . . 0.0 110.257 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -71.78 -32.66 67.89 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.575 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 210' ' ' ALA . 1.5 m-20 -59.44 -41.68 90.19 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.554 ' CD2' ' O ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -60.73 -47.13 87.69 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -65.15 -19.06 65.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.674 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 208' ' ' SER . 16.2 t -90.8 -79.53 0.36 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.457 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 207' ' ' SER . 3.0 t 155.59 -11.68 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.87 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.586 ' O ' ' CE1' ' A' ' 122' ' ' TYR . 6.8 m-20 -88.97 40.07 0.96 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.212 0.529 . . . . 0.0 110.412 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 204' ' ' ASP . . . 161.96 99.75 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.78 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.601 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 6.0 t30 173.25 -55.42 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.215 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 1.5 Cg_endo -45.81 -55.24 3.75 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.272 1.981 . . . . 0.0 110.889 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.03 108.85 9.13 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.515 ' HB ' ' CG2' ' A' ' 240' ' ' VAL . 0.9 OUTLIER -117.5 124.71 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.628 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -113.18 127.3 56.14 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.551 -178.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.565 ' CD1' ' CG1' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -131.94 123.61 27.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.71 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . 0.554 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -122.71 107.27 11.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.8 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 244' ' ' LYS . . . 176.22 166.14 33.06 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.571 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.579 ' CB ' ' CD ' ' A' ' 220' ' ' PRO . 24.3 Cg_exo -55.45 -170.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.721 2.281 . . . . 0.0 112.594 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 219' ' ' PRO . 23.6 Cg_exo -64.72 -19.69 64.68 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 123.192 2.595 . . . . 0.0 113.002 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -83.09 -54.61 3.14 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.839 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' MET . . . . . 0.527 ' CE ' HG23 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -57.13 -34.39 68.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.124 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 242' ' ' PHE . 0.1 OUTLIER -76.66 -34.14 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.452 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 220' ' ' PRO . 12.3 m-20 -72.96 -47.0 49.25 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.851 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.538 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -61.43 -48.12 82.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.724 0.297 . . . . 0.0 111.74 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.467 ' O ' ' HG ' ' A' ' 229' ' ' LEU . . . -69.57 -34.87 74.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.566 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 223' ' ' ILE . 8.2 p -70.05 -31.93 69.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 110.263 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.99 -44.82 95.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.551 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 225' ' ' ALA . 0.0 OUTLIER -62.11 -39.62 93.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.093 0.473 . . . . 0.0 110.847 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.537 ' CG1' HG23 ' A' ' 235' ' ' ILE . 3.8 t -65.88 -45.68 90.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.456 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 23.5 mtt-85 -72.76 -30.25 63.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.782 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 33.3 m -69.08 -43.63 74.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.348 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 202' ' ' ARG . 1.0 OUTLIER -80.99 -74.35 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.967 0.413 . . . . 0.0 111.354 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 148.76 -18.64 1.26 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.865 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.537 HG23 ' CG1' ' A' ' 230' ' ' VAL . 0.0 OUTLIER -22.86 82.41 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.533 ' N ' ' O ' ' A' ' 234' ' ' GLY . 6.0 Cg_exo -75.82 113.05 3.64 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.156 2.571 . . . . 0.0 111.811 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -119.84 -174.54 15.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.827 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.2 -35.92 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.621 0.248 . . . . 0.0 111.277 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.59 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 5.7 mm-40 -101.81 32.52 3.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.493 . . . . 0.0 110.834 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.515 ' CG2' ' HB ' ' A' ' 214' ' ' ILE . 2.2 t -94.6 134.67 31.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.248 0.547 . . . . 0.0 110.451 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.652 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.24 149.36 33.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.947 -177.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.528 ' HB2' ' CD1' ' A' ' 223' ' ' ILE . 5.7 p90 -131.55 148.68 52.64 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.247 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . 0.505 ' N ' HD12 ' A' ' 223' ' ' ILE . 2.2 tt0 -132.8 148.81 52.32 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -106.61 111.43 23.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.328 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.574 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -136.97 147.64 46.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.773 HD21 H51A ' A' ' 252' ' ' FDA . 0.4 OUTLIER -20.34 146.09 0.01 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.588 ' HG2' HO3A ' A' ' 252' ' ' FDA . 71.9 Cg_exo -50.28 -155.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.69 2.927 . . . . 0.0 113.122 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 247' ' ' PRO . 5.6 m 92.72 -19.29 0.1 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.816 0.817 . . . . 0.0 110.428 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 190' ' ' TRP . . . -128.45 -24.14 1.16 Allowed Glycine 0 C--N 1.309 -0.921 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.569 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . . . -108.38 150.27 27.59 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 122.747 0.419 . . . . 0.0 110.52 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.51 ' HA ' ' HG3' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.229 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' FDA . . . . . 0.82 H52A ' O ' ' A' ' 81' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.509 ' HB2' ' HG3' ' A' ' 105' ' ' LYS . 83.8 p -110.36 150.88 28.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.863 0.364 . . . . 0.0 111.038 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.726 ' CE1' ' HB2' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -131.46 162.67 29.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.547 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.587 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 8.3 mt-10 -110.8 129.97 55.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.814 0.34 . . . . 0.0 111.03 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.854 ' HB1' ' CB ' ' A' ' 31' ' ' LEU . . . -127.77 135.15 49.73 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.976 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.55 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 14.9 tp10 -93.64 122.62 36.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.394 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.74 ' HA ' HD23 ' A' ' 31' ' ' LEU . 32.6 m -71.25 104.34 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.643 ' HA ' HG23 ' A' ' 98' ' ' VAL . 2.6 p -122.51 -34.47 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.433 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -87.5 -130.61 3.2 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.306 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.831 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER 87.87 71.63 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.436 0.636 . . . . 0.0 110.291 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.584 ' O ' HG23 ' A' ' 27' ' ' VAL . 20.2 p30 -108.91 146.54 33.61 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.818 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -88.54 114.3 25.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.44 HG12 ' OD1' ' A' ' 20' ' ' ASN . 1.7 m -95.04 -27.53 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.54 0.686 . . . . 0.0 109.692 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.547 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 11.7 m -138.51 172.13 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.297 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 t -51.64 -56.85 11.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.977 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.506 ' CA ' ' O ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -118.48 43.03 2.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.708 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.561 HG21 ' CB ' ' A' ' 128' ' ' THR . 0.2 OUTLIER -147.2 140.39 25.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.317 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.831 HG21 ' CD2' ' A' ' 19' ' ' LEU . 1.4 p -141.02 146.44 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.097 0.475 . . . . 0.0 112.236 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 6.4 tt0 -110.0 103.02 11.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.568 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.634 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -94.02 125.3 38.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.494 -178.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.562 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -112.61 116.29 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.074 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.854 ' CB ' ' HB1' ' A' ' 14' ' ' ALA . 2.2 mt -121.73 132.81 54.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 111.539 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 38.4 mt-30 -145.81 109.29 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.393 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.552 ' HB3' ' CA ' ' A' ' 14' ' ' ALA . 12.2 tptt -149.22 -0.32 0.5 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.473 ' HG3' ' HB2' ' A' ' 13' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.139 0.495 . . . . 0.0 112.077 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.361 0.6 . . . . 0.0 111.797 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 1.5 ttpm? -163.07 26.65 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.967 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.69 ' CD1' ' NE2' ' A' ' 139' ' ' GLN . 0.0 OUTLIER 76.55 96.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.584 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -108.75 165.79 12.03 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.437 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.59 59.12 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.713 2.275 . . . . 0.0 111.858 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.665 ' O ' HG12 ' A' ' 110' ' ' VAL . . . 58.48 61.68 7.12 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.66 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.488 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 1.3 mm100 -35.44 146.21 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.664 0.232 . . . . 0.0 110.493 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 1.05 ' CD2' HD21 ' A' ' 108' ' ' LEU . 2.6 t80 -152.69 139.34 18.8 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.667 0.27 . . . . 0.0 111.696 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.579 ' O ' ' CE1' ' A' ' 50' ' ' PHE . 3.8 mtt -139.94 -162.68 1.38 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.852 0.358 . . . . 0.0 111.922 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 3.4 t0 -134.96 123.3 23.14 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.008 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.56 157.71 43.32 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.024 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.858 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -108.72 149.6 28.77 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.094 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.881 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -34.49 -70.95 0.11 Allowed Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.249 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 1.063 ' HD2' HG23 ' A' ' 58' ' ' THR . 51.3 Cg_endo -103.98 14.45 0.24 Allowed 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 123.39 2.727 . . . . 0.0 111.941 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 98.52 0.34 58.01 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.663 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 1.063 HG23 ' HD2' ' A' ' 56' ' ' PRO . 13.0 p -40.69 -103.18 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.852 0.461 . . . . 0.0 111.596 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.858 ' N ' HG21 ' A' ' 54' ' ' THR . 1.3 m-20 160.23 36.16 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.009 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 60' ' ' VAL . 6.1 t -152.32 27.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.958 0.408 . . . . 0.0 110.888 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.65 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 36.8 t -97.46 -101.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.631 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 170.64 -176.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.102 0.477 . . . . 0.0 111.36 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.589 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 2.4 m -99.19 142.56 30.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.689 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.532 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 1.8 t80 -141.36 131.4 24.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 19.7 m -79.28 108.89 9.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.62 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.876 ' CB ' HD13 ' A' ' 76' ' ' LEU . 72.9 Cg_endo -91.61 165.11 3.45 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.921 2.414 . . . . 0.0 112.189 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.17 135.55 25.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.867 0.365 . . . . 0.0 111.647 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.679 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -105.35 -69.76 0.81 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.999 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 68' ' ' ASN . 1.4 mt 138.3 160.27 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.468 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.565 ' HD3' ' CG ' ' A' ' 45' ' ' PHE . 20.2 Cg_endo -60.93 87.75 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 121.973 1.782 . . . . 0.0 111.341 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -168.08 117.65 0.65 Allowed Pre-proline 0 N--CA 1.457 -0.102 0 CA-C-O 120.807 0.337 . . . . 0.0 110.891 -179.206 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.13 89.95 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.429 2.086 . . . . 0.0 111.861 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -158.09 -82.87 0.05 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.853 0.359 . . . . 0.0 110.094 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.11 96.41 0.28 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.788 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 37.4 mtm180 -151.87 106.33 3.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.463 0.173 . . . . 0.0 110.925 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.876 HD13 ' CB ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -97.79 130.92 44.7 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.852 0.358 . . . . 0.0 110.446 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.778 ' N ' HD12 ' A' ' 76' ' ' LEU . 3.1 mt-10 -129.16 117.88 21.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.319 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.634 ' CE2' ' HB3' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -109.99 146.94 34.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.144 0.497 . . . . 0.0 111.715 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.029 HD22 ' CG2' ' A' ' 128' ' ' THR . 7.5 mt -111.17 84.53 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.032 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.639 HG22 HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -91.79 129.53 42.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.873 -178.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.43 95.91 5.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.164 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.639 HG13 HG22 ' A' ' 80' ' ' ILE . 7.4 m -98.15 141.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.765 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.905 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -121.35 112.92 32.59 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.587 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.817 ' N ' HD22 ' A' ' 83' ' ' LEU . 82.5 Cg_exo -44.17 122.01 3.39 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.649 2.233 . . . . 0.0 112.181 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 84' ' ' PRO . 17.6 tp10 84.47 5.29 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.413 ' N ' HD13 ' A' ' 83' ' ' LEU . . . -74.08 -130.99 0.2 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.459 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -125.25 -26.03 3.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.602 0.239 . . . . 0.0 111.484 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 2.4 t80 -106.12 -31.26 8.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.544 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.55 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 1.0 OUTLIER -70.89 -34.17 71.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.685 0.279 . . . . 0.0 111.698 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 67.2 m-20 -74.91 -40.35 60.92 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.517 0.675 . . . . 0.0 109.752 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.617 ' O ' HD11 ' A' ' 55' ' ' ILE . 2.6 t80 -73.67 -24.48 59.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.508 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.941 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -68.08 -41.08 82.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.801 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -16.64 27.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.596 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 44.2 m-20 -101.22 -7.28 23.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.452 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.435 ' HB2' ' CD1' ' A' ' 91' ' ' TYR . 0.9 OUTLIER -151.56 13.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.941 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -139.79 26.24 2.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.97 0.415 . . . . 0.0 111.156 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.505 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -56.81 -171.98 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.01 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.643 HG23 ' HA ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -88.13 2.03 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.714 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.35 58.06 0.41 Allowed Glycine 0 C--N 1.321 -0.286 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.203 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.714 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -162.09 -178.85 6.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.027 0.442 . . . . 0.0 111.413 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.06 131.54 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.489 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.008 HD11 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.73 123.71 31.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.708 0.29 . . . . 0.0 110.781 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.609 ' N ' HD12 ' A' ' 102' ' ' LEU . 3.6 m -95.5 131.65 41.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.762 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.675 HG13 ' CE1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -99.82 134.61 38.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.509 ' HG3' ' HB2' ' A' ' 11' ' ' SER . 0.0 OUTLIER -130.15 113.78 14.91 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.37 -178.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 169.6 70.05 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.54 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.37 60.74 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.555 2.17 . . . . 0.0 110.308 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.05 HD21 ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -133.77 170.36 15.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.019 -177.857 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.513 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -117.01 173.54 14.75 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.094 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 48' ' ' GLY . 8.3 p -112.6 112.1 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.324 0.583 . . . . 0.0 110.548 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.5 120.89 39.7 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.569 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.12 -37.93 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.701 HD12 ' C ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -126.04 120.02 29.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.72 179.352 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.646 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 2.7 tptt -130.38 108.61 10.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.464 ' HB3' ' HE3' ' A' ' 140' ' ' MET . 0.0 OUTLIER -78.68 140.56 38.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.667 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -89.38 13.45 13.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.815 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.58 -76.05 0.28 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.504 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.83 89.81 2.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.855 0.36 . . . . 0.0 110.293 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.515 ' O ' ' NE ' ' A' ' 121' ' ' ARG . . . -168.57 144.27 2.94 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.21 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 25.9 Cg_endo -62.16 105.0 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.697 2.265 . . . . 0.0 111.944 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -117.37 143.84 45.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.249 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.64 ' CD2' ' HB2' ' A' ' 150' ' ' ARG . 14.6 m-85 -119.59 127.18 52.72 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.734 0.302 . . . . 0.0 111.131 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.943 ' CE2' HG13 ' A' ' 133' ' ' VAL . 1.3 t80 -117.48 106.73 13.48 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 1.02 HG12 HD23 ' A' ' 216' ' ' LEU . 4.5 p -98.73 110.96 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.371 0.605 . . . . 0.0 111.809 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -102.96 133.63 47.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.527 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.987 ' O ' HD21 ' A' ' 246' ' ' LEU . . . -105.62 103.17 2.1 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.497 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.836 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 118.22 -154.52 16.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.834 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.029 ' CG2' HD22 ' A' ' 79' ' ' LEU . 18.8 m -107.88 -11.89 15.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.805 0.336 . . . . 0.0 111.111 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.642 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -66.92 9.72 0.91 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.545 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.665 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -78.05 4.15 13.06 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.912 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -47.34 -44.54 52.32 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.098 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 5.9 Cg_exo -73.32 -30.73 9.99 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.836 2.357 . . . . 0.0 110.104 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.012 ' O ' HG23 ' A' ' 137' ' ' VAL . 17.7 t -65.79 -49.49 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.921 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.665 HG13 ' HG ' ' A' ' 130' ' ' LEU . 19.0 m -64.54 -33.28 62.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.541 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.5 -50.65 66.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.235 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -31.82 71.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.885 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.012 HG23 ' O ' ' A' ' 133' ' ' VAL . 74.7 t -59.85 -52.9 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 134' ' ' VAL . 0.8 OUTLIER -60.76 -31.38 70.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.622 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.69 ' NE2' ' CD1' ' A' ' 45' ' ' PHE . 34.3 mt-30 -63.0 -38.55 91.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.264 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.817 ' HE1' HG23 ' A' ' 149' ' ' THR . 2.5 ptm -67.91 -42.76 80.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.268 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.612 HE22 HD22 ' A' ' 170' ' ' LEU . 21.4 mt-30 -68.5 -42.83 78.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.116 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -12.37 60.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.788 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.459 ' HB2' ' O ' ' A' ' 139' ' ' GLN . 0.8 OUTLIER -80.54 -84.34 0.1 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.455 0.645 . . . . 0.0 111.164 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.498 ' C ' ' CD ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -156.6 23.66 0.34 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.678 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 140' ' ' MET . . . -112.66 49.69 0.38 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.356 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.505 ' HA ' ' HG2' ' A' ' 175' ' ' ARG . 52.6 Cg_endo -69.31 -3.6 12.03 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.579 2.186 . . . . 0.0 111.922 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -69.97 -159.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.256 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.546 ' CB ' ' HB2' ' A' ' 176' ' ' ASN . 1.0 OUTLIER -73.03 105.28 4.43 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.62 0.724 . . . . 0.0 111.515 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.817 HG23 ' HE1' ' A' ' 140' ' ' MET . 0.5 OUTLIER -110.04 115.21 29.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.237 178.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.64 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -106.34 138.56 42.29 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.745 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.909 HD12 ' N ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -133.52 134.95 56.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.026 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.909 ' N ' HD12 ' A' ' 151' ' ' ILE . 21.8 m-30 -109.51 123.24 49.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.071 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.446 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 7.2 t80 -119.87 131.01 55.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.775 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.769 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -158.49 158.6 29.43 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 119.492 -1.337 . . . . 0.0 113.775 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.866 HG11 ' CD2' ' A' ' 161' ' ' LEU . 11.8 m -164.15 -116.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.841 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.6 OUTLIER -119.91 -164.27 1.06 Allowed 'General case' 0 C--N 1.343 0.285 0 O-C-N 122.459 -0.151 . . . . 0.0 110.895 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.811 HG23 ' HA ' ' A' ' 187' ' ' SER . 65.3 p -25.95 -41.38 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.456 0.302 . . . . 0.0 111.515 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.604 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.8 OUTLIER 107.82 -43.27 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.617 0 O-C-N 123.967 0.792 . . . . 0.0 112.402 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 157' ' ' THR . 80.3 Cg_exo -46.2 -22.02 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.199 1.933 . . . . 0.0 112.335 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -98.4 -13.96 20.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.764 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.866 ' CD2' HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -110.58 -165.69 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.756 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.49 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 0.1 OUTLIER 178.26 -154.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.903 0.382 . . . . 0.0 111.349 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.522 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 77.13 16.12 1.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.097 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 1.033 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -70.27 -39.17 76.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.246 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 1.033 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.6 OUTLIER -73.68 -27.45 61.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.097 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.458 ' O ' ' OG ' ' A' ' 169' ' ' SER . 3.5 mm-40 -64.79 -49.61 70.02 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.605 HD11 ' HA ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -76.21 -31.13 58.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.584 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 165' ' ' ASP . 7.7 mttt -62.74 -36.67 83.77 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 166' ' ' GLU . 15.0 p -66.96 -32.95 74.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.808 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -63.01 -41.57 99.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.185 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.659 ' OE1' HD22 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -68.91 -36.45 78.04 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.913 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -76.21 -25.05 54.72 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.348 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 169' ' ' SER . 37.4 t -61.48 -71.06 0.16 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.707 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.02 ' O ' HD12 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -179.92 -153.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.133 0.492 . . . . 0.0 112.083 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER 42.59 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.577 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.546 ' HB2' ' CB ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -13.45 73.69 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 124.433 1.083 . . . . 0.0 111.736 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.02 HD12 ' O ' ' A' ' 174' ' ' MET . 0.3 OUTLIER -94.65 148.53 22.17 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.201 -178.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.522 ' OG1' ' CZ ' ' A' ' 150' ' ' ARG . 6.8 m -137.18 115.33 11.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.03 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.482 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 7.3 p -101.22 127.77 54.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.161 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.578 ' CB ' ' CD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -95.84 135.52 37.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.539 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -101.0 104.97 16.15 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.354 0.597 . . . . 0.0 110.899 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.624 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 34.5 m -88.67 -160.76 0.68 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.108 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.841 HG21 ' O ' ' A' ' 156' ' ' ASN . 40.6 t 56.23 146.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.765 0.793 . . . . 0.0 111.815 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.718 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.3 -63.4 0.76 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.751 -178.163 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.563 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 1.1 t60 -168.65 51.47 0.2 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.541 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.569 ' HG2' ' CA ' ' A' ' 156' ' ' ASN . 62.6 Cg_endo -88.01 -101.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.054 2.503 . . . . 0.0 112.793 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.811 ' HA ' HG23 ' A' ' 157' ' ' THR . 0.4 OUTLIER 153.23 -8.01 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.605 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 130.34 12.11 2.35 Favored Glycine 0 C--N 1.322 -0.214 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.728 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.54 63.39 1.55 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.518 ' N ' ' OG ' ' A' ' 248' ' ' SER . 7.5 t-105 -125.86 117.53 23.54 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.21 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.404 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 10.0 mm-40 -92.01 104.18 16.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 251' ' ' ALA . . . 142.06 -120.05 1.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.438 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -167.09 -85.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 0.0 OUTLIER -85.82 126.78 34.29 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.636 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -25.99 106.74 0.01 OUTLIER Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.085 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 2.2 m 146.25 166.01 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 114.961 -0.619 . . . . 0.0 110.896 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.465 ' HG2' ' OD2' ' A' ' 199' ' ' ASP . 83.5 Cg_endo -81.93 44.33 1.7 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.899 2.399 . . . . 0.0 112.566 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.025 HG13 ' HB1' ' A' ' 251' ' ' ALA . 0.1 OUTLIER 65.81 17.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.297 0.57 . . . . 0.0 110.754 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.465 ' OD2' ' HG2' ' A' ' 197' ' ' PRO . 1.0 OUTLIER -58.41 -36.77 74.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.442 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.88 -43.68 94.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.685 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.883 ' HB2' HD12 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -65.8 -31.38 72.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.927 0.394 . . . . 0.0 110.527 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.576 ' HG2' HD22 ' A' ' 229' ' ' LEU . 5.7 mtm180 -58.83 -42.13 88.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.5 0.666 . . . . 0.0 110.178 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.84 -32.71 65.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.088 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -58.79 -43.2 90.41 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.758 HD11 ' HB2' ' A' ' 229' ' ' LEU . 0.0 OUTLIER -60.79 -46.06 91.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.0 -24.22 66.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.352 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 208' ' ' SER . 16.4 t -92.11 -87.96 0.21 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.885 0.374 . . . . 0.0 111.18 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 1.9 p 163.28 103.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.645 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 1.2 m-20 156.69 57.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.52 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ALA . . . . . 0.934 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 147.4 105.37 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.397 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.6 ' O ' HG23 ' A' ' 240' ' ' VAL . 56.3 t30 177.27 -56.01 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.208 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 9.6 Cg_endo -52.82 -55.69 3.51 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.953 1.769 . . . . 0.0 110.667 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.47 109.45 9.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.979 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.994 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.9 OUTLIER -121.12 125.56 74.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.677 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -117.39 126.21 52.29 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.49 0.662 . . . . 0.0 110.163 -178.577 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 1.02 HD23 HG12 ' A' ' 124' ' ' VAL . 34.0 mt -122.73 118.78 28.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.042 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' CYS . . . . . 0.573 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -123.42 132.31 53.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.107 178.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 245' ' ' PHE . . . 136.32 -154.78 22.16 Favored Glycine 0 C--O 1.224 -0.475 0 C-N-CA 120.333 -0.936 . . . . 0.0 112.859 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.581 ' HG3' ' HA ' ' A' ' 248' ' ' SER . 11.8 Cg_endo -53.79 161.21 4.78 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.005 2.47 . . . . 0.0 112.648 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.564 ' O ' HG22 ' A' ' 223' ' ' ILE . 50.5 Cg_endo -69.28 -8.97 25.03 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.611 2.208 . . . . 0.0 111.572 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.48 -49.17 52.94 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.282 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.775 ' O ' ' HB3' ' A' ' 226' ' ' ALA . 0.0 OUTLIER -55.7 -25.71 41.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.3 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.574 HD11 ' C ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -76.59 -42.54 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.487 178.336 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -74.67 -47.57 31.04 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.561 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -76.41 -48.99 17.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.911 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -59.5 -37.79 79.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.76 0.314 . . . . 0.0 110.594 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 37.9 t -69.64 -31.22 69.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.946 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 232' ' ' SER . 4.8 mt-10 -70.95 -45.13 64.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.738 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.758 ' HB2' HD11 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -60.67 -37.38 81.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.178 0.513 . . . . 0.0 110.702 -179.608 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 1.048 HG13 HG23 ' A' ' 235' ' ' ILE . 12.5 t -65.24 -45.63 93.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.393 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.8 -30.16 61.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.035 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 228' ' ' GLU . 0.6 OUTLIER -75.37 -44.16 46.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.391 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.54 ' HD3' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -79.65 -70.57 0.5 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.008 0.432 . . . . 0.0 111.11 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 154.9 -31.42 0.67 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.8 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 1.048 HG23 HG13 ' A' ' 230' ' ' VAL . 0.0 OUTLIER -26.33 84.59 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 123.064 0.545 . . . . 0.0 112.423 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.539 ' N ' ' O ' ' A' ' 234' ' ' GLY . 5.8 Cg_exo -76.37 114.35 3.87 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 123.427 2.751 . . . . 0.0 112.232 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -106.22 161.08 14.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.931 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -117.51 -45.96 2.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.736 0.303 . . . . 0.0 110.91 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 19.3 mm-40 -105.87 40.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.354 0.597 . . . . 0.0 110.281 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.994 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.3 t -92.04 134.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.928 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.36 145.67 30.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.248 -178.596 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 1.004 ' CD1' HD12 ' A' ' 216' ' ' LEU . 1.5 m-85 -131.64 144.24 50.89 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.721 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLU . . . . . 0.521 ' O ' ' CE ' ' A' ' 222' ' ' MET . 21.2 tt0 -132.72 148.72 52.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -111.19 106.48 15.51 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.871 ' CE1' HD23 ' A' ' 246' ' ' LEU . 0.0 OUTLIER -137.0 145.28 43.93 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.557 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.987 HD21 ' O ' ' A' ' 126' ' ' GLY . 0.2 OUTLIER 51.59 171.52 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 247' ' ' PRO . . . . . 0.564 ' CD ' ' HB2' ' A' ' 246' ' ' LEU . 32.2 Cg_exo -60.36 -138.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.914 3.076 . . . . 0.0 113.054 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.581 ' HA ' ' HG3' ' A' ' 219' ' ' PRO . 1.0 OUTLIER -72.75 161.15 31.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.808 0.337 . . . . 0.0 111.847 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.484 ' C ' ' HA3' ' A' ' 126' ' ' GLY . . . 143.41 -20.75 2.24 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.609 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.55 ' O ' ' OXT' ' A' ' 251' ' ' ALA . . . -105.78 153.43 21.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.903 0.383 . . . . 0.0 111.785 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 1.025 ' HB1' HG13 ' A' ' 198' ' ' ILE . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.037 -0.982 . . . . 0.0 112.614 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 105' ' ' LYS . . . . . . . . 0 N--CA 1.449 -0.454 0 CA-C-O 121.062 0.257 . . . . 0.0 112.6 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 105' ' ' LYS . 3.6 p -112.61 150.99 30.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.583 -0.308 . . . . 0.0 110.711 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.898 ' CE1' ' HB2' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -132.41 165.63 23.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.034 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.582 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 3.3 mt-10 -113.53 129.89 56.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.989 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.979 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -125.86 150.68 47.69 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 1.9 pt-20 -102.11 112.19 24.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.825 0.345 . . . . 0.0 110.303 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 100' ' ' GLN . 11.4 t -71.36 105.67 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.012 0.434 . . . . 0.0 110.715 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 17' ' ' VAL . 7.7 p -120.21 19.53 6.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.98 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -132.8 -124.75 2.57 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.558 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.719 HD12 ' C ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 74.71 95.31 0.07 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.861 0.839 . . . . 0.0 109.586 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.427 ' O ' HG23 ' A' ' 27' ' ' VAL . 19.3 p30 -142.33 139.35 31.76 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.808 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.564 ' CZ2' ' HG3' ' A' ' 93' ' ' ARG . 22.3 m0 -89.47 113.31 24.65 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 m -86.6 -33.25 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-O 121.928 0.871 . . . . 0.0 109.265 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 160' ' ' GLU . 0.4 OUTLIER -129.85 -174.19 3.24 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.411 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.462 ' HB3' ' HG3' ' A' ' 160' ' ' GLU . 9.8 t -60.06 -40.66 90.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.433 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 8.9 m-80 -133.66 40.84 3.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.197 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.712 HG23 HG21 ' A' ' 128' ' ' THR . 17.7 m -133.92 123.42 24.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.674 ' CG2' HD13 ' A' ' 19' ' ' LEU . 6.6 p -136.72 132.63 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 111.747 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 3.1 tt0 -119.98 134.58 55.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.577 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.741 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -130.68 142.61 50.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.406 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.73 HD13 ' C ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -113.04 116.93 30.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.591 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.979 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 38.8 mt -101.57 142.93 32.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 1.3 mt-30 -146.79 134.18 20.75 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.635 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . 2.7 tmtp? -178.14 -70.67 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.465 ' HG2' ' HD3' ' A' ' 33' ' ' LYS . 8.2 mtp180 . . . . . 0 C--N 1.322 -0.616 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.951 HG22 ' CA ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.257 0.551 . . . . 0.0 110.311 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' O ' ' CA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -146.69 -142.2 0.12 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.962 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.01 81.24 2.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.165 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.5 mp0 -113.21 165.31 13.52 Favored Pre-proline 0 C--N 1.332 -0.194 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.522 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 14.6 Cg_endo -57.57 72.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.422 2.082 . . . . 0.0 111.484 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 41.96 73.94 0.19 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.324 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -28.28 145.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.512 0.196 . . . . 0.0 110.979 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 1.034 ' CD2' HD21 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -143.7 142.27 30.89 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.722 0.296 . . . . 0.0 111.724 -178.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.581 ' O ' ' CE1' ' A' ' 50' ' ' PHE . 3.7 mtt -141.38 -155.59 0.6 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 105' ' ' LYS . 19.9 t70 -136.5 119.11 15.98 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.041 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.81 157.21 42.66 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.93 HG23 ' C ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -95.7 154.48 17.2 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.875 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.993 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -31.49 -66.08 0.19 Allowed Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 123.309 0.381 . . . . 0.0 110.701 -179.092 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.993 ' HD3' HG23 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -112.36 8.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.834 3.022 . . . . 0.0 111.704 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 101.08 -6.26 56.42 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.64 -177.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.955 HG23 ' CG ' ' A' ' 56' ' ' PRO . 69.0 p -23.02 -87.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.269 0.628 . . . . 0.0 111.703 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.634 ' O ' HG12 ' A' ' 60' ' ' VAL . 4.8 m-20 -151.64 42.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.105 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.93 ' C ' HG23 ' A' ' 54' ' ' THR . 0.4 OUTLIER 80.96 125.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.874 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.851 ' N ' HG23 ' A' ' 54' ' ' THR . 27.0 t -111.23 -57.73 2.2 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.692 0.758 . . . . 0.0 110.005 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -179.9 -177.92 0.41 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.175 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -88.62 129.65 35.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.144 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.489 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 2.1 t80 -140.65 125.76 18.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.949 0.404 . . . . 0.0 110.778 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 32.0 t -75.33 106.27 2.75 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.674 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.87 ' HB2' HD22 ' A' ' 76' ' ' LEU . 11.1 Cg_endo -91.24 154.33 3.75 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.439 2.759 . . . . 0.0 111.1 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 132' ' ' PRO . . . -144.38 128.91 18.05 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 69' ' ' LEU . 12.0 t-20 -108.94 -67.79 0.96 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.554 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER 142.28 151.11 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 O-C-N 123.825 0.703 . . . . 0.0 109.977 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.567 ' CD ' ' HG ' ' A' ' 69' ' ' LEU . 12.0 Cg_endo -55.56 108.0 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 121.732 1.621 . . . . 0.0 109.962 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.92 ' O ' HG23 ' A' ' 43' ' ' VAL . 6.8 p30 178.0 -168.19 0.04 OUTLIER Pre-proline 0 C--O 1.217 -0.657 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.831 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.621 ' CD ' ' HB2' ' A' ' 71' ' ' ASN . 53.2 Cg_exo -53.19 -21.86 18.12 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.842 1.695 . . . . 0.0 113.295 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.951 ' CA ' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER 79.81 70.02 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 177.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -141.61 28.1 2.32 Favored Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.143 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 59.8 mtm-85 -152.86 93.59 1.77 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.073 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.87 HD22 ' HB2' ' A' ' 66' ' ' PRO . 8.5 mt -91.08 143.18 26.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -127.47 111.21 13.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.0 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.741 ' CD2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -108.7 142.35 39.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.776 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.019 HD12 ' HB2' ' A' ' 131' ' ' ALA . 9.2 mt -126.36 80.6 1.94 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.143 0.497 . . . . 0.0 109.768 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.622 ' HB ' ' CE2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -92.56 122.07 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.171 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.59 ' NH1' HD11 ' A' ' 161' ' ' LEU . 0.4 OUTLIER -79.55 95.77 5.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.438 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.551 HG13 HG12 ' A' ' 27' ' ' VAL . 2.4 m -90.59 141.22 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.983 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.494 HD12 ' H ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -87.25 167.51 21.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.591 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 83' ' ' LEU . 30.4 Cg_endo -63.8 77.7 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.593 2.195 . . . . 0.0 112.251 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.42 61.47 3.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.465 ' CA ' HD13 ' A' ' 83' ' ' LEU . . . -109.88 -39.71 1.53 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.731 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.81 -63.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 111.383 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.531 ' CE1' HG21 ' A' ' 80' ' ' ILE . 6.1 t80 -71.74 -39.76 69.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.004 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -69.04 -24.02 64.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.923 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 2.3 m-20 -76.11 -37.77 57.69 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.812 0.815 . . . . 0.0 109.214 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.621 ' CE1' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -73.19 -28.8 62.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.304 -1.317 . . . . 0.0 110.777 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.695 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -68.41 -43.24 77.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.302 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.564 ' HG3' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -90.58 -23.75 20.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.753 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 20.2 m120 -87.26 -15.25 38.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.576 0.227 . . . . 0.0 111.325 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.451 ' CG ' ' HG3' ' A' ' 56' ' ' PRO . 1.5 t70 -127.92 -23.68 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -118.13 36.87 4.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.954 0.407 . . . . 0.0 111.078 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -70.58 -41.21 72.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.545 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.744 ' O ' HG12 ' A' ' 98' ' ' VAL . 2.2 t -121.8 90.45 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.203 0.525 . . . . 0.0 111.834 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.516 ' CA ' ' O ' ' A' ' 16' ' ' VAL . . . 8.77 56.7 0.01 OUTLIER Glycine 0 N--CA 1.459 0.181 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.153 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.62 ' O ' HG23 ' A' ' 16' ' ' VAL . 4.6 mt-30 -68.92 -179.27 1.42 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.715 0.293 . . . . 0.0 110.852 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.0 p -92.94 133.42 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.824 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.041 HD11 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.74 120.81 25.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.798 0.332 . . . . 0.0 110.453 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.552 ' N ' HD12 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -89.66 136.5 33.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.182 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.784 HG13 ' CE1' ' A' ' 12' ' ' PHE . 1.4 m -111.11 127.55 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -129.75 117.53 20.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.497 -178.508 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.53 ' CA ' ' HB3' ' A' ' 51' ' ' MET . . . 164.64 71.44 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.751 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.41 58.93 1.03 Allowed 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.159 1.906 . . . . 0.0 110.228 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.034 HD21 ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -129.36 169.87 14.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.031 -178.128 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.548 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -116.17 173.25 14.62 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.49 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 47' ' ' PRO . 2.5 p -121.25 111.75 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.325 0.583 . . . . 0.0 110.587 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -81.14 114.25 19.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.406 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 241' ' ' PHE . . . -179.0 -48.18 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.675 HD22 HG22 ' A' ' 133' ' ' VAL . 1.1 pp -124.4 118.06 25.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.212 0.53 . . . . 0.0 110.867 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.627 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -139.46 114.13 9.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.04 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.446 ' OE1' ' HE3' ' A' ' 140' ' ' MET . 2.0 tp10 -89.59 138.25 31.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.47 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -91.34 13.66 16.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.025 0.44 . . . . 0.0 110.839 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.46 -73.8 0.43 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.461 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.54 ' HA ' ' CB ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -129.83 89.56 2.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.846 0.355 . . . . 0.0 110.409 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 121' ' ' ARG . . . -164.09 155.85 14.31 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.406 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 10.2 Cg_exo -71.36 107.65 2.19 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.077 2.518 . . . . 0.0 111.747 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.505 ' NH1' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -136.82 138.1 40.45 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.226 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.669 ' CE2' ' CD ' ' A' ' 150' ' ' ARG . 1.9 m-85 -107.62 127.29 53.52 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.141 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.588 ' CD2' ' HB2' ' A' ' 113' ' ' LEU . 1.1 m-85 -106.73 104.34 14.0 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 1.039 HG13 ' CB ' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -99.1 111.18 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.344 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -110.14 133.73 52.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.285 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -109.63 102.63 1.62 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.674 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.926 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 122.58 -152.79 16.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.992 -1.099 . . . . 0.0 112.349 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.862 ' CG2' HD22 ' A' ' 79' ' ' LEU . 2.9 m -111.55 -16.32 13.3 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.247 0.546 . . . . 0.0 110.51 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.618 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -65.58 11.21 0.4 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.857 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.686 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -74.99 4.34 6.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.52 0.328 . . . . 0.0 110.191 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 1.019 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -45.32 -41.93 17.29 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.29 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 7.3 Cg_exo -72.36 -31.08 11.94 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.39 2.06 . . . . 0.0 109.936 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.675 HG22 HD22 ' A' ' 113' ' ' LEU . 5.9 t -66.85 -44.31 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.41 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.686 HG13 ' HG ' ' A' ' 130' ' ' LEU . 10.5 m -70.59 -30.4 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.893 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -64.37 -51.31 63.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.3 tpt -64.19 -45.45 88.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.169 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.487 HG12 ' OE1' ' A' ' 141' ' ' GLN . 42.6 t -61.82 -30.52 48.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.227 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER -62.1 -38.0 87.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.336 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -42.18 98.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.395 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.623 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 4.7 tpp -68.66 -34.77 76.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.503 0.668 . . . . 0.0 110.732 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.766 ' OE1' HD22 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -77.77 -30.74 51.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.519 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -70.47 -44.5 67.63 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.764 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -79.04 -21.14 47.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.432 0.634 . . . . 0.0 109.828 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 141' ' ' GLN . 1.1 p 54.17 26.64 6.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.917 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.764 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -37.27 161.11 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.775 0.322 . . . . 0.0 110.586 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' ' 145' ' ' ALA . 57.7 Cg_endo -72.44 5.36 2.83 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 122.662 2.241 . . . . 0.0 112.9 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.631 ' OD1' ' HB3' ' A' ' 145' ' ' ALA . 19.0 p-10 -86.2 136.8 33.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 111.85 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 0.9 OUTLIER -73.62 113.69 11.03 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.753 0.787 . . . . 0.0 111.012 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 53.8 m -107.96 115.09 29.5 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.539 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.669 ' CD ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -103.4 140.91 36.83 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.266 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.941 HD12 ' N ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -134.54 133.96 54.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.162 0.506 . . . . 0.0 110.816 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 1.039 ' CB ' HG13 ' A' ' 124' ' ' VAL . 19.1 m-30 -114.05 110.66 20.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.497 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 154' ' ' GLY . 1.0 OUTLIER -116.45 133.42 56.04 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 122.091 -0.38 . . . . 0.0 111.064 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.866 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -158.73 158.79 29.68 Favored Glycine 0 CA--C 1.502 -0.748 0 C-N-CA 119.366 -1.397 . . . . 0.0 113.649 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 1.118 HG21 HD22 ' A' ' 161' ' ' LEU . 2.5 m -168.76 -108.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.874 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.4 OUTLIER -122.19 -169.71 1.94 Allowed 'General case' 0 C--N 1.344 0.331 0 CA-C-O 120.773 0.32 . . . . 0.0 111.517 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.765 HG23 ' N ' ' A' ' 187' ' ' SER . 76.9 p -29.51 -63.38 0.12 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.488 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.56 ' CB ' ' O ' ' A' ' 157' ' ' THR . 4.4 mm-40 153.32 -53.54 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.194 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 79.0 Cg_exo -37.65 -27.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.955 2.437 . . . . 0.0 112.732 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -86.41 -30.56 22.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.897 0.379 . . . . 0.0 110.976 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.118 HD22 HG21 ' A' ' 155' ' ' VAL . 1.0 OUTLIER -108.86 -174.66 2.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.268 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.53 ' O ' ' CB ' ' A' ' 163' ' ' TYR . 0.3 OUTLIER -171.05 -167.12 0.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.302 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.53 ' CB ' ' O ' ' A' ' 162' ' ' PHE . 0.2 OUTLIER 85.57 13.17 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.823 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.492 ' HA ' HD13 ' A' ' 164' ' ' ILE . 0.1 OUTLIER -65.45 -49.59 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.293 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.48 ' N ' HG22 ' A' ' 164' ' ' ILE . 0.7 OUTLIER -69.27 -33.37 73.12 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.271 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.438 ' CD ' ' CE1' ' A' ' 163' ' ' TYR . 1.6 mt-10 -72.42 -36.14 68.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.582 ' CD2' HG21 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -60.89 -32.07 71.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.05 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 171' ' ' GLU . 4.5 mtpt -63.14 -49.04 75.92 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 6.8 m -61.83 -31.54 71.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.766 HD22 ' OE1' ' A' ' 141' ' ' GLN . 0.8 OUTLIER -62.86 -34.6 77.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.783 ' HA ' HD11 ' A' ' 177' ' ' LEU . 40.6 mt-10 -63.86 -42.08 97.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.28 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 -78.21 -33.62 49.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.603 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.27 -46.29 55.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.639 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.065 ' HB2' HD23 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -77.15 -163.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.176 0.512 . . . . 0.0 111.602 -179.334 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER -105.08 -62.38 1.35 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.351 -179.579 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -130.28 64.02 1.54 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.795 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.065 HD23 ' HB2' ' A' ' 174' ' ' MET . 0.7 OUTLIER -105.1 154.25 20.41 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.032 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.488 ' N ' HD12 ' A' ' 177' ' ' LEU . 9.1 m -136.72 117.37 13.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.578 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.623 HG11 ' OE2' ' A' ' 171' ' ' GLU . 7.6 p -95.43 135.33 29.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.671 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.553 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 1.9 tppt? -97.95 135.95 38.94 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.852 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 194' ' ' GLN . . . -102.11 105.34 16.04 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 121.517 0.675 . . . . 0.0 111.751 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.631 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 34.7 m -87.35 -159.15 0.49 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.645 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.874 HG21 ' O ' ' A' ' 156' ' ' ASN . 28.4 t 55.93 148.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.64 0.733 . . . . 0.0 111.77 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.723 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -136.37 -62.55 0.66 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.197 -178.024 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.597 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 3.7 t60 -166.86 51.43 0.22 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.724 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.625 ' HG2' ' HA ' ' A' ' 156' ' ' ASN . 98.5 Cg_endo -88.97 -98.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.044 2.496 . . . . 0.0 112.704 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.765 ' N ' HG23 ' A' ' 157' ' ' THR . 13.6 t 143.11 2.28 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.603 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 123.73 12.29 4.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.453 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.27 62.72 1.58 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 249' ' ' GLY . 8.3 t-105 -130.83 120.6 23.93 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.249 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 250' ' ' ALA . 0.0 OUTLIER -98.96 104.45 16.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.341 178.187 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.585 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 145.18 -117.75 1.04 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.506 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 183' ' ' VAL . 18.7 mt-10 -165.04 -98.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -87.41 126.85 35.13 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . 2.46 108.92 0.0 OUTLIER Glycine 0 C--N 1.339 0.7 0 O-C-N 124.061 0.851 . . . . 0.0 113.726 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 5.9 m 96.83 156.21 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.286 0 CA-C-O 121.06 0.457 . . . . 0.0 111.086 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 196' ' ' SER . 58.0 Cg_exo -35.75 -69.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.349 2.699 . . . . 0.0 113.638 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.719 ' O ' HG23 ' A' ' 198' ' ' ILE . 0.1 OUTLIER 173.36 35.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 122.093 0.949 . . . . 0.0 110.636 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.516 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 0.9 OUTLIER -57.61 -37.19 72.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.859 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.81 -32.81 70.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.316 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.706 ' HB2' HD13 ' A' ' 198' ' ' ILE . 0.3 OUTLIER -69.54 -32.13 70.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 110.489 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.729 ' HG2' HD22 ' A' ' 229' ' ' LEU . 2.8 mtt180 -59.86 -52.25 66.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.533 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.11 -40.93 86.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.566 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 207' ' ' SER . 11.3 m-20 -60.18 -28.49 67.99 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.788 ' HG ' HD11 ' A' ' 235' ' ' ILE . 0.1 OUTLIER -61.79 -47.99 82.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.25 178.654 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -14.38 59.69 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.016 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.449 ' HB2' ' HA ' ' A' ' 204' ' ' ASP . 3.8 m -91.98 -76.59 0.45 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.803 0.335 . . . . 0.0 111.497 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.548 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 17.3 p 168.97 102.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.677 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.63 ' O ' ' HB3' ' A' ' 210' ' ' ALA . 5.0 m-20 153.32 86.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.696 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ALA . . . . . 0.766 ' CB ' HD11 ' A' ' 214' ' ' ILE . . . 101.6 109.79 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.579 ' HB2' HD13 ' A' ' 235' ' ' ILE . 11.7 t30 -175.26 -58.51 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.437 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 11.7 Cg_endo -57.23 -83.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.043 1.829 . . . . 0.0 110.676 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.89 ' HA ' HG21 ' A' ' 240' ' ' VAL . 0.0 OUTLIER -114.38 111.59 21.7 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.766 HD11 ' CB ' ' A' ' 210' ' ' ALA . 0.8 OUTLIER -109.5 126.48 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.689 ' CE1' ' CD2' ' A' ' 241' ' ' PHE . 2.7 m-85 -116.72 134.2 55.1 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.77 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.803 HD23 ' HB ' ' A' ' 124' ' ' VAL . 1.5 mt -134.45 115.58 14.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.791 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' CYS . . . . . 0.53 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 42.3 t -123.48 107.54 11.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.851 0.357 . . . . 0.0 110.476 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.613 ' CA ' ' CD2' ' A' ' 245' ' ' PHE . . . 114.14 -36.92 3.77 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.769 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 218' ' ' GLY . 45.0 Cg_endo -92.82 79.99 0.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.812 2.341 . . . . 0.0 113.956 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.783 ' HD2' ' HB2' ' A' ' 250' ' ' ALA . 9.2 Cg_endo -51.59 -66.8 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.452 2.101 . . . . 0.0 111.074 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.844 ' N ' ' HB1' ' A' ' 250' ' ' ALA . . . -54.09 -48.77 61.91 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.012 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.571 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -55.22 -24.73 28.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.729 HD11 ' H ' ' A' ' 243' ' ' GLU . 0.1 OUTLIER -74.56 -37.07 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.111 177.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 221' ' ' GLY . 7.2 m-20 -71.85 -46.43 58.0 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.813 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.528 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -67.59 -33.14 74.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -60.13 -39.43 86.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.361 0.6 . . . . 0.0 110.055 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.436 ' HB2' ' OE1' ' A' ' 239' ' ' GLN . 31.5 t -70.49 -31.8 69.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.784 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -44.02 92.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.638 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.729 HD22 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -59.74 -37.59 79.38 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.077 0.465 . . . . 0.0 110.636 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.782 HG22 ' CG ' ' A' ' 238' ' ' GLU . 3.0 t -62.46 -46.45 96.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.424 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -74.56 -30.28 61.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.783 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 51.5 m -74.11 -42.05 60.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.303 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.499 ' HD3' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -85.11 -74.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.236 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 158.75 -56.58 0.35 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.07 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.847 ' O ' HD12 ' A' ' 235' ' ' ILE . 2.2 pp -39.36 98.69 0.18 Allowed Pre-proline 0 N--CA 1.453 -0.288 0 CA-C-O 121.255 0.55 . . . . 0.0 111.221 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 57.7 Cg_endo -70.33 164.43 35.12 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 123.404 2.736 . . . . 0.0 112.646 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 211' ' ' ASN . . . 76.3 9.42 85.75 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.642 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.782 ' CG ' HG22 ' A' ' 230' ' ' VAL . 8.7 tp10 -71.53 1.02 7.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.68 0.276 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.535 ' O ' ' O ' ' A' ' 214' ' ' ILE . 39.3 mt-30 -101.95 -76.98 0.56 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.369 0.604 . . . . 0.0 109.874 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.89 HG21 ' HA ' ' A' ' 213' ' ' ASP . 4.0 t 65.06 -83.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.46 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.788 ' CG ' HG12 ' A' ' 240' ' ' VAL . 9.5 m-85 -115.64 127.82 55.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.894 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.411 ' HB3' HG12 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -132.57 132.84 42.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.438 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLU . . . . . 0.729 ' H ' HD11 ' A' ' 223' ' ' ILE . 11.0 tp10 -132.56 149.04 52.38 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.281 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 220' ' ' PRO . 0.9 OUTLIER -127.74 106.23 8.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.618 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -138.58 146.11 41.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.342 179.134 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.566 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 5.7 mt 64.71 167.63 0.11 Allowed Pre-proline 0 N--CA 1.471 0.588 0 O-C-N 121.886 -0.509 . . . . 0.0 111.925 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' PRO . . . . . 0.476 ' CD ' HD22 ' A' ' 246' ' ' LEU . 38.6 Cg_endo -88.6 -107.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.764 2.976 . . . . 0.0 112.422 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 247' ' ' PRO . 30.7 m -36.4 136.49 0.33 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 110.959 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 190' ' ' TRP . . . 125.84 -15.87 6.97 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.844 ' HB1' ' N ' ' A' ' 221' ' ' GLY . . . -106.38 119.36 39.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.81 -0.695 . . . . 0.0 111.364 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.585 ' N ' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 CA-C-O 121.077 0.265 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -118.91 152.82 35.62 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.818 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.976 ' CE1' ' HB2' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -132.45 165.19 24.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.93 0.395 . . . . 0.0 110.947 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.582 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -104.84 123.99 48.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.635 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.976 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . . . -121.44 154.2 36.87 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.536 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -118.99 116.56 26.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.323 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.569 HG12 ' CD2' ' A' ' 31' ' ' LEU . 17.3 m -71.16 125.66 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.454 . . . . 0.0 111.194 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.538 ' HA ' ' CG1' ' A' ' 98' ' ' VAL . 8.7 p -144.56 16.31 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.367 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -140.97 -135.38 3.17 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.691 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.004 HD11 HD22 ' A' ' 92' ' ' LEU . 0.2 OUTLIER 92.17 70.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.196 0.522 . . . . 0.0 110.494 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.555 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -111.8 147.88 34.75 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.677 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -89.31 114.37 25.75 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 m -89.37 -29.19 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.523 0.677 . . . . 0.0 109.718 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.532 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 20.9 m -137.11 177.18 8.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.435 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.444 ' OG ' ' OD1' ' A' ' 25' ' ' ASN . 2.9 t -51.88 -58.37 6.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.894 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 2.5 m-20 -117.55 44.85 2.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.441 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.928 HG23 ' HG2' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -146.06 137.29 24.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.602 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.811 HG21 ' CD2' ' A' ' 19' ' ' LEU . 1.5 p -140.34 143.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.595 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -115.42 103.14 10.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.213 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.62 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.6 OUTLIER -91.4 121.24 32.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.676 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.604 HD13 ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -102.37 116.02 31.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.375 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.677 HD22 HD23 ' A' ' 102' ' ' LEU . 6.9 mt -111.9 133.78 53.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 46.8 mt-30 -142.79 129.49 20.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.589 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.591 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -152.38 -97.48 0.05 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.163 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.46 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 2.8 mmp_? . . . . . 0 C--N 1.329 -0.31 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 120.807 0.337 . . . . 0.0 111.279 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.678 ' N ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -166.69 22.57 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.006 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.888 ' CB ' HD12 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -103.94 -169.38 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.265 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.521 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 20.5 mm-40 -107.55 130.28 23.05 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.905 0.383 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.965 ' HA ' HD23 ' A' ' 69' ' ' LEU . 99.8 Cg_exo -41.75 -23.01 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.618 2.212 . . . . 0.0 112.219 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . -51.83 -34.35 37.12 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.961 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.44 158.91 32.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.904 0.383 . . . . 0.0 110.909 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 1.043 ' HB2' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -125.79 164.06 21.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.445 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.537 ' CA ' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -114.84 143.33 45.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.978 0.418 . . . . 0.0 111.902 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.545 ' HA ' ' CB ' ' A' ' 63' ' ' SER . 14.1 t70 -98.95 107.8 20.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.031 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -148.96 157.08 43.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.361 -178.021 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.937 HG22 ' HB2' ' A' ' 61' ' ' SER . 0.2 OUTLIER -93.42 151.52 19.69 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.96 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -32.72 -66.06 0.21 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.519 -178.445 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.96 ' HD3' HG23 ' A' ' 55' ' ' ILE . 7.5 Cg_endo -106.32 4.19 0.2 Allowed 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 123.424 2.75 . . . . 0.0 111.486 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 106.95 -3.02 35.61 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.261 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.799 HG23 ' CD ' ' A' ' 56' ' ' PRO . 31.4 p -24.52 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.178 0.513 . . . . 0.0 111.744 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.85 ' H ' HG21 ' A' ' 54' ' ' THR . 19.8 p-10 -178.06 -28.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.77 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.703 ' O ' HG13 ' A' ' 60' ' ' VAL . 6.2 p -147.58 109.28 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.682 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.937 ' HB2' HG22 ' A' ' 54' ' ' THR . 0.3 OUTLIER -143.15 -76.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.793 179.288 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER 170.49 155.22 0.06 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.47 . . . . 0.0 111.901 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.712 ' CB ' HD21 ' A' ' 108' ' ' LEU . 46.6 p -89.54 131.82 35.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.382 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.547 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -120.78 119.62 33.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.404 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.538 ' CA ' ' HB3' ' A' ' 50' ' ' PHE . 60.7 p -60.41 102.68 0.32 Allowed Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HB2' HD13 ' A' ' 76' ' ' LEU . 92.6 Cg_endo -102.9 -178.42 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.276 2.651 . . . . 0.0 113.563 -178.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.651 ' O ' ' ND2' ' A' ' 68' ' ' ASN . . . -87.21 167.37 14.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.984 ' O ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER 89.63 117.55 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -177.197 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.984 HD22 ' O ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -167.47 -65.59 0.01 OUTLIER Pre-proline 0 C--O 1.215 -0.734 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.543 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 66.4 Cg_endo -99.07 75.26 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.379 2.053 . . . . 0.0 113.244 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.622 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.5 OUTLIER 178.9 125.33 0.21 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.718 0.294 . . . . 0.0 110.48 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.26 56.98 0.23 Allowed 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.313 2.009 . . . . 0.0 111.675 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 71' ' ' ASN . 2.4 mt-10 -135.93 -81.44 0.4 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.017 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.77 15.25 2.66 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.854 -1.165 . . . . 0.0 114.255 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.488 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -61.96 85.25 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.284 0.542 . . . . 0.0 110.257 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.814 HD12 ' C ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -96.18 128.76 43.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.599 0.714 . . . . 0.0 111.197 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.708 ' N ' HD12 ' A' ' 76' ' ' LEU . 7.7 mt-10 -132.72 141.4 48.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.625 -1.171 . . . . 0.0 111.251 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.62 ' CE2' ' HB3' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -133.4 133.09 41.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.222 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.903 HD12 ' HB2' ' A' ' 131' ' ' ALA . 9.1 mt -106.78 85.6 2.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.189 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.608 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -90.48 116.57 32.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.945 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.928 ' HG2' HG23 ' A' ' 26' ' ' THR . 0.1 OUTLIER -78.12 96.07 5.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.408 0.623 . . . . 0.0 110.19 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.615 HG13 HG12 ' A' ' 27' ' ' VAL . 2.5 m -89.07 141.47 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.84 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.84 HD21 ' HB2' ' A' ' 87' ' ' ARG . 3.9 pp -74.46 169.73 18.25 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.845 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 83' ' ' LEU . 34.5 Cg_exo -61.22 63.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.804 2.336 . . . . 0.0 112.192 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER 51.15 107.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.52 ' CA ' HD11 ' A' ' 83' ' ' LEU . . . -178.55 -35.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.573 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.84 ' HB2' HD21 ' A' ' 83' ' ' LEU . 2.1 mpt_? -133.26 -81.58 0.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.752 0.311 . . . . 0.0 111.175 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -74.03 -45.17 51.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.203 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.536 ' HB3' ' CG2' ' A' ' 82' ' ' VAL . 3.3 p -67.94 -23.33 65.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.513 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -75.66 -46.07 33.5 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.486 0.66 . . . . 0.0 109.493 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.408 ' HB3' HD13 ' A' ' 55' ' ' ILE . 7.8 t80 -73.35 -23.28 60.2 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.52 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.004 HD22 HD11 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -65.75 -49.37 68.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.275 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.89 -19.0 21.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.662 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 1.5 m-20 -94.38 -2.37 52.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.399 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.69 30.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.651 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.839 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . . . -151.03 25.95 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -170.02 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.87 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.538 ' CG1' ' HA ' ' A' ' 17' ' ' VAL . 1.5 t -97.9 -137.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.551 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 98' ' ' VAL . . . 31.7 53.92 0.35 Allowed Glycine 0 CA--C 1.516 0.128 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.021 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.446 ' C ' HG22 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -159.68 -170.96 3.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 111.197 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 14' ' ' ALA . 2.3 t -129.04 143.61 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.882 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.031 HD11 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -128.81 153.75 47.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.016 0.436 . . . . 0.0 111.541 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.689 ' N ' HD12 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -99.14 119.17 37.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.587 178.577 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.835 HG23 HD12 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -113.89 143.0 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.18 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.537 ' O ' ' CA ' ' A' ' 51' ' ' MET . 5.1 mtpt -128.7 168.25 16.07 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.521 ' N ' ' HD3' ' A' ' 107' ' ' PRO . . . -153.38 49.66 0.51 Allowed Glycine 0 C--N 1.313 -0.708 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.628 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 106' ' ' GLY . 91.5 Cg_endo -86.17 27.4 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.722 2.281 . . . . 0.0 111.403 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.043 HD23 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -88.27 172.96 9.05 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 122.108 0.956 . . . . 0.0 113.01 -178.53 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.592 ' O ' ' CE2' ' A' ' 50' ' ' PHE . . . -110.27 174.04 17.07 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.574 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.45 107.56 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 117.911 0.856 . . . . 0.0 110.801 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 4.3 m-85 -123.11 114.84 20.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.525 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . 136.63 -82.88 0.27 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.633 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.839 HD11 ' SD ' ' A' ' 136' ' ' MET . 0.4 OUTLIER -95.53 117.97 31.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.19 0.519 . . . . 0.0 111.206 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -138.49 113.09 8.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.033 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.458 ' OE1' ' CE2' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -106.52 140.54 39.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.12 12.0 30.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.115 0.483 . . . . 0.0 110.946 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 129.18 -90.77 0.31 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.919 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.469 ' HA ' ' OD1' ' A' ' 147' ' ' ASN . 19.6 ptt? -130.52 90.98 3.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.77 0.319 . . . . 0.0 110.835 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.699 ' HB3' ' CZ ' ' A' ' 121' ' ' ARG . . . -149.29 147.29 23.03 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.984 0.421 . . . . 0.0 111.285 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 36.4 Cg_endo -65.38 110.2 1.54 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.842 2.361 . . . . 0.0 112.071 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.699 ' CZ ' ' HB3' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -136.71 146.77 46.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.884 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 150' ' ' ARG . 0.6 OUTLIER -115.08 122.2 45.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.58 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 1.15 ' CE2' HG13 ' A' ' 133' ' ' VAL . 1.0 OUTLIER -106.44 108.08 19.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.144 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.727 HG13 HD23 ' A' ' 216' ' ' LEU . 10.0 p -98.41 111.63 28.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.571 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -101.28 132.69 46.68 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.419 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.99 103.07 1.2 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.542 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.819 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 115.99 -154.88 16.6 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.134 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.76 ' CG2' HD13 ' A' ' 79' ' ' LEU . 14.5 m -105.66 -9.59 17.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.205 0.526 . . . . 0.0 110.54 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.576 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -64.66 10.01 0.36 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.537 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.873 ' O ' HG22 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -81.22 5.55 16.68 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.82 0.31 . . . . 0.0 110.632 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.903 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -47.03 -46.71 54.62 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.306 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 131' ' ' ALA . 90.0 Cg_endo -79.72 -29.92 2.61 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.653 2.235 . . . . 0.0 111.053 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.15 HG13 ' CE2' ' A' ' 123' ' ' PHE . 20.9 t -63.11 -52.4 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.566 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 130' ' ' LEU . 2.0 m -61.78 -36.56 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.659 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 139' ' ' GLN . 18.6 m -62.08 -50.35 72.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.333 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.839 ' SD ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -62.56 -36.17 81.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.469 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.073 HG23 ' O ' ' A' ' 133' ' ' VAL . 17.7 t -66.97 -53.45 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.302 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.975 ' CG ' HD21 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -63.63 -31.83 73.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.708 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -67.47 -37.34 82.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.026 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.569 ' SD ' HG21 ' A' ' 149' ' ' THR . 3.0 ptm -63.43 -43.38 97.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.509 ' HG2' ' CG ' ' A' ' 174' ' ' MET . 0.0 OUTLIER -73.06 -34.86 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.4 ' OE1' ' O ' ' A' ' 138' ' ' ARG . 1.5 mp0 -79.62 -12.84 59.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.913 0.387 . . . . 0.0 110.672 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.47 ' HB2' ' O ' ' A' ' 139' ' ' GLN . 2.8 m95 -92.23 -85.33 0.25 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.443 0.64 . . . . 0.0 111.264 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 144' ' ' THR . 0.2 OUTLIER -154.81 20.34 0.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.242 -178.814 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.555 ' N ' ' CD ' ' A' ' 146' ' ' PRO . . . -125.3 44.87 1.21 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.343 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 145' ' ' ALA . 73.1 Cg_endo -76.16 5.75 4.35 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.606 2.204 . . . . 0.0 112.005 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 118' ' ' MET . 8.4 p-10 -58.46 -159.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.149 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 40.9 mt-10 -74.55 104.63 5.32 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.408 0.623 . . . . 0.0 111.273 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.569 HG21 ' SD ' ' A' ' 140' ' ' MET . 2.8 m -119.06 117.92 30.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.095 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.633 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 1.8 mmt180 -101.52 146.15 28.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.992 0.425 . . . . 0.0 110.369 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.707 HD13 ' O ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -133.47 134.11 57.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.811 -178.71 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.726 ' CD2' HD21 ' A' ' 201' ' ' LEU . 18.2 m-30 -112.91 110.47 20.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.238 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.496 ' HZ ' HD23 ' A' ' 161' ' ' LEU . 3.4 t80 -112.99 126.72 55.81 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.484 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.818 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -155.58 151.89 23.41 Favored Glycine 0 CA--C 1.499 -0.939 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.105 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 1.03 HG21 HD22 ' A' ' 161' ' ' LEU . 3.8 m -164.64 -111.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.776 ' O ' HG21 ' A' ' 183' ' ' VAL . 19.9 p30 -105.85 -168.05 1.39 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.369 0.604 . . . . 0.0 112.182 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.639 HG23 ' HA ' ' A' ' 187' ' ' SER . 34.1 p -33.96 -32.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.83 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.586 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.9 tt0 105.46 -52.09 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.974 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.524 ' HD2' ' C ' ' A' ' 157' ' ' THR . 86.3 Cg_exo -48.26 -21.57 3.14 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 121.994 1.796 . . . . 0.0 112.003 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -87.29 -30.75 20.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.491 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.03 HD22 HG21 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -89.23 -160.51 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.396 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 38.0 p90 177.14 -176.59 0.15 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.0 0.429 . . . . 0.0 111.501 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 162' ' ' PHE . 0.2 OUTLIER 79.84 2.46 2.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.336 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.976 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -71.28 -45.42 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.817 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.976 ' N ' HD13 ' A' ' 164' ' ' ILE . 6.8 m-20 -67.16 -35.02 78.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.24 0.543 . . . . 0.0 110.172 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -72.28 -37.03 69.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -61.05 -32.15 71.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.015 179.052 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.475 ' HG3' ' HA ' ' A' ' 165' ' ' ASP . 8.1 mttt -65.9 -39.3 90.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 m -62.88 -32.0 73.16 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.315 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.975 HD21 ' CG ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -63.8 -36.89 85.38 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.626 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' A' ' 177' ' ' LEU . 2.3 mm-40 -67.53 -37.66 83.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.224 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -78.76 -32.27 46.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.235 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 170' ' ' LEU . 58.4 p -75.01 -16.17 60.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.006 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.865 ' HB3' HD13 ' A' ' 177' ' ' LEU . 0.7 OUTLIER -94.95 -168.93 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.178 0.513 . . . . 0.0 111.643 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.493 ' CB ' ' O ' ' A' ' 146' ' ' PRO . 0.7 OUTLIER -81.76 -63.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.331 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.9 70.11 1.33 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.943 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.865 HD13 ' HB3' ' A' ' 174' ' ' MET . 7.3 mp -98.68 151.75 20.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.827 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.491 ' CB ' ' HD3' ' A' ' 150' ' ' ARG . 4.8 m -136.83 115.01 11.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.822 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.424 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 7.7 p -92.85 134.97 29.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.505 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -99.1 136.44 39.06 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.588 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -96.55 105.44 17.54 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.851 0.834 . . . . 0.0 111.04 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.762 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 92.3 m -95.1 -167.96 1.72 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.16 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.815 HG23 ' H ' ' A' ' 155' ' ' VAL . 6.2 t 56.07 148.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.785 0.802 . . . . 0.0 111.186 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.75 -49.78 0.53 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.409 -1.268 . . . . 0.0 108.238 -177.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.594 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 12.1 t-80 178.55 57.04 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.498 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 187' ' ' SER . 33.5 Cg_endo -94.02 -93.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.538 2.825 . . . . 0.0 112.886 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 27.4 t 137.22 20.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.6 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 96.79 11.05 54.55 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.585 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.432 ' C ' ' HA ' ' A' ' 251' ' ' ALA . 0.4 OUTLIER -136.96 63.31 1.57 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.308 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.553 ' O ' ' O ' ' A' ' 249' ' ' GLY . 4.9 t-105 -125.44 123.19 38.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.448 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.741 ' N ' ' HB2' ' A' ' 251' ' ' ALA . 2.5 mt-10 -84.33 105.36 15.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.51 ' C ' ' CG ' ' A' ' 193' ' ' GLU . . . 131.42 -111.15 1.05 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.092 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.548 ' CB ' ' SG ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -167.51 -71.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.615 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -102.33 150.67 23.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.176 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.645 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -37.46 107.29 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.74 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.623 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 48.0 m 127.66 143.77 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 123.658 0.783 . . . . 0.0 110.169 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 199' ' ' ASP . 27.5 Cg_endo -62.32 56.83 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.797 2.331 . . . . 0.0 112.752 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.928 HD11 ' CD1' ' A' ' 229' ' ' LEU . 0.5 OUTLIER 37.17 26.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.574 0.702 . . . . 0.0 111.961 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.553 ' HA ' ' CD ' ' A' ' 202' ' ' ARG . 5.1 m-20 -57.67 -34.77 69.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.126 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.83 89.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.543 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.866 ' HB2' HD12 ' A' ' 198' ' ' ILE . 0.4 OUTLIER -69.21 -30.86 69.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.172 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.805 ' HG2' HD13 ' A' ' 229' ' ' LEU . 11.0 mtp-105 -58.46 -48.57 80.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.513 0.673 . . . . 0.0 110.645 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.536 ' HA ' ' NH1' ' A' ' 233' ' ' ARG . 2.1 mt-10 -71.41 -33.66 69.65 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.318 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -59.87 -39.07 84.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.609 -0.436 . . . . 0.0 109.937 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.884 ' HB2' HG21 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -61.18 -49.61 76.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.183 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -64.53 -21.63 66.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.816 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.8 -85.27 0.2 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.751 0.31 . . . . 0.0 111.202 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 2.2 p 174.03 99.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.719 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.667 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 7.9 m-20 154.18 42.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.15 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ALA . . . . . 1.002 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 150.05 104.35 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.539 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.581 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 14.5 t-20 177.87 -57.32 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.06 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 8.4 Cg_endo -51.75 -55.79 3.59 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.17 1.913 . . . . 0.0 110.984 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -133.32 109.37 9.33 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.229 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 1.002 HD11 ' HB1' ' A' ' 210' ' ' ALA . 1.0 OUTLIER -116.45 125.82 73.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.58 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.4 m-85 -117.52 126.47 52.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.484 0.659 . . . . 0.0 110.533 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.727 HD23 HG13 ' A' ' 124' ' ' VAL . 0.7 OUTLIER -125.66 117.22 23.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.163 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 217' ' ' CYS . . . . . 0.509 ' SG ' ' CG2' ' A' ' 133' ' ' VAL . 48.8 t -124.53 107.8 11.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.978 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.577 ' HA2' ' CD2' ' A' ' 245' ' ' PHE . . . 168.57 -175.81 43.06 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.005 -1.093 . . . . 0.0 113.187 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.561 ' HB2' ' CB ' ' A' ' 250' ' ' ALA . 5.4 Cg_exo -38.18 168.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.773 2.982 . . . . 0.0 112.904 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 73.3 Cg_endo -75.52 -28.12 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.888 2.392 . . . . 0.0 111.84 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.484 ' HA2' ' HB2' ' A' ' 224' ' ' ASP . . . -81.75 -46.55 6.71 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.23 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.554 ' SD ' HD12 ' A' ' 223' ' ' ILE . 1.3 tmt? -57.07 -35.49 69.43 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.712 HD11 ' HB3' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -76.97 -34.53 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.985 178.46 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.484 ' HB2' ' HA2' ' A' ' 221' ' ' GLY . 0.2 OUTLIER -67.59 -46.81 71.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.161 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -61.42 -47.05 87.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.808 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -68.28 -31.21 70.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.675 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 223' ' ' ILE . 49.6 t -70.32 -31.8 69.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.165 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.84 -44.37 85.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.867 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.928 ' CD1' HD11 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -60.49 -39.88 89.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.793 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.891 HG12 ' HG3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -66.05 -41.6 89.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 -179.219 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -72.9 -30.0 63.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.151 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.42 -29.83 19.92 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.59 ' HD3' HD12 ' A' ' 205' ' ' LEU . 1.4 mmp_? -72.91 -66.83 0.62 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.874 0.368 . . . . 0.0 111.415 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.52 ' C ' ' HD2' ' A' ' 236' ' ' PRO . . . 122.09 9.67 6.62 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.795 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.884 HG21 ' HB2' ' A' ' 205' ' ' LEU . 1.0 OUTLIER -83.3 -19.18 0.26 Allowed Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.891 ' HG3' HG12 ' A' ' 230' ' ' VAL . 66.1 Cg_exo -39.99 117.23 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.68 1.587 . . . . 0.0 112.382 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -96.49 -116.79 3.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.753 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -129.53 -32.8 1.92 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.585 0.231 . . . . 0.0 111.401 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.577 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 9.7 mm-40 -99.87 30.74 3.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.008 0.433 . . . . 0.0 111.147 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.988 HG22 ' HB ' ' A' ' 214' ' ' ILE . 1.7 t -94.52 131.87 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.041 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.645 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.66 151.4 37.19 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.653 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.65 151.27 51.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.097 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLU . . . . . 0.591 ' O ' HD13 ' A' ' 223' ' ' ILE . 8.8 tm-20 -132.47 149.4 52.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.269 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -117.85 107.35 14.01 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 111.674 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.577 ' CD2' ' HA2' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -136.48 148.14 47.53 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.147 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.594 HD22 ' HB2' ' A' ' 81' ' ' ARG . 3.0 tt -15.72 139.99 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' PRO . . . . . 0.57 ' O ' ' CB ' ' A' ' 248' ' ' SER . 77.7 Cg_exo -50.8 -149.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.885 3.057 . . . . 0.0 113.565 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 247' ' ' PRO . 7.4 m 97.01 -19.43 0.05 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.907 0.86 . . . . 0.0 109.871 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 190' ' ' TRP . . . -122.15 -18.5 3.44 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.085 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.561 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . . . -109.08 151.67 26.09 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.606 0.762 . . . . 0.0 110.339 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.741 ' HB2' ' N ' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.07 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 CA-C-O 121.084 0.269 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -111.47 158.49 19.07 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.922 0.391 . . . . 0.0 111.055 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 34' ' ' ARG . 1.9 t80 -128.55 165.24 21.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.957 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -110.46 129.63 55.73 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.084 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -137.8 154.62 49.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.864 0.364 . . . . 0.0 111.153 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -103.52 121.38 42.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.881 HG13 ' HE1' ' A' ' 29' ' ' PHE . 24.3 t -72.1 136.03 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 17' ' ' VAL . 10.5 p -162.2 24.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.264 0.554 . . . . 0.0 109.711 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.596 ' O ' ' CE1' ' A' ' 29' ' ' PHE . . . -153.05 122.2 1.26 Allowed Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.85 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.933 ' CD2' HD22 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -170.85 90.44 0.14 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.665 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -140.39 144.04 36.0 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.7 178.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.415 ' HA ' ' O ' ' A' ' 26' ' ' THR . 10.1 m0 -89.94 112.6 24.03 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.579 -0.849 . . . . 0.0 108.87 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.585 HG22 ' HB ' ' A' ' 26' ' ' THR . 0.7 OUTLIER -71.41 -19.02 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.639 0.733 . . . . 0.0 109.122 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.533 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 37.9 m -153.17 -175.24 5.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.074 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.3 m -52.2 -57.86 8.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.113 0.483 . . . . 0.0 110.917 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -118.79 47.26 1.68 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.14 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.585 ' HB ' HG22 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -143.28 128.59 18.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.754 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.537 HG11 ' CD1' ' A' ' 92' ' ' LEU . 2.5 p -131.0 133.83 62.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.301 0.572 . . . . 0.0 112.476 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.487 ' HG2' HD21 ' A' ' 30' ' ' LEU . 15.2 tt0 -100.62 131.36 46.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.792 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.881 ' HE1' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -126.02 128.42 47.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.917 -178.326 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.862 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -121.35 115.77 23.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.213 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.078 HD13 HD21 ' A' ' 102' ' ' LEU . 2.8 mt -115.28 148.73 38.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.455 . . . . 0.0 111.753 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -124.01 108.32 12.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.523 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.65 ' HD3' HG11 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -105.35 -165.43 1.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.048 -179.091 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.832 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 69' ' ' LEU . 21.9 m . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 121.258 0.551 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -155.77 23.12 0.39 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.803 -178.015 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.643 ' O ' ' CG ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER 99.07 92.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.583 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -115.2 125.4 28.94 Favored Pre-proline 0 N--CA 1.453 -0.317 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.937 178.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.447 ' C ' ' O ' ' A' ' 46' ' ' GLU . 53.5 Cg_exo -28.13 84.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.055 2.503 . . . . 0.0 112.739 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.635 ' N ' ' CD2' ' A' ' 111' ' ' PHE . . . 40.56 75.97 0.1 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.612 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.446 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 1.6 tm0? -69.74 109.7 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 111.021 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.664 ' CE1' ' HB2' ' A' ' 65' ' ' SER . 1.5 m-30 -109.97 164.15 12.88 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.549 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.485 ' HB3' ' O ' ' A' ' 105' ' ' LYS . 5.2 mmt -135.74 -171.48 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.418 0.628 . . . . 0.0 112.414 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 9.3 t0 -131.79 102.5 5.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.665 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.01 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -134.58 157.93 45.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.451 0.643 . . . . 0.0 112.228 -177.514 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.866 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -109.19 151.2 26.8 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.968 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.891 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -30.45 -69.62 0.1 Allowed Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.224 0.327 . . . . 0.0 110.897 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 1.094 ' HD2' HG23 ' A' ' 58' ' ' THR . 59.9 Cg_endo -104.69 7.64 0.28 Allowed 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.451 2.767 . . . . 0.0 111.735 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.41 18.56 14.28 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.093 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 1.094 HG23 ' HD2' ' A' ' 56' ' ' PRO . 6.8 p -63.65 -110.51 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.128 -0.536 . . . . 0.0 111.4 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.866 ' N ' HG21 ' A' ' 54' ' ' THR . 0.3 OUTLIER 175.45 28.5 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.757 HG12 ' O ' ' A' ' 60' ' ' VAL . 48.3 t -140.83 31.94 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.712 0.291 . . . . 0.0 111.289 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.59 ' CB ' ' HA ' ' A' ' 54' ' ' THR . 34.0 t -103.5 -103.23 0.29 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.681 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 61' ' ' SER . 8.6 mtt180 166.99 -179.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.088 0.471 . . . . 0.0 111.569 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 2.7 t -88.76 143.01 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.591 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 1.014 ' CE2' HG22 ' A' ' 80' ' ' ILE . 1.9 t80 -141.25 130.29 23.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.664 ' HB2' ' CE1' ' A' ' 50' ' ' PHE . 22.4 p -75.9 105.63 2.34 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.533 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 72.4 Cg_endo -99.45 -169.92 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.905 2.403 . . . . 0.0 113.348 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.713 ' HB3' ' N ' ' A' ' 77' ' ' GLU . . . -86.15 176.77 7.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.721 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.2 t30 106.61 123.71 0.01 OUTLIER 'General case' 0 C--N 1.343 0.31 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.952 HD13 ' CB ' ' A' ' 135' ' ' SER . 0.4 OUTLIER -170.96 -84.32 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 122.139 -0.351 . . . . 0.0 110.615 -178.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 55.3 Cg_endo -85.81 72.57 4.07 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 120.384 1.173 . . . . 0.0 112.397 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 43' ' ' VAL . 1.2 m120 -164.51 139.09 4.4 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.586 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.513 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 60.3 Cg_endo -91.15 53.57 0.91 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.665 2.243 . . . . 0.0 116.234 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 72' ' ' PRO . 61.6 mt-10 -158.66 -106.91 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.269 0.94 . . . . 0.0 112.558 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.57 78.0 0.17 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.46 81.92 1.95 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.159 0.98 . . . . 0.0 111.332 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.65 HD12 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -97.48 132.14 43.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.713 ' N ' ' HB3' ' A' ' 67' ' ' ALA . 1.3 tt0 -129.99 111.69 12.77 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.443 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.868 ' CD1' HG23 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -104.78 137.18 42.96 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.226 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.864 HD22 ' CG2' ' A' ' 128' ' ' THR . 0.2 OUTLIER -122.53 75.41 1.25 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.918 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.014 HG22 ' CE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -92.61 130.4 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.121 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.79 ' HG3' HD21 ' A' ' 246' ' ' LEU . 0.3 OUTLIER -78.11 102.7 7.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.178 -178.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' CB ' ' A' ' 89' ' ' SER . 3.5 m -102.02 138.22 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.313 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.461 ' O ' ' OG ' ' A' ' 89' ' ' SER . 5.4 mt -68.99 129.01 92.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.738 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.23 110.14 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.666 2.244 . . . . 0.0 111.938 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.525 ' N ' ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER 47.25 43.73 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.422 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.54 -68.88 0.58 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.956 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -137.24 -68.2 0.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.268 . . . . 0.0 111.663 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -76.98 -33.57 57.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.714 0.292 . . . . 0.0 111.515 -179.29 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.686 ' CB ' HG23 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -78.84 -20.74 48.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.404 -179.545 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.414 ' O ' ' CG ' ' A' ' 94' ' ' ASN . 0.7 OUTLIER -75.68 -46.66 30.03 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.692 0.758 . . . . 0.0 109.069 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.728 ' O ' HD11 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -74.62 -24.52 58.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.498 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.933 HD22 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.78 -49.4 73.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.001 -179.601 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -89.05 -16.95 30.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.447 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.414 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 73.8 m-20 -95.04 -9.32 34.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.286 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.481 ' HB3' HD11 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -135.13 2.99 3.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.383 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -139.16 28.91 2.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.825 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -77.53 -49.58 14.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.467 -179.507 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.931 HG13 ' HG3' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -74.95 3.2 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.142 0.496 . . . . 0.0 111.796 -179.223 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 100' ' ' GLN . . . 54.12 36.92 57.67 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.415 -0.897 . . . . 0.0 111.722 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.931 ' HG3' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -52.8 -160.41 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.943 0.401 . . . . 0.0 111.065 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.65 143.14 12.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.775 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.078 HD21 HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -128.91 132.95 47.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.468 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.578 ' N ' HD12 ' A' ' 102' ' ' LEU . 6.8 m -92.02 123.1 35.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.088 0.471 . . . . 0.0 111.063 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.65 HG11 ' HD3' ' A' ' 33' ' ' LYS . 2.0 m -96.8 127.85 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 51' ' ' MET . 0.1 OUTLIER -127.0 170.17 12.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.557 -178.214 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 51' ' ' MET . . . 69.59 83.88 0.17 Allowed Glycine 0 C--N 1.312 -0.795 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.05 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.22 54.03 4.49 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.427 2.084 . . . . 0.0 110.053 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.626 ' HG ' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -97.42 166.52 11.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.134 -177.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.626 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -156.9 129.32 2.37 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.485 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 110' ' ' VAL . 10.7 p -158.25 113.51 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.865 0.364 . . . . 0.0 110.769 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.635 ' CD2' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -119.24 150.26 40.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.681 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -95.09 9.41 70.12 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.948 HD11 ' HG2' ' A' ' 136' ' ' MET . 3.7 pp -116.09 119.4 35.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.278 0.561 . . . . 0.0 110.848 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.647 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.5 OUTLIER -137.5 112.92 9.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.485 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 121' ' ' ARG . 0.1 OUTLIER -87.2 140.54 29.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.54 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -94.12 14.29 20.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.2 -74.68 0.22 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.765 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -129.59 89.96 2.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.941 0.401 . . . . 0.0 110.461 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 121' ' ' ARG . . . -164.37 144.73 6.4 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.363 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 43.8 Cg_endo -67.98 116.93 4.56 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.765 2.31 . . . . 0.0 111.905 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.1 OUTLIER -130.96 158.53 40.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.647 ' CE2' ' CD ' ' A' ' 150' ' ' ARG . 3.5 m-85 -126.68 130.53 50.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.079 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.809 ' HE2' HD13 ' A' ' 113' ' ' LEU . 0.4 OUTLIER -106.46 103.71 13.23 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.631 HG13 HD23 ' A' ' 216' ' ' LEU . 0.8 OUTLIER -101.01 111.09 29.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.275 0.56 . . . . 0.0 110.843 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -114.47 133.08 56.02 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.898 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -105.82 102.7 2.01 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.841 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.968 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 124.08 -164.32 17.41 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.417 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.864 ' CG2' HD22 ' A' ' 79' ' ' LEU . 5.4 m -106.4 -10.39 16.34 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.45 0.643 . . . . 0.0 110.746 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.605 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -68.01 10.63 1.17 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.459 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.777 HD23 ' C ' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -75.75 5.14 6.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 122.894 0.478 . . . . 0.0 110.283 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.716 ' N ' HD23 ' A' ' 130' ' ' LEU . . . -44.98 -41.24 12.36 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.197 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 3.7 Cg_exo -73.53 -31.39 8.91 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.49 2.127 . . . . 0.0 110.063 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.717 HG21 ' HB2' ' A' ' 217' ' ' CYS . 21.4 t -64.86 -42.7 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.614 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.715 HG13 ' HG ' ' A' ' 130' ' ' LEU . 10.6 m -70.15 -29.78 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.533 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.952 ' CB ' HD13 ' A' ' 69' ' ' LEU . 16.7 m -66.49 -53.09 39.09 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.948 ' HG2' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -60.5 -42.4 96.3 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.511 0.672 . . . . 0.0 109.215 178.199 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.741 HG12 ' HG3' ' A' ' 141' ' ' GLN . 26.8 t -62.35 -32.39 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.927 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 135' ' ' SER . 5.3 mtm180 -59.6 -32.12 70.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.198 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.567 ' OE1' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -68.4 -43.03 78.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.09 178.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.626 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -71.5 -34.96 70.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.507 0.67 . . . . 0.0 111.047 179.324 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.926 ' CD ' HD22 ' A' ' 170' ' ' LEU . 0.4 OUTLIER -78.05 -30.45 49.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.239 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 138' ' ' ARG . 3.4 mm-40 -69.8 -44.99 68.93 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -79.24 -21.14 46.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.436 0.636 . . . . 0.0 109.736 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 141' ' ' GLN . 0.6 OUTLIER 52.74 28.03 5.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.735 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.857 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -33.09 153.95 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.946 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.454 ' HA ' ' HG3' ' A' ' 175' ' ' ARG . 41.8 Cg_endo -67.63 -3.58 10.52 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.667 2.245 . . . . 0.0 112.71 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.571 ' ND2' ' NH2' ' A' ' 121' ' ' ARG . 40.3 t30 -76.37 144.12 40.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 111.567 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 1.2 mt-10 -73.59 111.41 8.71 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.624 0.726 . . . . 0.0 111.072 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.646 ' HB ' HD11 ' A' ' 177' ' ' LEU . 1.1 m -108.5 115.38 29.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.892 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.647 ' CD ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -106.6 141.49 37.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.455 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.818 HD12 ' N ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -133.59 129.33 55.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.262 0.554 . . . . 0.0 111.032 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.818 ' N ' HD12 ' A' ' 151' ' ' ILE . 22.0 m-30 -108.33 115.06 29.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.47 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.466 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 37.2 t80 -120.15 132.02 55.24 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.396 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.925 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -155.06 160.67 29.9 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 119.511 -1.328 . . . . 0.0 113.288 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.977 ' CG2' HD13 ' A' ' 161' ' ' LEU . 1.2 m -170.73 -106.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.873 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.3 OUTLIER -126.17 -169.59 2.04 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 120.663 0.268 . . . . 0.0 111.287 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.829 HG23 ' CA ' ' A' ' 187' ' ' SER . 72.0 p -28.29 -62.67 0.1 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.655 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.57 ' HA ' HD21 ' A' ' 161' ' ' LEU . 0.2 OUTLIER 153.1 -54.05 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.495 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 40.7 Cg_exo -31.28 -31.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.155 2.57 . . . . 0.0 112.96 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.2 mm-40 -85.44 -60.11 2.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.016 0.436 . . . . 0.0 110.636 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.977 HD13 ' CG2' ' A' ' 155' ' ' VAL . 0.4 OUTLIER -67.3 -174.68 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.394 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 163' ' ' TYR . 0.8 OUTLIER 175.27 176.11 0.2 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.86 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 162' ' ' PHE . 0.3 OUTLIER 87.66 6.75 0.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.313 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.983 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -71.39 -45.51 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.771 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.983 ' N ' HD13 ' A' ' 164' ' ' ILE . 3.5 m-20 -66.0 -35.7 81.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.243 0.544 . . . . 0.0 110.107 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.454 ' O ' ' OG ' ' A' ' 169' ' ' SER . 0.9 OUTLIER -72.38 -36.22 68.66 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.666 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -61.61 -31.83 71.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.095 179.007 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 164' ' ' ILE . 24.2 mttt -62.92 -48.54 78.5 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 166' ' ' GLU . 3.9 p -61.8 -31.41 71.62 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.926 HD22 ' CD ' ' A' ' 141' ' ' GLN . 1.1 mt -63.57 -37.41 87.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.648 ' HA ' HD23 ' A' ' 177' ' ' LEU . 4.4 mm-40 -68.43 -36.07 78.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.922 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -34.53 59.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.143 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.1 t -53.7 -49.17 68.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.521 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.895 ' HB3' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -69.31 -154.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 111.588 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.454 ' HG3' ' HA ' ' A' ' 146' ' ' PRO . 0.3 OUTLIER -106.49 -54.26 2.5 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.718 -179.224 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -132.35 69.91 1.47 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.112 0.482 . . . . 0.0 110.706 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.895 HD13 ' HB3' ' A' ' 174' ' ' MET . 3.6 mp -98.81 150.47 21.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.888 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.513 ' OG1' ' CZ ' ' A' ' 150' ' ' ARG . 2.4 m -137.48 115.41 11.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.718 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.48 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 2.6 p -101.15 134.65 40.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.776 0.322 . . . . 0.0 111.352 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.6 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -101.69 135.28 43.49 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.562 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -100.82 105.51 16.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.491 0.663 . . . . 0.0 111.824 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.645 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 29.6 m -88.53 -161.93 0.79 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.181 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.873 HG21 ' O ' ' A' ' 156' ' ' ASN . 14.9 t 54.73 147.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-O 121.703 0.763 . . . . 0.0 111.812 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.24 -60.78 0.61 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.188 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.604 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 1.9 t-80 -164.99 51.26 0.25 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.789 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 187' ' ' SER . 86.3 Cg_endo -90.3 -98.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.21 2.607 . . . . 0.0 112.542 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.829 ' CA ' HG23 ' A' ' 157' ' ' THR . 21.7 t 137.85 6.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.596 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 120.64 12.19 6.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.259 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.16 62.62 1.59 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.469 ' HE1' ' C ' ' A' ' 193' ' ' GLU . 8.5 t-105 -132.08 121.31 23.61 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.305 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 250' ' ' ALA . 3.9 mt-10 -95.92 104.71 16.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.52 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.564 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 140.82 -117.02 1.2 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.696 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.595 ' C ' ' HB3' ' A' ' 182' ' ' CYS . 13.6 mt-10 -162.98 -95.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.514 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -86.73 139.34 30.83 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.641 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -21.37 107.08 0.01 OUTLIER Glycine 0 C--N 1.334 0.448 0 O-C-N 123.688 0.618 . . . . 0.0 113.096 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.614 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 67.1 m 120.65 154.45 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 123.481 0.712 . . . . 0.0 110.701 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.65 -75.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 123.234 2.623 . . . . 0.0 112.728 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.703 ' O ' HG23 ' A' ' 198' ' ' ILE . 0.2 OUTLIER 174.88 32.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.985 0.897 . . . . 0.0 110.732 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.505 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 35.9 m-20 -58.61 -37.27 75.49 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.191 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.46 73.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.637 ' HB2' HD13 ' A' ' 198' ' ' ILE . 0.2 OUTLIER -69.32 -34.04 74.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.873 0.368 . . . . 0.0 110.904 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.688 ' HG2' HD22 ' A' ' 229' ' ' LEU . 5.9 mtm180 -59.84 -52.15 66.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -41.87 96.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.814 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.2 -29.16 68.53 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 1.04 ' CD2' HD11 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -62.67 -43.96 97.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.337 178.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.44 -18.07 57.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.538 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 208' ' ' SER . 59.4 m -75.79 -80.45 0.09 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.93 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 207' ' ' SER . 0.4 OUTLIER 164.99 34.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.449 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.663 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 2.0 m-20 -137.85 52.29 1.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.697 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 209' ' ' ASP . . . 151.5 102.01 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.208 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.875 ' HB2' HD13 ' A' ' 235' ' ' ILE . 13.5 t30 174.04 -56.78 0.0 OUTLIER Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.143 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 18.8 Cg_endo -59.53 -58.04 0.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.294 1.996 . . . . 0.0 111.207 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.14 109.23 9.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.309 178.493 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.933 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.5 OUTLIER -121.63 125.76 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.716 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -120.62 127.1 51.78 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.388 0.613 . . . . 0.0 111.063 -178.414 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.631 HD23 HG13 ' A' ' 124' ' ' VAL . 3.4 mt -125.71 116.45 21.66 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.284 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' CYS . . . . . 0.717 ' HB2' HG21 ' A' ' 133' ' ' VAL . 38.9 m -124.8 107.09 10.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.077 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.621 ' N ' ' CD ' ' A' ' 219' ' ' PRO . . . 110.44 -28.13 10.58 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.93 -1.128 . . . . 0.0 114.075 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 218' ' ' GLY . 46.3 Cg_endo -89.76 83.17 0.53 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.238 1.958 . . . . 0.0 114.72 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.799 ' CD ' ' HB2' ' A' ' 250' ' ' ALA . 11.9 Cg_endo -53.48 -71.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 111.301 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.824 ' N ' ' HB1' ' A' ' 250' ' ' ALA . . . -54.2 -48.62 62.94 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.427 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.588 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -54.77 -24.08 20.89 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.595 ' CD1' ' HB3' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -72.76 -36.81 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.942 178.132 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 221' ' ' GLY . 65.6 m-20 -73.45 -47.04 44.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.003 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -69.72 -37.02 76.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.641 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.796 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -59.4 -38.5 80.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.385 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 31.7 m -69.91 -31.19 68.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.572 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -44.5 82.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.811 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.688 HD22 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -60.76 -37.14 80.83 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.013 0.435 . . . . 0.0 110.664 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 226' ' ' ALA . 3.6 t -66.23 -45.62 89.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.392 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -72.75 -30.02 63.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 6.2 m -76.98 -44.15 32.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.557 ' NE ' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -68.21 -75.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.166 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.472 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 137.8 -36.13 1.97 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.255 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 1.04 HD11 ' CD2' ' A' ' 205' ' ' LEU . 1.6 pp -35.84 95.29 0.09 OUTLIER Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 111.005 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 18.7 Cg_endo -59.86 115.33 2.55 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.757 2.305 . . . . 0.0 112.185 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -93.85 173.72 33.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.437 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -143.71 -41.92 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 110.91 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.582 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 43.7 mm-40 -107.5 37.78 2.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.933 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.1 t -92.84 132.45 37.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.647 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -144.72 144.5 31.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.42 -178.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -130.75 140.93 50.35 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLU . . . . . 0.576 ' O ' HD13 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -132.79 149.12 52.31 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.75 178.628 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 244' ' ' LYS . 1.0 OUTLIER -127.22 108.09 10.57 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.692 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.629 ' CD1' ' HB2' ' A' ' 246' ' ' LEU . 0.4 OUTLIER -138.22 144.32 40.57 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.538 178.364 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.834 HD23 ' HD2' ' A' ' 247' ' ' PRO . 0.1 OUTLIER 68.31 148.55 0.12 Allowed Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 121.917 -0.49 . . . . 0.0 111.379 -179.101 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 247' ' ' PRO . . . . . 0.834 ' HD2' HD23 ' A' ' 246' ' ' LEU . 97.7 Cg_endo -73.28 -104.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.959 2.439 . . . . 0.0 112.371 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 247' ' ' PRO . 52.8 p -37.66 134.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.183 0.516 . . . . 0.0 110.912 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 127.71 -15.69 6.27 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.824 ' HB1' ' N ' ' A' ' 221' ' ' GLY . . . -106.53 120.55 42.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.709 -0.745 . . . . 0.0 111.541 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.564 ' N ' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.066 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 CA-C-O 121.022 0.234 . . . . 0.0 112.81 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.558 ' CB ' ' HB3' ' A' ' 105' ' ' LYS . 0.8 OUTLIER -115.03 149.34 37.62 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.693 -0.253 . . . . 0.0 111.022 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.795 ' CE1' HG13 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -134.05 165.54 24.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -113.31 135.29 54.0 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.992 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -134.53 150.35 50.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.755 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 1.1 pt-20 -96.5 116.63 29.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 110.754 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.003 HG22 ' O ' ' A' ' 100' ' ' GLN . 2.9 m -75.34 135.34 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.284 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 17' ' ' VAL . 7.4 p -149.4 20.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.168 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -106.63 -129.82 6.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.028 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.988 HD22 HD22 ' A' ' 92' ' ' LEU . 0.1 OUTLIER 74.9 80.39 0.11 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.831 -0.685 . . . . 0.0 110.445 -178.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -123.25 139.45 54.04 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.079 178.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 7.9 m0 -90.1 113.49 25.24 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.164 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.429 HG12 ' OD1' ' A' ' 20' ' ' ASN . 1.3 m -96.26 -26.99 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.542 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 8.2 m -143.43 171.09 14.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.244 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.468 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -52.88 -53.83 43.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.116 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -119.46 45.47 2.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.58 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.542 ' CB ' ' HB2' ' A' ' 23' ' ' SER . 0.3 OUTLIER -148.06 140.36 24.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.426 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.863 HG11 HD13 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -140.89 141.28 31.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.26 0.552 . . . . 0.0 112.036 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.654 ' HB2' HD21 ' A' ' 79' ' ' LEU . 17.0 tt0 -121.44 110.52 16.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.895 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.961 ' CE1' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -118.74 140.52 49.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 111.446 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.834 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -117.13 143.66 45.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.347 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.973 HD22 HG12 ' A' ' 16' ' ' VAL . 0.7 OUTLIER -122.14 154.91 36.78 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.17 0.509 . . . . 0.0 111.954 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -116.13 104.81 11.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.491 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.643 ' CG ' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -60.63 -171.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.459 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? . . . . . 0 CA--C 1.544 0.714 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.698 -179.328 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.595 ' CG2' ' ND2' ' A' ' 68' ' ' ASN . 18.8 m . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 121.281 0.563 . . . . 0.0 112.441 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.704 ' HA ' ' CA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.32 41.37 1.09 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.282 178.123 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.6 ' CZ ' ' O ' ' A' ' 132' ' ' PRO . 83.9 t80 71.66 143.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.064 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.594 ' O ' ' CE2' ' A' ' 45' ' ' PHE . 4.9 mt-10 -112.91 161.88 24.5 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.743 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' GLY . 5.1 Cg_endo -47.44 80.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.717 2.278 . . . . 0.0 112.326 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.59 ' O ' HG12 ' A' ' 110' ' ' VAL . . . 34.85 41.2 0.24 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.862 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.497 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 4.8 mt-30 -53.46 161.04 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.67 0.235 . . . . 0.0 110.442 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.718 ' CD2' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -152.82 160.47 43.09 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.964 0.411 . . . . 0.0 111.703 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.627 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -138.73 -172.35 3.29 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.389 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.7 108.79 17.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.084 ' CD1' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -149.64 155.92 41.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.692 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 1.008 HG23 ' C ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -106.9 155.3 19.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.792 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.968 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -29.89 -68.62 0.11 Allowed Pre-proline 0 CA--C 1.54 0.58 0 O-C-N 123.393 0.433 . . . . 0.0 110.666 -179.171 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.968 ' HD3' HG23 ' A' ' 55' ' ' ILE . 6.3 Cg_endo -107.89 3.69 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.434 2.756 . . . . 0.0 111.807 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 107.23 -4.35 35.42 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.132 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.893 HG21 ' OH ' ' A' ' 91' ' ' TYR . 70.5 p -25.52 -89.76 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.975 0.51 . . . . 0.0 111.864 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.622 ' O ' HG12 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -147.2 43.11 1.12 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.182 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.008 ' C ' HG23 ' A' ' 54' ' ' THR . 0.4 OUTLIER 79.25 125.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.676 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.815 ' N ' HG23 ' A' ' 54' ' ' THR . 4.1 m -101.44 -54.32 2.79 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.372 0.606 . . . . 0.0 110.493 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 175.2 -155.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.438 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.683 ' CB ' ' CE1' ' A' ' 50' ' ' PHE . 3.6 p -105.73 119.36 38.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.898 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.488 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 4.2 t80 -140.72 124.51 17.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.119 0.485 . . . . 0.0 112.086 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.616 ' N ' ' HB2' ' A' ' 50' ' ' PHE . 1.3 t -80.85 108.25 9.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.063 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.663 ' HB2' HD13 ' A' ' 76' ' ' LEU . 87.9 Cg_endo -83.61 159.41 14.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.795 2.33 . . . . 0.0 111.667 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.722 ' HB2' ' HA ' ' A' ' 132' ' ' PRO . . . -119.48 129.51 54.76 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.603 ' O ' ' CB ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -82.21 -75.31 0.31 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.328 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.603 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 10.8 tp 101.53 141.38 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.22 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.704 ' CA ' ' HA ' ' A' ' 44' ' ' LYS . 5.5 Cg_exo -36.25 86.31 0.01 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 123.001 2.467 . . . . 0.0 112.0 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -162.67 117.96 1.2 Allowed Pre-proline 0 CA--C 1.518 -0.251 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.086 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.56 38.55 0.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.484 2.123 . . . . 0.0 112.379 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.06 -51.47 1.21 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.34 107.95 1.48 Allowed Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.81 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 5.9 mtt180 -139.53 93.55 2.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.517 0.199 . . . . 0.0 110.506 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.814 HD12 ' C ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -95.88 131.55 42.1 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.351 0.596 . . . . 0.0 111.368 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.766 ' N ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.9 150.74 30.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.138 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.703 ' CD1' ' CD2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -135.29 129.99 34.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.367 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.832 HD12 ' HB2' ' A' ' 131' ' ' ALA . 2.7 mt -135.6 103.37 5.42 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-O 120.846 0.355 . . . . 0.0 110.355 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.703 HD13 ' CZ ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -115.04 127.33 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.194 -178.87 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.617 ' HG3' HD11 ' A' ' 246' ' ' LEU . 1.8 mmt180 -79.69 95.57 5.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.595 ' CG2' ' CB ' ' A' ' 89' ' ' SER . 3.0 m -90.56 142.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.114 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.508 ' HA ' HD12 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -88.15 151.35 48.96 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.612 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.481 ' HD2' ' HG ' ' A' ' 83' ' ' LEU . 55.3 Cg_endo -69.87 -8.46 23.66 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.753 2.302 . . . . 0.0 112.392 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -70.51 -25.87 63.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.503 ' CA ' ' HB2' ' A' ' 90' ' ' ASP . . . 115.43 -4.06 21.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.569 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 86' ' ' GLY . 9.3 mmm180 -36.63 -73.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 110.792 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -116.92 -21.88 8.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.595 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 1.3 p -65.75 -36.79 84.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.206 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.503 ' HB2' ' CA ' ' A' ' 86' ' ' GLY . 2.1 m-20 -75.09 -33.47 61.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.364 0.602 . . . . 0.0 109.868 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.893 ' OH ' HG21 ' A' ' 58' ' ' THR . 2.0 t80 -73.34 -31.59 64.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.702 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.988 HD22 HD22 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -68.73 -39.36 80.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.203 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.08 -19.88 21.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 9.0 m-20 -97.48 -10.97 24.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.43 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.549 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -124.73 -12.3 7.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.452 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -132.56 33.2 3.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.028 0.442 . . . . 0.0 110.909 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -52.88 61.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.682 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 99' ' ' GLY . 1.8 t -89.32 -135.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 120.737 0.303 . . . . 0.0 111.129 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 100' ' ' GLN . . . -120.97 28.07 6.24 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.995 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 1.003 ' O ' HG22 ' A' ' 16' ' ' VAL . 17.2 mp0 -39.26 163.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 110.911 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' ALA . 4.8 p -92.83 139.77 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.953 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.084 HD11 ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.67 125.33 35.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -92.38 134.55 34.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.97 0.414 . . . . 0.0 111.086 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.795 HG13 ' CE1' ' A' ' 12' ' ' PHE . 1.9 m -112.91 129.37 68.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.445 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.558 ' HB3' ' CB ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -130.55 112.97 13.67 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.759 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 151.56 73.66 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.022 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.94 53.97 4.37 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.496 2.131 . . . . 0.0 110.924 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.718 HD22 ' CD2' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -102.17 166.61 10.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.781 -178.52 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.58 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -108.75 172.7 16.84 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.492 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.65 ' O ' HG13 ' A' ' 110' ' ' VAL . 4.4 p -152.18 113.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.201 0.524 . . . . 0.0 111.205 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.471 ' HB3' ' HB3' ' A' ' 241' ' ' PHE . 13.0 m-30 -71.01 114.74 9.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.419 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -149.99 -46.46 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.611 ' HA ' ' CG ' ' A' ' 215' ' ' TYR . 2.0 pt? -146.43 119.59 8.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.937 0.399 . . . . 0.0 110.488 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -137.9 112.83 9.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.853 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -78.95 140.2 38.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.287 179.191 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.46 ' HD3' ' HG3' ' A' ' 239' ' ' GLN . 17.2 ttp180 -98.37 11.7 37.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.185 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.478 ' C ' ' NH2' ' A' ' 121' ' ' ARG . . . 107.27 -78.08 0.24 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.693 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.46 ' HA ' ' HB3' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -129.91 89.83 2.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.844 0.354 . . . . 0.0 110.577 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.713 ' HB3' HH12 ' A' ' 121' ' ' ARG . . . -166.86 151.93 7.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 33.0 Cg_endo -64.47 116.73 3.93 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.652 2.235 . . . . 0.0 111.606 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.713 HH12 ' HB3' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -124.76 128.24 48.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.081 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.636 ' CD2' ' CE1' ' A' ' 152' ' ' TYR . 2.5 m-30 -106.65 115.84 30.9 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 1.157 ' CE2' HG21 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -119.66 111.01 17.51 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.258 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.938 ' CG1' HD23 ' A' ' 216' ' ' LEU . 7.4 p -109.15 111.06 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.206 0.527 . . . . 0.0 110.978 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -103.7 133.58 48.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.951 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.57 ' HA3' ' N ' ' A' ' 250' ' ' ALA . . . -109.59 103.61 1.77 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.944 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.599 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 123.55 -158.91 18.21 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 119.782 -1.199 . . . . 0.0 112.757 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.737 ' CG2' HD13 ' A' ' 79' ' ' LEU . 3.2 m -110.09 -14.41 14.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.675 0.274 . . . . 0.0 111.409 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.604 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -67.67 9.36 1.35 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.355 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.839 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -77.99 3.88 13.59 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 122.491 0.316 . . . . 0.0 110.192 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.832 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -46.52 -43.34 36.5 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 120.516 -0.473 . . . . 0.0 109.998 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.722 ' HA ' ' HB2' ' A' ' 67' ' ' ALA . 2.8 Cg_exo -73.82 -35.35 4.51 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.529 2.152 . . . . 0.0 109.718 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.659 HG11 ' CE1' ' A' ' 123' ' ' PHE . 15.8 t -63.36 -42.88 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.208 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.839 HG13 ' HG ' ' A' ' 130' ' ' LEU . 20.8 m -70.48 -29.74 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.414 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.479 ' HB3' ' CG ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -63.21 -52.7 61.23 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -46.44 89.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.477 0.656 . . . . 0.0 109.628 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.157 HG21 ' CE2' ' A' ' 123' ' ' PHE . 0.9 OUTLIER -59.53 -33.42 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.623 178.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -34.19 71.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.224 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.443 ' CD ' ' HG3' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -65.3 -42.45 93.05 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.601 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.7 OUTLIER -70.49 -34.01 71.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.661 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 1.021 ' OE1' HD11 ' A' ' 170' ' ' LEU . 0.6 OUTLIER -77.06 -30.61 55.66 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.287 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -70.55 -44.82 66.66 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.879 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -80.66 -20.56 42.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.411 0.624 . . . . 0.0 110.192 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.514 ' O ' ' CG ' ' A' ' 175' ' ' ARG . 0.1 OUTLIER 51.21 28.75 4.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.656 178.626 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.879 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -31.17 150.56 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 111.1 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.42 -9.19 6.37 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.877 2.385 . . . . 0.0 113.083 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.584 ' OD1' ' HB3' ' A' ' 145' ' ' ALA . 8.4 p-10 -76.35 143.34 40.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.128 0.49 . . . . 0.0 111.861 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 9.1 mt-10 -73.75 127.38 32.65 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.827 0.822 . . . . 0.0 110.88 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.584 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 26.1 m -118.27 121.67 41.02 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.477 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.628 ' HB2' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.46 134.77 44.05 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.062 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.708 HG22 ' HA ' ' A' ' 179' ' ' VAL . 0.5 OUTLIER -113.88 130.81 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.957 -179.052 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.636 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 45.4 m-85 -123.76 109.28 13.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.034 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.984 ' CE2' HD11 ' A' ' 161' ' ' LEU . 4.4 t80 -122.15 132.26 54.37 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.397 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.84 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -160.85 153.63 24.51 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 119.697 -1.239 . . . . 0.0 113.723 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 1.012 HG21 HD13 ' A' ' 161' ' ' LEU . 2.4 m -167.58 -105.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.822 ' O ' HG21 ' A' ' 183' ' ' VAL . 4.0 p30 -108.3 174.39 5.9 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.936 0.398 . . . . 0.0 111.738 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 187' ' ' SER . 0.5 OUTLIER -34.28 -41.81 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.401 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.0 OUTLIER 153.85 -41.53 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.241 0 O-C-N 123.307 0.379 . . . . 0.0 111.88 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.612 ' HD2' HG23 ' A' ' 157' ' ' THR . 62.4 Cg_exo -40.1 -30.23 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.458 2.105 . . . . 0.0 112.707 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.494 ' CB ' ' ND2' ' A' ' 156' ' ' ASN . 1.2 mp0 -103.61 -13.93 16.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.701 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.012 HD13 HG21 ' A' ' 155' ' ' VAL . 10.9 tp -94.75 171.85 8.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.846 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 1.1 p90 176.28 -163.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.977 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.6 OUTLIER 72.05 9.22 6.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.393 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 1.003 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -57.62 -41.65 79.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 109.986 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 1.003 ' N ' HD13 ' A' ' 164' ' ' ILE . 16.8 m-20 -64.24 -27.76 69.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.873 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -71.57 -47.49 54.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.88 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.54 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -62.95 -31.28 72.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.088 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -60.7 -45.93 92.34 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.6 m -61.76 -31.76 71.97 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 1.021 HD11 ' OE1' ' A' ' 141' ' ' GLN . 1.0 OUTLIER -62.75 -38.02 88.89 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.556 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.534 ' HA ' HD11 ' A' ' 177' ' ' LEU . 30.8 mt-10 -66.68 -36.22 82.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.309 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -78.65 -35.93 44.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.31 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.461 ' O ' ' C ' ' A' ' 174' ' ' MET . 0.5 OUTLIER -87.77 -79.14 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.684 0.278 . . . . 0.0 111.606 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.644 ' HB3' HD12 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -23.69 126.5 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.458 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 144' ' ' THR . 1.7 mmp_? -38.41 -91.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.427 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.44 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -119.0 61.3 0.8 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.27 0.557 . . . . 0.0 109.894 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.07 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -103.58 157.77 16.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.622 -179.094 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . 1.07 ' N ' HD22 ' A' ' 177' ' ' LEU . 3.7 m -137.1 123.13 20.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.932 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.708 ' HA ' HG22 ' A' ' 151' ' ' ILE . 64.2 t -89.18 136.57 23.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.638 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.468 ' HE2' ' OE1' ' A' ' 194' ' ' GLN . 17.8 tptt -102.63 130.31 49.48 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.642 0.258 . . . . 0.0 110.582 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' NE2' ' A' ' 194' ' ' GLN . . . -97.51 104.93 17.0 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.74 0.781 . . . . 0.0 110.798 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.736 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 97.6 m -91.16 -168.54 2.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.11 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.822 HG21 ' O ' ' A' ' 156' ' ' ASN . 19.4 t 56.47 148.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.913 0.864 . . . . 0.0 111.407 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.98 -69.27 0.54 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.979 -178.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.606 ' N ' ' CD ' ' A' ' 186' ' ' PRO . 2.1 m-70 -155.89 34.93 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.584 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.633 ' O ' ' CB ' ' A' ' 187' ' ' SER . 83.3 Cg_endo -73.47 -100.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.502 2.135 . . . . 0.0 112.791 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.711 ' HA ' HG22 ' A' ' 157' ' ' THR . 27.4 t 137.69 30.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.972 0.509 . . . . 0.0 111.707 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.618 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 94.06 12.57 56.28 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.3 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.07 63.4 1.57 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.509 ' HB2' ' HB3' ' A' ' 186' ' ' PRO . 4.0 t-105 -132.25 113.7 13.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.723 -177.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.444 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 1.3 mt-10 -84.34 103.66 13.71 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.818 ' HA2' ' HB3' ' A' ' 251' ' ' ALA . . . 146.05 -122.09 1.59 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.056 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.565 ' CB ' ' SG ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -159.21 -79.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.606 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -100.88 148.59 24.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.07 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.651 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -40.49 105.92 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.674 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 3.5 m 148.71 172.72 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 111.264 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.532 ' O ' ' HB ' ' A' ' 198' ' ' ILE . 2.6 Cg_exo -75.86 -70.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.994 2.462 . . . . 0.0 112.606 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.067 HD12 HD21 ' A' ' 201' ' ' LEU . 0.0 OUTLIER 169.13 37.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-O 122.372 1.082 . . . . 0.0 110.136 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 199' ' ' ASP . 0.5 OUTLIER -72.57 -34.24 67.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.054 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -57.81 -45.49 86.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 1.067 HD21 HD12 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -71.39 -29.73 65.28 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.175 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.516 ' O ' ' NE ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -58.06 -52.89 63.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.786 -178.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.23 -43.17 64.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.334 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.61 -29.2 67.83 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.935 ' O ' HG21 ' A' ' 235' ' ' ILE . 0.5 OUTLIER -63.31 -48.69 76.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.397 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.422 ' CD ' ' NH2' ' A' ' 233' ' ' ARG . 3.4 mt-10 -67.73 -26.93 66.39 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.666 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 208' ' ' SER . 69.9 m -75.32 -82.5 0.07 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.893 0.377 . . . . 0.0 110.789 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 209' ' ' ASP . 0.1 OUTLIER 166.08 90.31 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.691 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.677 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 0.2 OUTLIER 164.23 53.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.837 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 209' ' ' ASP . . . 151.94 99.92 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.189 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.649 ' HB2' HD13 ' A' ' 235' ' ' ILE . 13.5 t30 172.65 -56.54 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.981 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 12.9 Cg_endo -56.63 -50.97 10.17 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.412 2.075 . . . . 0.0 111.025 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -132.67 109.06 9.44 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.415 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.982 ' HB ' HG22 ' A' ' 240' ' ' VAL . 1.0 OUTLIER -122.11 125.08 72.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.611 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.3 m-85 -118.75 126.71 52.49 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.397 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.938 HD23 ' CG1' ' A' ' 124' ' ' VAL . 20.5 mt -125.16 118.81 26.9 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.829 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -122.87 131.66 53.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.658 178.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.63 ' HA3' ' HB3' ' A' ' 250' ' ' ALA . . . 144.08 -151.46 23.44 Favored Glycine 0 C--O 1.224 -0.511 0 C-N-CA 120.058 -1.067 . . . . 0.0 113.075 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 250' ' ' ALA . 56.7 Cg_endo -70.73 166.61 28.23 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.65 2.233 . . . . 0.0 112.459 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.491 ' O ' HG22 ' A' ' 223' ' ' ILE . 27.7 Cg_exo -61.1 -9.07 11.34 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.77 2.313 . . . . 0.0 112.189 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -69.32 -54.83 11.65 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.959 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.918 ' O ' ' HB3' ' A' ' 226' ' ' ALA . 0.0 OUTLIER -55.51 -25.66 38.5 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -77.07 -42.41 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.376 178.398 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -75.58 -48.68 21.26 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 229' ' ' LEU . . . -77.44 -48.37 17.33 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.918 ' HB3' ' O ' ' A' ' 222' ' ' MET . . . -66.36 -39.49 89.17 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.559 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 223' ' ' ILE . 49.9 t -65.32 -45.83 82.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.543 0.211 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 232' ' ' SER . 0.8 OUTLIER -66.87 -36.3 82.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.302 0.573 . . . . 0.0 109.701 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.627 HD12 HG23 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -60.15 -56.36 22.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.349 179.037 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.994 HG13 HD11 ' A' ' 235' ' ' ILE . 94.7 t -72.53 -42.57 63.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.242 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.47 ' HD2' ' SG ' ' A' ' 227' ' ' CYS . 30.7 mtp180 -62.38 -30.17 71.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.427 . . . . 0.0 110.074 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 228' ' ' GLU . 21.5 m -91.41 -27.11 18.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.516 ' NE ' ' O ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -57.57 -67.98 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.1 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 146.78 -54.12 0.54 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.852 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.994 HD11 HG13 ' A' ' 230' ' ' VAL . 2.1 pp -34.03 95.21 0.08 OUTLIER Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 121.151 0.5 . . . . 0.0 111.556 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.441 ' N ' ' O ' ' A' ' 234' ' ' GLY . 32.7 Cg_endo -64.48 118.16 5.15 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.855 2.37 . . . . 0.0 112.257 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.464 ' CA ' ' OD1' ' A' ' 211' ' ' ASN . . . -108.97 154.94 16.3 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.56 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -117.95 -37.26 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.738 0.304 . . . . 0.0 110.866 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.572 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 70.5 mm-40 -102.17 35.66 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.22 0.534 . . . . 0.0 110.359 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.982 HG22 ' HB ' ' A' ' 214' ' ' ILE . 1.8 t -89.65 128.83 41.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.365 0.602 . . . . 0.0 110.873 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.645 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.73 142.56 27.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.86 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.55 ' HB2' ' CD1' ' A' ' 223' ' ' ILE . 0.7 OUTLIER -131.32 141.1 49.88 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.912 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 216' ' ' LEU . 7.2 pt-20 -132.12 148.46 52.48 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.243 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 4.5 ptmm? -116.35 105.83 12.96 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.604 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -137.02 144.46 43.25 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.309 178.237 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.617 HD11 ' HG3' ' A' ' 81' ' ' ARG . 5.1 mt 62.43 155.73 0.12 Allowed Pre-proline 0 N--CA 1.467 0.405 0 CA-C-O 121.131 0.491 . . . . 0.0 111.993 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' PRO . . . . . 0.486 ' CD ' HD22 ' A' ' 246' ' ' LEU . 22.5 Cg_exo -65.1 -141.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.628 2.886 . . . . 0.0 112.363 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.491 ' HA ' ' HG3' ' A' ' 219' ' ' PRO . 0.4 OUTLIER -52.98 151.95 4.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.144 0.497 . . . . 0.0 111.391 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 152.45 -51.61 0.49 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.818 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.63 ' HB3' ' HA3' ' A' ' 218' ' ' GLY . . . -108.19 142.03 39.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.533 -0.334 . . . . 0.0 111.272 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.818 ' HB3' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.837 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.392 0 CA-C-O 120.99 0.217 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.511 ' HB2' ' CD ' ' A' ' 105' ' ' LYS . 2.3 t -102.74 151.52 22.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.672 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.668 ' CE2' ' HB2' ' A' ' 14' ' ' ALA . 5.0 t80 -132.1 152.76 51.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.695 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.592 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -111.13 126.11 54.49 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 110.826 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.717 ' HB1' ' CB ' ' A' ' 31' ' ' LEU . . . -131.18 154.12 48.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.154 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.562 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 19.8 tt0 -98.86 124.89 44.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.018 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.935 HG22 ' O ' ' A' ' 100' ' ' GLN . 6.4 m -70.69 115.71 10.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 110.561 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 17' ' ' VAL . 13.7 p -146.05 14.91 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.047 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 29' ' ' PHE . . . -150.34 117.63 0.86 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.064 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.791 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -155.74 52.82 0.58 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.654 -0.773 . . . . 0.0 109.996 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.406 ' OD1' ' C ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -95.6 150.72 20.03 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.679 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 7.8 m95 -88.86 112.39 23.2 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.602 HG22 ' HB ' ' A' ' 26' ' ' THR . 2.6 m -76.92 -23.13 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.569 0.7 . . . . 0.0 109.74 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.522 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 38.8 m -150.5 -175.27 5.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.3 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.97 -57.02 9.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.632 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -121.92 49.25 1.58 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.724 179.308 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.602 ' HB ' HG22 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -147.56 141.12 25.48 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.473 -179.527 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.791 HG21 ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -140.8 148.26 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.162 -178.186 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.568 ' HG2' HD21 ' A' ' 30' ' ' LEU . 1.9 tt0 -108.74 129.23 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.554 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.876 ' CE1' HD21 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -124.37 121.83 36.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.622 -178.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.823 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -112.3 115.5 28.87 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.887 HD12 HD21 ' A' ' 76' ' ' LEU . 3.2 mt -120.64 133.74 55.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.261 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.465 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 29.6 mt-30 -145.64 110.18 5.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.601 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.562 ' HB2' ' N ' ' A' ' 15' ' ' GLU . 8.1 tmtm? -156.43 6.28 0.18 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.545 ' CD ' ' HB2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.158 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.332 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.86 ' HA ' ' N ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER . . . . . 0 C--O 1.21 -0.986 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.758 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 10.4 ttmt -13.85 74.0 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.854 0.861 . . . . 0.0 112.886 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.596 ' N ' ' O ' ' A' ' 43' ' ' VAL . 55.4 t80 -99.19 -103.59 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.655 0.264 . . . . 0.0 110.868 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.5 OUTLIER -113.42 155.76 44.23 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 120.771 0.319 . . . . 0.0 110.703 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 1.032 ' HD2' HG21 ' A' ' 110' ' ' VAL . 72.8 Cg_exo -49.53 80.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.665 2.243 . . . . 0.0 112.231 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 49.09 63.47 3.93 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.762 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.531 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -48.45 -179.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.576 -0.157 . . . . 0.0 110.576 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.664 ' CD1' ' CB ' ' A' ' 65' ' ' SER . 0.2 OUTLIER -131.95 163.21 28.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.947 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.535 ' O ' ' CB ' ' A' ' 63' ' ' SER . 2.6 mmt -129.9 -168.41 1.95 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.942 0.401 . . . . 0.0 111.703 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -138.47 96.34 3.15 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.957 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -132.82 158.18 43.14 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.764 -177.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.889 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -106.85 151.13 25.62 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.983 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.01 ' CA ' ' O ' ' A' ' 103' ' ' SER 10.821 1.9 mp -53.53 102.83 0.33 Allowed Pre-proline 2 N--CA 7.684 311.237 3 C-N-CA 11.143 -44.223 . . . . 0.0 17.059 -71.011 . . . . . . . . 5 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.824 ' HD3' ' HB ' ' A' ' 55' ' ' ILE . 7.2 Cg_endo -95.54 4.88 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 1 CA-C-N 103.419 -4.886 . . . . 0.0 111.153 72.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 105.82 2.43 39.77 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.494 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.811 HG23 ' CG ' ' A' ' 56' ' ' PRO . 27.0 p -46.43 -105.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.582 0.229 . . . . 0.0 111.345 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.889 ' N ' HG21 ' A' ' 54' ' ' THR . 6.0 p-10 172.33 29.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 60' ' ' VAL . 58.3 t -137.99 34.47 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.733 0.302 . . . . 0.0 111.223 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.598 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 38.8 t -107.82 -104.77 0.35 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.738 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 162.94 -173.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.095 0.474 . . . . 0.0 111.501 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -88.97 135.05 33.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.21 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.611 ' CE1' ' HB2' ' A' ' 78' ' ' PHE . 1.7 t80 -134.16 126.03 29.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.747 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.664 ' CB ' ' CD1' ' A' ' 50' ' ' PHE . 91.6 p -64.77 106.67 1.05 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.569 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.573 ' CB ' HD13 ' A' ' 76' ' ' LEU . 90.5 Cg_endo -92.15 171.03 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.639 2.226 . . . . 0.0 112.72 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . . . -87.2 159.36 18.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.513 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.575 ' HB3' ' O ' ' A' ' 67' ' ' ALA . 9.2 t30 82.17 138.74 0.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 124.167 0.917 . . . . 0.0 110.371 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.596 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER 151.64 -46.58 0.0 OUTLIER Pre-proline 0 CA--C 1.512 -0.512 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.793 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.758 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 97.6 Cg_endo -92.74 55.15 0.53 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.167 2.578 . . . . 0.0 111.609 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.567 ' N ' ' N ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER 158.16 109.17 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.413 -179.012 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.86 ' N ' ' HA ' ' A' ' 43' ' ' VAL . 6.2 Cg_endo -48.18 106.15 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.274 2.649 . . . . 0.0 113.88 -177.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -158.71 -74.73 0.08 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.803 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . 105.36 72.56 0.86 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.011 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 9.7 mtm180 -151.98 109.25 3.57 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.887 HD21 HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -93.88 128.03 39.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.622 -178.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.707 ' N ' HD12 ' A' ' 76' ' ' LEU . 56.0 mt-10 -130.26 115.75 17.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.236 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.686 ' CD1' ' CG2' ' A' ' 80' ' ' ILE . 1.6 p90 -121.5 135.04 55.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.865 0.364 . . . . 0.0 110.996 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.921 HD22 ' HB2' ' A' ' 131' ' ' ALA . 0.6 OUTLIER -114.78 82.17 1.68 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.979 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.686 ' CG2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -92.14 129.2 43.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.108 -179.161 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -77.52 110.13 12.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.233 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.57 ' CG2' ' CB ' ' A' ' 89' ' ' SER . 4.4 m -102.5 127.81 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.293 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.724 HD12 ' HB2' ' A' ' 87' ' ' ARG . 13.5 mt -42.66 166.56 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 83' ' ' LEU . 74.7 Cg_exo -49.77 -50.01 14.37 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.654 2.236 . . . . 0.0 112.391 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 175.83 67.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 87' ' ' ARG . . . 176.27 64.25 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.575 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.724 ' HB2' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER 164.07 -93.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.676 0.274 . . . . 0.0 111.005 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.599 ' CE1' ' CG1' ' A' ' 55' ' ' ILE . 1.1 t80 -94.99 -29.96 14.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.343 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.57 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 4.8 p -81.36 -27.14 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.862 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.516 ' O ' ' ND2' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -75.8 -43.44 46.21 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.571 0.701 . . . . 0.0 109.822 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -72.89 -25.29 61.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.934 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.7 OUTLIER -68.46 -47.49 67.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.282 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.446 ' O ' ' CD ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -90.2 -25.61 20.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 90' ' ' ASP . 17.1 m-80 -96.9 2.29 51.5 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.166 -0.213 . . . . 0.0 111.343 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.59 19.72 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.955 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . . . -146.96 27.68 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.671 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 96' ' ' ALA . 39.7 mmm-85 -45.39 173.36 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.114 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.736 HG13 ' HB ' ' A' ' 16' ' ' VAL . 0.5 OUTLIER -95.31 -144.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.44 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.37 -44.9 1.99 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.986 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.935 ' O ' HG22 ' A' ' 16' ' ' VAL . 9.3 pt20 -83.52 -158.52 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.282 0.563 . . . . 0.0 112.372 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.521 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 5.3 p -125.13 144.19 36.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.483 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.957 HD11 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.32 136.1 49.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.711 0.291 . . . . 0.0 110.638 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . 1.01 ' O ' ' CA ' ' A' ' 55' ' ' ILE . 16.1 t -102.67 127.22 49.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.03 0.443 . . . . 0.0 111.066 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.847 ' HA ' ' CA ' ' A' ' 55' ' ' ILE . 2.0 m -101.37 122.61 53.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.978 ' HG3' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -130.18 113.01 13.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.624 -178.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 52' ' ' ASP . . . -173.56 85.14 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.972 -1.108 . . . . 0.0 113.779 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.01 64.37 1.36 Allowed 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.353 2.036 . . . . 0.0 110.786 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.44 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -88.47 173.75 8.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.231 -178.495 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.573 ' O ' ' CE2' ' A' ' 50' ' ' PHE . . . -108.54 174.51 18.79 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.282 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.032 HG21 ' HD2' ' A' ' 47' ' ' PRO . 18.7 m -107.46 109.2 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 121.605 0.717 . . . . 0.0 110.516 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 1.3 m-85 -121.54 132.82 54.92 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.26 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 215' ' ' TYR . . . 124.43 -86.98 0.37 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.012 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.6 ' HB3' ' CE2' ' A' ' 123' ' ' PHE . 0.4 OUTLIER -81.75 118.36 22.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.935 0.397 . . . . 0.0 110.001 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.641 ' CB ' ' CD2' ' A' ' 241' ' ' PHE . 0.9 OUTLIER -137.5 114.63 10.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.959 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.21 129.54 53.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.205 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.05 14.28 24.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.956 0.408 . . . . 0.0 111.114 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.26 -66.23 1.81 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.527 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.535 ' HA ' ' HB2' ' A' ' 147' ' ' ASN . 17.3 ttm -128.82 89.05 2.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.896 0.379 . . . . 0.0 110.376 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.66 ' HB3' ' HE ' ' A' ' 121' ' ' ARG . . . -167.15 142.92 3.5 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.597 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 97.1 Cg_endo -78.28 108.81 2.55 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 123.148 2.565 . . . . 0.0 112.219 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.66 ' HE ' ' HB3' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -136.99 153.03 50.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.949 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.616 ' CD2' ' HB2' ' A' ' 150' ' ' ARG . 2.1 m-85 -120.64 123.03 41.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.022 0.439 . . . . 0.0 110.985 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.945 ' CE1' HG11 ' A' ' 133' ' ' VAL . 45.6 t80 -108.23 111.3 23.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.181 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.834 HG23 ' HB2' ' A' ' 152' ' ' TYR . 3.2 p -98.15 112.25 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 121.473 0.654 . . . . 0.0 111.914 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.838 ' HB2' ' HE1' ' A' ' 123' ' ' PHE . . . -118.23 132.22 56.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.815 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.706 ' O ' HD21 ' A' ' 246' ' ' LEU . . . -123.98 101.97 0.7 Allowed Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.433 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.596 ' N ' HG12 ' A' ' 155' ' ' VAL . . . 142.1 -152.01 23.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.006 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.745 ' CG2' HD23 ' A' ' 79' ' ' LEU . 32.1 m -119.39 -15.82 9.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.056 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.534 ' C ' ' CZ ' ' A' ' 245' ' ' PHE . . . -66.65 9.37 0.9 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.8 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.934 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -80.4 4.72 17.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 120.875 0.369 . . . . 0.0 110.01 179.511 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.921 ' HB2' HD22 ' A' ' 79' ' ' LEU . . . -46.8 -52.5 31.77 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.516 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 131' ' ' ALA . 39.8 Cg_endo -65.68 -30.83 50.43 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.915 1.743 . . . . 0.0 109.946 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.954 ' O ' HG23 ' A' ' 137' ' ' VAL . 41.6 t -67.27 -45.75 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.403 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.934 HG13 ' HG ' ' A' ' 130' ' ' LEU . 15.5 m -70.6 -29.81 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.012 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.21 -52.56 58.21 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 109.991 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.562 ' CE ' ' CE ' ' A' ' 140' ' ' MET . 7.8 tpt -62.29 -44.12 97.25 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.312 0.577 . . . . 0.0 109.504 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.988 HG12 ' NE2' ' A' ' 141' ' ' GLN . 61.5 t -61.61 -30.21 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.079 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -36.29 80.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.412 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.32 -42.83 87.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 110.236 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.646 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 2.4 tpp -70.56 -33.26 70.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.002 0.906 . . . . 0.0 110.103 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.988 ' NE2' HG12 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -77.32 -29.81 53.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.307 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -71.7 -45.11 62.89 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.796 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -77.25 -22.41 52.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.389 0.614 . . . . 0.0 109.798 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 145' ' ' ALA . 1.2 p 58.4 26.3 13.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.229 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.796 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -37.01 160.4 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.541 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.64 14.15 1.05 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.12 2.547 . . . . 0.0 113.328 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 118' ' ' MET . 2.1 p-10 -83.14 132.3 35.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.99 0.424 . . . . 0.0 111.779 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 1.0 OUTLIER -73.94 105.12 5.05 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.626 0.727 . . . . 0.0 111.08 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.697 ' HB ' HD11 ' A' ' 177' ' ' LEU . 2.7 m -113.48 115.5 28.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.109 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.616 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -105.66 139.81 39.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.094 0.473 . . . . 0.0 110.157 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.42 HD11 ' HD1' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -133.98 126.93 51.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.51 -178.264 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.834 ' HB2' HG23 ' A' ' 124' ' ' VAL . 17.3 m-85 -103.15 108.7 19.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.551 ' CE1' ' CD1' ' A' ' 130' ' ' LEU . 31.9 t80 -125.92 156.36 39.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 182' ' ' CYS . . . 153.87 -172.62 32.57 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.711 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.741 HG21 HD13 ' A' ' 161' ' ' LEU . 22.4 m -161.97 -124.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.621 ' CA ' HG22 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -108.67 160.14 16.18 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 117.484 0.129 . . . . 0.0 110.978 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.68 HG22 ' N ' ' A' ' 187' ' ' SER . 0.1 OUTLIER -4.69 -65.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.66 0.784 . . . . 0.0 112.315 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 156' ' ' ASN . 1.4 mt-10 165.67 59.14 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.229 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.458 ' HD3' ' H ' ' A' ' 158' ' ' GLU . 26.5 Cg_exo -61.2 -16.45 46.49 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.736 1.624 . . . . 0.0 109.491 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.496 ' O ' ' O ' ' A' ' 161' ' ' LEU . 1.3 tp10 174.26 -58.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.779 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.741 HD13 HG21 ' A' ' 155' ' ' VAL . 3.5 tp 41.63 -177.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.306 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.566 ' CG ' ' O ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER 154.56 179.95 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.701 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.574 ' CE1' ' HG2' ' A' ' 166' ' ' GLU . 0.0 OUTLIER 83.01 3.41 1.0 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.695 179.323 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 1.019 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -56.84 -41.21 75.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 1.019 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.6 OUTLIER -64.9 -27.6 68.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.831 178.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.574 ' HG2' ' CE1' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -71.54 -46.61 59.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.955 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.954 ' HB2' HG21 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -59.72 -30.09 68.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.515 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.467 ' HE3' HG12 ' A' ' 164' ' ' ILE . 11.9 mttt -75.83 -24.47 55.85 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -32.75 65.96 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.745 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.982 ' HB2' HD23 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -66.89 -48.09 69.8 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.163 176.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.924 ' OE2' HG12 ' A' ' 179' ' ' VAL . 1.2 mm-40 -56.97 -39.61 74.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.284 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -29.32 40.22 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.532 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 174' ' ' MET . 49.5 m -79.63 -72.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.778 ' CB ' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -52.42 -163.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.182 0.515 . . . . 0.0 111.76 -178.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -114.24 -42.34 3.36 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.604 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.499 ' HB2' ' CB ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -132.21 64.02 1.61 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.077 -179.51 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.982 HD23 ' HB2' ' A' ' 170' ' ' LEU . 3.2 mp -102.69 152.74 20.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.262 0.554 . . . . 0.0 111.388 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.482 ' OG1' ' HD3' ' A' ' 150' ' ' ARG . 27.3 m -136.51 114.82 11.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.899 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.954 HG21 ' HB2' ' A' ' 167' ' ' LEU . 8.9 p -99.63 135.27 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.431 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -112.74 135.62 53.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.027 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.513 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -104.38 106.76 17.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.213 0.53 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.655 ' HB2' ' HA3' ' A' ' 154' ' ' GLY . 31.3 m -80.07 -163.7 0.58 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.334 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.621 HG22 ' CA ' ' A' ' 156' ' ' ASN . 24.1 t 66.72 149.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 122.365 1.078 . . . . 0.0 113.639 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.695 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -139.09 -84.17 0.26 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.846 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.699 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 1.6 m-70 -140.78 29.27 0.11 Allowed Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.43 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.699 ' HD3' ' N ' ' A' ' 185' ' ' HIS . 52.3 Cg_exo -53.88 -138.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 122.209 1.939 . . . . 0.0 113.714 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.68 ' N ' HG22 ' A' ' 157' ' ' THR . 47.0 t 173.24 35.59 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.402 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.498 ' H ' ' CB ' ' A' ' 156' ' ' ASN . . . 86.52 16.18 62.56 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.145 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.51 64.76 1.45 Allowed 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' A' ' 249' ' ' GLY . 13.3 t-105 -133.37 127.39 33.37 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.687 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.516 ' HG2' ' CG ' ' A' ' 219' ' ' PRO . 1.2 mt-10 -113.98 105.74 13.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.717 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.529 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 148.44 -108.6 0.42 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.351 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.566 ' HA ' ' HB3' ' A' ' 182' ' ' CYS . 16.4 mt-10 -168.89 -95.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.513 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 64.5 mt-30 -86.95 133.95 33.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.61 ' HA2' ' CD1' ' A' ' 184' ' ' TRP . . . -22.24 106.82 0.01 OUTLIER Glycine 0 C--N 1.333 0.406 0 O-C-N 123.717 0.635 . . . . 0.0 113.214 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 5.9 m 140.11 158.98 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 O-C-N 124.245 0.615 . . . . 0.0 110.539 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.455 ' O ' ' HB ' ' A' ' 198' ' ' ILE . 49.4 Cg_exo -54.08 -70.44 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.445 2.097 . . . . 0.0 112.077 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.72 ' O ' HG23 ' A' ' 198' ' ' ILE . 0.3 OUTLIER 169.65 29.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 121.665 0.745 . . . . 0.0 111.111 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.507 ' OD1' ' NH2' ' A' ' 202' ' ' ARG . 1.4 m-20 -64.11 -36.81 85.25 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.312 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.33 -37.53 78.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.547 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -69.42 -35.22 75.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.812 0.339 . . . . 0.0 110.978 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.704 ' HG2' HD13 ' A' ' 229' ' ' LEU . 26.8 mtt180 -59.37 -49.96 75.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.421 0.629 . . . . 0.0 111.246 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -31.94 71.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.63 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.451 ' OD1' ' OD2' ' A' ' 209' ' ' ASP . 0.5 OUTLIER -58.56 -43.23 89.29 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.287 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.725 HD12 ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -61.24 -48.24 82.36 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.486 ' OE2' ' HG3' ' A' ' 233' ' ' ARG . 2.4 mt-10 -62.25 -22.15 65.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.706 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.65 -86.8 0.28 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.823 0.344 . . . . 0.0 111.623 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 0.0 OUTLIER 179.37 97.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.806 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.674 ' O ' ' HB3' ' A' ' 210' ' ' ALA . 3.9 p30 152.55 87.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.537 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ALA . . . . . 1.043 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 96.37 106.09 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.657 ' HA ' HD13 ' A' ' 235' ' ' ILE . 1.1 t30 -172.39 -58.82 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.737 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 10.0 Cg_endo -52.72 -64.47 0.18 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.218 1.945 . . . . 0.0 110.895 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.551 ' HA ' HG21 ' A' ' 240' ' ' VAL . 0.4 OUTLIER -125.34 110.19 13.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.371 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 1.043 HD11 ' HB1' ' A' ' 210' ' ' ALA . 1.0 OUTLIER -107.45 125.71 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 114' ' ' LYS . 2.3 m-85 -116.13 129.68 56.44 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.648 HD23 HG12 ' A' ' 124' ' ' VAL . 0.6 OUTLIER -139.86 123.42 17.23 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -178.055 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 217' ' ' CYS . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 123' ' ' PHE . 2.5 m -123.75 110.37 14.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.71 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.667 ' HA3' ' HB3' ' A' ' 250' ' ' ALA . . . -176.98 -156.85 16.73 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.678 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.518 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 37.3 Cg_endo -65.79 175.61 4.35 Favored 'Trans proline' 0 N--CA 1.466 -0.11 0 C-N-CA 122.326 2.017 . . . . 0.0 111.687 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 219' ' ' PRO . 26.2 Cg_endo -62.53 -8.84 13.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.457 2.105 . . . . 0.0 112.136 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -83.15 -40.36 9.3 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 120.734 -0.745 . . . . 0.0 113.127 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.56 ' HB2' ' HB1' ' A' ' 250' ' ' ALA . 0.0 OUTLIER -56.38 -33.85 66.12 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.536 ' CB ' ' HE2' ' A' ' 222' ' ' MET . 0.0 OUTLIER -77.6 -36.81 23.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.896 178.533 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.481 ' OD1' HG22 ' A' ' 223' ' ' ILE . 16.0 m-20 -73.94 -47.67 35.98 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 251' ' ' ALA . . . -73.22 -48.68 33.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 1.017 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -60.85 -34.07 74.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.823 0.344 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 223' ' ' ILE . 8.0 m -70.0 -32.28 70.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.029 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -71.09 -45.32 63.93 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.568 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.704 HD13 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -62.43 -46.21 89.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.112 0.482 . . . . 0.0 110.799 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 1.017 HG23 ' O ' ' A' ' 226' ' ' ALA . 13.0 t -60.01 -45.58 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.106 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -67.55 -29.82 69.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.187 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -31.37 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.945 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.725 ' HD3' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -84.22 -83.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.135 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 235' ' ' ILE . . . 140.87 -23.68 2.61 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.33 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.657 HD13 ' HA ' ' A' ' 211' ' ' ASN . 1.4 pp -31.51 105.17 0.23 Allowed Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-O 121.128 0.489 . . . . 0.0 111.681 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.486 ' O ' ' OD1' ' A' ' 211' ' ' ASN . 79.0 Cg_exo -33.15 158.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.605 2.87 . . . . 0.0 112.542 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 238' ' ' GLU . . . 68.84 6.08 49.65 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.693 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.665 ' C ' HG11 ' A' ' 230' ' ' VAL . 2.9 mp0 29.12 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.841 0.353 . . . . 0.0 111.253 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.985 ' HG2' HG21 ' A' ' 230' ' ' VAL . 7.5 mt-30 -122.68 -2.62 8.83 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.658 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.801 HG12 ' N ' ' A' ' 241' ' ' PHE . 2.3 t 52.25 -82.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.153 0.501 . . . . 0.0 111.344 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.801 ' N ' HG12 ' A' ' 240' ' ' VAL . 10.1 m-85 -119.28 125.4 49.01 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.26 129.62 37.89 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.874 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -132.21 148.26 52.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.048 178.705 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -125.37 106.55 9.91 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.657 ' O ' HD23 ' A' ' 246' ' ' LEU . 0.2 OUTLIER -136.94 144.9 43.67 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 178.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.706 HD21 ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER 83.29 160.8 0.12 Allowed Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.429 0.691 . . . . 0.0 112.775 179.109 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -61.66 -138.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.67 2.913 . . . . 0.0 111.741 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.435 ' HB2' ' C ' ' A' ' 190' ' ' TRP . 10.1 p -72.84 145.84 46.67 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.298 0.571 . . . . 0.0 110.858 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 190' ' ' TRP . . . 167.98 -53.99 0.22 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.667 ' HB3' ' HA3' ' A' ' 218' ' ' GLY . . . -107.69 149.12 28.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.54 -0.33 . . . . 0.0 110.49 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.687 ' O ' ' HB3' ' A' ' 225' ' ' ALA . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.173 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 m -96.29 150.6 20.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.889 0.376 . . . . 0.0 111.07 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.592 ' CE1' ' O ' ' A' ' 13' ' ' GLU . 2.6 t80 -132.09 149.02 52.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.939 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.592 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 3.9 mt-10 -108.79 119.81 40.63 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.873 0.368 . . . . 0.0 111.02 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.897 ' O ' HG13 ' A' ' 101' ' ' VAL . . . -119.74 131.78 55.46 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.965 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.544 ' CB ' ' HB2' ' A' ' 33' ' ' LYS . 1.2 tt0 -92.71 137.57 32.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.117 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.763 ' HA ' HD23 ' A' ' 31' ' ' LEU . 10.9 t -71.28 124.55 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.75 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 17' ' ' VAL . 7.6 p -154.36 22.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.126 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.496 ' HA3' ' HG ' ' A' ' 30' ' ' LEU . . . -150.55 -139.77 3.09 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.548 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.767 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER 82.57 62.71 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.174 0.512 . . . . 0.0 110.471 -179.592 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.512 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -101.69 148.96 24.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.589 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 12.2 m95 -89.16 114.63 25.94 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 m -95.04 -27.6 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 121.529 0.681 . . . . 0.0 109.301 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.543 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 13.8 m -143.9 173.68 11.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.348 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -54.27 -58.07 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.958 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 0.3 OUTLIER -112.69 39.23 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.801 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.617 ' CG2' HG21 ' A' ' 128' ' ' THR . 0.2 OUTLIER -145.92 135.53 23.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.522 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.767 HG21 ' CD2' ' A' ' 19' ' ' LEU . 1.5 p -140.6 147.19 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.084 0.469 . . . . 0.0 112.019 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -116.57 122.17 43.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.981 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.751 ' CZ ' HG13 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -114.09 121.35 43.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.797 0.332 . . . . 0.0 111.726 -178.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.822 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -108.62 116.37 31.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.883 179.046 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.97 HD22 HD11 ' A' ' 102' ' ' LEU . 2.3 mt -122.63 133.15 54.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.048 0.452 . . . . 0.0 111.746 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.486 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -145.05 131.37 19.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.079 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.544 ' HB2' ' CB ' ' A' ' 15' ' ' GLU . 7.2 tptm -164.74 -33.38 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.696 HG21 ' OD1' ' A' ' 68' ' ' ASN . 0.3 OUTLIER . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 121.435 0.636 . . . . 0.0 111.849 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HE3' ' CE1' ' A' ' 45' ' ' PHE . 4.8 tttp -154.72 -142.03 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.733 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.547 ' CE1' ' HE3' ' A' ' 44' ' ' LYS . 22.2 p90 -122.06 78.11 1.45 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.376 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 48' ' ' GLY . 28.1 mm-40 -113.04 166.55 10.86 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.579 ' HD2' HG11 ' A' ' 110' ' ' VAL . 32.1 Cg_exo -58.05 65.98 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.389 2.06 . . . . 0.0 111.616 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 40.39 62.46 1.57 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.223 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.508 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -30.32 148.98 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.716 0.258 . . . . 0.0 110.844 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.701 ' C ' HD23 ' A' ' 108' ' ' LEU . 5.3 m-85 -116.16 163.17 16.36 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.719 ' N ' HD23 ' A' ' 108' ' ' LEU . 4.7 mtt -131.41 162.56 29.89 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.962 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 105' ' ' LYS . 4.4 t0 -125.31 102.46 7.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.842 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.983 HD12 HG12 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -150.07 156.95 42.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.958 HG23 ' C ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -85.63 154.69 21.52 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.313 178.495 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.716 HD11 ' CZ ' ' A' ' 88' ' ' PHE . 1.3 mt -30.4 -71.91 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 123.411 0.444 . . . . 0.0 109.906 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.907 ' CG ' HG23 ' A' ' 58' ' ' THR . 9.3 Cg_endo -99.82 4.47 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.568 2.179 . . . . 0.0 111.583 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 101.41 -3.05 54.0 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.832 -178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.907 HG23 ' CG ' ' A' ' 56' ' ' PRO . 64.9 p -27.81 -87.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 122.841 0.456 . . . . 0.0 112.084 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.683 ' O ' HG12 ' A' ' 60' ' ' VAL . 43.9 p-10 -150.45 40.02 0.75 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.958 ' C ' HG23 ' A' ' 54' ' ' THR . 0.3 OUTLIER 90.68 121.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 178.382 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.723 ' N ' HG23 ' A' ' 54' ' ' THR . 40.3 t -120.72 -66.95 1.01 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.708 0.766 . . . . 0.0 109.931 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -170.41 157.94 6.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.227 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.895 ' HB2' HD21 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -88.73 120.7 30.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.669 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.527 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 3.0 t80 -111.7 121.18 44.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.901 0.381 . . . . 0.0 111.608 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.694 ' CB ' ' CD1' ' A' ' 50' ' ' PHE . 82.4 p -55.56 98.69 0.17 Allowed Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.732 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.983 ' HB2' HD13 ' A' ' 76' ' ' LEU . 2.1 Cg_endo -82.94 155.34 15.13 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.83 2.353 . . . . 0.0 111.54 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 132' ' ' PRO . . . -144.65 130.65 19.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.711 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -115.88 -63.62 1.43 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.764 178.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 68' ' ' ASN . 0.6 OUTLIER 144.42 154.44 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.936 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.652 ' HD2' HD23 ' A' ' 69' ' ' LEU . 18.0 Cg_endo -59.63 96.89 0.1 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.283 1.989 . . . . 0.0 111.225 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.557 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -179.2 138.06 0.33 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.058 0.456 . . . . 0.0 111.519 -179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.07 79.63 3.07 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.377 . . . . 0.0 111.998 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.461 ' OE1' ' NH1' ' A' ' 75' ' ' ARG . 39.3 mt-10 -144.23 -72.84 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.961 0.41 . . . . 0.0 110.008 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.504 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . 122.83 97.08 1.33 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.335 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 74' ' ' GLY . 85.0 mtm-85 -162.33 83.66 0.55 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 122.633 0.373 . . . . 0.0 110.888 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.983 HD13 ' HB2' ' A' ' 66' ' ' PRO . 30.0 mt -96.91 145.94 25.42 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.61 0.719 . . . . 0.0 112.496 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 5.9 pt-20 -131.24 141.89 50.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.433 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.662 ' CE1' ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -115.95 133.76 55.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.013 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.995 HD22 ' HB2' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -101.58 82.31 2.28 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.431 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.662 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -91.22 118.01 35.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.854 -178.599 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.432 ' HG2' HG23 ' A' ' 26' ' ' THR . 0.0 OUTLIER -78.33 95.99 5.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.213 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.584 ' CG1' ' CG2' ' A' ' 80' ' ' ILE . 2.3 m -94.0 142.12 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.999 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.518 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -68.14 172.63 4.05 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.799 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 83' ' ' LEU . 44.6 Cg_endo -68.68 58.39 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 0.0 112.149 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 84' ' ' PRO . 0.6 OUTLIER 67.48 72.58 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 87' ' ' ARG . . . 173.12 66.58 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.691 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 163.09 -90.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 111.132 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.716 ' CZ ' HD11 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -108.6 -27.19 10.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.26 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.572 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -60.1 -32.99 71.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 111.185 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 0.8 OUTLIER -75.93 -32.0 59.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.386 0.612 . . . . 0.0 110.842 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.562 ' CG ' HD13 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -68.94 -51.26 41.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.878 -178.291 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.646 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -71.59 -30.75 66.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -31.04 18.07 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.662 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 2.1 t-20 -95.87 -11.29 26.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.7 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 91' ' ' TYR . 2.2 t70 -135.58 -15.28 1.87 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.646 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . . . -119.43 29.02 7.85 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.993 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 96' ' ' ALA . 1.1 mmt180 -56.58 -163.37 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.614 HG13 HG12 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -86.74 -153.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-O 121.195 0.522 . . . . 0.0 110.65 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.41 -47.26 1.38 Allowed Glycine 0 C--N 1.316 -0.548 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.469 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.756 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -96.55 179.45 5.0 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.549 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 14' ' ' ALA . 99.6 t -121.85 145.23 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.259 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.97 HD11 HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.6 120.36 40.74 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 108.57 13.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.983 HG12 HD12 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -108.49 165.43 4.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.066 0.46 . . . . 0.0 112.079 -177.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.63 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -132.24 112.49 12.29 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.475 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 51' ' ' MET . . . -103.54 44.97 1.38 Allowed Glycine 0 CA--C 1.519 0.321 0 C-N-CA 119.533 -1.318 . . . . 0.0 115.74 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.518 ' HD3' ' C ' ' A' ' 105' ' ' LYS . 82.5 Cg_endo -81.83 38.81 0.78 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.173 1.915 . . . . 0.0 111.481 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.895 HD21 ' HB2' ' A' ' 63' ' ' SER . 0.0 OUTLIER -88.33 173.19 8.89 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.813 0.816 . . . . 0.0 112.761 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.01 173.42 19.41 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.477 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.579 HG11 ' HD2' ' A' ' 47' ' ' PRO . 9.3 m -108.63 107.16 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 117.925 0.862 . . . . 0.0 110.923 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 0.3 OUTLIER -123.74 122.53 38.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.476 178.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 215' ' ' TYR . . . 123.35 -84.78 0.37 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.283 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.588 ' HB2' ' CE2' ' A' ' 123' ' ' PHE . 7.7 tp -75.88 117.87 18.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.057 0.456 . . . . 0.0 110.073 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.616 ' O ' ' CZ ' ' A' ' 215' ' ' TYR . 0.1 OUTLIER -138.7 127.3 23.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.605 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.535 ' HA ' ' CZ ' ' A' ' 121' ' ' ARG . 2.2 pp20? -112.45 134.56 53.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.624 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -110.32 6.35 22.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.974 0.416 . . . . 0.0 111.197 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.81 -75.73 0.4 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.544 ' HA ' ' CB ' ' A' ' 147' ' ' ASN . 3.7 mpp? -129.91 89.33 2.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.887 0.375 . . . . 0.0 110.524 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.49 ' O ' ' HD3' ' A' ' 121' ' ' ARG . . . -158.36 144.2 12.41 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.243 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.86 94.67 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.599 2.2 . . . . 0.0 111.613 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -127.81 150.45 49.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.257 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.745 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -124.17 144.39 49.95 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.923 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.885 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.9 t80 -128.35 115.36 18.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.746 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.76 HG21 ' CE ' ' A' ' 222' ' ' MET . 8.0 p -98.82 111.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.101 0.477 . . . . 0.0 111.33 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.564 ' HB2' HG11 ' A' ' 133' ' ' VAL . . . -111.31 132.84 54.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.784 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.454 ' HA3' ' C ' ' A' ' 249' ' ' GLY . . . -129.18 104.34 0.64 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.412 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 134.64 -166.13 24.33 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.033 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.839 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -98.84 -28.15 13.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.118 0.485 . . . . 0.0 110.56 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.57 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -65.5 8.24 0.8 Allowed Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.764 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.829 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -79.23 4.51 14.75 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.828 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.995 ' HB2' HD22 ' A' ' 79' ' ' LEU . . . -46.9 -44.57 47.26 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.904 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 8.9 Cg_exo -69.48 -30.89 22.86 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.425 2.084 . . . . 0.0 109.748 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.074 ' O ' HG23 ' A' ' 137' ' ' VAL . 13.7 t -68.12 -53.08 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.576 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.829 HG13 ' HG ' ' A' ' 130' ' ' LEU . 29.1 m -66.57 -30.47 49.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.625 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.3 OUTLIER -61.16 -50.73 71.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.183 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.438 ' HA ' ' CD ' ' A' ' 139' ' ' GLN . 0.5 OUTLIER -66.93 -43.03 84.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.791 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.074 HG23 ' O ' ' A' ' 133' ' ' VAL . 13.5 t -59.81 -37.59 72.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 134' ' ' VAL . 3.2 mtm-85 -69.43 -31.03 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.1 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.492 ' O ' ' HB3' ' A' ' 143' ' ' TRP . 43.7 mt-30 -63.15 -43.03 99.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.259 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.475 ' HE1' HG21 ' A' ' 149' ' ' THR . 3.9 ptp -71.38 -48.87 47.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.189 0.519 . . . . 0.0 110.6 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.529 ' NE2' ' CD2' ' A' ' 177' ' ' LEU . 0.7 OUTLIER -58.2 -30.99 66.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.716 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 138' ' ' ARG . 1.3 mt-10 -82.16 -37.31 26.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.266 0.555 . . . . 0.0 110.085 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.789 ' CD1' ' HB2' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -67.59 -9.65 44.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.651 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 143' ' ' TRP . 1.6 p 87.55 10.45 0.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.766 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.789 ' HB2' ' CD1' ' A' ' 143' ' ' TRP . . . -38.79 98.42 0.17 Allowed Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.737 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.543 ' HA ' ' HB2' ' A' ' 175' ' ' ARG . 81.0 Cg_endo -78.12 8.41 3.54 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.906 2.404 . . . . 0.0 112.679 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.583 ' OD1' ' HB1' ' A' ' 145' ' ' ALA . 14.7 p-10 -78.58 150.3 32.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.944 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 176' ' ' ASN . 0.2 OUTLIER -74.18 104.77 5.09 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.49 0.662 . . . . 0.0 110.99 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.7 OUTLIER -123.01 117.21 24.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.936 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.659 ' CB ' ' CD2' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -102.71 141.55 35.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.885 HD13 ' O ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -134.27 126.23 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.745 ' CE1' ' HB3' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -102.89 108.1 19.17 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.678 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.6 ' CD1' ' CD1' ' A' ' 130' ' ' LEU . 7.1 t80 -124.91 153.96 41.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.852 0.358 . . . . 0.0 111.949 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.686 ' O ' HG13 ' A' ' 155' ' ' VAL . . . 150.07 -168.21 30.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.711 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.91 HG21 HD13 ' A' ' 161' ' ' LEU . 16.4 m -163.52 -120.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.781 ' O ' HG21 ' A' ' 183' ' ' VAL . 1.7 p30 -103.93 -166.01 1.21 Allowed 'General case' 0 C--N 1.35 0.613 0 C-N-CA 122.371 0.268 . . . . 0.0 111.122 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.61 ' CG2' ' HA ' ' A' ' 187' ' ' SER . 0.1 OUTLIER -28.03 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.608 0.242 . . . . 0.0 111.415 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 156' ' ' ASN . 39.6 mt-10 93.35 41.0 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.684 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 37.7 Cg_endo -66.85 -26.09 44.91 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 C-N-CA 122.137 1.891 . . . . 0.0 110.626 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -130.58 20.8 5.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.208 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.91 HD13 HG21 ' A' ' 155' ' ' VAL . 9.9 tp -88.57 165.31 14.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.063 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.478 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 0.9 OUTLIER 176.26 -160.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.998 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.3 OUTLIER 72.85 26.63 2.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.243 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 1.047 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -69.8 -35.87 67.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.912 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 1.047 ' N ' HD13 ' A' ' 164' ' ' ILE . 9.2 m-20 -62.29 -28.47 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.299 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.466 ' O ' ' CD2' ' A' ' 170' ' ' LEU . 2.3 mm-40 -72.08 -47.46 51.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.705 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -64.22 -30.25 71.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.763 178.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 172' ' ' ARG . 4.8 mtmm -72.55 -24.8 61.17 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -35.82 71.17 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.415 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -67.64 -48.52 66.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.476 ' O ' ' SD ' ' A' ' 174' ' ' MET . 3.3 mt-10 -57.65 -32.15 67.0 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.864 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 168' ' ' LYS . 1.1 mtt-85 -79.56 -41.69 26.68 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 174' ' ' MET . 6.4 t -93.1 -50.67 5.4 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.911 ' HB2' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -35.62 167.19 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.966 0.889 . . . . 0.0 112.892 -178.585 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.543 ' HB2' ' HA ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -99.75 -71.92 0.68 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.473 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -124.63 56.31 1.3 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.787 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.911 HD13 ' HB2' ' A' ' 174' ' ' MET . 5.8 mp -114.47 154.69 27.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.397 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.472 ' OG1' ' HG3' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -136.06 117.79 15.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.464 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.464 ' HB ' ' OE2' ' A' ' 171' ' ' GLU . 91.0 t -89.66 134.32 29.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.6 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.552 ' CB ' ' HA ' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -104.13 135.72 45.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.013 0.435 . . . . 0.0 111.676 -179.302 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -103.14 107.05 17.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.905 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.698 ' HB3' ' HA ' ' A' ' 193' ' ' GLU . 38.1 m -79.91 -168.26 1.55 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.311 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 155' ' ' VAL . 52.5 t 70.07 148.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.875 0.845 . . . . 0.0 112.835 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.714 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.53 -53.3 0.6 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.586 -177.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.547 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 4.7 p-80 167.77 62.2 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 113.623 -1.626 . . . . 0.0 108.696 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.626 ' O ' ' CB ' ' A' ' 187' ' ' SER . 67.0 Cg_endo -95.65 -96.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.797 2.998 . . . . 0.0 114.305 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.626 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 28.6 t 136.78 78.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.985 0.514 . . . . 0.0 110.34 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.508 ' HA2' ' ND2' ' A' ' 156' ' ' ASN . . . 41.65 23.13 0.11 Allowed Glycine 0 C--N 1.329 0.148 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.066 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 187' ' ' SER . 0.2 OUTLIER -139.23 62.05 1.54 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.541 ' NE1' ' O ' ' A' ' 193' ' ' GLU . 19.4 t-105 -135.24 129.12 33.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 1.052 ' C ' ' HB3' ' A' ' 251' ' ' ALA . 1.6 mp0 -113.83 104.87 12.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.376 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.628 ' N ' ' HB3' ' A' ' 251' ' ' ALA . . . 147.0 -113.07 0.63 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.272 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.698 ' HA ' ' HB3' ' A' ' 182' ' ' CYS . 80.8 mt-10 -161.42 -118.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.578 ' O ' ' O ' ' A' ' 195' ' ' GLY . 2.1 tt0 -87.75 117.74 26.79 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 194' ' ' GLN . . . 31.74 104.31 0.01 OUTLIER Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.348 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.538 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 5.86 66.68 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.2 0.6 . . . . 0.0 112.435 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.502 ' HG2' ' HB2' ' A' ' 193' ' ' GLU . 22.2 Cg_endo -97.12 22.6 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.28 2.653 . . . . 0.0 113.872 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 201' ' ' LEU . 0.2 OUTLIER -87.92 -9.44 10.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.469 -179.641 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.16 -36.99 83.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -61.03 -29.58 69.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.334 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.557 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -64.04 -39.64 94.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.938 0.399 . . . . 0.0 110.13 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.638 ' HG2' HD13 ' A' ' 229' ' ' LEU . 12.9 mtt180 -58.88 -48.37 81.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.514 0.673 . . . . 0.0 110.259 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.29 -32.04 68.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.013 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.76 -42.65 89.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.707 ' HB2' HG21 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -60.47 -48.05 83.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.545 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.428 ' OE1' ' HG3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -61.31 -21.05 63.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.019 178.611 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.0 t -86.31 -90.5 0.11 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.773 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 173.65 33.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.473 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.673 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 0.0 OUTLIER -145.09 58.46 1.29 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ALA . . . . . 0.851 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 148.87 101.02 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.23 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.595 ' O ' HG23 ' A' ' 240' ' ' VAL . 19.1 t30 173.84 -56.91 0.0 OUTLIER Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.175 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 12.3 Cg_endo -57.25 -53.74 4.43 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.265 1.977 . . . . 0.0 111.144 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.536 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -133.0 108.59 8.99 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.508 0.671 . . . . 0.0 109.319 178.463 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.93 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.8 OUTLIER -123.51 131.04 73.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.128 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.623 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -127.89 131.96 49.38 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.302 0.572 . . . . 0.0 110.679 -178.509 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.747 HD12 ' HB3' ' A' ' 242' ' ' PHE . 0.2 OUTLIER -142.53 119.49 11.3 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.787 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 217' ' ' CYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.5 OUTLIER -122.45 109.15 14.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.871 179.467 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.548 ' HA3' ' HB3' ' A' ' 250' ' ' ALA . . . -178.57 -147.52 7.08 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.618 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 220' ' ' PRO . 58.7 Cg_endo -72.48 174.5 11.52 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.504 2.136 . . . . 0.0 111.918 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 219' ' ' PRO . 26.8 Cg_endo -62.05 -8.66 12.48 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.551 2.167 . . . . 0.0 112.215 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -72.0 -54.16 8.51 Favored Glycine 0 C--O 1.224 -0.483 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.893 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.908 ' O ' ' HB3' ' A' ' 226' ' ' ALA . 1.1 tpp -55.31 -27.96 50.42 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.538 ' O ' ' CB ' ' A' ' 227' ' ' CYS . 0.0 OUTLIER -77.17 -41.56 30.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.404 178.276 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -75.37 -49.22 19.71 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.552 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -77.13 -49.53 15.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 222' ' ' MET . . . -62.63 -35.62 80.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.948 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 223' ' ' ILE . 52.3 t -70.19 -31.96 69.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 110.306 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.5 -44.95 81.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.638 HD13 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -61.02 -38.96 87.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.979 0.419 . . . . 0.0 111.011 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 226' ' ' ALA . 2.3 t -64.45 -45.29 96.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.288 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.5 ' CZ ' ' SG ' ' A' ' 227' ' ' CYS . 19.0 mtt180 -74.22 -29.97 61.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.871 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 2.7 m -75.43 -44.41 44.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.469 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.545 ' NE ' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -68.4 -45.01 73.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.191 -179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 235' ' ' ILE . . . 109.18 -31.01 8.02 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.983 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.707 HG21 ' HB2' ' A' ' 205' ' ' LEU . 1.2 pp -34.27 95.99 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-O 120.829 0.347 . . . . 0.0 111.4 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 235' ' ' ILE . 11.6 Cg_endo -55.25 112.5 1.06 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.744 2.296 . . . . 0.0 111.877 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -93.75 116.59 5.25 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.699 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -88.35 -46.77 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 110.67 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 241' ' ' PHE . 6.0 mt-30 -110.31 37.56 2.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.082 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.93 HG22 ' HB ' ' A' ' 214' ' ' ILE . 1.5 t -89.89 129.41 40.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.178 0.513 . . . . 0.0 110.348 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 239' ' ' GLN . 0.8 OUTLIER -146.11 135.1 22.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.451 -178.179 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.747 ' HB3' HD12 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -131.07 140.93 50.12 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.56 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 8.0 tp10 -131.42 148.66 52.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.108 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -111.51 106.73 15.69 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.593 ' CD1' ' HB2' ' A' ' 246' ' ' LEU . 0.1 OUTLIER -136.16 143.97 44.75 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.052 178.238 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.593 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 3.2 mt 59.42 151.12 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-O 120.95 0.405 . . . . 0.0 111.337 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' PRO . . . . . 0.473 ' HD2' HD22 ' A' ' 246' ' ' LEU . 24.9 Cg_exo -64.05 -141.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.128 2.552 . . . . 0.0 112.056 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 190' ' ' TRP . 0.5 OUTLIER -43.14 148.64 0.26 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.274 0.559 . . . . 0.0 111.662 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.454 ' C ' ' HA3' ' A' ' 126' ' ' GLY . . . 157.56 -66.88 0.29 Allowed Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.207 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.548 ' HB3' ' HA3' ' A' ' 218' ' ' GLY . . . -106.82 137.11 45.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.274 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 1.052 ' HB3' ' C ' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.699 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.41 0 CA-C-O 121.141 0.301 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -125.22 150.04 47.39 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.927 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.786 ' CZ ' HG11 ' A' ' 104' ' ' VAL . 1.5 p90 -133.79 166.73 21.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.789 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -103.77 137.33 41.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.249 0.547 . . . . 0.0 111.388 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.832 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -130.65 140.16 50.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.592 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . 2.3 tp10 -93.41 119.03 32.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.225 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 100' ' ' GLN . 9.9 m -71.34 107.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 17' ' ' VAL . 6.7 p -129.3 20.19 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.807 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -133.0 -128.73 2.92 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.639 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.878 HD21 ' CD1' ' A' ' 92' ' ' LEU . 0.1 OUTLIER 74.74 95.84 0.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.808 0.813 . . . . 0.0 109.407 -178.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 20' ' ' ASN . 18.7 p30 -142.19 137.76 31.04 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.607 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -88.5 112.49 23.04 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 m -90.27 -30.65 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.712 0.768 . . . . 0.0 109.32 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.544 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 19.0 m -137.3 175.04 9.96 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.626 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.7 t -51.09 -53.41 34.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.071 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 1.9 m120 -123.27 52.52 1.38 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.026 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.544 ' OG1' ' HB2' ' A' ' 23' ' ' SER . 0.2 OUTLIER -150.73 137.18 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.846 -179.489 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.659 HG12 HG13 ' A' ' 82' ' ' VAL . 2.0 p -141.27 147.15 22.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.119 0.485 . . . . 0.0 112.007 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.473 ' HG3' ' HG ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -119.98 113.63 20.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.154 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CB ' ' CZ ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -111.95 121.08 44.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.364 -179.259 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.561 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -102.67 119.49 38.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.329 179.359 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.023 HD22 HD23 ' A' ' 102' ' ' LEU . 1.2 mt -122.89 136.25 54.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 0.0 112.06 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 1.7 mt-30 -144.65 135.49 24.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.376 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.5 ' HG3' ' HB2' ' A' ' 15' ' ' GLU . 0.0 OUTLIER 166.21 -23.48 0.0 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.903 0.383 . . . . 0.0 111.962 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.621 ' HB3' ' CD1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.183 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.898 HG11 ' ND2' ' A' ' 68' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.013 0.435 . . . . 0.0 110.774 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -153.92 22.67 0.51 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.756 -178.318 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.61 ' CE1' ' HA ' ' A' ' 136' ' ' MET . 0.0 OUTLIER 58.21 127.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.538 -179.512 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.562 ' O ' ' N ' ' A' ' 48' ' ' GLY . 32.0 mt-10 -113.28 145.27 32.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.513 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 80.6 Cg_exo -45.11 81.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.63 2.22 . . . . 0.0 112.36 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 38.9 46.77 2.35 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.335 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.585 ' HA ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -71.88 151.18 43.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.622 0.249 . . . . 0.0 110.698 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.632 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -133.31 163.21 29.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.96 0.409 . . . . 0.0 111.392 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.546 ' O ' ' CB ' ' A' ' 63' ' ' SER . 1.7 mtt -131.74 -167.82 1.93 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.699 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' A' ' 105' ' ' LYS . 7.9 t0 -133.39 115.32 14.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.969 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.932 ' O ' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -149.6 157.39 43.21 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.528 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.872 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -109.97 150.87 27.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.737 179.319 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.808 HG23 ' HB2' ' A' ' 96' ' ' ALA . 1.5 mt -32.85 -77.12 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.828 ' HG2' HG23 ' A' ' 58' ' ' THR . 4.1 Cg_endo -96.01 9.31 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.199 1.932 . . . . 0.0 111.582 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 102.37 1.67 50.65 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.669 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.828 HG23 ' HG2' ' A' ' 56' ' ' PRO . 29.8 p -46.58 -104.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.661 0.267 . . . . 0.0 111.302 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.872 ' N ' HG21 ' A' ' 54' ' ' THR . 1.3 m-20 169.24 30.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.726 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.415 ' H ' ' CG2' ' A' ' 54' ' ' THR . 0.6 OUTLIER -140.89 34.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.684 0.278 . . . . 0.0 111.111 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.656 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 28.2 t -108.63 -104.17 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.901 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.455 ' CG ' ' O ' ' A' ' 61' ' ' SER . 0.3 OUTLIER 172.44 -169.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 111.019 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 51' ' ' MET . 1.8 m -101.89 145.07 29.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.86 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.644 ' CE2' HG22 ' A' ' 80' ' ' ILE . 2.4 t80 -143.51 130.3 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -59.84 105.49 0.57 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.454 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.826 ' CB ' HD13 ' A' ' 76' ' ' LEU . 57.6 Cg_endo -90.34 131.93 1.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.648 2.232 . . . . 0.0 111.482 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -144.28 138.61 28.07 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.898 ' ND2' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -113.21 -67.69 0.98 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.365 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.568 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER 151.03 150.5 0.0 OUTLIER Pre-proline 0 CA--C 1.521 -0.166 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.998 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.646 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 12.6 Cg_endo -56.75 96.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.719 1.613 . . . . 0.0 111.37 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.879 ' O ' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER 177.21 166.48 0.49 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-O 121.362 0.601 . . . . 0.0 112.053 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 71' ' ' ASN . 88.7 Cg_endo -90.5 73.64 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.347 2.698 . . . . 0.0 112.543 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.507 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 3.2 tp10 -129.19 -16.68 3.96 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.783 ' H ' HG13 ' A' ' 43' ' ' VAL . . . 42.46 78.78 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.23 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -155.96 112.85 3.18 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 120.738 0.304 . . . . 0.0 110.313 -178.684 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.826 HD13 ' CB ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -95.23 130.65 41.89 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.062 0.458 . . . . 0.0 110.275 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.746 ' N ' HD12 ' A' ' 76' ' ' LEU . 16.9 pt-20 -127.54 125.49 40.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.123 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.686 ' CD1' ' CG2' ' A' ' 80' ' ' ILE . 2.0 p90 -118.93 144.15 46.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.343 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.019 HD12 ' HB2' ' A' ' 131' ' ' ALA . 2.7 mt -112.6 74.97 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.73 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.686 ' CG2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -91.85 127.08 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.456 0.646 . . . . 0.0 111.085 -179.073 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 0.7 OUTLIER -78.59 105.98 10.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.194 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.659 HG13 HG12 ' A' ' 27' ' ' VAL . 2.6 m -96.17 122.45 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.206 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.88 HD12 ' HB2' ' A' ' 87' ' ' ARG . 16.2 mt -41.28 168.52 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.98 0.419 . . . . 0.0 111.178 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 52.8 Cg_exo -54.53 -49.66 16.09 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.703 2.269 . . . . 0.0 112.361 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 84' ' ' PRO . 2.5 mt-10 176.29 61.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 87' ' ' ARG . . . -175.86 57.72 0.11 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.749 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.88 ' HB2' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER 170.34 -95.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.597 0.237 . . . . 0.0 111.135 179.717 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.631 ' CE1' HD11 ' A' ' 55' ' ' ILE . 2.8 t80 -93.64 -27.01 16.82 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 111.195 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 80.4 p -73.16 -20.39 60.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 5.0 m-20 -74.22 -40.21 62.59 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.653 ' OH ' HG21 ' A' ' 58' ' ' THR . 0.9 OUTLIER -73.16 -21.14 60.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.867 178.782 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.957 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -65.76 -47.59 74.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.602 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -16.6 24.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.591 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 1.9 t-20 -99.82 1.71 43.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.561 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.511 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -171.1 22.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.957 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -138.56 28.39 2.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.235 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -51.51 -166.92 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.715 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.66 ' O ' HG12 ' A' ' 98' ' ' VAL . 2.1 t -125.21 95.96 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-O 121.463 0.649 . . . . 0.0 110.717 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 158.16 34.2 0.02 OUTLIER Glycine 0 C--N 1.316 -0.561 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.735 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.872 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -144.63 174.93 10.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.959 0.409 . . . . 0.0 111.198 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.5 p -105.59 143.74 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.466 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.023 HD23 HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -120.28 140.9 50.54 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.797 0.332 . . . . 0.0 110.986 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.52 ' N ' HD12 ' A' ' 102' ' ' LEU . 4.3 m -100.34 115.2 29.41 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.876 HG23 HD12 ' A' ' 53' ' ' LEU . 1.1 t -105.26 133.72 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.626 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -130.56 110.67 11.6 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.019 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.543 ' HA3' ' CB ' ' A' ' 51' ' ' MET . . . -123.75 84.08 0.36 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 119.597 -1.287 . . . . 0.0 114.924 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -91.72 30.05 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.126 2.551 . . . . 0.0 110.417 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -88.07 173.04 9.09 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.842 -178.252 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -114.59 174.71 15.62 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.317 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.793 HG23 ' HE2' ' A' ' 114' ' ' LYS . 35.9 m -107.62 107.45 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 117.91 0.855 . . . . 0.0 110.936 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.446 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 55.5 m-85 -123.0 114.75 20.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.548 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 241' ' ' PHE . . . 142.85 -88.92 0.17 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.366 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.833 HD22 ' CZ ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -82.86 116.4 22.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 110.565 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.793 ' HE2' HG23 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -139.19 110.6 7.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.514 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.512 ' HB2' ' NH1' ' A' ' 121' ' ' ARG . 2.0 tt0 -95.21 138.63 32.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.67 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -103.06 9.53 38.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.453 . . . . 0.0 111.071 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.88 -79.02 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.559 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.492 ' HA ' ' HB3' ' A' ' 147' ' ' ASN . 5.9 mtp -130.18 90.14 2.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.87 0.367 . . . . 0.0 110.44 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 121' ' ' ARG . . . -159.53 146.04 12.34 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.435 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.479 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 42.7 Cg_endo -67.35 102.43 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.696 2.264 . . . . 0.0 111.24 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.544 ' HB2' ' CE2' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -124.1 147.01 48.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.353 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.653 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 3.3 m-85 -110.19 122.3 47.3 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.99 ' CE2' HG13 ' A' ' 133' ' ' VAL . 2.3 t80 -123.46 126.61 47.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.671 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -131.34 145.24 35.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.049 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.813 ' HB2' HG11 ' A' ' 133' ' ' VAL . . . -116.95 133.68 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.288 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -102.49 103.8 2.5 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.939 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.8 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 105.41 -161.81 14.56 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.875 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 79' ' ' LEU . 19.4 m -96.14 -10.4 28.3 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 110.791 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.643 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -67.25 11.34 0.75 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.393 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.826 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.8 OUTLIER -73.01 3.08 5.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 122.662 0.385 . . . . 0.0 110.279 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 1.019 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -45.96 -40.95 18.27 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.27 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 2.9 Cg_endo -78.46 -31.02 2.88 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.821 2.347 . . . . 0.0 110.279 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.008 ' O ' HG23 ' A' ' 137' ' ' VAL . 24.6 t -65.14 -43.82 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.828 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.826 HG13 ' HG ' ' A' ' 130' ' ' LEU . 33.8 m -70.26 -31.26 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.704 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -51.09 66.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.61 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -62.42 -46.91 86.45 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.172 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 133' ' ' VAL . 23.6 t -60.1 -30.63 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.108 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -62.77 -36.52 83.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.438 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.569 ' HG3' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -63.93 -42.65 97.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.448 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.635 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -64.52 -34.25 77.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.771 0.796 . . . . 0.0 110.173 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.873 ' OE1' HD22 ' A' ' 170' ' ' LEU . 0.1 OUTLIER -79.36 -30.12 42.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.603 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -44.83 79.02 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.728 0.299 . . . . 0.0 111.356 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.802 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -82.46 -19.94 37.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.582 0.706 . . . . 0.0 109.718 179.026 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.501 ' O ' ' O ' ' A' ' 145' ' ' ALA . 5.1 m 51.61 29.45 5.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.268 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.802 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -37.22 162.3 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.824 0.345 . . . . 0.0 110.568 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.542 ' HD2' ' HB1' ' A' ' 145' ' ' ALA . 74.6 Cg_endo -78.79 13.32 1.96 Allowed 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.741 2.294 . . . . 0.0 112.955 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.492 ' HB3' ' HA ' ' A' ' 118' ' ' MET . 31.6 p-10 -91.35 136.71 32.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.153 0.502 . . . . 0.0 111.989 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 120' ' ' PRO . 3.6 pm0 -73.84 119.67 18.37 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.66 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 41.9 m -115.55 124.53 51.24 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.671 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.625 ' NE ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.4 131.17 47.63 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.845 178.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -127.19 109.08 19.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.43 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.69 ' O ' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -121.31 110.04 15.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.457 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.506 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 0.3 OUTLIER -122.22 147.3 46.36 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.394 -178.466 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.867 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -148.82 171.4 29.13 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.606 -1.283 . . . . 0.0 114.224 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 1.0 HG21 HD22 ' A' ' 161' ' ' LEU . 3.0 m -167.72 -111.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.872 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.4 OUTLIER -124.36 -170.32 2.12 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 120.709 0.29 . . . . 0.0 111.414 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.782 HG23 ' N ' ' A' ' 187' ' ' SER . 49.5 p -27.04 -64.47 0.08 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.705 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.9 mt-10 152.26 -50.75 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.312 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 85.9 Cg_exo -38.85 -26.84 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.745 2.297 . . . . 0.0 112.511 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -87.93 -30.87 19.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.025 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.0 HD22 HG21 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -105.07 -172.5 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.0 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 0.5 OUTLIER 176.71 -155.56 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.071 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.553 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 77.4 9.58 2.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.632 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.985 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -57.74 -44.33 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 110.162 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.985 ' N ' HD13 ' A' ' 164' ' ' ILE . 2.4 m-20 -62.43 -28.09 69.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.111 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 1.8 mt-10 -71.72 -47.41 54.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.837 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.553 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -62.34 -30.64 71.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.98 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 171' ' ' GLU . 13.2 mttm -60.41 -47.72 84.87 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -31.66 72.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.873 HD22 ' OE1' ' A' ' 141' ' ' GLN . 0.5 OUTLIER -65.15 -35.62 81.68 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.43 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.695 ' HA ' HD11 ' A' ' 177' ' ' LEU . 0.9 OUTLIER -62.96 -41.64 99.59 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.967 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.54 -37.65 59.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.397 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.5 t -65.34 -14.79 61.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.478 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.615 ' CG ' ' HB3' ' A' ' 177' ' ' LEU . 2.2 tpt -94.3 178.63 5.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.203 0.525 . . . . 0.0 111.311 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 6.0 tpp180 -96.18 -71.61 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.119 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -128.04 63.16 1.41 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.671 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.028 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -109.49 160.3 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.255 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . 1.028 ' N ' HD22 ' A' ' 177' ' ' LEU . 1.8 m -137.55 121.95 18.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.117 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.613 HG23 ' HG2' ' A' ' 171' ' ' GLU . 53.7 t -90.06 135.71 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.167 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.539 ' CB ' ' HB3' ' A' ' 152' ' ' TYR . 3.2 tptp -108.47 130.27 55.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.687 0.28 . . . . 0.0 110.882 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.54 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -99.78 104.61 16.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 111.038 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.67 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 63.1 m -80.43 -157.87 0.17 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.956 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.872 HG21 ' O ' ' A' ' 156' ' ' ASN . 22.5 t 57.66 143.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.485 0.66 . . . . 0.0 111.166 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.737 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -130.16 -59.82 1.03 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.916 -178.005 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.579 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 0.1 OUTLIER -168.06 51.84 0.22 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.692 178.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.624 ' O ' ' CB ' ' A' ' 187' ' ' SER . 96.2 Cg_endo -89.87 -98.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.967 2.445 . . . . 0.0 112.876 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.782 ' N ' HG23 ' A' ' 157' ' ' THR . 23.6 t 139.6 3.41 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.454 0.471 . . . . 0.0 112.199 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.589 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 124.22 11.47 4.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.539 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.31 62.4 1.59 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.569 ' CE3' ' N ' ' A' ' 191' ' ' GLU . 4.5 t-105 -129.86 116.25 18.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.387 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.569 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 0.9 OUTLIER -91.52 103.83 16.39 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.874 ' CA ' ' HB2' ' A' ' 251' ' ' ALA . . . 143.06 -123.82 2.2 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.344 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.869 ' OE2' HD11 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -163.1 -93.92 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.592 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -87.56 120.72 29.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 194' ' ' GLN . . . 5.14 107.3 0.0 OUTLIER Glycine 0 C--N 1.35 1.321 0 O-C-N 123.735 0.647 . . . . 0.0 112.748 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER 11.98 -73.11 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.7 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 196' ' ' SER . 75.3 Cg_exo -22.67 68.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.845 3.697 . . . . 0.0 114.535 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.869 HD11 ' OE2' ' A' ' 193' ' ' GLU . 0.3 OUTLIER -88.28 14.49 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.416 0.627 . . . . 0.0 110.311 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.485 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 0.2 OUTLIER -59.43 -36.24 75.53 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.911 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -58.72 -31.37 68.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.673 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.517 ' O ' ' CD2' ' A' ' 205' ' ' LEU . 0.2 OUTLIER -69.27 -34.15 74.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.154 0.502 . . . . 0.0 110.27 179.315 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.736 ' HG2' HD13 ' A' ' 229' ' ' LEU . 46.8 mtt180 -60.1 -45.72 92.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.325 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.74 -32.78 71.51 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.946 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 207' ' ' SER . 88.6 m-20 -58.95 -43.76 91.31 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.019 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.628 HD12 ' HD2' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -60.59 -45.86 92.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.414 ' CD ' ' HG3' ' A' ' 233' ' ' ARG . 1.1 mt-10 -62.15 -25.6 67.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.487 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 208' ' ' SER . 1.1 t -70.81 -86.71 0.02 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.157 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.41 ' N ' ' OG ' ' A' ' 207' ' ' SER . 0.5 OUTLIER 178.31 30.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.517 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.695 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 1.8 m-20 -148.87 60.98 1.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.779 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ALA . . . . . 0.789 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 155.96 97.22 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.655 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.762 ' HB2' HD13 ' A' ' 235' ' ' ILE . 17.6 t30 174.39 -56.53 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.992 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 27.5 Cg_endo -62.08 -50.49 4.86 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.477 2.118 . . . . 0.0 111.208 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.533 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -132.44 109.97 10.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.181 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.951 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.9 OUTLIER -123.26 125.42 71.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -123.06 127.5 48.84 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.76 0.791 . . . . 0.0 112.007 -177.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.486 ' O ' HD11 ' A' ' 223' ' ' ILE . 0.9 OUTLIER -134.97 115.36 13.46 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.716 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 217' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 1.8 t -124.64 112.81 17.22 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.55 ' N ' ' CD ' ' A' ' 219' ' ' PRO . . . 112.83 -40.08 2.65 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.285 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.575 ' HB2' ' CB ' ' A' ' 222' ' ' MET . 55.7 Cg_endo -91.84 83.9 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.618 2.212 . . . . 0.0 113.562 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.853 ' HD2' ' HB2' ' A' ' 250' ' ' ALA . 9.9 Cg_endo -52.03 -70.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.689 2.26 . . . . 0.0 111.587 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.84 ' H ' ' HB1' ' A' ' 250' ' ' ALA . . . -53.35 -48.17 60.46 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.836 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.575 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.2 OUTLIER -55.66 -25.14 37.88 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.427 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.594 HD11 ' H ' ' A' ' 243' ' ' GLU . 0.0 OUTLIER -75.84 -37.45 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.387 178.382 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -70.35 -46.67 63.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.849 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.564 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -70.18 -47.62 60.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.281 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.883 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -59.73 -39.97 86.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.329 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.3 t -70.28 -31.92 69.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.16 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -44.65 77.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.831 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.736 HD13 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -60.52 -35.93 77.16 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.108 0.48 . . . . 0.0 110.453 179.717 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 226' ' ' ALA . 2.8 t -65.68 -44.89 93.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.035 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.5 mtt85 -73.48 -30.3 63.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.0 -44.08 32.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.628 ' HD2' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -55.99 -59.69 4.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.989 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 137.65 -50.9 0.8 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.214 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.762 HD13 ' HB2' ' A' ' 211' ' ' ASN . 0.7 OUTLIER -34.99 94.84 0.08 OUTLIER Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.128 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 28.1 Cg_endo -62.7 127.47 20.71 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.825 2.35 . . . . 0.0 112.225 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -95.31 -175.33 37.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.687 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -157.47 -40.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 110.622 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.576 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 8.3 mm-40 -110.73 42.38 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.336 0.589 . . . . 0.0 110.48 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.951 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.4 t -91.64 137.52 21.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.652 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -141.69 140.73 33.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.159 -178.301 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.544 ' CB ' HG12 ' A' ' 223' ' ' ILE . 5.6 p90 -131.14 139.27 49.77 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.296 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLU . . . . . 0.594 ' H ' HD11 ' A' ' 223' ' ' ILE . 0.8 OUTLIER -131.79 148.74 52.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.036 179.015 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 220' ' ' PRO . 1.9 mptt -124.03 105.71 9.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.643 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.2 OUTLIER -138.02 145.84 42.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 178.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.55 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 5.2 mt 67.83 163.99 0.13 Allowed Pre-proline 0 N--CA 1.468 0.461 0 CA-C-O 120.81 0.338 . . . . 0.0 111.294 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' PRO . . . . . 0.478 ' CD ' HD22 ' A' ' 246' ' ' LEU . 54.9 Cg_endo -86.41 -103.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.284 2.656 . . . . 0.0 112.111 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 247' ' ' PRO . 32.3 m -37.93 137.29 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.013 0.435 . . . . 0.0 110.547 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 124.76 -15.38 7.5 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.853 ' HB2' ' HD2' ' A' ' 220' ' ' PRO . . . -107.49 110.76 22.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.957 -0.621 . . . . 0.0 111.515 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.874 ' HB2' ' CA ' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.108 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.454 ' C ' ' HG3' ' A' ' 105' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.349 0 CA-C-O 121.081 0.267 . . . . 0.0 112.637 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.529 ' CB ' ' HB2' ' A' ' 105' ' ' LYS . 25.4 t -123.48 150.04 44.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.845 0.355 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.789 ' CZ ' ' HB2' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -133.01 165.37 24.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.15 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.515 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 2.0 mp0 -105.98 133.08 51.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.134 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.791 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -123.23 144.29 49.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.727 0.299 . . . . 0.0 111.012 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 32' ' ' GLN . 1.2 pt-20 -93.58 120.75 34.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.811 0.338 . . . . 0.0 110.123 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.961 HG22 ' O ' ' A' ' 100' ' ' GLN . 3.9 m -71.67 105.74 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.252 0.549 . . . . 0.0 111.06 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.93 -33.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.018 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -79.18 -129.02 0.61 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.03 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.785 HD23 ' CB ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER 71.39 95.53 0.07 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.978 0.894 . . . . 0.0 109.747 -179.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -142.32 143.22 32.67 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.858 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.535 ' NE1' ' HD3' ' A' ' 93' ' ' ARG . 3.3 m0 -88.43 113.16 23.74 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 m -92.05 -29.9 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-O 121.747 0.784 . . . . 0.0 108.963 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.552 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 12.0 m -137.6 173.83 11.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.471 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.535 ' CB ' ' HG2' ' A' ' 160' ' ' GLU . 18.6 t -53.51 -53.34 52.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.095 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 82' ' ' VAL . 98.6 m-20 -119.19 47.6 1.65 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.397 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 1.008 ' CG2' HG21 ' A' ' 128' ' ' THR . 0.2 OUTLIER -149.02 140.97 23.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.735 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.591 ' CG2' HD13 ' A' ' 19' ' ' LEU . 1.4 p -140.34 147.4 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.144 0.497 . . . . 0.0 112.087 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.496 ' HG3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -113.8 105.26 13.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.932 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -100.07 128.69 46.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.882 -178.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 6.9 mp -118.35 116.86 27.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.899 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.791 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 5.1 mt -114.03 133.84 55.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.029 0.442 . . . . 0.0 112.054 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.516 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -144.27 136.71 26.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.648 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -170.43 -94.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.707 0.289 . . . . 0.0 111.586 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.523 0 CA-C-O 121.118 0.485 . . . . 0.0 110.185 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.921 HG21 ' CG ' ' A' ' 68' ' ' ASN . 0.6 OUTLIER . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 121.356 0.598 . . . . 0.0 111.66 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.542 ' HG2' ' CD1' ' A' ' 45' ' ' PHE . 5.9 ttpt -148.57 -141.63 0.11 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.689 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.542 ' CD1' ' HG2' ' A' ' 44' ' ' LYS . 48.6 p90 -95.06 56.46 1.94 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.282 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.6 OUTLIER -114.21 127.61 26.65 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 48' ' ' GLY . 63.3 Cg_exo -32.01 84.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.842 2.361 . . . . 0.0 112.111 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 33.32 73.06 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.889 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.504 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -32.66 154.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.906 0.353 . . . . 0.0 110.851 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.869 ' CZ ' HG12 ' A' ' 110' ' ' VAL . 1.3 m-85 -122.92 163.23 20.74 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.561 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -133.06 162.82 30.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.47 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 105' ' ' LYS . 2.8 t0 -122.66 109.29 14.09 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 110.249 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.73 ' CD1' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.16 158.9 44.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.53 0.681 . . . . 0.0 112.225 -178.351 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.772 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -103.09 151.0 23.06 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.455 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.983 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -32.32 -68.62 0.15 Allowed Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.72 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.983 ' HD3' HG23 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -103.89 2.27 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.926 2.417 . . . . 0.0 111.144 177.261 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 109.9 -0.07 30.26 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.084 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.828 HG23 ' CD ' ' A' ' 56' ' ' PRO . 30.4 p -31.16 -98.47 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.515 0.326 . . . . 0.0 111.449 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.772 ' N ' HG21 ' A' ' 54' ' ' THR . 10.1 p-10 160.5 31.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.71 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 59' ' ' ASP . 2.7 t -158.8 40.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.044 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.698 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 45.4 t -107.66 -103.34 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 4.7 mtm180 172.77 -174.36 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.99 0.424 . . . . 0.0 111.037 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -105.33 123.95 48.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.636 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 78' ' ' PHE . 1.2 t80 -107.36 126.14 52.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.819 0.343 . . . . 0.0 110.633 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.671 ' CB ' ' CD2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -63.78 104.94 0.57 Allowed Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.791 -179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.942 ' HB3' HD13 ' A' ' 76' ' ' LEU . 7.2 Cg_exo -73.25 152.74 50.52 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.528 2.152 . . . . 0.0 110.861 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.4 128.53 52.3 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.921 ' CG ' HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -135.71 -81.11 0.41 Allowed 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.631 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.66 HD22 ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER 146.59 171.65 0.0 OUTLIER Pre-proline 0 C--N 1.339 0.134 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.156 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 69' ' ' LEU . 29.4 Cg_endo -63.63 88.26 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 121.654 1.569 . . . . 0.0 111.858 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -170.41 139.29 1.42 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 111.173 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -86.8 67.13 4.48 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.942 2.428 . . . . 0.0 114.541 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.497 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 37.2 mp0 -136.77 -116.26 0.17 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.69 71.61 0.17 Allowed Glycine 0 CA--C 1.543 1.829 0 N-CA-C 116.114 1.206 . . . . 0.0 116.114 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -121.72 82.0 1.89 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.275 1.537 . . . . 0.0 110.296 178.345 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.942 HD13 ' HB3' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -97.17 129.3 44.55 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.333 0.587 . . . . 0.0 111.447 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.718 ' N ' HD12 ' A' ' 76' ' ' LEU . 3.5 mt-10 -130.77 121.17 24.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.739 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 29' ' ' PHE . 1.3 p90 -114.86 140.55 48.87 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.968 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.103 HD22 ' HB2' ' A' ' 131' ' ' ALA . 0.7 OUTLIER -102.44 84.1 2.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.349 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.613 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -90.37 139.94 16.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.728 -177.395 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.55 ' NE ' ' HD3' ' A' ' 247' ' ' PRO . 0.0 OUTLIER -78.05 112.03 14.56 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.517 HG23 ' N ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -105.9 138.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.783 -178.277 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 85' ' ' GLU . 9.0 mt -101.4 158.55 31.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.768 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 83' ' ' LEU . 26.2 Cg_endo -62.06 67.71 0.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.673 2.249 . . . . 0.0 112.023 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 83' ' ' LEU . 29.2 mm-40 75.63 53.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.647 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.14 -97.19 1.35 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.665 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -125.57 -48.46 1.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.67 0.271 . . . . 0.0 111.157 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.592 ' CZ ' ' HA ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -85.52 -32.95 21.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 0.0 110.859 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.582 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 3.3 p -70.01 -20.58 63.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.28 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 9.9 m-20 -77.25 -34.12 55.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.31 0.576 . . . . 0.0 110.867 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.961 ' HB2' HD11 ' A' ' 55' ' ' ILE . 35.0 t80 -73.51 -51.41 17.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.93 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.968 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -70.97 -29.63 65.68 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.074 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.535 ' HD3' ' NE1' ' A' ' 21' ' ' TRP . 8.4 mtm180 -90.55 -27.46 19.13 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.81 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 1.9 t-20 -102.56 -5.45 23.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.702 0.287 . . . . 0.0 110.845 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 91' ' ' TYR . 2.9 t70 -130.22 -23.47 2.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.968 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -96.51 28.67 3.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.15 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 7.2 mmm180 -97.03 -47.4 5.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.045 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.795 HG13 ' CG ' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -72.95 -1.17 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.864 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.662 ' HA2' HG23 ' A' ' 16' ' ' VAL . . . 77.05 20.41 75.82 Favored Glycine 0 C--N 1.32 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.047 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.961 ' O ' HG22 ' A' ' 16' ' ' VAL . 5.1 mt-30 -47.96 179.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 111.186 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.439 ' CG1' ' O ' ' A' ' 14' ' ' ALA . 2.1 t -109.54 139.77 31.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.977 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.73 HD11 ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -130.09 126.21 37.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.298 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.483 ' HB2' ' HG3' ' A' ' 13' ' ' GLU . 1.5 t -94.78 140.47 29.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 111.915 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.716 HG22 ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -115.91 142.22 30.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.901 178.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 25.6 ttpp -131.63 113.23 13.36 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.192 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 50' ' ' PHE . . . 162.49 98.38 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 118.921 -1.609 . . . . 0.0 114.592 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -92.9 29.95 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.414 2.743 . . . . 0.0 110.014 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -88.61 166.74 13.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.466 -177.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.59 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -146.07 171.78 26.89 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.354 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.869 HG12 ' CZ ' ' A' ' 50' ' ' PHE . 3.5 p -158.05 121.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.222 0.534 . . . . 0.0 111.067 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -70.1 135.93 49.72 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.508 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -146.66 -41.09 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.942 HD13 ' CE2' ' A' ' 123' ' ' PHE . 1.4 pt? -133.27 119.51 19.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.166 0.508 . . . . 0.0 110.432 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.651 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.4 OUTLIER -137.93 114.79 10.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.452 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.47 ' HA ' ' OH ' ' A' ' 215' ' ' TYR . 7.5 pm0 -83.62 140.62 32.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.693 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.41 15.01 5.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.746 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.82 -78.06 0.25 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.9 mtt -130.04 89.92 2.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.85 0.357 . . . . 0.0 110.153 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 121' ' ' ARG . . . -165.6 150.84 8.03 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.455 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 47.6 Cg_endo -68.75 104.83 1.21 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.806 2.337 . . . . 0.0 112.078 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.657 HH12 HG23 ' A' ' 149' ' ' THR . 0.0 OUTLIER -120.81 146.66 46.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.692 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.673 ' HB3' ' CZ ' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -115.52 141.05 48.58 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.168 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 1.123 ' CE2' HG13 ' A' ' 133' ' ' VAL . 1.1 t80 -122.42 117.16 25.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.866 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.745 HG23 ' CD1' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -106.2 113.29 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.365 0.602 . . . . 0.0 111.943 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.577 ' HB2' HG11 ' A' ' 133' ' ' VAL . . . -100.83 133.12 45.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.201 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.526 ' O ' HD11 ' A' ' 246' ' ' LEU . . . -112.47 103.62 1.48 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.643 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.861 ' HA3' HD21 ' A' ' 246' ' ' LEU . . . 106.31 -156.57 16.24 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.621 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.008 HG21 ' CG2' ' A' ' 26' ' ' THR . 8.6 m -100.35 -17.01 17.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.955 0.407 . . . . 0.0 111.132 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -63.71 10.1 0.23 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.098 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.565 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -77.86 3.62 13.95 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.895 0.348 . . . . 0.0 110.08 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 1.103 ' HB2' HD22 ' A' ' 79' ' ' LEU . . . -46.75 -43.96 42.25 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.966 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 2.8 Cg_exo -74.02 -30.74 8.68 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.933 2.422 . . . . 0.0 110.399 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.123 HG13 ' CE2' ' A' ' 123' ' ' PHE . 10.7 t -64.64 -46.82 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.601 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.565 HG13 ' HG ' ' A' ' 130' ' ' LEU . 19.3 m -66.86 -30.75 50.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.21 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -66.72 -50.82 61.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.859 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.782 ' HG3' HD21 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -63.88 -39.07 93.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.029 178.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 133' ' ' VAL . 27.7 t -62.61 -44.8 99.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.333 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -60.9 -31.04 70.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.229 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 136' ' ' MET . 75.2 mt-30 -63.47 -41.74 98.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.485 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.809 ' HG3' ' HB3' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -57.68 -51.98 67.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.687 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.57 ' OE1' HD21 ' A' ' 170' ' ' LEU . 1.7 mp0 -69.23 -33.46 73.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.701 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -80.89 -12.25 59.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.983 0.42 . . . . 0.0 111.012 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.671 ' C ' HG22 ' A' ' 144' ' ' THR . 3.8 m95 -89.21 -85.05 0.21 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.303 0.573 . . . . 0.0 111.554 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.671 HG22 ' C ' ' A' ' 143' ' ' TRP . 0.6 OUTLIER -174.69 26.52 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.652 -178.465 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.809 ' HB3' ' HG3' ' A' ' 140' ' ' MET . . . -111.81 54.39 0.42 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.388 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.526 ' O ' ' CB ' ' A' ' 175' ' ' ARG . 57.7 Cg_endo -70.75 -1.56 9.48 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.663 2.242 . . . . 0.0 112.132 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 146' ' ' PRO . 0.7 OUTLIER -50.43 -169.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 1.2 mt-10 -71.87 105.2 3.72 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.586 0.707 . . . . 0.0 110.294 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.657 HG23 HH12 ' A' ' 121' ' ' ARG . 98.8 m -117.43 117.38 29.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.595 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.657 ' CD ' ' CZ ' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -102.73 135.72 43.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.091 0.472 . . . . 0.0 110.493 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.658 HD13 ' O ' ' A' ' 123' ' ' PHE . 0.3 OUTLIER -133.19 109.72 14.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.033 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.745 ' CD1' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -107.1 109.27 21.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.646 ' HZ ' HD11 ' A' ' 161' ' ' LEU . 2.1 t80 -111.91 145.39 39.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.586 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.717 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -162.0 167.01 36.52 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.63 -1.748 . . . . 0.0 114.717 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 1.078 HG21 HD13 ' A' ' 161' ' ' LEU . 17.0 m -164.95 -119.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.471 -0.865 . . . . 0.0 110.998 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.864 ' O ' HG21 ' A' ' 183' ' ' VAL . 1.4 p30 -112.55 -171.38 1.85 Allowed 'General case' 0 C--N 1.343 0.284 0 O-C-N 122.243 -0.285 . . . . 0.0 111.118 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.573 ' CG2' ' HA ' ' A' ' 187' ' ' SER . 0.2 OUTLIER -32.01 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.768 0.318 . . . . 0.0 111.071 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 19.5 mt-10 89.05 39.1 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.305 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 24.8 Cg_endo -62.22 -25.97 77.25 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 C-N-CA 122.296 1.997 . . . . 0.0 110.698 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.535 ' HG2' ' CB ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -121.73 -28.15 4.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.045 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.078 HD13 HG21 ' A' ' 155' ' ' VAL . 5.3 tp -40.41 165.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.783 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 0.0 OUTLIER 177.38 -153.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.926 0.393 . . . . 0.0 111.079 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.524 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 72.33 7.68 5.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.361 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.976 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -59.72 -41.81 86.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.976 ' N ' HD13 ' A' ' 164' ' ' ILE . 18.5 m-20 -61.88 -27.84 69.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.179 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.509 ' HG3' ' CD1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -72.33 -41.85 66.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.994 179.576 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -71.5 -31.53 67.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.075 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.505 ' HD3' ' HA ' ' A' ' 165' ' ' ASP . 14.1 mtpp -61.3 -46.36 90.65 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 6.0 m -63.0 -31.87 73.11 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.57 HD21 ' OE1' ' A' ' 141' ' ' GLN . 1.0 OUTLIER -62.9 -36.67 84.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.346 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 1.01 ' HG2' HD11 ' A' ' 177' ' ' LEU . 3.6 mt-10 -63.04 -41.0 99.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.203 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -33.98 47.73 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.09 -6.59 53.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.022 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.694 ' CB ' HD23 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -106.29 -168.64 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.032 0.444 . . . . 0.0 111.242 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' A' ' 146' ' ' PRO . 6.9 ttt-85 -103.26 -64.43 1.08 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.901 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.91 66.37 1.4 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.431 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.01 HD11 ' HG2' ' A' ' 171' ' ' GLU . 0.6 OUTLIER -106.65 153.68 22.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.6 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.506 ' HB ' ' HG3' ' A' ' 150' ' ' ARG . 40.9 m -136.08 115.12 12.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.278 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 151' ' ' ILE . 8.8 p -89.66 135.1 26.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.658 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.38 133.92 47.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.101 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.551 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -98.66 104.26 16.28 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.463 0.649 . . . . 0.0 110.541 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.631 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 95.6 m -80.71 -167.44 1.38 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.186 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.864 HG21 ' O ' ' A' ' 156' ' ' ASN . 77.2 t 64.33 148.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.689 0.757 . . . . 0.0 111.822 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.717 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.45 -61.12 0.82 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.288 -178.267 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.539 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 0.7 OUTLIER -174.95 53.38 0.12 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.728 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.581 ' HG2' ' HA ' ' A' ' 156' ' ' ASN . 91.3 Cg_endo -86.88 -98.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.922 2.414 . . . . 0.0 112.632 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.573 ' HA ' ' CG2' ' A' ' 157' ' ' THR . 0.4 OUTLIER 156.35 -0.63 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.613 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 124.04 11.18 4.89 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.356 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.8 63.26 1.55 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.507 ' CE3' ' N ' ' A' ' 191' ' ' GLU . 1.8 t-105 -127.46 108.81 11.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.455 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.703 ' C ' ' HB3' ' A' ' 251' ' ' ALA . 0.2 OUTLIER -98.55 104.86 16.94 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.56 178.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.673 ' CA ' ' HB3' ' A' ' 251' ' ' ALA . . . 164.84 -76.28 0.15 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.734 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.835 ' OE2' ' HB1' ' A' ' 250' ' ' ALA . 1.1 mt-10 148.03 -100.14 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.551 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 0.0 OUTLIER -87.09 131.91 33.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.656 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -31.02 105.28 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 C-N-CA 119.888 -1.148 . . . . 0.0 111.962 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.525 ' CB ' ' CD ' ' A' ' 197' ' ' PRO . 0.3 OUTLIER 162.57 -178.44 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.305 -0.447 . . . . 0.0 111.301 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.525 ' CD ' ' CB ' ' A' ' 196' ' ' SER . 69.7 Cg_endo -91.3 -1.15 4.73 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.168 2.579 . . . . 0.0 114.05 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.137 HD12 HD21 ' A' ' 201' ' ' LEU . 0.2 OUTLIER 75.64 33.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.669 1.223 . . . . 0.0 109.522 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.498 ' OD1' ' NE ' ' A' ' 202' ' ' ARG . 0.2 OUTLIER -78.29 -33.54 49.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.579 -1.192 . . . . 0.0 112.492 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -56.61 -44.78 81.49 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 1.137 HD21 HD12 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -65.79 -31.2 72.03 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.399 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.773 ' CD ' HD22 ' A' ' 229' ' ' LEU . 18.6 mtm180 -57.71 -48.71 78.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.429 0.633 . . . . 0.0 110.265 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.19 -32.66 67.01 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.313 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -59.4 -40.92 88.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.598 ' CB ' HD11 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -60.69 -47.75 84.85 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -20.67 66.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.946 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.97 12.35 27.1 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.677 0.275 . . . . 0.0 111.425 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 0.7 OUTLIER 72.24 100.11 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.87 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.661 ' O ' ' HB3' ' A' ' 210' ' ' ALA . 0.9 OUTLIER 155.47 86.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ALA . . . . . 0.775 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 96.32 102.17 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.281 0.562 . . . . 0.0 110.381 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.674 ' O ' HG23 ' A' ' 240' ' ' VAL . 23.2 t30 174.45 -55.53 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.888 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 10.0 Cg_endo -51.01 -48.0 23.04 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.199 1.933 . . . . 0.0 110.58 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.68 108.41 8.52 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.893 ' HB ' HG22 ' A' ' 240' ' ' VAL . 1.0 OUTLIER -121.26 125.43 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.67 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -121.03 127.16 51.47 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.804 -178.409 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.557 HD22 HG11 ' A' ' 124' ' ' VAL . 3.0 mt -138.44 115.88 11.23 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.622 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' CYS . . . . . 0.531 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 1.0 OUTLIER -125.84 119.66 28.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.582 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.594 ' HA2' ' CG ' ' A' ' 245' ' ' PHE . . . 115.29 -48.8 0.9 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.779 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.861 ' CB ' ' HB3' ' A' ' 250' ' ' ALA . 97.8 Cg_endo -80.51 110.01 2.37 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.424 2.083 . . . . 0.0 113.549 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.488 ' O ' ' HB ' ' A' ' 223' ' ' ILE . 16.0 Cg_exo -66.72 -45.35 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.718 2.279 . . . . 0.0 110.825 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.49 -38.35 90.65 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.589 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.828 ' O ' ' HB3' ' A' ' 226' ' ' ALA . 3.6 tpt -56.08 -25.27 44.7 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.577 HG13 ' CB ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -69.09 -45.49 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.12 178.295 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 223' ' ' ILE . 69.8 m-20 -75.04 -47.78 27.25 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.531 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.557 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -77.34 -50.24 13.24 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.842 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -59.84 -40.1 87.38 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.436 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 223' ' ' ILE . 42.5 t -69.95 -30.86 68.33 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 232' ' ' SER . 3.5 mm-40 -69.61 -44.62 70.31 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.578 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.773 HD22 ' CD ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -60.06 -37.92 81.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.002 0.429 . . . . 0.0 110.658 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 226' ' ' ALA . 2.3 t -64.19 -45.34 96.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.181 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -30.19 61.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.059 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.506 ' OG ' ' NH1' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -75.48 -46.22 33.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.181 0.515 . . . . 0.0 111.258 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.563 ' CG ' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -58.91 -51.1 71.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.026 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 125.34 -52.48 0.8 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.098 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.643 ' HB ' ' ND2' ' A' ' 211' ' ' ASN . 0.9 OUTLIER -36.04 95.73 0.1 OUTLIER Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 121.08 0.467 . . . . 0.0 111.128 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 31.8 Cg_endo -64.16 119.61 6.7 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.897 2.398 . . . . 0.0 112.47 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -90.75 176.71 41.38 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.45 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.7 -40.25 0.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 0.0 111.081 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.581 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 67.6 mm-40 -105.64 36.03 2.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.017 0.437 . . . . 0.0 110.67 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.893 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.1 t -89.19 136.5 23.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.322 0.582 . . . . 0.0 111.062 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.651 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.6 OUTLIER -144.92 138.02 26.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.94 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.577 ' CB ' HG13 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -129.52 130.39 45.73 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.081 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLU . . . . . 0.489 ' CA ' HD11 ' A' ' 223' ' ' ILE . 0.3 OUTLIER -132.65 149.39 52.3 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.543 179.601 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 244' ' ' LYS . 1.7 ptmm? -129.08 115.0 17.07 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.594 ' CG ' ' HA2' ' A' ' 218' ' ' GLY . 0.5 OUTLIER -137.42 146.86 44.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.171 179.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.861 HD21 ' HA3' ' A' ' 127' ' ' GLY . 0.2 OUTLIER 57.61 174.3 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.477 0 C-N-CA 122.922 0.489 . . . . 0.0 111.731 -178.7 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 247' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 246' ' ' LEU . 75.9 Cg_exo -52.78 -141.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.371 2.714 . . . . 0.0 113.643 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 190' ' ' TRP . 2.4 p -81.4 177.25 9.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.485 0.66 . . . . 0.0 112.085 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 163.2 -71.0 0.21 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.578 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.861 ' HB3' ' CB ' ' A' ' 219' ' ' PRO . . . -107.74 149.64 27.92 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.703 ' HB3' ' C ' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.46 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.521 ' CB ' ' HB2' ' A' ' 105' ' ' LYS . 83.9 p -95.71 153.87 17.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.821 0.343 . . . . 0.0 110.892 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.939 ' CE2' ' HB2' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -132.05 156.88 45.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.916 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.61 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 1.6 mt-10 -106.04 121.79 44.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.939 ' HB2' ' CE2' ' A' ' 12' ' ' PHE . . . -126.73 127.69 45.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.183 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.487 ' OE1' HG22 ' A' ' 101' ' ' VAL . 4.2 tp10 -93.41 128.08 39.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.899 0.38 . . . . 0.0 110.697 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.061 HG22 ' O ' ' A' ' 100' ' ' GLN . 28.0 m -71.88 106.14 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.091 0.472 . . . . 0.0 111.096 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 17' ' ' VAL . 2.4 p -127.2 2.31 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.314 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -120.14 -128.86 3.71 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.526 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.885 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER 82.49 58.77 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.329 0.585 . . . . 0.0 110.063 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -95.63 145.42 25.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.669 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -88.69 113.86 24.69 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.3 -27.59 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.554 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 13.2 m -141.44 173.62 11.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.133 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.404 ' CB ' ' HG2' ' A' ' 160' ' ' GLU . 14.9 t -52.19 -57.06 10.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.692 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.519 ' CA ' ' O ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -118.07 44.45 2.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.553 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.907 HG23 ' HG2' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -148.34 138.66 22.66 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.311 0.577 . . . . 0.0 110.886 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.885 HG21 ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -141.34 148.35 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.138 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -114.55 103.54 11.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.367 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.729 ' C ' HD13 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -99.26 127.51 45.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.886 -178.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.734 HD13 ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -113.28 116.65 30.07 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.37 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.027 HD22 HD11 ' A' ' 102' ' ' LEU . 4.6 mt -112.37 131.57 55.47 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.025 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -144.77 109.86 5.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.72 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.607 ' HB2' ' CA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -114.92 -49.17 2.81 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.011 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.684 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.105 HG13 HD23 ' A' ' 76' ' ' LEU . 20.4 m . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 119.716 -0.183 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.695 ' HA ' ' N ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -112.76 84.02 1.91 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.131 0.973 . . . . 0.0 111.14 178.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.598 ' O ' ' CG ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER 7.06 61.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.171 0.919 . . . . 0.0 112.572 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -84.92 160.94 54.43 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.816 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.976 ' O ' HG23 ' A' ' 110' ' ' VAL . 37.1 Cg_exo -57.99 68.53 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.589 2.193 . . . . 0.0 111.837 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.736 ' O ' HG21 ' A' ' 110' ' ' VAL . . . 59.39 37.74 92.43 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.003 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 65' ' ' SER . 4.8 tt0 -52.95 158.12 1.51 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.064 0.432 . . . . 0.0 110.077 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.84 ' CE2' HD21 ' A' ' 108' ' ' LEU . 28.7 p90 -151.96 163.47 39.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 63' ' ' SER . 2.0 mmt -121.14 175.36 6.14 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.705 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.54 108.09 15.07 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.907 ' O ' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -150.49 156.69 41.92 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.693 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.973 HG23 ' C ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -96.6 154.15 17.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.602 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.028 ' O ' HD23 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -29.45 -68.14 0.12 Allowed Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 123.443 0.464 . . . . 0.0 110.601 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.96 ' HD3' HG23 ' A' ' 55' ' ' ILE . 4.4 Cg_endo -110.05 6.26 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.719 2.946 . . . . 0.0 111.733 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 104.51 -5.88 44.76 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.019 -178.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.812 HG23 ' CG ' ' A' ' 56' ' ' PRO . 67.6 p -24.34 -88.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.127 0.571 . . . . 0.0 111.814 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.667 ' O ' HG12 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -154.12 42.84 0.53 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.973 ' C ' HG23 ' A' ' 54' ' ' THR . 0.3 OUTLIER 88.19 125.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.783 ' N ' HG23 ' A' ' 54' ' ' THR . 28.8 t -117.41 -72.42 0.69 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.502 0.668 . . . . 0.0 110.268 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.63 171.14 10.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.597 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.648 ' CB ' ' CE1' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -101.54 118.96 38.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.903 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.542 ' C ' ' HB2' ' A' ' 50' ' ' PHE . 1.6 t80 -118.57 127.34 53.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.994 0.426 . . . . 0.0 111.94 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.586 ' HA ' ' CB ' ' A' ' 50' ' ' PHE . 92.4 p -72.18 109.54 6.04 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.741 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.545 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 88.6 Cg_endo -85.67 169.65 9.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.956 2.438 . . . . 0.0 112.694 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.4 130.53 19.55 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.964 0.412 . . . . 0.0 111.655 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 1.0 ' HB3' HG22 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -129.68 -56.09 1.14 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.555 0.693 . . . . 0.0 109.844 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.575 ' HB3' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER 164.61 -164.93 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 96.6 Cg_endo -91.31 63.16 1.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.102 1.201 . . . . 0.0 112.372 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.695 ' N ' ' HA ' ' A' ' 44' ' ' LYS . 1.6 p30 -174.46 109.74 0.29 Allowed Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.512 ' HG3' ' HB2' ' A' ' 44' ' ' LYS . 4.1 Cg_exo -74.17 40.85 0.62 Allowed 'Trans proline' 0 CA--C 1.515 -0.429 0 C-N-CA 122.336 2.024 . . . . 0.0 112.409 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -138.14 6.79 2.62 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.579 178.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.29 -116.05 1.74 Allowed Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.912 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -152.34 119.49 5.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.875 -0.662 . . . . 0.0 110.012 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.105 HD23 HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -96.8 148.33 23.03 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 122.22 1.009 . . . . 0.0 113.169 -178.5 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.73 ' CB ' HD12 ' A' ' 30' ' ' LEU . 1.8 pt-20 -131.07 150.56 52.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.972 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.773 ' HE2' HD11 ' A' ' 31' ' ' LEU . 1.9 p90 -126.37 139.8 52.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.938 0.399 . . . . 0.0 111.549 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.921 HD22 HG21 ' A' ' 128' ' ' THR . 1.3 mt -104.4 91.56 3.95 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.604 ' O ' HG13 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -92.36 118.61 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.197 -178.675 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.907 ' HG2' HG23 ' A' ' 26' ' ' THR . 0.8 OUTLIER -79.34 96.25 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.978 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.971 HG11 HD11 ' A' ' 92' ' ' LEU . 2.9 m -92.69 141.5 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.006 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.53 ' HG ' ' CD ' ' A' ' 84' ' ' PRO . 1.1 mp -60.73 -179.97 0.21 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.747 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.53 ' CD ' ' HG ' ' A' ' 83' ' ' LEU . 37.4 Cg_exo -56.8 -32.35 91.38 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.593 2.195 . . . . 0.0 112.182 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER 157.94 100.7 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.831 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 155.04 -16.91 0.53 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.645 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.481 ' CG ' HD22 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -102.72 -98.19 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.881 -0.188 . . . . 0.0 110.975 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -97.07 -30.17 13.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.717 0.294 . . . . 0.0 111.204 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.706 ' HB2' HG21 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -60.47 -27.31 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.99 0.424 . . . . 0.0 110.921 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -76.24 -32.47 58.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.555 0.693 . . . . 0.0 109.819 179.469 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.814 ' CD1' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -73.43 -45.31 55.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.129 -179.137 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.971 HD11 HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -67.73 -34.72 77.4 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -29.68 15.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 2.4 t-20 -95.2 -5.14 44.56 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.384 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.49 15.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.911 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . . . -153.61 30.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.668 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -47.49 -102.1 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 98' ' ' VAL . 2.5 t -148.01 103.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.115 0.484 . . . . 0.0 110.98 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.58 ' H ' HG23 ' A' ' 16' ' ' VAL . . . 150.7 -12.65 0.87 Allowed Glycine 0 C--N 1.32 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.021 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 1.061 ' O ' HG22 ' A' ' 16' ' ' VAL . 27.1 mp0 -91.29 162.46 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 111.133 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.487 HG22 ' OE1' ' A' ' 15' ' ' GLU . 40.9 t -129.62 142.22 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.581 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.028 HD23 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -118.94 153.4 34.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.089 0.471 . . . . 0.0 111.415 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.6 t -105.95 97.56 7.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.815 HG12 ' CD1' ' A' ' 53' ' ' LEU . 2.0 m -90.88 118.54 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.521 ' HB2' ' CB ' ' A' ' 11' ' ' SER . 3.7 tttt -129.52 123.08 30.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.496 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 161.79 65.66 0.02 OUTLIER Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.732 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.44 57.4 1.33 Allowed 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.422 2.081 . . . . 0.0 110.883 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.84 HD21 ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -100.55 170.03 8.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.864 -178.543 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.654 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -118.83 172.09 14.41 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.976 HG23 ' O ' ' A' ' 47' ' ' PRO . 0.2 OUTLIER -157.13 115.33 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.564 0.682 . . . . 0.0 111.683 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -69.67 113.81 7.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.539 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -147.02 -40.5 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.849 HD11 ' HB3' ' A' ' 136' ' ' MET . 0.9 OUTLIER -146.14 119.14 8.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.431 178.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.652 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.1 OUTLIER -138.28 117.48 12.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.294 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -92.29 140.62 29.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.435 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -90.05 15.89 9.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.018 0.437 . . . . 0.0 110.98 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.46 -77.39 0.23 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.69 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.56 89.87 2.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.939 0.4 . . . . 0.0 110.37 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -163.59 149.94 9.97 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.16 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.462 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 32.2 Cg_endo -64.24 115.22 3.03 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.569 2.179 . . . . 0.0 111.69 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.581 ' CZ ' ' CG2' ' A' ' 149' ' ' THR . 0.0 OUTLIER -124.77 146.31 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.393 -179.32 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.642 ' CD2' ' HB3' ' A' ' 150' ' ' ARG . 39.5 m-85 -126.09 122.78 36.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 110.63 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 1.11 ' CZ ' HG22 ' A' ' 133' ' ' VAL . 0.9 OUTLIER -111.93 106.05 14.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.418 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.735 HG22 ' HE1' ' A' ' 222' ' ' MET . 6.9 p -99.11 111.0 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 121.233 0.539 . . . . 0.0 111.125 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -109.79 133.68 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.143 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.439 ' C ' ' HA3' ' A' ' 249' ' ' GLY . . . -107.82 103.08 1.86 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.047 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.769 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 118.86 -167.94 13.2 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.372 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.921 HG21 HD22 ' A' ' 79' ' ' LEU . 6.1 m -91.74 -13.42 31.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.024 0.44 . . . . 0.0 110.847 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.577 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -64.72 10.02 0.36 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 116.111 -0.495 . . . . 0.0 113.409 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.734 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -79.97 3.68 19.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 117.177 0.489 . . . . 0.0 110.033 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.584 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -47.55 -43.43 49.41 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.917 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 6.7 Cg_exo -71.35 -30.87 14.93 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.525 2.15 . . . . 0.0 109.655 177.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.11 HG22 ' CZ ' ' A' ' 123' ' ' PHE . 17.9 t -66.07 -44.33 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.208 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.734 HG13 ' HG ' ' A' ' 130' ' ' LEU . 14.4 m -70.44 -29.91 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.532 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.14 -52.69 57.88 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.849 ' HB3' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -62.13 -44.95 95.5 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.389 0.614 . . . . 0.0 109.46 178.312 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.464 HG13 ' NE2' ' A' ' 141' ' ' GLN . 5.3 t -60.17 -30.16 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.846 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.82 -37.99 83.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.254 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.552 ' OE1' ' CE2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -63.61 -42.66 98.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.065 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.611 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.6 OUTLIER -70.05 -33.31 71.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.664 0.745 . . . . 0.0 110.366 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 1.019 ' CG ' HD21 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -76.4 -30.38 57.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.51 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -73.11 -44.67 60.01 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.798 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -78.14 -21.26 50.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.335 0.588 . . . . 0.0 110.115 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER 53.57 27.84 7.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.761 178.472 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.798 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -36.6 160.32 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 0.0 110.693 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.514 ' HD2' ' HB1' ' A' ' 145' ' ' ALA . 60.2 Cg_endo -73.23 4.27 3.96 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.691 2.26 . . . . 0.0 112.728 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 148' ' ' GLU . 10.8 t30 -81.48 135.83 35.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.984 0.421 . . . . 0.0 111.522 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.555 ' CB ' ' HB2' ' A' ' 176' ' ' ASN . 4.6 pt-20 -73.78 112.7 10.14 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.437 0.637 . . . . 0.0 110.957 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.581 ' CG2' ' CZ ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -111.74 116.35 30.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.052 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.642 ' HB3' ' CD2' ' A' ' 122' ' ' TYR . 0.8 OUTLIER -107.12 142.82 36.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.76 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.945 HD12 ' N ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -134.05 136.2 53.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.152 0.501 . . . . 0.0 110.697 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.945 ' N ' HD12 ' A' ' 151' ' ' ILE . 18.2 m-30 -110.5 112.02 23.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.881 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.82 ' HZ ' HD11 ' A' ' 161' ' ' LEU . 8.6 t80 -113.9 130.34 56.51 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 122.199 -0.313 . . . . 0.0 111.364 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.683 ' HA2' ' HB2' ' A' ' 182' ' ' CYS . . . -154.12 161.19 29.89 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 119.535 -1.316 . . . . 0.0 113.865 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.939 HG21 HD13 ' A' ' 161' ' ' LEU . 21.0 m -164.05 -122.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.379 -0.411 . . . . 0.0 111.265 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.827 ' O ' HG21 ' A' ' 183' ' ' VAL . 44.7 p-10 -103.45 -174.34 2.52 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 120.557 0.218 . . . . 0.0 110.783 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.621 HG23 ' HD3' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -42.95 -25.31 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.323 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.668 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 40.1 mt-10 94.16 22.41 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.711 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 77.9 Cg_exo -46.78 -23.82 2.65 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.28 1.32 . . . . 0.0 111.252 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -131.59 -28.85 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.674 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.939 HD13 HG21 ' A' ' 155' ' ' VAL . 13.3 tp -35.76 158.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.71 -157.99 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.564 ' CE1' ' HG2' ' A' ' 166' ' ' GLU . 0.1 OUTLIER 74.15 27.61 1.52 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.1 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 1.024 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -70.23 -39.07 76.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.071 0.462 . . . . 0.0 110.306 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 1.024 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.2 OUTLIER -73.7 -27.2 61.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.825 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.564 ' HG2' ' CE1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -64.17 -49.16 73.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 -179.303 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -75.19 -30.84 60.77 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 164' ' ' ILE . 1.8 mttm -61.64 -41.26 97.25 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.16 -32.4 73.01 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 1.019 HD21 ' CG ' ' A' ' 141' ' ' GLN . 0.3 OUTLIER -61.72 -48.58 80.08 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.099 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.468 ' O ' ' SD ' ' A' ' 174' ' ' MET . 36.2 mt-10 -56.58 -32.65 65.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.89 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -39.94 30.85 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 m -112.13 28.8 8.44 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.633 ' HB2' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -113.65 167.05 10.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.164 0.507 . . . . 0.0 111.615 179.365 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -84.85 -80.05 0.21 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.373 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.565 ' C ' HD12 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -130.61 63.48 1.57 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.245 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.633 HD13 ' HB2' ' A' ' 174' ' ' MET . 4.5 mp -112.27 149.65 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.077 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.465 ' HB ' ' HG2' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -137.08 126.9 25.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.283 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 151' ' ' ILE . 72.6 t -100.99 135.8 35.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.314 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.625 ' CG ' ' CD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -99.79 136.69 39.34 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.196 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -98.22 105.89 18.1 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.68 0.752 . . . . 0.0 111.389 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.683 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 64.4 m -86.06 -164.75 1.08 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.358 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.827 HG21 ' O ' ' A' ' 156' ' ' ASN . 37.3 t 54.17 147.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 122.151 0.977 . . . . 0.0 112.646 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.729 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -137.18 -62.94 0.61 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.523 -1.672 . . . . 0.0 108.484 -178.351 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.538 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 50.8 m-70 -167.64 49.45 0.18 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.698 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.574 ' O ' ' CB ' ' A' ' 187' ' ' SER . 40.7 Cg_endo -85.95 -104.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.384 2.723 . . . . 0.0 112.895 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 9.6 t 150.81 21.78 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.618 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 97.84 10.4 52.62 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.636 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 251' ' ' ALA . 0.4 OUTLIER -138.07 63.88 1.52 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 178.4 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 190' ' ' TRP . . . . . 0.523 ' O ' ' O ' ' A' ' 249' ' ' GLY . 5.6 t-105 -122.81 123.63 41.46 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.778 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.52 ' HG3' ' HA ' ' A' ' 251' ' ' ALA . 0.3 OUTLIER -83.84 105.57 14.84 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.856 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.501 ' C ' ' CG ' ' A' ' 193' ' ' GLU . . . 127.33 -108.8 1.0 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.256 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.576 ' C ' ' HB3' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -168.9 -74.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.583 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -99.35 153.31 19.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 179.466 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.639 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -28.22 108.95 0.02 OUTLIER Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.465 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 8.2 m 95.4 155.61 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.268 -0.466 . . . . 0.0 110.418 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.471 ' O ' ' C ' ' A' ' 198' ' ' ILE . 32.5 Cg_exo -59.79 58.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.998 2.466 . . . . 0.0 112.634 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.987 HG13 HD23 ' A' ' 201' ' ' LEU . 0.1 OUTLIER 30.16 92.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 122.031 0.92 . . . . 0.0 110.066 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.89 -33.69 59.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.534 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -57.73 -31.56 66.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.987 HD23 HG13 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -69.52 -41.76 75.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.806 0.336 . . . . 0.0 110.672 -178.569 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.506 ' O ' ' HG ' ' A' ' 205' ' ' LEU . 13.6 mtm180 -57.19 -49.23 76.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.367 0.603 . . . . 0.0 110.257 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -71.78 -32.66 67.89 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.575 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.974 ' HB3' ' HB3' ' A' ' 210' ' ' ALA . 1.5 m-20 -59.44 -41.68 90.19 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.669 HD12 ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -60.73 -47.13 87.69 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.468 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.401 ' CG ' ' HG2' ' A' ' 233' ' ' ARG . 1.8 mm-40 -65.15 -19.06 65.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.674 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 208' ' ' SER . 16.2 t -90.8 -79.53 0.36 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.457 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 207' ' ' SER . 3.0 t 155.59 -11.68 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.87 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 6.8 m-20 -88.97 40.07 0.96 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.212 0.529 . . . . 0.0 110.412 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ALA . . . . . 0.974 ' HB3' ' HB3' ' A' ' 204' ' ' ASP . . . 161.96 99.75 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.78 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.693 ' HA ' HD11 ' A' ' 235' ' ' ILE . 6.0 t30 173.25 -55.42 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.215 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 1.5 Cg_endo -45.81 -55.24 3.75 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.272 1.981 . . . . 0.0 110.889 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.03 108.85 9.13 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 1.007 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.9 OUTLIER -117.5 124.71 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.649 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -113.18 127.3 56.14 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.551 -178.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.565 ' CD1' ' CG1' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -131.94 123.61 27.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.71 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 217' ' ' CYS . . . . . 0.558 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -122.71 107.27 11.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.8 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 244' ' ' LYS . . . 176.22 166.14 33.06 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.571 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.768 ' HG2' ' HB3' ' A' ' 250' ' ' ALA . 24.3 Cg_exo -55.45 -170.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.721 2.281 . . . . 0.0 112.594 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 219' ' ' PRO . 23.6 Cg_exo -64.72 -19.69 64.68 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 123.192 2.595 . . . . 0.0 113.002 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -83.09 -54.61 3.14 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.839 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' MET . . . . . 0.735 ' HE1' HG22 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -57.13 -34.39 68.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.124 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 242' ' ' PHE . 0.1 OUTLIER -76.66 -34.14 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.452 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.473 ' HA ' ' SG ' ' A' ' 227' ' ' CYS . 12.3 m-20 -72.96 -47.0 49.25 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.851 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.538 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -61.43 -48.12 82.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.724 0.297 . . . . 0.0 111.74 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.793 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -69.57 -34.87 74.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.566 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 223' ' ' ILE . 8.2 p -70.05 -31.93 69.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 110.263 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.99 -44.82 95.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.551 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.653 HD11 HD11 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -62.11 -39.62 93.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.093 0.473 . . . . 0.0 110.847 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.881 HG13 ' CG2' ' A' ' 235' ' ' ILE . 3.8 t -65.88 -45.68 90.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.456 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 23.5 mtt-85 -72.76 -30.25 63.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.782 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 33.3 m -69.08 -43.63 74.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.348 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.669 ' HD3' HD12 ' A' ' 205' ' ' LEU . 1.0 OUTLIER -80.99 -74.35 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.967 0.413 . . . . 0.0 111.354 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 148.76 -18.64 1.26 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.865 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.881 ' CG2' HG13 ' A' ' 230' ' ' VAL . 0.0 OUTLIER -22.86 82.41 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.533 ' N ' ' O ' ' A' ' 234' ' ' GLY . 6.0 Cg_exo -75.82 113.05 3.64 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.156 2.571 . . . . 0.0 111.811 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -119.84 -174.54 15.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.827 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.2 -35.92 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.621 0.248 . . . . 0.0 111.277 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.59 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 5.7 mm-40 -101.81 32.52 3.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.493 . . . . 0.0 110.834 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 1.007 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.2 t -94.6 134.67 31.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.248 0.547 . . . . 0.0 110.451 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.652 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.24 149.36 33.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.947 -177.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.568 ' HB2' HD11 ' A' ' 223' ' ' ILE . 5.7 p90 -131.55 148.68 52.64 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.247 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLU . . . . . 0.467 ' N ' HD11 ' A' ' 223' ' ' ILE . 2.2 tt0 -132.8 148.81 52.32 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -106.61 111.43 23.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.328 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.577 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -136.97 147.64 46.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.549 ' CD2' ' HD2' ' A' ' 247' ' ' PRO . 0.4 OUTLIER -20.34 146.09 0.01 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 247' ' ' PRO . . . . . 0.61 ' HA ' ' HG2' ' A' ' 219' ' ' PRO . 71.9 Cg_exo -50.28 -155.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.69 2.927 . . . . 0.0 113.122 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 247' ' ' PRO . 5.6 m 92.72 -19.29 0.1 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.816 0.817 . . . . 0.0 110.428 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 190' ' ' TRP . . . -128.45 -24.14 1.16 Allowed Glycine 0 C--N 1.309 -0.921 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.569 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.768 ' HB3' ' HG2' ' A' ' 219' ' ' PRO . . . -108.38 150.27 27.59 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 122.747 0.419 . . . . 0.0 110.52 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.52 ' HA ' ' HG3' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.229 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.865 0.364 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -74.62 177.68 5.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.3 mt -73.48 135.89 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.28 110.96 1.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.938 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -168.12 71.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.997 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.85 77.03 0.66 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.64 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -135.91 91.63 2.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.359 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.28 101.77 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.12 23.84 4.74 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.549 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.509 ' HB2' ' HG3' ' A' ' 105' ' ' LYS . 83.8 p -110.36 150.88 28.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.863 0.364 . . . . 0.0 111.038 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.726 ' CE1' ' HB2' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -131.46 162.67 29.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.547 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.587 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 8.3 mt-10 -110.8 129.97 55.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.814 0.34 . . . . 0.0 111.03 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.854 ' HB1' ' CB ' ' A' ' 31' ' ' LEU . . . -127.77 135.15 49.73 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.976 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.55 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 14.9 tp10 -93.64 122.62 36.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.394 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.74 ' HA ' HD23 ' A' ' 31' ' ' LEU . 32.6 m -71.25 104.34 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.643 ' HA ' HG23 ' A' ' 98' ' ' VAL . 2.6 p -122.51 -34.47 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.433 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -87.5 -130.61 3.2 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.306 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.831 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER 87.87 71.63 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.436 0.636 . . . . 0.0 110.291 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.584 ' O ' HG23 ' A' ' 27' ' ' VAL . 20.2 p30 -108.91 146.54 33.61 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.818 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -88.54 114.3 25.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.44 HG12 ' OD1' ' A' ' 20' ' ' ASN . 1.7 m -95.04 -27.53 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.54 0.686 . . . . 0.0 109.692 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.547 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 11.7 m -138.51 172.13 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.297 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 t -51.64 -56.85 11.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.977 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.578 ' ND2' ' N1A' ' A' ' 252' ' ' FDA . 0.2 OUTLIER -118.48 43.03 2.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.708 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.561 HG21 ' CB ' ' A' ' 128' ' ' THR . 0.2 OUTLIER -147.2 140.39 25.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.317 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.831 HG21 ' CD2' ' A' ' 19' ' ' LEU . 1.4 p -141.02 146.44 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.097 0.475 . . . . 0.0 112.236 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 6.4 tt0 -110.0 103.02 11.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.568 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.634 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -94.02 125.3 38.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.494 -178.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.562 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -112.61 116.29 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.074 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.854 ' CB ' ' HB1' ' A' ' 14' ' ' ALA . 2.2 mt -121.73 132.81 54.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 111.539 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.505 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 38.4 mt-30 -145.81 109.29 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.393 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.552 ' HB3' ' CA ' ' A' ' 14' ' ' ALA . 12.2 tptt -149.22 -0.32 0.5 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 38' ' ' CYS . 1.0 OUTLIER -168.39 168.04 5.94 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.139 0.495 . . . . 0.0 112.077 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 36' ' ' ASP . 36.7 Cg_exo -60.33 107.19 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.087 2.525 . . . . 0.0 111.863 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.59 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . 3.5 m-20 155.03 -34.68 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.645 0.735 . . . . 0.0 110.696 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.537 ' OE1' HD22 ' A' ' 76' ' ' LEU . 6.8 mt-10 -169.87 59.91 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.381 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.535 ' H ' ' HA3' ' A' ' 74' ' ' GLY . 13.8 t -164.07 -65.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.983 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -153.91 -12.88 0.06 OUTLIER Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.428 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.546 ' HB2' ' CB ' ' A' ' 35' ' ' PRO . 18.1 m120 -121.92 13.49 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.889 0.844 . . . . 0.0 111.54 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.902 ' CZ ' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -83.83 -34.79 24.6 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.804 0.812 . . . . 0.0 109.021 178.249 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 72' ' ' PRO . . . 57.49 96.3 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.423 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.902 HG13 ' CZ ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -96.31 160.98 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.361 0.6 . . . . 0.0 111.797 -179.131 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 1.5 ttpm? -163.07 26.65 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.967 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.69 ' CD1' ' NE2' ' A' ' 139' ' ' GLN . 0.0 OUTLIER 76.55 96.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.584 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -108.75 165.79 12.03 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.437 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.59 59.12 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.713 2.275 . . . . 0.0 111.858 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.665 ' O ' HG12 ' A' ' 110' ' ' VAL . . . 58.48 61.68 7.12 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.66 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.488 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 1.3 mm100 -35.44 146.21 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.664 0.232 . . . . 0.0 110.493 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 1.05 ' CD2' HD21 ' A' ' 108' ' ' LEU . 2.6 t80 -152.69 139.34 18.8 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.667 0.27 . . . . 0.0 111.696 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.579 ' O ' ' CE1' ' A' ' 50' ' ' PHE . 3.8 mtt -139.94 -162.68 1.38 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.852 0.358 . . . . 0.0 111.922 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 3.4 t0 -134.96 123.3 23.14 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.008 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.56 157.71 43.32 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.024 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.858 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -108.72 149.6 28.77 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.094 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.881 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -34.49 -70.95 0.11 Allowed Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.249 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 1.063 ' HD2' HG23 ' A' ' 58' ' ' THR . 51.3 Cg_endo -103.98 14.45 0.24 Allowed 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 123.39 2.727 . . . . 0.0 111.941 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 98.52 0.34 58.01 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.663 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 1.063 HG23 ' HD2' ' A' ' 56' ' ' PRO . 13.0 p -40.69 -103.18 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.852 0.461 . . . . 0.0 111.596 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.858 ' N ' HG21 ' A' ' 54' ' ' THR . 1.3 m-20 160.23 36.16 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.009 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 60' ' ' VAL . 6.1 t -152.32 27.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.958 0.408 . . . . 0.0 110.888 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.65 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 36.8 t -97.46 -101.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.631 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 170.64 -176.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.102 0.477 . . . . 0.0 111.36 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.589 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 2.4 m -99.19 142.56 30.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.689 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.532 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 1.8 t80 -141.36 131.4 24.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 19.7 m -79.28 108.89 9.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.62 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.876 ' CB ' HD13 ' A' ' 76' ' ' LEU . 72.9 Cg_endo -91.61 165.11 3.45 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.921 2.414 . . . . 0.0 112.189 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.17 135.55 25.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.867 0.365 . . . . 0.0 111.647 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.679 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -105.35 -69.76 0.81 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.999 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 68' ' ' ASN . 1.4 mt 138.3 160.27 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.468 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.565 ' HD3' ' CG ' ' A' ' 45' ' ' PHE . 20.2 Cg_endo -60.93 87.75 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 121.973 1.782 . . . . 0.0 111.341 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -168.08 117.65 0.65 Allowed Pre-proline 0 N--CA 1.457 -0.102 0 CA-C-O 120.807 0.337 . . . . 0.0 110.891 -179.206 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.569 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 42.3 Cg_endo -68.13 89.95 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.429 2.086 . . . . 0.0 111.861 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' O ' ' CA ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -158.09 -82.87 0.05 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.853 0.359 . . . . 0.0 110.094 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.535 ' HA3' ' H ' ' A' ' 38' ' ' CYS . . . 141.11 96.41 0.28 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.788 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 37.4 mtm180 -151.87 106.33 3.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.463 0.173 . . . . 0.0 110.925 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.876 HD13 ' CB ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -97.79 130.92 44.7 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.852 0.358 . . . . 0.0 110.446 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.778 ' N ' HD12 ' A' ' 76' ' ' LEU . 3.1 mt-10 -129.16 117.88 21.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.319 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.634 ' CE2' ' HB3' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -109.99 146.94 34.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.144 0.497 . . . . 0.0 111.715 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.029 HD22 ' CG2' ' A' ' 128' ' ' THR . 7.5 mt -111.17 84.53 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.032 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.639 HG22 HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -91.79 129.53 42.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.873 -178.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.65 ' CD ' ' N7A' ' A' ' 252' ' ' FDA . 0.0 OUTLIER -78.43 95.91 5.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.164 179.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.639 HG13 HG22 ' A' ' 80' ' ' ILE . 7.4 m -98.15 141.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.765 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.905 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -121.35 112.92 32.59 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.587 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.817 ' N ' HD22 ' A' ' 83' ' ' LEU . 82.5 Cg_exo -44.17 122.01 3.39 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.649 2.233 . . . . 0.0 112.181 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 84' ' ' PRO . 17.6 tp10 84.47 5.29 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.413 ' N ' HD13 ' A' ' 83' ' ' LEU . . . -74.08 -130.99 0.2 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.459 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -125.25 -26.03 3.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.602 0.239 . . . . 0.0 111.484 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 2.4 t80 -106.12 -31.26 8.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.544 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.55 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 1.0 OUTLIER -70.89 -34.17 71.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.685 0.279 . . . . 0.0 111.698 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 67.2 m-20 -74.91 -40.35 60.92 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.517 0.675 . . . . 0.0 109.752 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.617 ' O ' HD11 ' A' ' 55' ' ' ILE . 2.6 t80 -73.67 -24.48 59.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.508 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.941 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -68.08 -41.08 82.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.801 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -16.64 27.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.596 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 44.2 m-20 -101.22 -7.28 23.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.452 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.435 ' HB2' ' CD1' ' A' ' 91' ' ' TYR . 0.9 OUTLIER -151.56 13.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.941 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -139.79 26.24 2.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.97 0.415 . . . . 0.0 111.156 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.505 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -56.81 -171.98 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.01 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.643 HG23 ' HA ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -88.13 2.03 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.714 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.35 58.06 0.41 Allowed Glycine 0 C--N 1.321 -0.286 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.203 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.714 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -162.09 -178.85 6.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.027 0.442 . . . . 0.0 111.413 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.06 131.54 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.489 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.008 HD11 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.73 123.71 31.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.708 0.29 . . . . 0.0 110.781 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.609 ' N ' HD12 ' A' ' 102' ' ' LEU . 3.6 m -95.5 131.65 41.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.762 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.675 HG13 ' CE1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -99.82 134.61 38.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.509 ' HG3' ' HB2' ' A' ' 11' ' ' SER . 0.0 OUTLIER -130.15 113.78 14.91 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.37 -178.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 169.6 70.05 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.54 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.37 60.74 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.555 2.17 . . . . 0.0 110.308 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.05 HD21 ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -133.77 170.36 15.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.019 -177.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.513 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -117.01 173.54 14.75 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.094 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 48' ' ' GLY . 8.3 p -112.6 112.1 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.324 0.583 . . . . 0.0 110.548 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.5 120.89 39.7 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.569 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.12 -37.93 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.701 HD12 ' C ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -126.04 120.02 29.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.72 179.352 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.646 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 2.7 tptt -130.38 108.61 10.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.464 ' HB3' ' HE3' ' A' ' 140' ' ' MET . 0.0 OUTLIER -78.68 140.56 38.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.667 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -89.38 13.45 13.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.815 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.58 -76.05 0.28 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.504 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.83 89.81 2.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.855 0.36 . . . . 0.0 110.293 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.515 ' O ' ' NE ' ' A' ' 121' ' ' ARG . . . -168.57 144.27 2.94 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.21 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 25.9 Cg_endo -62.16 105.0 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.697 2.265 . . . . 0.0 111.944 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -117.37 143.84 45.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.249 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.64 ' CD2' ' HB2' ' A' ' 150' ' ' ARG . 14.6 m-85 -119.59 127.18 52.72 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.734 0.302 . . . . 0.0 111.131 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.943 ' CE2' HG13 ' A' ' 133' ' ' VAL . 1.3 t80 -117.48 106.73 13.48 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 1.02 HG12 HD23 ' A' ' 216' ' ' LEU . 4.5 p -98.73 110.96 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.371 0.605 . . . . 0.0 111.809 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -102.96 133.63 47.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.527 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.987 ' O ' HD21 ' A' ' 246' ' ' LEU . . . -105.62 103.17 2.1 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.497 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.836 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 118.22 -154.52 16.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.834 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.029 ' CG2' HD22 ' A' ' 79' ' ' LEU . 18.8 m -107.88 -11.89 15.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.805 0.336 . . . . 0.0 111.111 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.642 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -66.92 9.72 0.91 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.545 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.665 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -78.05 4.15 13.06 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.912 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -47.34 -44.54 52.32 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.098 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 5.9 Cg_exo -73.32 -30.73 9.99 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.836 2.357 . . . . 0.0 110.104 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.012 ' O ' HG23 ' A' ' 137' ' ' VAL . 17.7 t -65.79 -49.49 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.921 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.665 HG13 ' HG ' ' A' ' 130' ' ' LEU . 19.0 m -64.54 -33.28 62.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.541 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.5 -50.65 66.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.235 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -31.82 71.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.885 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.012 HG23 ' O ' ' A' ' 133' ' ' VAL . 74.7 t -59.85 -52.9 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 134' ' ' VAL . 0.8 OUTLIER -60.76 -31.38 70.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.622 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.69 ' NE2' ' CD1' ' A' ' 45' ' ' PHE . 34.3 mt-30 -63.0 -38.55 91.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.264 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.817 ' HE1' HG23 ' A' ' 149' ' ' THR . 2.5 ptm -67.91 -42.76 80.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.268 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.612 HE22 HD22 ' A' ' 170' ' ' LEU . 21.4 mt-30 -68.5 -42.83 78.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.116 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -12.37 60.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.788 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.459 ' HB2' ' O ' ' A' ' 139' ' ' GLN . 0.8 OUTLIER -80.54 -84.34 0.1 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.455 0.645 . . . . 0.0 111.164 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.498 ' C ' ' CD ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -156.6 23.66 0.34 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.678 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 140' ' ' MET . . . -112.66 49.69 0.38 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.356 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.505 ' HA ' ' HG2' ' A' ' 175' ' ' ARG . 52.6 Cg_endo -69.31 -3.6 12.03 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.579 2.186 . . . . 0.0 111.922 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -69.97 -159.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.256 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.546 ' CB ' ' HB2' ' A' ' 176' ' ' ASN . 1.0 OUTLIER -73.03 105.28 4.43 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.62 0.724 . . . . 0.0 111.515 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.817 HG23 ' HE1' ' A' ' 140' ' ' MET . 0.5 OUTLIER -110.04 115.21 29.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.237 178.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.64 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -106.34 138.56 42.29 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.745 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.909 HD12 ' N ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -133.52 134.95 56.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.026 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.909 ' N ' HD12 ' A' ' 151' ' ' ILE . 21.8 m-30 -109.51 123.24 49.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.071 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.446 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 7.2 t80 -119.87 131.01 55.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.775 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.769 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -158.49 158.6 29.43 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 119.492 -1.337 . . . . 0.0 113.775 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.866 HG11 ' CD2' ' A' ' 161' ' ' LEU . 11.8 m -164.15 -116.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.841 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.6 OUTLIER -119.91 -164.27 1.06 Allowed 'General case' 0 C--N 1.343 0.285 0 O-C-N 122.459 -0.151 . . . . 0.0 110.895 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.811 HG23 ' HA ' ' A' ' 187' ' ' SER . 65.3 p -25.95 -41.38 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.456 0.302 . . . . 0.0 111.515 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.604 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.8 OUTLIER 107.82 -43.27 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.617 0 O-C-N 123.967 0.792 . . . . 0.0 112.402 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 157' ' ' THR . 80.3 Cg_exo -46.2 -22.02 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.199 1.933 . . . . 0.0 112.335 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -98.4 -13.96 20.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.764 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.866 ' CD2' HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -110.58 -165.69 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.756 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.49 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 0.1 OUTLIER 178.26 -154.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.903 0.382 . . . . 0.0 111.349 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.522 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 77.13 16.12 1.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.097 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 1.033 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -70.27 -39.17 76.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.246 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 1.033 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.6 OUTLIER -73.68 -27.45 61.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.097 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.458 ' O ' ' OG ' ' A' ' 169' ' ' SER . 3.5 mm-40 -64.79 -49.61 70.02 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.605 HD11 ' HA ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -76.21 -31.13 58.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.584 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 165' ' ' ASP . 7.7 mttt -62.74 -36.67 83.77 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 166' ' ' GLU . 15.0 p -66.96 -32.95 74.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.808 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -63.01 -41.57 99.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.185 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.659 ' OE1' HD22 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -68.91 -36.45 78.04 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.913 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -76.21 -25.05 54.72 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.348 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 169' ' ' SER . 37.4 t -61.48 -71.06 0.16 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.707 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.02 ' O ' HD12 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -179.92 -153.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.133 0.492 . . . . 0.0 112.083 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER 42.59 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.577 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.546 ' HB2' ' CB ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -13.45 73.69 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 124.433 1.083 . . . . 0.0 111.736 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.02 HD12 ' O ' ' A' ' 174' ' ' MET . 0.3 OUTLIER -94.65 148.53 22.17 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.201 -178.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.522 ' OG1' ' CZ ' ' A' ' 150' ' ' ARG . 6.8 m -137.18 115.33 11.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.03 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.482 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 7.3 p -101.22 127.77 54.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.161 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.578 ' CB ' ' CD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -95.84 135.52 37.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.539 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -101.0 104.97 16.15 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.354 0.597 . . . . 0.0 110.899 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.624 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 34.5 m -88.67 -160.76 0.68 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.108 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.841 HG21 ' O ' ' A' ' 156' ' ' ASN . 40.6 t 56.23 146.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.765 0.793 . . . . 0.0 111.815 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.718 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.3 -63.4 0.76 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.751 -178.163 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.563 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 1.1 t60 -168.65 51.47 0.2 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.541 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.569 ' HG2' ' CA ' ' A' ' 156' ' ' ASN . 62.6 Cg_endo -88.01 -101.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.054 2.503 . . . . 0.0 112.793 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.811 ' HA ' HG23 ' A' ' 157' ' ' THR . 0.4 OUTLIER 153.23 -8.01 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.605 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 130.34 12.11 2.35 Favored Glycine 0 C--N 1.322 -0.214 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.728 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.54 63.39 1.55 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.518 ' N ' ' OG ' ' A' ' 248' ' ' SER . 7.5 t-105 -125.86 117.53 23.54 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.21 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.404 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 10.0 mm-40 -92.01 104.18 16.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 251' ' ' ALA . . . 142.06 -120.05 1.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.438 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -167.09 -85.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 0.0 OUTLIER -85.82 126.78 34.29 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.636 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -25.99 106.74 0.01 OUTLIER Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.085 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 2.2 m 146.25 166.01 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 114.961 -0.619 . . . . 0.0 110.896 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.465 ' HG2' ' OD2' ' A' ' 199' ' ' ASP . 83.5 Cg_endo -81.93 44.33 1.7 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.899 2.399 . . . . 0.0 112.566 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.025 HG13 ' HB1' ' A' ' 251' ' ' ALA . 0.1 OUTLIER 65.81 17.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.297 0.57 . . . . 0.0 110.754 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.465 ' OD2' ' HG2' ' A' ' 197' ' ' PRO . 1.0 OUTLIER -58.41 -36.77 74.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.442 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.88 -43.68 94.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.685 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.883 ' HB2' HD12 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -65.8 -31.38 72.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.927 0.394 . . . . 0.0 110.527 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.576 ' HG2' HD22 ' A' ' 229' ' ' LEU . 5.7 mtm180 -58.83 -42.13 88.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.5 0.666 . . . . 0.0 110.178 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.84 -32.71 65.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.088 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -58.79 -43.2 90.41 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.758 HD11 ' HB2' ' A' ' 229' ' ' LEU . 0.0 OUTLIER -60.79 -46.06 91.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.0 -24.22 66.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.352 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 208' ' ' SER . 16.4 t -92.11 -87.96 0.21 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.885 0.374 . . . . 0.0 111.18 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 1.9 p 163.28 103.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.645 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 1.2 m-20 156.69 57.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.52 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 0.934 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 147.4 105.37 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.397 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.6 ' O ' HG23 ' A' ' 240' ' ' VAL . 56.3 t30 177.27 -56.01 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.208 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 9.6 Cg_endo -52.82 -55.69 3.51 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.953 1.769 . . . . 0.0 110.667 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.47 109.45 9.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.979 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.994 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.9 OUTLIER -121.12 125.56 74.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.677 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -117.39 126.21 52.29 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.49 0.662 . . . . 0.0 110.163 -178.577 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 1.02 HD23 HG12 ' A' ' 124' ' ' VAL . 34.0 mt -122.73 118.78 28.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.042 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' CYS . . . . . 0.573 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -123.42 132.31 53.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.107 178.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 245' ' ' PHE . . . 136.32 -154.78 22.16 Favored Glycine 0 C--O 1.224 -0.475 0 C-N-CA 120.333 -0.936 . . . . 0.0 112.859 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.581 ' HG3' ' HA ' ' A' ' 248' ' ' SER . 11.8 Cg_endo -53.79 161.21 4.78 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.005 2.47 . . . . 0.0 112.648 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.564 ' O ' HG22 ' A' ' 223' ' ' ILE . 50.5 Cg_endo -69.28 -8.97 25.03 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.611 2.208 . . . . 0.0 111.572 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.48 -49.17 52.94 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.282 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.775 ' O ' ' HB3' ' A' ' 226' ' ' ALA . 0.0 OUTLIER -55.7 -25.71 41.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.3 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.574 HD11 ' C ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -76.59 -42.54 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.487 178.336 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -74.67 -47.57 31.04 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.561 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -76.41 -48.99 17.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.911 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -59.5 -37.79 79.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.76 0.314 . . . . 0.0 110.594 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 37.9 t -69.64 -31.22 69.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.946 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 232' ' ' SER . 4.8 mt-10 -70.95 -45.13 64.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.738 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.758 ' HB2' HD11 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -60.67 -37.38 81.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.178 0.513 . . . . 0.0 110.702 -179.608 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 1.048 HG13 HG23 ' A' ' 235' ' ' ILE . 12.5 t -65.24 -45.63 93.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.393 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.8 -30.16 61.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.035 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 228' ' ' GLU . 0.6 OUTLIER -75.37 -44.16 46.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.391 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.54 ' HD3' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -79.65 -70.57 0.5 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.008 0.432 . . . . 0.0 111.11 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 154.9 -31.42 0.67 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.8 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 1.048 HG23 HG13 ' A' ' 230' ' ' VAL . 0.0 OUTLIER -26.33 84.59 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 123.064 0.545 . . . . 0.0 112.423 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.539 ' N ' ' O ' ' A' ' 234' ' ' GLY . 5.8 Cg_exo -76.37 114.35 3.87 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 123.427 2.751 . . . . 0.0 112.232 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -106.22 161.08 14.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.931 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -117.51 -45.96 2.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.736 0.303 . . . . 0.0 110.91 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 19.3 mm-40 -105.87 40.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.354 0.597 . . . . 0.0 110.281 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.994 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.3 t -92.04 134.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.928 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.36 145.67 30.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.248 -178.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 1.004 ' CD1' HD12 ' A' ' 216' ' ' LEU . 1.5 m-85 -131.64 144.24 50.89 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.721 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLU . . . . . 0.521 ' O ' ' CE ' ' A' ' 222' ' ' MET . 21.2 tt0 -132.72 148.72 52.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -111.19 106.48 15.51 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.871 ' CE1' HD23 ' A' ' 246' ' ' LEU . 0.0 OUTLIER -137.0 145.28 43.93 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.557 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.987 HD21 ' O ' ' A' ' 126' ' ' GLY . 0.2 OUTLIER 51.59 171.52 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.564 ' CD ' ' HB2' ' A' ' 246' ' ' LEU . 32.2 Cg_exo -60.36 -138.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.914 3.076 . . . . 0.0 113.054 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.581 ' HA ' ' HG3' ' A' ' 219' ' ' PRO . 1.0 OUTLIER -72.75 161.15 31.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.808 0.337 . . . . 0.0 111.847 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.484 ' C ' ' HA3' ' A' ' 126' ' ' GLY . . . 143.41 -20.75 2.24 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.609 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.55 ' O ' ' OXT' ' A' ' 251' ' ' ALA . . . -105.78 153.43 21.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.903 0.383 . . . . 0.0 111.785 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 1.025 ' HB1' HG13 ' A' ' 198' ' ' ILE . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.037 -0.982 . . . . 0.0 112.614 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' FDA . . . . . 0.963 HM82 ' CZ ' ' A' ' 50' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.776 0.322 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -116.59 -70.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.771 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.8 mt -114.9 82.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.988 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 t -94.36 33.87 1.35 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 70.53 46.87 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.78 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.79 159.0 7.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.607 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.74 155.59 48.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.0 110.735 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.13 100.6 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.003 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 105' ' ' LYS . . . -105.81 20.77 35.68 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.6 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 105' ' ' LYS . 3.6 p -112.61 150.99 30.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.583 -0.308 . . . . 0.0 110.711 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.898 ' CE1' ' HB2' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -132.41 165.63 23.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.034 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.582 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 3.3 mt-10 -113.53 129.89 56.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.989 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.979 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -125.86 150.68 47.69 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 1.9 pt-20 -102.11 112.19 24.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.825 0.345 . . . . 0.0 110.303 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 100' ' ' GLN . 11.4 t -71.36 105.67 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.012 0.434 . . . . 0.0 110.715 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 17' ' ' VAL . 7.7 p -120.21 19.53 6.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.98 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -132.8 -124.75 2.57 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.558 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.719 HD12 ' C ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 74.71 95.31 0.07 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.861 0.839 . . . . 0.0 109.586 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.427 ' O ' HG23 ' A' ' 27' ' ' VAL . 19.3 p30 -142.33 139.35 31.76 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.808 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.564 ' CZ2' ' HG3' ' A' ' 93' ' ' ARG . 22.3 m0 -89.47 113.31 24.65 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 m -86.6 -33.25 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-O 121.928 0.871 . . . . 0.0 109.265 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 160' ' ' GLU . 0.4 OUTLIER -129.85 -174.19 3.24 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.411 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.462 ' HB3' ' HG3' ' A' ' 160' ' ' GLU . 9.8 t -60.06 -40.66 90.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.433 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 8.9 m-80 -133.66 40.84 3.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.197 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.712 HG23 HG21 ' A' ' 128' ' ' THR . 17.7 m -133.92 123.42 24.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.674 ' CG2' HD13 ' A' ' 19' ' ' LEU . 6.6 p -136.72 132.63 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 111.747 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 3.1 tt0 -119.98 134.58 55.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.577 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.741 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -130.68 142.61 50.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.406 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.73 HD13 ' C ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -113.04 116.93 30.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.591 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.979 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 38.8 mt -101.57 142.93 32.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 1.3 mt-30 -146.79 134.18 20.75 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.635 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . 2.7 tmtp? -178.14 -70.67 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.66 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 8.2 mtp180 -139.84 -163.4 0.06 OUTLIER Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.66 ' CD ' ' CB ' ' A' ' 34' ' ' ARG . 41.5 Cg_exo -40.9 108.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 122.74 2.294 . . . . 0.0 113.742 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.57 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . 21.3 m-20 144.68 -179.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.638 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.864 ' HG3' HD21 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -70.68 60.73 0.23 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.564 ' C ' ' HA2' ' A' ' 74' ' ' GLY . 67.7 m -159.19 -54.61 0.06 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.403 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.507 ' O ' ' NE ' ' A' ' 41' ' ' ARG . . . -87.34 26.44 7.06 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.446 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 73' ' ' GLU . 1.8 p-10 40.56 50.03 2.78 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.533 ' HD3' ' N ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -86.16 -41.52 14.63 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.669 178.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 72' ' ' PRO . . . 154.87 109.59 0.34 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 119.776 -1.202 . . . . 0.0 116.063 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.951 HG22 ' CA ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -103.4 167.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 121.257 0.551 . . . . 0.0 110.311 176.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' O ' ' CA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -146.69 -142.2 0.12 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.962 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.01 81.24 2.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.165 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.5 mp0 -113.21 165.31 13.52 Favored Pre-proline 0 C--N 1.332 -0.194 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.522 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 14.6 Cg_endo -57.57 72.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.422 2.082 . . . . 0.0 111.484 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 41.96 73.94 0.19 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.324 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -28.28 145.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.512 0.196 . . . . 0.0 110.979 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 1.034 ' CD2' HD21 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -143.7 142.27 30.89 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.722 0.296 . . . . 0.0 111.724 -178.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.581 ' O ' ' CE1' ' A' ' 50' ' ' PHE . 3.7 mtt -141.38 -155.59 0.6 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 105' ' ' LYS . 19.9 t70 -136.5 119.11 15.98 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.041 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.81 157.21 42.66 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.93 HG23 ' C ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -95.7 154.48 17.2 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.875 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.993 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -31.49 -66.08 0.19 Allowed Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 123.309 0.381 . . . . 0.0 110.701 -179.092 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.993 ' HD3' HG23 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -112.36 8.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.834 3.022 . . . . 0.0 111.704 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 101.08 -6.26 56.42 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.64 -177.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.955 HG23 ' CG ' ' A' ' 56' ' ' PRO . 69.0 p -23.02 -87.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.269 0.628 . . . . 0.0 111.703 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.634 ' O ' HG12 ' A' ' 60' ' ' VAL . 4.8 m-20 -151.64 42.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.105 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.93 ' C ' HG23 ' A' ' 54' ' ' THR . 0.4 OUTLIER 80.96 125.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.874 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.851 ' N ' HG23 ' A' ' 54' ' ' THR . 27.0 t -111.23 -57.73 2.2 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.692 0.758 . . . . 0.0 110.005 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -179.9 -177.92 0.41 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.175 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.585 ' O ' " H2'" ' A' ' 252' ' ' FDA . 0.7 OUTLIER -88.62 129.65 35.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.144 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.489 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 2.1 t80 -140.65 125.76 18.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.949 0.404 . . . . 0.0 110.778 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 32.0 t -75.33 106.27 2.75 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.674 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.87 ' HB2' HD22 ' A' ' 76' ' ' LEU . 11.1 Cg_endo -91.24 154.33 3.75 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.439 2.759 . . . . 0.0 111.1 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 132' ' ' PRO . . . -144.38 128.91 18.05 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.613 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 12.0 t-20 -108.94 -67.79 0.96 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.554 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER 142.28 151.11 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 O-C-N 123.825 0.703 . . . . 0.0 109.977 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.567 ' CD ' ' HG ' ' A' ' 69' ' ' LEU . 12.0 Cg_endo -55.56 108.0 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 121.732 1.621 . . . . 0.0 109.962 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.92 ' O ' HG23 ' A' ' 43' ' ' VAL . 6.8 p30 178.0 -168.19 0.04 OUTLIER Pre-proline 0 C--O 1.217 -0.657 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.831 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.621 ' CD ' ' HB2' ' A' ' 71' ' ' ASN . 53.2 Cg_exo -53.19 -21.86 18.12 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.842 1.695 . . . . 0.0 113.295 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.951 ' CA ' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER 79.81 70.02 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 177.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.564 ' HA2' ' C ' ' A' ' 38' ' ' CYS . . . -141.61 28.1 2.32 Favored Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.143 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 59.8 mtm-85 -152.86 93.59 1.77 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.073 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.87 HD22 ' HB2' ' A' ' 66' ' ' PRO . 8.5 mt -91.08 143.18 26.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -127.47 111.21 13.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.0 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.741 ' CD2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -108.7 142.35 39.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.776 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.019 HD12 ' HB2' ' A' ' 131' ' ' ALA . 9.2 mt -126.36 80.6 1.94 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.143 0.497 . . . . 0.0 109.768 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.622 ' HB ' ' CE2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -92.56 122.07 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.171 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.736 ' O ' H52A ' A' ' 252' ' ' FDA . 0.4 OUTLIER -79.55 95.77 5.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.438 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.551 HG13 HG12 ' A' ' 27' ' ' VAL . 2.4 m -90.59 141.22 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.983 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.708 HD23 ' H4B' ' A' ' 252' ' ' FDA . 0.2 OUTLIER -87.25 167.51 21.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.591 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 83' ' ' LEU . 30.4 Cg_endo -63.8 77.7 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.593 2.195 . . . . 0.0 112.251 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.42 61.47 3.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.465 ' CA ' HD13 ' A' ' 83' ' ' LEU . . . -109.88 -39.71 1.53 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.731 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.81 -63.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 111.383 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.535 ' CD2' ' O2P' ' A' ' 252' ' ' FDA . 6.1 t80 -71.74 -39.76 69.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.004 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -69.04 -24.02 64.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.923 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 2.3 m-20 -76.11 -37.77 57.69 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.812 0.815 . . . . 0.0 109.214 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.621 ' CE1' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -73.19 -28.8 62.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.304 -1.317 . . . . 0.0 110.777 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.695 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -68.41 -43.24 77.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.302 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.564 ' HG3' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -90.58 -23.75 20.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.753 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 20.2 m120 -87.26 -15.25 38.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.576 0.227 . . . . 0.0 111.325 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.451 ' CG ' ' HG3' ' A' ' 56' ' ' PRO . 1.5 t70 -127.92 -23.68 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -118.13 36.87 4.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.954 0.407 . . . . 0.0 111.078 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -70.58 -41.21 72.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.545 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.744 ' O ' HG12 ' A' ' 98' ' ' VAL . 2.2 t -121.8 90.45 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.203 0.525 . . . . 0.0 111.834 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.516 ' CA ' ' O ' ' A' ' 16' ' ' VAL . . . 8.77 56.7 0.01 OUTLIER Glycine 0 N--CA 1.459 0.181 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.153 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.62 ' O ' HG23 ' A' ' 16' ' ' VAL . 4.6 mt-30 -68.92 -179.27 1.42 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.715 0.293 . . . . 0.0 110.852 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.0 p -92.94 133.42 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.824 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.041 HD11 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.74 120.81 25.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.798 0.332 . . . . 0.0 110.453 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.552 ' N ' HD12 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -89.66 136.5 33.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.182 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.784 HG13 ' CE1' ' A' ' 12' ' ' PHE . 1.4 m -111.11 127.55 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -129.75 117.53 20.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.497 -178.508 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.53 ' CA ' ' HB3' ' A' ' 51' ' ' MET . . . 164.64 71.44 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.751 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.41 58.93 1.03 Allowed 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.159 1.906 . . . . 0.0 110.228 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.034 HD21 ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -129.36 169.87 14.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.031 -178.128 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.548 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -116.17 173.25 14.62 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.49 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 47' ' ' PRO . 2.5 p -121.25 111.75 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.325 0.583 . . . . 0.0 110.587 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -81.14 114.25 19.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.406 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 241' ' ' PHE . . . -179.0 -48.18 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.675 HD22 HG22 ' A' ' 133' ' ' VAL . 1.1 pp -124.4 118.06 25.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.212 0.53 . . . . 0.0 110.867 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.627 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -139.46 114.13 9.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.04 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.446 ' OE1' ' HE3' ' A' ' 140' ' ' MET . 2.0 tp10 -89.59 138.25 31.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.47 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -91.34 13.66 16.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.025 0.44 . . . . 0.0 110.839 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.46 -73.8 0.43 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.461 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.54 ' HA ' ' CB ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -129.83 89.56 2.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.846 0.355 . . . . 0.0 110.409 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 121' ' ' ARG . . . -164.09 155.85 14.31 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.406 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 10.2 Cg_exo -71.36 107.65 2.19 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.077 2.518 . . . . 0.0 111.747 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.505 ' NH1' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -136.82 138.1 40.45 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.226 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.669 ' CE2' ' CD ' ' A' ' 150' ' ' ARG . 1.9 m-85 -107.62 127.29 53.52 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.141 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.588 ' CD2' ' HB2' ' A' ' 113' ' ' LEU . 1.1 m-85 -106.73 104.34 14.0 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 1.039 HG13 ' CB ' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -99.1 111.18 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.344 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -110.14 133.73 52.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.285 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -109.63 102.63 1.62 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.674 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.926 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 122.58 -152.79 16.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.992 -1.099 . . . . 0.0 112.349 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.862 ' CG2' HD22 ' A' ' 79' ' ' LEU . 2.9 m -111.55 -16.32 13.3 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.247 0.546 . . . . 0.0 110.51 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.618 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -65.58 11.21 0.4 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.857 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.686 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -74.99 4.34 6.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.52 0.328 . . . . 0.0 110.191 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 1.019 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -45.32 -41.93 17.29 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.29 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 7.3 Cg_exo -72.36 -31.08 11.94 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.39 2.06 . . . . 0.0 109.936 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.675 HG22 HD22 ' A' ' 113' ' ' LEU . 5.9 t -66.85 -44.31 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.41 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.686 HG13 ' HG ' ' A' ' 130' ' ' LEU . 10.5 m -70.59 -30.4 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.893 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -64.37 -51.31 63.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.3 tpt -64.19 -45.45 88.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.169 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.487 HG12 ' OE1' ' A' ' 141' ' ' GLN . 42.6 t -61.82 -30.52 48.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.227 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER -62.1 -38.0 87.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.336 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -42.18 98.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.395 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.623 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 4.7 tpp -68.66 -34.77 76.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.503 0.668 . . . . 0.0 110.732 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.766 ' OE1' HD22 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -77.77 -30.74 51.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.519 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -70.47 -44.5 67.63 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.764 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -79.04 -21.14 47.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.432 0.634 . . . . 0.0 109.828 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 141' ' ' GLN . 1.1 p 54.17 26.64 6.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.917 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.764 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -37.27 161.11 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.775 0.322 . . . . 0.0 110.586 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' ' 145' ' ' ALA . 57.7 Cg_endo -72.44 5.36 2.83 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 122.662 2.241 . . . . 0.0 112.9 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.631 ' OD1' ' HB3' ' A' ' 145' ' ' ALA . 19.0 p-10 -86.2 136.8 33.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 111.85 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 0.9 OUTLIER -73.62 113.69 11.03 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.753 0.787 . . . . 0.0 111.012 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 53.8 m -107.96 115.09 29.5 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.539 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.669 ' CD ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -103.4 140.91 36.83 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.266 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.941 HD12 ' N ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -134.54 133.96 54.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.162 0.506 . . . . 0.0 110.816 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 1.039 ' CB ' HG13 ' A' ' 124' ' ' VAL . 19.1 m-30 -114.05 110.66 20.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.497 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 154' ' ' GLY . 1.0 OUTLIER -116.45 133.42 56.04 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 122.091 -0.38 . . . . 0.0 111.064 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.866 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -158.73 158.79 29.68 Favored Glycine 0 CA--C 1.502 -0.748 0 C-N-CA 119.366 -1.397 . . . . 0.0 113.649 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 1.118 HG21 HD22 ' A' ' 161' ' ' LEU . 2.5 m -168.76 -108.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.874 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.4 OUTLIER -122.19 -169.71 1.94 Allowed 'General case' 0 C--N 1.344 0.331 0 CA-C-O 120.773 0.32 . . . . 0.0 111.517 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.765 HG23 ' N ' ' A' ' 187' ' ' SER . 76.9 p -29.51 -63.38 0.12 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.488 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.56 ' CB ' ' O ' ' A' ' 157' ' ' THR . 4.4 mm-40 153.32 -53.54 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.194 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 79.0 Cg_exo -37.65 -27.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.955 2.437 . . . . 0.0 112.732 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -86.41 -30.56 22.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.897 0.379 . . . . 0.0 110.976 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.118 HD22 HG21 ' A' ' 155' ' ' VAL . 1.0 OUTLIER -108.86 -174.66 2.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.268 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.53 ' O ' ' CB ' ' A' ' 163' ' ' TYR . 0.3 OUTLIER -171.05 -167.12 0.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.302 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.53 ' CB ' ' O ' ' A' ' 162' ' ' PHE . 0.2 OUTLIER 85.57 13.17 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.823 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.492 ' HA ' HD13 ' A' ' 164' ' ' ILE . 0.1 OUTLIER -65.45 -49.59 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.293 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.48 ' N ' HG22 ' A' ' 164' ' ' ILE . 0.7 OUTLIER -69.27 -33.37 73.12 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.271 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.438 ' CD ' ' CE1' ' A' ' 163' ' ' TYR . 1.6 mt-10 -72.42 -36.14 68.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.582 ' CD2' HG21 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -60.89 -32.07 71.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.05 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 171' ' ' GLU . 4.5 mtpt -63.14 -49.04 75.92 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 6.8 m -61.83 -31.54 71.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.766 HD22 ' OE1' ' A' ' 141' ' ' GLN . 0.8 OUTLIER -62.86 -34.6 77.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.783 ' HA ' HD11 ' A' ' 177' ' ' LEU . 40.6 mt-10 -63.86 -42.08 97.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.28 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 -78.21 -33.62 49.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.603 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.27 -46.29 55.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.639 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.065 ' HB2' HD23 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -77.15 -163.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.176 0.512 . . . . 0.0 111.602 -179.334 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER -105.08 -62.38 1.35 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.351 -179.579 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -130.28 64.02 1.54 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.795 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.065 HD23 ' HB2' ' A' ' 174' ' ' MET . 0.7 OUTLIER -105.1 154.25 20.41 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.032 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.488 ' N ' HD12 ' A' ' 177' ' ' LEU . 9.1 m -136.72 117.37 13.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.578 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.623 HG11 ' OE2' ' A' ' 171' ' ' GLU . 7.6 p -95.43 135.33 29.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.671 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.553 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 1.9 tppt? -97.95 135.95 38.94 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.852 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 194' ' ' GLN . . . -102.11 105.34 16.04 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 121.517 0.675 . . . . 0.0 111.751 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.631 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 34.7 m -87.35 -159.15 0.49 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.645 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.874 HG21 ' O ' ' A' ' 156' ' ' ASN . 28.4 t 55.93 148.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.64 0.733 . . . . 0.0 111.77 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.723 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -136.37 -62.55 0.66 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.197 -178.024 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.597 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 3.7 t60 -166.86 51.43 0.22 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.724 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.625 ' HG2' ' HA ' ' A' ' 156' ' ' ASN . 98.5 Cg_endo -88.97 -98.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.044 2.496 . . . . 0.0 112.704 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.765 ' N ' HG23 ' A' ' 157' ' ' THR . 13.6 t 143.11 2.28 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.603 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 123.73 12.29 4.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.453 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.27 62.72 1.58 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 249' ' ' GLY . 8.3 t-105 -130.83 120.6 23.93 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.249 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 250' ' ' ALA . 0.0 OUTLIER -98.96 104.45 16.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.341 178.187 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.585 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 145.18 -117.75 1.04 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.506 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 183' ' ' VAL . 18.7 mt-10 -165.04 -98.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -87.41 126.85 35.13 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . 2.46 108.92 0.0 OUTLIER Glycine 0 C--N 1.339 0.7 0 O-C-N 124.061 0.851 . . . . 0.0 113.726 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 5.9 m 96.83 156.21 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.286 0 CA-C-O 121.06 0.457 . . . . 0.0 111.086 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 196' ' ' SER . 58.0 Cg_exo -35.75 -69.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.349 2.699 . . . . 0.0 113.638 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.719 ' O ' HG23 ' A' ' 198' ' ' ILE . 0.1 OUTLIER 173.36 35.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 122.093 0.949 . . . . 0.0 110.636 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.516 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 0.9 OUTLIER -57.61 -37.19 72.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.859 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.81 -32.81 70.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.316 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.706 ' HB2' HD13 ' A' ' 198' ' ' ILE . 0.3 OUTLIER -69.54 -32.13 70.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 110.489 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.729 ' HG2' HD22 ' A' ' 229' ' ' LEU . 2.8 mtt180 -59.86 -52.25 66.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.533 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.11 -40.93 86.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.566 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 207' ' ' SER . 11.3 m-20 -60.18 -28.49 67.99 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.788 ' HG ' HD11 ' A' ' 235' ' ' ILE . 0.1 OUTLIER -61.79 -47.99 82.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.25 178.654 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -14.38 59.69 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.016 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.449 ' HB2' ' HA ' ' A' ' 204' ' ' ASP . 3.8 m -91.98 -76.59 0.45 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.803 0.335 . . . . 0.0 111.497 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.548 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 17.3 p 168.97 102.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.677 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.63 ' O ' ' HB3' ' A' ' 210' ' ' ALA . 5.0 m-20 153.32 86.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.696 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 0.766 ' CB ' HD11 ' A' ' 214' ' ' ILE . . . 101.6 109.79 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.579 ' HB2' HD13 ' A' ' 235' ' ' ILE . 11.7 t30 -175.26 -58.51 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.437 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 11.7 Cg_endo -57.23 -83.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.043 1.829 . . . . 0.0 110.676 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.89 ' HA ' HG21 ' A' ' 240' ' ' VAL . 0.0 OUTLIER -114.38 111.59 21.7 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.766 HD11 ' CB ' ' A' ' 210' ' ' ALA . 0.8 OUTLIER -109.5 126.48 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.689 ' CE1' ' CD2' ' A' ' 241' ' ' PHE . 2.7 m-85 -116.72 134.2 55.1 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.77 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.803 HD23 ' HB ' ' A' ' 124' ' ' VAL . 1.5 mt -134.45 115.58 14.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.791 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' CYS . . . . . 0.53 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 42.3 t -123.48 107.54 11.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.851 0.357 . . . . 0.0 110.476 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.613 ' CA ' ' CD2' ' A' ' 245' ' ' PHE . . . 114.14 -36.92 3.77 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.769 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 218' ' ' GLY . 45.0 Cg_endo -92.82 79.99 0.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.812 2.341 . . . . 0.0 113.956 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.783 ' HD2' ' HB2' ' A' ' 250' ' ' ALA . 9.2 Cg_endo -51.59 -66.8 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.452 2.101 . . . . 0.0 111.074 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.844 ' N ' ' HB1' ' A' ' 250' ' ' ALA . . . -54.09 -48.77 61.91 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.012 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.571 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -55.22 -24.73 28.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.729 HD11 ' H ' ' A' ' 243' ' ' GLU . 0.1 OUTLIER -74.56 -37.07 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.111 177.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 221' ' ' GLY . 7.2 m-20 -71.85 -46.43 58.0 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.813 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.528 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -67.59 -33.14 74.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -60.13 -39.43 86.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.361 0.6 . . . . 0.0 110.055 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.436 ' HB2' ' OE1' ' A' ' 239' ' ' GLN . 31.5 t -70.49 -31.8 69.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.784 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -44.02 92.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.638 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.729 HD22 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -59.74 -37.59 79.38 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.077 0.465 . . . . 0.0 110.636 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.782 HG22 ' CG ' ' A' ' 238' ' ' GLU . 3.0 t -62.46 -46.45 96.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.424 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -74.56 -30.28 61.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.783 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 51.5 m -74.11 -42.05 60.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.303 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.499 ' HD3' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -85.11 -74.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.236 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 158.75 -56.58 0.35 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.07 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.847 ' O ' HD12 ' A' ' 235' ' ' ILE . 2.2 pp -39.36 98.69 0.18 Allowed Pre-proline 0 N--CA 1.453 -0.288 0 CA-C-O 121.255 0.55 . . . . 0.0 111.221 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 57.7 Cg_endo -70.33 164.43 35.12 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 123.404 2.736 . . . . 0.0 112.646 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 211' ' ' ASN . . . 76.3 9.42 85.75 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.642 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.782 ' CG ' HG22 ' A' ' 230' ' ' VAL . 8.7 tp10 -71.53 1.02 7.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.68 0.276 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.535 ' O ' ' O ' ' A' ' 214' ' ' ILE . 39.3 mt-30 -101.95 -76.98 0.56 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.369 0.604 . . . . 0.0 109.874 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.89 HG21 ' HA ' ' A' ' 213' ' ' ASP . 4.0 t 65.06 -83.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.46 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.788 ' CG ' HG12 ' A' ' 240' ' ' VAL . 9.5 m-85 -115.64 127.82 55.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.894 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.411 ' HB3' HG12 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -132.57 132.84 42.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.438 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLU . . . . . 0.729 ' H ' HD11 ' A' ' 223' ' ' ILE . 11.0 tp10 -132.56 149.04 52.38 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.281 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 220' ' ' PRO . 0.9 OUTLIER -127.74 106.23 8.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.618 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -138.58 146.11 41.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.342 179.134 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.566 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 5.7 mt 64.71 167.63 0.11 Allowed Pre-proline 0 N--CA 1.471 0.588 0 O-C-N 121.886 -0.509 . . . . 0.0 111.925 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.476 ' CD ' HD22 ' A' ' 246' ' ' LEU . 38.6 Cg_endo -88.6 -107.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.764 2.976 . . . . 0.0 112.422 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 247' ' ' PRO . 30.7 m -36.4 136.49 0.33 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 110.959 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 190' ' ' TRP . . . 125.84 -15.87 6.97 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.844 ' HB1' ' N ' ' A' ' 221' ' ' GLY . . . -106.38 119.36 39.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.81 -0.695 . . . . 0.0 111.364 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.585 ' N ' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' FDA . . . . . 0.92 ' N1 ' " H3'" ' A' ' 252' ' ' FDA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.752 0.311 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -116.65 0.83 12.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.102 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.1 mm -79.14 104.9 7.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.867 0.365 . . . . 0.0 111.079 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.0 t -61.63 156.58 19.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -67.3 138.29 56.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.98 35.3 0.78 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.548 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.68 104.45 16.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.713 0.292 . . . . 0.0 110.821 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.11 100.41 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.075 0.464 . . . . 0.0 111.096 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.06 21.02 9.66 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.602 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -118.91 152.82 35.62 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.818 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.976 ' CE1' ' HB2' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -132.45 165.19 24.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.93 0.395 . . . . 0.0 110.947 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.582 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -104.84 123.99 48.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.635 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.976 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . . . -121.44 154.2 36.87 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.536 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -118.99 116.56 26.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.323 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.569 HG12 ' CD2' ' A' ' 31' ' ' LEU . 17.3 m -71.16 125.66 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.454 . . . . 0.0 111.194 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.538 ' HA ' ' CG1' ' A' ' 98' ' ' VAL . 8.7 p -144.56 16.31 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.367 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -140.97 -135.38 3.17 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.691 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.004 HD11 HD22 ' A' ' 92' ' ' LEU . 0.2 OUTLIER 92.17 70.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.196 0.522 . . . . 0.0 110.494 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.555 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -111.8 147.88 34.75 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.677 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -89.31 114.37 25.75 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 m -89.37 -29.19 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.523 0.677 . . . . 0.0 109.718 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.532 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 20.9 m -137.11 177.18 8.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.435 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.444 ' OG ' ' OD1' ' A' ' 25' ' ' ASN . 2.9 t -51.88 -58.37 6.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.894 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 2.5 m-20 -117.55 44.85 2.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.441 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.928 HG23 ' HG2' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -146.06 137.29 24.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.602 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.811 HG21 ' CD2' ' A' ' 19' ' ' LEU . 1.5 p -140.34 143.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.595 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -115.42 103.14 10.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.213 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.62 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.6 OUTLIER -91.4 121.24 32.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.676 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.604 HD13 ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -102.37 116.02 31.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.375 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.677 HD22 HD23 ' A' ' 102' ' ' LEU . 6.9 mt -111.9 133.78 53.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 46.8 mt-30 -142.79 129.49 20.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.589 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.591 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -152.38 -97.48 0.05 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.163 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.554 ' HB3' ' CB ' ' A' ' 41' ' ' ARG . 2.8 mmp_? -37.75 98.0 0.15 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 57.9 Cg_endo -71.76 90.43 0.72 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.16 2.573 . . . . 0.0 115.206 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.533 ' OD2' ' CA ' ' A' ' 42' ' ' GLY . 1.8 t70 -107.96 -36.62 6.3 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 122.343 1.068 . . . . 0.0 108.426 176.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -173.27 -39.57 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.24 -1.8 . . . . 0.0 108.146 178.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' CB ' ' N ' ' A' ' 75' ' ' ARG . 86.6 m -116.67 -52.96 2.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.14 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 34' ' ' ARG . . . 154.5 52.33 0.01 OUTLIER Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.471 -0.871 . . . . 0.0 114.114 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.612 ' CB ' ' CA ' ' A' ' 74' ' ' GLY . 26.1 t-20 -144.59 6.71 1.26 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.451 0.625 . . . . 0.0 112.488 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.554 ' CB ' ' HB3' ' A' ' 34' ' ' ARG . 0.0 OUTLIER 78.84 -5.81 1.98 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 72' ' ' PRO . . . 117.12 101.6 2.18 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.752 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -94.39 163.93 2.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.807 0.337 . . . . 0.0 111.279 -179.686 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.678 ' N ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -166.69 22.57 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.006 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.888 ' CB ' HD12 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -103.94 -169.38 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.265 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.521 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 20.5 mm-40 -107.55 130.28 23.05 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.905 0.383 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.965 ' HA ' HD23 ' A' ' 69' ' ' LEU . 99.8 Cg_exo -41.75 -23.01 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.618 2.212 . . . . 0.0 112.219 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . -51.83 -34.35 37.12 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.961 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.44 158.91 32.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.904 0.383 . . . . 0.0 110.909 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 1.043 ' HB2' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -125.79 164.06 21.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.445 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.537 ' CA ' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -114.84 143.33 45.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.978 0.418 . . . . 0.0 111.902 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.545 ' HA ' ' CB ' ' A' ' 63' ' ' SER . 14.1 t70 -98.95 107.8 20.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.031 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -148.96 157.08 43.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.361 -178.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.937 HG22 ' HB2' ' A' ' 61' ' ' SER . 0.2 OUTLIER -93.42 151.52 19.69 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.96 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -32.72 -66.06 0.21 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.519 -178.445 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.96 ' HD3' HG23 ' A' ' 55' ' ' ILE . 7.5 Cg_endo -106.32 4.19 0.2 Allowed 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 123.424 2.75 . . . . 0.0 111.486 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 106.95 -3.02 35.61 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.261 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.799 HG23 ' CD ' ' A' ' 56' ' ' PRO . 31.4 p -24.52 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.178 0.513 . . . . 0.0 111.744 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.85 ' H ' HG21 ' A' ' 54' ' ' THR . 19.8 p-10 -178.06 -28.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.77 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.703 ' O ' HG13 ' A' ' 60' ' ' VAL . 6.2 p -147.58 109.28 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.682 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.937 ' HB2' HG22 ' A' ' 54' ' ' THR . 0.3 OUTLIER -143.15 -76.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.793 179.288 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.556 ' HG3' " H3'" ' A' ' 252' ' ' FDA . 0.4 OUTLIER 170.49 155.22 0.06 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.47 . . . . 0.0 111.901 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.712 ' CB ' HD21 ' A' ' 108' ' ' LEU . 46.6 p -89.54 131.82 35.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.382 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.547 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -120.78 119.62 33.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.404 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.562 ' HB3' ' H6 ' ' A' ' 252' ' ' FDA . 60.7 p -60.41 102.68 0.32 Allowed Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HB2' HD13 ' A' ' 76' ' ' LEU . 92.6 Cg_endo -102.9 -178.42 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.276 2.651 . . . . 0.0 113.563 -178.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.651 ' O ' ' ND2' ' A' ' 68' ' ' ASN . . . -87.21 167.37 14.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.984 ' O ' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER 89.63 117.55 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -177.197 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.984 HD22 ' O ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -167.47 -65.59 0.01 OUTLIER Pre-proline 0 C--O 1.215 -0.734 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.543 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 66.4 Cg_endo -99.07 75.26 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.379 2.053 . . . . 0.0 113.244 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.622 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.5 OUTLIER 178.9 125.33 0.21 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.718 0.294 . . . . 0.0 110.48 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.577 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 30.8 Cg_endo -64.26 56.98 0.23 Allowed 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.313 2.009 . . . . 0.0 111.675 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.575 ' HB3' ' N ' ' A' ' 38' ' ' CYS . 2.4 mt-10 -135.93 -81.44 0.4 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.017 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.612 ' CA ' ' CB ' ' A' ' 40' ' ' ASN . . . 126.77 15.25 2.66 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.854 -1.165 . . . . 0.0 114.255 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.593 ' N ' ' CB ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -61.96 85.25 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.284 0.542 . . . . 0.0 110.257 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.814 HD12 ' C ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -96.18 128.76 43.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.599 0.714 . . . . 0.0 111.197 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.708 ' N ' HD12 ' A' ' 76' ' ' LEU . 7.7 mt-10 -132.72 141.4 48.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.625 -1.171 . . . . 0.0 111.251 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.62 ' CE2' ' HB3' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -133.4 133.09 41.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.222 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.903 HD12 ' HB2' ' A' ' 131' ' ' ALA . 9.1 mt -106.78 85.6 2.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.189 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.608 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -90.48 116.57 32.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.945 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.928 ' HG2' HG23 ' A' ' 26' ' ' THR . 0.1 OUTLIER -78.12 96.07 5.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.408 0.623 . . . . 0.0 110.19 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.615 HG13 HG12 ' A' ' 27' ' ' VAL . 2.5 m -89.07 141.47 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.84 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.84 HD21 ' HB2' ' A' ' 87' ' ' ARG . 3.9 pp -74.46 169.73 18.25 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.845 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 83' ' ' LEU . 34.5 Cg_exo -61.22 63.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.804 2.336 . . . . 0.0 112.192 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER 51.15 107.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.52 ' CA ' HD11 ' A' ' 83' ' ' LEU . . . -178.55 -35.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.573 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.84 ' HB2' HD21 ' A' ' 83' ' ' LEU . 2.1 mpt_? -133.26 -81.58 0.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.752 0.311 . . . . 0.0 111.175 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.565 ' CE2' H5'1 ' A' ' 252' ' ' FDA . 2.3 t80 -74.03 -45.17 51.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.203 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.536 ' HB3' ' CG2' ' A' ' 82' ' ' VAL . 3.3 p -67.94 -23.33 65.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.513 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -75.66 -46.07 33.5 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.486 0.66 . . . . 0.0 109.493 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.408 ' HB3' HD13 ' A' ' 55' ' ' ILE . 7.8 t80 -73.35 -23.28 60.2 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.52 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.004 HD22 HD11 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -65.75 -49.37 68.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.275 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.89 -19.0 21.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.662 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 1.5 m-20 -94.38 -2.37 52.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.399 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.69 30.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.651 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.839 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . . . -151.03 25.95 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -170.02 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.87 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.538 ' CG1' ' HA ' ' A' ' 17' ' ' VAL . 1.5 t -97.9 -137.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.551 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 98' ' ' VAL . . . 31.7 53.92 0.35 Allowed Glycine 0 CA--C 1.516 0.128 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.021 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.446 ' C ' HG22 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -159.68 -170.96 3.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 111.197 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 14' ' ' ALA . 2.3 t -129.04 143.61 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.882 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.031 HD11 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -128.81 153.75 47.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.016 0.436 . . . . 0.0 111.541 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.689 ' N ' HD12 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -99.14 119.17 37.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.587 178.577 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.835 HG23 HD12 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -113.89 143.0 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.18 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.537 ' O ' ' CA ' ' A' ' 51' ' ' MET . 5.1 mtpt -128.7 168.25 16.07 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.521 ' N ' ' HD3' ' A' ' 107' ' ' PRO . . . -153.38 49.66 0.51 Allowed Glycine 0 C--N 1.313 -0.708 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.628 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 106' ' ' GLY . 91.5 Cg_endo -86.17 27.4 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.722 2.281 . . . . 0.0 111.403 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.043 HD23 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -88.27 172.96 9.05 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 122.108 0.956 . . . . 0.0 113.01 -178.53 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.592 ' O ' ' CE2' ' A' ' 50' ' ' PHE . . . -110.27 174.04 17.07 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.574 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.45 107.56 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 117.911 0.856 . . . . 0.0 110.801 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 4.3 m-85 -123.11 114.84 20.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.525 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . 136.63 -82.88 0.27 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.633 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.839 HD11 ' SD ' ' A' ' 136' ' ' MET . 0.4 OUTLIER -95.53 117.97 31.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.19 0.519 . . . . 0.0 111.206 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -138.49 113.09 8.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.033 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.458 ' OE1' ' CE2' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -106.52 140.54 39.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.12 12.0 30.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.115 0.483 . . . . 0.0 110.946 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 129.18 -90.77 0.31 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.919 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.469 ' HA ' ' OD1' ' A' ' 147' ' ' ASN . 19.6 ptt? -130.52 90.98 3.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.77 0.319 . . . . 0.0 110.835 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.699 ' HB3' ' CZ ' ' A' ' 121' ' ' ARG . . . -149.29 147.29 23.03 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.984 0.421 . . . . 0.0 111.285 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 36.4 Cg_endo -65.38 110.2 1.54 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.842 2.361 . . . . 0.0 112.071 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.699 ' CZ ' ' HB3' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -136.71 146.77 46.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.884 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 150' ' ' ARG . 0.6 OUTLIER -115.08 122.2 45.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.58 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 1.15 ' CE2' HG13 ' A' ' 133' ' ' VAL . 1.0 OUTLIER -106.44 108.08 19.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.144 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.727 HG13 HD23 ' A' ' 216' ' ' LEU . 10.0 p -98.41 111.63 28.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.571 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -101.28 132.69 46.68 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.419 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.99 103.07 1.2 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.542 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.819 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 115.99 -154.88 16.6 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.134 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.76 ' CG2' HD13 ' A' ' 79' ' ' LEU . 14.5 m -105.66 -9.59 17.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.205 0.526 . . . . 0.0 110.54 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.576 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -64.66 10.01 0.36 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.537 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.873 ' O ' HG22 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -81.22 5.55 16.68 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.82 0.31 . . . . 0.0 110.632 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.903 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -47.03 -46.71 54.62 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.306 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 131' ' ' ALA . 90.0 Cg_endo -79.72 -29.92 2.61 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.653 2.235 . . . . 0.0 111.053 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.15 HG13 ' CE2' ' A' ' 123' ' ' PHE . 20.9 t -63.11 -52.4 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.566 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 130' ' ' LEU . 2.0 m -61.78 -36.56 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.659 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 139' ' ' GLN . 18.6 m -62.08 -50.35 72.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.333 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.839 ' SD ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -62.56 -36.17 81.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.469 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.073 HG23 ' O ' ' A' ' 133' ' ' VAL . 17.7 t -66.97 -53.45 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.302 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.975 ' CG ' HD21 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -63.63 -31.83 73.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.708 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -67.47 -37.34 82.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.026 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.569 ' SD ' HG21 ' A' ' 149' ' ' THR . 3.0 ptm -63.43 -43.38 97.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.509 ' HG2' ' CG ' ' A' ' 174' ' ' MET . 0.0 OUTLIER -73.06 -34.86 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.4 ' OE1' ' O ' ' A' ' 138' ' ' ARG . 1.5 mp0 -79.62 -12.84 59.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.913 0.387 . . . . 0.0 110.672 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.47 ' HB2' ' O ' ' A' ' 139' ' ' GLN . 2.8 m95 -92.23 -85.33 0.25 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.443 0.64 . . . . 0.0 111.264 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 144' ' ' THR . 0.2 OUTLIER -154.81 20.34 0.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.242 -178.814 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.555 ' N ' ' CD ' ' A' ' 146' ' ' PRO . . . -125.3 44.87 1.21 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.343 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 145' ' ' ALA . 73.1 Cg_endo -76.16 5.75 4.35 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.606 2.204 . . . . 0.0 112.005 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 118' ' ' MET . 8.4 p-10 -58.46 -159.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.149 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 40.9 mt-10 -74.55 104.63 5.32 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.408 0.623 . . . . 0.0 111.273 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.569 HG21 ' SD ' ' A' ' 140' ' ' MET . 2.8 m -119.06 117.92 30.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.095 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.633 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 1.8 mmt180 -101.52 146.15 28.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.992 0.425 . . . . 0.0 110.369 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.707 HD13 ' O ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -133.47 134.11 57.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.811 -178.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.726 ' CD2' HD21 ' A' ' 201' ' ' LEU . 18.2 m-30 -112.91 110.47 20.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.238 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.496 ' HZ ' HD23 ' A' ' 161' ' ' LEU . 3.4 t80 -112.99 126.72 55.81 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.484 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.818 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -155.58 151.89 23.41 Favored Glycine 0 CA--C 1.499 -0.939 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.105 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 1.03 HG21 HD22 ' A' ' 161' ' ' LEU . 3.8 m -164.64 -111.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.776 ' O ' HG21 ' A' ' 183' ' ' VAL . 19.9 p30 -105.85 -168.05 1.39 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.369 0.604 . . . . 0.0 112.182 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.639 HG23 ' HA ' ' A' ' 187' ' ' SER . 34.1 p -33.96 -32.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.83 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.586 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.9 tt0 105.46 -52.09 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.974 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.524 ' HD2' ' C ' ' A' ' 157' ' ' THR . 86.3 Cg_exo -48.26 -21.57 3.14 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 121.994 1.796 . . . . 0.0 112.003 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -87.29 -30.75 20.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.491 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.03 HD22 HG21 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -89.23 -160.51 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.396 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 38.0 p90 177.14 -176.59 0.15 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.0 0.429 . . . . 0.0 111.501 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 162' ' ' PHE . 0.2 OUTLIER 79.84 2.46 2.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.336 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.976 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -71.28 -45.42 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.817 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.976 ' N ' HD13 ' A' ' 164' ' ' ILE . 6.8 m-20 -67.16 -35.02 78.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.24 0.543 . . . . 0.0 110.172 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -72.28 -37.03 69.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -61.05 -32.15 71.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.015 179.052 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.475 ' HG3' ' HA ' ' A' ' 165' ' ' ASP . 8.1 mttt -65.9 -39.3 90.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 m -62.88 -32.0 73.16 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.315 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.975 HD21 ' CG ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -63.8 -36.89 85.38 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.626 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' A' ' 177' ' ' LEU . 2.3 mm-40 -67.53 -37.66 83.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.224 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -78.76 -32.27 46.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.235 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 170' ' ' LEU . 58.4 p -75.01 -16.17 60.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.006 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.865 ' HB3' HD13 ' A' ' 177' ' ' LEU . 0.7 OUTLIER -94.95 -168.93 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.178 0.513 . . . . 0.0 111.643 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.493 ' CB ' ' O ' ' A' ' 146' ' ' PRO . 0.7 OUTLIER -81.76 -63.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.331 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.9 70.11 1.33 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.943 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.865 HD13 ' HB3' ' A' ' 174' ' ' MET . 7.3 mp -98.68 151.75 20.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.827 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.491 ' CB ' ' HD3' ' A' ' 150' ' ' ARG . 4.8 m -136.83 115.01 11.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.822 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.424 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 7.7 p -92.85 134.97 29.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.505 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -99.1 136.44 39.06 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.588 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -96.55 105.44 17.54 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.851 0.834 . . . . 0.0 111.04 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.762 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 92.3 m -95.1 -167.96 1.72 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.16 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.815 HG23 ' H ' ' A' ' 155' ' ' VAL . 6.2 t 56.07 148.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.785 0.802 . . . . 0.0 111.186 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.75 -49.78 0.53 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.409 -1.268 . . . . 0.0 108.238 -177.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.594 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 12.1 t-80 178.55 57.04 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.498 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 187' ' ' SER . 33.5 Cg_endo -94.02 -93.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.538 2.825 . . . . 0.0 112.886 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 27.4 t 137.22 20.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.6 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 96.79 11.05 54.55 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.585 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.432 ' C ' ' HA ' ' A' ' 251' ' ' ALA . 0.4 OUTLIER -136.96 63.31 1.57 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.553 ' O ' ' O ' ' A' ' 249' ' ' GLY . 4.9 t-105 -125.44 123.19 38.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.448 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.741 ' N ' ' HB2' ' A' ' 251' ' ' ALA . 2.5 mt-10 -84.33 105.36 15.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.51 ' C ' ' CG ' ' A' ' 193' ' ' GLU . . . 131.42 -111.15 1.05 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.092 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.548 ' CB ' ' SG ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -167.51 -71.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.615 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -102.33 150.67 23.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.176 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.645 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -37.46 107.29 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.74 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.623 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 48.0 m 127.66 143.77 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 123.658 0.783 . . . . 0.0 110.169 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 199' ' ' ASP . 27.5 Cg_endo -62.32 56.83 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.797 2.331 . . . . 0.0 112.752 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.928 HD11 ' CD1' ' A' ' 229' ' ' LEU . 0.5 OUTLIER 37.17 26.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.574 0.702 . . . . 0.0 111.961 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.553 ' HA ' ' CD ' ' A' ' 202' ' ' ARG . 5.1 m-20 -57.67 -34.77 69.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.126 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.83 89.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.543 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.866 ' HB2' HD12 ' A' ' 198' ' ' ILE . 0.4 OUTLIER -69.21 -30.86 69.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.172 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.805 ' HG2' HD13 ' A' ' 229' ' ' LEU . 11.0 mtp-105 -58.46 -48.57 80.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.513 0.673 . . . . 0.0 110.645 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.536 ' HA ' ' NH1' ' A' ' 233' ' ' ARG . 2.1 mt-10 -71.41 -33.66 69.65 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.318 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -59.87 -39.07 84.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.609 -0.436 . . . . 0.0 109.937 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.884 ' HB2' HG21 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -61.18 -49.61 76.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.183 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -64.53 -21.63 66.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.816 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.8 -85.27 0.2 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.751 0.31 . . . . 0.0 111.202 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 2.2 p 174.03 99.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.719 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.667 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 7.9 m-20 154.18 42.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.15 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 1.002 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 150.05 104.35 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.539 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.581 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 14.5 t-20 177.87 -57.32 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.06 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 8.4 Cg_endo -51.75 -55.79 3.59 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.17 1.913 . . . . 0.0 110.984 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -133.32 109.37 9.33 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.229 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 1.002 HD11 ' HB1' ' A' ' 210' ' ' ALA . 1.0 OUTLIER -116.45 125.82 73.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.58 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.4 m-85 -117.52 126.47 52.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.484 0.659 . . . . 0.0 110.533 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.727 HD23 HG13 ' A' ' 124' ' ' VAL . 0.7 OUTLIER -125.66 117.22 23.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.163 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 217' ' ' CYS . . . . . 0.509 ' SG ' ' CG2' ' A' ' 133' ' ' VAL . 48.8 t -124.53 107.8 11.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.978 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.577 ' HA2' ' CD2' ' A' ' 245' ' ' PHE . . . 168.57 -175.81 43.06 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.005 -1.093 . . . . 0.0 113.187 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.561 ' HB2' ' CB ' ' A' ' 250' ' ' ALA . 5.4 Cg_exo -38.18 168.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.773 2.982 . . . . 0.0 112.904 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 73.3 Cg_endo -75.52 -28.12 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.888 2.392 . . . . 0.0 111.84 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.484 ' HA2' ' HB2' ' A' ' 224' ' ' ASP . . . -81.75 -46.55 6.71 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.23 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.554 ' SD ' HD12 ' A' ' 223' ' ' ILE . 1.3 tmt? -57.07 -35.49 69.43 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.712 HD11 ' HB3' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -76.97 -34.53 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.985 178.46 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.484 ' HB2' ' HA2' ' A' ' 221' ' ' GLY . 0.2 OUTLIER -67.59 -46.81 71.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.161 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -61.42 -47.05 87.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.808 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -68.28 -31.21 70.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.675 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 223' ' ' ILE . 49.6 t -70.32 -31.8 69.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.165 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.84 -44.37 85.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.867 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.928 ' CD1' HD11 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -60.49 -39.88 89.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.793 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.891 HG12 ' HG3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -66.05 -41.6 89.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 -179.219 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -72.9 -30.0 63.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.151 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.42 -29.83 19.92 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.59 ' HD3' HD12 ' A' ' 205' ' ' LEU . 1.4 mmp_? -72.91 -66.83 0.62 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.874 0.368 . . . . 0.0 111.415 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.52 ' C ' ' HD2' ' A' ' 236' ' ' PRO . . . 122.09 9.67 6.62 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.795 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.884 HG21 ' HB2' ' A' ' 205' ' ' LEU . 1.0 OUTLIER -83.3 -19.18 0.26 Allowed Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.891 ' HG3' HG12 ' A' ' 230' ' ' VAL . 66.1 Cg_exo -39.99 117.23 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.68 1.587 . . . . 0.0 112.382 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -96.49 -116.79 3.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.753 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -129.53 -32.8 1.92 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.585 0.231 . . . . 0.0 111.401 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.577 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 9.7 mm-40 -99.87 30.74 3.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.008 0.433 . . . . 0.0 111.147 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.988 HG22 ' HB ' ' A' ' 214' ' ' ILE . 1.7 t -94.52 131.87 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.041 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.645 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.66 151.4 37.19 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.65 151.27 51.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.097 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLU . . . . . 0.591 ' O ' HD13 ' A' ' 223' ' ' ILE . 8.8 tm-20 -132.47 149.4 52.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.269 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -117.85 107.35 14.01 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 111.674 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.577 ' CD2' ' HA2' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -136.48 148.14 47.53 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.147 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.664 ' HB2' ' N1 ' ' A' ' 252' ' ' FDA . 3.0 tt -15.72 139.99 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.57 ' O ' ' CB ' ' A' ' 248' ' ' SER . 77.7 Cg_exo -50.8 -149.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.885 3.057 . . . . 0.0 113.565 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 247' ' ' PRO . 7.4 m 97.01 -19.43 0.05 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.907 0.86 . . . . 0.0 109.871 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 190' ' ' TRP . . . -122.15 -18.5 3.44 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.085 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.561 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . . . -109.08 151.67 26.09 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.606 0.762 . . . . 0.0 110.339 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.741 ' HB2' ' N ' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.07 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' FDA . . . . . 0.94 HM72 ' CG ' ' A' ' 50' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 81.9 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.42 -54.75 1.87 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.04 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.3 mt -116.33 117.13 54.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.468 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -154.85 57.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 5' ' ' SER . 2.2 m-85 179.23 91.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.43 -139.47 9.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.504 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -121.06 45.48 2.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 111.057 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.79 101.02 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.59 24.58 3.38 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.47 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -111.47 158.49 19.07 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.922 0.391 . . . . 0.0 111.055 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 34' ' ' ARG . 1.9 t80 -128.55 165.24 21.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.957 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -110.46 129.63 55.73 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.084 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -137.8 154.62 49.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.864 0.364 . . . . 0.0 111.153 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -103.52 121.38 42.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.881 HG13 ' HE1' ' A' ' 29' ' ' PHE . 24.3 t -72.1 136.03 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 17' ' ' VAL . 10.5 p -162.2 24.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.264 0.554 . . . . 0.0 109.711 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.596 ' O ' ' CE1' ' A' ' 29' ' ' PHE . . . -153.05 122.2 1.26 Allowed Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.85 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.933 ' CD2' HD22 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -170.85 90.44 0.14 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.665 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -140.39 144.04 36.0 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.7 178.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.415 ' HA ' ' O ' ' A' ' 26' ' ' THR . 10.1 m0 -89.94 112.6 24.03 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.579 -0.849 . . . . 0.0 108.87 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.585 HG22 ' HB ' ' A' ' 26' ' ' THR . 0.7 OUTLIER -71.41 -19.02 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.639 0.733 . . . . 0.0 109.122 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.533 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 37.9 m -153.17 -175.24 5.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.074 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.3 m -52.2 -57.86 8.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.113 0.483 . . . . 0.0 110.917 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -118.79 47.26 1.68 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.14 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.585 ' HB ' HG22 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -143.28 128.59 18.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.754 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.537 HG11 ' CD1' ' A' ' 92' ' ' LEU . 2.5 p -131.0 133.83 62.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.301 0.572 . . . . 0.0 112.476 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.487 ' HG2' HD21 ' A' ' 30' ' ' LEU . 15.2 tt0 -100.62 131.36 46.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.792 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.881 ' HE1' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -126.02 128.42 47.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.917 -178.326 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.862 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -121.35 115.77 23.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.213 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.078 HD13 HD21 ' A' ' 102' ' ' LEU . 2.8 mt -115.28 148.73 38.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.455 . . . . 0.0 111.753 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -124.01 108.32 12.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.523 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.65 ' HD3' HG11 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -105.35 -165.43 1.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.048 -179.091 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.628 ' N ' ' HD2' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -28.81 -55.41 0.26 Allowed Pre-proline 0 N--CA 1.463 0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.832 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 34' ' ' ARG . 9.5 Cg_endo -52.95 -153.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.019 2.479 . . . . 0.0 111.972 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.603 ' CB ' ' HB3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -129.89 -156.51 0.76 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.402 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -93.04 67.81 4.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 111.644 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.599 ' CB ' ' HB2' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -161.28 -63.2 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 179.476 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.647 ' CA ' HG22 ' A' ' 43' ' ' VAL . . . -164.96 99.16 0.16 Allowed Glycine 0 C--N 1.344 1.003 0 C-N-CA 120.325 -0.94 . . . . 0.0 114.151 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.786 ' N ' ' HA2' ' A' ' 74' ' ' GLY . 18.0 t30 -14.81 138.3 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 124.499 1.12 . . . . 0.0 113.334 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.457 ' C ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER 31.5 35.51 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.584 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.7 ' HA2' ' HA ' ' A' ' 72' ' ' PRO . . . 61.69 81.36 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.935 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 40' ' ' ASN . 21.9 m -94.41 170.68 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.258 0.551 . . . . 0.0 111.459 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -155.77 23.12 0.39 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.803 -178.015 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.643 ' O ' ' CG ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER 99.07 92.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.583 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -115.2 125.4 28.94 Favored Pre-proline 0 N--CA 1.453 -0.317 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.937 178.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.447 ' C ' ' O ' ' A' ' 46' ' ' GLU . 53.5 Cg_exo -28.13 84.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.055 2.503 . . . . 0.0 112.739 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.635 ' N ' ' CD2' ' A' ' 111' ' ' PHE . . . 40.56 75.97 0.1 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.612 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.446 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 1.6 tm0? -69.74 109.7 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 111.021 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.664 ' CE1' ' HB2' ' A' ' 65' ' ' SER . 1.5 m-30 -109.97 164.15 12.88 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.549 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.485 ' HB3' ' O ' ' A' ' 105' ' ' LYS . 5.2 mmt -135.74 -171.48 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.418 0.628 . . . . 0.0 112.414 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 9.3 t0 -131.79 102.5 5.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.665 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.01 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -134.58 157.93 45.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.451 0.643 . . . . 0.0 112.228 -177.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.866 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -109.19 151.2 26.8 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.968 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.891 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -30.45 -69.62 0.1 Allowed Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.224 0.327 . . . . 0.0 110.897 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 1.094 ' HD2' HG23 ' A' ' 58' ' ' THR . 59.9 Cg_endo -104.69 7.64 0.28 Allowed 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.451 2.767 . . . . 0.0 111.735 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.41 18.56 14.28 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.093 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 1.094 HG23 ' HD2' ' A' ' 56' ' ' PRO . 6.8 p -63.65 -110.51 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.128 -0.536 . . . . 0.0 111.4 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.866 ' N ' HG21 ' A' ' 54' ' ' THR . 0.3 OUTLIER 175.45 28.5 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.757 HG12 ' O ' ' A' ' 60' ' ' VAL . 48.3 t -140.83 31.94 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.712 0.291 . . . . 0.0 111.289 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.59 ' CB ' ' HA ' ' A' ' 54' ' ' THR . 34.0 t -103.5 -103.23 0.29 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.681 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 61' ' ' SER . 8.6 mtt180 166.99 -179.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.088 0.471 . . . . 0.0 111.569 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 2.7 t -88.76 143.01 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.591 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 1.014 ' CE2' HG22 ' A' ' 80' ' ' ILE . 1.9 t80 -141.25 130.29 23.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.664 ' HB2' ' CE1' ' A' ' 50' ' ' PHE . 22.4 p -75.9 105.63 2.34 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.533 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 72.4 Cg_endo -99.45 -169.92 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.905 2.403 . . . . 0.0 113.348 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.713 ' HB3' ' N ' ' A' ' 77' ' ' GLU . . . -86.15 176.77 7.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.721 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.2 t30 106.61 123.71 0.01 OUTLIER 'General case' 0 C--N 1.343 0.31 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.952 HD13 ' CB ' ' A' ' 135' ' ' SER . 0.4 OUTLIER -170.96 -84.32 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 122.139 -0.351 . . . . 0.0 110.615 -178.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 55.3 Cg_endo -85.81 72.57 4.07 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 120.384 1.173 . . . . 0.0 112.397 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.598 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 1.2 m120 -164.51 139.09 4.4 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.586 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.7 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 60.3 Cg_endo -91.15 53.57 0.91 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.665 2.243 . . . . 0.0 116.234 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.603 ' HB3' ' CB ' ' A' ' 36' ' ' ASP . 61.6 mt-10 -158.66 -106.91 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.269 0.94 . . . . 0.0 112.558 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.786 ' HA2' ' N ' ' A' ' 40' ' ' ASN . . . -160.57 78.0 0.17 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.591 ' CG ' ' N ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -123.46 81.92 1.95 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.159 0.98 . . . . 0.0 111.332 178.536 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.65 HD12 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -97.48 132.14 43.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.713 ' N ' ' HB3' ' A' ' 67' ' ' ALA . 1.3 tt0 -129.99 111.69 12.77 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.443 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.868 ' CD1' HG23 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -104.78 137.18 42.96 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.226 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.864 HD22 ' CG2' ' A' ' 128' ' ' THR . 0.2 OUTLIER -122.53 75.41 1.25 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.918 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.014 HG22 ' CE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -92.61 130.4 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.121 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.79 ' HG3' HD21 ' A' ' 246' ' ' LEU . 0.3 OUTLIER -78.11 102.7 7.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.178 -178.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' CB ' ' A' ' 89' ' ' SER . 3.5 m -102.02 138.22 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.313 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.508 ' HG ' ' H4B' ' A' ' 252' ' ' FDA . 5.4 mt -68.99 129.01 92.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.738 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.23 110.14 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.666 2.244 . . . . 0.0 111.938 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.525 ' N ' ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER 47.25 43.73 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.422 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.54 -68.88 0.58 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.956 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -137.24 -68.2 0.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.268 . . . . 0.0 111.663 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.455 ' HB2' ' O1A' ' A' ' 252' ' ' FDA . 0.2 OUTLIER -76.98 -33.57 57.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.714 0.292 . . . . 0.0 111.515 -179.29 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.686 ' CB ' HG23 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -78.84 -20.74 48.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.404 -179.545 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.414 ' O ' ' CG ' ' A' ' 94' ' ' ASN . 0.7 OUTLIER -75.68 -46.66 30.03 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.692 0.758 . . . . 0.0 109.069 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.728 ' O ' HD11 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -74.62 -24.52 58.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.498 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.933 HD22 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.78 -49.4 73.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.001 -179.601 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -89.05 -16.95 30.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.447 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.414 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 73.8 m-20 -95.04 -9.32 34.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.286 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.481 ' HB3' HD11 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -135.13 2.99 3.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.383 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -139.16 28.91 2.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.825 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -77.53 -49.58 14.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.467 -179.507 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.931 HG13 ' HG3' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -74.95 3.2 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.142 0.496 . . . . 0.0 111.796 -179.223 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 100' ' ' GLN . . . 54.12 36.92 57.67 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.415 -0.897 . . . . 0.0 111.722 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.931 ' HG3' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -52.8 -160.41 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.943 0.401 . . . . 0.0 111.065 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.65 143.14 12.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.775 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.078 HD21 HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -128.91 132.95 47.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.468 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.578 ' N ' HD12 ' A' ' 102' ' ' LEU . 6.8 m -92.02 123.1 35.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.088 0.471 . . . . 0.0 111.063 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.65 HG11 ' HD3' ' A' ' 33' ' ' LYS . 2.0 m -96.8 127.85 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 51' ' ' MET . 0.1 OUTLIER -127.0 170.17 12.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.557 -178.214 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 51' ' ' MET . . . 69.59 83.88 0.17 Allowed Glycine 0 C--N 1.312 -0.795 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.05 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.22 54.03 4.49 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.427 2.084 . . . . 0.0 110.053 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.626 ' HG ' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -97.42 166.52 11.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.134 -177.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.626 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -156.9 129.32 2.37 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.485 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 110' ' ' VAL . 10.7 p -158.25 113.51 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.865 0.364 . . . . 0.0 110.769 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.635 ' CD2' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -119.24 150.26 40.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.681 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -95.09 9.41 70.12 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.948 HD11 ' HG2' ' A' ' 136' ' ' MET . 3.7 pp -116.09 119.4 35.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.278 0.561 . . . . 0.0 110.848 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.647 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.5 OUTLIER -137.5 112.92 9.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.485 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 121' ' ' ARG . 0.1 OUTLIER -87.2 140.54 29.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.54 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -94.12 14.29 20.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.2 -74.68 0.22 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.765 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -129.59 89.96 2.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.941 0.401 . . . . 0.0 110.461 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 121' ' ' ARG . . . -164.37 144.73 6.4 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.363 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 43.8 Cg_endo -67.98 116.93 4.56 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.765 2.31 . . . . 0.0 111.905 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.1 OUTLIER -130.96 158.53 40.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.647 ' CE2' ' CD ' ' A' ' 150' ' ' ARG . 3.5 m-85 -126.68 130.53 50.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.079 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.809 ' HE2' HD13 ' A' ' 113' ' ' LEU . 0.4 OUTLIER -106.46 103.71 13.23 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.631 HG13 HD23 ' A' ' 216' ' ' LEU . 0.8 OUTLIER -101.01 111.09 29.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.275 0.56 . . . . 0.0 110.843 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -114.47 133.08 56.02 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.898 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -105.82 102.7 2.01 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.841 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.968 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 124.08 -164.32 17.41 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.417 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.864 ' CG2' HD22 ' A' ' 79' ' ' LEU . 5.4 m -106.4 -10.39 16.34 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.45 0.643 . . . . 0.0 110.746 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.605 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -68.01 10.63 1.17 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.459 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.777 HD23 ' C ' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -75.75 5.14 6.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 122.894 0.478 . . . . 0.0 110.283 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.716 ' N ' HD23 ' A' ' 130' ' ' LEU . . . -44.98 -41.24 12.36 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.197 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 3.7 Cg_exo -73.53 -31.39 8.91 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.49 2.127 . . . . 0.0 110.063 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.717 HG21 ' HB2' ' A' ' 217' ' ' CYS . 21.4 t -64.86 -42.7 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.614 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.715 HG13 ' HG ' ' A' ' 130' ' ' LEU . 10.6 m -70.15 -29.78 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.533 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.952 ' CB ' HD13 ' A' ' 69' ' ' LEU . 16.7 m -66.49 -53.09 39.09 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.948 ' HG2' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -60.5 -42.4 96.3 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.511 0.672 . . . . 0.0 109.215 178.199 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.741 HG12 ' HG3' ' A' ' 141' ' ' GLN . 26.8 t -62.35 -32.39 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.927 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 135' ' ' SER . 5.3 mtm180 -59.6 -32.12 70.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.198 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.567 ' OE1' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -68.4 -43.03 78.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.09 178.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.626 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -71.5 -34.96 70.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.507 0.67 . . . . 0.0 111.047 179.324 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.926 ' CD ' HD22 ' A' ' 170' ' ' LEU . 0.4 OUTLIER -78.05 -30.45 49.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.239 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 138' ' ' ARG . 3.4 mm-40 -69.8 -44.99 68.93 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -79.24 -21.14 46.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.436 0.636 . . . . 0.0 109.736 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 141' ' ' GLN . 0.6 OUTLIER 52.74 28.03 5.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.735 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.857 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -33.09 153.95 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.946 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.454 ' HA ' ' HG3' ' A' ' 175' ' ' ARG . 41.8 Cg_endo -67.63 -3.58 10.52 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.667 2.245 . . . . 0.0 112.71 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.571 ' ND2' ' NH2' ' A' ' 121' ' ' ARG . 40.3 t30 -76.37 144.12 40.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 111.567 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 1.2 mt-10 -73.59 111.41 8.71 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.624 0.726 . . . . 0.0 111.072 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.646 ' HB ' HD11 ' A' ' 177' ' ' LEU . 1.1 m -108.5 115.38 29.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.892 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.647 ' CD ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -106.6 141.49 37.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.455 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.818 HD12 ' N ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -133.59 129.33 55.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.262 0.554 . . . . 0.0 111.032 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.818 ' N ' HD12 ' A' ' 151' ' ' ILE . 22.0 m-30 -108.33 115.06 29.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.47 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.466 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 37.2 t80 -120.15 132.02 55.24 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.396 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.925 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -155.06 160.67 29.9 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 119.511 -1.328 . . . . 0.0 113.288 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.977 ' CG2' HD13 ' A' ' 161' ' ' LEU . 1.2 m -170.73 -106.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.873 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.3 OUTLIER -126.17 -169.59 2.04 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 120.663 0.268 . . . . 0.0 111.287 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.829 HG23 ' CA ' ' A' ' 187' ' ' SER . 72.0 p -28.29 -62.67 0.1 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.655 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.57 ' HA ' HD21 ' A' ' 161' ' ' LEU . 0.2 OUTLIER 153.1 -54.05 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.495 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 40.7 Cg_exo -31.28 -31.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.155 2.57 . . . . 0.0 112.96 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.2 mm-40 -85.44 -60.11 2.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.016 0.436 . . . . 0.0 110.636 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.977 HD13 ' CG2' ' A' ' 155' ' ' VAL . 0.4 OUTLIER -67.3 -174.68 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.394 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 163' ' ' TYR . 0.8 OUTLIER 175.27 176.11 0.2 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.86 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 162' ' ' PHE . 0.3 OUTLIER 87.66 6.75 0.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.313 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.983 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -71.39 -45.51 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.771 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.983 ' N ' HD13 ' A' ' 164' ' ' ILE . 3.5 m-20 -66.0 -35.7 81.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.243 0.544 . . . . 0.0 110.107 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.454 ' O ' ' OG ' ' A' ' 169' ' ' SER . 0.9 OUTLIER -72.38 -36.22 68.66 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.666 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -61.61 -31.83 71.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.095 179.007 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 164' ' ' ILE . 24.2 mttt -62.92 -48.54 78.5 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 166' ' ' GLU . 3.9 p -61.8 -31.41 71.62 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.926 HD22 ' CD ' ' A' ' 141' ' ' GLN . 1.1 mt -63.57 -37.41 87.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.648 ' HA ' HD23 ' A' ' 177' ' ' LEU . 4.4 mm-40 -68.43 -36.07 78.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.922 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -34.53 59.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.143 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.1 t -53.7 -49.17 68.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.521 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.895 ' HB3' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -69.31 -154.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 111.588 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.454 ' HG3' ' HA ' ' A' ' 146' ' ' PRO . 0.3 OUTLIER -106.49 -54.26 2.5 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.718 -179.224 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -132.35 69.91 1.47 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.112 0.482 . . . . 0.0 110.706 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.895 HD13 ' HB3' ' A' ' 174' ' ' MET . 3.6 mp -98.81 150.47 21.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.888 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.513 ' OG1' ' CZ ' ' A' ' 150' ' ' ARG . 2.4 m -137.48 115.41 11.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.718 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.48 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 2.6 p -101.15 134.65 40.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.776 0.322 . . . . 0.0 111.352 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.6 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -101.69 135.28 43.49 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.562 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -100.82 105.51 16.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.491 0.663 . . . . 0.0 111.824 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.645 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 29.6 m -88.53 -161.93 0.79 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.181 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.873 HG21 ' O ' ' A' ' 156' ' ' ASN . 14.9 t 54.73 147.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-O 121.703 0.763 . . . . 0.0 111.812 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.24 -60.78 0.61 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.188 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.604 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 1.9 t-80 -164.99 51.26 0.25 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.789 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 187' ' ' SER . 86.3 Cg_endo -90.3 -98.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.21 2.607 . . . . 0.0 112.542 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.829 ' CA ' HG23 ' A' ' 157' ' ' THR . 21.7 t 137.85 6.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.596 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 120.64 12.19 6.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.259 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.16 62.62 1.59 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.469 ' HE1' ' C ' ' A' ' 193' ' ' GLU . 8.5 t-105 -132.08 121.31 23.61 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.305 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 250' ' ' ALA . 3.9 mt-10 -95.92 104.71 16.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.52 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.564 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 140.82 -117.02 1.2 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.696 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.595 ' C ' ' HB3' ' A' ' 182' ' ' CYS . 13.6 mt-10 -162.98 -95.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.514 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -86.73 139.34 30.83 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.641 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -21.37 107.08 0.01 OUTLIER Glycine 0 C--N 1.334 0.448 0 O-C-N 123.688 0.618 . . . . 0.0 113.096 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.614 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 67.1 m 120.65 154.45 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 123.481 0.712 . . . . 0.0 110.701 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.65 -75.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 123.234 2.623 . . . . 0.0 112.728 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.703 ' O ' HG23 ' A' ' 198' ' ' ILE . 0.2 OUTLIER 174.88 32.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.985 0.897 . . . . 0.0 110.732 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.505 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 35.9 m-20 -58.61 -37.27 75.49 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.191 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.46 73.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.637 ' HB2' HD13 ' A' ' 198' ' ' ILE . 0.2 OUTLIER -69.32 -34.04 74.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.873 0.368 . . . . 0.0 110.904 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.688 ' HG2' HD22 ' A' ' 229' ' ' LEU . 5.9 mtm180 -59.84 -52.15 66.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -41.87 96.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.814 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.2 -29.16 68.53 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 1.04 ' CD2' HD11 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -62.67 -43.96 97.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.337 178.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.44 -18.07 57.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.538 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 208' ' ' SER . 59.4 m -75.79 -80.45 0.09 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.93 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 207' ' ' SER . 0.4 OUTLIER 164.99 34.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.449 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.663 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 2.0 m-20 -137.85 52.29 1.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.697 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 209' ' ' ASP . . . 151.5 102.01 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.208 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.875 ' HB2' HD13 ' A' ' 235' ' ' ILE . 13.5 t30 174.04 -56.78 0.0 OUTLIER Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.143 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 18.8 Cg_endo -59.53 -58.04 0.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.294 1.996 . . . . 0.0 111.207 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.14 109.23 9.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.309 178.493 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.933 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.5 OUTLIER -121.63 125.76 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.716 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -120.62 127.1 51.78 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.388 0.613 . . . . 0.0 111.063 -178.414 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.631 HD23 HG13 ' A' ' 124' ' ' VAL . 3.4 mt -125.71 116.45 21.66 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.284 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' CYS . . . . . 0.717 ' HB2' HG21 ' A' ' 133' ' ' VAL . 38.9 m -124.8 107.09 10.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.077 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.621 ' N ' ' CD ' ' A' ' 219' ' ' PRO . . . 110.44 -28.13 10.58 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.93 -1.128 . . . . 0.0 114.075 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 218' ' ' GLY . 46.3 Cg_endo -89.76 83.17 0.53 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.238 1.958 . . . . 0.0 114.72 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.799 ' CD ' ' HB2' ' A' ' 250' ' ' ALA . 11.9 Cg_endo -53.48 -71.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 111.301 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.824 ' N ' ' HB1' ' A' ' 250' ' ' ALA . . . -54.2 -48.62 62.94 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.427 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.588 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -54.77 -24.08 20.89 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.595 ' CD1' ' HB3' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -72.76 -36.81 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.942 178.132 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 221' ' ' GLY . 65.6 m-20 -73.45 -47.04 44.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.003 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -69.72 -37.02 76.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.641 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.796 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -59.4 -38.5 80.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.385 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 31.7 m -69.91 -31.19 68.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.572 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -44.5 82.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.811 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.688 HD22 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -60.76 -37.14 80.83 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.013 0.435 . . . . 0.0 110.664 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 226' ' ' ALA . 3.6 t -66.23 -45.62 89.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.392 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -72.75 -30.02 63.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 6.2 m -76.98 -44.15 32.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.557 ' NE ' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -68.21 -75.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.166 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.472 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 137.8 -36.13 1.97 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.255 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 1.04 HD11 ' CD2' ' A' ' 205' ' ' LEU . 1.6 pp -35.84 95.29 0.09 OUTLIER Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 111.005 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 18.7 Cg_endo -59.86 115.33 2.55 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.757 2.305 . . . . 0.0 112.185 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -93.85 173.72 33.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.437 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -143.71 -41.92 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 110.91 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.582 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 43.7 mm-40 -107.5 37.78 2.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.933 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.1 t -92.84 132.45 37.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.647 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -144.72 144.5 31.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.42 -178.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -130.75 140.93 50.35 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLU . . . . . 0.576 ' O ' HD13 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -132.79 149.12 52.31 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.75 178.628 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 244' ' ' LYS . 1.0 OUTLIER -127.22 108.09 10.57 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.692 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.629 ' CD1' ' HB2' ' A' ' 246' ' ' LEU . 0.4 OUTLIER -138.22 144.32 40.57 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.538 178.364 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.834 HD23 ' HD2' ' A' ' 247' ' ' PRO . 0.1 OUTLIER 68.31 148.55 0.12 Allowed Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 121.917 -0.49 . . . . 0.0 111.379 -179.101 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.834 ' HD2' HD23 ' A' ' 246' ' ' LEU . 97.7 Cg_endo -73.28 -104.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.959 2.439 . . . . 0.0 112.371 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 247' ' ' PRO . 52.8 p -37.66 134.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.183 0.516 . . . . 0.0 110.912 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 127.71 -15.69 6.27 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.824 ' HB1' ' N ' ' A' ' 221' ' ' GLY . . . -106.53 120.55 42.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.709 -0.745 . . . . 0.0 111.541 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.564 ' N ' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.066 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' FDA . . . . . 0.782 H52A ' O ' ' A' ' 81' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.807 0.337 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -126.11 125.61 42.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.946 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 mt -124.82 133.75 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.063 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.57 -162.89 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -134.71 37.55 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.47 39.33 4.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.433 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -108.43 44.31 1.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.846 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 t -122.56 103.62 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.154 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.05 22.5 17.37 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.81 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.558 ' CB ' ' HB3' ' A' ' 105' ' ' LYS . 0.8 OUTLIER -115.03 149.34 37.62 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.693 -0.253 . . . . 0.0 111.022 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.795 ' CE1' HG13 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -134.05 165.54 24.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -113.31 135.29 54.0 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.992 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -134.53 150.35 50.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.755 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 1.1 pt-20 -96.5 116.63 29.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 110.754 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.003 HG22 ' O ' ' A' ' 100' ' ' GLN . 2.9 m -75.34 135.34 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.284 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 17' ' ' VAL . 7.4 p -149.4 20.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.168 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -106.63 -129.82 6.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.028 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.988 HD22 HD22 ' A' ' 92' ' ' LEU . 0.1 OUTLIER 74.9 80.39 0.11 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.831 -0.685 . . . . 0.0 110.445 -178.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -123.25 139.45 54.04 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.079 178.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 7.9 m0 -90.1 113.49 25.24 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.164 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.429 HG12 ' OD1' ' A' ' 20' ' ' ASN . 1.3 m -96.26 -26.99 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.542 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 8.2 m -143.43 171.09 14.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.244 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.468 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -52.88 -53.83 43.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.116 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -119.46 45.47 2.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.58 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.542 ' CB ' ' HB2' ' A' ' 23' ' ' SER . 0.3 OUTLIER -148.06 140.36 24.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.426 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.863 HG11 HD13 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -140.89 141.28 31.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.26 0.552 . . . . 0.0 112.036 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.654 ' HB2' HD21 ' A' ' 79' ' ' LEU . 17.0 tt0 -121.44 110.52 16.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.895 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.961 ' CE1' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -118.74 140.52 49.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 111.446 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.834 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -117.13 143.66 45.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.347 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.973 HD22 HG12 ' A' ' 16' ' ' VAL . 0.7 OUTLIER -122.14 154.91 36.78 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.17 0.509 . . . . 0.0 111.954 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 6.0 mt-30 -116.13 104.81 11.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.491 178.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.643 ' CG ' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -60.63 -171.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.459 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.644 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 1.9 mmp_? -55.57 -90.36 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.698 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.644 ' CD ' ' CB ' ' A' ' 34' ' ' ARG . 32.4 Cg_exo -45.67 -82.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.185 0 CA-C-N 120.474 1.205 . . . . 0.0 112.333 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -104.31 -164.31 1.04 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.767 0.712 . . . . 0.0 109.725 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.631 ' HB2' ' HA ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -54.55 -26.41 31.91 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.981 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' CB ' ' CA ' ' A' ' 74' ' ' GLY . 5.0 t -110.91 -6.1 14.76 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.684 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.551 ' CA ' ' HB3' ' A' ' 33' ' ' LYS . . . 78.92 68.77 1.46 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.805 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.601 ' N ' ' HB2' ' A' ' 35' ' ' PRO . 13.0 t30 61.89 12.95 5.15 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.206 0.527 . . . . 0.0 110.261 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 1.027 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -73.84 -15.23 61.17 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.314 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.619 ' CA ' ' HA ' ' A' ' 72' ' ' PRO . . . -2.19 75.28 0.0 OUTLIER Glycine 0 C--N 1.343 0.935 0 O-C-N 124.151 0.907 . . . . 0.0 114.41 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.027 HG13 ' O ' ' A' ' 41' ' ' ARG . 18.8 m -134.0 164.39 34.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.281 0.563 . . . . 0.0 112.441 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.704 ' HA ' ' CA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.32 41.37 1.09 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.282 178.123 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.6 ' CZ ' ' O ' ' A' ' 132' ' ' PRO . 83.9 t80 71.66 143.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.064 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.594 ' O ' ' CE2' ' A' ' 45' ' ' PHE . 4.9 mt-10 -112.91 161.88 24.5 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.743 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' GLY . 5.1 Cg_endo -47.44 80.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.717 2.278 . . . . 0.0 112.326 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.59 ' O ' HG12 ' A' ' 110' ' ' VAL . . . 34.85 41.2 0.24 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.862 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.497 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 4.8 mt-30 -53.46 161.04 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.67 0.235 . . . . 0.0 110.442 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.718 ' CD2' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -152.82 160.47 43.09 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.964 0.411 . . . . 0.0 111.703 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.627 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -138.73 -172.35 3.29 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.389 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.7 108.79 17.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.084 ' CD1' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -149.64 155.92 41.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.692 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 1.008 HG23 ' C ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -106.9 155.3 19.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.792 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.968 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -29.89 -68.62 0.11 Allowed Pre-proline 0 CA--C 1.54 0.58 0 O-C-N 123.393 0.433 . . . . 0.0 110.666 -179.171 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.968 ' HD3' HG23 ' A' ' 55' ' ' ILE . 6.3 Cg_endo -107.89 3.69 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.434 2.756 . . . . 0.0 111.807 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 107.23 -4.35 35.42 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.132 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.893 HG21 ' OH ' ' A' ' 91' ' ' TYR . 70.5 p -25.52 -89.76 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.975 0.51 . . . . 0.0 111.864 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.622 ' O ' HG12 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -147.2 43.11 1.12 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.182 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.008 ' C ' HG23 ' A' ' 54' ' ' THR . 0.4 OUTLIER 79.25 125.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.676 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.815 ' N ' HG23 ' A' ' 54' ' ' THR . 4.1 m -101.44 -54.32 2.79 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.372 0.606 . . . . 0.0 110.493 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.451 ' HB3' " O4'" ' A' ' 252' ' ' FDA . 0.0 OUTLIER 175.2 -155.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.438 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.683 ' CB ' ' CE1' ' A' ' 50' ' ' PHE . 3.6 p -105.73 119.36 38.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.898 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.527 ' CE2' ' N3 ' ' A' ' 252' ' ' FDA . 4.2 t80 -140.72 124.51 17.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.119 0.485 . . . . 0.0 112.086 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.712 ' HB3' ' H6 ' ' A' ' 252' ' ' FDA . 1.3 t -80.85 108.25 9.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.063 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.663 ' HB2' HD13 ' A' ' 76' ' ' LEU . 87.9 Cg_endo -83.61 159.41 14.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.795 2.33 . . . . 0.0 111.667 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.722 ' HB2' ' HA ' ' A' ' 132' ' ' PRO . . . -119.48 129.51 54.76 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.603 ' O ' ' CB ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -82.21 -75.31 0.31 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.328 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.603 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 10.8 tp 101.53 141.38 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.22 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.704 ' CA ' ' HA ' ' A' ' 44' ' ' LYS . 5.5 Cg_exo -36.25 86.31 0.01 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 123.001 2.467 . . . . 0.0 112.0 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -162.67 117.96 1.2 Allowed Pre-proline 0 CA--C 1.518 -0.251 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.086 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.619 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 88.7 Cg_endo -85.56 38.55 0.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.484 2.123 . . . . 0.0 112.379 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.601 ' N ' ' HA2' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -129.06 -51.47 1.21 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.419 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.594 ' O ' ' CB ' ' A' ' 37' ' ' GLU . . . 127.34 107.95 1.48 Allowed Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.81 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.631 ' HA ' ' HB2' ' A' ' 37' ' ' GLU . 5.9 mtt180 -139.53 93.55 2.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.517 0.199 . . . . 0.0 110.506 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.814 HD12 ' C ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -95.88 131.55 42.1 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.351 0.596 . . . . 0.0 111.368 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.766 ' N ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.9 150.74 30.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.138 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.703 ' CD1' ' CD2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -135.29 129.99 34.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.367 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.832 HD12 ' HB2' ' A' ' 131' ' ' ALA . 2.7 mt -135.6 103.37 5.42 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-O 120.846 0.355 . . . . 0.0 110.355 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.703 HD13 ' CZ ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -115.04 127.33 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.194 -178.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.617 ' HG3' HD11 ' A' ' 246' ' ' LEU . 1.8 mmt180 -79.69 95.57 5.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.595 ' CG2' ' CB ' ' A' ' 89' ' ' SER . 3.0 m -90.56 142.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.114 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.672 ' CD1' ' H1B' ' A' ' 252' ' ' FDA . 0.5 OUTLIER -88.15 151.35 48.96 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.612 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.481 ' HD2' ' HG ' ' A' ' 83' ' ' LEU . 55.3 Cg_endo -69.87 -8.46 23.66 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.753 2.302 . . . . 0.0 112.392 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -70.51 -25.87 63.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.503 ' CA ' ' HB2' ' A' ' 90' ' ' ASP . . . 115.43 -4.06 21.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.569 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 86' ' ' GLY . 9.3 mmm180 -36.63 -73.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 110.792 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.493 ' CB ' ' O1A' ' A' ' 252' ' ' FDA . 13.4 t80 -116.92 -21.88 8.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.595 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 1.3 p -65.75 -36.79 84.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.206 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.503 ' HB2' ' CA ' ' A' ' 86' ' ' GLY . 2.1 m-20 -75.09 -33.47 61.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.364 0.602 . . . . 0.0 109.868 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.893 ' OH ' HG21 ' A' ' 58' ' ' THR . 2.0 t80 -73.34 -31.59 64.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.702 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.988 HD22 HD22 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -68.73 -39.36 80.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.203 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.08 -19.88 21.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 9.0 m-20 -97.48 -10.97 24.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.43 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.549 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -124.73 -12.3 7.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.452 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -132.56 33.2 3.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.028 0.442 . . . . 0.0 110.909 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -52.88 61.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.682 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 99' ' ' GLY . 1.8 t -89.32 -135.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 120.737 0.303 . . . . 0.0 111.129 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 100' ' ' GLN . . . -120.97 28.07 6.24 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.995 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 1.003 ' O ' HG22 ' A' ' 16' ' ' VAL . 17.2 mp0 -39.26 163.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 110.911 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' ALA . 4.8 p -92.83 139.77 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.953 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.084 HD11 ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.67 125.33 35.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -92.38 134.55 34.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.97 0.414 . . . . 0.0 111.086 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.795 HG13 ' CE1' ' A' ' 12' ' ' PHE . 1.9 m -112.91 129.37 68.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.445 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.558 ' HB3' ' CB ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -130.55 112.97 13.67 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.759 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 151.56 73.66 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.022 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.94 53.97 4.37 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.496 2.131 . . . . 0.0 110.924 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.718 HD22 ' CD2' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -102.17 166.61 10.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.781 -178.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.58 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -108.75 172.7 16.84 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.492 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.968 HG21 HM73 ' A' ' 252' ' ' FDA . 4.4 p -152.18 113.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.201 0.524 . . . . 0.0 111.205 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.471 ' HB3' ' HB3' ' A' ' 241' ' ' PHE . 13.0 m-30 -71.01 114.74 9.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.419 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -149.99 -46.46 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.611 ' HA ' ' CG ' ' A' ' 215' ' ' TYR . 2.0 pt? -146.43 119.59 8.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.937 0.399 . . . . 0.0 110.488 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -137.9 112.83 9.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.853 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -78.95 140.2 38.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.287 179.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.46 ' HD3' ' HG3' ' A' ' 239' ' ' GLN . 17.2 ttp180 -98.37 11.7 37.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.185 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.478 ' C ' ' NH2' ' A' ' 121' ' ' ARG . . . 107.27 -78.08 0.24 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.693 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.46 ' HA ' ' HB3' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -129.91 89.83 2.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.844 0.354 . . . . 0.0 110.577 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.713 ' HB3' HH12 ' A' ' 121' ' ' ARG . . . -166.86 151.93 7.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 33.0 Cg_endo -64.47 116.73 3.93 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.652 2.235 . . . . 0.0 111.606 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.713 HH12 ' HB3' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -124.76 128.24 48.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.081 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.636 ' CD2' ' CE1' ' A' ' 152' ' ' TYR . 2.5 m-30 -106.65 115.84 30.9 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 1.157 ' CE2' HG21 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -119.66 111.01 17.51 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.258 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.938 ' CG1' HD23 ' A' ' 216' ' ' LEU . 7.4 p -109.15 111.06 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.206 0.527 . . . . 0.0 110.978 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -103.7 133.58 48.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.951 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.57 ' HA3' ' N ' ' A' ' 250' ' ' ALA . . . -109.59 103.61 1.77 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.944 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.599 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 123.55 -158.91 18.21 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 119.782 -1.199 . . . . 0.0 112.757 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.737 ' CG2' HD13 ' A' ' 79' ' ' LEU . 3.2 m -110.09 -14.41 14.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.675 0.274 . . . . 0.0 111.409 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.604 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -67.67 9.36 1.35 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.355 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.839 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -77.99 3.88 13.59 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 122.491 0.316 . . . . 0.0 110.192 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.832 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -46.52 -43.34 36.5 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 120.516 -0.473 . . . . 0.0 109.998 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.722 ' HA ' ' HB2' ' A' ' 67' ' ' ALA . 2.8 Cg_exo -73.82 -35.35 4.51 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.529 2.152 . . . . 0.0 109.718 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.659 HG11 ' CE1' ' A' ' 123' ' ' PHE . 15.8 t -63.36 -42.88 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.208 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.839 HG13 ' HG ' ' A' ' 130' ' ' LEU . 20.8 m -70.48 -29.74 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.414 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.479 ' HB3' ' CG ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -63.21 -52.7 61.23 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -46.44 89.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.477 0.656 . . . . 0.0 109.628 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.157 HG21 ' CE2' ' A' ' 123' ' ' PHE . 0.9 OUTLIER -59.53 -33.42 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.623 178.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -34.19 71.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.224 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.443 ' CD ' ' HG3' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -65.3 -42.45 93.05 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.601 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.7 OUTLIER -70.49 -34.01 71.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.661 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 1.021 ' OE1' HD11 ' A' ' 170' ' ' LEU . 0.6 OUTLIER -77.06 -30.61 55.66 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.287 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -70.55 -44.82 66.66 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.879 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -80.66 -20.56 42.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.411 0.624 . . . . 0.0 110.192 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.514 ' O ' ' CG ' ' A' ' 175' ' ' ARG . 0.1 OUTLIER 51.21 28.75 4.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.656 178.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.879 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -31.17 150.56 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 111.1 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.42 -9.19 6.37 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.877 2.385 . . . . 0.0 113.083 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.584 ' OD1' ' HB3' ' A' ' 145' ' ' ALA . 8.4 p-10 -76.35 143.34 40.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.128 0.49 . . . . 0.0 111.861 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 9.1 mt-10 -73.75 127.38 32.65 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.827 0.822 . . . . 0.0 110.88 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.584 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 26.1 m -118.27 121.67 41.02 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.477 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.628 ' HB2' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.46 134.77 44.05 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.062 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.708 HG22 ' HA ' ' A' ' 179' ' ' VAL . 0.5 OUTLIER -113.88 130.81 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.957 -179.052 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.636 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 45.4 m-85 -123.76 109.28 13.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.034 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.984 ' CE2' HD11 ' A' ' 161' ' ' LEU . 4.4 t80 -122.15 132.26 54.37 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.397 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.84 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -160.85 153.63 24.51 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 119.697 -1.239 . . . . 0.0 113.723 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 1.012 HG21 HD13 ' A' ' 161' ' ' LEU . 2.4 m -167.58 -105.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.822 ' O ' HG21 ' A' ' 183' ' ' VAL . 4.0 p30 -108.3 174.39 5.9 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.936 0.398 . . . . 0.0 111.738 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 187' ' ' SER . 0.5 OUTLIER -34.28 -41.81 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.401 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.0 OUTLIER 153.85 -41.53 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.241 0 O-C-N 123.307 0.379 . . . . 0.0 111.88 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.612 ' HD2' HG23 ' A' ' 157' ' ' THR . 62.4 Cg_exo -40.1 -30.23 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.458 2.105 . . . . 0.0 112.707 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.494 ' CB ' ' ND2' ' A' ' 156' ' ' ASN . 1.2 mp0 -103.61 -13.93 16.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.701 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.012 HD13 HG21 ' A' ' 155' ' ' VAL . 10.9 tp -94.75 171.85 8.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.846 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 1.1 p90 176.28 -163.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.977 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.6 OUTLIER 72.05 9.22 6.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.393 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 1.003 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -57.62 -41.65 79.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 109.986 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 1.003 ' N ' HD13 ' A' ' 164' ' ' ILE . 16.8 m-20 -64.24 -27.76 69.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.873 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -71.57 -47.49 54.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.88 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.54 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -62.95 -31.28 72.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.088 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -60.7 -45.93 92.34 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.6 m -61.76 -31.76 71.97 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 1.021 HD11 ' OE1' ' A' ' 141' ' ' GLN . 1.0 OUTLIER -62.75 -38.02 88.89 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.534 ' HA ' HD11 ' A' ' 177' ' ' LEU . 30.8 mt-10 -66.68 -36.22 82.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.309 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -78.65 -35.93 44.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.31 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.461 ' O ' ' C ' ' A' ' 174' ' ' MET . 0.5 OUTLIER -87.77 -79.14 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.684 0.278 . . . . 0.0 111.606 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.644 ' HB3' HD12 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -23.69 126.5 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.458 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 144' ' ' THR . 1.7 mmp_? -38.41 -91.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.427 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.44 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -119.0 61.3 0.8 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.27 0.557 . . . . 0.0 109.894 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.07 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -103.58 157.77 16.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.622 -179.094 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . 1.07 ' N ' HD22 ' A' ' 177' ' ' LEU . 3.7 m -137.1 123.13 20.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.932 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.708 ' HA ' HG22 ' A' ' 151' ' ' ILE . 64.2 t -89.18 136.57 23.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.638 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.468 ' HE2' ' OE1' ' A' ' 194' ' ' GLN . 17.8 tptt -102.63 130.31 49.48 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.642 0.258 . . . . 0.0 110.582 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' NE2' ' A' ' 194' ' ' GLN . . . -97.51 104.93 17.0 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.74 0.781 . . . . 0.0 110.798 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.736 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 97.6 m -91.16 -168.54 2.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.11 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.822 HG21 ' O ' ' A' ' 156' ' ' ASN . 19.4 t 56.47 148.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.913 0.864 . . . . 0.0 111.407 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.98 -69.27 0.54 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.979 -178.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.606 ' N ' ' CD ' ' A' ' 186' ' ' PRO . 2.1 m-70 -155.89 34.93 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.584 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.633 ' O ' ' CB ' ' A' ' 187' ' ' SER . 83.3 Cg_endo -73.47 -100.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.502 2.135 . . . . 0.0 112.791 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.711 ' HA ' HG22 ' A' ' 157' ' ' THR . 27.4 t 137.69 30.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.972 0.509 . . . . 0.0 111.707 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.618 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 94.06 12.57 56.28 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.3 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.07 63.4 1.57 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.509 ' HB2' ' HB3' ' A' ' 186' ' ' PRO . 4.0 t-105 -132.25 113.7 13.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.723 -177.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.444 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 1.3 mt-10 -84.34 103.66 13.71 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.818 ' HA2' ' HB3' ' A' ' 251' ' ' ALA . . . 146.05 -122.09 1.59 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.056 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.565 ' CB ' ' SG ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -159.21 -79.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.606 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -100.88 148.59 24.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.07 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.651 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -40.49 105.92 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.674 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 3.5 m 148.71 172.72 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 111.264 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.532 ' O ' ' HB ' ' A' ' 198' ' ' ILE . 2.6 Cg_exo -75.86 -70.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.994 2.462 . . . . 0.0 112.606 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.067 HD12 HD21 ' A' ' 201' ' ' LEU . 0.0 OUTLIER 169.13 37.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-O 122.372 1.082 . . . . 0.0 110.136 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 199' ' ' ASP . 0.5 OUTLIER -72.57 -34.24 67.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.054 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -57.81 -45.49 86.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 1.067 HD21 HD12 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -71.39 -29.73 65.28 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.175 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.516 ' O ' ' NE ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -58.06 -52.89 63.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.786 -178.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.23 -43.17 64.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.334 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.61 -29.2 67.83 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.935 ' O ' HG21 ' A' ' 235' ' ' ILE . 0.5 OUTLIER -63.31 -48.69 76.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.397 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.422 ' CD ' ' NH2' ' A' ' 233' ' ' ARG . 3.4 mt-10 -67.73 -26.93 66.39 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.666 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 208' ' ' SER . 69.9 m -75.32 -82.5 0.07 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.893 0.377 . . . . 0.0 110.789 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 209' ' ' ASP . 0.1 OUTLIER 166.08 90.31 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.691 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.677 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 0.2 OUTLIER 164.23 53.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.837 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 209' ' ' ASP . . . 151.94 99.92 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.189 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.649 ' HB2' HD13 ' A' ' 235' ' ' ILE . 13.5 t30 172.65 -56.54 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.981 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 12.9 Cg_endo -56.63 -50.97 10.17 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.412 2.075 . . . . 0.0 111.025 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -132.67 109.06 9.44 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.415 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.982 ' HB ' HG22 ' A' ' 240' ' ' VAL . 1.0 OUTLIER -122.11 125.08 72.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.611 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.3 m-85 -118.75 126.71 52.49 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.397 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.938 HD23 ' CG1' ' A' ' 124' ' ' VAL . 20.5 mt -125.16 118.81 26.9 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.829 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -122.87 131.66 53.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.658 178.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.63 ' HA3' ' HB3' ' A' ' 250' ' ' ALA . . . 144.08 -151.46 23.44 Favored Glycine 0 C--O 1.224 -0.511 0 C-N-CA 120.058 -1.067 . . . . 0.0 113.075 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 250' ' ' ALA . 56.7 Cg_endo -70.73 166.61 28.23 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.65 2.233 . . . . 0.0 112.459 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.491 ' O ' HG22 ' A' ' 223' ' ' ILE . 27.7 Cg_exo -61.1 -9.07 11.34 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.77 2.313 . . . . 0.0 112.189 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -69.32 -54.83 11.65 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.959 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.918 ' O ' ' HB3' ' A' ' 226' ' ' ALA . 0.0 OUTLIER -55.51 -25.66 38.5 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -77.07 -42.41 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.376 178.398 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -75.58 -48.68 21.26 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 229' ' ' LEU . . . -77.44 -48.37 17.33 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.918 ' HB3' ' O ' ' A' ' 222' ' ' MET . . . -66.36 -39.49 89.17 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.559 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 223' ' ' ILE . 49.9 t -65.32 -45.83 82.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.543 0.211 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 232' ' ' SER . 0.8 OUTLIER -66.87 -36.3 82.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.302 0.573 . . . . 0.0 109.701 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.627 HD12 HG23 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -60.15 -56.36 22.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.349 179.037 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.994 HG13 HD11 ' A' ' 235' ' ' ILE . 94.7 t -72.53 -42.57 63.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.242 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.47 ' HD2' ' SG ' ' A' ' 227' ' ' CYS . 30.7 mtp180 -62.38 -30.17 71.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.427 . . . . 0.0 110.074 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 228' ' ' GLU . 21.5 m -91.41 -27.11 18.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.516 ' NE ' ' O ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -57.57 -67.98 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.1 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 146.78 -54.12 0.54 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.852 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.994 HD11 HG13 ' A' ' 230' ' ' VAL . 2.1 pp -34.03 95.21 0.08 OUTLIER Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 121.151 0.5 . . . . 0.0 111.556 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.441 ' N ' ' O ' ' A' ' 234' ' ' GLY . 32.7 Cg_endo -64.48 118.16 5.15 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.855 2.37 . . . . 0.0 112.257 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.464 ' CA ' ' OD1' ' A' ' 211' ' ' ASN . . . -108.97 154.94 16.3 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.56 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -117.95 -37.26 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.738 0.304 . . . . 0.0 110.866 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.572 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 70.5 mm-40 -102.17 35.66 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.22 0.534 . . . . 0.0 110.359 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.982 HG22 ' HB ' ' A' ' 214' ' ' ILE . 1.8 t -89.65 128.83 41.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.365 0.602 . . . . 0.0 110.873 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.645 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.73 142.56 27.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.86 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.55 ' HB2' ' CD1' ' A' ' 223' ' ' ILE . 0.7 OUTLIER -131.32 141.1 49.88 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.912 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 216' ' ' LEU . 7.2 pt-20 -132.12 148.46 52.48 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.243 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 4.5 ptmm? -116.35 105.83 12.96 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.604 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -137.02 144.46 43.25 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.309 178.237 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.617 HD11 ' HG3' ' A' ' 81' ' ' ARG . 5.1 mt 62.43 155.73 0.12 Allowed Pre-proline 0 N--CA 1.467 0.405 0 CA-C-O 121.131 0.491 . . . . 0.0 111.993 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.763 ' HG2' ' H3B' ' A' ' 252' ' ' FDA . 22.5 Cg_exo -65.1 -141.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.628 2.886 . . . . 0.0 112.363 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.491 ' HA ' ' HG3' ' A' ' 219' ' ' PRO . 0.4 OUTLIER -52.98 151.95 4.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.144 0.497 . . . . 0.0 111.391 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 152.45 -51.61 0.49 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.818 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.63 ' HB3' ' HA3' ' A' ' 218' ' ' GLY . . . -108.19 142.03 39.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.533 -0.334 . . . . 0.0 111.272 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.818 ' HB3' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.837 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' FDA . . . . . 0.968 HM73 HG21 ' A' ' 110' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.799 0.333 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -123.87 32.77 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.56 125.89 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.031 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.4 m 47.94 58.22 5.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.014 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.9 t80 72.86 132.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.53 40.51 1.65 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.514 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 47.66 47.35 17.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.831 0.348 . . . . 0.0 111.093 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.39 102.37 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.8 20.5 2.17 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.7 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.511 ' HB2' ' CD ' ' A' ' 105' ' ' LYS . 2.3 t -102.74 151.52 22.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.672 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.668 ' CE2' ' HB2' ' A' ' 14' ' ' ALA . 5.0 t80 -132.1 152.76 51.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.695 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.592 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -111.13 126.11 54.49 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 110.826 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.717 ' HB1' ' CB ' ' A' ' 31' ' ' LEU . . . -131.18 154.12 48.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.154 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.562 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 19.8 tt0 -98.86 124.89 44.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.018 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.935 HG22 ' O ' ' A' ' 100' ' ' GLN . 6.4 m -70.69 115.71 10.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 110.561 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 17' ' ' VAL . 13.7 p -146.05 14.91 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.047 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 29' ' ' PHE . . . -150.34 117.63 0.86 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.064 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.791 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -155.74 52.82 0.58 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.654 -0.773 . . . . 0.0 109.996 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.406 ' OD1' ' C ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -95.6 150.72 20.03 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.679 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 7.8 m95 -88.86 112.39 23.2 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.602 HG22 ' HB ' ' A' ' 26' ' ' THR . 2.6 m -76.92 -23.13 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.569 0.7 . . . . 0.0 109.74 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.522 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 38.8 m -150.5 -175.27 5.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.3 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.97 -57.02 9.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.632 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -121.92 49.25 1.58 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.724 179.308 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.602 ' HB ' HG22 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -147.56 141.12 25.48 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.473 -179.527 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.791 HG21 ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -140.8 148.26 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.162 -178.186 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.568 ' HG2' HD21 ' A' ' 30' ' ' LEU . 1.9 tt0 -108.74 129.23 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.554 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.876 ' CE1' HD21 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -124.37 121.83 36.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.622 -178.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.823 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -112.3 115.5 28.87 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.887 HD12 HD21 ' A' ' 76' ' ' LEU . 3.2 mt -120.64 133.74 55.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.261 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 29.6 mt-30 -145.64 110.18 5.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.601 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.562 ' HB2' ' N ' ' A' ' 15' ' ' GLU . 8.1 tmtm? -156.43 6.28 0.18 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.545 ' CD ' ' HB2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -163.0 168.72 9.9 Favored Pre-proline 0 N--CA 1.462 0.158 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.332 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.519 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 35.4 Cg_exo -59.91 78.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.899 2.399 . . . . 0.0 112.049 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.598 ' N ' ' HB3' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -170.08 -70.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.585 0.707 . . . . 0.0 110.106 179.455 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.543 ' CB ' ' HB3' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -131.81 64.82 1.59 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.072 178.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.554 ' CA ' ' O ' ' A' ' 74' ' ' GLY . 17.4 t -161.48 -74.23 0.06 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 73' ' ' GLU . . . -81.37 -81.52 0.85 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.43 -177.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 6.7 t-20 -154.98 47.1 0.53 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.566 -0.317 . . . . 0.0 110.761 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.678 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -107.19 -28.7 9.78 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.652 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.709 ' O ' ' O ' ' A' ' 71' ' ' ASN . . . -69.98 90.48 0.34 Allowed Glycine 0 CA--C 1.491 -1.44 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.426 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.86 ' HA ' ' N ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -122.85 142.48 39.23 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.758 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 10.4 ttmt -13.85 74.0 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.854 0.861 . . . . 0.0 112.886 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.596 ' N ' ' O ' ' A' ' 43' ' ' VAL . 55.4 t80 -99.19 -103.59 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.655 0.264 . . . . 0.0 110.868 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.5 OUTLIER -113.42 155.76 44.23 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 120.771 0.319 . . . . 0.0 110.703 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 1.032 ' HD2' HG21 ' A' ' 110' ' ' VAL . 72.8 Cg_exo -49.53 80.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.665 2.243 . . . . 0.0 112.231 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 49.09 63.47 3.93 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.762 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.531 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -48.45 -179.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.576 -0.157 . . . . 0.0 110.576 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.664 ' CD1' ' CB ' ' A' ' 65' ' ' SER . 0.2 OUTLIER -131.95 163.21 28.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.947 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.535 ' O ' ' CB ' ' A' ' 63' ' ' SER . 2.6 mmt -129.9 -168.41 1.95 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.942 0.401 . . . . 0.0 111.703 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -138.47 96.34 3.15 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.957 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -132.82 158.18 43.14 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.764 -177.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.889 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -106.85 151.13 25.62 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.983 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.01 ' CA ' ' O ' ' A' ' 103' ' ' SER 10.821 1.9 mp -53.53 102.83 0.33 Allowed Pre-proline 2 N--CA 7.684 311.237 3 C-N-CA 11.143 -44.223 . . . . 0.0 17.059 -71.011 . . . . . . . . 5 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.824 ' HD3' ' HB ' ' A' ' 55' ' ' ILE . 7.2 Cg_endo -95.54 4.88 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 1 CA-C-N 103.419 -4.886 . . . . 0.0 111.153 72.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 105.82 2.43 39.77 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.494 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.811 HG23 ' CG ' ' A' ' 56' ' ' PRO . 27.0 p -46.43 -105.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.582 0.229 . . . . 0.0 111.345 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.889 ' N ' HG21 ' A' ' 54' ' ' THR . 6.0 p-10 172.33 29.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 60' ' ' VAL . 58.3 t -137.99 34.47 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.733 0.302 . . . . 0.0 111.223 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.598 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 38.8 t -107.82 -104.77 0.35 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.738 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 162.94 -173.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.095 0.474 . . . . 0.0 111.501 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -88.97 135.05 33.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.21 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.611 ' CE1' ' HB2' ' A' ' 78' ' ' PHE . 1.7 t80 -134.16 126.03 29.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.747 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.664 ' CB ' ' CD1' ' A' ' 50' ' ' PHE . 91.6 p -64.77 106.67 1.05 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.569 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.573 ' CB ' HD13 ' A' ' 76' ' ' LEU . 90.5 Cg_endo -92.15 171.03 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.639 2.226 . . . . 0.0 112.72 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . . . -87.2 159.36 18.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.513 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.575 ' HB3' ' O ' ' A' ' 67' ' ' ALA . 9.2 t30 82.17 138.74 0.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 124.167 0.917 . . . . 0.0 110.371 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.596 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER 151.64 -46.58 0.0 OUTLIER Pre-proline 0 CA--C 1.512 -0.512 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.758 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 97.6 Cg_endo -92.74 55.15 0.53 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.167 2.578 . . . . 0.0 111.609 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.709 ' O ' ' O ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER 158.16 109.17 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.413 -179.012 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.86 ' N ' ' HA ' ' A' ' 43' ' ' VAL . 6.2 Cg_endo -48.18 106.15 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.274 2.649 . . . . 0.0 113.88 -177.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 40' ' ' ASN . 10.8 mm-40 -158.71 -74.73 0.08 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.803 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.554 ' O ' ' CA ' ' A' ' 38' ' ' CYS . . . 105.36 72.56 0.86 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.011 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 9.7 mtm180 -151.98 109.25 3.57 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.887 HD21 HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -93.88 128.03 39.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.622 -178.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.707 ' N ' HD12 ' A' ' 76' ' ' LEU . 56.0 mt-10 -130.26 115.75 17.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.236 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.686 ' CD1' ' CG2' ' A' ' 80' ' ' ILE . 1.6 p90 -121.5 135.04 55.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.865 0.364 . . . . 0.0 110.996 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.921 HD22 ' HB2' ' A' ' 131' ' ' ALA . 0.6 OUTLIER -114.78 82.17 1.68 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.979 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.686 ' CG2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -92.14 129.2 43.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.108 -179.161 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.685 ' NH1' H61A ' A' ' 252' ' ' FDA . 0.3 OUTLIER -77.52 110.13 12.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.233 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.57 ' CG2' ' CB ' ' A' ' 89' ' ' SER . 4.4 m -102.5 127.81 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.293 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.724 HD12 ' HB2' ' A' ' 87' ' ' ARG . 13.5 mt -42.66 166.56 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 83' ' ' LEU . 74.7 Cg_exo -49.77 -50.01 14.37 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.654 2.236 . . . . 0.0 112.391 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 175.83 67.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 87' ' ' ARG . . . 176.27 64.25 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.575 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.724 ' HB2' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER 164.07 -93.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.676 0.274 . . . . 0.0 111.005 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.599 ' CE1' ' CG1' ' A' ' 55' ' ' ILE . 1.1 t80 -94.99 -29.96 14.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.343 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.57 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 4.8 p -81.36 -27.14 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.862 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.516 ' O ' ' ND2' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -75.8 -43.44 46.21 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.571 0.701 . . . . 0.0 109.822 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -72.89 -25.29 61.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.934 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.7 OUTLIER -68.46 -47.49 67.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.282 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.446 ' O ' ' CD ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -90.2 -25.61 20.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 90' ' ' ASP . 17.1 m-80 -96.9 2.29 51.5 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.166 -0.213 . . . . 0.0 111.343 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.59 19.72 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.955 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . . . -146.96 27.68 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.671 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 96' ' ' ALA . 39.7 mmm-85 -45.39 173.36 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.114 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.736 HG13 ' HB ' ' A' ' 16' ' ' VAL . 0.5 OUTLIER -95.31 -144.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.44 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.37 -44.9 1.99 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.986 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.935 ' O ' HG22 ' A' ' 16' ' ' VAL . 9.3 pt20 -83.52 -158.52 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.282 0.563 . . . . 0.0 112.372 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.521 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 5.3 p -125.13 144.19 36.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.483 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.957 HD11 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.32 136.1 49.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.711 0.291 . . . . 0.0 110.638 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . 1.01 ' O ' ' CA ' ' A' ' 55' ' ' ILE . 16.1 t -102.67 127.22 49.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.03 0.443 . . . . 0.0 111.066 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.847 ' HA ' ' CA ' ' A' ' 55' ' ' ILE . 2.0 m -101.37 122.61 53.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.978 ' HG3' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -130.18 113.01 13.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.624 -178.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 52' ' ' ASP . . . -173.56 85.14 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.972 -1.108 . . . . 0.0 113.779 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.01 64.37 1.36 Allowed 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.353 2.036 . . . . 0.0 110.786 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.44 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -88.47 173.75 8.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.231 -178.495 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.573 ' O ' ' CE2' ' A' ' 50' ' ' PHE . . . -108.54 174.51 18.79 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.282 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.032 HG21 ' HD2' ' A' ' 47' ' ' PRO . 18.7 m -107.46 109.2 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 121.605 0.717 . . . . 0.0 110.516 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 1.3 m-85 -121.54 132.82 54.92 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.26 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 215' ' ' TYR . . . 124.43 -86.98 0.37 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.012 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.6 ' HB3' ' CE2' ' A' ' 123' ' ' PHE . 0.4 OUTLIER -81.75 118.36 22.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.935 0.397 . . . . 0.0 110.001 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.641 ' CB ' ' CD2' ' A' ' 241' ' ' PHE . 0.9 OUTLIER -137.5 114.63 10.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.959 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.21 129.54 53.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.205 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.05 14.28 24.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.956 0.408 . . . . 0.0 111.114 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.26 -66.23 1.81 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.527 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.535 ' HA ' ' HB2' ' A' ' 147' ' ' ASN . 17.3 ttm -128.82 89.05 2.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.896 0.379 . . . . 0.0 110.376 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.66 ' HB3' ' HE ' ' A' ' 121' ' ' ARG . . . -167.15 142.92 3.5 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.597 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 97.1 Cg_endo -78.28 108.81 2.55 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 123.148 2.565 . . . . 0.0 112.219 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.66 ' HE ' ' HB3' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -136.99 153.03 50.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.949 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.616 ' CD2' ' HB2' ' A' ' 150' ' ' ARG . 2.1 m-85 -120.64 123.03 41.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.022 0.439 . . . . 0.0 110.985 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.945 ' CE1' HG11 ' A' ' 133' ' ' VAL . 45.6 t80 -108.23 111.3 23.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.181 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.834 HG23 ' HB2' ' A' ' 152' ' ' TYR . 3.2 p -98.15 112.25 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 121.473 0.654 . . . . 0.0 111.914 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.838 ' HB2' ' HE1' ' A' ' 123' ' ' PHE . . . -118.23 132.22 56.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.815 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.706 ' O ' HD21 ' A' ' 246' ' ' LEU . . . -123.98 101.97 0.7 Allowed Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.433 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.596 ' N ' HG12 ' A' ' 155' ' ' VAL . . . 142.1 -152.01 23.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.006 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.745 ' CG2' HD23 ' A' ' 79' ' ' LEU . 32.1 m -119.39 -15.82 9.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.056 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.72 ' HA3' ' HN3' ' A' ' 252' ' ' FDA . . . -66.65 9.37 0.9 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.8 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.934 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -80.4 4.72 17.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 120.875 0.369 . . . . 0.0 110.01 179.511 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.921 ' HB2' HD22 ' A' ' 79' ' ' LEU . . . -46.8 -52.5 31.77 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.516 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 131' ' ' ALA . 39.8 Cg_endo -65.68 -30.83 50.43 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.915 1.743 . . . . 0.0 109.946 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.954 ' O ' HG23 ' A' ' 137' ' ' VAL . 41.6 t -67.27 -45.75 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.403 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.934 HG13 ' HG ' ' A' ' 130' ' ' LEU . 15.5 m -70.6 -29.81 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.012 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.21 -52.56 58.21 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 109.991 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.562 ' CE ' ' CE ' ' A' ' 140' ' ' MET . 7.8 tpt -62.29 -44.12 97.25 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.312 0.577 . . . . 0.0 109.504 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.988 HG12 ' NE2' ' A' ' 141' ' ' GLN . 61.5 t -61.61 -30.21 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.079 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -36.29 80.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.412 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.32 -42.83 87.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 110.236 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.646 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 2.4 tpp -70.56 -33.26 70.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.002 0.906 . . . . 0.0 110.103 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.988 ' NE2' HG12 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -77.32 -29.81 53.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.307 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -71.7 -45.11 62.89 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.796 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -77.25 -22.41 52.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.389 0.614 . . . . 0.0 109.798 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 145' ' ' ALA . 1.2 p 58.4 26.3 13.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.229 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.796 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -37.01 160.4 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.541 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.64 14.15 1.05 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.12 2.547 . . . . 0.0 113.328 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 118' ' ' MET . 2.1 p-10 -83.14 132.3 35.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.99 0.424 . . . . 0.0 111.779 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 1.0 OUTLIER -73.94 105.12 5.05 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.626 0.727 . . . . 0.0 111.08 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.697 ' HB ' HD11 ' A' ' 177' ' ' LEU . 2.7 m -113.48 115.5 28.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.109 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.616 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -105.66 139.81 39.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.094 0.473 . . . . 0.0 110.157 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.42 HD11 ' HD1' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -133.98 126.93 51.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.51 -178.264 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.834 ' HB2' HG23 ' A' ' 124' ' ' VAL . 17.3 m-85 -103.15 108.7 19.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.551 ' CE1' ' CD1' ' A' ' 130' ' ' LEU . 31.9 t80 -125.92 156.36 39.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 182' ' ' CYS . . . 153.87 -172.62 32.57 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.711 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.741 HG21 HD13 ' A' ' 161' ' ' LEU . 22.4 m -161.97 -124.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.621 ' CA ' HG22 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -108.67 160.14 16.18 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 117.484 0.129 . . . . 0.0 110.978 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.68 HG22 ' N ' ' A' ' 187' ' ' SER . 0.1 OUTLIER -4.69 -65.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.66 0.784 . . . . 0.0 112.315 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 156' ' ' ASN . 1.4 mt-10 165.67 59.14 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.229 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.54 ' HG2' H62A ' A' ' 252' ' ' FDA . 26.5 Cg_exo -61.2 -16.45 46.49 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.736 1.624 . . . . 0.0 109.491 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.496 ' O ' ' O ' ' A' ' 161' ' ' LEU . 1.3 tp10 174.26 -58.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.779 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.741 HD13 HG21 ' A' ' 155' ' ' VAL . 3.5 tp 41.63 -177.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.306 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.566 ' CG ' ' O ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER 154.56 179.95 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.701 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.574 ' CE1' ' HG2' ' A' ' 166' ' ' GLU . 0.0 OUTLIER 83.01 3.41 1.0 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.695 179.323 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 1.019 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -56.84 -41.21 75.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 1.019 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.6 OUTLIER -64.9 -27.6 68.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.831 178.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.574 ' HG2' ' CE1' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -71.54 -46.61 59.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.955 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.954 ' HB2' HG21 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -59.72 -30.09 68.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.515 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.467 ' HE3' HG12 ' A' ' 164' ' ' ILE . 11.9 mttt -75.83 -24.47 55.85 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -32.75 65.96 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.745 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.982 ' HB2' HD23 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -66.89 -48.09 69.8 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.163 176.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.924 ' OE2' HG12 ' A' ' 179' ' ' VAL . 1.2 mm-40 -56.97 -39.61 74.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.284 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -29.32 40.22 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.532 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 174' ' ' MET . 49.5 m -79.63 -72.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.778 ' CB ' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -52.42 -163.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.182 0.515 . . . . 0.0 111.76 -178.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -114.24 -42.34 3.36 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.604 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.499 ' HB2' ' CB ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -132.21 64.02 1.61 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.077 -179.51 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.982 HD23 ' HB2' ' A' ' 170' ' ' LEU . 3.2 mp -102.69 152.74 20.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.262 0.554 . . . . 0.0 111.388 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.482 ' OG1' ' HD3' ' A' ' 150' ' ' ARG . 27.3 m -136.51 114.82 11.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.899 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.954 HG21 ' HB2' ' A' ' 167' ' ' LEU . 8.9 p -99.63 135.27 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.431 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -112.74 135.62 53.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.027 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.513 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -104.38 106.76 17.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.213 0.53 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.655 ' HB2' ' HA3' ' A' ' 154' ' ' GLY . 31.3 m -80.07 -163.7 0.58 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.334 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.621 HG22 ' CA ' ' A' ' 156' ' ' ASN . 24.1 t 66.72 149.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 122.365 1.078 . . . . 0.0 113.639 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.695 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -139.09 -84.17 0.26 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.846 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.699 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 1.6 m-70 -140.78 29.27 0.11 Allowed Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.43 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.699 ' HD3' ' N ' ' A' ' 185' ' ' HIS . 52.3 Cg_exo -53.88 -138.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 122.209 1.939 . . . . 0.0 113.714 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.68 ' N ' HG22 ' A' ' 157' ' ' THR . 47.0 t 173.24 35.59 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.402 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.498 ' H ' ' CB ' ' A' ' 156' ' ' ASN . . . 86.52 16.18 62.56 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.145 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.51 64.76 1.45 Allowed 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' A' ' 249' ' ' GLY . 13.3 t-105 -133.37 127.39 33.37 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.687 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.516 ' HG2' ' CG ' ' A' ' 219' ' ' PRO . 1.2 mt-10 -113.98 105.74 13.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.717 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.529 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 148.44 -108.6 0.42 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.351 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.566 ' HA ' ' HB3' ' A' ' 182' ' ' CYS . 16.4 mt-10 -168.89 -95.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.513 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 64.5 mt-30 -86.95 133.95 33.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.61 ' HA2' ' CD1' ' A' ' 184' ' ' TRP . . . -22.24 106.82 0.01 OUTLIER Glycine 0 C--N 1.333 0.406 0 O-C-N 123.717 0.635 . . . . 0.0 113.214 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 5.9 m 140.11 158.98 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 O-C-N 124.245 0.615 . . . . 0.0 110.539 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.455 ' O ' ' HB ' ' A' ' 198' ' ' ILE . 49.4 Cg_exo -54.08 -70.44 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.445 2.097 . . . . 0.0 112.077 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.72 ' O ' HG23 ' A' ' 198' ' ' ILE . 0.3 OUTLIER 169.65 29.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 121.665 0.745 . . . . 0.0 111.111 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.507 ' OD1' ' NH2' ' A' ' 202' ' ' ARG . 1.4 m-20 -64.11 -36.81 85.25 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.312 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.33 -37.53 78.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.547 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -69.42 -35.22 75.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.812 0.339 . . . . 0.0 110.978 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.704 ' HG2' HD13 ' A' ' 229' ' ' LEU . 26.8 mtt180 -59.37 -49.96 75.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.421 0.629 . . . . 0.0 111.246 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -31.94 71.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.63 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.451 ' OD1' ' OD2' ' A' ' 209' ' ' ASP . 0.5 OUTLIER -58.56 -43.23 89.29 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.287 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.725 HD12 ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -61.24 -48.24 82.36 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.486 ' OE2' ' HG3' ' A' ' 233' ' ' ARG . 2.4 mt-10 -62.25 -22.15 65.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.706 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.65 -86.8 0.28 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.823 0.344 . . . . 0.0 111.623 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 0.0 OUTLIER 179.37 97.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.806 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.674 ' O ' ' HB3' ' A' ' 210' ' ' ALA . 3.9 p30 152.55 87.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.537 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 1.043 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 96.37 106.09 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.657 ' HA ' HD13 ' A' ' 235' ' ' ILE . 1.1 t30 -172.39 -58.82 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.737 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 10.0 Cg_endo -52.72 -64.47 0.18 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.218 1.945 . . . . 0.0 110.895 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.551 ' HA ' HG21 ' A' ' 240' ' ' VAL . 0.4 OUTLIER -125.34 110.19 13.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.371 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 1.043 HD11 ' HB1' ' A' ' 210' ' ' ALA . 1.0 OUTLIER -107.45 125.71 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 114' ' ' LYS . 2.3 m-85 -116.13 129.68 56.44 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.648 HD23 HG12 ' A' ' 124' ' ' VAL . 0.6 OUTLIER -139.86 123.42 17.23 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -178.055 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 217' ' ' CYS . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 123' ' ' PHE . 2.5 m -123.75 110.37 14.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.71 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.667 ' HA3' ' HB3' ' A' ' 250' ' ' ALA . . . -176.98 -156.85 16.73 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.678 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.518 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 37.3 Cg_endo -65.79 175.61 4.35 Favored 'Trans proline' 0 N--CA 1.466 -0.11 0 C-N-CA 122.326 2.017 . . . . 0.0 111.687 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 219' ' ' PRO . 26.2 Cg_endo -62.53 -8.84 13.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.457 2.105 . . . . 0.0 112.136 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -83.15 -40.36 9.3 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 120.734 -0.745 . . . . 0.0 113.127 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.56 ' HB2' ' HB1' ' A' ' 250' ' ' ALA . 0.0 OUTLIER -56.38 -33.85 66.12 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.536 ' CB ' ' HE2' ' A' ' 222' ' ' MET . 0.0 OUTLIER -77.6 -36.81 23.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.896 178.533 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.481 ' OD1' HG22 ' A' ' 223' ' ' ILE . 16.0 m-20 -73.94 -47.67 35.98 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 251' ' ' ALA . . . -73.22 -48.68 33.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 1.017 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -60.85 -34.07 74.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.823 0.344 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 223' ' ' ILE . 8.0 m -70.0 -32.28 70.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.029 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -71.09 -45.32 63.93 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.568 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.704 HD13 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -62.43 -46.21 89.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.112 0.482 . . . . 0.0 110.799 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 1.017 HG23 ' O ' ' A' ' 226' ' ' ALA . 13.0 t -60.01 -45.58 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.106 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -67.55 -29.82 69.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.187 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -31.37 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.945 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.725 ' HD3' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -84.22 -83.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.135 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 235' ' ' ILE . . . 140.87 -23.68 2.61 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.33 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.657 HD13 ' HA ' ' A' ' 211' ' ' ASN . 1.4 pp -31.51 105.17 0.23 Allowed Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-O 121.128 0.489 . . . . 0.0 111.681 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.486 ' O ' ' OD1' ' A' ' 211' ' ' ASN . 79.0 Cg_exo -33.15 158.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.605 2.87 . . . . 0.0 112.542 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 238' ' ' GLU . . . 68.84 6.08 49.65 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.693 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.665 ' C ' HG11 ' A' ' 230' ' ' VAL . 2.9 mp0 29.12 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.841 0.353 . . . . 0.0 111.253 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.985 ' HG2' HG21 ' A' ' 230' ' ' VAL . 7.5 mt-30 -122.68 -2.62 8.83 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.658 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.801 HG12 ' N ' ' A' ' 241' ' ' PHE . 2.3 t 52.25 -82.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.153 0.501 . . . . 0.0 111.344 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.801 ' N ' HG12 ' A' ' 240' ' ' VAL . 10.1 m-85 -119.28 125.4 49.01 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.26 129.62 37.89 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.874 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -132.21 148.26 52.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.048 178.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -125.37 106.55 9.91 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.657 ' O ' HD23 ' A' ' 246' ' ' LEU . 0.2 OUTLIER -136.94 144.9 43.67 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 178.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.706 HD21 ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER 83.29 160.8 0.12 Allowed Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.429 0.691 . . . . 0.0 112.775 179.109 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.807 ' HG2' ' H8A' ' A' ' 252' ' ' FDA . 37.3 Cg_exo -61.66 -138.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.67 2.913 . . . . 0.0 111.741 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.435 ' HB2' ' C ' ' A' ' 190' ' ' TRP . 10.1 p -72.84 145.84 46.67 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.298 0.571 . . . . 0.0 110.858 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 190' ' ' TRP . . . 167.98 -53.99 0.22 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.667 ' HB3' ' HA3' ' A' ' 218' ' ' GLY . . . -107.69 149.12 28.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.54 -0.33 . . . . 0.0 110.49 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.687 ' O ' ' HB3' ' A' ' 225' ' ' ALA . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.173 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' FDA . . . . . 0.807 ' H8A' ' HG2' ' A' ' 247' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.818 0.342 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 177.05 -55.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.07 155.57 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.62 121.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.827 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -144.6 95.72 2.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.952 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.47 94.42 1.94 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.476 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -62.03 175.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.13 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.93 99.77 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.523 0.678 . . . . 0.0 111.111 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.13 22.09 31.1 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.457 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 m -96.29 150.6 20.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.889 0.376 . . . . 0.0 111.07 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.622 ' CD1' ' HB2' ' A' ' 36' ' ' ASP . 2.6 t80 -132.09 149.02 52.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.939 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.592 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 3.9 mt-10 -108.79 119.81 40.63 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.873 0.368 . . . . 0.0 111.02 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.897 ' O ' HG13 ' A' ' 101' ' ' VAL . . . -119.74 131.78 55.46 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.965 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.544 ' CB ' ' HB2' ' A' ' 33' ' ' LYS . 1.2 tt0 -92.71 137.57 32.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.117 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.763 ' HA ' HD23 ' A' ' 31' ' ' LEU . 10.9 t -71.28 124.55 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.75 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 17' ' ' VAL . 7.6 p -154.36 22.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.126 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.496 ' HA3' ' HG ' ' A' ' 30' ' ' LEU . . . -150.55 -139.77 3.09 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.548 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.767 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER 82.57 62.71 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.174 0.512 . . . . 0.0 110.471 -179.592 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.512 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -101.69 148.96 24.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.589 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 12.2 m95 -89.16 114.63 25.94 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 m -95.04 -27.6 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 121.529 0.681 . . . . 0.0 109.301 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.543 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 13.8 m -143.9 173.68 11.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.348 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -54.27 -58.07 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.958 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 0.3 OUTLIER -112.69 39.23 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.801 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.617 ' CG2' HG21 ' A' ' 128' ' ' THR . 0.2 OUTLIER -145.92 135.53 23.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.522 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.767 HG21 ' CD2' ' A' ' 19' ' ' LEU . 1.5 p -140.6 147.19 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.084 0.469 . . . . 0.0 112.019 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -116.57 122.17 43.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.981 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.751 ' CZ ' HG13 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -114.09 121.35 43.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.797 0.332 . . . . 0.0 111.726 -178.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.822 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -108.62 116.37 31.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.883 179.046 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.97 HD22 HD11 ' A' ' 102' ' ' LEU . 2.3 mt -122.63 133.15 54.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.048 0.452 . . . . 0.0 111.746 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.519 ' CA ' ' HB2' ' A' ' 38' ' ' CYS . 0.5 OUTLIER -145.05 131.37 19.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.079 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.544 ' HB2' ' CB ' ' A' ' 15' ' ' GLU . 7.2 tptm -164.74 -33.38 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.508 ' CD ' ' HD2' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -147.08 177.22 1.84 Allowed Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' A' ' 36' ' ' ASP . 75.6 Cg_exo -49.18 106.59 0.12 Allowed 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.505 2.137 . . . . 0.0 111.987 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.622 ' HB2' ' CD1' ' A' ' 12' ' ' PHE . 1.5 m-20 157.37 -36.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.288 0.565 . . . . 0.0 111.475 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.524 ' HB3' ' HB2' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -169.93 51.28 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.193 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.586 ' H ' ' HA3' ' A' ' 74' ' ' GLY . 53.2 t -163.71 -58.2 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -137.75 -66.02 0.05 OUTLIER Glycine 0 CA--C 1.51 -0.263 0 C-N-CA 119.97 -1.109 . . . . 0.0 113.69 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.528 ' CB ' ' HG3' ' A' ' 35' ' ' PRO . 0.8 OUTLIER -88.08 18.82 3.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.87 0.367 . . . . 0.0 111.259 -179.229 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.948 ' HG3' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -56.45 -45.52 80.77 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.47 0.652 . . . . 0.0 109.624 178.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 72' ' ' PRO . . . 60.14 78.15 0.15 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.911 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.948 HG22 ' HG3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -93.45 163.4 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.435 0.636 . . . . 0.0 111.849 -178.526 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HE3' ' CE1' ' A' ' 45' ' ' PHE . 4.8 tttp -154.72 -142.03 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.733 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.547 ' CE1' ' HE3' ' A' ' 44' ' ' LYS . 22.2 p90 -122.06 78.11 1.45 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.376 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 48' ' ' GLY . 28.1 mm-40 -113.04 166.55 10.86 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.579 ' HD2' HG11 ' A' ' 110' ' ' VAL . 32.1 Cg_exo -58.05 65.98 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.389 2.06 . . . . 0.0 111.616 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 40.39 62.46 1.57 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.223 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.508 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -30.32 148.98 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.716 0.258 . . . . 0.0 110.844 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.701 ' C ' HD23 ' A' ' 108' ' ' LEU . 5.3 m-85 -116.16 163.17 16.36 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.719 ' N ' HD23 ' A' ' 108' ' ' LEU . 4.7 mtt -131.41 162.56 29.89 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.962 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 105' ' ' LYS . 4.4 t0 -125.31 102.46 7.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.842 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.983 HD12 HG12 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -150.07 156.95 42.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.958 HG23 ' C ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -85.63 154.69 21.52 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.313 178.495 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.716 HD11 ' CZ ' ' A' ' 88' ' ' PHE . 1.3 mt -30.4 -71.91 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 123.411 0.444 . . . . 0.0 109.906 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.907 ' CG ' HG23 ' A' ' 58' ' ' THR . 9.3 Cg_endo -99.82 4.47 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.568 2.179 . . . . 0.0 111.583 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 101.41 -3.05 54.0 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.832 -178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.907 HG23 ' CG ' ' A' ' 56' ' ' PRO . 64.9 p -27.81 -87.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 122.841 0.456 . . . . 0.0 112.084 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.683 ' O ' HG12 ' A' ' 60' ' ' VAL . 43.9 p-10 -150.45 40.02 0.75 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.958 ' C ' HG23 ' A' ' 54' ' ' THR . 0.3 OUTLIER 90.68 121.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 178.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.723 ' N ' HG23 ' A' ' 54' ' ' THR . 40.3 t -120.72 -66.95 1.01 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.708 0.766 . . . . 0.0 109.931 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -170.41 157.94 6.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.227 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.895 ' HB2' HD21 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -88.73 120.7 30.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.669 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.527 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 3.0 t80 -111.7 121.18 44.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.901 0.381 . . . . 0.0 111.608 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.694 ' CB ' ' CD1' ' A' ' 50' ' ' PHE . 82.4 p -55.56 98.69 0.17 Allowed Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.732 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.983 ' HB2' HD13 ' A' ' 76' ' ' LEU . 2.1 Cg_endo -82.94 155.34 15.13 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.83 2.353 . . . . 0.0 111.54 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 132' ' ' PRO . . . -144.65 130.65 19.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.711 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -115.88 -63.62 1.43 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.764 178.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 68' ' ' ASN . 0.6 OUTLIER 144.42 154.44 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.936 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.652 ' HD2' HD23 ' A' ' 69' ' ' LEU . 18.0 Cg_endo -59.63 96.89 0.1 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.283 1.989 . . . . 0.0 111.225 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.557 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -179.2 138.06 0.33 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.058 0.456 . . . . 0.0 111.519 -179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.459 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 85.5 Cg_endo -82.07 79.63 3.07 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.377 . . . . 0.0 111.998 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.529 ' O ' ' CA ' ' A' ' 39' ' ' GLY . 39.3 mt-10 -144.23 -72.84 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.961 0.41 . . . . 0.0 110.008 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.586 ' HA3' ' H ' ' A' ' 38' ' ' CYS . . . 122.83 97.08 1.33 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.335 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 74' ' ' GLY . 85.0 mtm-85 -162.33 83.66 0.55 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 122.633 0.373 . . . . 0.0 110.888 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.983 HD13 ' HB2' ' A' ' 66' ' ' PRO . 30.0 mt -96.91 145.94 25.42 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.61 0.719 . . . . 0.0 112.496 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 5.9 pt-20 -131.24 141.89 50.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.433 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.662 ' CE1' ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -115.95 133.76 55.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.013 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.995 HD22 ' HB2' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -101.58 82.31 2.28 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.431 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.662 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -91.22 118.01 35.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.854 -178.599 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.674 ' O ' H52A ' A' ' 252' ' ' FDA . 0.0 OUTLIER -78.33 95.99 5.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.213 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.584 ' CG1' ' CG2' ' A' ' 80' ' ' ILE . 2.3 m -94.0 142.12 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.999 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.534 HD13 ' C4B' ' A' ' 252' ' ' FDA . 0.1 OUTLIER -68.14 172.63 4.05 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.799 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 83' ' ' LEU . 44.6 Cg_endo -68.68 58.39 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 0.0 112.149 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 84' ' ' PRO . 0.6 OUTLIER 67.48 72.58 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 87' ' ' ARG . . . 173.12 66.58 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.691 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 163.09 -90.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 111.132 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.716 ' CZ ' HD11 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -108.6 -27.19 10.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.26 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.572 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -60.1 -32.99 71.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 111.185 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 0.8 OUTLIER -75.93 -32.0 59.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.386 0.612 . . . . 0.0 110.842 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.562 ' CG ' HD13 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -68.94 -51.26 41.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.878 -178.291 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.646 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -71.59 -30.75 66.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -31.04 18.07 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.662 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 2.1 t-20 -95.87 -11.29 26.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.7 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 91' ' ' TYR . 2.2 t70 -135.58 -15.28 1.87 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.646 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . . . -119.43 29.02 7.85 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.993 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 96' ' ' ALA . 1.1 mmt180 -56.58 -163.37 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.614 HG13 HG12 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -86.74 -153.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-O 121.195 0.522 . . . . 0.0 110.65 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.41 -47.26 1.38 Allowed Glycine 0 C--N 1.316 -0.548 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.469 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.756 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -96.55 179.45 5.0 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 14' ' ' ALA . 99.6 t -121.85 145.23 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.259 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.97 HD11 HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.6 120.36 40.74 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 108.57 13.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.983 HG12 HD12 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -108.49 165.43 4.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.066 0.46 . . . . 0.0 112.079 -177.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.63 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -132.24 112.49 12.29 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.475 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 51' ' ' MET . . . -103.54 44.97 1.38 Allowed Glycine 0 CA--C 1.519 0.321 0 C-N-CA 119.533 -1.318 . . . . 0.0 115.74 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.518 ' HD3' ' C ' ' A' ' 105' ' ' LYS . 82.5 Cg_endo -81.83 38.81 0.78 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.173 1.915 . . . . 0.0 111.481 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.895 HD21 ' HB2' ' A' ' 63' ' ' SER . 0.0 OUTLIER -88.33 173.19 8.89 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.813 0.816 . . . . 0.0 112.761 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.01 173.42 19.41 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.477 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.579 HG11 ' HD2' ' A' ' 47' ' ' PRO . 9.3 m -108.63 107.16 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 117.925 0.862 . . . . 0.0 110.923 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 0.3 OUTLIER -123.74 122.53 38.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.476 178.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 215' ' ' TYR . . . 123.35 -84.78 0.37 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.283 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.588 ' HB2' ' CE2' ' A' ' 123' ' ' PHE . 7.7 tp -75.88 117.87 18.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.057 0.456 . . . . 0.0 110.073 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.616 ' O ' ' CZ ' ' A' ' 215' ' ' TYR . 0.1 OUTLIER -138.7 127.3 23.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.605 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.535 ' HA ' ' CZ ' ' A' ' 121' ' ' ARG . 2.2 pp20? -112.45 134.56 53.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.624 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -110.32 6.35 22.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.974 0.416 . . . . 0.0 111.197 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.81 -75.73 0.4 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.544 ' HA ' ' CB ' ' A' ' 147' ' ' ASN . 3.7 mpp? -129.91 89.33 2.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.887 0.375 . . . . 0.0 110.524 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.49 ' O ' ' HD3' ' A' ' 121' ' ' ARG . . . -158.36 144.2 12.41 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.243 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.86 94.67 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.599 2.2 . . . . 0.0 111.613 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -127.81 150.45 49.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.257 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.745 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -124.17 144.39 49.95 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.923 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.885 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.9 t80 -128.35 115.36 18.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.746 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.76 HG21 ' CE ' ' A' ' 222' ' ' MET . 8.0 p -98.82 111.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.101 0.477 . . . . 0.0 111.33 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.564 ' HB2' HG11 ' A' ' 133' ' ' VAL . . . -111.31 132.84 54.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.784 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.454 ' HA3' ' C ' ' A' ' 249' ' ' GLY . . . -129.18 104.34 0.64 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.412 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 134.64 -166.13 24.33 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.033 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.839 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -98.84 -28.15 13.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.118 0.485 . . . . 0.0 110.56 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.63 ' HA3' ' HN3' ' A' ' 252' ' ' FDA . . . -65.5 8.24 0.8 Allowed Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.764 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.829 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -79.23 4.51 14.75 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.828 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.995 ' HB2' HD22 ' A' ' 79' ' ' LEU . . . -46.9 -44.57 47.26 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.904 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 8.9 Cg_exo -69.48 -30.89 22.86 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.425 2.084 . . . . 0.0 109.748 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.074 ' O ' HG23 ' A' ' 137' ' ' VAL . 13.7 t -68.12 -53.08 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.576 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.829 HG13 ' HG ' ' A' ' 130' ' ' LEU . 29.1 m -66.57 -30.47 49.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.625 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.3 OUTLIER -61.16 -50.73 71.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.183 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.438 ' HA ' ' CD ' ' A' ' 139' ' ' GLN . 0.5 OUTLIER -66.93 -43.03 84.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.791 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.074 HG23 ' O ' ' A' ' 133' ' ' VAL . 13.5 t -59.81 -37.59 72.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 134' ' ' VAL . 3.2 mtm-85 -69.43 -31.03 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.1 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.492 ' O ' ' HB3' ' A' ' 143' ' ' TRP . 43.7 mt-30 -63.15 -43.03 99.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.259 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.475 ' HE1' HG21 ' A' ' 149' ' ' THR . 3.9 ptp -71.38 -48.87 47.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.189 0.519 . . . . 0.0 110.6 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.529 ' NE2' ' CD2' ' A' ' 177' ' ' LEU . 0.7 OUTLIER -58.2 -30.99 66.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.716 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 138' ' ' ARG . 1.3 mt-10 -82.16 -37.31 26.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.266 0.555 . . . . 0.0 110.085 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.789 ' CD1' ' HB2' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -67.59 -9.65 44.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.651 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 143' ' ' TRP . 1.6 p 87.55 10.45 0.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.766 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.789 ' HB2' ' CD1' ' A' ' 143' ' ' TRP . . . -38.79 98.42 0.17 Allowed Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.737 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.543 ' HA ' ' HB2' ' A' ' 175' ' ' ARG . 81.0 Cg_endo -78.12 8.41 3.54 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.906 2.404 . . . . 0.0 112.679 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.583 ' OD1' ' HB1' ' A' ' 145' ' ' ALA . 14.7 p-10 -78.58 150.3 32.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.944 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 176' ' ' ASN . 0.2 OUTLIER -74.18 104.77 5.09 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.49 0.662 . . . . 0.0 110.99 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.7 OUTLIER -123.01 117.21 24.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.936 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.659 ' CB ' ' CD2' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -102.71 141.55 35.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.885 HD13 ' O ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -134.27 126.23 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.745 ' CE1' ' HB3' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -102.89 108.1 19.17 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.678 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.6 ' CD1' ' CD1' ' A' ' 130' ' ' LEU . 7.1 t80 -124.91 153.96 41.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.852 0.358 . . . . 0.0 111.949 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.686 ' O ' HG13 ' A' ' 155' ' ' VAL . . . 150.07 -168.21 30.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.711 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.91 HG21 HD13 ' A' ' 161' ' ' LEU . 16.4 m -163.52 -120.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.781 ' O ' HG21 ' A' ' 183' ' ' VAL . 2.4 p-10 -103.93 -166.01 1.21 Allowed 'General case' 0 C--N 1.35 0.613 0 C-N-CA 122.371 0.268 . . . . 0.0 111.122 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.61 ' CG2' ' HA ' ' A' ' 187' ' ' SER . 0.1 OUTLIER -28.03 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.608 0.242 . . . . 0.0 111.415 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 156' ' ' ASN . 39.6 mt-10 93.35 41.0 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.684 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 37.7 Cg_endo -66.85 -26.09 44.91 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 C-N-CA 122.137 1.891 . . . . 0.0 110.626 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -130.58 20.8 5.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.208 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.91 HD13 HG21 ' A' ' 155' ' ' VAL . 9.9 tp -88.57 165.31 14.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.063 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.478 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 0.9 OUTLIER 176.26 -160.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.998 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.3 OUTLIER 72.85 26.63 2.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.243 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 1.047 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -69.8 -35.87 67.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.912 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 1.047 ' N ' HD13 ' A' ' 164' ' ' ILE . 9.2 m-20 -62.29 -28.47 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.299 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.466 ' O ' ' CD2' ' A' ' 170' ' ' LEU . 2.3 mm-40 -72.08 -47.46 51.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.705 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -64.22 -30.25 71.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.763 178.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 172' ' ' ARG . 4.8 mtmm -72.55 -24.8 61.17 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -35.82 71.17 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.415 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -67.64 -48.52 66.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.476 ' O ' ' SD ' ' A' ' 174' ' ' MET . 3.3 mt-10 -57.65 -32.15 67.0 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.864 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 168' ' ' LYS . 1.1 mtt-85 -79.56 -41.69 26.68 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 174' ' ' MET . 6.4 t -93.1 -50.67 5.4 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.911 ' HB2' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -35.62 167.19 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.966 0.889 . . . . 0.0 112.892 -178.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.543 ' HB2' ' HA ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -99.75 -71.92 0.68 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.473 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -124.63 56.31 1.3 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.787 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.911 HD13 ' HB2' ' A' ' 174' ' ' MET . 5.8 mp -114.47 154.69 27.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.397 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.472 ' OG1' ' HG3' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -136.06 117.79 15.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.464 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.464 ' HB ' ' OE2' ' A' ' 171' ' ' GLU . 91.0 t -89.66 134.32 29.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.6 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.552 ' CB ' ' HA ' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -104.13 135.72 45.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.013 0.435 . . . . 0.0 111.676 -179.302 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -103.14 107.05 17.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.905 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.698 ' HB3' ' HA ' ' A' ' 193' ' ' GLU . 38.1 m -79.91 -168.26 1.55 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.311 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 155' ' ' VAL . 52.5 t 70.07 148.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.875 0.845 . . . . 0.0 112.835 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.714 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.53 -53.3 0.6 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.586 -177.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.547 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 4.7 p-80 167.77 62.2 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 113.623 -1.626 . . . . 0.0 108.696 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.626 ' O ' ' CB ' ' A' ' 187' ' ' SER . 67.0 Cg_endo -95.65 -96.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.797 2.998 . . . . 0.0 114.305 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.626 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 28.6 t 136.78 78.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.985 0.514 . . . . 0.0 110.34 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.509 ' O ' ' H2A' ' A' ' 252' ' ' FDA . . . 41.65 23.13 0.11 Allowed Glycine 0 C--N 1.329 0.148 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.066 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 187' ' ' SER . 0.2 OUTLIER -139.23 62.05 1.54 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.541 ' NE1' ' O ' ' A' ' 193' ' ' GLU . 19.4 t-105 -135.24 129.12 33.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 1.052 ' C ' ' HB3' ' A' ' 251' ' ' ALA . 1.6 mp0 -113.83 104.87 12.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.376 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.628 ' N ' ' HB3' ' A' ' 251' ' ' ALA . . . 147.0 -113.07 0.63 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.272 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.698 ' HA ' ' HB3' ' A' ' 182' ' ' CYS . 80.8 mt-10 -161.42 -118.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.578 ' O ' ' O ' ' A' ' 195' ' ' GLY . 2.1 tt0 -87.75 117.74 26.79 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 194' ' ' GLN . . . 31.74 104.31 0.01 OUTLIER Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.348 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.538 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 5.86 66.68 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.2 0.6 . . . . 0.0 112.435 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.502 ' HG2' ' HB2' ' A' ' 193' ' ' GLU . 22.2 Cg_endo -97.12 22.6 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.28 2.653 . . . . 0.0 113.872 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 201' ' ' LEU . 0.2 OUTLIER -87.92 -9.44 10.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.469 -179.641 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.16 -36.99 83.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -61.03 -29.58 69.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.334 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.557 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -64.04 -39.64 94.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.938 0.399 . . . . 0.0 110.13 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.638 ' HG2' HD13 ' A' ' 229' ' ' LEU . 12.9 mtt180 -58.88 -48.37 81.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.514 0.673 . . . . 0.0 110.259 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.29 -32.04 68.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.013 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.76 -42.65 89.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.707 ' HB2' HG21 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -60.47 -48.05 83.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.545 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.428 ' OE1' ' HG3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -61.31 -21.05 63.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.019 178.611 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.0 t -86.31 -90.5 0.11 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.773 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 173.65 33.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.473 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.673 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 0.0 OUTLIER -145.09 58.46 1.29 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 0.851 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 148.87 101.02 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.23 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.595 ' O ' HG23 ' A' ' 240' ' ' VAL . 19.1 t30 173.84 -56.91 0.0 OUTLIER Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.175 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 12.3 Cg_endo -57.25 -53.74 4.43 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.265 1.977 . . . . 0.0 111.144 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.536 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -133.0 108.59 8.99 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.508 0.671 . . . . 0.0 109.319 178.463 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.93 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.8 OUTLIER -123.51 131.04 73.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.128 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.623 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -127.89 131.96 49.38 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.302 0.572 . . . . 0.0 110.679 -178.509 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.747 HD12 ' HB3' ' A' ' 242' ' ' PHE . 0.2 OUTLIER -142.53 119.49 11.3 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.787 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 217' ' ' CYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.5 OUTLIER -122.45 109.15 14.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.871 179.467 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.548 ' HA3' ' HB3' ' A' ' 250' ' ' ALA . . . -178.57 -147.52 7.08 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.618 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 220' ' ' PRO . 58.7 Cg_endo -72.48 174.5 11.52 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.504 2.136 . . . . 0.0 111.918 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 219' ' ' PRO . 26.8 Cg_endo -62.05 -8.66 12.48 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.551 2.167 . . . . 0.0 112.215 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -72.0 -54.16 8.51 Favored Glycine 0 C--O 1.224 -0.483 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.893 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.908 ' O ' ' HB3' ' A' ' 226' ' ' ALA . 1.1 tpp -55.31 -27.96 50.42 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.538 ' O ' ' CB ' ' A' ' 227' ' ' CYS . 0.0 OUTLIER -77.17 -41.56 30.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.404 178.276 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -75.37 -49.22 19.71 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.552 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -77.13 -49.53 15.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 222' ' ' MET . . . -62.63 -35.62 80.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.948 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 223' ' ' ILE . 52.3 t -70.19 -31.96 69.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 110.306 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.5 -44.95 81.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.638 HD13 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -61.02 -38.96 87.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.979 0.419 . . . . 0.0 111.011 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 226' ' ' ALA . 2.3 t -64.45 -45.29 96.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.288 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.5 ' CZ ' ' SG ' ' A' ' 227' ' ' CYS . 19.0 mtt180 -74.22 -29.97 61.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.871 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 2.7 m -75.43 -44.41 44.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.469 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.545 ' NE ' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -68.4 -45.01 73.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.191 -179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 235' ' ' ILE . . . 109.18 -31.01 8.02 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.983 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.707 HG21 ' HB2' ' A' ' 205' ' ' LEU . 1.2 pp -34.27 95.99 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-O 120.829 0.347 . . . . 0.0 111.4 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 235' ' ' ILE . 11.6 Cg_endo -55.25 112.5 1.06 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.744 2.296 . . . . 0.0 111.877 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -93.75 116.59 5.25 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.699 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -88.35 -46.77 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 110.67 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 241' ' ' PHE . 6.0 mt-30 -110.31 37.56 2.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.082 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.93 HG22 ' HB ' ' A' ' 214' ' ' ILE . 1.5 t -89.89 129.41 40.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.178 0.513 . . . . 0.0 110.348 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 239' ' ' GLN . 0.8 OUTLIER -146.11 135.1 22.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.451 -178.179 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.747 ' HB3' HD12 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -131.07 140.93 50.12 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.56 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 8.0 tp10 -131.42 148.66 52.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.108 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -111.51 106.73 15.69 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.593 ' CD1' ' HB2' ' A' ' 246' ' ' LEU . 0.1 OUTLIER -136.16 143.97 44.75 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.052 178.238 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.593 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 3.2 mt 59.42 151.12 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-O 120.95 0.405 . . . . 0.0 111.337 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.791 ' HG2' ' H3B' ' A' ' 252' ' ' FDA . 24.9 Cg_exo -64.05 -141.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.128 2.552 . . . . 0.0 112.056 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 190' ' ' TRP . 0.5 OUTLIER -43.14 148.64 0.26 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.274 0.559 . . . . 0.0 111.662 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.454 ' C ' ' HA3' ' A' ' 126' ' ' GLY . . . 157.56 -66.88 0.29 Allowed Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.207 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.548 ' HB3' ' HA3' ' A' ' 218' ' ' GLY . . . -106.82 137.11 45.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.274 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 1.052 ' HB3' ' C ' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.699 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' FDA . . . . . 0.791 ' H3B' ' HG2' ' A' ' 247' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.822 0.344 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.29 -70.44 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.512 HG22 ' N ' ' A' ' 5' ' ' SER . 3.9 mm 60.01 166.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 4' ' ' ILE . 11.7 p 171.64 118.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.843 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.428 ' CB ' ' O ' ' A' ' 5' ' ' SER . 1.0 OUTLIER 78.43 124.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.36 138.71 20.16 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.558 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -158.08 175.43 13.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.834 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.5 p -108.55 105.08 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 121.599 0.714 . . . . 0.0 111.137 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.47 18.6 5.73 Favored Glycine 0 C--N 1.315 -0.634 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.362 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -125.22 150.04 47.39 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.927 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.786 ' CZ ' HG11 ' A' ' 104' ' ' VAL . 1.5 p90 -133.79 166.73 21.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.789 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -103.77 137.33 41.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.249 0.547 . . . . 0.0 111.388 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.832 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -130.65 140.16 50.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.592 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . 2.3 tp10 -93.41 119.03 32.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.225 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 100' ' ' GLN . 9.9 m -71.34 107.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 17' ' ' VAL . 6.7 p -129.3 20.19 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.807 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -133.0 -128.73 2.92 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.639 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.878 HD21 ' CD1' ' A' ' 92' ' ' LEU . 0.1 OUTLIER 74.74 95.84 0.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.808 0.813 . . . . 0.0 109.407 -178.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 20' ' ' ASN . 18.7 p30 -142.19 137.76 31.04 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.607 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -88.5 112.49 23.04 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 m -90.27 -30.65 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.712 0.768 . . . . 0.0 109.32 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.544 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 19.0 m -137.3 175.04 9.96 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.626 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.7 t -51.09 -53.41 34.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.071 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 1.9 m120 -123.27 52.52 1.38 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.026 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.544 ' OG1' ' HB2' ' A' ' 23' ' ' SER . 0.2 OUTLIER -150.73 137.18 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.846 -179.489 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.659 HG12 HG13 ' A' ' 82' ' ' VAL . 2.0 p -141.27 147.15 22.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.119 0.485 . . . . 0.0 112.007 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.473 ' HG3' ' HG ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -119.98 113.63 20.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.154 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CB ' ' CZ ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -111.95 121.08 44.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.364 -179.259 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.561 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -102.67 119.49 38.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.329 179.359 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.023 HD22 HD23 ' A' ' 102' ' ' LEU . 1.2 mt -122.89 136.25 54.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 0.0 112.06 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 1.7 mt-30 -144.65 135.49 24.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.376 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.5 ' HG3' ' HB2' ' A' ' 15' ' ' GLU . 0.0 OUTLIER 166.21 -23.48 0.0 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.903 0.383 . . . . 0.0 111.962 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.621 ' HB3' ' CD1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -75.66 161.68 75.25 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.183 -179.098 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.681 ' HA ' ' HB2' ' A' ' 40' ' ' ASN . 73.9 Cg_endo -95.77 77.6 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.889 3.059 . . . . 0.0 112.953 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.485 ' N ' ' HD2' ' A' ' 34' ' ' ARG . 0.1 OUTLIER 170.35 -159.61 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 121.091 0.472 . . . . 0.0 111.807 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.748 ' HA ' HG12 ' A' ' 43' ' ' VAL . 23.3 mp0 -76.87 65.71 2.62 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.452 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.507 ' HG ' ' HZ ' ' A' ' 12' ' ' PHE . 4.8 t -174.87 -31.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.5 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 74' ' ' GLY . . . -157.88 24.78 0.42 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.217 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.681 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 64.3 t30 -132.47 39.58 3.36 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 117.822 0.811 . . . . 0.0 112.408 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.538 ' HA ' ' CA ' ' A' ' 73' ' ' GLU . 1.7 mpp_? 46.17 21.92 0.13 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.445 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.46 ' N ' ' C ' ' A' ' 40' ' ' ASN . . . -137.14 73.69 0.43 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.285 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.898 HG11 ' ND2' ' A' ' 68' ' ' ASN . 1.0 OUTLIER -118.66 165.66 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.013 0.435 . . . . 0.0 110.774 179.318 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -153.92 22.67 0.51 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.756 -178.318 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.61 ' CE1' ' HA ' ' A' ' 136' ' ' MET . 0.0 OUTLIER 58.21 127.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.538 -179.512 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.562 ' O ' ' N ' ' A' ' 48' ' ' GLY . 32.0 mt-10 -113.28 145.27 32.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.513 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 80.6 Cg_exo -45.11 81.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.63 2.22 . . . . 0.0 112.36 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 38.9 46.77 2.35 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.335 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.585 ' HA ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -71.88 151.18 43.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.622 0.249 . . . . 0.0 110.698 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.889 ' CG ' HM72 ' A' ' 252' ' ' FDA . 0.0 OUTLIER -133.31 163.21 29.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.96 0.409 . . . . 0.0 111.392 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.546 ' O ' ' CB ' ' A' ' 63' ' ' SER . 1.7 mtt -131.74 -167.82 1.93 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.699 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' A' ' 105' ' ' LYS . 7.9 t0 -133.39 115.32 14.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.969 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.932 ' O ' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -149.6 157.39 43.21 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.528 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.872 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -109.97 150.87 27.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.737 179.319 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.808 HG23 ' HB2' ' A' ' 96' ' ' ALA . 1.5 mt -32.85 -77.12 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.828 ' HG2' HG23 ' A' ' 58' ' ' THR . 4.1 Cg_endo -96.01 9.31 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.199 1.932 . . . . 0.0 111.582 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 102.37 1.67 50.65 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.669 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.828 HG23 ' HG2' ' A' ' 56' ' ' PRO . 29.8 p -46.58 -104.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.661 0.267 . . . . 0.0 111.302 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.872 ' N ' HG21 ' A' ' 54' ' ' THR . 1.3 m-20 169.24 30.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.726 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.415 ' H ' ' CG2' ' A' ' 54' ' ' THR . 0.6 OUTLIER -140.89 34.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.684 0.278 . . . . 0.0 111.111 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.656 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 28.2 t -108.63 -104.17 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.901 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.455 ' CG ' ' O ' ' A' ' 61' ' ' SER . 0.3 OUTLIER 172.44 -169.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 111.019 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 51' ' ' MET . 1.8 m -101.89 145.07 29.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.86 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.644 ' CE2' HG22 ' A' ' 80' ' ' ILE . 2.4 t80 -143.51 130.3 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -59.84 105.49 0.57 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.454 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.826 ' CB ' HD13 ' A' ' 76' ' ' LEU . 57.6 Cg_endo -90.34 131.93 1.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.648 2.232 . . . . 0.0 111.482 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -144.28 138.61 28.07 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.898 ' ND2' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -113.21 -67.69 0.98 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.365 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.568 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER 151.03 150.5 0.0 OUTLIER Pre-proline 0 CA--C 1.521 -0.166 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.998 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.646 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 12.6 Cg_endo -56.75 96.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.719 1.613 . . . . 0.0 111.37 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.879 ' O ' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER 177.21 166.48 0.49 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-O 121.362 0.601 . . . . 0.0 112.053 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.531 ' CA ' ' O ' ' A' ' 41' ' ' ARG . 88.7 Cg_endo -90.5 73.64 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.347 2.698 . . . . 0.0 112.543 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' CA ' ' HA ' ' A' ' 41' ' ' ARG . 3.2 tp10 -129.19 -16.68 3.96 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.783 ' H ' HG13 ' A' ' 43' ' ' VAL . . . 42.46 78.78 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.23 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -155.96 112.85 3.18 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 120.738 0.304 . . . . 0.0 110.313 -178.684 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.826 HD13 ' CB ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -95.23 130.65 41.89 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.062 0.458 . . . . 0.0 110.275 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.746 ' N ' HD12 ' A' ' 76' ' ' LEU . 16.9 pt-20 -127.54 125.49 40.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.123 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.686 ' CD1' ' CG2' ' A' ' 80' ' ' ILE . 2.0 p90 -118.93 144.15 46.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.343 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.019 HD12 ' HB2' ' A' ' 131' ' ' ALA . 2.7 mt -112.6 74.97 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.73 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.686 ' CG2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -91.85 127.08 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.456 0.646 . . . . 0.0 111.085 -179.073 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.699 ' NH1' H61A ' A' ' 252' ' ' FDA . 0.7 OUTLIER -78.59 105.98 10.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.194 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.659 HG13 HG12 ' A' ' 27' ' ' VAL . 2.6 m -96.17 122.45 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.206 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.88 HD12 ' HB2' ' A' ' 87' ' ' ARG . 16.2 mt -41.28 168.52 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.98 0.419 . . . . 0.0 111.178 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 52.8 Cg_exo -54.53 -49.66 16.09 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.703 2.269 . . . . 0.0 112.361 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 84' ' ' PRO . 2.5 mt-10 176.29 61.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 87' ' ' ARG . . . -175.86 57.72 0.11 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.749 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.88 ' HB2' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER 170.34 -95.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.597 0.237 . . . . 0.0 111.135 179.717 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.631 ' CE1' HD11 ' A' ' 55' ' ' ILE . 2.8 t80 -93.64 -27.01 16.82 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 111.195 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 80.4 p -73.16 -20.39 60.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 5.0 m-20 -74.22 -40.21 62.59 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.653 ' OH ' HG21 ' A' ' 58' ' ' THR . 0.9 OUTLIER -73.16 -21.14 60.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.867 178.782 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.957 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -65.76 -47.59 74.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.602 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -16.6 24.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.591 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 1.9 t-20 -99.82 1.71 43.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.561 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.511 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -171.1 22.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.957 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -138.56 28.39 2.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.235 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -51.51 -166.92 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.715 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.66 ' O ' HG12 ' A' ' 98' ' ' VAL . 2.1 t -125.21 95.96 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-O 121.463 0.649 . . . . 0.0 110.717 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 158.16 34.2 0.02 OUTLIER Glycine 0 C--N 1.316 -0.561 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.735 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.872 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -144.63 174.93 10.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.959 0.409 . . . . 0.0 111.198 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.5 p -105.59 143.74 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.466 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.023 HD23 HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -120.28 140.9 50.54 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.797 0.332 . . . . 0.0 110.986 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.52 ' N ' HD12 ' A' ' 102' ' ' LEU . 4.3 m -100.34 115.2 29.41 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.876 HG23 HD12 ' A' ' 53' ' ' LEU . 1.1 t -105.26 133.72 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.626 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -130.56 110.67 11.6 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.019 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.543 ' HA3' ' CB ' ' A' ' 51' ' ' MET . . . -123.75 84.08 0.36 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 119.597 -1.287 . . . . 0.0 114.924 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -91.72 30.05 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.126 2.551 . . . . 0.0 110.417 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -88.07 173.04 9.09 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.842 -178.252 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -114.59 174.71 15.62 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.317 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.793 HG23 ' HE2' ' A' ' 114' ' ' LYS . 35.9 m -107.62 107.45 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 117.91 0.855 . . . . 0.0 110.936 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.446 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 55.5 m-85 -123.0 114.75 20.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.548 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 241' ' ' PHE . . . 142.85 -88.92 0.17 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.366 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.833 HD22 ' CZ ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -82.86 116.4 22.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 110.565 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.793 ' HE2' HG23 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -139.19 110.6 7.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.514 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.512 ' HB2' ' NH1' ' A' ' 121' ' ' ARG . 2.0 tt0 -95.21 138.63 32.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.67 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -103.06 9.53 38.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.453 . . . . 0.0 111.071 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.88 -79.02 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.559 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.492 ' HA ' ' HB3' ' A' ' 147' ' ' ASN . 5.9 mtp -130.18 90.14 2.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.87 0.367 . . . . 0.0 110.44 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 121' ' ' ARG . . . -159.53 146.04 12.34 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.435 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.479 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 42.7 Cg_endo -67.35 102.43 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.696 2.264 . . . . 0.0 111.24 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.544 ' HB2' ' CE2' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -124.1 147.01 48.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.353 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.653 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 3.3 m-85 -110.19 122.3 47.3 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.99 ' CE2' HG13 ' A' ' 133' ' ' VAL . 2.3 t80 -123.46 126.61 47.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.671 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -131.34 145.24 35.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.049 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.813 ' HB2' HG11 ' A' ' 133' ' ' VAL . . . -116.95 133.68 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.288 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -102.49 103.8 2.5 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.939 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.8 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 105.41 -161.81 14.56 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.875 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 79' ' ' LEU . 19.4 m -96.14 -10.4 28.3 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 110.791 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.643 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -67.25 11.34 0.75 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.393 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.826 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.8 OUTLIER -73.01 3.08 5.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 122.662 0.385 . . . . 0.0 110.279 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 1.019 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -45.96 -40.95 18.27 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.27 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 2.9 Cg_endo -78.46 -31.02 2.88 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.821 2.347 . . . . 0.0 110.279 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.008 ' O ' HG23 ' A' ' 137' ' ' VAL . 24.6 t -65.14 -43.82 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.828 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.826 HG13 ' HG ' ' A' ' 130' ' ' LEU . 33.8 m -70.26 -31.26 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.704 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -51.09 66.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.61 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -62.42 -46.91 86.45 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.172 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 133' ' ' VAL . 23.6 t -60.1 -30.63 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.108 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -62.77 -36.52 83.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.438 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.569 ' HG3' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -63.93 -42.65 97.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.448 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.635 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -64.52 -34.25 77.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.771 0.796 . . . . 0.0 110.173 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.873 ' OE1' HD22 ' A' ' 170' ' ' LEU . 0.1 OUTLIER -79.36 -30.12 42.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.603 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -44.83 79.02 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.728 0.299 . . . . 0.0 111.356 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.802 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -82.46 -19.94 37.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.582 0.706 . . . . 0.0 109.718 179.026 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.501 ' O ' ' O ' ' A' ' 145' ' ' ALA . 5.1 m 51.61 29.45 5.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.268 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.802 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -37.22 162.3 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.824 0.345 . . . . 0.0 110.568 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.542 ' HD2' ' HB1' ' A' ' 145' ' ' ALA . 74.6 Cg_endo -78.79 13.32 1.96 Allowed 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.741 2.294 . . . . 0.0 112.955 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.492 ' HB3' ' HA ' ' A' ' 118' ' ' MET . 31.6 p-10 -91.35 136.71 32.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.153 0.502 . . . . 0.0 111.989 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 120' ' ' PRO . 3.6 pm0 -73.84 119.67 18.37 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.66 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 41.9 m -115.55 124.53 51.24 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.671 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.625 ' NE ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.4 131.17 47.63 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.845 178.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -127.19 109.08 19.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.43 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.69 ' O ' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -121.31 110.04 15.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.457 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.506 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 0.3 OUTLIER -122.22 147.3 46.36 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.394 -178.466 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.867 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -148.82 171.4 29.13 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.606 -1.283 . . . . 0.0 114.224 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 1.0 HG21 HD22 ' A' ' 161' ' ' LEU . 3.0 m -167.72 -111.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.872 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.4 OUTLIER -124.36 -170.32 2.12 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 120.709 0.29 . . . . 0.0 111.414 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.782 HG23 ' N ' ' A' ' 187' ' ' SER . 49.5 p -27.04 -64.47 0.08 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.705 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.9 mt-10 152.26 -50.75 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.312 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 85.9 Cg_exo -38.85 -26.84 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.745 2.297 . . . . 0.0 112.511 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -87.93 -30.87 19.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.025 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.0 HD22 HG21 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -105.07 -172.5 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.0 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 0.5 OUTLIER 176.71 -155.56 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.071 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.553 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 77.4 9.58 2.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.632 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.985 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -57.74 -44.33 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 110.162 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.985 ' N ' HD13 ' A' ' 164' ' ' ILE . 2.4 m-20 -62.43 -28.09 69.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.111 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 1.8 mt-10 -71.72 -47.41 54.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.837 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.553 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -62.34 -30.64 71.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.98 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 171' ' ' GLU . 13.2 mttm -60.41 -47.72 84.87 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -31.66 72.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.873 HD22 ' OE1' ' A' ' 141' ' ' GLN . 0.5 OUTLIER -65.15 -35.62 81.68 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.43 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.695 ' HA ' HD11 ' A' ' 177' ' ' LEU . 0.9 OUTLIER -62.96 -41.64 99.59 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.967 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.54 -37.65 59.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.397 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.5 t -65.34 -14.79 61.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.478 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.615 ' CG ' ' HB3' ' A' ' 177' ' ' LEU . 2.2 tpt -94.3 178.63 5.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.203 0.525 . . . . 0.0 111.311 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 6.0 tpp180 -96.18 -71.61 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.119 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -128.04 63.16 1.41 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.671 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.028 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -109.49 160.3 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.255 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . 1.028 ' N ' HD22 ' A' ' 177' ' ' LEU . 1.8 m -137.55 121.95 18.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.117 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.613 HG23 ' HG2' ' A' ' 171' ' ' GLU . 53.7 t -90.06 135.71 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.167 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.539 ' CB ' ' HB3' ' A' ' 152' ' ' TYR . 3.2 tptp -108.47 130.27 55.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.687 0.28 . . . . 0.0 110.882 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.54 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -99.78 104.61 16.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 111.038 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.67 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 63.1 m -80.43 -157.87 0.17 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.956 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.872 HG21 ' O ' ' A' ' 156' ' ' ASN . 22.5 t 57.66 143.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.485 0.66 . . . . 0.0 111.166 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.737 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -130.16 -59.82 1.03 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.916 -178.005 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.579 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 0.1 OUTLIER -168.06 51.84 0.22 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.692 178.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.624 ' O ' ' CB ' ' A' ' 187' ' ' SER . 96.2 Cg_endo -89.87 -98.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.967 2.445 . . . . 0.0 112.876 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.782 ' N ' HG23 ' A' ' 157' ' ' THR . 23.6 t 139.6 3.41 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.454 0.471 . . . . 0.0 112.199 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.62 ' HA3' ' N1A' ' A' ' 252' ' ' FDA . . . 124.22 11.47 4.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.539 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.31 62.4 1.59 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.569 ' CE3' ' N ' ' A' ' 191' ' ' GLU . 4.5 t-105 -129.86 116.25 18.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.387 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.569 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 0.9 OUTLIER -91.52 103.83 16.39 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.874 ' CA ' ' HB2' ' A' ' 251' ' ' ALA . . . 143.06 -123.82 2.2 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.344 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.869 ' OE2' HD11 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -163.1 -93.92 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.592 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -87.56 120.72 29.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 194' ' ' GLN . . . 5.14 107.3 0.0 OUTLIER Glycine 0 C--N 1.35 1.321 0 O-C-N 123.735 0.647 . . . . 0.0 112.748 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER 11.98 -73.11 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.7 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 196' ' ' SER . 75.3 Cg_exo -22.67 68.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.845 3.697 . . . . 0.0 114.535 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.869 HD11 ' OE2' ' A' ' 193' ' ' GLU . 0.3 OUTLIER -88.28 14.49 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.416 0.627 . . . . 0.0 110.311 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.485 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 0.2 OUTLIER -59.43 -36.24 75.53 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.911 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -58.72 -31.37 68.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.673 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.517 ' O ' ' CD2' ' A' ' 205' ' ' LEU . 0.2 OUTLIER -69.27 -34.15 74.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.154 0.502 . . . . 0.0 110.27 179.315 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.736 ' HG2' HD13 ' A' ' 229' ' ' LEU . 46.8 mtt180 -60.1 -45.72 92.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.325 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.74 -32.78 71.51 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.946 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 207' ' ' SER . 88.6 m-20 -58.95 -43.76 91.31 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.019 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.628 HD12 ' HD2' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -60.59 -45.86 92.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.414 ' CD ' ' HG3' ' A' ' 233' ' ' ARG . 1.1 mt-10 -62.15 -25.6 67.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.487 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 208' ' ' SER . 1.1 t -70.81 -86.71 0.02 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.157 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.41 ' N ' ' OG ' ' A' ' 207' ' ' SER . 0.5 OUTLIER 178.31 30.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.517 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.695 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 1.8 m-20 -148.87 60.98 1.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.779 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 0.789 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 155.96 97.22 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.655 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.762 ' HB2' HD13 ' A' ' 235' ' ' ILE . 17.6 t30 174.39 -56.53 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.992 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 27.5 Cg_endo -62.08 -50.49 4.86 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.477 2.118 . . . . 0.0 111.208 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.533 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -132.44 109.97 10.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.181 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.951 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.9 OUTLIER -123.26 125.42 71.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -123.06 127.5 48.84 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.76 0.791 . . . . 0.0 112.007 -177.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.486 ' O ' HD11 ' A' ' 223' ' ' ILE . 0.9 OUTLIER -134.97 115.36 13.46 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.716 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 217' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 1.8 t -124.64 112.81 17.22 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.55 ' N ' ' CD ' ' A' ' 219' ' ' PRO . . . 112.83 -40.08 2.65 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.285 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.575 ' HB2' ' CB ' ' A' ' 222' ' ' MET . 55.7 Cg_endo -91.84 83.9 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.618 2.212 . . . . 0.0 113.562 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.853 ' HD2' ' HB2' ' A' ' 250' ' ' ALA . 9.9 Cg_endo -52.03 -70.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.689 2.26 . . . . 0.0 111.587 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.84 ' H ' ' HB1' ' A' ' 250' ' ' ALA . . . -53.35 -48.17 60.46 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.836 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.575 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.2 OUTLIER -55.66 -25.14 37.88 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.427 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.594 HD11 ' H ' ' A' ' 243' ' ' GLU . 0.0 OUTLIER -75.84 -37.45 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.387 178.382 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -70.35 -46.67 63.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.849 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.564 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -70.18 -47.62 60.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.281 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.883 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -59.73 -39.97 86.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.329 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.3 t -70.28 -31.92 69.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.16 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -44.65 77.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.831 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.736 HD13 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -60.52 -35.93 77.16 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.108 0.48 . . . . 0.0 110.453 179.717 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 226' ' ' ALA . 2.8 t -65.68 -44.89 93.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.035 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.5 mtt85 -73.48 -30.3 63.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.0 -44.08 32.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.628 ' HD2' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -55.99 -59.69 4.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.989 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 137.65 -50.9 0.8 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.214 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.762 HD13 ' HB2' ' A' ' 211' ' ' ASN . 0.7 OUTLIER -34.99 94.84 0.08 OUTLIER Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.128 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 28.1 Cg_endo -62.7 127.47 20.71 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.825 2.35 . . . . 0.0 112.225 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -95.31 -175.33 37.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.687 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -157.47 -40.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 110.622 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.576 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 8.3 mm-40 -110.73 42.38 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.336 0.589 . . . . 0.0 110.48 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.951 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.4 t -91.64 137.52 21.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.652 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -141.69 140.73 33.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.159 -178.301 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.544 ' CB ' HG12 ' A' ' 223' ' ' ILE . 5.6 p90 -131.14 139.27 49.77 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.296 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLU . . . . . 0.594 ' H ' HD11 ' A' ' 223' ' ' ILE . 0.8 OUTLIER -131.79 148.74 52.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.036 179.015 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 220' ' ' PRO . 1.9 mptt -124.03 105.71 9.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.643 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.2 OUTLIER -138.02 145.84 42.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 178.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.573 HD21 ' O2 ' ' A' ' 252' ' ' FDA . 5.2 mt 67.83 163.99 0.13 Allowed Pre-proline 0 N--CA 1.468 0.461 0 CA-C-O 120.81 0.338 . . . . 0.0 111.294 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.478 ' CD ' HD22 ' A' ' 246' ' ' LEU . 54.9 Cg_endo -86.41 -103.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.284 2.656 . . . . 0.0 112.111 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 247' ' ' PRO . 32.3 m -37.93 137.29 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.013 0.435 . . . . 0.0 110.547 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 124.76 -15.38 7.5 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.853 ' HB2' ' HD2' ' A' ' 220' ' ' PRO . . . -107.49 110.76 22.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.957 -0.621 . . . . 0.0 111.515 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.874 ' HB2' ' CA ' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.108 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' FDA . . . . . 0.889 HM72 ' CG ' ' A' ' 50' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.3 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.828 0.346 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.97 16.31 5.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.809 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 tt -148.81 132.58 8.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.044 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.406 ' OG ' ' N ' ' A' ' 6' ' ' PHE . 29.4 t -56.86 -179.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.933 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' N ' ' OG ' ' A' ' 5' ' ' SER . 80.5 m-85 59.23 158.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.975 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.08 -81.35 1.2 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.57 26.57 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.921 0.391 . . . . 0.0 110.906 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.35 99.76 7.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.05 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.454 ' C ' ' HG3' ' A' ' 105' ' ' LYS . . . -157.17 20.29 0.41 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.637 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.529 ' CB ' ' HB2' ' A' ' 105' ' ' LYS . 25.4 t -123.48 150.04 44.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.845 0.355 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.789 ' CZ ' ' HB2' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -133.01 165.37 24.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.15 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.515 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 2.0 mp0 -105.98 133.08 51.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.134 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.791 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -123.23 144.29 49.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.727 0.299 . . . . 0.0 111.012 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 32' ' ' GLN . 1.2 pt-20 -93.58 120.75 34.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.811 0.338 . . . . 0.0 110.123 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.961 HG22 ' O ' ' A' ' 100' ' ' GLN . 3.9 m -71.67 105.74 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.252 0.549 . . . . 0.0 111.06 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.93 -33.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.018 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -79.18 -129.02 0.61 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.03 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.785 HD23 ' CB ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER 71.39 95.53 0.07 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.978 0.894 . . . . 0.0 109.747 -179.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -142.32 143.22 32.67 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.858 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.535 ' NE1' ' HD3' ' A' ' 93' ' ' ARG . 3.3 m0 -88.43 113.16 23.74 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 m -92.05 -29.9 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-O 121.747 0.784 . . . . 0.0 108.963 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.552 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 12.0 m -137.6 173.83 11.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.471 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.535 ' CB ' ' HG2' ' A' ' 160' ' ' GLU . 18.6 t -53.51 -53.34 52.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.095 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 82' ' ' VAL . 98.6 m-20 -119.19 47.6 1.65 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.397 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 1.008 ' CG2' HG21 ' A' ' 128' ' ' THR . 0.2 OUTLIER -149.02 140.97 23.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.735 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.591 ' CG2' HD13 ' A' ' 19' ' ' LEU . 1.4 p -140.34 147.4 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.144 0.497 . . . . 0.0 112.087 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.496 ' HG3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -113.8 105.26 13.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.932 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -100.07 128.69 46.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.882 -178.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 6.9 mp -118.35 116.86 27.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.899 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.791 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 5.1 mt -114.03 133.84 55.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.029 0.442 . . . . 0.0 112.054 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.516 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -144.27 136.71 26.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.648 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -170.43 -94.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.707 0.289 . . . . 0.0 111.586 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.565 ' N ' ' CD ' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -48.01 -47.53 64.49 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 121.118 0.485 . . . . 0.0 110.185 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.638 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 91.2 Cg_endo -80.89 -142.1 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.015 2.477 . . . . 0.0 111.531 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 74' ' ' GLY . 0.2 OUTLIER -138.17 -162.64 1.33 Allowed 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.879 -0.513 . . . . 0.0 110.182 179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.504 ' C ' ' CG ' ' A' ' 75' ' ' ARG . 5.1 pt-20 -98.06 65.01 1.72 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.589 ' N ' ' CG ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -170.55 1.93 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -178.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.827 ' CA ' HG22 ' A' ' 43' ' ' VAL . . . 163.53 90.6 0.08 OUTLIER Glycine 0 C--O 1.218 -0.897 0 C-N-CA 118.544 -1.789 . . . . 0.0 115.127 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.604 ' CA ' ' HA2' ' A' ' 74' ' ' GLY . 60.5 t-20 -25.35 115.2 0.05 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 49.09 27.62 1.8 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.955 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.672 ' HA2' ' HA ' ' A' ' 72' ' ' PRO . . . 76.01 86.38 0.34 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.698 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.921 HG21 ' CG ' ' A' ' 68' ' ' ASN . 0.6 OUTLIER -94.75 170.46 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.356 0.598 . . . . 0.0 111.66 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.542 ' HG2' ' CD1' ' A' ' 45' ' ' PHE . 5.9 ttpt -148.57 -141.63 0.11 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.689 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.542 ' CD1' ' HG2' ' A' ' 44' ' ' LYS . 48.6 p90 -95.06 56.46 1.94 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.282 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.6 OUTLIER -114.21 127.61 26.65 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 48' ' ' GLY . 63.3 Cg_exo -32.01 84.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.842 2.361 . . . . 0.0 112.111 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 33.32 73.06 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.889 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.504 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -32.66 154.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.906 0.353 . . . . 0.0 110.851 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 1.031 ' CD2' HM72 ' A' ' 252' ' ' FDA . 1.3 m-85 -122.92 163.23 20.74 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.561 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -133.06 162.82 30.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.47 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 105' ' ' LYS . 2.8 t0 -122.66 109.29 14.09 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 110.249 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.73 ' CD1' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.16 158.9 44.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.53 0.681 . . . . 0.0 112.225 -178.351 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.772 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -103.09 151.0 23.06 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.455 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.983 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -32.32 -68.62 0.15 Allowed Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.72 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.983 ' HD3' HG23 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -103.89 2.27 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.926 2.417 . . . . 0.0 111.144 177.261 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 109.9 -0.07 30.26 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.084 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.828 HG23 ' CD ' ' A' ' 56' ' ' PRO . 30.4 p -31.16 -98.47 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.515 0.326 . . . . 0.0 111.449 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.772 ' N ' HG21 ' A' ' 54' ' ' THR . 10.1 p-10 160.5 31.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.71 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 59' ' ' ASP . 2.7 t -158.8 40.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.044 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.698 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 45.4 t -107.66 -103.34 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 4.7 mtm180 172.77 -174.36 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.99 0.424 . . . . 0.0 111.037 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -105.33 123.95 48.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.636 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 78' ' ' PHE . 1.2 t80 -107.36 126.14 52.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.819 0.343 . . . . 0.0 110.633 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.671 ' CB ' ' CD2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -63.78 104.94 0.57 Allowed Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.791 -179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.942 ' HB3' HD13 ' A' ' 76' ' ' LEU . 7.2 Cg_exo -73.25 152.74 50.52 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.528 2.152 . . . . 0.0 110.861 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.4 128.53 52.3 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.921 ' CG ' HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -135.71 -81.11 0.41 Allowed 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.631 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.66 HD22 ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER 146.59 171.65 0.0 OUTLIER Pre-proline 0 C--N 1.339 0.134 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.156 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 69' ' ' LEU . 29.4 Cg_endo -63.63 88.26 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 121.654 1.569 . . . . 0.0 111.858 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -170.41 139.29 1.42 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 111.173 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.672 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 91.5 Cg_endo -86.8 67.13 4.48 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.942 2.428 . . . . 0.0 114.541 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.638 ' O ' ' HB2' ' A' ' 35' ' ' PRO . 37.2 mp0 -136.77 -116.26 0.17 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.636 ' HA3' ' HB2' ' A' ' 35' ' ' PRO . . . -166.69 71.61 0.17 Allowed Glycine 0 CA--C 1.543 1.829 0 N-CA-C 116.114 1.206 . . . . 0.0 116.114 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.589 ' CG ' ' N ' ' A' ' 38' ' ' CYS . 0.1 OUTLIER -121.72 82.0 1.89 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.275 1.537 . . . . 0.0 110.296 178.345 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.942 HD13 ' HB3' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -97.17 129.3 44.55 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.333 0.587 . . . . 0.0 111.447 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.718 ' N ' HD12 ' A' ' 76' ' ' LEU . 3.5 mt-10 -130.77 121.17 24.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.739 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 29' ' ' PHE . 1.3 p90 -114.86 140.55 48.87 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.968 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.103 HD22 ' HB2' ' A' ' 131' ' ' ALA . 0.7 OUTLIER -102.44 84.1 2.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.349 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.613 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -90.37 139.94 16.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.728 -177.395 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.684 ' HB3' ' H8A' ' A' ' 252' ' ' FDA . 0.0 OUTLIER -78.05 112.03 14.56 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG23 ' N ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -105.9 138.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.783 -178.277 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.729 HD11 ' H4B' ' A' ' 252' ' ' FDA . 9.0 mt -101.4 158.55 31.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.768 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 83' ' ' LEU . 26.2 Cg_endo -62.06 67.71 0.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.673 2.249 . . . . 0.0 112.023 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 83' ' ' LEU . 29.2 mm-40 75.63 53.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.647 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.14 -97.19 1.35 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.665 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -125.57 -48.46 1.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.67 0.271 . . . . 0.0 111.157 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.592 ' CZ ' ' HA ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -85.52 -32.95 21.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 0.0 110.859 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.582 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 3.3 p -70.01 -20.58 63.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.28 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 9.9 m-20 -77.25 -34.12 55.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.31 0.576 . . . . 0.0 110.867 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.961 ' HB2' HD11 ' A' ' 55' ' ' ILE . 35.0 t80 -73.51 -51.41 17.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.93 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.968 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -70.97 -29.63 65.68 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.074 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.535 ' HD3' ' NE1' ' A' ' 21' ' ' TRP . 8.4 mtm180 -90.55 -27.46 19.13 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.81 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 1.9 t-20 -102.56 -5.45 23.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.702 0.287 . . . . 0.0 110.845 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 91' ' ' TYR . 2.9 t70 -130.22 -23.47 2.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.968 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -96.51 28.67 3.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.15 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 7.2 mmm180 -97.03 -47.4 5.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.045 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.795 HG13 ' CG ' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -72.95 -1.17 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.864 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.662 ' HA2' HG23 ' A' ' 16' ' ' VAL . . . 77.05 20.41 75.82 Favored Glycine 0 C--N 1.32 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.047 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.961 ' O ' HG22 ' A' ' 16' ' ' VAL . 5.1 mt-30 -47.96 179.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 111.186 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.439 ' CG1' ' O ' ' A' ' 14' ' ' ALA . 2.1 t -109.54 139.77 31.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.977 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.73 HD11 ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -130.09 126.21 37.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.298 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.483 ' HB2' ' HG3' ' A' ' 13' ' ' GLU . 1.5 t -94.78 140.47 29.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 111.915 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.716 HG22 ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -115.91 142.22 30.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.901 178.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 25.6 ttpp -131.63 113.23 13.36 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.192 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 50' ' ' PHE . . . 162.49 98.38 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 118.921 -1.609 . . . . 0.0 114.592 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -92.9 29.95 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.414 2.743 . . . . 0.0 110.014 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -88.61 166.74 13.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.466 -177.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.59 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -146.07 171.78 26.89 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.354 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.869 HG12 ' CZ ' ' A' ' 50' ' ' PHE . 3.5 p -158.05 121.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.222 0.534 . . . . 0.0 111.067 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -70.1 135.93 49.72 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.508 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -146.66 -41.09 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.942 HD13 ' CE2' ' A' ' 123' ' ' PHE . 1.4 pt? -133.27 119.51 19.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.166 0.508 . . . . 0.0 110.432 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.651 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.4 OUTLIER -137.93 114.79 10.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.452 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.47 ' HA ' ' OH ' ' A' ' 215' ' ' TYR . 7.5 pm0 -83.62 140.62 32.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.693 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.41 15.01 5.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.746 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.82 -78.06 0.25 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.9 mtt -130.04 89.92 2.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.85 0.357 . . . . 0.0 110.153 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 121' ' ' ARG . . . -165.6 150.84 8.03 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.455 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 47.6 Cg_endo -68.75 104.83 1.21 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.806 2.337 . . . . 0.0 112.078 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.657 HH12 HG23 ' A' ' 149' ' ' THR . 0.0 OUTLIER -120.81 146.66 46.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.692 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.673 ' HB3' ' CZ ' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -115.52 141.05 48.58 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.168 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 1.123 ' CE2' HG13 ' A' ' 133' ' ' VAL . 1.1 t80 -122.42 117.16 25.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.866 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.745 HG23 ' CD1' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -106.2 113.29 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.365 0.602 . . . . 0.0 111.943 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.577 ' HB2' HG11 ' A' ' 133' ' ' VAL . . . -100.83 133.12 45.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.201 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.526 ' O ' HD11 ' A' ' 246' ' ' LEU . . . -112.47 103.62 1.48 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.643 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.861 ' HA3' HD21 ' A' ' 246' ' ' LEU . . . 106.31 -156.57 16.24 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.621 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.008 HG21 ' CG2' ' A' ' 26' ' ' THR . 8.6 m -100.35 -17.01 17.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.955 0.407 . . . . 0.0 111.132 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -63.71 10.1 0.23 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.098 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.565 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -77.86 3.62 13.95 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.895 0.348 . . . . 0.0 110.08 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 1.103 ' HB2' HD22 ' A' ' 79' ' ' LEU . . . -46.75 -43.96 42.25 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.966 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 2.8 Cg_exo -74.02 -30.74 8.68 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.933 2.422 . . . . 0.0 110.399 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.123 HG13 ' CE2' ' A' ' 123' ' ' PHE . 10.7 t -64.64 -46.82 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.601 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.565 HG13 ' HG ' ' A' ' 130' ' ' LEU . 19.3 m -66.86 -30.75 50.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.21 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -66.72 -50.82 61.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.859 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.782 ' HG3' HD21 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -63.88 -39.07 93.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.029 178.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 133' ' ' VAL . 27.7 t -62.61 -44.8 99.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.333 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -60.9 -31.04 70.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.229 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 136' ' ' MET . 75.2 mt-30 -63.47 -41.74 98.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.485 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.809 ' HG3' ' HB3' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -57.68 -51.98 67.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.687 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.57 ' OE1' HD21 ' A' ' 170' ' ' LEU . 1.7 mp0 -69.23 -33.46 73.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.701 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -80.89 -12.25 59.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.983 0.42 . . . . 0.0 111.012 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.671 ' C ' HG22 ' A' ' 144' ' ' THR . 3.8 m95 -89.21 -85.05 0.21 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.303 0.573 . . . . 0.0 111.554 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.671 HG22 ' C ' ' A' ' 143' ' ' TRP . 0.6 OUTLIER -174.69 26.52 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.652 -178.465 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.809 ' HB3' ' HG3' ' A' ' 140' ' ' MET . . . -111.81 54.39 0.42 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.388 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.526 ' O ' ' CB ' ' A' ' 175' ' ' ARG . 57.7 Cg_endo -70.75 -1.56 9.48 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.663 2.242 . . . . 0.0 112.132 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 146' ' ' PRO . 0.7 OUTLIER -50.43 -169.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 1.2 mt-10 -71.87 105.2 3.72 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.586 0.707 . . . . 0.0 110.294 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.657 HG23 HH12 ' A' ' 121' ' ' ARG . 98.8 m -117.43 117.38 29.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.595 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.657 ' CD ' ' CZ ' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -102.73 135.72 43.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.091 0.472 . . . . 0.0 110.493 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.658 HD13 ' O ' ' A' ' 123' ' ' PHE . 0.3 OUTLIER -133.19 109.72 14.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.033 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.745 ' CD1' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -107.1 109.27 21.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.646 ' HZ ' HD11 ' A' ' 161' ' ' LEU . 2.1 t80 -111.91 145.39 39.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.586 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.717 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -162.0 167.01 36.52 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.63 -1.748 . . . . 0.0 114.717 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 1.078 HG21 HD13 ' A' ' 161' ' ' LEU . 17.0 m -164.95 -119.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.471 -0.865 . . . . 0.0 110.998 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.864 ' O ' HG21 ' A' ' 183' ' ' VAL . 1.4 p30 -112.55 -171.38 1.85 Allowed 'General case' 0 C--N 1.343 0.284 0 O-C-N 122.243 -0.285 . . . . 0.0 111.118 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.573 ' CG2' ' HA ' ' A' ' 187' ' ' SER . 0.2 OUTLIER -32.01 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.768 0.318 . . . . 0.0 111.071 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 19.5 mt-10 89.05 39.1 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.305 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 24.8 Cg_endo -62.22 -25.97 77.25 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 C-N-CA 122.296 1.997 . . . . 0.0 110.698 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.535 ' HG2' ' CB ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -121.73 -28.15 4.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.045 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.078 HD13 HG21 ' A' ' 155' ' ' VAL . 5.3 tp -40.41 165.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.783 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 0.0 OUTLIER 177.38 -153.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.926 0.393 . . . . 0.0 111.079 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.524 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 72.33 7.68 5.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.361 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.976 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -59.72 -41.81 86.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.976 ' N ' HD13 ' A' ' 164' ' ' ILE . 18.5 m-20 -61.88 -27.84 69.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.179 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.509 ' HG3' ' CD1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -72.33 -41.85 66.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.994 179.576 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -71.5 -31.53 67.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.075 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.505 ' HD3' ' HA ' ' A' ' 165' ' ' ASP . 14.1 mtpp -61.3 -46.36 90.65 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 6.0 m -63.0 -31.87 73.11 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.57 HD21 ' OE1' ' A' ' 141' ' ' GLN . 1.0 OUTLIER -62.9 -36.67 84.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.346 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 1.01 ' HG2' HD11 ' A' ' 177' ' ' LEU . 3.6 mt-10 -63.04 -41.0 99.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.203 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -33.98 47.73 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.09 -6.59 53.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.022 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.694 ' CB ' HD23 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -106.29 -168.64 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.032 0.444 . . . . 0.0 111.242 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' A' ' 146' ' ' PRO . 6.9 ttt-85 -103.26 -64.43 1.08 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.901 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.91 66.37 1.4 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.431 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.01 HD11 ' HG2' ' A' ' 171' ' ' GLU . 0.6 OUTLIER -106.65 153.68 22.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.6 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.506 ' HB ' ' HG3' ' A' ' 150' ' ' ARG . 40.9 m -136.08 115.12 12.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.278 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 151' ' ' ILE . 8.8 p -89.66 135.1 26.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.658 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.38 133.92 47.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.101 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.551 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -98.66 104.26 16.28 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.463 0.649 . . . . 0.0 110.541 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.631 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 95.6 m -80.71 -167.44 1.38 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.186 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.864 HG21 ' O ' ' A' ' 156' ' ' ASN . 77.2 t 64.33 148.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.689 0.757 . . . . 0.0 111.822 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.717 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.45 -61.12 0.82 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.288 -178.267 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.539 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 0.7 OUTLIER -174.95 53.38 0.12 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.728 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.581 ' HG2' ' HA ' ' A' ' 156' ' ' ASN . 91.3 Cg_endo -86.88 -98.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.922 2.414 . . . . 0.0 112.632 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.573 ' HA ' ' CG2' ' A' ' 157' ' ' THR . 0.4 OUTLIER 156.35 -0.63 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.613 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 124.04 11.18 4.89 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.356 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.8 63.26 1.55 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.507 ' CE3' ' N ' ' A' ' 191' ' ' GLU . 1.8 t-105 -127.46 108.81 11.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.455 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.703 ' C ' ' HB3' ' A' ' 251' ' ' ALA . 0.2 OUTLIER -98.55 104.86 16.94 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.56 178.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.673 ' CA ' ' HB3' ' A' ' 251' ' ' ALA . . . 164.84 -76.28 0.15 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.734 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.835 ' OE2' ' HB1' ' A' ' 250' ' ' ALA . 1.1 mt-10 148.03 -100.14 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.551 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 0.0 OUTLIER -87.09 131.91 33.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.656 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -31.02 105.28 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 C-N-CA 119.888 -1.148 . . . . 0.0 111.962 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.525 ' CB ' ' CD ' ' A' ' 197' ' ' PRO . 0.3 OUTLIER 162.57 -178.44 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.305 -0.447 . . . . 0.0 111.301 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.525 ' CD ' ' CB ' ' A' ' 196' ' ' SER . 69.7 Cg_endo -91.3 -1.15 4.73 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.168 2.579 . . . . 0.0 114.05 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.137 HD12 HD21 ' A' ' 201' ' ' LEU . 0.2 OUTLIER 75.64 33.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.669 1.223 . . . . 0.0 109.522 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.498 ' OD1' ' NE ' ' A' ' 202' ' ' ARG . 0.2 OUTLIER -78.29 -33.54 49.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.579 -1.192 . . . . 0.0 112.492 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -56.61 -44.78 81.49 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 1.137 HD21 HD12 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -65.79 -31.2 72.03 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.399 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.773 ' CD ' HD22 ' A' ' 229' ' ' LEU . 18.6 mtm180 -57.71 -48.71 78.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.429 0.633 . . . . 0.0 110.265 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.19 -32.66 67.01 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.313 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -59.4 -40.92 88.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.598 ' CB ' HD11 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -60.69 -47.75 84.85 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -20.67 66.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.946 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.97 12.35 27.1 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.677 0.275 . . . . 0.0 111.425 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 0.7 OUTLIER 72.24 100.11 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.87 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.661 ' O ' ' HB3' ' A' ' 210' ' ' ALA . 0.9 OUTLIER 155.47 86.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 0.775 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 96.32 102.17 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.281 0.562 . . . . 0.0 110.381 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.674 ' O ' HG23 ' A' ' 240' ' ' VAL . 23.2 t30 174.45 -55.53 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.888 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 10.0 Cg_endo -51.01 -48.0 23.04 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.199 1.933 . . . . 0.0 110.58 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.68 108.41 8.52 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.893 ' HB ' HG22 ' A' ' 240' ' ' VAL . 1.0 OUTLIER -121.26 125.43 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.67 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -121.03 127.16 51.47 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.804 -178.409 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.557 HD22 HG11 ' A' ' 124' ' ' VAL . 3.0 mt -138.44 115.88 11.23 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.622 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' CYS . . . . . 0.531 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 1.0 OUTLIER -125.84 119.66 28.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.582 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.594 ' HA2' ' CG ' ' A' ' 245' ' ' PHE . . . 115.29 -48.8 0.9 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.779 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.861 ' CB ' ' HB3' ' A' ' 250' ' ' ALA . 97.8 Cg_endo -80.51 110.01 2.37 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.424 2.083 . . . . 0.0 113.549 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.488 ' O ' ' HB ' ' A' ' 223' ' ' ILE . 16.0 Cg_exo -66.72 -45.35 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.718 2.279 . . . . 0.0 110.825 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.49 -38.35 90.65 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.589 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.828 ' O ' ' HB3' ' A' ' 226' ' ' ALA . 3.6 tpt -56.08 -25.27 44.7 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.577 HG13 ' CB ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -69.09 -45.49 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.12 178.295 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 223' ' ' ILE . 69.8 m-20 -75.04 -47.78 27.25 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.531 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.557 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -77.34 -50.24 13.24 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.842 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -59.84 -40.1 87.38 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.436 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 223' ' ' ILE . 42.5 t -69.95 -30.86 68.33 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 232' ' ' SER . 3.5 mm-40 -69.61 -44.62 70.31 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.578 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.773 HD22 ' CD ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -60.06 -37.92 81.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.002 0.429 . . . . 0.0 110.658 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 226' ' ' ALA . 2.3 t -64.19 -45.34 96.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.181 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -30.19 61.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.059 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.506 ' OG ' ' NH1' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -75.48 -46.22 33.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.181 0.515 . . . . 0.0 111.258 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.563 ' CG ' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -58.91 -51.1 71.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.026 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 125.34 -52.48 0.8 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.098 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.643 ' HB ' ' ND2' ' A' ' 211' ' ' ASN . 0.9 OUTLIER -36.04 95.73 0.1 OUTLIER Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 121.08 0.467 . . . . 0.0 111.128 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 31.8 Cg_endo -64.16 119.61 6.7 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.897 2.398 . . . . 0.0 112.47 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -90.75 176.71 41.38 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.45 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.7 -40.25 0.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 0.0 111.081 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.581 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 67.6 mm-40 -105.64 36.03 2.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.017 0.437 . . . . 0.0 110.67 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.893 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.1 t -89.19 136.5 23.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.322 0.582 . . . . 0.0 111.062 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.651 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.6 OUTLIER -144.92 138.02 26.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.94 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.577 ' CB ' HG13 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -129.52 130.39 45.73 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.081 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLU . . . . . 0.489 ' CA ' HD11 ' A' ' 223' ' ' ILE . 0.3 OUTLIER -132.65 149.39 52.3 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.543 179.601 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 244' ' ' LYS . 1.7 ptmm? -129.08 115.0 17.07 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.594 ' CG ' ' HA2' ' A' ' 218' ' ' GLY . 0.5 OUTLIER -137.42 146.86 44.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.171 179.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.861 HD21 ' HA3' ' A' ' 127' ' ' GLY . 0.2 OUTLIER 57.61 174.3 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.477 0 C-N-CA 122.922 0.489 . . . . 0.0 111.731 -178.7 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 246' ' ' LEU . 75.9 Cg_exo -52.78 -141.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.371 2.714 . . . . 0.0 113.643 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 190' ' ' TRP . 2.4 p -81.4 177.25 9.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.485 0.66 . . . . 0.0 112.085 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 163.2 -71.0 0.21 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.578 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.861 ' HB3' ' CB ' ' A' ' 219' ' ' PRO . . . -107.74 149.64 27.92 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.703 ' HB3' ' C ' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.46 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' FDA . . . . . 1.031 HM72 ' CD2' ' A' ' 50' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.782 0.325 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.711 ' O ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -141.87 144.58 33.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.797 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.711 HD13 ' O ' ' A' ' 3' ' ' ARG . 20.4 mm -149.82 46.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.198 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.13 173.75 8.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.782 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.45 147.64 30.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.976 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.96 -167.35 11.04 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.467 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.8 mp0 -66.14 128.61 36.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 110.947 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 t -121.99 101.14 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.102 0.477 . . . . 0.0 110.982 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.11 25.23 29.06 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.443 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.521 ' CB ' ' HB2' ' A' ' 105' ' ' LYS . 83.9 p -95.71 153.87 17.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.821 0.343 . . . . 0.0 110.892 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.939 ' CE2' ' HB2' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -132.05 156.88 45.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.916 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.61 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 1.6 mt-10 -106.04 121.79 44.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.939 ' HB2' ' CE2' ' A' ' 12' ' ' PHE . . . -126.73 127.69 45.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.183 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.487 ' OE1' HG22 ' A' ' 101' ' ' VAL . 4.2 tp10 -93.41 128.08 39.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.899 0.38 . . . . 0.0 110.697 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.061 HG22 ' O ' ' A' ' 100' ' ' GLN . 28.0 m -71.88 106.14 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.091 0.472 . . . . 0.0 111.096 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 17' ' ' VAL . 2.4 p -127.2 2.31 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.314 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -120.14 -128.86 3.71 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.526 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.885 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER 82.49 58.77 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.329 0.585 . . . . 0.0 110.063 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -95.63 145.42 25.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.669 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -88.69 113.86 24.69 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.3 -27.59 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.554 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 13.2 m -141.44 173.62 11.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.133 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.404 ' CB ' ' HG2' ' A' ' 160' ' ' GLU . 14.9 t -52.19 -57.06 10.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.692 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.519 ' CA ' ' O ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -118.07 44.45 2.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.553 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.907 HG23 ' HG2' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -148.34 138.66 22.66 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.311 0.577 . . . . 0.0 110.886 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.885 HG21 ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -141.34 148.35 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.138 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -114.55 103.54 11.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.367 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.729 ' C ' HD13 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -99.26 127.51 45.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.886 -178.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.734 HD13 ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -113.28 116.65 30.07 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.37 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.027 HD22 HD11 ' A' ' 102' ' ' LEU . 4.6 mt -112.37 131.57 55.47 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.025 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.535 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -144.77 109.86 5.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.72 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.607 ' HB2' ' CA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -114.92 -49.17 2.81 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.011 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.613 ' HB3' ' HD2' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -63.68 -164.68 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.071 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 34' ' ' ARG . 88.1 Cg_exo -44.54 -74.46 0.04 OUTLIER 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 121.645 1.563 . . . . 0.0 113.546 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.639 ' O ' ' N ' ' A' ' 38' ' ' CYS . 2.4 m-20 153.81 -169.83 0.0 OUTLIER 'General case' 0 C--N 1.345 0.372 0 CA-C-N 118.089 0.404 . . . . 0.0 110.784 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.592 ' CA ' ' HB3' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -58.0 59.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.592 0.558 . . . . 0.0 111.391 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER 166.56 -16.04 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.596 ' HA3' ' HB2' ' A' ' 35' ' ' PRO . . . -103.87 -84.33 1.77 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 119.578 -1.296 . . . . 0.0 114.991 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.715 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 8.0 t-20 -157.47 88.26 0.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.789 HH12 HD12 ' A' ' 76' ' ' LEU . 1.1 ptt85 -177.26 -29.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.612 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.601 ' C ' ' HA ' ' A' ' 72' ' ' PRO . . . -57.64 -166.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.689 -0.767 . . . . 0.0 114.293 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.105 HG13 HD23 ' A' ' 76' ' ' LEU . 20.4 m -134.4 167.4 26.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 C-N-CA 123.793 0.837 . . . . 0.0 111.029 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.695 ' HA ' ' N ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -112.76 84.02 1.91 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.131 0.973 . . . . 0.0 111.14 178.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.598 ' O ' ' CG ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER 7.06 61.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.171 0.919 . . . . 0.0 112.572 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -84.92 160.94 54.43 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.816 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.976 ' O ' HG23 ' A' ' 110' ' ' VAL . 37.1 Cg_exo -57.99 68.53 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.589 2.193 . . . . 0.0 111.837 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.736 ' O ' HG21 ' A' ' 110' ' ' VAL . . . 59.39 37.74 92.43 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.003 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 65' ' ' SER . 4.8 tt0 -52.95 158.12 1.51 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.064 0.432 . . . . 0.0 110.077 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.84 ' CE2' HD21 ' A' ' 108' ' ' LEU . 28.7 p90 -151.96 163.47 39.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 63' ' ' SER . 2.0 mmt -121.14 175.36 6.14 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.705 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.54 108.09 15.07 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.907 ' O ' HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -150.49 156.69 41.92 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.973 HG23 ' C ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -96.6 154.15 17.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.602 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.028 ' O ' HD23 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -29.45 -68.14 0.12 Allowed Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 123.443 0.464 . . . . 0.0 110.601 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.96 ' HD3' HG23 ' A' ' 55' ' ' ILE . 4.4 Cg_endo -110.05 6.26 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.719 2.946 . . . . 0.0 111.733 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 104.51 -5.88 44.76 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.019 -178.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.812 HG23 ' CG ' ' A' ' 56' ' ' PRO . 67.6 p -24.34 -88.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.127 0.571 . . . . 0.0 111.814 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.667 ' O ' HG12 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -154.12 42.84 0.53 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.973 ' C ' HG23 ' A' ' 54' ' ' THR . 0.3 OUTLIER 88.19 125.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.783 ' N ' HG23 ' A' ' 54' ' ' THR . 28.8 t -117.41 -72.42 0.69 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.502 0.668 . . . . 0.0 110.268 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HB3' " H4'" ' A' ' 252' ' ' FDA . 0.0 OUTLIER -167.63 171.14 10.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.597 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.648 ' CB ' ' CE1' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -101.54 118.96 38.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.903 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.542 ' C ' ' HB2' ' A' ' 50' ' ' PHE . 1.6 t80 -118.57 127.34 53.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.994 0.426 . . . . 0.0 111.94 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.586 ' HA ' ' CB ' ' A' ' 50' ' ' PHE . 92.4 p -72.18 109.54 6.04 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.741 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.545 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 88.6 Cg_endo -85.67 169.65 9.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.956 2.438 . . . . 0.0 112.694 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.4 130.53 19.55 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.964 0.412 . . . . 0.0 111.655 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 1.0 ' HB3' HG22 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -129.68 -56.09 1.14 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.555 0.693 . . . . 0.0 109.844 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.575 ' HB3' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER 164.61 -164.93 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 96.6 Cg_endo -91.31 63.16 1.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.102 1.201 . . . . 0.0 112.372 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.695 ' N ' ' HA ' ' A' ' 44' ' ' LYS . 1.6 p30 -174.46 109.74 0.29 Allowed Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.601 ' HA ' ' C ' ' A' ' 42' ' ' GLY . 4.1 Cg_exo -74.17 40.85 0.62 Allowed 'Trans proline' 0 CA--C 1.515 -0.429 0 C-N-CA 122.336 2.024 . . . . 0.0 112.409 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.715 ' HA ' ' HA ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -138.14 6.79 2.62 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.579 178.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.612 ' O ' ' CG ' ' A' ' 41' ' ' ARG . . . -90.29 -116.05 1.74 Allowed Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.912 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.592 ' HB3' ' CA ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -152.34 119.49 5.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.875 -0.662 . . . . 0.0 110.012 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.105 HD23 HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -96.8 148.33 23.03 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 122.22 1.009 . . . . 0.0 113.169 -178.5 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.73 ' CB ' HD12 ' A' ' 30' ' ' LEU . 1.8 pt-20 -131.07 150.56 52.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.972 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.773 ' HE2' HD11 ' A' ' 31' ' ' LEU . 1.9 p90 -126.37 139.8 52.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.938 0.399 . . . . 0.0 111.549 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.921 HD22 HG21 ' A' ' 128' ' ' THR . 1.3 mt -104.4 91.56 3.95 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.604 ' O ' HG13 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -92.36 118.61 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.197 -178.675 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.907 ' HG2' HG23 ' A' ' 26' ' ' THR . 0.8 OUTLIER -79.34 96.25 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.978 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.971 HG11 HD11 ' A' ' 92' ' ' LEU . 2.9 m -92.69 141.5 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.006 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.53 ' HG ' ' CD ' ' A' ' 84' ' ' PRO . 1.1 mp -60.73 -179.97 0.21 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.747 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.53 ' CD ' ' HG ' ' A' ' 83' ' ' LEU . 37.4 Cg_exo -56.8 -32.35 91.38 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.593 2.195 . . . . 0.0 112.182 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER 157.94 100.7 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.831 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 155.04 -16.91 0.53 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.645 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.481 ' CG ' HD22 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -102.72 -98.19 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.881 -0.188 . . . . 0.0 110.975 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -97.07 -30.17 13.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.717 0.294 . . . . 0.0 111.204 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.706 ' HB2' HG21 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -60.47 -27.31 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.99 0.424 . . . . 0.0 110.921 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -76.24 -32.47 58.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.555 0.693 . . . . 0.0 109.819 179.469 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.814 ' CD1' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -73.43 -45.31 55.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.129 -179.137 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.971 HD11 HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -67.73 -34.72 77.4 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -29.68 15.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 2.4 t-20 -95.2 -5.14 44.56 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.384 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.49 15.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.911 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . . . -153.61 30.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.668 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -47.49 -102.1 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 98' ' ' VAL . 2.5 t -148.01 103.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.115 0.484 . . . . 0.0 110.98 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.58 ' H ' HG23 ' A' ' 16' ' ' VAL . . . 150.7 -12.65 0.87 Allowed Glycine 0 C--N 1.32 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.021 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 1.061 ' O ' HG22 ' A' ' 16' ' ' VAL . 27.1 mp0 -91.29 162.46 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 111.133 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.487 HG22 ' OE1' ' A' ' 15' ' ' GLU . 40.9 t -129.62 142.22 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.581 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.028 HD23 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -118.94 153.4 34.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.089 0.471 . . . . 0.0 111.415 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.6 t -105.95 97.56 7.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.815 HG12 ' CD1' ' A' ' 53' ' ' LEU . 2.0 m -90.88 118.54 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.521 ' HB2' ' CB ' ' A' ' 11' ' ' SER . 3.7 tttt -129.52 123.08 30.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.496 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 161.79 65.66 0.02 OUTLIER Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.732 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.44 57.4 1.33 Allowed 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.422 2.081 . . . . 0.0 110.883 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.84 HD21 ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -100.55 170.03 8.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.864 -178.543 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.654 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -118.83 172.09 14.41 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.987 HG11 ' C7M' ' A' ' 252' ' ' FDA . 0.2 OUTLIER -157.13 115.33 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.564 0.682 . . . . 0.0 111.683 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -69.67 113.81 7.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.539 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -147.02 -40.5 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.849 HD11 ' HB3' ' A' ' 136' ' ' MET . 0.9 OUTLIER -146.14 119.14 8.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.431 178.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.652 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.1 OUTLIER -138.28 117.48 12.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.294 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -92.29 140.62 29.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.435 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -90.05 15.89 9.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.018 0.437 . . . . 0.0 110.98 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.46 -77.39 0.23 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.69 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.56 89.87 2.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.939 0.4 . . . . 0.0 110.37 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -163.59 149.94 9.97 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.16 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.462 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 32.2 Cg_endo -64.24 115.22 3.03 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.569 2.179 . . . . 0.0 111.69 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.581 ' CZ ' ' CG2' ' A' ' 149' ' ' THR . 0.0 OUTLIER -124.77 146.31 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.393 -179.32 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.642 ' CD2' ' HB3' ' A' ' 150' ' ' ARG . 39.5 m-85 -126.09 122.78 36.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 110.63 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 1.11 ' CZ ' HG22 ' A' ' 133' ' ' VAL . 0.9 OUTLIER -111.93 106.05 14.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.418 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.735 HG22 ' HE1' ' A' ' 222' ' ' MET . 6.9 p -99.11 111.0 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 121.233 0.539 . . . . 0.0 111.125 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -109.79 133.68 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.143 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.439 ' C ' ' HA3' ' A' ' 249' ' ' GLY . . . -107.82 103.08 1.86 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.047 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.769 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 118.86 -167.94 13.2 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.372 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.921 HG21 HD22 ' A' ' 79' ' ' LEU . 6.1 m -91.74 -13.42 31.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.024 0.44 . . . . 0.0 110.847 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.577 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -64.72 10.02 0.36 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 116.111 -0.495 . . . . 0.0 113.409 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.734 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -79.97 3.68 19.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 117.177 0.489 . . . . 0.0 110.033 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.584 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -47.55 -43.43 49.41 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.917 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 6.7 Cg_exo -71.35 -30.87 14.93 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.525 2.15 . . . . 0.0 109.655 177.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.11 HG22 ' CZ ' ' A' ' 123' ' ' PHE . 17.9 t -66.07 -44.33 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.208 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.734 HG13 ' HG ' ' A' ' 130' ' ' LEU . 14.4 m -70.44 -29.91 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.532 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.14 -52.69 57.88 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.849 ' HB3' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -62.13 -44.95 95.5 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.389 0.614 . . . . 0.0 109.46 178.312 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.464 HG13 ' NE2' ' A' ' 141' ' ' GLN . 5.3 t -60.17 -30.16 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.846 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.82 -37.99 83.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.254 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.552 ' OE1' ' CE2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -63.61 -42.66 98.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.065 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.611 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.6 OUTLIER -70.05 -33.31 71.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.664 0.745 . . . . 0.0 110.366 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 1.019 ' CG ' HD21 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -76.4 -30.38 57.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.51 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -73.11 -44.67 60.01 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.798 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -78.14 -21.26 50.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.335 0.588 . . . . 0.0 110.115 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER 53.57 27.84 7.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.761 178.472 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.798 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -36.6 160.32 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 0.0 110.693 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.514 ' HD2' ' HB1' ' A' ' 145' ' ' ALA . 60.2 Cg_endo -73.23 4.27 3.96 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.691 2.26 . . . . 0.0 112.728 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 148' ' ' GLU . 10.8 t30 -81.48 135.83 35.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.984 0.421 . . . . 0.0 111.522 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.555 ' CB ' ' HB2' ' A' ' 176' ' ' ASN . 4.6 pt-20 -73.78 112.7 10.14 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.437 0.637 . . . . 0.0 110.957 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.581 ' CG2' ' CZ ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -111.74 116.35 30.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.052 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.642 ' HB3' ' CD2' ' A' ' 122' ' ' TYR . 0.8 OUTLIER -107.12 142.82 36.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.76 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.945 HD12 ' N ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -134.05 136.2 53.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.152 0.501 . . . . 0.0 110.697 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.945 ' N ' HD12 ' A' ' 151' ' ' ILE . 18.2 m-30 -110.5 112.02 23.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.881 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.82 ' HZ ' HD11 ' A' ' 161' ' ' LEU . 8.6 t80 -113.9 130.34 56.51 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 122.199 -0.313 . . . . 0.0 111.364 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.683 ' HA2' ' HB2' ' A' ' 182' ' ' CYS . . . -154.12 161.19 29.89 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 119.535 -1.316 . . . . 0.0 113.865 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.939 HG21 HD13 ' A' ' 161' ' ' LEU . 21.0 m -164.05 -122.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.379 -0.411 . . . . 0.0 111.265 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.827 ' O ' HG21 ' A' ' 183' ' ' VAL . 44.7 p-10 -103.45 -174.34 2.52 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 120.557 0.218 . . . . 0.0 110.783 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.621 HG23 ' HD3' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -42.95 -25.31 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.323 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.668 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 40.1 mt-10 94.16 22.41 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.711 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 77.9 Cg_exo -46.78 -23.82 2.65 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.28 1.32 . . . . 0.0 111.252 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -131.59 -28.85 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.674 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.939 HD13 HG21 ' A' ' 155' ' ' VAL . 13.3 tp -35.76 158.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.71 -157.99 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.564 ' CE1' ' HG2' ' A' ' 166' ' ' GLU . 0.1 OUTLIER 74.15 27.61 1.52 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.1 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 1.024 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -70.23 -39.07 76.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.071 0.462 . . . . 0.0 110.306 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 1.024 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.2 OUTLIER -73.7 -27.2 61.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.825 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.564 ' HG2' ' CE1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -64.17 -49.16 73.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 -179.303 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -75.19 -30.84 60.77 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 164' ' ' ILE . 1.8 mttm -61.64 -41.26 97.25 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.16 -32.4 73.01 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 1.019 HD21 ' CG ' ' A' ' 141' ' ' GLN . 0.3 OUTLIER -61.72 -48.58 80.08 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.099 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.468 ' O ' ' SD ' ' A' ' 174' ' ' MET . 36.2 mt-10 -56.58 -32.65 65.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.89 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -39.94 30.85 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 m -112.13 28.8 8.44 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.633 ' HB2' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -113.65 167.05 10.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.164 0.507 . . . . 0.0 111.615 179.365 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -84.85 -80.05 0.21 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.373 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.565 ' C ' HD12 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -130.61 63.48 1.57 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.245 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.633 HD13 ' HB2' ' A' ' 174' ' ' MET . 4.5 mp -112.27 149.65 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.077 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.465 ' HB ' ' HG2' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -137.08 126.9 25.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.283 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 151' ' ' ILE . 72.6 t -100.99 135.8 35.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.314 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.625 ' CG ' ' CD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -99.79 136.69 39.34 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.196 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -98.22 105.89 18.1 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.68 0.752 . . . . 0.0 111.389 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.683 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 64.4 m -86.06 -164.75 1.08 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.358 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.827 HG21 ' O ' ' A' ' 156' ' ' ASN . 37.3 t 54.17 147.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 122.151 0.977 . . . . 0.0 112.646 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.729 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -137.18 -62.94 0.61 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.523 -1.672 . . . . 0.0 108.484 -178.351 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.538 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 50.8 m-70 -167.64 49.45 0.18 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.698 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.574 ' O ' ' CB ' ' A' ' 187' ' ' SER . 40.7 Cg_endo -85.95 -104.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.384 2.723 . . . . 0.0 112.895 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 9.6 t 150.81 21.78 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.618 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 97.84 10.4 52.62 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.636 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 251' ' ' ALA . 0.4 OUTLIER -138.07 63.88 1.52 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 178.4 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 190' ' ' TRP . . . . . 0.523 ' O ' ' O ' ' A' ' 249' ' ' GLY . 5.6 t-105 -122.81 123.63 41.46 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.778 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.52 ' HG3' ' HA ' ' A' ' 251' ' ' ALA . 0.3 OUTLIER -83.84 105.57 14.84 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.856 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.501 ' C ' ' CG ' ' A' ' 193' ' ' GLU . . . 127.33 -108.8 1.0 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.256 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.576 ' C ' ' HB3' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -168.9 -74.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.583 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -99.35 153.31 19.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 179.466 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.639 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -28.22 108.95 0.02 OUTLIER Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.465 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 8.2 m 95.4 155.61 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.268 -0.466 . . . . 0.0 110.418 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.471 ' O ' ' C ' ' A' ' 198' ' ' ILE . 32.5 Cg_exo -59.79 58.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.998 2.466 . . . . 0.0 112.634 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.987 HG13 HD23 ' A' ' 201' ' ' LEU . 0.1 OUTLIER 30.16 92.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 122.031 0.92 . . . . 0.0 110.066 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.89 -33.69 59.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.534 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -57.73 -31.56 66.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.987 HD23 HG13 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -69.52 -41.76 75.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.806 0.336 . . . . 0.0 110.672 -178.569 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.506 ' O ' ' HG ' ' A' ' 205' ' ' LEU . 13.6 mtm180 -57.19 -49.23 76.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.367 0.603 . . . . 0.0 110.257 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -71.78 -32.66 67.89 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.575 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.974 ' HB3' ' HB3' ' A' ' 210' ' ' ALA . 1.5 m-20 -59.44 -41.68 90.19 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.669 HD12 ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -60.73 -47.13 87.69 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.468 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.401 ' CG ' ' HG2' ' A' ' 233' ' ' ARG . 1.8 mm-40 -65.15 -19.06 65.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.674 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 208' ' ' SER . 16.2 t -90.8 -79.53 0.36 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.457 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 207' ' ' SER . 3.0 t 155.59 -11.68 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.87 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 6.8 m-20 -88.97 40.07 0.96 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.212 0.529 . . . . 0.0 110.412 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 0.974 ' HB3' ' HB3' ' A' ' 204' ' ' ASP . . . 161.96 99.75 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.78 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.693 ' HA ' HD11 ' A' ' 235' ' ' ILE . 6.0 t30 173.25 -55.42 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.215 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 1.5 Cg_endo -45.81 -55.24 3.75 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.272 1.981 . . . . 0.0 110.889 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.03 108.85 9.13 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 1.007 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.9 OUTLIER -117.5 124.71 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.649 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -113.18 127.3 56.14 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.551 -178.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.565 ' CD1' ' CG1' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -131.94 123.61 27.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.71 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 217' ' ' CYS . . . . . 0.558 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -122.71 107.27 11.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.8 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 244' ' ' LYS . . . 176.22 166.14 33.06 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.571 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.768 ' HG2' ' HB3' ' A' ' 250' ' ' ALA . 24.3 Cg_exo -55.45 -170.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.721 2.281 . . . . 0.0 112.594 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 219' ' ' PRO . 23.6 Cg_exo -64.72 -19.69 64.68 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 123.192 2.595 . . . . 0.0 113.002 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -83.09 -54.61 3.14 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.839 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' MET . . . . . 0.735 ' HE1' HG22 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -57.13 -34.39 68.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.124 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 242' ' ' PHE . 0.1 OUTLIER -76.66 -34.14 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.452 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.473 ' HA ' ' SG ' ' A' ' 227' ' ' CYS . 12.3 m-20 -72.96 -47.0 49.25 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.851 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.538 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -61.43 -48.12 82.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.724 0.297 . . . . 0.0 111.74 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.793 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -69.57 -34.87 74.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.566 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 223' ' ' ILE . 8.2 p -70.05 -31.93 69.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 110.263 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.99 -44.82 95.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.551 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.653 HD11 HD11 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -62.11 -39.62 93.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.093 0.473 . . . . 0.0 110.847 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.881 HG13 ' CG2' ' A' ' 235' ' ' ILE . 3.8 t -65.88 -45.68 90.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.456 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 23.5 mtt-85 -72.76 -30.25 63.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.782 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 33.3 m -69.08 -43.63 74.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.348 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.669 ' HD3' HD12 ' A' ' 205' ' ' LEU . 1.0 OUTLIER -80.99 -74.35 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.967 0.413 . . . . 0.0 111.354 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 148.76 -18.64 1.26 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.865 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.881 ' CG2' HG13 ' A' ' 230' ' ' VAL . 0.0 OUTLIER -22.86 82.41 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.533 ' N ' ' O ' ' A' ' 234' ' ' GLY . 6.0 Cg_exo -75.82 113.05 3.64 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.156 2.571 . . . . 0.0 111.811 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -119.84 -174.54 15.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.827 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.2 -35.92 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.621 0.248 . . . . 0.0 111.277 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.59 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 5.7 mm-40 -101.81 32.52 3.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.493 . . . . 0.0 110.834 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 1.007 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.2 t -94.6 134.67 31.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.248 0.547 . . . . 0.0 110.451 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.652 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.24 149.36 33.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.947 -177.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.568 ' HB2' HD11 ' A' ' 223' ' ' ILE . 5.7 p90 -131.55 148.68 52.64 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.247 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLU . . . . . 0.467 ' N ' HD11 ' A' ' 223' ' ' ILE . 2.2 tt0 -132.8 148.81 52.32 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -106.61 111.43 23.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.328 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.577 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -136.97 147.64 46.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 1.046 HD21 H51A ' A' ' 252' ' ' FDA . 0.4 OUTLIER -20.34 146.09 0.01 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.61 ' HA ' ' HG2' ' A' ' 219' ' ' PRO . 71.9 Cg_exo -50.28 -155.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.69 2.927 . . . . 0.0 113.122 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 247' ' ' PRO . 5.6 m 92.72 -19.29 0.1 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.816 0.817 . . . . 0.0 110.428 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 190' ' ' TRP . . . -128.45 -24.14 1.16 Allowed Glycine 0 C--N 1.309 -0.921 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.569 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.768 ' HB3' ' HG2' ' A' ' 219' ' ' PRO . . . -108.38 150.27 27.59 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 122.747 0.419 . . . . 0.0 110.52 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.52 ' HA ' ' HG3' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.229 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' FDA . . . . . 1.046 H51A HD21 ' A' ' 246' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.509 ' HB2' ' HG3' ' A' ' 105' ' ' LYS . 83.8 p -110.36 150.88 28.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.863 0.364 . . . . 0.0 111.038 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.726 ' CE1' ' HB2' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -131.46 162.67 29.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.547 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.587 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 8.3 mt-10 -110.8 129.97 55.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.814 0.34 . . . . 0.0 111.03 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.854 ' HB1' ' CB ' ' A' ' 31' ' ' LEU . . . -127.77 135.15 49.73 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.976 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.55 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 14.9 tp10 -93.64 122.62 36.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.394 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.74 ' HA ' HD23 ' A' ' 31' ' ' LEU . 32.6 m -71.25 104.34 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.643 ' HA ' HG23 ' A' ' 98' ' ' VAL . 2.6 p -122.51 -34.47 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.433 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -87.5 -130.61 3.2 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.306 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.831 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER 87.87 71.63 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.436 0.636 . . . . 0.0 110.291 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.59 ' ND2' HG12 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -108.91 146.54 33.61 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.818 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -88.54 114.3 25.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.59 HG12 ' ND2' ' A' ' 20' ' ' ASN . 1.7 m -95.04 -27.53 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.54 0.686 . . . . 0.0 109.692 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.547 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 11.7 m -138.51 172.13 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.297 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 t -51.64 -56.85 11.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.977 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.506 ' CA ' ' O ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -118.48 43.03 2.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.708 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.561 HG21 ' CB ' ' A' ' 128' ' ' THR . 0.2 OUTLIER -147.2 140.39 25.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.317 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.831 HG21 ' CD2' ' A' ' 19' ' ' LEU . 1.4 p -141.02 146.44 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.097 0.475 . . . . 0.0 112.236 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 6.4 tt0 -110.0 103.02 11.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.568 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.634 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -94.02 125.3 38.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.494 -178.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.562 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -112.61 116.29 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.074 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.854 ' CB ' ' HB1' ' A' ' 14' ' ' ALA . 2.2 mt -121.73 132.81 54.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 111.539 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 38.4 mt-30 -145.81 109.29 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.393 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.552 ' HB3' ' CA ' ' A' ' 14' ' ' ALA . 12.2 tptt -149.22 -0.32 0.5 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.473 ' HG3' ' HB2' ' A' ' 13' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.139 0.495 . . . . 0.0 112.077 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.361 0.6 . . . . 0.0 111.797 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 1.5 ttpm? -163.07 26.65 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.967 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.631 ' CG ' ' CG ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER 76.55 96.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.584 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -108.75 165.79 12.03 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.437 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.59 59.12 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.713 2.275 . . . . 0.0 111.858 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.665 ' O ' HG12 ' A' ' 110' ' ' VAL . . . 58.48 61.68 7.12 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.66 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.488 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 1.2 mm-40 -35.44 146.21 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.664 0.232 . . . . 0.0 110.493 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 1.05 ' CD2' HD21 ' A' ' 108' ' ' LEU . 2.6 t80 -152.69 139.34 18.8 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.667 0.27 . . . . 0.0 111.696 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.579 ' O ' ' CE1' ' A' ' 50' ' ' PHE . 3.8 mtt -139.94 -162.68 1.38 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.852 0.358 . . . . 0.0 111.922 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 3.4 t0 -134.96 123.3 23.14 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.008 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.56 157.71 43.32 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.858 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -108.72 149.6 28.77 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.094 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.881 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -34.49 -70.95 0.11 Allowed Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.249 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 1.063 ' HD2' HG23 ' A' ' 58' ' ' THR . 51.3 Cg_endo -103.98 14.45 0.24 Allowed 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 123.39 2.727 . . . . 0.0 111.941 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 98.52 0.34 58.01 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.663 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 1.063 HG23 ' HD2' ' A' ' 56' ' ' PRO . 13.0 p -40.69 -103.18 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.852 0.461 . . . . 0.0 111.596 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.858 ' N ' HG21 ' A' ' 54' ' ' THR . 1.3 m-20 160.23 36.16 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.009 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 60' ' ' VAL . 6.1 t -152.32 27.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.958 0.408 . . . . 0.0 110.888 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.65 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 36.8 t -97.46 -101.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.631 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 170.64 -176.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.102 0.477 . . . . 0.0 111.36 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.589 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 2.4 m -99.19 142.56 30.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.689 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.532 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 1.8 t80 -141.36 131.4 24.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 19.7 m -79.28 108.89 9.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.62 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.876 ' CB ' HD13 ' A' ' 76' ' ' LEU . 72.9 Cg_endo -91.61 165.11 3.45 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.921 2.414 . . . . 0.0 112.189 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.17 135.55 25.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.867 0.365 . . . . 0.0 111.647 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.679 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -105.35 -69.76 0.81 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.999 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 68' ' ' ASN . 1.4 mt 138.3 160.27 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.468 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.565 ' HD3' ' CG ' ' A' ' 45' ' ' PHE . 20.2 Cg_endo -60.93 87.75 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 121.973 1.782 . . . . 0.0 111.341 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -168.08 117.65 0.65 Allowed Pre-proline 0 N--CA 1.457 -0.102 0 CA-C-O 120.807 0.337 . . . . 0.0 110.891 -179.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.13 89.95 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.429 2.086 . . . . 0.0 111.861 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -158.09 -82.87 0.05 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.853 0.359 . . . . 0.0 110.094 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.11 96.41 0.28 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.788 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 37.4 mtm180 -151.87 106.33 3.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.463 0.173 . . . . 0.0 110.925 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.876 HD13 ' CB ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -97.79 130.92 44.7 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.852 0.358 . . . . 0.0 110.446 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.778 ' N ' HD12 ' A' ' 76' ' ' LEU . 3.1 mt-10 -129.16 117.88 21.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.319 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.634 ' CE2' ' HB3' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -109.99 146.94 34.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.144 0.497 . . . . 0.0 111.715 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.029 HD22 ' CG2' ' A' ' 128' ' ' THR . 7.5 mt -111.17 84.53 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.032 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.639 HG22 HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -91.79 129.53 42.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.873 -178.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.43 95.91 5.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.164 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.639 HG13 HG22 ' A' ' 80' ' ' ILE . 7.4 m -98.15 141.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.765 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.905 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -121.35 112.92 32.59 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.587 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.817 ' N ' HD22 ' A' ' 83' ' ' LEU . 82.5 Cg_exo -44.17 122.01 3.39 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.649 2.233 . . . . 0.0 112.181 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 84' ' ' PRO . 17.6 tp10 84.47 5.29 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.413 ' N ' HD13 ' A' ' 83' ' ' LEU . . . -74.08 -130.99 0.2 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.459 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -125.25 -26.03 3.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.602 0.239 . . . . 0.0 111.484 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 2.4 t80 -106.12 -31.26 8.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.544 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.55 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 1.0 OUTLIER -70.89 -34.17 71.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.685 0.279 . . . . 0.0 111.698 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 67.2 m-20 -74.91 -40.35 60.92 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.517 0.675 . . . . 0.0 109.752 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.617 ' O ' HD11 ' A' ' 55' ' ' ILE . 2.6 t80 -73.67 -24.48 59.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.508 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.941 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -68.08 -41.08 82.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.801 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -16.64 27.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.596 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 44.2 m-20 -101.22 -7.28 23.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.452 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.435 ' HB2' ' CD1' ' A' ' 91' ' ' TYR . 0.9 OUTLIER -151.56 13.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.941 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -139.79 26.24 2.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.97 0.415 . . . . 0.0 111.156 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.505 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -56.81 -171.98 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.01 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.643 HG23 ' HA ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -88.13 2.03 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.714 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.35 58.06 0.41 Allowed Glycine 0 C--N 1.321 -0.286 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.203 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.714 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -162.09 -178.85 6.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.027 0.442 . . . . 0.0 111.413 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.06 131.54 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.489 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.008 HD11 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.73 123.71 31.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.708 0.29 . . . . 0.0 110.781 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.609 ' N ' HD12 ' A' ' 102' ' ' LEU . 3.6 m -95.5 131.65 41.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.762 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.675 HG13 ' CE1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -99.82 134.61 38.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.509 ' HG3' ' HB2' ' A' ' 11' ' ' SER . 0.0 OUTLIER -130.15 113.78 14.91 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.37 -178.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 169.6 70.05 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.54 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.37 60.74 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.555 2.17 . . . . 0.0 110.308 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.05 HD21 ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -133.77 170.36 15.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.019 -177.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.513 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -117.01 173.54 14.75 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.094 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 48' ' ' GLY . 8.3 p -112.6 112.1 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.324 0.583 . . . . 0.0 110.548 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.5 120.89 39.7 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.569 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.12 -37.93 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.701 ' C ' HD12 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -126.04 120.02 29.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.72 179.352 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.646 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 2.7 tptt -130.38 108.61 10.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.464 ' HB3' ' HE3' ' A' ' 140' ' ' MET . 0.0 OUTLIER -78.68 140.56 38.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.667 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -89.38 13.45 13.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.815 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.58 -76.05 0.28 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.504 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.83 89.81 2.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.855 0.36 . . . . 0.0 110.293 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.515 ' O ' ' NE ' ' A' ' 121' ' ' ARG . . . -168.57 144.27 2.94 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.21 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 25.9 Cg_endo -62.16 105.0 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.697 2.265 . . . . 0.0 111.944 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -117.37 143.84 45.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.249 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.64 ' CD2' ' HB2' ' A' ' 150' ' ' ARG . 14.6 m-85 -119.59 127.18 52.72 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.734 0.302 . . . . 0.0 111.131 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.943 ' CE2' HG13 ' A' ' 133' ' ' VAL . 1.3 t80 -117.48 106.73 13.48 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 1.02 HG12 HD23 ' A' ' 216' ' ' LEU . 4.5 p -98.73 110.96 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.371 0.605 . . . . 0.0 111.809 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -102.96 133.63 47.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.527 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.987 ' O ' HD21 ' A' ' 246' ' ' LEU . . . -105.62 103.17 2.1 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.497 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.836 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 118.22 -154.52 16.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.834 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.029 ' CG2' HD22 ' A' ' 79' ' ' LEU . 18.8 m -107.88 -11.89 15.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.805 0.336 . . . . 0.0 111.111 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.642 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -66.92 9.72 0.91 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.545 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.665 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -78.05 4.15 13.06 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.912 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -47.34 -44.54 52.32 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.098 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 5.9 Cg_exo -73.32 -30.73 9.99 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.836 2.357 . . . . 0.0 110.104 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.012 ' O ' HG23 ' A' ' 137' ' ' VAL . 17.7 t -65.79 -49.49 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.921 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.665 HG13 ' HG ' ' A' ' 130' ' ' LEU . 19.0 m -64.54 -33.28 62.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.541 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.5 -50.65 66.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.235 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -31.82 71.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.885 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.012 HG23 ' O ' ' A' ' 133' ' ' VAL . 74.7 t -59.85 -52.9 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 134' ' ' VAL . 0.8 OUTLIER -60.76 -31.38 70.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.622 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.631 ' CG ' ' CG ' ' A' ' 45' ' ' PHE . 31.7 mt-30 -63.0 -38.55 91.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.264 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.817 ' HE1' HG23 ' A' ' 149' ' ' THR . 2.5 ptm -67.91 -42.76 80.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.268 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.612 HE22 HD22 ' A' ' 170' ' ' LEU . 21.4 mt-30 -68.5 -42.83 78.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.116 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -12.37 60.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.788 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.459 ' HB2' ' O ' ' A' ' 139' ' ' GLN . 0.8 OUTLIER -80.54 -84.34 0.1 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.455 0.645 . . . . 0.0 111.164 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.498 ' C ' ' CD ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -156.6 23.66 0.34 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.678 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 140' ' ' MET . . . -112.66 49.69 0.38 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.356 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.505 ' HA ' ' HG2' ' A' ' 175' ' ' ARG . 52.6 Cg_endo -69.31 -3.6 12.03 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.579 2.186 . . . . 0.0 111.922 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -69.97 -159.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.256 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.546 ' CB ' ' HB2' ' A' ' 176' ' ' ASN . 1.0 OUTLIER -73.03 105.28 4.43 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.62 0.724 . . . . 0.0 111.515 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.817 HG23 ' HE1' ' A' ' 140' ' ' MET . 0.5 OUTLIER -110.04 115.21 29.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.237 178.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.64 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -106.34 138.56 42.29 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.745 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.909 HD12 ' N ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -133.52 134.95 56.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.026 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.909 ' N ' HD12 ' A' ' 151' ' ' ILE . 21.8 m-30 -109.51 123.24 49.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.071 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.446 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 7.2 t80 -119.87 131.01 55.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.775 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.769 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -158.49 158.6 29.43 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 119.492 -1.337 . . . . 0.0 113.775 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.866 HG11 ' CD2' ' A' ' 161' ' ' LEU . 11.8 m -164.15 -116.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.841 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.6 OUTLIER -119.91 -164.27 1.06 Allowed 'General case' 0 C--N 1.343 0.285 0 O-C-N 122.459 -0.151 . . . . 0.0 110.895 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.811 HG23 ' HA ' ' A' ' 187' ' ' SER . 65.3 p -25.95 -41.38 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.456 0.302 . . . . 0.0 111.515 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.604 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.8 OUTLIER 107.82 -43.27 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.617 0 O-C-N 123.967 0.792 . . . . 0.0 112.402 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 157' ' ' THR . 80.3 Cg_exo -46.2 -22.02 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.199 1.933 . . . . 0.0 112.335 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -98.4 -13.96 20.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.764 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.866 ' CD2' HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -110.58 -165.69 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.756 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.49 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 0.1 OUTLIER 178.26 -154.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.903 0.382 . . . . 0.0 111.349 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.522 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 77.13 16.12 1.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.097 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 1.033 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -70.27 -39.17 76.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.246 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 1.033 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.6 OUTLIER -73.68 -27.45 61.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.097 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.458 ' O ' ' OG ' ' A' ' 169' ' ' SER . 3.5 mm-40 -64.79 -49.61 70.02 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -76.21 -31.13 58.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 165' ' ' ASP . 7.7 mttt -62.74 -36.67 83.77 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 166' ' ' GLU . 15.0 p -66.96 -32.95 74.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.808 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -63.01 -41.57 99.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.659 ' OE1' HD22 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -68.91 -36.45 78.04 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.913 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -76.21 -25.05 54.72 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.348 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 169' ' ' SER . 37.4 t -61.48 -71.06 0.16 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.707 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.02 ' O ' HD12 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -179.92 -153.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.133 0.492 . . . . 0.0 112.083 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER 42.59 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.577 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 176' ' ' ASN . 0.0 OUTLIER -13.45 73.69 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 124.433 1.083 . . . . 0.0 111.736 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.02 HD12 ' O ' ' A' ' 174' ' ' MET . 0.3 OUTLIER -94.65 148.53 22.17 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.201 -178.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.522 ' OG1' ' CZ ' ' A' ' 150' ' ' ARG . 6.8 m -137.18 115.33 11.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.03 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.482 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 7.3 p -101.22 127.77 54.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.161 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.578 ' CB ' ' CD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -95.84 135.52 37.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.539 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -101.0 104.97 16.15 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.354 0.597 . . . . 0.0 110.899 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.624 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 34.5 m -88.67 -160.76 0.68 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.108 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.841 HG21 ' O ' ' A' ' 156' ' ' ASN . 40.6 t 56.23 146.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.765 0.793 . . . . 0.0 111.815 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.718 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.3 -63.4 0.76 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.751 -178.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.563 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 1.1 t60 -168.65 51.47 0.2 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.541 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.569 ' HG2' ' CA ' ' A' ' 156' ' ' ASN . 62.6 Cg_endo -88.01 -101.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.054 2.503 . . . . 0.0 112.793 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.811 ' HA ' HG23 ' A' ' 157' ' ' THR . 0.4 OUTLIER 153.23 -8.01 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.605 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 130.34 12.11 2.35 Favored Glycine 0 C--N 1.322 -0.214 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.728 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.54 63.39 1.55 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.518 ' N ' ' OG ' ' A' ' 248' ' ' SER . 7.5 t-105 -125.86 117.53 23.54 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.21 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.404 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 10.0 mm-40 -92.01 104.18 16.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 251' ' ' ALA . . . 142.06 -120.05 1.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.438 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -167.09 -85.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 0.0 OUTLIER -85.82 126.78 34.29 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.636 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -25.99 106.74 0.01 OUTLIER Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.085 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 2.2 m 146.25 166.01 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 114.961 -0.619 . . . . 0.0 110.896 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.465 ' HG2' ' OD2' ' A' ' 199' ' ' ASP . 83.5 Cg_endo -81.93 44.33 1.7 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.899 2.399 . . . . 0.0 112.566 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.025 HG13 ' HB1' ' A' ' 251' ' ' ALA . 0.1 OUTLIER 65.81 17.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.297 0.57 . . . . 0.0 110.754 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.465 ' OD2' ' HG2' ' A' ' 197' ' ' PRO . 1.0 OUTLIER -58.41 -36.77 74.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.442 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.88 -43.68 94.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.685 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.883 ' HB2' HD12 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -65.8 -31.38 72.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.927 0.394 . . . . 0.0 110.527 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.576 ' HG2' HD22 ' A' ' 229' ' ' LEU . 5.7 mtm180 -58.83 -42.13 88.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.5 0.666 . . . . 0.0 110.178 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.84 -32.71 65.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.088 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -58.79 -43.2 90.41 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.758 HD11 ' HB2' ' A' ' 229' ' ' LEU . 0.0 OUTLIER -60.79 -46.06 91.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.0 -24.22 66.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.352 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 208' ' ' SER . 16.4 t -92.11 -87.96 0.21 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.885 0.374 . . . . 0.0 111.18 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 1.9 p 163.28 103.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.645 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 1.2 m-20 156.69 57.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.52 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . 0.934 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 147.4 105.37 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.397 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.6 ' O ' HG23 ' A' ' 240' ' ' VAL . 56.3 t30 177.27 -56.01 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.208 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 9.6 Cg_endo -52.82 -55.69 3.51 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.953 1.769 . . . . 0.0 110.667 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.47 109.45 9.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.979 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.994 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.9 OUTLIER -121.12 125.56 74.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.677 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -117.39 126.21 52.29 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.49 0.662 . . . . 0.0 110.163 -178.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 1.02 HD23 HG12 ' A' ' 124' ' ' VAL . 34.0 mt -122.73 118.78 28.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.042 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . 0.573 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -123.42 132.31 53.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.107 178.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 245' ' ' PHE . . . 136.32 -154.78 22.16 Favored Glycine 0 C--O 1.224 -0.475 0 C-N-CA 120.333 -0.936 . . . . 0.0 112.859 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.581 ' HG3' ' HA ' ' A' ' 248' ' ' SER . 11.8 Cg_endo -53.79 161.21 4.78 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.005 2.47 . . . . 0.0 112.648 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.564 ' O ' HG22 ' A' ' 223' ' ' ILE . 50.5 Cg_endo -69.28 -8.97 25.03 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.611 2.208 . . . . 0.0 111.572 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.48 -49.17 52.94 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.282 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.775 ' O ' ' HB3' ' A' ' 226' ' ' ALA . 0.0 OUTLIER -55.7 -25.71 41.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.574 HD11 ' C ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -76.59 -42.54 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.487 178.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -74.67 -47.57 31.04 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.561 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -76.41 -48.99 17.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.911 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -59.5 -37.79 79.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.76 0.314 . . . . 0.0 110.594 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 37.9 t -69.64 -31.22 69.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.946 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 232' ' ' SER . 4.8 mt-10 -70.95 -45.13 64.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.738 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.758 ' HB2' HD11 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -60.67 -37.38 81.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.178 0.513 . . . . 0.0 110.702 -179.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 1.048 HG13 HG23 ' A' ' 235' ' ' ILE . 12.5 t -65.24 -45.63 93.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.393 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.8 -30.16 61.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.035 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 228' ' ' GLU . 0.6 OUTLIER -75.37 -44.16 46.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.391 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.54 ' HD3' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -79.65 -70.57 0.5 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.008 0.432 . . . . 0.0 111.11 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 154.9 -31.42 0.67 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.8 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 1.048 HG23 HG13 ' A' ' 230' ' ' VAL . 0.0 OUTLIER -26.33 84.59 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 123.064 0.545 . . . . 0.0 112.423 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.539 ' N ' ' O ' ' A' ' 234' ' ' GLY . 5.8 Cg_exo -76.37 114.35 3.87 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 123.427 2.751 . . . . 0.0 112.232 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -106.22 161.08 14.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.931 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -117.51 -45.96 2.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.736 0.303 . . . . 0.0 110.91 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 19.3 mm-40 -105.87 40.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.354 0.597 . . . . 0.0 110.281 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.994 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.3 t -92.04 134.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.928 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.36 145.67 30.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.248 -178.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 1.004 ' CD1' HD12 ' A' ' 216' ' ' LEU . 1.5 m-85 -131.64 144.24 50.89 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.721 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . 0.521 ' O ' ' CE ' ' A' ' 222' ' ' MET . 21.2 tt0 -132.72 148.72 52.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -111.19 106.48 15.51 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.871 ' CE1' HD23 ' A' ' 246' ' ' LEU . 0.0 OUTLIER -137.0 145.28 43.93 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.557 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.987 HD21 ' O ' ' A' ' 126' ' ' GLY . 0.2 OUTLIER 51.59 171.52 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . 0.564 ' CD ' ' HB2' ' A' ' 246' ' ' LEU . 32.2 Cg_exo -60.36 -138.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.914 3.076 . . . . 0.0 113.054 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.581 ' HA ' ' HG3' ' A' ' 219' ' ' PRO . 1.0 OUTLIER -72.75 161.15 31.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.808 0.337 . . . . 0.0 111.847 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.484 ' C ' ' HA3' ' A' ' 126' ' ' GLY . . . 143.41 -20.75 2.24 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.609 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.55 ' O ' ' OXT' ' A' ' 251' ' ' ALA . . . -105.78 153.43 21.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.903 0.383 . . . . 0.0 111.785 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 1.025 ' HB1' HG13 ' A' ' 198' ' ' ILE . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.037 -0.982 . . . . 0.0 112.614 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 105' ' ' LYS . . . . . . . . 0 N--CA 1.449 -0.454 0 CA-C-O 121.062 0.257 . . . . 0.0 112.6 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 105' ' ' LYS . 3.6 p -112.61 150.99 30.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.583 -0.308 . . . . 0.0 110.711 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.898 ' CE1' ' HB2' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -132.41 165.63 23.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.034 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.582 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 3.3 mt-10 -113.53 129.89 56.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.989 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.979 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -125.86 150.68 47.69 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 1.9 pt-20 -102.11 112.19 24.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.825 0.345 . . . . 0.0 110.303 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 100' ' ' GLN . 11.4 t -71.36 105.67 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.012 0.434 . . . . 0.0 110.715 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 17' ' ' VAL . 7.7 p -120.21 19.53 6.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.98 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -132.8 -124.75 2.57 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.558 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.719 HD12 ' C ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 74.71 95.31 0.07 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.861 0.839 . . . . 0.0 109.586 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -142.33 139.35 31.76 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.808 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.564 ' CZ2' ' HG3' ' A' ' 93' ' ' ARG . 22.3 m0 -89.47 113.31 24.65 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.485 HG12 ' ND2' ' A' ' 20' ' ' ASN . 1.5 m -86.6 -33.25 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-O 121.928 0.871 . . . . 0.0 109.265 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 160' ' ' GLU . 0.4 OUTLIER -129.85 -174.19 3.24 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.411 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.462 ' HB3' ' HG3' ' A' ' 160' ' ' GLU . 9.8 t -60.06 -40.66 90.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.433 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 8.9 m-80 -133.66 40.84 3.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.197 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.712 HG23 HG21 ' A' ' 128' ' ' THR . 17.7 m -133.92 123.42 24.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.674 ' CG2' HD13 ' A' ' 19' ' ' LEU . 6.6 p -136.72 132.63 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 111.747 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 3.1 tt0 -119.98 134.58 55.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.577 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.741 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -130.68 142.61 50.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.406 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.73 HD13 ' C ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -113.04 116.93 30.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.591 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.979 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 38.8 mt -101.57 142.93 32.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 1.3 mt-30 -146.79 134.18 20.75 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.635 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . 2.7 tmtp? -178.14 -70.67 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.465 ' HG2' ' HD3' ' A' ' 33' ' ' LYS . 8.2 mtp180 . . . . . 0 C--N 1.322 -0.616 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.951 HG22 ' CA ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.257 0.551 . . . . 0.0 110.311 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' O ' ' CA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -146.69 -142.2 0.12 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.962 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.01 81.24 2.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.165 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.5 mp0 -113.21 165.31 13.52 Favored Pre-proline 0 C--N 1.332 -0.194 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.522 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 14.6 Cg_endo -57.57 72.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.422 2.082 . . . . 0.0 111.484 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 41.96 73.94 0.19 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.324 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -28.28 145.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.512 0.196 . . . . 0.0 110.979 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 1.034 ' CD2' HD21 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -143.7 142.27 30.89 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.722 0.296 . . . . 0.0 111.724 -178.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.581 ' O ' ' CE1' ' A' ' 50' ' ' PHE . 3.7 mtt -141.38 -155.59 0.6 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 105' ' ' LYS . 19.9 t70 -136.5 119.11 15.98 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.041 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.81 157.21 42.66 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.93 HG23 ' C ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -95.7 154.48 17.2 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.875 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.993 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -31.49 -66.08 0.19 Allowed Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 123.309 0.381 . . . . 0.0 110.701 -179.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.993 ' HD3' HG23 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -112.36 8.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.834 3.022 . . . . 0.0 111.704 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 101.08 -6.26 56.42 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.64 -177.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.955 HG23 ' CG ' ' A' ' 56' ' ' PRO . 69.0 p -23.02 -87.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.269 0.628 . . . . 0.0 111.703 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.634 ' O ' HG12 ' A' ' 60' ' ' VAL . 4.8 m-20 -151.64 42.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.105 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.93 ' C ' HG23 ' A' ' 54' ' ' THR . 0.4 OUTLIER 80.96 125.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.874 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.851 ' N ' HG23 ' A' ' 54' ' ' THR . 27.0 t -111.23 -57.73 2.2 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.692 0.758 . . . . 0.0 110.005 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -179.9 -177.92 0.41 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.175 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -88.62 129.65 35.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.144 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.489 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 2.1 t80 -140.65 125.76 18.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.949 0.404 . . . . 0.0 110.778 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 32.0 t -75.33 106.27 2.75 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.674 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.87 ' HB2' HD22 ' A' ' 76' ' ' LEU . 11.1 Cg_endo -91.24 154.33 3.75 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.439 2.759 . . . . 0.0 111.1 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 132' ' ' PRO . . . -144.38 128.91 18.05 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 69' ' ' LEU . 12.0 t-20 -108.94 -67.79 0.96 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.554 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER 142.28 151.11 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 O-C-N 123.825 0.703 . . . . 0.0 109.977 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.567 ' CD ' ' HG ' ' A' ' 69' ' ' LEU . 12.0 Cg_endo -55.56 108.0 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 121.732 1.621 . . . . 0.0 109.962 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.92 ' O ' HG23 ' A' ' 43' ' ' VAL . 6.8 p30 178.0 -168.19 0.04 OUTLIER Pre-proline 0 C--O 1.217 -0.657 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.831 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.621 ' CD ' ' HB2' ' A' ' 71' ' ' ASN . 53.2 Cg_exo -53.19 -21.86 18.12 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.842 1.695 . . . . 0.0 113.295 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.951 ' CA ' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER 79.81 70.02 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 177.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -141.61 28.1 2.32 Favored Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.143 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 59.8 mtm-85 -152.86 93.59 1.77 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.073 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.87 HD22 ' HB2' ' A' ' 66' ' ' PRO . 8.5 mt -91.08 143.18 26.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -127.47 111.21 13.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.0 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.741 ' CD2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -108.7 142.35 39.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.776 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.019 HD12 ' HB2' ' A' ' 131' ' ' ALA . 9.2 mt -126.36 80.6 1.94 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.143 0.497 . . . . 0.0 109.768 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.622 ' HB ' ' CE2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -92.56 122.07 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.171 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.59 ' NH1' HD11 ' A' ' 161' ' ' LEU . 0.4 OUTLIER -79.55 95.77 5.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.438 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.551 HG13 HG12 ' A' ' 27' ' ' VAL . 2.4 m -90.59 141.22 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.983 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -87.25 167.51 21.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.591 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 83' ' ' LEU . 30.4 Cg_endo -63.8 77.7 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.593 2.195 . . . . 0.0 112.251 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.42 61.47 3.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.465 ' CA ' HD13 ' A' ' 83' ' ' LEU . . . -109.88 -39.71 1.53 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.731 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.81 -63.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 111.383 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.531 ' CE1' HG21 ' A' ' 80' ' ' ILE . 6.1 t80 -71.74 -39.76 69.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.004 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -69.04 -24.02 64.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.923 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 2.3 m-20 -76.11 -37.77 57.69 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.812 0.815 . . . . 0.0 109.214 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.621 ' CE1' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -73.19 -28.8 62.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.304 -1.317 . . . . 0.0 110.777 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.695 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -68.41 -43.24 77.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.302 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.564 ' HG3' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -90.58 -23.75 20.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.753 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 20.2 m120 -87.26 -15.25 38.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.576 0.227 . . . . 0.0 111.325 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.509 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 1.5 t70 -127.92 -23.68 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -118.13 36.87 4.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.954 0.407 . . . . 0.0 111.078 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -70.58 -41.21 72.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.545 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 98' ' ' VAL . 2.2 t -121.8 90.45 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.203 0.525 . . . . 0.0 111.834 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.516 ' CA ' ' O ' ' A' ' 16' ' ' VAL . . . 8.77 56.7 0.01 OUTLIER Glycine 0 N--CA 1.459 0.181 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.153 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.62 ' O ' HG23 ' A' ' 16' ' ' VAL . 3.6 mt-30 -68.92 -179.27 1.42 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.715 0.293 . . . . 0.0 110.852 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.0 p -92.94 133.42 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.824 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.041 HD11 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.74 120.81 25.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.798 0.332 . . . . 0.0 110.453 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.552 ' N ' HD12 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -89.66 136.5 33.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.182 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.784 HG13 ' CE1' ' A' ' 12' ' ' PHE . 1.4 m -111.11 127.55 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -129.75 117.53 20.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.497 -178.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.53 ' CA ' ' HB3' ' A' ' 51' ' ' MET . . . 164.64 71.44 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.751 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.41 58.93 1.03 Allowed 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.159 1.906 . . . . 0.0 110.228 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.034 HD21 ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -129.36 169.87 14.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.031 -178.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.548 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -116.17 173.25 14.62 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.49 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 47' ' ' PRO . 2.5 p -121.25 111.75 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.325 0.583 . . . . 0.0 110.587 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -81.14 114.25 19.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.406 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 241' ' ' PHE . . . -179.0 -48.18 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.675 HD22 HG22 ' A' ' 133' ' ' VAL . 1.1 pp -124.4 118.06 25.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.212 0.53 . . . . 0.0 110.867 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.627 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -139.46 114.13 9.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.04 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.446 ' OE1' ' HE3' ' A' ' 140' ' ' MET . 2.0 tp10 -89.59 138.25 31.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.47 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -91.34 13.66 16.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.025 0.44 . . . . 0.0 110.839 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.46 -73.8 0.43 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.461 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.54 ' HA ' ' CB ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -129.83 89.56 2.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.846 0.355 . . . . 0.0 110.409 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 121' ' ' ARG . . . -164.09 155.85 14.31 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.406 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 10.2 Cg_exo -71.36 107.65 2.19 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.077 2.518 . . . . 0.0 111.747 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.505 ' NH1' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -136.82 138.1 40.45 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.226 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.669 ' CE2' ' CD ' ' A' ' 150' ' ' ARG . 1.9 m-85 -107.62 127.29 53.52 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.141 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.588 ' CD2' ' HB2' ' A' ' 113' ' ' LEU . 1.1 m-85 -106.73 104.34 14.0 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 1.039 HG13 ' CB ' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -99.1 111.18 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.344 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -110.14 133.73 52.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.285 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -109.63 102.63 1.62 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.674 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.926 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 122.58 -152.79 16.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.992 -1.099 . . . . 0.0 112.349 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.862 ' CG2' HD22 ' A' ' 79' ' ' LEU . 2.9 m -111.55 -16.32 13.3 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.247 0.546 . . . . 0.0 110.51 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.618 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -65.58 11.21 0.4 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.857 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.686 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -74.99 4.34 6.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.52 0.328 . . . . 0.0 110.191 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 1.019 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -45.32 -41.93 17.29 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.29 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 7.3 Cg_exo -72.36 -31.08 11.94 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.39 2.06 . . . . 0.0 109.936 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.675 HG22 HD22 ' A' ' 113' ' ' LEU . 5.9 t -66.85 -44.31 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.41 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.686 HG13 ' HG ' ' A' ' 130' ' ' LEU . 10.5 m -70.59 -30.4 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.893 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -64.37 -51.31 63.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.3 tpt -64.19 -45.45 88.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.169 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.487 HG12 ' OE1' ' A' ' 141' ' ' GLN . 42.6 t -61.82 -30.52 48.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.227 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER -62.1 -38.0 87.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.336 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -42.18 98.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.395 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.623 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 4.7 tpp -68.66 -34.77 76.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.503 0.668 . . . . 0.0 110.732 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.766 ' OE1' HD22 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -77.77 -30.74 51.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.519 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -70.47 -44.5 67.63 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.764 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -79.04 -21.14 47.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.432 0.634 . . . . 0.0 109.828 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 141' ' ' GLN . 1.1 p 54.17 26.64 6.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.917 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.764 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -37.27 161.11 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.775 0.322 . . . . 0.0 110.586 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' ' 145' ' ' ALA . 57.7 Cg_endo -72.44 5.36 2.83 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 122.662 2.241 . . . . 0.0 112.9 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.631 ' OD1' ' HB3' ' A' ' 145' ' ' ALA . 19.0 p-10 -86.2 136.8 33.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 111.85 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 0.9 OUTLIER -73.62 113.69 11.03 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.753 0.787 . . . . 0.0 111.012 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 53.8 m -107.96 115.09 29.5 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.539 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.669 ' CD ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -103.4 140.91 36.83 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.266 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.941 HD12 ' N ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -134.54 133.96 54.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.162 0.506 . . . . 0.0 110.816 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 1.039 ' CB ' HG13 ' A' ' 124' ' ' VAL . 19.1 m-30 -114.05 110.66 20.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.497 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 154' ' ' GLY . 1.0 OUTLIER -116.45 133.42 56.04 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 122.091 -0.38 . . . . 0.0 111.064 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.866 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -158.73 158.79 29.68 Favored Glycine 0 CA--C 1.502 -0.748 0 C-N-CA 119.366 -1.397 . . . . 0.0 113.649 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 1.118 HG21 HD22 ' A' ' 161' ' ' LEU . 2.5 m -168.76 -108.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.874 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.4 OUTLIER -122.19 -169.71 1.94 Allowed 'General case' 0 C--N 1.344 0.331 0 CA-C-O 120.773 0.32 . . . . 0.0 111.517 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.765 HG23 ' N ' ' A' ' 187' ' ' SER . 76.9 p -29.51 -63.38 0.12 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.488 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.56 ' CB ' ' O ' ' A' ' 157' ' ' THR . 4.4 mm-40 153.32 -53.54 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.194 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 79.0 Cg_exo -37.65 -27.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.955 2.437 . . . . 0.0 112.732 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -86.41 -30.56 22.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.897 0.379 . . . . 0.0 110.976 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.118 HD22 HG21 ' A' ' 155' ' ' VAL . 1.0 OUTLIER -108.86 -174.66 2.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.268 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.53 ' O ' ' CB ' ' A' ' 163' ' ' TYR . 0.3 OUTLIER -171.05 -167.12 0.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.302 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.53 ' CB ' ' O ' ' A' ' 162' ' ' PHE . 0.2 OUTLIER 85.57 13.17 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.823 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.492 HD13 ' HA ' ' A' ' 164' ' ' ILE . 0.1 OUTLIER -65.45 -49.59 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.293 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.48 ' N ' HG22 ' A' ' 164' ' ' ILE . 0.7 OUTLIER -69.27 -33.37 73.12 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.271 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.438 ' CD ' ' CE1' ' A' ' 163' ' ' TYR . 1.6 mt-10 -72.42 -36.14 68.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.582 ' CD2' HG21 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -60.89 -32.07 71.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.05 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 171' ' ' GLU . 4.5 mtpt -63.14 -49.04 75.92 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 6.8 m -61.83 -31.54 71.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.766 HD22 ' OE1' ' A' ' 141' ' ' GLN . 0.8 OUTLIER -62.86 -34.6 77.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.783 ' HA ' HD11 ' A' ' 177' ' ' LEU . 40.6 mt-10 -63.86 -42.08 97.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.28 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 -78.21 -33.62 49.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.603 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.27 -46.29 55.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.639 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.065 ' HB2' HD23 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -77.15 -163.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.176 0.512 . . . . 0.0 111.602 -179.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER -105.08 -62.38 1.35 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.351 -179.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 176' ' ' ASN . 0.0 OUTLIER -130.28 64.02 1.54 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.795 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.065 HD23 ' HB2' ' A' ' 174' ' ' MET . 0.7 OUTLIER -105.1 154.25 20.41 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.032 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.488 ' N ' HD12 ' A' ' 177' ' ' LEU . 9.1 m -136.72 117.37 13.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.578 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.623 HG11 ' OE2' ' A' ' 171' ' ' GLU . 7.6 p -95.43 135.33 29.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.671 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.553 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 1.9 tppt? -97.95 135.95 38.94 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.852 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 194' ' ' GLN . . . -102.11 105.34 16.04 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 121.517 0.675 . . . . 0.0 111.751 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.631 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 34.7 m -87.35 -159.15 0.49 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.645 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.874 HG21 ' O ' ' A' ' 156' ' ' ASN . 28.4 t 55.93 148.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.64 0.733 . . . . 0.0 111.77 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.723 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -136.37 -62.55 0.66 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.197 -178.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.597 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 3.7 t60 -166.86 51.43 0.22 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.724 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.625 ' HG2' ' HA ' ' A' ' 156' ' ' ASN . 98.5 Cg_endo -88.97 -98.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.044 2.496 . . . . 0.0 112.704 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.765 ' N ' HG23 ' A' ' 157' ' ' THR . 13.6 t 143.11 2.28 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.603 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 123.73 12.29 4.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.453 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.27 62.72 1.58 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 249' ' ' GLY . 8.3 t-105 -130.83 120.6 23.93 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.249 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 250' ' ' ALA . 0.0 OUTLIER -98.96 104.45 16.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.341 178.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.585 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 145.18 -117.75 1.04 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.506 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 183' ' ' VAL . 18.7 mt-10 -165.04 -98.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -87.41 126.85 35.13 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . 2.46 108.92 0.0 OUTLIER Glycine 0 C--N 1.339 0.7 0 O-C-N 124.061 0.851 . . . . 0.0 113.726 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 5.9 m 96.83 156.21 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.286 0 CA-C-O 121.06 0.457 . . . . 0.0 111.086 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 196' ' ' SER . 58.0 Cg_exo -35.75 -69.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.349 2.699 . . . . 0.0 113.638 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER 173.36 35.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 122.093 0.949 . . . . 0.0 110.636 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.516 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 0.9 OUTLIER -57.61 -37.19 72.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.859 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.81 -32.81 70.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.316 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.706 ' HB2' HD13 ' A' ' 198' ' ' ILE . 0.3 OUTLIER -69.54 -32.13 70.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 110.489 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.729 ' HG2' HD22 ' A' ' 229' ' ' LEU . 2.8 mtt180 -59.86 -52.25 66.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.533 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.11 -40.93 86.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.566 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 207' ' ' SER . 11.3 m-20 -60.18 -28.49 67.99 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.788 ' HG ' HD11 ' A' ' 235' ' ' ILE . 0.1 OUTLIER -61.79 -47.99 82.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.25 178.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -14.38 59.69 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.016 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.449 ' HB2' ' HA ' ' A' ' 204' ' ' ASP . 3.8 m -91.98 -76.59 0.45 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.803 0.335 . . . . 0.0 111.497 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.548 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 17.3 p 168.97 102.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.677 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.63 ' O ' ' HB3' ' A' ' 210' ' ' ALA . 5.0 m-20 153.32 86.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.696 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . 0.766 ' CB ' HD11 ' A' ' 214' ' ' ILE . . . 101.6 109.79 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.579 ' HB2' HD13 ' A' ' 235' ' ' ILE . 1.4 t-20 -175.26 -58.51 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.437 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 11.7 Cg_endo -57.23 -83.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.043 1.829 . . . . 0.0 110.676 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.89 ' HA ' HG21 ' A' ' 240' ' ' VAL . 0.0 OUTLIER -114.38 111.59 21.7 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.766 HD11 ' CB ' ' A' ' 210' ' ' ALA . 0.8 OUTLIER -109.5 126.48 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.689 ' CE1' ' CD2' ' A' ' 241' ' ' PHE . 2.7 m-85 -116.72 134.2 55.1 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.77 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.803 HD23 ' HB ' ' A' ' 124' ' ' VAL . 1.5 mt -134.45 115.58 14.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.791 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . 0.53 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 42.3 t -123.48 107.54 11.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.851 0.357 . . . . 0.0 110.476 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.613 ' CA ' ' CD2' ' A' ' 245' ' ' PHE . . . 114.14 -36.92 3.77 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.769 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 218' ' ' GLY . 45.0 Cg_endo -92.82 79.99 0.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.812 2.341 . . . . 0.0 113.956 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.783 ' HD2' ' HB2' ' A' ' 250' ' ' ALA . 9.2 Cg_endo -51.59 -66.8 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.452 2.101 . . . . 0.0 111.074 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.844 ' N ' ' HB1' ' A' ' 250' ' ' ALA . . . -54.09 -48.77 61.91 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.012 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.571 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -55.22 -24.73 28.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.729 HD11 ' H ' ' A' ' 243' ' ' GLU . 0.1 OUTLIER -74.56 -37.07 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.111 177.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 221' ' ' GLY . 7.2 m-20 -71.85 -46.43 58.0 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.813 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.528 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -67.59 -33.14 74.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -60.13 -39.43 86.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.361 0.6 . . . . 0.0 110.055 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.436 ' HB2' ' OE1' ' A' ' 239' ' ' GLN . 31.5 t -70.49 -31.8 69.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.784 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -44.02 92.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.638 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.729 HD22 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -59.74 -37.59 79.38 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.077 0.465 . . . . 0.0 110.636 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.782 HG22 ' CG ' ' A' ' 238' ' ' GLU . 3.0 t -62.46 -46.45 96.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.424 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -74.56 -30.28 61.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.783 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 51.5 m -74.11 -42.05 60.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.303 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.499 ' HD3' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -85.11 -74.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.236 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 158.75 -56.58 0.35 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.07 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.847 ' O ' HD12 ' A' ' 235' ' ' ILE . 2.2 pp -39.36 98.69 0.18 Allowed Pre-proline 0 N--CA 1.453 -0.288 0 CA-C-O 121.255 0.55 . . . . 0.0 111.221 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.505 ' O ' ' ND2' ' A' ' 211' ' ' ASN . 57.7 Cg_endo -70.33 164.43 35.12 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 123.404 2.736 . . . . 0.0 112.646 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 211' ' ' ASN . . . 76.3 9.42 85.75 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.642 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.782 ' CG ' HG22 ' A' ' 230' ' ' VAL . 8.7 tp10 -71.53 1.02 7.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.68 0.276 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.535 ' O ' ' O ' ' A' ' 214' ' ' ILE . 39.3 mt-30 -101.95 -76.98 0.56 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.369 0.604 . . . . 0.0 109.874 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.89 HG21 ' HA ' ' A' ' 213' ' ' ASP . 4.0 t 65.06 -83.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.46 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.788 ' CG ' HG12 ' A' ' 240' ' ' VAL . 9.5 m-85 -115.64 127.82 55.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.894 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.411 ' HB3' HG12 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -132.57 132.84 42.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.438 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . 0.729 ' H ' HD11 ' A' ' 223' ' ' ILE . 11.0 tp10 -132.56 149.04 52.38 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.281 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 220' ' ' PRO . 0.9 OUTLIER -127.74 106.23 8.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.618 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -138.58 146.11 41.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.342 179.134 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.566 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 5.7 mt 64.71 167.63 0.11 Allowed Pre-proline 0 N--CA 1.471 0.588 0 O-C-N 121.886 -0.509 . . . . 0.0 111.925 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . 0.476 ' CD ' HD22 ' A' ' 246' ' ' LEU . 38.6 Cg_endo -88.6 -107.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.764 2.976 . . . . 0.0 112.422 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 247' ' ' PRO . 30.7 m -36.4 136.49 0.33 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 110.959 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 190' ' ' TRP . . . 125.84 -15.87 6.97 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.844 ' HB1' ' N ' ' A' ' 221' ' ' GLY . . . -106.38 119.36 39.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.81 -0.695 . . . . 0.0 111.364 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.585 ' N ' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 CA-C-O 121.077 0.265 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -118.91 152.82 35.62 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.818 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.976 ' CE1' ' HB2' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -132.45 165.19 24.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.93 0.395 . . . . 0.0 110.947 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.582 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -104.84 123.99 48.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.635 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.976 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . . . -121.44 154.2 36.87 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.536 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -118.99 116.56 26.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.569 HG12 ' CD2' ' A' ' 31' ' ' LEU . 17.3 m -71.16 125.66 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.454 . . . . 0.0 111.194 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.538 ' HA ' ' CG1' ' A' ' 98' ' ' VAL . 8.7 p -144.56 16.31 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.367 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -140.97 -135.38 3.17 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.691 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.004 HD11 HD22 ' A' ' 92' ' ' LEU . 0.2 OUTLIER 92.17 70.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.196 0.522 . . . . 0.0 110.494 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.639 HD21 HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -111.8 147.88 34.75 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.677 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -89.31 114.37 25.75 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.639 HG12 HD21 ' A' ' 20' ' ' ASN . 2.0 m -89.37 -29.19 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.523 0.677 . . . . 0.0 109.718 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.532 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 20.9 m -137.11 177.18 8.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.435 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.444 ' OG ' ' OD1' ' A' ' 25' ' ' ASN . 2.9 t -51.88 -58.37 6.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.894 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 2.5 m-20 -117.55 44.85 2.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.441 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.928 HG23 ' HG2' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -146.06 137.29 24.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.602 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.811 HG21 ' CD2' ' A' ' 19' ' ' LEU . 1.5 p -140.34 143.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.595 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -115.42 103.14 10.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.213 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.62 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.6 OUTLIER -91.4 121.24 32.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.676 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.604 ' N ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -102.37 116.02 31.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.375 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.677 HD22 HD23 ' A' ' 102' ' ' LEU . 6.9 mt -111.9 133.78 53.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 46.8 mt-30 -142.79 129.49 20.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.589 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.591 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -152.38 -97.48 0.05 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.163 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.46 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 2.8 mmp_? . . . . . 0 C--N 1.329 -0.31 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 120.807 0.337 . . . . 0.0 111.279 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.678 ' N ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -166.69 22.57 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.006 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.888 ' CB ' HD12 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -103.94 -169.38 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.265 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.521 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 20.5 mm-40 -107.55 130.28 23.05 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.905 0.383 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.965 ' HA ' HD23 ' A' ' 69' ' ' LEU . 99.8 Cg_exo -41.75 -23.01 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.618 2.212 . . . . 0.0 112.219 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . -51.83 -34.35 37.12 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.961 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.492 ' NE2' ' O ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -68.44 158.91 32.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.904 0.383 . . . . 0.0 110.909 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 1.043 ' HB2' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -125.79 164.06 21.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.445 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.537 ' CA ' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -114.84 143.33 45.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.978 0.418 . . . . 0.0 111.902 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.545 ' HA ' ' CB ' ' A' ' 63' ' ' SER . 14.1 t70 -98.95 107.8 20.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.031 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -148.96 157.08 43.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.361 -178.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.937 HG22 ' HB2' ' A' ' 61' ' ' SER . 0.2 OUTLIER -93.42 151.52 19.69 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.96 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -32.72 -66.06 0.21 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.519 -178.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.96 ' HD3' HG23 ' A' ' 55' ' ' ILE . 7.5 Cg_endo -106.32 4.19 0.2 Allowed 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 123.424 2.75 . . . . 0.0 111.486 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 106.95 -3.02 35.61 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.261 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.799 HG23 ' CD ' ' A' ' 56' ' ' PRO . 31.4 p -24.52 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.178 0.513 . . . . 0.0 111.744 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.85 ' H ' HG21 ' A' ' 54' ' ' THR . 19.8 p-10 -178.06 -28.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.77 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 60' ' ' VAL . 6.2 p -147.58 109.28 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.682 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.937 ' HB2' HG22 ' A' ' 54' ' ' THR . 0.3 OUTLIER -143.15 -76.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.793 179.288 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER 170.49 155.22 0.06 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.47 . . . . 0.0 111.901 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.712 ' CB ' HD21 ' A' ' 108' ' ' LEU . 46.6 p -89.54 131.82 35.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.382 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.547 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -120.78 119.62 33.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.404 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.538 ' CA ' ' HB3' ' A' ' 50' ' ' PHE . 60.7 p -60.41 102.68 0.32 Allowed Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HB2' HD13 ' A' ' 76' ' ' LEU . 92.6 Cg_endo -102.9 -178.42 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.276 2.651 . . . . 0.0 113.563 -178.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 76' ' ' LEU . . . -87.21 167.37 14.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.984 ' O ' HD22 ' A' ' 69' ' ' LEU . 0.2 OUTLIER 89.63 117.55 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -177.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.984 HD22 ' O ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -167.47 -65.59 0.01 OUTLIER Pre-proline 0 C--O 1.215 -0.734 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.543 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 66.4 Cg_endo -99.07 75.26 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.379 2.053 . . . . 0.0 113.244 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.622 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.5 OUTLIER 178.9 125.33 0.21 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.718 0.294 . . . . 0.0 110.48 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.26 56.98 0.23 Allowed 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.313 2.009 . . . . 0.0 111.675 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 71' ' ' ASN . 2.4 mt-10 -135.93 -81.44 0.4 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.017 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.444 ' HA2' HD22 ' A' ' 68' ' ' ASN . . . 126.77 15.25 2.66 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.854 -1.165 . . . . 0.0 114.255 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.488 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -61.96 85.25 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.284 0.542 . . . . 0.0 110.257 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.814 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -96.18 128.76 43.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.599 0.714 . . . . 0.0 111.197 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.708 ' N ' HD12 ' A' ' 76' ' ' LEU . 7.7 mt-10 -132.72 141.4 48.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.625 -1.171 . . . . 0.0 111.251 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.62 ' CE2' ' HB3' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -133.4 133.09 41.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.222 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.903 HD12 ' HB2' ' A' ' 131' ' ' ALA . 9.1 mt -106.78 85.6 2.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.189 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.608 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -90.48 116.57 32.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.945 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.928 ' HG2' HG23 ' A' ' 26' ' ' THR . 0.1 OUTLIER -78.12 96.07 5.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.408 0.623 . . . . 0.0 110.19 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.615 HG13 HG12 ' A' ' 27' ' ' VAL . 2.5 m -89.07 141.47 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.84 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.84 HD21 ' HB2' ' A' ' 87' ' ' ARG . 3.9 pp -74.46 169.73 18.25 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.845 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 83' ' ' LEU . 34.5 Cg_exo -61.22 63.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.804 2.336 . . . . 0.0 112.192 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER 51.15 107.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.52 ' CA ' HD11 ' A' ' 83' ' ' LEU . . . -178.55 -35.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.573 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.84 ' HB2' HD21 ' A' ' 83' ' ' LEU . 2.1 mpt_? -133.26 -81.58 0.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.752 0.311 . . . . 0.0 111.175 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -74.03 -45.17 51.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.203 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.536 ' HB3' ' CG2' ' A' ' 82' ' ' VAL . 3.3 p -67.94 -23.33 65.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.513 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -75.66 -46.07 33.5 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.486 0.66 . . . . 0.0 109.493 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.408 ' HB3' HD13 ' A' ' 55' ' ' ILE . 7.8 t80 -73.35 -23.28 60.2 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.52 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.004 HD22 HD11 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -65.75 -49.37 68.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.275 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.89 -19.0 21.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.662 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 1.5 m-20 -94.38 -2.37 52.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.399 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.69 30.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.651 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.839 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . . . -151.03 25.95 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -170.02 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.87 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.538 ' CG1' ' HA ' ' A' ' 17' ' ' VAL . 1.5 t -97.9 -137.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.551 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 98' ' ' VAL . . . 31.7 53.92 0.35 Allowed Glycine 0 CA--C 1.516 0.128 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.021 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.446 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -159.68 -170.96 3.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 111.197 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 14' ' ' ALA . 2.3 t -129.04 143.61 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.882 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.031 HD11 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -128.81 153.75 47.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.016 0.436 . . . . 0.0 111.541 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.689 ' N ' HD12 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -99.14 119.17 37.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.587 178.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.835 HG23 HD12 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -113.89 143.0 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.18 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.537 ' O ' ' CA ' ' A' ' 51' ' ' MET . 5.1 mtpt -128.7 168.25 16.07 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.521 ' N ' ' HD3' ' A' ' 107' ' ' PRO . . . -153.38 49.66 0.51 Allowed Glycine 0 C--N 1.313 -0.708 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.628 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 106' ' ' GLY . 91.5 Cg_endo -86.17 27.4 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.722 2.281 . . . . 0.0 111.403 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.043 HD23 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -88.27 172.96 9.05 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 122.108 0.956 . . . . 0.0 113.01 -178.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.592 ' O ' ' CE2' ' A' ' 50' ' ' PHE . . . -110.27 174.04 17.07 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.574 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.45 107.56 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 117.911 0.856 . . . . 0.0 110.801 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 4.3 m-85 -123.11 114.84 20.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.525 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . 136.63 -82.88 0.27 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.633 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.839 HD11 ' SD ' ' A' ' 136' ' ' MET . 0.4 OUTLIER -95.53 117.97 31.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.19 0.519 . . . . 0.0 111.206 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -138.49 113.09 8.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.033 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.458 ' OE1' ' CE2' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -106.52 140.54 39.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.12 12.0 30.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.115 0.483 . . . . 0.0 110.946 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 129.18 -90.77 0.31 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.919 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.469 ' HA ' ' OD1' ' A' ' 147' ' ' ASN . 19.6 ptt? -130.52 90.98 3.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.77 0.319 . . . . 0.0 110.835 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.699 ' HB3' ' CZ ' ' A' ' 121' ' ' ARG . . . -149.29 147.29 23.03 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.984 0.421 . . . . 0.0 111.285 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 36.4 Cg_endo -65.38 110.2 1.54 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.842 2.361 . . . . 0.0 112.071 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.699 ' CZ ' ' HB3' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -136.71 146.77 46.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.884 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 150' ' ' ARG . 0.6 OUTLIER -115.08 122.2 45.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.58 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 1.15 ' CE2' HG13 ' A' ' 133' ' ' VAL . 1.0 OUTLIER -106.44 108.08 19.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.144 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.727 HG13 HD23 ' A' ' 216' ' ' LEU . 10.0 p -98.41 111.63 28.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.571 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -101.28 132.69 46.68 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.419 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.99 103.07 1.2 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.542 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.819 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 115.99 -154.88 16.6 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.134 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.76 ' CG2' HD13 ' A' ' 79' ' ' LEU . 14.5 m -105.66 -9.59 17.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.205 0.526 . . . . 0.0 110.54 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.576 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -64.66 10.01 0.36 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.537 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.873 ' O ' HG22 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -81.22 5.55 16.68 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.82 0.31 . . . . 0.0 110.632 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.903 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -47.03 -46.71 54.62 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.306 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 131' ' ' ALA . 90.0 Cg_endo -79.72 -29.92 2.61 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.653 2.235 . . . . 0.0 111.053 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.15 HG13 ' CE2' ' A' ' 123' ' ' PHE . 20.9 t -63.11 -52.4 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.566 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 130' ' ' LEU . 2.0 m -61.78 -36.56 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.659 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 139' ' ' GLN . 18.6 m -62.08 -50.35 72.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.333 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.839 ' SD ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -62.56 -36.17 81.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.469 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.073 HG23 ' O ' ' A' ' 133' ' ' VAL . 17.7 t -66.97 -53.45 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.302 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.975 ' CG ' HD21 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -63.63 -31.83 73.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.708 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -67.47 -37.34 82.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.026 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.569 ' SD ' HG21 ' A' ' 149' ' ' THR . 3.0 ptm -63.43 -43.38 97.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.736 HE22 HG12 ' A' ' 137' ' ' VAL . 2.0 mt-30 -73.06 -34.86 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.4 ' OE1' ' O ' ' A' ' 138' ' ' ARG . 1.5 mp0 -79.62 -12.84 59.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.913 0.387 . . . . 0.0 110.672 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.47 ' HB2' ' O ' ' A' ' 139' ' ' GLN . 2.8 m95 -92.23 -85.33 0.25 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.443 0.64 . . . . 0.0 111.264 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 144' ' ' THR . 0.2 OUTLIER -154.81 20.34 0.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.242 -178.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.555 ' N ' ' CD ' ' A' ' 146' ' ' PRO . . . -125.3 44.87 1.21 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.343 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 145' ' ' ALA . 73.1 Cg_endo -76.16 5.75 4.35 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.606 2.204 . . . . 0.0 112.005 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.482 ' C ' ' ND2' ' A' ' 176' ' ' ASN . 8.4 p-10 -58.46 -159.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.149 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 40.9 mt-10 -74.55 104.63 5.32 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.408 0.623 . . . . 0.0 111.273 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.569 HG21 ' SD ' ' A' ' 140' ' ' MET . 2.8 m -119.06 117.92 30.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.095 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.633 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 1.8 mmt180 -101.52 146.15 28.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.992 0.425 . . . . 0.0 110.369 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.707 HD13 ' O ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -133.47 134.11 57.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.811 -178.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.726 ' CD2' HD21 ' A' ' 201' ' ' LEU . 18.2 m-30 -112.91 110.47 20.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.238 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.496 ' HZ ' HD23 ' A' ' 161' ' ' LEU . 3.4 t80 -112.99 126.72 55.81 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.484 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.818 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -155.58 151.89 23.41 Favored Glycine 0 CA--C 1.499 -0.939 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.105 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 1.03 HG21 HD22 ' A' ' 161' ' ' LEU . 3.8 m -164.64 -111.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.776 ' O ' HG21 ' A' ' 183' ' ' VAL . 19.9 p30 -105.85 -168.05 1.39 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.369 0.604 . . . . 0.0 112.182 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.639 HG23 ' HA ' ' A' ' 187' ' ' SER . 34.1 p -33.96 -32.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.83 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.586 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.9 tt0 105.46 -52.09 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.974 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.524 ' HD2' ' C ' ' A' ' 157' ' ' THR . 86.3 Cg_exo -48.26 -21.57 3.14 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 121.994 1.796 . . . . 0.0 112.003 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -87.29 -30.75 20.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.491 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.03 HD22 HG21 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -89.23 -160.51 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.396 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 38.0 p90 177.14 -176.59 0.15 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.0 0.429 . . . . 0.0 111.501 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 162' ' ' PHE . 0.2 OUTLIER 79.84 2.46 2.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.336 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.976 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -71.28 -45.42 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.817 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.976 ' N ' HD13 ' A' ' 164' ' ' ILE . 6.8 m-20 -67.16 -35.02 78.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.24 0.543 . . . . 0.0 110.172 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -72.28 -37.03 69.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -61.05 -32.15 71.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.015 179.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.475 ' HG3' ' HA ' ' A' ' 165' ' ' ASP . 8.1 mttt -65.9 -39.3 90.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 m -62.88 -32.0 73.16 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.315 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.975 HD21 ' CG ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -63.8 -36.89 85.38 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' A' ' 177' ' ' LEU . 2.3 mm-40 -67.53 -37.66 83.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.224 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -78.76 -32.27 46.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.235 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 170' ' ' LEU . 58.4 p -75.01 -16.17 60.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.006 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.865 ' HB3' HD13 ' A' ' 177' ' ' LEU . 0.7 OUTLIER -94.95 -168.93 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.178 0.513 . . . . 0.0 111.643 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.493 ' CB ' ' O ' ' A' ' 146' ' ' PRO . 0.7 OUTLIER -81.76 -63.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.331 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.49 ' ND2' ' N ' ' A' ' 176' ' ' ASN . 0.0 OUTLIER -141.9 70.11 1.33 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.943 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.865 HD13 ' HB3' ' A' ' 174' ' ' MET . 7.3 mp -98.68 151.75 20.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.827 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.491 ' CB ' ' HD3' ' A' ' 150' ' ' ARG . 4.8 m -136.83 115.01 11.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.822 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.424 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 7.7 p -92.85 134.97 29.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.505 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -99.1 136.44 39.06 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.588 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -96.55 105.44 17.54 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.851 0.834 . . . . 0.0 111.04 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.762 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 92.3 m -95.1 -167.96 1.72 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.16 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.815 HG23 ' H ' ' A' ' 155' ' ' VAL . 6.2 t 56.07 148.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.785 0.802 . . . . 0.0 111.186 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.75 -49.78 0.53 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.409 -1.268 . . . . 0.0 108.238 -177.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.594 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 12.1 t-80 178.55 57.04 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.498 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 187' ' ' SER . 33.5 Cg_endo -94.02 -93.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.538 2.825 . . . . 0.0 112.886 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 27.4 t 137.22 20.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.6 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 96.79 11.05 54.55 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.585 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.432 ' C ' ' HA ' ' A' ' 251' ' ' ALA . 0.4 OUTLIER -136.96 63.31 1.57 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.553 ' O ' ' O ' ' A' ' 249' ' ' GLY . 4.9 t-105 -125.44 123.19 38.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.448 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.741 ' N ' ' HB2' ' A' ' 251' ' ' ALA . 2.5 mt-10 -84.33 105.36 15.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.51 ' C ' ' CG ' ' A' ' 193' ' ' GLU . . . 131.42 -111.15 1.05 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.092 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.548 ' CB ' ' SG ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -167.51 -71.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.615 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -102.33 150.67 23.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.176 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.645 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -37.46 107.29 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.74 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.623 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 48.0 m 127.66 143.77 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 123.658 0.783 . . . . 0.0 110.169 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 199' ' ' ASP . 27.5 Cg_endo -62.32 56.83 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.797 2.331 . . . . 0.0 112.752 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.928 HD11 ' CD1' ' A' ' 229' ' ' LEU . 0.5 OUTLIER 37.17 26.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.574 0.702 . . . . 0.0 111.961 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.553 ' HA ' ' CD ' ' A' ' 202' ' ' ARG . 5.1 m-20 -57.67 -34.77 69.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.126 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.83 89.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.543 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.866 ' HB2' HD12 ' A' ' 198' ' ' ILE . 0.4 OUTLIER -69.21 -30.86 69.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.172 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.805 ' HG2' HD13 ' A' ' 229' ' ' LEU . 11.0 mtp-105 -58.46 -48.57 80.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.513 0.673 . . . . 0.0 110.645 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.536 ' HA ' ' NH1' ' A' ' 233' ' ' ARG . 2.1 mt-10 -71.41 -33.66 69.65 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.318 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -59.87 -39.07 84.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.609 -0.436 . . . . 0.0 109.937 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.884 ' HB2' HG21 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -61.18 -49.61 76.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -64.53 -21.63 66.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.816 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.8 -85.27 0.2 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.751 0.31 . . . . 0.0 111.202 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 2.2 p 174.03 99.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.719 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.667 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 7.9 m-20 154.18 42.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.15 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . 1.002 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 150.05 104.35 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.539 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.581 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 14.5 t-20 177.87 -57.32 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.06 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 8.4 Cg_endo -51.75 -55.79 3.59 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.17 1.913 . . . . 0.0 110.984 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -133.32 109.37 9.33 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 1.002 HD11 ' HB1' ' A' ' 210' ' ' ALA . 1.0 OUTLIER -116.45 125.82 73.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.58 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.4 m-85 -117.52 126.47 52.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.484 0.659 . . . . 0.0 110.533 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.727 HD23 HG13 ' A' ' 124' ' ' VAL . 0.7 OUTLIER -125.66 117.22 23.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.163 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . 0.509 ' SG ' ' CG2' ' A' ' 133' ' ' VAL . 48.8 t -124.53 107.8 11.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.978 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.577 ' HA2' ' CD2' ' A' ' 245' ' ' PHE . . . 168.57 -175.81 43.06 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.005 -1.093 . . . . 0.0 113.187 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.561 ' HB2' ' CB ' ' A' ' 250' ' ' ALA . 5.4 Cg_exo -38.18 168.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.773 2.982 . . . . 0.0 112.904 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 73.3 Cg_endo -75.52 -28.12 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.888 2.392 . . . . 0.0 111.84 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.484 ' HA2' ' HB2' ' A' ' 224' ' ' ASP . . . -81.75 -46.55 6.71 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.23 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.554 ' SD ' HD12 ' A' ' 223' ' ' ILE . 1.3 tmt? -57.07 -35.49 69.43 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.712 HD11 ' HB3' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -76.97 -34.53 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.985 178.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.484 ' HB2' ' HA2' ' A' ' 221' ' ' GLY . 0.2 OUTLIER -67.59 -46.81 71.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.161 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -61.42 -47.05 87.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.808 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -68.28 -31.21 70.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.675 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 223' ' ' ILE . 49.6 t -70.32 -31.8 69.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.165 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.84 -44.37 85.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.867 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.928 ' CD1' HD11 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -60.49 -39.88 89.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.793 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.891 HG12 ' HG3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -66.05 -41.6 89.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 -179.219 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -72.9 -30.0 63.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.151 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.42 -29.83 19.92 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.59 ' HD3' HD12 ' A' ' 205' ' ' LEU . 1.4 mmp_? -72.91 -66.83 0.62 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.874 0.368 . . . . 0.0 111.415 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.52 ' C ' ' HD2' ' A' ' 236' ' ' PRO . . . 122.09 9.67 6.62 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.795 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.884 HG21 ' HB2' ' A' ' 205' ' ' LEU . 1.0 OUTLIER -83.3 -19.18 0.26 Allowed Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.891 ' HG3' HG12 ' A' ' 230' ' ' VAL . 66.1 Cg_exo -39.99 117.23 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.68 1.587 . . . . 0.0 112.382 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -96.49 -116.79 3.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.753 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -129.53 -32.8 1.92 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.585 0.231 . . . . 0.0 111.401 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.577 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 9.7 mm-40 -99.87 30.74 3.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.008 0.433 . . . . 0.0 111.147 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.988 HG22 ' HB ' ' A' ' 214' ' ' ILE . 1.7 t -94.52 131.87 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.041 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.645 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.66 151.4 37.19 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.65 151.27 51.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.097 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . 0.591 ' O ' HD13 ' A' ' 223' ' ' ILE . 8.8 tm-20 -132.47 149.4 52.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.269 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -117.85 107.35 14.01 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 111.674 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.577 ' CD2' ' HA2' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -136.48 148.14 47.53 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.147 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.594 HD22 ' HB2' ' A' ' 81' ' ' ARG . 3.0 tt -15.72 139.99 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . 0.57 ' O ' ' CB ' ' A' ' 248' ' ' SER . 77.7 Cg_exo -50.8 -149.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.885 3.057 . . . . 0.0 113.565 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 247' ' ' PRO . 7.4 m 97.01 -19.43 0.05 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.907 0.86 . . . . 0.0 109.871 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 190' ' ' TRP . . . -122.15 -18.5 3.44 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.085 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.561 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . . . -109.08 151.67 26.09 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.606 0.762 . . . . 0.0 110.339 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.741 ' HB2' ' N ' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.07 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 CA-C-O 121.084 0.269 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -111.47 158.49 19.07 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.922 0.391 . . . . 0.0 111.055 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 34' ' ' ARG . 1.9 t80 -128.55 165.24 21.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.957 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -110.46 129.63 55.73 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.084 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -137.8 154.62 49.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.864 0.364 . . . . 0.0 111.153 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -103.52 121.38 42.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.881 HG13 ' HE1' ' A' ' 29' ' ' PHE . 24.3 t -72.1 136.03 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 17' ' ' VAL . 10.5 p -162.2 24.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.264 0.554 . . . . 0.0 109.711 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.596 ' O ' ' CE1' ' A' ' 29' ' ' PHE . . . -153.05 122.2 1.26 Allowed Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.85 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.933 ' CD2' HD22 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -170.85 90.44 0.14 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.665 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -140.39 144.04 36.0 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.7 178.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.415 ' HA ' ' O ' ' A' ' 26' ' ' THR . 10.1 m0 -89.94 112.6 24.03 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.579 -0.849 . . . . 0.0 108.87 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.585 HG22 ' HB ' ' A' ' 26' ' ' THR . 0.7 OUTLIER -71.41 -19.02 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.639 0.733 . . . . 0.0 109.122 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.533 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 37.9 m -153.17 -175.24 5.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.074 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.3 m -52.2 -57.86 8.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.113 0.483 . . . . 0.0 110.917 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -118.79 47.26 1.68 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.14 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.585 ' HB ' HG22 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -143.28 128.59 18.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.754 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.537 HG11 ' CD1' ' A' ' 92' ' ' LEU . 2.5 p -131.0 133.83 62.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.301 0.572 . . . . 0.0 112.476 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.487 ' HG2' HD21 ' A' ' 30' ' ' LEU . 15.2 tt0 -100.62 131.36 46.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.792 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.881 ' HE1' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -126.02 128.42 47.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.917 -178.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.862 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -121.35 115.77 23.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.213 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.078 HD13 HD21 ' A' ' 102' ' ' LEU . 2.8 mt -115.28 148.73 38.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.455 . . . . 0.0 111.753 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -124.01 108.32 12.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.523 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.65 ' HD3' HG11 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -105.35 -165.43 1.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.048 -179.091 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.832 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 69' ' ' LEU . 21.9 m . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 121.258 0.551 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -155.77 23.12 0.39 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.803 -178.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.643 ' CG ' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER 99.07 92.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.583 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -115.2 125.4 28.94 Favored Pre-proline 0 N--CA 1.453 -0.317 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.937 178.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.447 ' C ' ' O ' ' A' ' 46' ' ' GLU . 53.5 Cg_exo -28.13 84.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.055 2.503 . . . . 0.0 112.739 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.635 ' N ' ' CD2' ' A' ' 111' ' ' PHE . . . 40.56 75.97 0.1 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.612 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.446 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 1.6 tm0? -69.74 109.7 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 111.021 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.664 ' CE1' ' HB2' ' A' ' 65' ' ' SER . 1.5 m-30 -109.97 164.15 12.88 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.549 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.485 ' HB3' ' O ' ' A' ' 105' ' ' LYS . 5.2 mmt -135.74 -171.48 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.418 0.628 . . . . 0.0 112.414 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 9.3 t0 -131.79 102.5 5.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.665 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.01 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -134.58 157.93 45.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.451 0.643 . . . . 0.0 112.228 -177.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.866 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -109.19 151.2 26.8 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.968 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.891 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -30.45 -69.62 0.1 Allowed Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.224 0.327 . . . . 0.0 110.897 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 1.094 ' HD2' HG23 ' A' ' 58' ' ' THR . 59.9 Cg_endo -104.69 7.64 0.28 Allowed 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.451 2.767 . . . . 0.0 111.735 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.41 18.56 14.28 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.093 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 1.094 HG23 ' HD2' ' A' ' 56' ' ' PRO . 6.8 p -63.65 -110.51 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.128 -0.536 . . . . 0.0 111.4 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.866 ' N ' HG21 ' A' ' 54' ' ' THR . 0.3 OUTLIER 175.45 28.5 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.757 HG12 ' O ' ' A' ' 60' ' ' VAL . 48.3 t -140.83 31.94 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.712 0.291 . . . . 0.0 111.289 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.59 ' CB ' ' HA ' ' A' ' 54' ' ' THR . 34.0 t -103.5 -103.23 0.29 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.681 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 61' ' ' SER . 8.6 mtt180 166.99 -179.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.088 0.471 . . . . 0.0 111.569 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 2.7 t -88.76 143.01 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.591 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 1.014 ' CE2' HG22 ' A' ' 80' ' ' ILE . 1.9 t80 -141.25 130.29 23.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.664 ' HB2' ' CE1' ' A' ' 50' ' ' PHE . 22.4 p -75.9 105.63 2.34 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.533 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 72.4 Cg_endo -99.45 -169.92 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.905 2.403 . . . . 0.0 113.348 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.713 ' HB3' ' N ' ' A' ' 77' ' ' GLU . . . -86.15 176.77 7.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.721 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.2 t30 106.61 123.71 0.01 OUTLIER 'General case' 0 C--N 1.343 0.31 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.952 HD13 ' CB ' ' A' ' 135' ' ' SER . 0.4 OUTLIER -170.96 -84.32 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 122.139 -0.351 . . . . 0.0 110.615 -178.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 55.3 Cg_endo -85.81 72.57 4.07 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 120.384 1.173 . . . . 0.0 112.397 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -164.51 139.09 4.4 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.586 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.513 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 60.3 Cg_endo -91.15 53.57 0.91 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.665 2.243 . . . . 0.0 116.234 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 72' ' ' PRO . 61.6 mt-10 -158.66 -106.91 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.269 0.94 . . . . 0.0 112.558 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.57 78.0 0.17 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.46 81.92 1.95 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.159 0.98 . . . . 0.0 111.332 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.65 HD12 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -97.48 132.14 43.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.713 ' N ' ' HB3' ' A' ' 67' ' ' ALA . 1.3 tt0 -129.99 111.69 12.77 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.443 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.868 ' CD1' HG23 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -104.78 137.18 42.96 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.226 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.864 HD22 ' CG2' ' A' ' 128' ' ' THR . 0.2 OUTLIER -122.53 75.41 1.25 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.918 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.014 HG22 ' CE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -92.61 130.4 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.121 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.79 ' HG3' HD21 ' A' ' 246' ' ' LEU . 0.3 OUTLIER -78.11 102.7 7.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.178 -178.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' CB ' ' A' ' 89' ' ' SER . 3.5 m -102.02 138.22 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.313 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.461 ' O ' ' OG ' ' A' ' 89' ' ' SER . 5.4 mt -68.99 129.01 92.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.738 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.23 110.14 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.666 2.244 . . . . 0.0 111.938 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.525 ' N ' ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER 47.25 43.73 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.422 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.54 -68.88 0.58 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.956 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -137.24 -68.2 0.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.268 . . . . 0.0 111.663 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -76.98 -33.57 57.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.714 0.292 . . . . 0.0 111.515 -179.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.686 ' CB ' HG23 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -78.84 -20.74 48.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.404 -179.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.414 ' O ' ' CG ' ' A' ' 94' ' ' ASN . 0.7 OUTLIER -75.68 -46.66 30.03 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.692 0.758 . . . . 0.0 109.069 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.728 ' O ' HD11 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -74.62 -24.52 58.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.498 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.933 HD22 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.78 -49.4 73.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.001 -179.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -89.05 -16.95 30.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.447 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.414 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 73.8 m-20 -95.04 -9.32 34.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.286 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.481 ' HB3' HD11 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -135.13 2.99 3.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.383 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -139.16 28.91 2.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.825 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -77.53 -49.58 14.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.467 -179.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.931 HG13 ' HG3' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -74.95 3.2 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.142 0.496 . . . . 0.0 111.796 -179.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 100' ' ' GLN . . . 54.12 36.92 57.67 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.415 -0.897 . . . . 0.0 111.722 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.931 ' HG3' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -52.8 -160.41 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.943 0.401 . . . . 0.0 111.065 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.65 143.14 12.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.775 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.078 HD21 HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -128.91 132.95 47.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.468 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.578 ' N ' HD12 ' A' ' 102' ' ' LEU . 6.8 m -92.02 123.1 35.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.088 0.471 . . . . 0.0 111.063 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.65 HG11 ' HD3' ' A' ' 33' ' ' LYS . 2.0 m -96.8 127.85 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 51' ' ' MET . 0.1 OUTLIER -127.0 170.17 12.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.557 -178.214 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 51' ' ' MET . . . 69.59 83.88 0.17 Allowed Glycine 0 C--N 1.312 -0.795 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.05 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.22 54.03 4.49 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.427 2.084 . . . . 0.0 110.053 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.626 ' HG ' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -97.42 166.52 11.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.134 -177.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.626 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -156.9 129.32 2.37 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.485 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 110' ' ' VAL . 10.7 p -158.25 113.51 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.865 0.364 . . . . 0.0 110.769 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.635 ' CD2' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -119.24 150.26 40.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.681 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -95.09 9.41 70.12 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.948 HD11 ' HG2' ' A' ' 136' ' ' MET . 3.7 pp -116.09 119.4 35.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.278 0.561 . . . . 0.0 110.848 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.647 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.5 OUTLIER -137.5 112.92 9.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.485 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 121' ' ' ARG . 0.1 OUTLIER -87.2 140.54 29.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.54 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -94.12 14.29 20.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.2 -74.68 0.22 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.765 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -129.59 89.96 2.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.941 0.401 . . . . 0.0 110.461 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 121' ' ' ARG . . . -164.37 144.73 6.4 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.363 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 43.8 Cg_endo -67.98 116.93 4.56 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.765 2.31 . . . . 0.0 111.905 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.1 OUTLIER -130.96 158.53 40.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.647 ' CE2' ' CD ' ' A' ' 150' ' ' ARG . 3.5 m-85 -126.68 130.53 50.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.079 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.809 ' HE2' HD13 ' A' ' 113' ' ' LEU . 0.4 OUTLIER -106.46 103.71 13.23 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.631 HG13 HD23 ' A' ' 216' ' ' LEU . 0.8 OUTLIER -101.01 111.09 29.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.275 0.56 . . . . 0.0 110.843 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -114.47 133.08 56.02 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.898 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -105.82 102.7 2.01 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.841 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.968 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 124.08 -164.32 17.41 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.417 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.864 ' CG2' HD22 ' A' ' 79' ' ' LEU . 5.4 m -106.4 -10.39 16.34 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.45 0.643 . . . . 0.0 110.746 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.605 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -68.01 10.63 1.17 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.459 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.777 ' C ' HD23 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -75.75 5.14 6.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 122.894 0.478 . . . . 0.0 110.283 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.716 ' N ' HD23 ' A' ' 130' ' ' LEU . . . -44.98 -41.24 12.36 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.197 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 3.7 Cg_exo -73.53 -31.39 8.91 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.49 2.127 . . . . 0.0 110.063 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.717 HG21 ' HB2' ' A' ' 217' ' ' CYS . 21.4 t -64.86 -42.7 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.614 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.715 HG13 ' HG ' ' A' ' 130' ' ' LEU . 10.6 m -70.15 -29.78 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.533 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.952 ' CB ' HD13 ' A' ' 69' ' ' LEU . 16.7 m -66.49 -53.09 39.09 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.948 ' HG2' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -60.5 -42.4 96.3 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.511 0.672 . . . . 0.0 109.215 178.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.741 HG12 ' HG3' ' A' ' 141' ' ' GLN . 26.8 t -62.35 -32.39 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.927 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 135' ' ' SER . 5.3 mtm180 -59.6 -32.12 70.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.198 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.567 ' OE1' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -68.4 -43.03 78.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.09 178.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.626 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -71.5 -34.96 70.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.507 0.67 . . . . 0.0 111.047 179.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.926 ' CD ' HD22 ' A' ' 170' ' ' LEU . 0.4 OUTLIER -78.05 -30.45 49.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.239 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 138' ' ' ARG . 3.4 mm-40 -69.8 -44.99 68.93 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -79.24 -21.14 46.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.436 0.636 . . . . 0.0 109.736 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 141' ' ' GLN . 0.6 OUTLIER 52.74 28.03 5.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.735 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.857 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -33.09 153.95 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.946 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.454 ' HA ' ' HG3' ' A' ' 175' ' ' ARG . 41.8 Cg_endo -67.63 -3.58 10.52 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.667 2.245 . . . . 0.0 112.71 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.571 ' ND2' ' NH2' ' A' ' 121' ' ' ARG . 40.3 t30 -76.37 144.12 40.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 111.567 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 1.2 mt-10 -73.59 111.41 8.71 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.624 0.726 . . . . 0.0 111.072 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.646 ' HB ' HD11 ' A' ' 177' ' ' LEU . 1.1 m -108.5 115.38 29.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.892 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.647 ' CD ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -106.6 141.49 37.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.455 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.818 HD12 ' N ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -133.59 129.33 55.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.262 0.554 . . . . 0.0 111.032 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.818 ' N ' HD12 ' A' ' 151' ' ' ILE . 22.0 m-30 -108.33 115.06 29.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.47 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.466 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 37.2 t80 -120.15 132.02 55.24 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.396 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.925 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -155.06 160.67 29.9 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 119.511 -1.328 . . . . 0.0 113.288 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.977 ' CG2' HD13 ' A' ' 161' ' ' LEU . 1.2 m -170.73 -106.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.873 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.3 OUTLIER -126.17 -169.59 2.04 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 120.663 0.268 . . . . 0.0 111.287 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.829 HG23 ' CA ' ' A' ' 187' ' ' SER . 72.0 p -28.29 -62.67 0.1 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.655 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.57 ' HA ' HD21 ' A' ' 161' ' ' LEU . 0.2 OUTLIER 153.1 -54.05 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.495 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 40.7 Cg_exo -31.28 -31.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.155 2.57 . . . . 0.0 112.96 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.2 mm-40 -85.44 -60.11 2.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.016 0.436 . . . . 0.0 110.636 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.977 HD13 ' CG2' ' A' ' 155' ' ' VAL . 0.4 OUTLIER -67.3 -174.68 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.394 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 163' ' ' TYR . 0.8 OUTLIER 175.27 176.11 0.2 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.86 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 162' ' ' PHE . 0.3 OUTLIER 87.66 6.75 0.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.313 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.983 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -71.39 -45.51 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.771 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.983 ' N ' HD13 ' A' ' 164' ' ' ILE . 3.5 m-20 -66.0 -35.7 81.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.243 0.544 . . . . 0.0 110.107 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.454 ' O ' ' OG ' ' A' ' 169' ' ' SER . 0.9 OUTLIER -72.38 -36.22 68.66 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -61.61 -31.83 71.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.095 179.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 164' ' ' ILE . 24.2 mttt -62.92 -48.54 78.5 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 166' ' ' GLU . 3.9 p -61.8 -31.41 71.62 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.926 HD22 ' CD ' ' A' ' 141' ' ' GLN . 1.1 mt -63.57 -37.41 87.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.648 ' HA ' HD23 ' A' ' 177' ' ' LEU . 4.4 mm-40 -68.43 -36.07 78.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.922 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -34.53 59.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.143 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.1 t -53.7 -49.17 68.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.521 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.895 ' HB3' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -69.31 -154.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 111.588 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.454 ' HG3' ' HA ' ' A' ' 146' ' ' PRO . 0.3 OUTLIER -106.49 -54.26 2.5 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.718 -179.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -132.35 69.91 1.47 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.112 0.482 . . . . 0.0 110.706 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.895 HD13 ' HB3' ' A' ' 174' ' ' MET . 3.6 mp -98.81 150.47 21.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.888 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.513 ' OG1' ' CZ ' ' A' ' 150' ' ' ARG . 2.4 m -137.48 115.41 11.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.718 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.48 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 2.6 p -101.15 134.65 40.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.776 0.322 . . . . 0.0 111.352 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.6 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -101.69 135.28 43.49 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.562 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -100.82 105.51 16.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.491 0.663 . . . . 0.0 111.824 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.645 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 29.6 m -88.53 -161.93 0.79 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.181 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.873 HG21 ' O ' ' A' ' 156' ' ' ASN . 14.9 t 54.73 147.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-O 121.703 0.763 . . . . 0.0 111.812 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.24 -60.78 0.61 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.188 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.604 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 1.9 t-80 -164.99 51.26 0.25 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.789 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 187' ' ' SER . 86.3 Cg_endo -90.3 -98.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.21 2.607 . . . . 0.0 112.542 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.829 ' CA ' HG23 ' A' ' 157' ' ' THR . 21.7 t 137.85 6.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.596 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 120.64 12.19 6.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.259 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.16 62.62 1.59 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.469 ' HE1' ' C ' ' A' ' 193' ' ' GLU . 8.5 t-105 -132.08 121.31 23.61 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.305 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 250' ' ' ALA . 3.9 mt-10 -95.92 104.71 16.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.52 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.564 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 140.82 -117.02 1.2 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.696 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.595 ' C ' ' HB3' ' A' ' 182' ' ' CYS . 13.6 mt-10 -162.98 -95.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.514 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -86.73 139.34 30.83 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.641 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -21.37 107.08 0.01 OUTLIER Glycine 0 C--N 1.334 0.448 0 O-C-N 123.688 0.618 . . . . 0.0 113.096 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.614 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 67.1 m 120.65 154.45 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 123.481 0.712 . . . . 0.0 110.701 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.65 -75.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 123.234 2.623 . . . . 0.0 112.728 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.703 HG23 ' O ' ' A' ' 198' ' ' ILE . 0.2 OUTLIER 174.88 32.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.985 0.897 . . . . 0.0 110.732 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.505 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 35.9 m-20 -58.61 -37.27 75.49 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.191 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.46 73.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.637 ' HB2' HD13 ' A' ' 198' ' ' ILE . 0.2 OUTLIER -69.32 -34.04 74.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.873 0.368 . . . . 0.0 110.904 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.688 ' HG2' HD22 ' A' ' 229' ' ' LEU . 5.9 mtm180 -59.84 -52.15 66.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -41.87 96.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.814 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.2 -29.16 68.53 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 1.04 ' CD2' HD11 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -62.67 -43.96 97.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.337 178.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.44 -18.07 57.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.538 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 208' ' ' SER . 59.4 m -75.79 -80.45 0.09 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.93 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 207' ' ' SER . 0.4 OUTLIER 164.99 34.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.449 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.663 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 2.0 m-20 -137.85 52.29 1.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.697 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 209' ' ' ASP . . . 151.5 102.01 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.208 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.875 ' HB2' HD13 ' A' ' 235' ' ' ILE . 13.5 t30 174.04 -56.78 0.0 OUTLIER Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.143 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 18.8 Cg_endo -59.53 -58.04 0.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.294 1.996 . . . . 0.0 111.207 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.14 109.23 9.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.309 178.493 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.933 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.5 OUTLIER -121.63 125.76 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.716 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -120.62 127.1 51.78 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.388 0.613 . . . . 0.0 111.063 -178.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.631 HD23 HG13 ' A' ' 124' ' ' VAL . 3.4 mt -125.71 116.45 21.66 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.284 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . 0.717 ' HB2' HG21 ' A' ' 133' ' ' VAL . 38.9 m -124.8 107.09 10.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.077 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.621 ' N ' ' CD ' ' A' ' 219' ' ' PRO . . . 110.44 -28.13 10.58 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.93 -1.128 . . . . 0.0 114.075 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 218' ' ' GLY . 46.3 Cg_endo -89.76 83.17 0.53 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.238 1.958 . . . . 0.0 114.72 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.799 ' CD ' ' HB2' ' A' ' 250' ' ' ALA . 11.9 Cg_endo -53.48 -71.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 111.301 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.824 ' N ' ' HB1' ' A' ' 250' ' ' ALA . . . -54.2 -48.62 62.94 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.427 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.588 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -54.77 -24.08 20.89 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.595 ' CD1' ' HB3' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -72.76 -36.81 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.942 178.132 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 221' ' ' GLY . 65.6 m-20 -73.45 -47.04 44.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.003 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -69.72 -37.02 76.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.641 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.796 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -59.4 -38.5 80.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.385 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 31.7 m -69.91 -31.19 68.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.572 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -44.5 82.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.811 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.688 HD22 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -60.76 -37.14 80.83 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.013 0.435 . . . . 0.0 110.664 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 226' ' ' ALA . 3.6 t -66.23 -45.62 89.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.392 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -72.75 -30.02 63.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 6.2 m -76.98 -44.15 32.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.557 ' NE ' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -68.21 -75.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.166 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.472 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 137.8 -36.13 1.97 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.255 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 1.04 HD11 ' CD2' ' A' ' 205' ' ' LEU . 1.6 pp -35.84 95.29 0.09 OUTLIER Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 111.005 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 18.7 Cg_endo -59.86 115.33 2.55 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.757 2.305 . . . . 0.0 112.185 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -93.85 173.72 33.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.437 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -143.71 -41.92 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 110.91 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.582 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 43.7 mm-40 -107.5 37.78 2.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.933 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.1 t -92.84 132.45 37.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.647 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -144.72 144.5 31.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.42 -178.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -130.75 140.93 50.35 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . 0.576 ' O ' HD13 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -132.79 149.12 52.31 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.75 178.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 244' ' ' LYS . 1.0 OUTLIER -127.22 108.09 10.57 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.629 ' CD1' ' HB2' ' A' ' 246' ' ' LEU . 0.4 OUTLIER -138.22 144.32 40.57 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.538 178.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.834 HD23 ' HD2' ' A' ' 247' ' ' PRO . 0.1 OUTLIER 68.31 148.55 0.12 Allowed Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 121.917 -0.49 . . . . 0.0 111.379 -179.101 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . 0.834 ' HD2' HD23 ' A' ' 246' ' ' LEU . 97.7 Cg_endo -73.28 -104.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.959 2.439 . . . . 0.0 112.371 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 247' ' ' PRO . 52.8 p -37.66 134.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.183 0.516 . . . . 0.0 110.912 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 127.71 -15.69 6.27 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.824 ' HB1' ' N ' ' A' ' 221' ' ' GLY . . . -106.53 120.55 42.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.709 -0.745 . . . . 0.0 111.541 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.564 ' N ' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.066 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 CA-C-O 121.022 0.234 . . . . 0.0 112.81 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.558 ' CB ' ' HB3' ' A' ' 105' ' ' LYS . 0.8 OUTLIER -115.03 149.34 37.62 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.693 -0.253 . . . . 0.0 111.022 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.795 ' CE1' HG13 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -134.05 165.54 24.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -113.31 135.29 54.0 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.992 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -134.53 150.35 50.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.755 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 1.1 pt-20 -96.5 116.63 29.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 110.754 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.003 HG22 ' O ' ' A' ' 100' ' ' GLN . 2.9 m -75.34 135.34 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.284 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 17' ' ' VAL . 7.4 p -149.4 20.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.168 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -106.63 -129.82 6.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.028 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.988 HD22 HD22 ' A' ' 92' ' ' LEU . 0.1 OUTLIER 74.9 80.39 0.11 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.831 -0.685 . . . . 0.0 110.445 -178.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.799 HD21 HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -123.25 139.45 54.04 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.079 178.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 7.9 m0 -90.1 113.49 25.24 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.164 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.799 HG12 HD21 ' A' ' 20' ' ' ASN . 1.3 m -96.26 -26.99 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.542 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 8.2 m -143.43 171.09 14.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.244 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.468 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -52.88 -53.83 43.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.116 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -119.46 45.47 2.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.58 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.542 ' CB ' ' HB2' ' A' ' 23' ' ' SER . 0.3 OUTLIER -148.06 140.36 24.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.426 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.863 HG11 HD13 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -140.89 141.28 31.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.26 0.552 . . . . 0.0 112.036 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.654 ' HB2' HD21 ' A' ' 79' ' ' LEU . 17.0 tt0 -121.44 110.52 16.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.895 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.961 ' CE1' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -118.74 140.52 49.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 111.446 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.834 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -117.13 143.66 45.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.347 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.973 HD22 HG12 ' A' ' 16' ' ' VAL . 0.7 OUTLIER -122.14 154.91 36.78 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.17 0.509 . . . . 0.0 111.954 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -116.13 104.81 11.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.491 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.643 ' CG ' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -60.63 -171.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.459 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? . . . . . 0 CA--C 1.544 0.714 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.698 -179.328 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.595 ' CG2' ' ND2' ' A' ' 68' ' ' ASN . 18.8 m . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 121.281 0.563 . . . . 0.0 112.441 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.704 ' HA ' ' CA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.32 41.37 1.09 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.282 178.123 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.6 ' CZ ' ' O ' ' A' ' 132' ' ' PRO . 83.9 t80 71.66 143.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.064 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.594 ' O ' ' CE2' ' A' ' 45' ' ' PHE . 4.9 mt-10 -112.91 161.88 24.5 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.743 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' GLY . 5.1 Cg_endo -47.44 80.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.717 2.278 . . . . 0.0 112.326 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.59 ' O ' HG12 ' A' ' 110' ' ' VAL . . . 34.85 41.2 0.24 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.862 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.497 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 4.8 mt-30 -53.46 161.04 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.67 0.235 . . . . 0.0 110.442 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.718 ' CD2' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -152.82 160.47 43.09 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.964 0.411 . . . . 0.0 111.703 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.627 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -138.73 -172.35 3.29 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.389 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.7 108.79 17.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.084 ' CD1' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -149.64 155.92 41.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 1.008 HG23 ' C ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -106.9 155.3 19.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.792 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.968 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -29.89 -68.62 0.11 Allowed Pre-proline 0 CA--C 1.54 0.58 0 O-C-N 123.393 0.433 . . . . 0.0 110.666 -179.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.968 ' HD3' HG23 ' A' ' 55' ' ' ILE . 6.3 Cg_endo -107.89 3.69 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.434 2.756 . . . . 0.0 111.807 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 107.23 -4.35 35.42 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.132 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.893 HG21 ' OH ' ' A' ' 91' ' ' TYR . 70.5 p -25.52 -89.76 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.975 0.51 . . . . 0.0 111.864 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.622 ' O ' HG12 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -147.2 43.11 1.12 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.008 ' C ' HG23 ' A' ' 54' ' ' THR . 0.4 OUTLIER 79.25 125.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.676 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.815 ' N ' HG23 ' A' ' 54' ' ' THR . 4.1 m -101.44 -54.32 2.79 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.372 0.606 . . . . 0.0 110.493 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 175.2 -155.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.438 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.683 ' CB ' ' CE1' ' A' ' 50' ' ' PHE . 3.6 p -105.73 119.36 38.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.898 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.488 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 4.2 t80 -140.72 124.51 17.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.119 0.485 . . . . 0.0 112.086 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.616 ' N ' ' HB2' ' A' ' 50' ' ' PHE . 1.3 t -80.85 108.25 9.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.063 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.663 ' HB2' HD13 ' A' ' 76' ' ' LEU . 87.9 Cg_endo -83.61 159.41 14.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.795 2.33 . . . . 0.0 111.667 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.722 ' HB2' ' HA ' ' A' ' 132' ' ' PRO . . . -119.48 129.51 54.76 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.603 ' O ' ' CB ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -82.21 -75.31 0.31 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.328 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.603 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 10.8 tp 101.53 141.38 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.22 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.704 ' CA ' ' HA ' ' A' ' 44' ' ' LYS . 5.5 Cg_exo -36.25 86.31 0.01 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 123.001 2.467 . . . . 0.0 112.0 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -162.67 117.96 1.2 Allowed Pre-proline 0 CA--C 1.518 -0.251 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.086 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.56 38.55 0.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.484 2.123 . . . . 0.0 112.379 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.06 -51.47 1.21 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.34 107.95 1.48 Allowed Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.81 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 5.9 mtt180 -139.53 93.55 2.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.517 0.199 . . . . 0.0 110.506 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.814 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -95.88 131.55 42.1 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.351 0.596 . . . . 0.0 111.368 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.766 ' N ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.9 150.74 30.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.138 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.703 ' CD1' ' CD2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -135.29 129.99 34.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.367 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.832 HD12 ' HB2' ' A' ' 131' ' ' ALA . 2.7 mt -135.6 103.37 5.42 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-O 120.846 0.355 . . . . 0.0 110.355 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.703 HD13 ' CZ ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -115.04 127.33 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.194 -178.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.617 ' HG3' HD11 ' A' ' 246' ' ' LEU . 1.8 mmt180 -79.69 95.57 5.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.595 ' CG2' ' CB ' ' A' ' 89' ' ' SER . 3.0 m -90.56 142.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.114 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.508 ' HA ' HD12 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -88.15 151.35 48.96 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.612 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.481 ' HD2' ' HG ' ' A' ' 83' ' ' LEU . 55.3 Cg_endo -69.87 -8.46 23.66 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.753 2.302 . . . . 0.0 112.392 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -70.51 -25.87 63.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.503 ' CA ' ' HB2' ' A' ' 90' ' ' ASP . . . 115.43 -4.06 21.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.569 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 86' ' ' GLY . 9.3 mmm180 -36.63 -73.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 110.792 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -116.92 -21.88 8.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.595 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 1.3 p -65.75 -36.79 84.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.206 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.503 ' HB2' ' CA ' ' A' ' 86' ' ' GLY . 2.1 m-20 -75.09 -33.47 61.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.364 0.602 . . . . 0.0 109.868 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.893 ' OH ' HG21 ' A' ' 58' ' ' THR . 2.0 t80 -73.34 -31.59 64.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.702 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.988 HD22 HD22 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -68.73 -39.36 80.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.203 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.08 -19.88 21.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 9.0 m-20 -97.48 -10.97 24.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.43 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.549 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -124.73 -12.3 7.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.452 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -132.56 33.2 3.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.028 0.442 . . . . 0.0 110.909 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -52.88 61.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.682 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 99' ' ' GLY . 1.8 t -89.32 -135.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 120.737 0.303 . . . . 0.0 111.129 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 100' ' ' GLN . . . -120.97 28.07 6.24 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.995 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 1.003 ' O ' HG22 ' A' ' 16' ' ' VAL . 17.2 mp0 -39.26 163.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 110.911 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' ALA . 4.8 p -92.83 139.77 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.953 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.084 HD11 ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.67 125.33 35.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -92.38 134.55 34.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.97 0.414 . . . . 0.0 111.086 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.795 HG13 ' CE1' ' A' ' 12' ' ' PHE . 1.9 m -112.91 129.37 68.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.445 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.558 ' HB3' ' CB ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -130.55 112.97 13.67 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.759 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 151.56 73.66 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.022 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.94 53.97 4.37 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.496 2.131 . . . . 0.0 110.924 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.718 HD22 ' CD2' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -102.17 166.61 10.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.781 -178.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.58 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -108.75 172.7 16.84 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.492 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.65 ' O ' HG13 ' A' ' 110' ' ' VAL . 4.4 p -152.18 113.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.201 0.524 . . . . 0.0 111.205 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.471 ' HB3' ' HB3' ' A' ' 241' ' ' PHE . 13.0 m-30 -71.01 114.74 9.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.419 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -149.99 -46.46 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.611 ' HA ' ' CG ' ' A' ' 215' ' ' TYR . 2.0 pt? -146.43 119.59 8.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.937 0.399 . . . . 0.0 110.488 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -137.9 112.83 9.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.853 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -78.95 140.2 38.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.287 179.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.46 ' HD3' ' HG3' ' A' ' 239' ' ' GLN . 17.2 ttp180 -98.37 11.7 37.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.185 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.478 ' C ' ' NH2' ' A' ' 121' ' ' ARG . . . 107.27 -78.08 0.24 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.693 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.46 ' HA ' ' HB3' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -129.91 89.83 2.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.844 0.354 . . . . 0.0 110.577 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.713 ' HB3' HH12 ' A' ' 121' ' ' ARG . . . -166.86 151.93 7.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 33.0 Cg_endo -64.47 116.73 3.93 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.652 2.235 . . . . 0.0 111.606 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.713 HH12 ' HB3' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -124.76 128.24 48.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.081 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.636 ' CD2' ' CE1' ' A' ' 152' ' ' TYR . 2.5 m-30 -106.65 115.84 30.9 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 1.157 ' CE2' HG21 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -119.66 111.01 17.51 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.258 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.938 ' CG1' HD23 ' A' ' 216' ' ' LEU . 7.4 p -109.15 111.06 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.206 0.527 . . . . 0.0 110.978 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -103.7 133.58 48.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.951 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.57 ' HA3' ' N ' ' A' ' 250' ' ' ALA . . . -109.59 103.61 1.77 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.944 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.599 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 123.55 -158.91 18.21 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 119.782 -1.199 . . . . 0.0 112.757 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.737 ' CG2' HD13 ' A' ' 79' ' ' LEU . 3.2 m -110.09 -14.41 14.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.675 0.274 . . . . 0.0 111.409 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.604 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -67.67 9.36 1.35 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.355 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.839 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -77.99 3.88 13.59 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 122.491 0.316 . . . . 0.0 110.192 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.832 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -46.52 -43.34 36.5 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 120.516 -0.473 . . . . 0.0 109.998 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.722 ' HA ' ' HB2' ' A' ' 67' ' ' ALA . 2.8 Cg_exo -73.82 -35.35 4.51 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.529 2.152 . . . . 0.0 109.718 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.659 HG11 ' CE1' ' A' ' 123' ' ' PHE . 15.8 t -63.36 -42.88 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.208 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.839 HG13 ' HG ' ' A' ' 130' ' ' LEU . 20.8 m -70.48 -29.74 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.414 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.479 ' HB3' ' CG ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -63.21 -52.7 61.23 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -46.44 89.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.477 0.656 . . . . 0.0 109.628 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.157 HG21 ' CE2' ' A' ' 123' ' ' PHE . 0.9 OUTLIER -59.53 -33.42 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.623 178.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -34.19 71.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.224 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.443 ' CD ' ' HG3' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -65.3 -42.45 93.05 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.601 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.7 OUTLIER -70.49 -34.01 71.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.661 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 1.021 ' OE1' HD11 ' A' ' 170' ' ' LEU . 0.6 OUTLIER -77.06 -30.61 55.66 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.287 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -70.55 -44.82 66.66 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.879 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -80.66 -20.56 42.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.411 0.624 . . . . 0.0 110.192 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.514 ' O ' ' CG ' ' A' ' 175' ' ' ARG . 0.1 OUTLIER 51.21 28.75 4.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.656 178.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.879 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -31.17 150.56 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 111.1 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.42 -9.19 6.37 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.877 2.385 . . . . 0.0 113.083 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.584 ' OD1' ' HB3' ' A' ' 145' ' ' ALA . 8.4 p-10 -76.35 143.34 40.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.128 0.49 . . . . 0.0 111.861 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 9.1 mt-10 -73.75 127.38 32.65 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.827 0.822 . . . . 0.0 110.88 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.584 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 26.1 m -118.27 121.67 41.02 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.477 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.628 ' HB2' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.46 134.77 44.05 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.062 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.708 HG22 ' HA ' ' A' ' 179' ' ' VAL . 0.5 OUTLIER -113.88 130.81 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.957 -179.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.636 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 45.4 m-85 -123.76 109.28 13.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.034 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.984 ' CE2' HD11 ' A' ' 161' ' ' LEU . 4.4 t80 -122.15 132.26 54.37 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.397 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.84 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -160.85 153.63 24.51 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 119.697 -1.239 . . . . 0.0 113.723 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 1.012 HG21 HD13 ' A' ' 161' ' ' LEU . 2.4 m -167.58 -105.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.822 ' O ' HG21 ' A' ' 183' ' ' VAL . 4.0 p30 -108.3 174.39 5.9 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.936 0.398 . . . . 0.0 111.738 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 187' ' ' SER . 0.5 OUTLIER -34.28 -41.81 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.401 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.0 OUTLIER 153.85 -41.53 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.241 0 O-C-N 123.307 0.379 . . . . 0.0 111.88 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.612 ' HD2' HG23 ' A' ' 157' ' ' THR . 62.4 Cg_exo -40.1 -30.23 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.458 2.105 . . . . 0.0 112.707 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.494 ' CB ' ' ND2' ' A' ' 156' ' ' ASN . 1.2 mp0 -103.61 -13.93 16.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.701 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.012 HD13 HG21 ' A' ' 155' ' ' VAL . 10.9 tp -94.75 171.85 8.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.846 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 1.1 p90 176.28 -163.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.977 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.6 OUTLIER 72.05 9.22 6.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.393 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 1.003 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -57.62 -41.65 79.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 109.986 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 1.003 ' N ' HD13 ' A' ' 164' ' ' ILE . 16.8 m-20 -64.24 -27.76 69.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.873 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -71.57 -47.49 54.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.88 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.54 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -62.95 -31.28 72.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.088 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -60.7 -45.93 92.34 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.6 m -61.76 -31.76 71.97 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 1.021 HD11 ' OE1' ' A' ' 141' ' ' GLN . 1.0 OUTLIER -62.75 -38.02 88.89 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.534 ' HA ' HD11 ' A' ' 177' ' ' LEU . 30.8 mt-10 -66.68 -36.22 82.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.309 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -78.65 -35.93 44.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.31 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.461 ' O ' ' C ' ' A' ' 174' ' ' MET . 0.5 OUTLIER -87.77 -79.14 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.684 0.278 . . . . 0.0 111.606 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.644 ' HB3' HD12 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -23.69 126.5 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.458 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 144' ' ' THR . 1.7 mmp_? -38.41 -91.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.427 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.44 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -119.0 61.3 0.8 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.27 0.557 . . . . 0.0 109.894 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.07 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -103.58 157.77 16.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.622 -179.094 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 1.07 ' N ' HD22 ' A' ' 177' ' ' LEU . 3.7 m -137.1 123.13 20.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.932 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.708 ' HA ' HG22 ' A' ' 151' ' ' ILE . 64.2 t -89.18 136.57 23.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.638 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.468 ' HE2' ' OE1' ' A' ' 194' ' ' GLN . 17.8 tptt -102.63 130.31 49.48 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.642 0.258 . . . . 0.0 110.582 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' NE2' ' A' ' 194' ' ' GLN . . . -97.51 104.93 17.0 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.74 0.781 . . . . 0.0 110.798 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.736 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 97.6 m -91.16 -168.54 2.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.11 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.822 HG21 ' O ' ' A' ' 156' ' ' ASN . 19.4 t 56.47 148.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.913 0.864 . . . . 0.0 111.407 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.98 -69.27 0.54 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.979 -178.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.606 ' N ' ' CD ' ' A' ' 186' ' ' PRO . 0.2 OUTLIER -155.89 34.93 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.584 178.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.633 ' O ' ' CB ' ' A' ' 187' ' ' SER . 83.3 Cg_endo -73.47 -100.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.502 2.135 . . . . 0.0 112.791 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.711 ' HA ' HG22 ' A' ' 157' ' ' THR . 27.4 t 137.69 30.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.972 0.509 . . . . 0.0 111.707 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.618 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 94.06 12.57 56.28 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.3 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.07 63.4 1.57 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.509 ' HB2' ' HB3' ' A' ' 186' ' ' PRO . 4.0 t-105 -132.25 113.7 13.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.723 -177.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.444 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 1.3 mt-10 -84.34 103.66 13.71 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.818 ' HA2' ' HB3' ' A' ' 251' ' ' ALA . . . 146.05 -122.09 1.59 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.056 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.565 ' CB ' ' SG ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -159.21 -79.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.606 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -100.88 148.59 24.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.07 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.651 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -40.49 105.92 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.674 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 3.5 m 148.71 172.72 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 111.264 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.532 ' O ' ' HB ' ' A' ' 198' ' ' ILE . 2.6 Cg_exo -75.86 -70.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.994 2.462 . . . . 0.0 112.606 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.067 HD12 HD21 ' A' ' 201' ' ' LEU . 0.0 OUTLIER 169.13 37.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-O 122.372 1.082 . . . . 0.0 110.136 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 199' ' ' ASP . 0.5 OUTLIER -72.57 -34.24 67.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.054 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -57.81 -45.49 86.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 1.067 HD21 HD12 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -71.39 -29.73 65.28 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.175 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.516 ' O ' ' NE ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -58.06 -52.89 63.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.786 -178.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.23 -43.17 64.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.334 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.61 -29.2 67.83 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.935 ' O ' HG21 ' A' ' 235' ' ' ILE . 0.5 OUTLIER -63.31 -48.69 76.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.422 ' CD ' ' NH2' ' A' ' 233' ' ' ARG . 3.4 mt-10 -67.73 -26.93 66.39 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.666 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 208' ' ' SER . 69.9 m -75.32 -82.5 0.07 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.893 0.377 . . . . 0.0 110.789 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 209' ' ' ASP . 0.1 OUTLIER 166.08 90.31 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.691 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.677 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 0.2 OUTLIER 164.23 53.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.837 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 209' ' ' ASP . . . 151.94 99.92 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.189 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.649 ' HB2' HD13 ' A' ' 235' ' ' ILE . 13.5 t30 172.65 -56.54 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.981 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 12.9 Cg_endo -56.63 -50.97 10.17 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.412 2.075 . . . . 0.0 111.025 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -132.67 109.06 9.44 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.982 ' HB ' HG22 ' A' ' 240' ' ' VAL . 1.0 OUTLIER -122.11 125.08 72.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.611 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.3 m-85 -118.75 126.71 52.49 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.397 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.938 HD23 ' CG1' ' A' ' 124' ' ' VAL . 20.5 mt -125.16 118.81 26.9 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.829 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -122.87 131.66 53.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.658 178.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.63 ' HA3' ' HB3' ' A' ' 250' ' ' ALA . . . 144.08 -151.46 23.44 Favored Glycine 0 C--O 1.224 -0.511 0 C-N-CA 120.058 -1.067 . . . . 0.0 113.075 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 250' ' ' ALA . 56.7 Cg_endo -70.73 166.61 28.23 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.65 2.233 . . . . 0.0 112.459 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.491 ' O ' HG22 ' A' ' 223' ' ' ILE . 27.7 Cg_exo -61.1 -9.07 11.34 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.77 2.313 . . . . 0.0 112.189 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -69.32 -54.83 11.65 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.959 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.918 ' O ' ' HB3' ' A' ' 226' ' ' ALA . 0.0 OUTLIER -55.51 -25.66 38.5 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -77.07 -42.41 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.376 178.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -75.58 -48.68 21.26 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 229' ' ' LEU . . . -77.44 -48.37 17.33 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.918 ' HB3' ' O ' ' A' ' 222' ' ' MET . . . -66.36 -39.49 89.17 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.559 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 223' ' ' ILE . 49.9 t -65.32 -45.83 82.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.543 0.211 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 232' ' ' SER . 0.8 OUTLIER -66.87 -36.3 82.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.302 0.573 . . . . 0.0 109.701 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.627 HD12 HG23 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -60.15 -56.36 22.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.349 179.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.994 HG13 HD11 ' A' ' 235' ' ' ILE . 94.7 t -72.53 -42.57 63.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.242 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.47 ' HD2' ' SG ' ' A' ' 227' ' ' CYS . 30.7 mtp180 -62.38 -30.17 71.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.427 . . . . 0.0 110.074 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 228' ' ' GLU . 21.5 m -91.41 -27.11 18.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.516 ' NE ' ' O ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -57.57 -67.98 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.1 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 146.78 -54.12 0.54 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.852 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.994 HD11 HG13 ' A' ' 230' ' ' VAL . 2.1 pp -34.03 95.21 0.08 OUTLIER Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 121.151 0.5 . . . . 0.0 111.556 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.441 ' N ' ' O ' ' A' ' 234' ' ' GLY . 32.7 Cg_endo -64.48 118.16 5.15 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.855 2.37 . . . . 0.0 112.257 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.464 ' CA ' ' OD1' ' A' ' 211' ' ' ASN . . . -108.97 154.94 16.3 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.56 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -117.95 -37.26 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.738 0.304 . . . . 0.0 110.866 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.572 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 70.5 mm-40 -102.17 35.66 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.22 0.534 . . . . 0.0 110.359 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.982 HG22 ' HB ' ' A' ' 214' ' ' ILE . 1.8 t -89.65 128.83 41.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.365 0.602 . . . . 0.0 110.873 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.645 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.73 142.56 27.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.86 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.55 ' HB2' ' CD1' ' A' ' 223' ' ' ILE . 0.7 OUTLIER -131.32 141.1 49.88 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.912 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 216' ' ' LEU . 7.2 pt-20 -132.12 148.46 52.48 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.243 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 4.5 ptmm? -116.35 105.83 12.96 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.604 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -137.02 144.46 43.25 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.309 178.237 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.617 HD11 ' HG3' ' A' ' 81' ' ' ARG . 5.1 mt 62.43 155.73 0.12 Allowed Pre-proline 0 N--CA 1.467 0.405 0 CA-C-O 121.131 0.491 . . . . 0.0 111.993 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . 0.486 ' CD ' HD22 ' A' ' 246' ' ' LEU . 22.5 Cg_exo -65.1 -141.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.628 2.886 . . . . 0.0 112.363 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.491 ' HA ' ' HG3' ' A' ' 219' ' ' PRO . 0.4 OUTLIER -52.98 151.95 4.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.144 0.497 . . . . 0.0 111.391 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 152.45 -51.61 0.49 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.818 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.63 ' HB3' ' HA3' ' A' ' 218' ' ' GLY . . . -108.19 142.03 39.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.533 -0.334 . . . . 0.0 111.272 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.818 ' HB3' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.837 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.392 0 CA-C-O 120.99 0.217 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.511 ' HB2' ' CG ' ' A' ' 105' ' ' LYS . 2.3 t -102.74 151.52 22.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.672 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.668 ' CE2' ' HB2' ' A' ' 14' ' ' ALA . 5.0 t80 -132.1 152.76 51.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.695 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.592 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -111.13 126.11 54.49 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 110.826 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.717 ' HB1' ' CB ' ' A' ' 31' ' ' LEU . . . -131.18 154.12 48.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.154 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.562 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 19.8 tt0 -98.86 124.89 44.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.018 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.935 HG22 ' O ' ' A' ' 100' ' ' GLN . 6.4 m -70.69 115.71 10.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 110.561 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 17' ' ' VAL . 13.7 p -146.05 14.91 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.047 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 29' ' ' PHE . . . -150.34 117.63 0.86 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.064 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.791 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -155.74 52.82 0.58 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.654 -0.773 . . . . 0.0 109.996 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.667 HD21 HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -95.6 150.72 20.03 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.679 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 7.8 m95 -88.86 112.39 23.2 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.667 HG12 HD21 ' A' ' 20' ' ' ASN . 2.6 m -76.92 -23.13 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.569 0.7 . . . . 0.0 109.74 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.522 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 38.8 m -150.5 -175.27 5.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.3 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.97 -57.02 9.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.632 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -121.92 49.25 1.58 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.724 179.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.602 ' HB ' HG22 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -147.56 141.12 25.48 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.473 -179.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.791 HG21 ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -140.8 148.26 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.162 -178.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.568 ' HG2' HD21 ' A' ' 30' ' ' LEU . 6.7 tt0 -108.74 129.23 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.554 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.876 ' CE1' HD21 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -124.37 121.83 36.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.622 -178.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.823 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -112.3 115.5 28.87 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.887 HD12 HD21 ' A' ' 76' ' ' LEU . 3.2 mt -120.64 133.74 55.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.261 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.465 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 29.6 mt-30 -145.64 110.18 5.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.601 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.562 ' HB2' ' N ' ' A' ' 15' ' ' GLU . 8.1 tmtm? -156.43 6.28 0.18 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.545 ' CD ' ' HB2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.158 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.332 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.86 ' HA ' ' N ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER . . . . . 0 C--O 1.21 -0.986 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.758 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 10.4 ttmt -13.85 74.0 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.854 0.861 . . . . 0.0 112.886 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.596 ' N ' ' O ' ' A' ' 43' ' ' VAL . 55.4 t80 -99.19 -103.59 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.655 0.264 . . . . 0.0 110.868 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.5 OUTLIER -113.42 155.76 44.23 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 120.771 0.319 . . . . 0.0 110.703 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 1.032 ' HD2' HG21 ' A' ' 110' ' ' VAL . 72.8 Cg_exo -49.53 80.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.665 2.243 . . . . 0.0 112.231 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 49.09 63.47 3.93 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.762 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.531 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -48.45 -179.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.576 -0.157 . . . . 0.0 110.576 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.664 ' CD1' ' CB ' ' A' ' 65' ' ' SER . 0.2 OUTLIER -131.95 163.21 28.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.947 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.535 ' O ' ' CB ' ' A' ' 63' ' ' SER . 2.6 mmt -129.9 -168.41 1.95 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.942 0.401 . . . . 0.0 111.703 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -138.47 96.34 3.15 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.957 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -132.82 158.18 43.14 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.764 -177.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.889 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -106.85 151.13 25.62 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.983 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.01 ' CA ' ' O ' ' A' ' 103' ' ' SER 10.821 1.9 mp -53.53 102.83 0.33 Allowed Pre-proline 2 N--CA 7.684 311.237 3 C-N-CA 11.143 -44.223 . . . . 0.0 17.059 -71.011 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.824 ' HD3' ' HB ' ' A' ' 55' ' ' ILE . 7.2 Cg_endo -95.54 4.88 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 1 CA-C-N 103.419 -4.886 . . . . 0.0 111.153 72.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 105.82 2.43 39.77 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.494 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.811 HG23 ' CG ' ' A' ' 56' ' ' PRO . 27.0 p -46.43 -105.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.582 0.229 . . . . 0.0 111.345 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.889 ' N ' HG21 ' A' ' 54' ' ' THR . 6.0 p-10 172.33 29.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 60' ' ' VAL . 58.3 t -137.99 34.47 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.733 0.302 . . . . 0.0 111.223 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.598 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 38.8 t -107.82 -104.77 0.35 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.738 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 162.94 -173.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.095 0.474 . . . . 0.0 111.501 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -88.97 135.05 33.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.21 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.611 ' CE1' ' HB2' ' A' ' 78' ' ' PHE . 1.7 t80 -134.16 126.03 29.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.747 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.664 ' CB ' ' CD1' ' A' ' 50' ' ' PHE . 91.6 p -64.77 106.67 1.05 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.569 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.573 ' CB ' HD13 ' A' ' 76' ' ' LEU . 90.5 Cg_endo -92.15 171.03 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.639 2.226 . . . . 0.0 112.72 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . . . -87.2 159.36 18.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.513 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.575 ' HB3' ' O ' ' A' ' 67' ' ' ALA . 9.2 t30 82.17 138.74 0.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 124.167 0.917 . . . . 0.0 110.371 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.596 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER 151.64 -46.58 0.0 OUTLIER Pre-proline 0 CA--C 1.512 -0.512 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.758 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 97.6 Cg_endo -92.74 55.15 0.53 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.167 2.578 . . . . 0.0 111.609 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.567 ' N ' ' N ' ' A' ' 44' ' ' LYS . 4.6 p30 158.16 109.17 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.413 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.86 ' N ' ' HA ' ' A' ' 43' ' ' VAL . 6.2 Cg_endo -48.18 106.15 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.274 2.649 . . . . 0.0 113.88 -177.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -158.71 -74.73 0.08 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.803 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . 105.36 72.56 0.86 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.011 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 9.7 mtm180 -151.98 109.25 3.57 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.887 HD21 HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -93.88 128.03 39.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.622 -178.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.707 ' N ' HD12 ' A' ' 76' ' ' LEU . 56.0 mt-10 -130.26 115.75 17.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.236 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.686 ' CD1' ' CG2' ' A' ' 80' ' ' ILE . 1.6 p90 -121.5 135.04 55.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.865 0.364 . . . . 0.0 110.996 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.921 HD22 ' HB2' ' A' ' 131' ' ' ALA . 0.6 OUTLIER -114.78 82.17 1.68 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.979 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.686 ' CG2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -92.14 129.2 43.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.108 -179.161 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -77.52 110.13 12.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.233 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.57 ' CG2' ' CB ' ' A' ' 89' ' ' SER . 4.4 m -102.5 127.81 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.293 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.724 HD12 ' HB2' ' A' ' 87' ' ' ARG . 13.5 mt -42.66 166.56 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 83' ' ' LEU . 74.7 Cg_exo -49.77 -50.01 14.37 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.654 2.236 . . . . 0.0 112.391 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 175.83 67.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 87' ' ' ARG . . . 176.27 64.25 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.575 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.724 ' HB2' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER 164.07 -93.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.676 0.274 . . . . 0.0 111.005 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.599 ' CE1' ' CG1' ' A' ' 55' ' ' ILE . 1.1 t80 -94.99 -29.96 14.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.343 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.57 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 4.8 p -81.36 -27.14 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.862 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -75.8 -43.44 46.21 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.571 0.701 . . . . 0.0 109.822 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -72.89 -25.29 61.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.934 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.7 OUTLIER -68.46 -47.49 67.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.282 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.446 ' O ' ' CD ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -90.2 -25.61 20.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 12.5 m120 -96.9 2.29 51.5 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.166 -0.213 . . . . 0.0 111.343 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.59 19.72 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.955 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . . . -146.96 27.68 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.671 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 96' ' ' ALA . 39.7 mmm-85 -45.39 173.36 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.114 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.736 HG13 ' HB ' ' A' ' 16' ' ' VAL . 0.5 OUTLIER -95.31 -144.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.44 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.37 -44.9 1.99 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.986 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.935 ' O ' HG22 ' A' ' 16' ' ' VAL . 9.3 pt20 -83.52 -158.52 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.282 0.563 . . . . 0.0 112.372 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.521 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 5.3 p -125.13 144.19 36.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.483 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.957 HD11 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.32 136.1 49.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.711 0.291 . . . . 0.0 110.638 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 1.01 ' O ' ' CA ' ' A' ' 55' ' ' ILE . 16.1 t -102.67 127.22 49.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.03 0.443 . . . . 0.0 111.066 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.847 ' HA ' ' CA ' ' A' ' 55' ' ' ILE . 2.0 m -101.37 122.61 53.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.978 ' HG3' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -130.18 113.01 13.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.624 -178.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 52' ' ' ASP . . . -173.56 85.14 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.972 -1.108 . . . . 0.0 113.779 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.01 64.37 1.36 Allowed 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.353 2.036 . . . . 0.0 110.786 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.44 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -88.47 173.75 8.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.231 -178.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.573 ' O ' ' CE2' ' A' ' 50' ' ' PHE . . . -108.54 174.51 18.79 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.282 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.032 HG21 ' HD2' ' A' ' 47' ' ' PRO . 18.7 m -107.46 109.2 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 121.605 0.717 . . . . 0.0 110.516 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 1.3 m-85 -121.54 132.82 54.92 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.26 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 215' ' ' TYR . . . 124.43 -86.98 0.37 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.012 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.6 ' HB3' ' CE2' ' A' ' 123' ' ' PHE . 0.4 OUTLIER -81.75 118.36 22.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.935 0.397 . . . . 0.0 110.001 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.641 ' CB ' ' CD2' ' A' ' 241' ' ' PHE . 0.9 OUTLIER -137.5 114.63 10.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.959 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.21 129.54 53.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.205 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.05 14.28 24.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.956 0.408 . . . . 0.0 111.114 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.26 -66.23 1.81 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.527 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.535 ' HA ' ' HB2' ' A' ' 147' ' ' ASN . 17.3 ttm -128.82 89.05 2.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.896 0.379 . . . . 0.0 110.376 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.66 ' HB3' ' HE ' ' A' ' 121' ' ' ARG . . . -167.15 142.92 3.5 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.597 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 97.1 Cg_endo -78.28 108.81 2.55 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 123.148 2.565 . . . . 0.0 112.219 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.66 ' HE ' ' HB3' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -136.99 153.03 50.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.949 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.616 ' CD2' ' HB2' ' A' ' 150' ' ' ARG . 2.1 m-85 -120.64 123.03 41.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.022 0.439 . . . . 0.0 110.985 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.945 ' CE1' HG11 ' A' ' 133' ' ' VAL . 45.6 t80 -108.23 111.3 23.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.181 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.834 HG23 ' HB2' ' A' ' 152' ' ' TYR . 3.2 p -98.15 112.25 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 121.473 0.654 . . . . 0.0 111.914 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.838 ' HB2' ' HE1' ' A' ' 123' ' ' PHE . . . -118.23 132.22 56.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.815 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.706 ' O ' HD21 ' A' ' 246' ' ' LEU . . . -123.98 101.97 0.7 Allowed Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.433 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.596 ' N ' HG12 ' A' ' 155' ' ' VAL . . . 142.1 -152.01 23.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.006 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.745 ' CG2' HD23 ' A' ' 79' ' ' LEU . 32.1 m -119.39 -15.82 9.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.056 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.534 ' C ' ' CZ ' ' A' ' 245' ' ' PHE . . . -66.65 9.37 0.9 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.8 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.934 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -80.4 4.72 17.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 120.875 0.369 . . . . 0.0 110.01 179.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.921 ' HB2' HD22 ' A' ' 79' ' ' LEU . . . -46.8 -52.5 31.77 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.516 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 131' ' ' ALA . 39.8 Cg_endo -65.68 -30.83 50.43 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.915 1.743 . . . . 0.0 109.946 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.954 ' O ' HG23 ' A' ' 137' ' ' VAL . 41.6 t -67.27 -45.75 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.403 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.934 HG13 ' HG ' ' A' ' 130' ' ' LEU . 15.5 m -70.6 -29.81 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.012 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.21 -52.56 58.21 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 109.991 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.562 ' CE ' ' CE ' ' A' ' 140' ' ' MET . 7.8 tpt -62.29 -44.12 97.25 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.312 0.577 . . . . 0.0 109.504 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 133' ' ' VAL . 61.5 t -61.61 -30.21 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.079 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -36.29 80.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.412 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -42.83 87.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 110.236 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.646 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 2.4 tpp -70.56 -33.26 70.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.002 0.906 . . . . 0.0 110.103 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.85 HE21 HD21 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -77.32 -29.81 53.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.307 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -71.7 -45.11 62.89 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.796 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -77.25 -22.41 52.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.389 0.614 . . . . 0.0 109.798 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 145' ' ' ALA . 1.2 p 58.4 26.3 13.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.229 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.796 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -37.01 160.4 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.541 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.64 14.15 1.05 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.12 2.547 . . . . 0.0 113.328 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 118' ' ' MET . 2.1 p-10 -83.14 132.3 35.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.99 0.424 . . . . 0.0 111.779 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 1.0 OUTLIER -73.94 105.12 5.05 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.626 0.727 . . . . 0.0 111.08 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.697 ' HB ' HD11 ' A' ' 177' ' ' LEU . 2.7 m -113.48 115.5 28.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.109 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.616 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -105.66 139.81 39.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.094 0.473 . . . . 0.0 110.157 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.42 HD11 ' HD1' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -133.98 126.93 51.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.51 -178.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.834 ' HB2' HG23 ' A' ' 124' ' ' VAL . 17.3 m-85 -103.15 108.7 19.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.551 ' CE1' ' CD1' ' A' ' 130' ' ' LEU . 31.9 t80 -125.92 156.36 39.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 182' ' ' CYS . . . 153.87 -172.62 32.57 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.711 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.741 HG21 HD13 ' A' ' 161' ' ' LEU . 22.4 m -161.97 -124.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.621 ' CA ' HG22 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -108.67 160.14 16.18 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 117.484 0.129 . . . . 0.0 110.978 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.68 HG22 ' N ' ' A' ' 187' ' ' SER . 0.1 OUTLIER -4.69 -65.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.66 0.784 . . . . 0.0 112.315 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 156' ' ' ASN . 1.4 mt-10 165.67 59.14 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.229 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.458 ' HD3' ' H ' ' A' ' 158' ' ' GLU . 26.5 Cg_exo -61.2 -16.45 46.49 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.736 1.624 . . . . 0.0 109.491 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.496 ' O ' ' O ' ' A' ' 161' ' ' LEU . 1.3 tp10 174.26 -58.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.779 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.741 HD13 HG21 ' A' ' 155' ' ' VAL . 3.5 tp 41.63 -177.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.306 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.566 ' CG ' ' O ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER 154.56 179.95 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.701 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.574 ' CE1' ' HG2' ' A' ' 166' ' ' GLU . 0.0 OUTLIER 83.01 3.41 1.0 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.695 179.323 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 1.019 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -56.84 -41.21 75.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 1.019 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.6 OUTLIER -64.9 -27.6 68.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.831 178.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.574 ' HG2' ' CE1' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -71.54 -46.61 59.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.955 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.954 ' HB2' HG21 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -59.72 -30.09 68.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.515 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.467 ' HE3' HG12 ' A' ' 164' ' ' ILE . 11.9 mttt -75.83 -24.47 55.85 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -32.75 65.96 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.745 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.982 ' HB2' HD23 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -66.89 -48.09 69.8 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.163 176.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.924 ' OE2' HG12 ' A' ' 179' ' ' VAL . 1.2 mm-40 -56.97 -39.61 74.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.284 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -29.32 40.22 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.532 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 174' ' ' MET . 49.5 m -79.63 -72.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.778 ' CB ' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -52.42 -163.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.182 0.515 . . . . 0.0 111.76 -178.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -114.24 -42.34 3.36 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.604 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.499 ' HB2' ' CB ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -132.21 64.02 1.61 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.077 -179.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.982 HD23 ' HB2' ' A' ' 170' ' ' LEU . 3.2 mp -102.69 152.74 20.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.262 0.554 . . . . 0.0 111.388 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.482 ' OG1' ' HD3' ' A' ' 150' ' ' ARG . 27.3 m -136.51 114.82 11.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.899 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.954 HG21 ' HB2' ' A' ' 167' ' ' LEU . 8.9 p -99.63 135.27 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.431 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -112.74 135.62 53.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.027 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.513 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -104.38 106.76 17.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.213 0.53 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.655 ' HB2' ' HA3' ' A' ' 154' ' ' GLY . 31.3 m -80.07 -163.7 0.58 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.334 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.621 HG22 ' CA ' ' A' ' 156' ' ' ASN . 24.1 t 66.72 149.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 122.365 1.078 . . . . 0.0 113.639 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.695 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -139.09 -84.17 0.26 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.846 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.699 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 0.2 OUTLIER -140.78 29.27 0.11 Allowed Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.43 176.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.699 ' HD3' ' N ' ' A' ' 185' ' ' HIS . 52.3 Cg_exo -53.88 -138.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 122.209 1.939 . . . . 0.0 113.714 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.68 ' N ' HG22 ' A' ' 157' ' ' THR . 47.0 t 173.24 35.59 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.402 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.498 ' H ' ' CB ' ' A' ' 156' ' ' ASN . . . 86.52 16.18 62.56 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.145 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.51 64.76 1.45 Allowed 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' A' ' 249' ' ' GLY . 13.3 t-105 -133.37 127.39 33.37 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.687 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.516 ' HG2' ' CG ' ' A' ' 219' ' ' PRO . 1.2 mt-10 -113.98 105.74 13.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.717 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.529 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 148.44 -108.6 0.42 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.351 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.566 ' HA ' ' HB3' ' A' ' 182' ' ' CYS . 16.4 mt-10 -168.89 -95.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.513 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 64.5 mt-30 -86.95 133.95 33.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.61 ' HA2' ' CD1' ' A' ' 184' ' ' TRP . . . -22.24 106.82 0.01 OUTLIER Glycine 0 C--N 1.333 0.406 0 O-C-N 123.717 0.635 . . . . 0.0 113.214 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 5.9 m 140.11 158.98 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 O-C-N 124.245 0.615 . . . . 0.0 110.539 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.455 ' O ' ' HB ' ' A' ' 198' ' ' ILE . 49.4 Cg_exo -54.08 -70.44 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.445 2.097 . . . . 0.0 112.077 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.72 HG23 ' O ' ' A' ' 198' ' ' ILE . 0.3 OUTLIER 169.65 29.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 121.665 0.745 . . . . 0.0 111.111 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.507 ' OD1' ' NH2' ' A' ' 202' ' ' ARG . 1.4 m-20 -64.11 -36.81 85.25 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.312 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.33 -37.53 78.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.547 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -69.42 -35.22 75.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.812 0.339 . . . . 0.0 110.978 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.704 ' HG2' HD13 ' A' ' 229' ' ' LEU . 26.8 mtt180 -59.37 -49.96 75.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.421 0.629 . . . . 0.0 111.246 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -31.94 71.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.63 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.451 ' OD1' ' OD2' ' A' ' 209' ' ' ASP . 0.5 OUTLIER -58.56 -43.23 89.29 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.287 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.725 HD12 ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -61.24 -48.24 82.36 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.486 ' OE2' ' HG3' ' A' ' 233' ' ' ARG . 2.4 mt-10 -62.25 -22.15 65.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.706 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.65 -86.8 0.28 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.823 0.344 . . . . 0.0 111.623 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 0.0 OUTLIER 179.37 97.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.806 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.674 ' O ' ' HB3' ' A' ' 210' ' ' ALA . 3.9 p30 152.55 87.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.537 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . 1.043 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 96.37 106.09 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.657 ' HA ' HD13 ' A' ' 235' ' ' ILE . 1.1 t30 -172.39 -58.82 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.737 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 10.0 Cg_endo -52.72 -64.47 0.18 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.218 1.945 . . . . 0.0 110.895 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.551 ' HA ' HG21 ' A' ' 240' ' ' VAL . 0.4 OUTLIER -125.34 110.19 13.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.371 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 1.043 HD11 ' HB1' ' A' ' 210' ' ' ALA . 1.0 OUTLIER -107.45 125.71 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 114' ' ' LYS . 2.3 m-85 -116.13 129.68 56.44 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.648 HD23 HG12 ' A' ' 124' ' ' VAL . 0.6 OUTLIER -139.86 123.42 17.23 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -178.055 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 123' ' ' PHE . 2.5 m -123.75 110.37 14.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.71 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.667 ' HA3' ' HB3' ' A' ' 250' ' ' ALA . . . -176.98 -156.85 16.73 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.678 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.518 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 37.3 Cg_endo -65.79 175.61 4.35 Favored 'Trans proline' 0 N--CA 1.466 -0.11 0 C-N-CA 122.326 2.017 . . . . 0.0 111.687 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 219' ' ' PRO . 26.2 Cg_endo -62.53 -8.84 13.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.457 2.105 . . . . 0.0 112.136 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -83.15 -40.36 9.3 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 120.734 -0.745 . . . . 0.0 113.127 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.56 ' HB2' ' HB1' ' A' ' 250' ' ' ALA . 0.0 OUTLIER -56.38 -33.85 66.12 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.536 ' CB ' ' HE2' ' A' ' 222' ' ' MET . 0.0 OUTLIER -77.6 -36.81 23.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.896 178.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.481 ' OD1' HG22 ' A' ' 223' ' ' ILE . 16.0 m-20 -73.94 -47.67 35.98 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 251' ' ' ALA . . . -73.22 -48.68 33.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 1.017 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -60.85 -34.07 74.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.823 0.344 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 223' ' ' ILE . 8.0 m -70.0 -32.28 70.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.029 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -71.09 -45.32 63.93 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.568 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.704 HD13 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -62.43 -46.21 89.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.112 0.482 . . . . 0.0 110.799 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 1.017 HG23 ' O ' ' A' ' 226' ' ' ALA . 13.0 t -60.01 -45.58 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.106 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -67.55 -29.82 69.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.187 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -31.37 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.945 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.725 ' HD3' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -84.22 -83.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.135 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 235' ' ' ILE . . . 140.87 -23.68 2.61 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.33 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.657 HD13 ' HA ' ' A' ' 211' ' ' ASN . 1.4 pp -31.51 105.17 0.23 Allowed Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-O 121.128 0.489 . . . . 0.0 111.681 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.486 ' O ' ' OD1' ' A' ' 211' ' ' ASN . 79.0 Cg_exo -33.15 158.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.605 2.87 . . . . 0.0 112.542 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 238' ' ' GLU . . . 68.84 6.08 49.65 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.693 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.665 ' C ' HG11 ' A' ' 230' ' ' VAL . 2.9 mp0 29.12 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.841 0.353 . . . . 0.0 111.253 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.985 ' HG2' HG21 ' A' ' 230' ' ' VAL . 7.5 mt-30 -122.68 -2.62 8.83 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.658 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.801 HG12 ' N ' ' A' ' 241' ' ' PHE . 2.3 t 52.25 -82.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.153 0.501 . . . . 0.0 111.344 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.801 ' N ' HG12 ' A' ' 240' ' ' VAL . 10.1 m-85 -119.28 125.4 49.01 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.26 129.62 37.89 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.874 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -132.21 148.26 52.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.048 178.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -125.37 106.55 9.91 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.657 ' O ' HD23 ' A' ' 246' ' ' LEU . 0.2 OUTLIER -136.94 144.9 43.67 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 178.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.706 HD21 ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER 83.29 160.8 0.12 Allowed Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.429 0.691 . . . . 0.0 112.775 179.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -61.66 -138.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.67 2.913 . . . . 0.0 111.741 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.435 ' HB2' ' C ' ' A' ' 190' ' ' TRP . 10.1 p -72.84 145.84 46.67 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.298 0.571 . . . . 0.0 110.858 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 190' ' ' TRP . . . 167.98 -53.99 0.22 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.667 ' HB3' ' HA3' ' A' ' 218' ' ' GLY . . . -107.69 149.12 28.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.54 -0.33 . . . . 0.0 110.49 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.687 ' O ' ' HB3' ' A' ' 225' ' ' ALA . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.173 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 m -96.29 150.6 20.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.889 0.376 . . . . 0.0 111.07 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.592 ' CE1' ' O ' ' A' ' 13' ' ' GLU . 2.6 t80 -132.09 149.02 52.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.939 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.592 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 3.9 mt-10 -108.79 119.81 40.63 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.873 0.368 . . . . 0.0 111.02 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.897 ' O ' HG13 ' A' ' 101' ' ' VAL . . . -119.74 131.78 55.46 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.965 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.544 ' CB ' ' HB2' ' A' ' 33' ' ' LYS . 1.2 tt0 -92.71 137.57 32.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.117 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.763 ' HA ' HD23 ' A' ' 31' ' ' LEU . 10.9 t -71.28 124.55 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.75 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 17' ' ' VAL . 7.6 p -154.36 22.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.126 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.496 ' HA3' ' HG ' ' A' ' 30' ' ' LEU . . . -150.55 -139.77 3.09 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.548 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.767 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER 82.57 62.71 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.174 0.512 . . . . 0.0 110.471 -179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.694 HD21 HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -101.69 148.96 24.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.589 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 12.2 m95 -89.16 114.63 25.94 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.694 HG12 HD21 ' A' ' 20' ' ' ASN . 1.5 m -95.04 -27.6 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 121.529 0.681 . . . . 0.0 109.301 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.543 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 13.8 m -143.9 173.68 11.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.348 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -54.27 -58.07 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.958 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 0.3 OUTLIER -112.69 39.23 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.801 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.617 ' CG2' HG21 ' A' ' 128' ' ' THR . 0.2 OUTLIER -145.92 135.53 23.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.522 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.767 HG21 ' CD2' ' A' ' 19' ' ' LEU . 1.5 p -140.6 147.19 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.084 0.469 . . . . 0.0 112.019 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -116.57 122.17 43.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.981 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.751 ' CZ ' HG13 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -114.09 121.35 43.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.797 0.332 . . . . 0.0 111.726 -178.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.822 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -108.62 116.37 31.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.883 179.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.97 HD22 HD11 ' A' ' 102' ' ' LEU . 2.3 mt -122.63 133.15 54.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.048 0.452 . . . . 0.0 111.746 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.486 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -145.05 131.37 19.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.079 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.544 ' HB2' ' CB ' ' A' ' 15' ' ' GLU . 7.2 tptm -164.74 -33.38 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.846 HG21 ' ND2' ' A' ' 68' ' ' ASN . 0.3 OUTLIER . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 121.435 0.636 . . . . 0.0 111.849 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HE3' ' CE1' ' A' ' 45' ' ' PHE . 4.8 tttp -154.72 -142.03 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.733 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.547 ' CE1' ' HE3' ' A' ' 44' ' ' LYS . 22.2 p90 -122.06 78.11 1.45 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.376 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 48' ' ' GLY . 28.1 mm-40 -113.04 166.55 10.86 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.579 ' HD2' HG11 ' A' ' 110' ' ' VAL . 32.1 Cg_exo -58.05 65.98 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.389 2.06 . . . . 0.0 111.616 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 40.39 62.46 1.57 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.223 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.508 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -30.32 148.98 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.716 0.258 . . . . 0.0 110.844 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.701 ' C ' HD23 ' A' ' 108' ' ' LEU . 5.3 m-85 -116.16 163.17 16.36 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.719 ' N ' HD23 ' A' ' 108' ' ' LEU . 4.7 mtt -131.41 162.56 29.89 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.962 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 105' ' ' LYS . 4.4 t0 -125.31 102.46 7.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.842 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.983 HD12 HG12 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -150.07 156.95 42.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.958 HG23 ' C ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -85.63 154.69 21.52 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.313 178.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.716 HD11 ' CZ ' ' A' ' 88' ' ' PHE . 1.3 mt -30.4 -71.91 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 123.411 0.444 . . . . 0.0 109.906 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.907 ' CG ' HG23 ' A' ' 58' ' ' THR . 9.3 Cg_endo -99.82 4.47 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.568 2.179 . . . . 0.0 111.583 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 101.41 -3.05 54.0 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.832 -178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.907 HG23 ' CG ' ' A' ' 56' ' ' PRO . 64.9 p -27.81 -87.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 122.841 0.456 . . . . 0.0 112.084 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.683 ' O ' HG12 ' A' ' 60' ' ' VAL . 43.9 p-10 -150.45 40.02 0.75 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.958 ' C ' HG23 ' A' ' 54' ' ' THR . 0.3 OUTLIER 90.68 121.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 178.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.723 ' N ' HG23 ' A' ' 54' ' ' THR . 40.3 t -120.72 -66.95 1.01 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.708 0.766 . . . . 0.0 109.931 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -170.41 157.94 6.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.227 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.895 ' HB2' HD21 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -88.73 120.7 30.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.669 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.527 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 3.0 t80 -111.7 121.18 44.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.901 0.381 . . . . 0.0 111.608 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.694 ' CB ' ' CD1' ' A' ' 50' ' ' PHE . 82.4 p -55.56 98.69 0.17 Allowed Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.732 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.983 ' HB2' HD13 ' A' ' 76' ' ' LEU . 2.1 Cg_endo -82.94 155.34 15.13 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.83 2.353 . . . . 0.0 111.54 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 132' ' ' PRO . . . -144.65 130.65 19.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.846 ' ND2' HG21 ' A' ' 43' ' ' VAL . 10.0 t-20 -115.88 -63.62 1.43 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.764 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 68' ' ' ASN . 0.6 OUTLIER 144.42 154.44 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.936 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.652 ' HD2' HD23 ' A' ' 69' ' ' LEU . 18.0 Cg_endo -59.63 96.89 0.1 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.283 1.989 . . . . 0.0 111.225 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.557 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -179.2 138.06 0.33 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.058 0.456 . . . . 0.0 111.519 -179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.07 79.63 3.07 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.377 . . . . 0.0 111.998 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.461 ' OE1' ' NH1' ' A' ' 75' ' ' ARG . 39.3 mt-10 -144.23 -72.84 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.961 0.41 . . . . 0.0 110.008 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.504 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . 122.83 97.08 1.33 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.335 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 74' ' ' GLY . 85.0 mtm-85 -162.33 83.66 0.55 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 122.633 0.373 . . . . 0.0 110.888 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.983 HD13 ' HB2' ' A' ' 66' ' ' PRO . 30.0 mt -96.91 145.94 25.42 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.61 0.719 . . . . 0.0 112.496 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 5.9 pt-20 -131.24 141.89 50.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.433 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.662 ' CE1' ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -115.95 133.76 55.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.013 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.995 HD22 ' HB2' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -101.58 82.31 2.28 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.662 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -91.22 118.01 35.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.854 -178.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.432 ' HG2' HG23 ' A' ' 26' ' ' THR . 0.0 OUTLIER -78.33 95.99 5.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.584 ' CG1' ' CG2' ' A' ' 80' ' ' ILE . 2.3 m -94.0 142.12 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.999 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.518 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -68.14 172.63 4.05 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.799 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 83' ' ' LEU . 44.6 Cg_endo -68.68 58.39 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 0.0 112.149 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 84' ' ' PRO . 0.6 OUTLIER 67.48 72.58 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 87' ' ' ARG . . . 173.12 66.58 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.691 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 163.09 -90.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 111.132 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.716 ' CZ ' HD11 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -108.6 -27.19 10.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.26 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.572 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -60.1 -32.99 71.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 111.185 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 0.8 OUTLIER -75.93 -32.0 59.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.386 0.612 . . . . 0.0 110.842 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.562 ' CG ' HD13 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -68.94 -51.26 41.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.878 -178.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.646 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -71.59 -30.75 66.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -31.04 18.07 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.662 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 2.1 t-20 -95.87 -11.29 26.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.7 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 91' ' ' TYR . 2.2 t70 -135.58 -15.28 1.87 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.646 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . . . -119.43 29.02 7.85 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.993 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 96' ' ' ALA . 1.1 mmt180 -56.58 -163.37 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.614 HG13 HG12 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -86.74 -153.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-O 121.195 0.522 . . . . 0.0 110.65 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.41 -47.26 1.38 Allowed Glycine 0 C--N 1.316 -0.548 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.469 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.756 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -96.55 179.45 5.0 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 14' ' ' ALA . 99.6 t -121.85 145.23 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.259 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.97 HD11 HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.6 120.36 40.74 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 108.57 13.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.983 HG12 HD12 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -108.49 165.43 4.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.066 0.46 . . . . 0.0 112.079 -177.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.63 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -132.24 112.49 12.29 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 51' ' ' MET . . . -103.54 44.97 1.38 Allowed Glycine 0 CA--C 1.519 0.321 0 C-N-CA 119.533 -1.318 . . . . 0.0 115.74 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.518 ' HD3' ' C ' ' A' ' 105' ' ' LYS . 82.5 Cg_endo -81.83 38.81 0.78 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.173 1.915 . . . . 0.0 111.481 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.895 HD21 ' HB2' ' A' ' 63' ' ' SER . 0.0 OUTLIER -88.33 173.19 8.89 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.813 0.816 . . . . 0.0 112.761 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.01 173.42 19.41 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.477 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.579 HG11 ' HD2' ' A' ' 47' ' ' PRO . 9.3 m -108.63 107.16 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 117.925 0.862 . . . . 0.0 110.923 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 0.3 OUTLIER -123.74 122.53 38.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.476 178.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 215' ' ' TYR . . . 123.35 -84.78 0.37 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.283 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.588 ' HB2' ' CE2' ' A' ' 123' ' ' PHE . 7.7 tp -75.88 117.87 18.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.057 0.456 . . . . 0.0 110.073 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.616 ' O ' ' CZ ' ' A' ' 215' ' ' TYR . 0.1 OUTLIER -138.7 127.3 23.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.605 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.535 ' HA ' ' CZ ' ' A' ' 121' ' ' ARG . 2.2 pp20? -112.45 134.56 53.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.624 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -110.32 6.35 22.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.974 0.416 . . . . 0.0 111.197 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.81 -75.73 0.4 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.544 ' HA ' ' CB ' ' A' ' 147' ' ' ASN . 3.7 mpp? -129.91 89.33 2.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.887 0.375 . . . . 0.0 110.524 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.49 ' O ' ' HD3' ' A' ' 121' ' ' ARG . . . -158.36 144.2 12.41 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.243 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.86 94.67 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.599 2.2 . . . . 0.0 111.613 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -127.81 150.45 49.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.257 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.745 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -124.17 144.39 49.95 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.923 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.885 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.9 t80 -128.35 115.36 18.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.746 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.76 HG21 ' CE ' ' A' ' 222' ' ' MET . 8.0 p -98.82 111.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.101 0.477 . . . . 0.0 111.33 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.564 ' HB2' HG11 ' A' ' 133' ' ' VAL . . . -111.31 132.84 54.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.784 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.454 ' HA3' ' C ' ' A' ' 249' ' ' GLY . . . -129.18 104.34 0.64 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.412 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 134.64 -166.13 24.33 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.033 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.839 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -98.84 -28.15 13.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.118 0.485 . . . . 0.0 110.56 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.57 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -65.5 8.24 0.8 Allowed Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.764 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.829 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -79.23 4.51 14.75 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.995 ' HB2' HD22 ' A' ' 79' ' ' LEU . . . -46.9 -44.57 47.26 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.904 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 8.9 Cg_exo -69.48 -30.89 22.86 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.425 2.084 . . . . 0.0 109.748 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.074 ' O ' HG23 ' A' ' 137' ' ' VAL . 13.7 t -68.12 -53.08 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.576 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.829 HG13 ' HG ' ' A' ' 130' ' ' LEU . 29.1 m -66.57 -30.47 49.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.625 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.3 OUTLIER -61.16 -50.73 71.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.183 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.438 ' HA ' ' CD ' ' A' ' 139' ' ' GLN . 0.5 OUTLIER -66.93 -43.03 84.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.791 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.074 HG23 ' O ' ' A' ' 133' ' ' VAL . 13.5 t -59.81 -37.59 72.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 134' ' ' VAL . 3.2 mtm-85 -69.43 -31.03 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.1 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.492 ' O ' ' HB3' ' A' ' 143' ' ' TRP . 43.7 mt-30 -63.15 -43.03 99.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.259 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.475 ' HE1' HG21 ' A' ' 149' ' ' THR . 3.9 ptp -71.38 -48.87 47.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.189 0.519 . . . . 0.0 110.6 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.529 ' NE2' ' CD2' ' A' ' 177' ' ' LEU . 0.7 OUTLIER -58.2 -30.99 66.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.716 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 138' ' ' ARG . 1.3 mt-10 -82.16 -37.31 26.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.266 0.555 . . . . 0.0 110.085 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.789 ' CD1' ' HB2' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -67.59 -9.65 44.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.651 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 143' ' ' TRP . 1.6 p 87.55 10.45 0.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.766 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.789 ' HB2' ' CD1' ' A' ' 143' ' ' TRP . . . -38.79 98.42 0.17 Allowed Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.737 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.543 ' HA ' ' HB2' ' A' ' 175' ' ' ARG . 81.0 Cg_endo -78.12 8.41 3.54 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.906 2.404 . . . . 0.0 112.679 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.583 ' OD1' ' HB1' ' A' ' 145' ' ' ALA . 14.7 p-10 -78.58 150.3 32.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.944 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 176' ' ' ASN . 0.2 OUTLIER -74.18 104.77 5.09 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.49 0.662 . . . . 0.0 110.99 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.7 OUTLIER -123.01 117.21 24.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.936 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.659 ' CB ' ' CD2' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -102.71 141.55 35.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.885 HD13 ' O ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -134.27 126.23 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.745 ' CE1' ' HB3' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -102.89 108.1 19.17 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.6 ' CD1' ' CD1' ' A' ' 130' ' ' LEU . 7.1 t80 -124.91 153.96 41.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.852 0.358 . . . . 0.0 111.949 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.686 ' O ' HG13 ' A' ' 155' ' ' VAL . . . 150.07 -168.21 30.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.711 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.91 HG21 HD13 ' A' ' 161' ' ' LEU . 16.4 m -163.52 -120.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.781 ' O ' HG21 ' A' ' 183' ' ' VAL . 2.4 p-10 -103.93 -166.01 1.21 Allowed 'General case' 0 C--N 1.35 0.613 0 C-N-CA 122.371 0.268 . . . . 0.0 111.122 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.61 ' CG2' ' HA ' ' A' ' 187' ' ' SER . 0.1 OUTLIER -28.03 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.608 0.242 . . . . 0.0 111.415 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 156' ' ' ASN . 39.6 mt-10 93.35 41.0 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.684 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 37.7 Cg_endo -66.85 -26.09 44.91 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 C-N-CA 122.137 1.891 . . . . 0.0 110.626 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -130.58 20.8 5.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.208 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.91 HD13 HG21 ' A' ' 155' ' ' VAL . 9.9 tp -88.57 165.31 14.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.063 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.478 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 0.9 OUTLIER 176.26 -160.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.998 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.3 OUTLIER 72.85 26.63 2.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.243 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 1.047 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -69.8 -35.87 67.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.912 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 1.047 ' N ' HD13 ' A' ' 164' ' ' ILE . 9.2 m-20 -62.29 -28.47 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.299 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.466 ' O ' ' CD2' ' A' ' 170' ' ' LEU . 2.3 mm-40 -72.08 -47.46 51.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.705 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -64.22 -30.25 71.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.763 178.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 172' ' ' ARG . 4.8 mtmm -72.55 -24.8 61.17 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -35.82 71.17 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.415 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -67.64 -48.52 66.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.476 ' O ' ' SD ' ' A' ' 174' ' ' MET . 3.3 mt-10 -57.65 -32.15 67.0 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.864 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 168' ' ' LYS . 1.1 mtt-85 -79.56 -41.69 26.68 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 174' ' ' MET . 6.4 t -93.1 -50.67 5.4 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.911 ' HB2' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -35.62 167.19 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.966 0.889 . . . . 0.0 112.892 -178.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.543 ' HB2' ' HA ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -99.75 -71.92 0.68 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.473 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -124.63 56.31 1.3 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.787 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.911 HD13 ' HB2' ' A' ' 174' ' ' MET . 5.8 mp -114.47 154.69 27.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.397 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.472 ' OG1' ' HG3' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -136.06 117.79 15.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.464 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.464 ' HB ' ' OE2' ' A' ' 171' ' ' GLU . 91.0 t -89.66 134.32 29.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.6 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.552 ' CB ' ' HA ' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -104.13 135.72 45.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.013 0.435 . . . . 0.0 111.676 -179.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -103.14 107.05 17.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.905 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.698 ' HB3' ' HA ' ' A' ' 193' ' ' GLU . 38.1 m -79.91 -168.26 1.55 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.311 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 155' ' ' VAL . 52.5 t 70.07 148.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.875 0.845 . . . . 0.0 112.835 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.714 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.53 -53.3 0.6 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.586 -177.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.547 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 4.7 p-80 167.77 62.2 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 113.623 -1.626 . . . . 0.0 108.696 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.626 ' O ' ' CB ' ' A' ' 187' ' ' SER . 67.0 Cg_endo -95.65 -96.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.797 2.998 . . . . 0.0 114.305 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.626 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 28.6 t 136.78 78.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.985 0.514 . . . . 0.0 110.34 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.443 ' HA2' ' CG ' ' A' ' 156' ' ' ASN . . . 41.65 23.13 0.11 Allowed Glycine 0 C--N 1.329 0.148 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.066 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 187' ' ' SER . 0.2 OUTLIER -139.23 62.05 1.54 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.541 ' NE1' ' O ' ' A' ' 193' ' ' GLU . 19.4 t-105 -135.24 129.12 33.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 1.052 ' C ' ' HB3' ' A' ' 251' ' ' ALA . 1.6 mp0 -113.83 104.87 12.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.376 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.628 ' N ' ' HB3' ' A' ' 251' ' ' ALA . . . 147.0 -113.07 0.63 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.272 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.698 ' HA ' ' HB3' ' A' ' 182' ' ' CYS . 80.8 mt-10 -161.42 -118.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.578 ' O ' ' O ' ' A' ' 195' ' ' GLY . 2.1 tt0 -87.75 117.74 26.79 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 194' ' ' GLN . . . 31.74 104.31 0.01 OUTLIER Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.348 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.538 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 5.86 66.68 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.2 0.6 . . . . 0.0 112.435 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.502 ' HG2' ' HB2' ' A' ' 193' ' ' GLU . 22.2 Cg_endo -97.12 22.6 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.28 2.653 . . . . 0.0 113.872 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 201' ' ' LEU . 0.2 OUTLIER -87.92 -9.44 10.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.469 -179.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.16 -36.99 83.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -61.03 -29.58 69.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.334 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.557 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -64.04 -39.64 94.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.938 0.399 . . . . 0.0 110.13 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.638 ' HG2' HD13 ' A' ' 229' ' ' LEU . 12.9 mtt180 -58.88 -48.37 81.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.514 0.673 . . . . 0.0 110.259 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.29 -32.04 68.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.013 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.76 -42.65 89.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.707 ' HB2' HG21 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -60.47 -48.05 83.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.428 ' OE1' ' HG3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -61.31 -21.05 63.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.019 178.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.0 t -86.31 -90.5 0.11 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.773 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 173.65 33.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.473 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.673 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 0.0 OUTLIER -145.09 58.46 1.29 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . 0.851 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 148.87 101.02 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.23 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.595 ' O ' HG23 ' A' ' 240' ' ' VAL . 19.1 t30 173.84 -56.91 0.0 OUTLIER Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.175 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 12.3 Cg_endo -57.25 -53.74 4.43 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.265 1.977 . . . . 0.0 111.144 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.536 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -133.0 108.59 8.99 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.508 0.671 . . . . 0.0 109.319 178.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.93 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.8 OUTLIER -123.51 131.04 73.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.128 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.623 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -127.89 131.96 49.38 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.302 0.572 . . . . 0.0 110.679 -178.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.747 HD12 ' HB3' ' A' ' 242' ' ' PHE . 0.2 OUTLIER -142.53 119.49 11.3 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.787 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.5 OUTLIER -122.45 109.15 14.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.871 179.467 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.548 ' HA3' ' HB3' ' A' ' 250' ' ' ALA . . . -178.57 -147.52 7.08 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.618 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 220' ' ' PRO . 58.7 Cg_endo -72.48 174.5 11.52 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.504 2.136 . . . . 0.0 111.918 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 219' ' ' PRO . 26.8 Cg_endo -62.05 -8.66 12.48 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.551 2.167 . . . . 0.0 112.215 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -72.0 -54.16 8.51 Favored Glycine 0 C--O 1.224 -0.483 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.893 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.908 ' O ' ' HB3' ' A' ' 226' ' ' ALA . 1.1 tpp -55.31 -27.96 50.42 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.538 ' O ' ' CB ' ' A' ' 227' ' ' CYS . 0.0 OUTLIER -77.17 -41.56 30.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.404 178.276 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -75.37 -49.22 19.71 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.552 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -77.13 -49.53 15.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 222' ' ' MET . . . -62.63 -35.62 80.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.948 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 223' ' ' ILE . 52.3 t -70.19 -31.96 69.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 110.306 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.5 -44.95 81.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.638 HD13 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -61.02 -38.96 87.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.979 0.419 . . . . 0.0 111.011 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 226' ' ' ALA . 2.3 t -64.45 -45.29 96.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.288 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.5 ' CZ ' ' SG ' ' A' ' 227' ' ' CYS . 19.0 mtt180 -74.22 -29.97 61.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.871 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 2.7 m -75.43 -44.41 44.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.469 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.545 ' NE ' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -68.4 -45.01 73.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.191 -179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 235' ' ' ILE . . . 109.18 -31.01 8.02 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.983 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.707 HG21 ' HB2' ' A' ' 205' ' ' LEU . 1.2 pp -34.27 95.99 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-O 120.829 0.347 . . . . 0.0 111.4 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 235' ' ' ILE . 11.6 Cg_endo -55.25 112.5 1.06 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.744 2.296 . . . . 0.0 111.877 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -93.75 116.59 5.25 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.699 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -88.35 -46.77 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 110.67 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 241' ' ' PHE . 6.0 mt-30 -110.31 37.56 2.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.082 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.93 HG22 ' HB ' ' A' ' 214' ' ' ILE . 1.5 t -89.89 129.41 40.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.178 0.513 . . . . 0.0 110.348 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 239' ' ' GLN . 0.8 OUTLIER -146.11 135.1 22.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.451 -178.179 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.747 ' HB3' HD12 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -131.07 140.93 50.12 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.56 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 8.0 tp10 -131.42 148.66 52.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.108 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -111.51 106.73 15.69 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.593 ' CD1' ' HB2' ' A' ' 246' ' ' LEU . 0.1 OUTLIER -136.16 143.97 44.75 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.052 178.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.593 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 3.2 mt 59.42 151.12 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-O 120.95 0.405 . . . . 0.0 111.337 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . 0.473 ' HD2' HD22 ' A' ' 246' ' ' LEU . 24.9 Cg_exo -64.05 -141.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.128 2.552 . . . . 0.0 112.056 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 190' ' ' TRP . 0.5 OUTLIER -43.14 148.64 0.26 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.274 0.559 . . . . 0.0 111.662 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.454 ' C ' ' HA3' ' A' ' 126' ' ' GLY . . . 157.56 -66.88 0.29 Allowed Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.207 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.548 ' HB3' ' HA3' ' A' ' 218' ' ' GLY . . . -106.82 137.11 45.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.274 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 1.052 ' HB3' ' C ' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.699 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.41 0 CA-C-O 121.141 0.301 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -125.22 150.04 47.39 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.927 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.786 ' CZ ' HG11 ' A' ' 104' ' ' VAL . 1.5 p90 -133.79 166.73 21.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.789 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -103.77 137.33 41.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.249 0.547 . . . . 0.0 111.388 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.832 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -130.65 140.16 50.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.592 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . 2.3 tp10 -93.41 119.03 32.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.225 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 100' ' ' GLN . 9.9 m -71.34 107.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 17' ' ' VAL . 6.7 p -129.3 20.19 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.807 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -133.0 -128.73 2.92 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.639 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.878 HD21 ' CD1' ' A' ' 92' ' ' LEU . 0.1 OUTLIER 74.74 95.84 0.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.808 0.813 . . . . 0.0 109.407 -178.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -142.19 137.76 31.04 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.607 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -88.5 112.49 23.04 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.537 HG12 ' ND2' ' A' ' 20' ' ' ASN . 2.0 m -90.27 -30.65 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.712 0.768 . . . . 0.0 109.32 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.544 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 19.0 m -137.3 175.04 9.96 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.626 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.7 t -51.09 -53.41 34.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.071 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 0.8 OUTLIER -123.27 52.52 1.38 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.026 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.544 ' OG1' ' HB2' ' A' ' 23' ' ' SER . 0.2 OUTLIER -150.73 137.18 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.846 -179.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.659 HG12 HG13 ' A' ' 82' ' ' VAL . 2.0 p -141.27 147.15 22.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.119 0.485 . . . . 0.0 112.007 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.473 ' HG3' ' HG ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -119.98 113.63 20.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.154 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CB ' ' CZ ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -111.95 121.08 44.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.364 -179.259 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.561 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -102.67 119.49 38.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.329 179.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.023 HD22 HD23 ' A' ' 102' ' ' LEU . 1.2 mt -122.89 136.25 54.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 0.0 112.06 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 1.7 mt-30 -144.65 135.49 24.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.376 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.5 ' HG3' ' HB2' ' A' ' 15' ' ' GLU . 0.0 OUTLIER 166.21 -23.48 0.0 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.903 0.383 . . . . 0.0 111.962 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.621 ' HB3' ' CD1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.183 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.898 HG11 ' ND2' ' A' ' 68' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.013 0.435 . . . . 0.0 110.774 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -153.92 22.67 0.51 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.756 -178.318 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.61 ' CE1' ' HA ' ' A' ' 136' ' ' MET . 0.0 OUTLIER 58.21 127.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.538 -179.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.562 ' O ' ' N ' ' A' ' 48' ' ' GLY . 32.0 mt-10 -113.28 145.27 32.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.513 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 80.6 Cg_exo -45.11 81.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.63 2.22 . . . . 0.0 112.36 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 38.9 46.77 2.35 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.335 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.585 ' HA ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -71.88 151.18 43.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.622 0.249 . . . . 0.0 110.698 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.632 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -133.31 163.21 29.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.96 0.409 . . . . 0.0 111.392 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.546 ' O ' ' CB ' ' A' ' 63' ' ' SER . 1.7 mtt -131.74 -167.82 1.93 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.699 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' A' ' 105' ' ' LYS . 7.9 t0 -133.39 115.32 14.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.969 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.932 HD23 ' O ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -149.6 157.39 43.21 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.872 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -109.97 150.87 27.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.737 179.319 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.808 HG23 ' HB2' ' A' ' 96' ' ' ALA . 1.5 mt -32.85 -77.12 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.828 ' HG2' HG23 ' A' ' 58' ' ' THR . 4.1 Cg_endo -96.01 9.31 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.199 1.932 . . . . 0.0 111.582 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 102.37 1.67 50.65 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.669 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.828 HG23 ' HG2' ' A' ' 56' ' ' PRO . 29.8 p -46.58 -104.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.661 0.267 . . . . 0.0 111.302 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.872 ' N ' HG21 ' A' ' 54' ' ' THR . 1.3 m-20 169.24 30.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.726 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.415 ' H ' ' CG2' ' A' ' 54' ' ' THR . 0.6 OUTLIER -140.89 34.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.684 0.278 . . . . 0.0 111.111 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.656 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 28.2 t -108.63 -104.17 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.901 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.455 ' CG ' ' O ' ' A' ' 61' ' ' SER . 0.3 OUTLIER 172.44 -169.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 111.019 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 51' ' ' MET . 1.8 m -101.89 145.07 29.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.86 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.644 ' CE2' HG22 ' A' ' 80' ' ' ILE . 2.4 t80 -143.51 130.3 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -59.84 105.49 0.57 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.454 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.826 ' CB ' HD13 ' A' ' 76' ' ' LEU . 57.6 Cg_endo -90.34 131.93 1.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.648 2.232 . . . . 0.0 111.482 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -144.28 138.61 28.07 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.898 ' ND2' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -113.21 -67.69 0.98 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.568 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER 151.03 150.5 0.0 OUTLIER Pre-proline 0 CA--C 1.521 -0.166 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.998 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.646 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 12.6 Cg_endo -56.75 96.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.719 1.613 . . . . 0.0 111.37 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.879 ' O ' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER 177.21 166.48 0.49 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-O 121.362 0.601 . . . . 0.0 112.053 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 71' ' ' ASN . 88.7 Cg_endo -90.5 73.64 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.347 2.698 . . . . 0.0 112.543 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.507 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 3.2 tp10 -129.19 -16.68 3.96 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.783 ' H ' HG13 ' A' ' 43' ' ' VAL . . . 42.46 78.78 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.23 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -155.96 112.85 3.18 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 120.738 0.304 . . . . 0.0 110.313 -178.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.826 HD13 ' CB ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -95.23 130.65 41.89 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.062 0.458 . . . . 0.0 110.275 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.746 ' N ' HD12 ' A' ' 76' ' ' LEU . 16.9 pt-20 -127.54 125.49 40.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.123 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.686 ' CD1' ' CG2' ' A' ' 80' ' ' ILE . 2.0 p90 -118.93 144.15 46.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.343 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.019 HD12 ' HB2' ' A' ' 131' ' ' ALA . 2.7 mt -112.6 74.97 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.73 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.686 ' CG2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -91.85 127.08 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.456 0.646 . . . . 0.0 111.085 -179.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 0.7 OUTLIER -78.59 105.98 10.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.194 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.659 HG13 HG12 ' A' ' 27' ' ' VAL . 2.6 m -96.17 122.45 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.206 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.88 HD12 ' HB2' ' A' ' 87' ' ' ARG . 16.2 mt -41.28 168.52 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.98 0.419 . . . . 0.0 111.178 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 52.8 Cg_exo -54.53 -49.66 16.09 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.703 2.269 . . . . 0.0 112.361 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 84' ' ' PRO . 2.5 mt-10 176.29 61.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 87' ' ' ARG . . . -175.86 57.72 0.11 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.749 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.88 ' HB2' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER 170.34 -95.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.597 0.237 . . . . 0.0 111.135 179.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.631 ' CE1' HD11 ' A' ' 55' ' ' ILE . 2.8 t80 -93.64 -27.01 16.82 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 111.195 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 80.4 p -73.16 -20.39 60.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 5.0 m-20 -74.22 -40.21 62.59 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.653 ' OH ' HG21 ' A' ' 58' ' ' THR . 0.9 OUTLIER -73.16 -21.14 60.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.867 178.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.957 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -65.76 -47.59 74.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.602 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -16.6 24.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.591 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 1.9 t-20 -99.82 1.71 43.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.561 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.511 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -171.1 22.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.957 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -138.56 28.39 2.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.235 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -51.51 -166.92 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.715 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.66 HG12 ' O ' ' A' ' 98' ' ' VAL . 2.1 t -125.21 95.96 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-O 121.463 0.649 . . . . 0.0 110.717 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 158.16 34.2 0.02 OUTLIER Glycine 0 C--N 1.316 -0.561 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.735 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.872 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -144.63 174.93 10.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.959 0.409 . . . . 0.0 111.198 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.5 p -105.59 143.74 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.466 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.023 HD23 HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -120.28 140.9 50.54 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.797 0.332 . . . . 0.0 110.986 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.52 ' N ' HD12 ' A' ' 102' ' ' LEU . 4.3 m -100.34 115.2 29.41 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.876 HG23 HD12 ' A' ' 53' ' ' LEU . 1.1 t -105.26 133.72 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.626 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -130.56 110.67 11.6 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.019 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.543 ' HA3' ' CB ' ' A' ' 51' ' ' MET . . . -123.75 84.08 0.36 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 119.597 -1.287 . . . . 0.0 114.924 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -91.72 30.05 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.126 2.551 . . . . 0.0 110.417 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -88.07 173.04 9.09 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.842 -178.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -114.59 174.71 15.62 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.317 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.793 HG23 ' HE2' ' A' ' 114' ' ' LYS . 35.9 m -107.62 107.45 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 117.91 0.855 . . . . 0.0 110.936 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.446 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 55.5 m-85 -123.0 114.75 20.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.548 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 241' ' ' PHE . . . 142.85 -88.92 0.17 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.366 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.833 HD22 ' CZ ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -82.86 116.4 22.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 110.565 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.793 ' HE2' HG23 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -139.19 110.6 7.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.514 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.512 ' HB2' ' NH1' ' A' ' 121' ' ' ARG . 2.0 tt0 -95.21 138.63 32.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.67 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -103.06 9.53 38.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.453 . . . . 0.0 111.071 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.88 -79.02 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.559 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.492 ' HA ' ' HB3' ' A' ' 147' ' ' ASN . 5.9 mtp -130.18 90.14 2.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.87 0.367 . . . . 0.0 110.44 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 121' ' ' ARG . . . -159.53 146.04 12.34 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.435 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.479 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 42.7 Cg_endo -67.35 102.43 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.696 2.264 . . . . 0.0 111.24 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.544 ' HB2' ' CE2' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -124.1 147.01 48.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.353 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.653 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 3.3 m-85 -110.19 122.3 47.3 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.99 ' CE2' HG13 ' A' ' 133' ' ' VAL . 2.3 t80 -123.46 126.61 47.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.671 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -131.34 145.24 35.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.049 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.813 ' HB2' HG11 ' A' ' 133' ' ' VAL . . . -116.95 133.68 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.288 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -102.49 103.8 2.5 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.939 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.8 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 105.41 -161.81 14.56 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.875 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 79' ' ' LEU . 19.4 m -96.14 -10.4 28.3 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 110.791 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.643 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -67.25 11.34 0.75 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.393 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.826 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.8 OUTLIER -73.01 3.08 5.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 122.662 0.385 . . . . 0.0 110.279 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 1.019 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -45.96 -40.95 18.27 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.27 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 2.9 Cg_endo -78.46 -31.02 2.88 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.821 2.347 . . . . 0.0 110.279 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.008 ' O ' HG23 ' A' ' 137' ' ' VAL . 24.6 t -65.14 -43.82 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.828 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.826 HG13 ' HG ' ' A' ' 130' ' ' LEU . 33.8 m -70.26 -31.26 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.704 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -51.09 66.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.61 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -62.42 -46.91 86.45 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.172 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 133' ' ' VAL . 23.6 t -60.1 -30.63 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.108 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -62.77 -36.52 83.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.438 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.569 ' HG3' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -63.93 -42.65 97.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.448 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.635 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -64.52 -34.25 77.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.771 0.796 . . . . 0.0 110.173 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.873 ' OE1' HD22 ' A' ' 170' ' ' LEU . 0.1 OUTLIER -79.36 -30.12 42.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.603 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -44.83 79.02 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.728 0.299 . . . . 0.0 111.356 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.802 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -82.46 -19.94 37.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.582 0.706 . . . . 0.0 109.718 179.026 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.501 ' O ' ' O ' ' A' ' 145' ' ' ALA . 5.1 m 51.61 29.45 5.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.268 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.802 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -37.22 162.3 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.824 0.345 . . . . 0.0 110.568 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.542 ' HD2' ' HB1' ' A' ' 145' ' ' ALA . 74.6 Cg_endo -78.79 13.32 1.96 Allowed 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.741 2.294 . . . . 0.0 112.955 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.492 ' HB3' ' HA ' ' A' ' 118' ' ' MET . 31.6 p-10 -91.35 136.71 32.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.153 0.502 . . . . 0.0 111.989 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 120' ' ' PRO . 3.6 pm0 -73.84 119.67 18.37 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.66 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 41.9 m -115.55 124.53 51.24 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.671 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.625 ' NE ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.4 131.17 47.63 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.845 178.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -127.19 109.08 19.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.43 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.69 ' O ' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -121.31 110.04 15.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.457 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.506 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 0.3 OUTLIER -122.22 147.3 46.36 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.394 -178.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.867 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -148.82 171.4 29.13 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.606 -1.283 . . . . 0.0 114.224 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 1.0 HG21 HD22 ' A' ' 161' ' ' LEU . 3.0 m -167.72 -111.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.872 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.4 OUTLIER -124.36 -170.32 2.12 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 120.709 0.29 . . . . 0.0 111.414 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.782 HG23 ' N ' ' A' ' 187' ' ' SER . 49.5 p -27.04 -64.47 0.08 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.705 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.9 mt-10 152.26 -50.75 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.312 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 85.9 Cg_exo -38.85 -26.84 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.745 2.297 . . . . 0.0 112.511 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -87.93 -30.87 19.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.025 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.0 HD22 HG21 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -105.07 -172.5 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.0 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 0.5 OUTLIER 176.71 -155.56 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.071 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.553 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 77.4 9.58 2.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.632 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.985 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -57.74 -44.33 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 110.162 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.985 ' N ' HD13 ' A' ' 164' ' ' ILE . 2.4 m-20 -62.43 -28.09 69.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.111 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 1.8 mt-10 -71.72 -47.41 54.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.837 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.553 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -62.34 -30.64 71.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.98 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 171' ' ' GLU . 13.2 mttm -60.41 -47.72 84.87 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -31.66 72.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.873 HD22 ' OE1' ' A' ' 141' ' ' GLN . 0.5 OUTLIER -65.15 -35.62 81.68 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.695 ' HA ' HD11 ' A' ' 177' ' ' LEU . 0.9 OUTLIER -62.96 -41.64 99.59 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.967 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.54 -37.65 59.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.397 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.5 t -65.34 -14.79 61.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.478 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.615 ' CG ' ' HB3' ' A' ' 177' ' ' LEU . 2.2 tpt -94.3 178.63 5.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.203 0.525 . . . . 0.0 111.311 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 6.0 tpp180 -96.18 -71.61 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.119 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.471 ' ND2' ' C ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -128.04 63.16 1.41 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.671 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.028 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -109.49 160.3 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.255 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 1.028 ' N ' HD22 ' A' ' 177' ' ' LEU . 1.8 m -137.55 121.95 18.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.117 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.613 HG23 ' HG2' ' A' ' 171' ' ' GLU . 53.7 t -90.06 135.71 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.167 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.539 ' CB ' ' HB3' ' A' ' 152' ' ' TYR . 3.2 tptp -108.47 130.27 55.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.687 0.28 . . . . 0.0 110.882 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.54 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -99.78 104.61 16.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 111.038 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.67 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 63.1 m -80.43 -157.87 0.17 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.956 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.872 HG21 ' O ' ' A' ' 156' ' ' ASN . 22.5 t 57.66 143.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.485 0.66 . . . . 0.0 111.166 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.737 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -130.16 -59.82 1.03 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.916 -178.005 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.579 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 0.1 OUTLIER -168.06 51.84 0.22 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.692 178.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.624 ' O ' ' CB ' ' A' ' 187' ' ' SER . 96.2 Cg_endo -89.87 -98.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.967 2.445 . . . . 0.0 112.876 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.782 ' N ' HG23 ' A' ' 157' ' ' THR . 23.6 t 139.6 3.41 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.454 0.471 . . . . 0.0 112.199 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.589 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 124.22 11.47 4.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.539 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.31 62.4 1.59 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.569 ' CE3' ' N ' ' A' ' 191' ' ' GLU . 4.5 t-105 -129.86 116.25 18.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.387 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.569 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 0.9 OUTLIER -91.52 103.83 16.39 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.874 ' CA ' ' HB2' ' A' ' 251' ' ' ALA . . . 143.06 -123.82 2.2 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.344 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.869 ' OE2' HD11 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -163.1 -93.92 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.592 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -87.56 120.72 29.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 194' ' ' GLN . . . 5.14 107.3 0.0 OUTLIER Glycine 0 C--N 1.35 1.321 0 O-C-N 123.735 0.647 . . . . 0.0 112.748 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER 11.98 -73.11 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.7 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 196' ' ' SER . 75.3 Cg_exo -22.67 68.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.845 3.697 . . . . 0.0 114.535 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.869 HD11 ' OE2' ' A' ' 193' ' ' GLU . 0.3 OUTLIER -88.28 14.49 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.416 0.627 . . . . 0.0 110.311 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.485 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 0.2 OUTLIER -59.43 -36.24 75.53 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.911 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -58.72 -31.37 68.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.673 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.517 ' O ' ' CD2' ' A' ' 205' ' ' LEU . 0.2 OUTLIER -69.27 -34.15 74.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.154 0.502 . . . . 0.0 110.27 179.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.736 ' HG2' HD13 ' A' ' 229' ' ' LEU . 46.8 mtt180 -60.1 -45.72 92.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.325 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.74 -32.78 71.51 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.946 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 207' ' ' SER . 88.6 m-20 -58.95 -43.76 91.31 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.019 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.628 HD12 ' HD2' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -60.59 -45.86 92.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.414 ' CD ' ' HG3' ' A' ' 233' ' ' ARG . 1.1 mt-10 -62.15 -25.6 67.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.487 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 208' ' ' SER . 1.1 t -70.81 -86.71 0.02 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.157 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.41 ' N ' ' OG ' ' A' ' 207' ' ' SER . 0.5 OUTLIER 178.31 30.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.517 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.695 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 1.8 m-20 -148.87 60.98 1.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.779 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . 0.789 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 155.96 97.22 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.655 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.762 ' HB2' HD13 ' A' ' 235' ' ' ILE . 17.6 t30 174.39 -56.53 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.992 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 27.5 Cg_endo -62.08 -50.49 4.86 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.477 2.118 . . . . 0.0 111.208 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.533 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -132.44 109.97 10.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.181 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.951 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.9 OUTLIER -123.26 125.42 71.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -123.06 127.5 48.84 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.76 0.791 . . . . 0.0 112.007 -177.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.486 ' O ' HD11 ' A' ' 223' ' ' ILE . 0.9 OUTLIER -134.97 115.36 13.46 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.716 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 1.8 t -124.64 112.81 17.22 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.55 ' N ' ' CD ' ' A' ' 219' ' ' PRO . . . 112.83 -40.08 2.65 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.285 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.575 ' HB2' ' CB ' ' A' ' 222' ' ' MET . 55.7 Cg_endo -91.84 83.9 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.618 2.212 . . . . 0.0 113.562 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.853 ' HD2' ' HB2' ' A' ' 250' ' ' ALA . 9.9 Cg_endo -52.03 -70.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.689 2.26 . . . . 0.0 111.587 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.84 ' H ' ' HB1' ' A' ' 250' ' ' ALA . . . -53.35 -48.17 60.46 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.836 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.575 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.2 OUTLIER -55.66 -25.14 37.88 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.594 HD11 ' H ' ' A' ' 243' ' ' GLU . 0.0 OUTLIER -75.84 -37.45 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.387 178.382 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -70.35 -46.67 63.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.849 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.564 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -70.18 -47.62 60.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.281 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.883 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -59.73 -39.97 86.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.329 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.3 t -70.28 -31.92 69.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.16 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -44.65 77.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.831 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.736 HD13 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -60.52 -35.93 77.16 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.108 0.48 . . . . 0.0 110.453 179.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 226' ' ' ALA . 2.8 t -65.68 -44.89 93.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.035 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.5 mtt85 -73.48 -30.3 63.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.0 -44.08 32.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.628 ' HD2' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -55.99 -59.69 4.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.989 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 137.65 -50.9 0.8 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.214 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.762 HD13 ' HB2' ' A' ' 211' ' ' ASN . 0.7 OUTLIER -34.99 94.84 0.08 OUTLIER Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.128 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 28.1 Cg_endo -62.7 127.47 20.71 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.825 2.35 . . . . 0.0 112.225 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -95.31 -175.33 37.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.687 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -157.47 -40.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 110.622 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.576 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 8.3 mm-40 -110.73 42.38 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.336 0.589 . . . . 0.0 110.48 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.951 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.4 t -91.64 137.52 21.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.652 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -141.69 140.73 33.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.159 -178.301 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.544 ' CB ' HG12 ' A' ' 223' ' ' ILE . 5.6 p90 -131.14 139.27 49.77 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.296 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . 0.594 ' H ' HD11 ' A' ' 223' ' ' ILE . 0.8 OUTLIER -131.79 148.74 52.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.036 179.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 220' ' ' PRO . 1.9 mptt -124.03 105.71 9.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.643 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.2 OUTLIER -138.02 145.84 42.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 178.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.55 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 5.2 mt 67.83 163.99 0.13 Allowed Pre-proline 0 N--CA 1.468 0.461 0 CA-C-O 120.81 0.338 . . . . 0.0 111.294 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . 0.478 ' CD ' HD22 ' A' ' 246' ' ' LEU . 54.9 Cg_endo -86.41 -103.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.284 2.656 . . . . 0.0 112.111 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 247' ' ' PRO . 32.3 m -37.93 137.29 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.013 0.435 . . . . 0.0 110.547 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 124.76 -15.38 7.5 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.853 ' HB2' ' HD2' ' A' ' 220' ' ' PRO . . . -107.49 110.76 22.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.957 -0.621 . . . . 0.0 111.515 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.874 ' HB2' ' CA ' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.108 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.454 ' C ' ' HG3' ' A' ' 105' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.349 0 CA-C-O 121.081 0.267 . . . . 0.0 112.637 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.529 ' CB ' ' HB2' ' A' ' 105' ' ' LYS . 25.4 t -123.48 150.04 44.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.845 0.355 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.789 ' CZ ' ' HB2' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -133.01 165.37 24.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.15 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.515 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 2.0 mp0 -105.98 133.08 51.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.134 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.791 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -123.23 144.29 49.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.727 0.299 . . . . 0.0 111.012 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 32' ' ' GLN . 1.2 pt-20 -93.58 120.75 34.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.811 0.338 . . . . 0.0 110.123 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.961 HG22 ' O ' ' A' ' 100' ' ' GLN . 3.9 m -71.67 105.74 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.252 0.549 . . . . 0.0 111.06 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.93 -33.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.018 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -79.18 -129.02 0.61 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.03 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.785 HD23 ' CB ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER 71.39 95.53 0.07 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.978 0.894 . . . . 0.0 109.747 -179.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.722 HD21 HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -142.32 143.22 32.67 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.858 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.535 ' NE1' ' HD3' ' A' ' 93' ' ' ARG . 3.3 m0 -88.43 113.16 23.74 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.722 HG12 HD21 ' A' ' 20' ' ' ASN . 2.0 m -92.05 -29.9 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-O 121.747 0.784 . . . . 0.0 108.963 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.552 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 12.0 m -137.6 173.83 11.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.471 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.535 ' CB ' ' HG2' ' A' ' 160' ' ' GLU . 18.6 t -53.51 -53.34 52.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.095 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 82' ' ' VAL . 98.6 m-20 -119.19 47.6 1.65 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.397 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 1.008 ' CG2' HG21 ' A' ' 128' ' ' THR . 0.2 OUTLIER -149.02 140.97 23.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.735 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.591 ' CG2' HD13 ' A' ' 19' ' ' LEU . 1.4 p -140.34 147.4 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.144 0.497 . . . . 0.0 112.087 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.496 ' HG3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -113.8 105.26 13.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.932 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -100.07 128.69 46.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.882 -178.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 6.9 mp -118.35 116.86 27.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.899 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.791 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 5.1 mt -114.03 133.84 55.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.029 0.442 . . . . 0.0 112.054 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.516 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -144.27 136.71 26.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.648 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -170.43 -94.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.707 0.289 . . . . 0.0 111.586 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.523 0 CA-C-O 121.118 0.485 . . . . 0.0 110.185 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.921 HG21 ' CG ' ' A' ' 68' ' ' ASN . 0.6 OUTLIER . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 121.356 0.598 . . . . 0.0 111.66 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.542 ' HG2' ' CD1' ' A' ' 45' ' ' PHE . 5.9 ttpt -148.57 -141.63 0.11 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.689 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.542 ' CD1' ' HG2' ' A' ' 44' ' ' LYS . 48.6 p90 -95.06 56.46 1.94 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.282 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.6 OUTLIER -114.21 127.61 26.65 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 48' ' ' GLY . 63.3 Cg_exo -32.01 84.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.842 2.361 . . . . 0.0 112.111 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 33.32 73.06 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.889 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.504 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -32.66 154.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.906 0.353 . . . . 0.0 110.851 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.869 ' CZ ' HG12 ' A' ' 110' ' ' VAL . 1.3 m-85 -122.92 163.23 20.74 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.561 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -133.06 162.82 30.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.47 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 105' ' ' LYS . 2.8 t0 -122.66 109.29 14.09 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 110.249 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.73 ' CD1' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.16 158.9 44.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.53 0.681 . . . . 0.0 112.225 -178.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.772 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -103.09 151.0 23.06 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.455 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.983 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -32.32 -68.62 0.15 Allowed Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.72 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.983 ' HD3' HG23 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -103.89 2.27 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.926 2.417 . . . . 0.0 111.144 177.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 109.9 -0.07 30.26 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.084 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.828 HG23 ' CD ' ' A' ' 56' ' ' PRO . 30.4 p -31.16 -98.47 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.515 0.326 . . . . 0.0 111.449 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.772 ' N ' HG21 ' A' ' 54' ' ' THR . 10.1 p-10 160.5 31.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.71 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 59' ' ' ASP . 2.7 t -158.8 40.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.044 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.698 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 45.4 t -107.66 -103.34 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 4.7 mtm180 172.77 -174.36 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.99 0.424 . . . . 0.0 111.037 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -105.33 123.95 48.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.636 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 78' ' ' PHE . 1.2 t80 -107.36 126.14 52.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.819 0.343 . . . . 0.0 110.633 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.671 ' CB ' ' CD2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -63.78 104.94 0.57 Allowed Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.791 -179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.942 ' HB3' HD13 ' A' ' 76' ' ' LEU . 7.2 Cg_exo -73.25 152.74 50.52 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.528 2.152 . . . . 0.0 110.861 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.4 128.53 52.3 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.921 ' CG ' HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -135.71 -81.11 0.41 Allowed 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.631 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.66 HD22 ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER 146.59 171.65 0.0 OUTLIER Pre-proline 0 C--N 1.339 0.134 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.156 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 69' ' ' LEU . 29.4 Cg_endo -63.63 88.26 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 121.654 1.569 . . . . 0.0 111.858 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.559 ' ND2' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -170.41 139.29 1.42 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 111.173 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -86.8 67.13 4.48 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.942 2.428 . . . . 0.0 114.541 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 73' ' ' GLU . 37.2 mp0 -136.77 -116.26 0.17 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.69 71.61 0.17 Allowed Glycine 0 CA--C 1.543 1.829 0 N-CA-C 116.114 1.206 . . . . 0.0 116.114 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -121.72 82.0 1.89 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.275 1.537 . . . . 0.0 110.296 178.345 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.942 HD13 ' HB3' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -97.17 129.3 44.55 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.333 0.587 . . . . 0.0 111.447 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.718 ' N ' HD12 ' A' ' 76' ' ' LEU . 3.5 mt-10 -130.77 121.17 24.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.739 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 29' ' ' PHE . 1.3 p90 -114.86 140.55 48.87 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.968 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.103 HD22 ' HB2' ' A' ' 131' ' ' ALA . 0.7 OUTLIER -102.44 84.1 2.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.613 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -90.37 139.94 16.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.728 -177.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.55 ' NE ' ' HD3' ' A' ' 247' ' ' PRO . 0.0 OUTLIER -78.05 112.03 14.56 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.517 HG23 ' N ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -105.9 138.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.783 -178.277 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 85' ' ' GLU . 9.0 mt -101.4 158.55 31.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.768 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 83' ' ' LEU . 26.2 Cg_endo -62.06 67.71 0.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.673 2.249 . . . . 0.0 112.023 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 83' ' ' LEU . 29.2 mm-40 75.63 53.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.647 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.14 -97.19 1.35 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.665 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -125.57 -48.46 1.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.67 0.271 . . . . 0.0 111.157 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.592 ' CZ ' ' HA ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -85.52 -32.95 21.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 0.0 110.859 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.582 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 3.3 p -70.01 -20.58 63.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.28 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 9.9 m-20 -77.25 -34.12 55.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.31 0.576 . . . . 0.0 110.867 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.961 ' HB2' HD11 ' A' ' 55' ' ' ILE . 35.0 t80 -73.51 -51.41 17.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.93 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.968 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -70.97 -29.63 65.68 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.074 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.535 ' HD3' ' NE1' ' A' ' 21' ' ' TRP . 8.4 mtm180 -90.55 -27.46 19.13 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.81 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 1.9 t-20 -102.56 -5.45 23.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.702 0.287 . . . . 0.0 110.845 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 91' ' ' TYR . 2.9 t70 -130.22 -23.47 2.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.968 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -96.51 28.67 3.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.15 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 7.2 mmm180 -97.03 -47.4 5.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.045 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.795 HG13 ' CG ' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -72.95 -1.17 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.864 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.662 ' HA2' HG23 ' A' ' 16' ' ' VAL . . . 77.05 20.41 75.82 Favored Glycine 0 C--N 1.32 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.047 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.961 ' O ' HG22 ' A' ' 16' ' ' VAL . 25.0 mt-30 -47.96 179.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 111.186 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.439 ' CG1' ' O ' ' A' ' 14' ' ' ALA . 2.1 t -109.54 139.77 31.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.977 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.73 HD11 ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -130.09 126.21 37.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.298 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.483 ' HB2' ' HG3' ' A' ' 13' ' ' GLU . 1.5 t -94.78 140.47 29.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 111.915 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.716 HG22 ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -115.91 142.22 30.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.901 178.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 25.6 ttpp -131.63 113.23 13.36 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.192 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 50' ' ' PHE . . . 162.49 98.38 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 118.921 -1.609 . . . . 0.0 114.592 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -92.9 29.95 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.414 2.743 . . . . 0.0 110.014 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -88.61 166.74 13.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.466 -177.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.59 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -146.07 171.78 26.89 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.354 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.869 HG12 ' CZ ' ' A' ' 50' ' ' PHE . 3.5 p -158.05 121.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.222 0.534 . . . . 0.0 111.067 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -70.1 135.93 49.72 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.508 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -146.66 -41.09 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.942 HD13 ' CE2' ' A' ' 123' ' ' PHE . 1.4 pt? -133.27 119.51 19.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.166 0.508 . . . . 0.0 110.432 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.651 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.4 OUTLIER -137.93 114.79 10.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.452 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.47 ' HA ' ' OH ' ' A' ' 215' ' ' TYR . 7.5 pm0 -83.62 140.62 32.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.693 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.41 15.01 5.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.746 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.82 -78.06 0.25 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.9 mtt -130.04 89.92 2.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.85 0.357 . . . . 0.0 110.153 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 121' ' ' ARG . . . -165.6 150.84 8.03 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.455 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 47.6 Cg_endo -68.75 104.83 1.21 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.806 2.337 . . . . 0.0 112.078 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.657 HH12 HG23 ' A' ' 149' ' ' THR . 0.0 OUTLIER -120.81 146.66 46.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.692 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.673 ' HB3' ' CZ ' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -115.52 141.05 48.58 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.168 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 1.123 ' CE2' HG13 ' A' ' 133' ' ' VAL . 1.1 t80 -122.42 117.16 25.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.866 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.745 HG23 ' CD1' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -106.2 113.29 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.365 0.602 . . . . 0.0 111.943 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.577 ' HB2' HG11 ' A' ' 133' ' ' VAL . . . -100.83 133.12 45.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.201 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.526 ' O ' HD11 ' A' ' 246' ' ' LEU . . . -112.47 103.62 1.48 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.643 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.861 ' HA3' HD21 ' A' ' 246' ' ' LEU . . . 106.31 -156.57 16.24 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.621 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.008 HG21 ' CG2' ' A' ' 26' ' ' THR . 8.6 m -100.35 -17.01 17.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.955 0.407 . . . . 0.0 111.132 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -63.71 10.1 0.23 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.098 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.565 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -77.86 3.62 13.95 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.895 0.348 . . . . 0.0 110.08 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 1.103 ' HB2' HD22 ' A' ' 79' ' ' LEU . . . -46.75 -43.96 42.25 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.966 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 2.8 Cg_exo -74.02 -30.74 8.68 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.933 2.422 . . . . 0.0 110.399 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.123 HG13 ' CE2' ' A' ' 123' ' ' PHE . 10.7 t -64.64 -46.82 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.601 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.565 HG13 ' HG ' ' A' ' 130' ' ' LEU . 19.3 m -66.86 -30.75 50.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.21 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -66.72 -50.82 61.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.859 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.782 ' HG3' HD21 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -63.88 -39.07 93.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.029 178.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 133' ' ' VAL . 27.7 t -62.61 -44.8 99.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.333 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -60.9 -31.04 70.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.229 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 136' ' ' MET . 75.2 mt-30 -63.47 -41.74 98.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.485 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.809 ' HG3' ' HB3' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -57.68 -51.98 67.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.687 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.57 ' OE1' HD21 ' A' ' 170' ' ' LEU . 1.7 mp0 -69.23 -33.46 73.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.701 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -80.89 -12.25 59.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.983 0.42 . . . . 0.0 111.012 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.671 ' C ' HG22 ' A' ' 144' ' ' THR . 3.8 m95 -89.21 -85.05 0.21 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.303 0.573 . . . . 0.0 111.554 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.671 HG22 ' C ' ' A' ' 143' ' ' TRP . 0.6 OUTLIER -174.69 26.52 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.652 -178.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.809 ' HB3' ' HG3' ' A' ' 140' ' ' MET . . . -111.81 54.39 0.42 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.388 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.526 ' O ' ' CB ' ' A' ' 175' ' ' ARG . 57.7 Cg_endo -70.75 -1.56 9.48 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.663 2.242 . . . . 0.0 112.132 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.501 ' C ' ' ND2' ' A' ' 176' ' ' ASN . 0.7 OUTLIER -50.43 -169.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 1.2 mt-10 -71.87 105.2 3.72 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.586 0.707 . . . . 0.0 110.294 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.657 HG23 HH12 ' A' ' 121' ' ' ARG . 98.8 m -117.43 117.38 29.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.595 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.657 ' CD ' ' CZ ' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -102.73 135.72 43.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.091 0.472 . . . . 0.0 110.493 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.658 HD13 ' O ' ' A' ' 123' ' ' PHE . 0.3 OUTLIER -133.19 109.72 14.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.033 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.745 ' CD1' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -107.1 109.27 21.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.646 ' HZ ' HD11 ' A' ' 161' ' ' LEU . 2.1 t80 -111.91 145.39 39.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.586 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.717 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -162.0 167.01 36.52 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.63 -1.748 . . . . 0.0 114.717 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 1.078 HG21 HD13 ' A' ' 161' ' ' LEU . 17.0 m -164.95 -119.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.471 -0.865 . . . . 0.0 110.998 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.864 ' O ' HG21 ' A' ' 183' ' ' VAL . 1.4 p30 -112.55 -171.38 1.85 Allowed 'General case' 0 C--N 1.343 0.284 0 O-C-N 122.243 -0.285 . . . . 0.0 111.118 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.573 ' CG2' ' HA ' ' A' ' 187' ' ' SER . 0.2 OUTLIER -32.01 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.768 0.318 . . . . 0.0 111.071 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 19.5 mt-10 89.05 39.1 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.305 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 24.8 Cg_endo -62.22 -25.97 77.25 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 C-N-CA 122.296 1.997 . . . . 0.0 110.698 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.535 ' HG2' ' CB ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -121.73 -28.15 4.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.045 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.078 HD13 HG21 ' A' ' 155' ' ' VAL . 5.3 tp -40.41 165.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.783 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 0.0 OUTLIER 177.38 -153.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.926 0.393 . . . . 0.0 111.079 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.524 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 72.33 7.68 5.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.361 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.976 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -59.72 -41.81 86.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.976 ' N ' HD13 ' A' ' 164' ' ' ILE . 18.5 m-20 -61.88 -27.84 69.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.179 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.509 ' HG3' ' CD1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -72.33 -41.85 66.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.994 179.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -71.5 -31.53 67.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.075 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.505 ' HD3' ' HA ' ' A' ' 165' ' ' ASP . 14.1 mtpp -61.3 -46.36 90.65 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 6.0 m -63.0 -31.87 73.11 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.57 HD21 ' OE1' ' A' ' 141' ' ' GLN . 1.0 OUTLIER -62.9 -36.67 84.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 1.01 ' HG2' HD11 ' A' ' 177' ' ' LEU . 3.6 mt-10 -63.04 -41.0 99.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.203 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -33.98 47.73 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.09 -6.59 53.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.022 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.694 ' CB ' HD23 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -106.29 -168.64 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.032 0.444 . . . . 0.0 111.242 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' A' ' 146' ' ' PRO . 6.9 ttt-85 -103.26 -64.43 1.08 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.901 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.501 ' ND2' ' C ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -139.91 66.37 1.4 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.431 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.01 HD11 ' HG2' ' A' ' 171' ' ' GLU . 0.6 OUTLIER -106.65 153.68 22.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.6 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.506 ' HB ' ' HG3' ' A' ' 150' ' ' ARG . 40.9 m -136.08 115.12 12.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.278 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 151' ' ' ILE . 8.8 p -89.66 135.1 26.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.658 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.38 133.92 47.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.101 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.551 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -98.66 104.26 16.28 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.463 0.649 . . . . 0.0 110.541 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.631 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 95.6 m -80.71 -167.44 1.38 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.186 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.864 HG21 ' O ' ' A' ' 156' ' ' ASN . 77.2 t 64.33 148.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.689 0.757 . . . . 0.0 111.822 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.717 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.45 -61.12 0.82 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.288 -178.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.539 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 2.6 m170 -174.95 53.38 0.12 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.728 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.581 ' HG2' ' HA ' ' A' ' 156' ' ' ASN . 91.3 Cg_endo -86.88 -98.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.922 2.414 . . . . 0.0 112.632 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.573 ' HA ' ' CG2' ' A' ' 157' ' ' THR . 0.4 OUTLIER 156.35 -0.63 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.613 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 124.04 11.18 4.89 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.356 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.8 63.26 1.55 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.507 ' CE3' ' N ' ' A' ' 191' ' ' GLU . 1.8 t-105 -127.46 108.81 11.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.455 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.703 ' C ' ' HB3' ' A' ' 251' ' ' ALA . 0.2 OUTLIER -98.55 104.86 16.94 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.56 178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.673 ' CA ' ' HB3' ' A' ' 251' ' ' ALA . . . 164.84 -76.28 0.15 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.734 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.835 ' OE2' ' HB1' ' A' ' 250' ' ' ALA . 1.1 mt-10 148.03 -100.14 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.551 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 0.0 OUTLIER -87.09 131.91 33.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.656 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -31.02 105.28 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 C-N-CA 119.888 -1.148 . . . . 0.0 111.962 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.525 ' CB ' ' CD ' ' A' ' 197' ' ' PRO . 0.3 OUTLIER 162.57 -178.44 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.305 -0.447 . . . . 0.0 111.301 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.525 ' CD ' ' CB ' ' A' ' 196' ' ' SER . 69.7 Cg_endo -91.3 -1.15 4.73 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.168 2.579 . . . . 0.0 114.05 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.137 HD12 HD21 ' A' ' 201' ' ' LEU . 0.2 OUTLIER 75.64 33.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.669 1.223 . . . . 0.0 109.522 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.498 ' OD1' ' NE ' ' A' ' 202' ' ' ARG . 0.2 OUTLIER -78.29 -33.54 49.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.579 -1.192 . . . . 0.0 112.492 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -56.61 -44.78 81.49 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 1.137 HD21 HD12 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -65.79 -31.2 72.03 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.399 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.773 ' CD ' HD22 ' A' ' 229' ' ' LEU . 18.6 mtm180 -57.71 -48.71 78.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.429 0.633 . . . . 0.0 110.265 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.19 -32.66 67.01 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.313 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -59.4 -40.92 88.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.598 ' CB ' HD11 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -60.69 -47.75 84.85 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -20.67 66.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.946 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.97 12.35 27.1 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.677 0.275 . . . . 0.0 111.425 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 0.7 OUTLIER 72.24 100.11 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.87 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.661 ' O ' ' HB3' ' A' ' 210' ' ' ALA . 0.9 OUTLIER 155.47 86.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . 0.775 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 96.32 102.17 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.281 0.562 . . . . 0.0 110.381 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.674 ' O ' HG23 ' A' ' 240' ' ' VAL . 4.5 t-20 174.45 -55.53 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.888 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 10.0 Cg_endo -51.01 -48.0 23.04 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.199 1.933 . . . . 0.0 110.58 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.68 108.41 8.52 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.893 ' HB ' HG22 ' A' ' 240' ' ' VAL . 1.0 OUTLIER -121.26 125.43 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.67 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -121.03 127.16 51.47 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.804 -178.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.557 HD22 HG11 ' A' ' 124' ' ' VAL . 3.0 mt -138.44 115.88 11.23 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.622 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . 0.531 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 1.0 OUTLIER -125.84 119.66 28.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.582 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.594 ' HA2' ' CG ' ' A' ' 245' ' ' PHE . . . 115.29 -48.8 0.9 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.779 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.861 ' CB ' ' HB3' ' A' ' 250' ' ' ALA . 97.8 Cg_endo -80.51 110.01 2.37 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.424 2.083 . . . . 0.0 113.549 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.488 ' O ' ' HB ' ' A' ' 223' ' ' ILE . 16.0 Cg_exo -66.72 -45.35 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.718 2.279 . . . . 0.0 110.825 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.49 -38.35 90.65 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.589 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.828 ' O ' ' HB3' ' A' ' 226' ' ' ALA . 3.6 tpt -56.08 -25.27 44.7 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.577 HG13 ' CB ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -69.09 -45.49 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.12 178.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 223' ' ' ILE . 69.8 m-20 -75.04 -47.78 27.25 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.531 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.557 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -77.34 -50.24 13.24 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.842 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -59.84 -40.1 87.38 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.436 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 223' ' ' ILE . 42.5 t -69.95 -30.86 68.33 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 232' ' ' SER . 3.5 mm-40 -69.61 -44.62 70.31 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.578 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.773 HD22 ' CD ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -60.06 -37.92 81.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.002 0.429 . . . . 0.0 110.658 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 226' ' ' ALA . 2.3 t -64.19 -45.34 96.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.181 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -30.19 61.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.059 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.506 ' OG ' ' NH1' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -75.48 -46.22 33.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.181 0.515 . . . . 0.0 111.258 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.563 ' CG ' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -58.91 -51.1 71.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.026 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 125.34 -52.48 0.8 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.098 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.598 HD11 ' CB ' ' A' ' 205' ' ' LEU . 0.9 OUTLIER -36.04 95.73 0.1 OUTLIER Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 121.08 0.467 . . . . 0.0 111.128 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 31.8 Cg_endo -64.16 119.61 6.7 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.897 2.398 . . . . 0.0 112.47 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -90.75 176.71 41.38 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.45 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.7 -40.25 0.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 0.0 111.081 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.581 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 21.0 mm100 -105.64 36.03 2.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.017 0.437 . . . . 0.0 110.67 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.893 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.1 t -89.19 136.5 23.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.322 0.582 . . . . 0.0 111.062 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.651 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.6 OUTLIER -144.92 138.02 26.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.94 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.577 ' CB ' HG13 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -129.52 130.39 45.73 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.081 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . 0.489 ' CA ' HD11 ' A' ' 223' ' ' ILE . 0.3 OUTLIER -132.65 149.39 52.3 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.543 179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 244' ' ' LYS . 1.7 ptmm? -129.08 115.0 17.07 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.594 ' CG ' ' HA2' ' A' ' 218' ' ' GLY . 0.5 OUTLIER -137.42 146.86 44.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.171 179.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.861 HD21 ' HA3' ' A' ' 127' ' ' GLY . 0.2 OUTLIER 57.61 174.3 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.477 0 C-N-CA 122.922 0.489 . . . . 0.0 111.731 -178.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 246' ' ' LEU . 75.9 Cg_exo -52.78 -141.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.371 2.714 . . . . 0.0 113.643 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 190' ' ' TRP . 2.4 p -81.4 177.25 9.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.485 0.66 . . . . 0.0 112.085 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 163.2 -71.0 0.21 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.578 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.861 ' HB3' ' CB ' ' A' ' 219' ' ' PRO . . . -107.74 149.64 27.92 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.703 ' HB3' ' C ' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.46 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.521 ' CB ' ' HB2' ' A' ' 105' ' ' LYS . 83.9 p -95.71 153.87 17.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.821 0.343 . . . . 0.0 110.892 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.939 ' CE2' ' HB2' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -132.05 156.88 45.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.916 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.61 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 1.6 mt-10 -106.04 121.79 44.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.939 ' HB2' ' CE2' ' A' ' 12' ' ' PHE . . . -126.73 127.69 45.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.183 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.487 ' OE1' HG22 ' A' ' 101' ' ' VAL . 4.2 tp10 -93.41 128.08 39.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.899 0.38 . . . . 0.0 110.697 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.061 HG22 ' O ' ' A' ' 100' ' ' GLN . 28.0 m -71.88 106.14 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.091 0.472 . . . . 0.0 111.096 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 17' ' ' VAL . 2.4 p -127.2 2.31 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.314 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -120.14 -128.86 3.71 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.526 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.885 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER 82.49 58.77 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.329 0.585 . . . . 0.0 110.063 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.543 ' ND2' HG12 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -95.63 145.42 25.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.669 -179.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -88.69 113.86 24.69 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG12 ' ND2' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -97.3 -27.59 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.554 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 13.2 m -141.44 173.62 11.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.133 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.404 ' CB ' ' HG2' ' A' ' 160' ' ' GLU . 14.9 t -52.19 -57.06 10.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.692 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.519 ' CA ' ' O ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -118.07 44.45 2.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.553 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.907 HG23 ' HG2' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -148.34 138.66 22.66 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.311 0.577 . . . . 0.0 110.886 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.885 HG21 ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -141.34 148.35 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.138 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -114.55 103.54 11.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.367 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.729 ' C ' HD13 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -99.26 127.51 45.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.886 -178.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -113.28 116.65 30.07 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.027 HD22 HD11 ' A' ' 102' ' ' LEU . 4.6 mt -112.37 131.57 55.47 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.025 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -144.77 109.86 5.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.72 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.607 ' HB2' ' CA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -114.92 -49.17 2.81 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.684 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.105 HG13 HD23 ' A' ' 76' ' ' LEU . 20.4 m . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 119.716 -0.183 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.695 ' HA ' ' N ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -112.76 84.02 1.91 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.131 0.973 . . . . 0.0 111.14 178.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER 7.06 61.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.171 0.919 . . . . 0.0 112.572 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -84.92 160.94 54.43 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.816 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.976 ' O ' HG23 ' A' ' 110' ' ' VAL . 37.1 Cg_exo -57.99 68.53 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.589 2.193 . . . . 0.0 111.837 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.736 ' O ' HG21 ' A' ' 110' ' ' VAL . . . 59.39 37.74 92.43 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.003 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 65' ' ' SER . 4.8 tt0 -52.95 158.12 1.51 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.064 0.432 . . . . 0.0 110.077 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.84 ' CE2' HD21 ' A' ' 108' ' ' LEU . 28.7 p90 -151.96 163.47 39.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 63' ' ' SER . 2.0 mmt -121.14 175.36 6.14 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.705 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.54 108.09 15.07 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.907 HD23 ' O ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -150.49 156.69 41.92 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.973 HG23 ' C ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -96.6 154.15 17.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.602 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.028 ' O ' HD23 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -29.45 -68.14 0.12 Allowed Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 123.443 0.464 . . . . 0.0 110.601 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.96 ' HD3' HG23 ' A' ' 55' ' ' ILE . 4.4 Cg_endo -110.05 6.26 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.719 2.946 . . . . 0.0 111.733 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 104.51 -5.88 44.76 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.019 -178.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.812 HG23 ' CG ' ' A' ' 56' ' ' PRO . 67.6 p -24.34 -88.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.127 0.571 . . . . 0.0 111.814 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.667 ' O ' HG12 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -154.12 42.84 0.53 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.973 ' C ' HG23 ' A' ' 54' ' ' THR . 0.3 OUTLIER 88.19 125.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.783 ' N ' HG23 ' A' ' 54' ' ' THR . 28.8 t -117.41 -72.42 0.69 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.502 0.668 . . . . 0.0 110.268 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.63 171.14 10.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.597 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.648 ' CB ' ' CE1' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -101.54 118.96 38.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.903 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.542 ' C ' ' HB2' ' A' ' 50' ' ' PHE . 1.6 t80 -118.57 127.34 53.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.994 0.426 . . . . 0.0 111.94 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.586 ' HA ' ' CB ' ' A' ' 50' ' ' PHE . 92.4 p -72.18 109.54 6.04 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.741 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.545 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 88.6 Cg_endo -85.67 169.65 9.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.956 2.438 . . . . 0.0 112.694 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.4 130.53 19.55 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.964 0.412 . . . . 0.0 111.655 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 1.0 ' HB3' HG22 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -129.68 -56.09 1.14 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.555 0.693 . . . . 0.0 109.844 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.575 ' HB3' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER 164.61 -164.93 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 96.6 Cg_endo -91.31 63.16 1.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.102 1.201 . . . . 0.0 112.372 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.695 ' N ' ' HA ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -174.46 109.74 0.29 Allowed Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.512 ' HG3' ' HB2' ' A' ' 44' ' ' LYS . 4.1 Cg_exo -74.17 40.85 0.62 Allowed 'Trans proline' 0 CA--C 1.515 -0.429 0 C-N-CA 122.336 2.024 . . . . 0.0 112.409 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -138.14 6.79 2.62 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.579 178.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.29 -116.05 1.74 Allowed Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.912 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -152.34 119.49 5.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.875 -0.662 . . . . 0.0 110.012 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.105 HD23 HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -96.8 148.33 23.03 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 122.22 1.009 . . . . 0.0 113.169 -178.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.73 ' CB ' HD12 ' A' ' 30' ' ' LEU . 1.8 pt-20 -131.07 150.56 52.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.972 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.773 ' HE2' HD11 ' A' ' 31' ' ' LEU . 1.9 p90 -126.37 139.8 52.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.938 0.399 . . . . 0.0 111.549 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.921 HD22 HG21 ' A' ' 128' ' ' THR . 1.3 mt -104.4 91.56 3.95 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.604 ' O ' HG13 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -92.36 118.61 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.197 -178.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.907 ' HG2' HG23 ' A' ' 26' ' ' THR . 0.8 OUTLIER -79.34 96.25 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.978 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.971 HG11 HD11 ' A' ' 92' ' ' LEU . 2.9 m -92.69 141.5 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.006 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.53 ' HG ' ' CD ' ' A' ' 84' ' ' PRO . 1.1 mp -60.73 -179.97 0.21 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.747 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.53 ' CD ' ' HG ' ' A' ' 83' ' ' LEU . 37.4 Cg_exo -56.8 -32.35 91.38 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.593 2.195 . . . . 0.0 112.182 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER 157.94 100.7 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.831 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 155.04 -16.91 0.53 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.645 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.481 ' CG ' HD22 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -102.72 -98.19 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.881 -0.188 . . . . 0.0 110.975 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -97.07 -30.17 13.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.717 0.294 . . . . 0.0 111.204 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.706 ' HB2' HG21 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -60.47 -27.31 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.99 0.424 . . . . 0.0 110.921 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -76.24 -32.47 58.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.555 0.693 . . . . 0.0 109.819 179.469 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.814 ' CD1' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -73.43 -45.31 55.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.129 -179.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.971 HD11 HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -67.73 -34.72 77.4 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -29.68 15.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 2.4 t-20 -95.2 -5.14 44.56 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.384 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.49 15.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.911 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . . . -153.61 30.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.668 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -47.49 -102.1 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 98' ' ' VAL . 2.5 t -148.01 103.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.115 0.484 . . . . 0.0 110.98 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.58 ' H ' HG23 ' A' ' 16' ' ' VAL . . . 150.7 -12.65 0.87 Allowed Glycine 0 C--N 1.32 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.021 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 1.061 ' O ' HG22 ' A' ' 16' ' ' VAL . 27.1 mp0 -91.29 162.46 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 111.133 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.487 HG22 ' OE1' ' A' ' 15' ' ' GLU . 40.9 t -129.62 142.22 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.581 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.028 HD23 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -118.94 153.4 34.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.089 0.471 . . . . 0.0 111.415 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.6 t -105.95 97.56 7.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.815 HG12 ' CD1' ' A' ' 53' ' ' LEU . 2.0 m -90.88 118.54 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.521 ' HB2' ' CB ' ' A' ' 11' ' ' SER . 3.7 tttt -129.52 123.08 30.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.496 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 161.79 65.66 0.02 OUTLIER Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.732 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.44 57.4 1.33 Allowed 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.422 2.081 . . . . 0.0 110.883 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.84 HD21 ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -100.55 170.03 8.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.864 -178.543 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.654 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -118.83 172.09 14.41 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.976 HG23 ' O ' ' A' ' 47' ' ' PRO . 0.2 OUTLIER -157.13 115.33 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.564 0.682 . . . . 0.0 111.683 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -69.67 113.81 7.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.539 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -147.02 -40.5 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.849 HD11 ' HB3' ' A' ' 136' ' ' MET . 0.9 OUTLIER -146.14 119.14 8.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.431 178.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.652 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.1 OUTLIER -138.28 117.48 12.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.294 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -92.29 140.62 29.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.435 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -90.05 15.89 9.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.018 0.437 . . . . 0.0 110.98 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.46 -77.39 0.23 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.69 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.56 89.87 2.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.939 0.4 . . . . 0.0 110.37 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -163.59 149.94 9.97 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.16 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.462 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 32.2 Cg_endo -64.24 115.22 3.03 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.569 2.179 . . . . 0.0 111.69 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.581 ' NE ' HG23 ' A' ' 149' ' ' THR . 0.0 OUTLIER -124.77 146.31 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.393 -179.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.642 ' CD2' ' HB3' ' A' ' 150' ' ' ARG . 39.5 m-85 -126.09 122.78 36.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 110.63 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 1.11 ' CZ ' HG22 ' A' ' 133' ' ' VAL . 0.9 OUTLIER -111.93 106.05 14.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.418 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.735 HG22 ' HE1' ' A' ' 222' ' ' MET . 6.9 p -99.11 111.0 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 121.233 0.539 . . . . 0.0 111.125 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -109.79 133.68 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.143 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.439 ' C ' ' HA3' ' A' ' 249' ' ' GLY . . . -107.82 103.08 1.86 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.047 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.769 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 118.86 -167.94 13.2 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.372 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.921 HG21 HD22 ' A' ' 79' ' ' LEU . 6.1 m -91.74 -13.42 31.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.024 0.44 . . . . 0.0 110.847 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.577 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -64.72 10.02 0.36 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 116.111 -0.495 . . . . 0.0 113.409 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.734 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -79.97 3.68 19.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 117.177 0.489 . . . . 0.0 110.033 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.584 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -47.55 -43.43 49.41 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.917 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 6.7 Cg_exo -71.35 -30.87 14.93 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.525 2.15 . . . . 0.0 109.655 177.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.11 HG22 ' CZ ' ' A' ' 123' ' ' PHE . 17.9 t -66.07 -44.33 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.208 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.734 HG13 ' HG ' ' A' ' 130' ' ' LEU . 14.4 m -70.44 -29.91 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.532 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.14 -52.69 57.88 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.849 ' HB3' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -62.13 -44.95 95.5 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.389 0.614 . . . . 0.0 109.46 178.312 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.464 HG13 ' NE2' ' A' ' 141' ' ' GLN . 5.3 t -60.17 -30.16 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.846 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.82 -37.99 83.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.254 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.552 ' OE1' ' CE2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -63.61 -42.66 98.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.065 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.611 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.6 OUTLIER -70.05 -33.31 71.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.664 0.745 . . . . 0.0 110.366 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 1.019 ' CG ' HD21 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -76.4 -30.38 57.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.51 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -73.11 -44.67 60.01 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.798 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -78.14 -21.26 50.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.335 0.588 . . . . 0.0 110.115 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER 53.57 27.84 7.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.761 178.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.798 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -36.6 160.32 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 0.0 110.693 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.514 ' HD2' ' HB1' ' A' ' 145' ' ' ALA . 60.2 Cg_endo -73.23 4.27 3.96 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.691 2.26 . . . . 0.0 112.728 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 148' ' ' GLU . 10.8 t30 -81.48 135.83 35.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.984 0.421 . . . . 0.0 111.522 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.555 ' CB ' ' HB2' ' A' ' 176' ' ' ASN . 4.6 pt-20 -73.78 112.7 10.14 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.437 0.637 . . . . 0.0 110.957 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.581 HG23 ' NE ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -111.74 116.35 30.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.052 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.642 ' HB3' ' CD2' ' A' ' 122' ' ' TYR . 0.8 OUTLIER -107.12 142.82 36.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.76 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.945 HD12 ' N ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -134.05 136.2 53.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.152 0.501 . . . . 0.0 110.697 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.945 ' N ' HD12 ' A' ' 151' ' ' ILE . 18.2 m-30 -110.5 112.02 23.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.881 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.82 ' HZ ' HD11 ' A' ' 161' ' ' LEU . 8.6 t80 -113.9 130.34 56.51 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 122.199 -0.313 . . . . 0.0 111.364 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.683 ' HA2' ' HB2' ' A' ' 182' ' ' CYS . . . -154.12 161.19 29.89 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 119.535 -1.316 . . . . 0.0 113.865 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.939 HG21 HD13 ' A' ' 161' ' ' LEU . 21.0 m -164.05 -122.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.379 -0.411 . . . . 0.0 111.265 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.827 ' O ' HG21 ' A' ' 183' ' ' VAL . 44.7 p-10 -103.45 -174.34 2.52 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 120.557 0.218 . . . . 0.0 110.783 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.621 HG23 ' HD3' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -42.95 -25.31 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.323 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.668 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 40.1 mt-10 94.16 22.41 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.711 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 77.9 Cg_exo -46.78 -23.82 2.65 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.28 1.32 . . . . 0.0 111.252 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -131.59 -28.85 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.674 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.939 HD13 HG21 ' A' ' 155' ' ' VAL . 13.3 tp -35.76 158.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.71 -157.99 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.564 ' CE1' ' HG2' ' A' ' 166' ' ' GLU . 0.1 OUTLIER 74.15 27.61 1.52 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.1 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 1.024 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -70.23 -39.07 76.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.071 0.462 . . . . 0.0 110.306 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 1.024 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.2 OUTLIER -73.7 -27.2 61.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.825 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.564 ' HG2' ' CE1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -64.17 -49.16 73.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 -179.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -75.19 -30.84 60.77 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 164' ' ' ILE . 1.8 mttm -61.64 -41.26 97.25 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.16 -32.4 73.01 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 1.019 HD21 ' CG ' ' A' ' 141' ' ' GLN . 0.3 OUTLIER -61.72 -48.58 80.08 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.468 ' O ' ' SD ' ' A' ' 174' ' ' MET . 36.2 mt-10 -56.58 -32.65 65.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.89 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -39.94 30.85 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 m -112.13 28.8 8.44 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.633 ' HB2' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -113.65 167.05 10.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.164 0.507 . . . . 0.0 111.615 179.365 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -84.85 -80.05 0.21 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.373 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.565 ' C ' HD12 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -130.61 63.48 1.57 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.245 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.633 HD13 ' HB2' ' A' ' 174' ' ' MET . 4.5 mp -112.27 149.65 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.077 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.465 ' HB ' ' HG2' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -137.08 126.9 25.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.283 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 151' ' ' ILE . 72.6 t -100.99 135.8 35.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.314 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.625 ' CG ' ' CD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -99.79 136.69 39.34 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.196 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -98.22 105.89 18.1 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.68 0.752 . . . . 0.0 111.389 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.683 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 64.4 m -86.06 -164.75 1.08 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.358 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.827 HG21 ' O ' ' A' ' 156' ' ' ASN . 37.3 t 54.17 147.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 122.151 0.977 . . . . 0.0 112.646 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.729 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -137.18 -62.94 0.61 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.523 -1.672 . . . . 0.0 108.484 -178.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.538 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 50.8 m-70 -167.64 49.45 0.18 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.698 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.574 ' O ' ' CB ' ' A' ' 187' ' ' SER . 40.7 Cg_endo -85.95 -104.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.384 2.723 . . . . 0.0 112.895 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 9.6 t 150.81 21.78 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.618 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 97.84 10.4 52.62 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.636 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 251' ' ' ALA . 0.4 OUTLIER -138.07 63.88 1.52 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 178.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' TRP . . . . . 0.523 ' O ' ' O ' ' A' ' 249' ' ' GLY . 5.6 t-105 -122.81 123.63 41.46 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.778 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.52 ' HG3' ' HA ' ' A' ' 251' ' ' ALA . 0.3 OUTLIER -83.84 105.57 14.84 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.856 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.501 ' C ' ' CG ' ' A' ' 193' ' ' GLU . . . 127.33 -108.8 1.0 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.256 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.576 ' C ' ' HB3' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -168.9 -74.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.583 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -99.35 153.31 19.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 179.466 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.639 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -28.22 108.95 0.02 OUTLIER Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.465 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 8.2 m 95.4 155.61 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.268 -0.466 . . . . 0.0 110.418 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.471 ' O ' ' C ' ' A' ' 198' ' ' ILE . 32.5 Cg_exo -59.79 58.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.998 2.466 . . . . 0.0 112.634 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.987 HG13 HD23 ' A' ' 201' ' ' LEU . 0.1 OUTLIER 30.16 92.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 122.031 0.92 . . . . 0.0 110.066 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.89 -33.69 59.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.534 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -57.73 -31.56 66.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.987 HD23 HG13 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -69.52 -41.76 75.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.806 0.336 . . . . 0.0 110.672 -178.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.506 ' O ' ' HG ' ' A' ' 205' ' ' LEU . 13.6 mtm180 -57.19 -49.23 76.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.367 0.603 . . . . 0.0 110.257 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -71.78 -32.66 67.89 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.575 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.974 ' HB3' ' HB3' ' A' ' 210' ' ' ALA . 1.5 m-20 -59.44 -41.68 90.19 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.669 HD12 ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -60.73 -47.13 87.69 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.401 ' CG ' ' HG2' ' A' ' 233' ' ' ARG . 1.8 mm-40 -65.15 -19.06 65.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.674 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 208' ' ' SER . 16.2 t -90.8 -79.53 0.36 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.457 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 207' ' ' SER . 3.0 t 155.59 -11.68 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.87 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 6.8 m-20 -88.97 40.07 0.96 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.212 0.529 . . . . 0.0 110.412 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . 0.974 ' HB3' ' HB3' ' A' ' 204' ' ' ASP . . . 161.96 99.75 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.78 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.693 ' HA ' HD11 ' A' ' 235' ' ' ILE . 6.0 t30 173.25 -55.42 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.215 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 1.5 Cg_endo -45.81 -55.24 3.75 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.272 1.981 . . . . 0.0 110.889 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.03 108.85 9.13 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 1.007 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.9 OUTLIER -117.5 124.71 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.649 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -113.18 127.3 56.14 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.551 -178.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.565 ' CD1' ' CG1' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -131.94 123.61 27.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.71 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . 0.558 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -122.71 107.27 11.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.8 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 244' ' ' LYS . . . 176.22 166.14 33.06 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.571 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.768 ' HG2' ' HB3' ' A' ' 250' ' ' ALA . 24.3 Cg_exo -55.45 -170.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.721 2.281 . . . . 0.0 112.594 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 219' ' ' PRO . 23.6 Cg_exo -64.72 -19.69 64.68 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 123.192 2.595 . . . . 0.0 113.002 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -83.09 -54.61 3.14 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.839 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . 0.735 ' HE1' HG22 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -57.13 -34.39 68.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 242' ' ' PHE . 0.1 OUTLIER -76.66 -34.14 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.452 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.473 ' HA ' ' SG ' ' A' ' 227' ' ' CYS . 12.3 m-20 -72.96 -47.0 49.25 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.851 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.538 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -61.43 -48.12 82.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.724 0.297 . . . . 0.0 111.74 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.793 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -69.57 -34.87 74.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.566 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 223' ' ' ILE . 8.2 p -70.05 -31.93 69.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 110.263 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.99 -44.82 95.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.551 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.653 HD11 HD11 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -62.11 -39.62 93.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.093 0.473 . . . . 0.0 110.847 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.881 HG13 ' CG2' ' A' ' 235' ' ' ILE . 3.8 t -65.88 -45.68 90.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.456 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 23.5 mtt-85 -72.76 -30.25 63.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.782 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 33.3 m -69.08 -43.63 74.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.348 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.669 ' HD3' HD12 ' A' ' 205' ' ' LEU . 1.0 OUTLIER -80.99 -74.35 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.967 0.413 . . . . 0.0 111.354 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 148.76 -18.64 1.26 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.865 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.881 ' CG2' HG13 ' A' ' 230' ' ' VAL . 0.0 OUTLIER -22.86 82.41 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.533 ' N ' ' O ' ' A' ' 234' ' ' GLY . 6.0 Cg_exo -75.82 113.05 3.64 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.156 2.571 . . . . 0.0 111.811 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -119.84 -174.54 15.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.827 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.2 -35.92 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.621 0.248 . . . . 0.0 111.277 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.59 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 5.7 mm-40 -101.81 32.52 3.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.493 . . . . 0.0 110.834 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 1.007 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.2 t -94.6 134.67 31.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.248 0.547 . . . . 0.0 110.451 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.652 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.24 149.36 33.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.947 -177.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.568 ' HB2' HD11 ' A' ' 223' ' ' ILE . 5.7 p90 -131.55 148.68 52.64 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.247 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . 0.467 ' N ' HD11 ' A' ' 223' ' ' ILE . 2.2 tt0 -132.8 148.81 52.32 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -106.61 111.43 23.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.328 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.577 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -136.97 147.64 46.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.549 ' CD2' ' HD2' ' A' ' 247' ' ' PRO . 0.4 OUTLIER -20.34 146.09 0.01 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' PRO . . . . . 0.61 ' HA ' ' HG2' ' A' ' 219' ' ' PRO . 71.9 Cg_exo -50.28 -155.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.69 2.927 . . . . 0.0 113.122 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 247' ' ' PRO . 5.6 m 92.72 -19.29 0.1 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.816 0.817 . . . . 0.0 110.428 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 190' ' ' TRP . . . -128.45 -24.14 1.16 Allowed Glycine 0 C--N 1.309 -0.921 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.569 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.768 ' HB3' ' HG2' ' A' ' 219' ' ' PRO . . . -108.38 150.27 27.59 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 122.747 0.419 . . . . 0.0 110.52 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.52 ' HA ' ' HG3' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.229 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.865 0.364 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -74.62 177.68 5.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.3 mt -73.48 135.89 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.28 110.96 1.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.938 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -168.12 71.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.997 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.85 77.03 0.66 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.64 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -135.91 91.63 2.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.359 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.28 101.77 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.12 23.84 4.74 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.549 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.509 ' HB2' ' HG3' ' A' ' 105' ' ' LYS . 83.8 p -110.36 150.88 28.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.863 0.364 . . . . 0.0 111.038 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.726 ' CE1' ' HB2' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -131.46 162.67 29.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.547 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.587 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 8.3 mt-10 -110.8 129.97 55.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.814 0.34 . . . . 0.0 111.03 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.854 ' HB1' ' CB ' ' A' ' 31' ' ' LEU . . . -127.77 135.15 49.73 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.976 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.55 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 14.9 tp10 -93.64 122.62 36.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.394 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.74 ' HA ' HD23 ' A' ' 31' ' ' LEU . 32.6 m -71.25 104.34 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.643 ' HA ' HG23 ' A' ' 98' ' ' VAL . 2.6 p -122.51 -34.47 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.433 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -87.5 -130.61 3.2 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.306 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.831 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER 87.87 71.63 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.436 0.636 . . . . 0.0 110.291 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.59 ' ND2' HG12 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -108.91 146.54 33.61 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.818 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -88.54 114.3 25.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.59 HG12 ' ND2' ' A' ' 20' ' ' ASN . 1.7 m -95.04 -27.53 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.54 0.686 . . . . 0.0 109.692 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.547 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 11.7 m -138.51 172.13 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.297 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 t -51.64 -56.85 11.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.977 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.506 ' CA ' ' O ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -118.48 43.03 2.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.708 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.561 HG21 ' CB ' ' A' ' 128' ' ' THR . 0.2 OUTLIER -147.2 140.39 25.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.317 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.831 HG21 ' CD2' ' A' ' 19' ' ' LEU . 1.4 p -141.02 146.44 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.097 0.475 . . . . 0.0 112.236 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 6.4 tt0 -110.0 103.02 11.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.568 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.634 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -94.02 125.3 38.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.494 -178.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.562 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -112.61 116.29 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.074 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.854 ' CB ' ' HB1' ' A' ' 14' ' ' ALA . 2.2 mt -121.73 132.81 54.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 111.539 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.505 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 38.4 mt-30 -145.81 109.29 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.393 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.552 ' HB3' ' CA ' ' A' ' 14' ' ' ALA . 12.2 tptt -149.22 -0.32 0.5 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 38' ' ' CYS . 1.0 OUTLIER -168.39 168.04 5.94 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.139 0.495 . . . . 0.0 112.077 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.555 ' O ' ' CB ' ' A' ' 36' ' ' ASP . 36.7 Cg_exo -60.33 107.19 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.087 2.525 . . . . 0.0 111.863 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.59 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . 3.5 m-20 155.03 -34.68 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.645 0.735 . . . . 0.0 110.696 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.537 ' OE1' HD22 ' A' ' 76' ' ' LEU . 6.8 mt-10 -169.87 59.91 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.381 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.535 ' H ' ' HA3' ' A' ' 74' ' ' GLY . 13.8 t -164.07 -65.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.983 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -153.91 -12.88 0.06 OUTLIER Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.428 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.546 ' HB2' ' CB ' ' A' ' 35' ' ' PRO . 18.1 m120 -121.92 13.49 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.889 0.844 . . . . 0.0 111.54 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.902 ' CZ ' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -83.83 -34.79 24.6 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.804 0.812 . . . . 0.0 109.021 178.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 72' ' ' PRO . . . 57.49 96.3 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.423 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.902 HG13 ' CZ ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -96.31 160.98 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.361 0.6 . . . . 0.0 111.797 -179.131 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 1.5 ttpm? -163.07 26.65 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.967 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.631 ' CG ' ' CG ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER 76.55 96.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.584 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -108.75 165.79 12.03 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.437 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.59 59.12 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.713 2.275 . . . . 0.0 111.858 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.665 ' O ' HG12 ' A' ' 110' ' ' VAL . . . 58.48 61.68 7.12 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.66 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.488 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 1.2 mm-40 -35.44 146.21 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.664 0.232 . . . . 0.0 110.493 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 1.05 ' CD2' HD21 ' A' ' 108' ' ' LEU . 2.6 t80 -152.69 139.34 18.8 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.667 0.27 . . . . 0.0 111.696 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.579 ' O ' ' CE1' ' A' ' 50' ' ' PHE . 3.8 mtt -139.94 -162.68 1.38 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.852 0.358 . . . . 0.0 111.922 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 3.4 t0 -134.96 123.3 23.14 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.008 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.56 157.71 43.32 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.858 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -108.72 149.6 28.77 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.094 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.881 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -34.49 -70.95 0.11 Allowed Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.249 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 1.063 ' HD2' HG23 ' A' ' 58' ' ' THR . 51.3 Cg_endo -103.98 14.45 0.24 Allowed 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 123.39 2.727 . . . . 0.0 111.941 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 98.52 0.34 58.01 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.663 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 1.063 HG23 ' HD2' ' A' ' 56' ' ' PRO . 13.0 p -40.69 -103.18 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.852 0.461 . . . . 0.0 111.596 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.858 ' N ' HG21 ' A' ' 54' ' ' THR . 1.3 m-20 160.23 36.16 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.009 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 60' ' ' VAL . 6.1 t -152.32 27.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.958 0.408 . . . . 0.0 110.888 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.65 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 36.8 t -97.46 -101.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.631 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 170.64 -176.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.102 0.477 . . . . 0.0 111.36 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.589 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 2.4 m -99.19 142.56 30.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.689 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.532 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 1.8 t80 -141.36 131.4 24.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 19.7 m -79.28 108.89 9.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.62 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.876 ' CB ' HD13 ' A' ' 76' ' ' LEU . 72.9 Cg_endo -91.61 165.11 3.45 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.921 2.414 . . . . 0.0 112.189 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.17 135.55 25.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.867 0.365 . . . . 0.0 111.647 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.679 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -105.35 -69.76 0.81 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.999 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 68' ' ' ASN . 1.4 mt 138.3 160.27 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.468 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.565 ' HD3' ' CG ' ' A' ' 45' ' ' PHE . 20.2 Cg_endo -60.93 87.75 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 121.973 1.782 . . . . 0.0 111.341 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -168.08 117.65 0.65 Allowed Pre-proline 0 N--CA 1.457 -0.102 0 CA-C-O 120.807 0.337 . . . . 0.0 110.891 -179.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.569 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 42.3 Cg_endo -68.13 89.95 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.429 2.086 . . . . 0.0 111.861 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' O ' ' CA ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -158.09 -82.87 0.05 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.853 0.359 . . . . 0.0 110.094 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.535 ' HA3' ' H ' ' A' ' 38' ' ' CYS . . . 141.11 96.41 0.28 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.788 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 37.4 mtm180 -151.87 106.33 3.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.463 0.173 . . . . 0.0 110.925 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.876 HD13 ' CB ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -97.79 130.92 44.7 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.852 0.358 . . . . 0.0 110.446 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.778 ' N ' HD12 ' A' ' 76' ' ' LEU . 3.1 mt-10 -129.16 117.88 21.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.319 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.634 ' CE2' ' HB3' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -109.99 146.94 34.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.144 0.497 . . . . 0.0 111.715 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.029 HD22 ' CG2' ' A' ' 128' ' ' THR . 7.5 mt -111.17 84.53 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.032 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.639 HG22 HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -91.79 129.53 42.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.873 -178.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.65 ' CD ' ' N7A' ' A' ' 252' ' ' FDA . 0.0 OUTLIER -78.43 95.91 5.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.164 179.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.639 HG13 HG22 ' A' ' 80' ' ' ILE . 7.4 m -98.15 141.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.765 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.905 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -121.35 112.92 32.59 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.587 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.817 ' N ' HD22 ' A' ' 83' ' ' LEU . 82.5 Cg_exo -44.17 122.01 3.39 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.649 2.233 . . . . 0.0 112.181 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 84' ' ' PRO . 17.6 tp10 84.47 5.29 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.413 ' N ' HD13 ' A' ' 83' ' ' LEU . . . -74.08 -130.99 0.2 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.459 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -125.25 -26.03 3.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.602 0.239 . . . . 0.0 111.484 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 2.4 t80 -106.12 -31.26 8.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.544 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.55 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 1.0 OUTLIER -70.89 -34.17 71.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.685 0.279 . . . . 0.0 111.698 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 67.2 m-20 -74.91 -40.35 60.92 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.517 0.675 . . . . 0.0 109.752 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.617 ' O ' HD11 ' A' ' 55' ' ' ILE . 2.6 t80 -73.67 -24.48 59.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.508 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.941 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -68.08 -41.08 82.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.801 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -16.64 27.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.596 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 44.2 m-20 -101.22 -7.28 23.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.452 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.435 ' HB2' ' CD1' ' A' ' 91' ' ' TYR . 0.9 OUTLIER -151.56 13.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.941 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -139.79 26.24 2.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.97 0.415 . . . . 0.0 111.156 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.505 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -56.81 -171.98 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.01 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.643 HG23 ' HA ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -88.13 2.03 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.714 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.35 58.06 0.41 Allowed Glycine 0 C--N 1.321 -0.286 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.203 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.714 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -162.09 -178.85 6.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.027 0.442 . . . . 0.0 111.413 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.06 131.54 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.489 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.008 HD11 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.73 123.71 31.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.708 0.29 . . . . 0.0 110.781 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.609 ' N ' HD12 ' A' ' 102' ' ' LEU . 3.6 m -95.5 131.65 41.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.762 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.675 HG13 ' CE1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -99.82 134.61 38.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.509 ' HG3' ' HB2' ' A' ' 11' ' ' SER . 0.0 OUTLIER -130.15 113.78 14.91 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.37 -178.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 169.6 70.05 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.54 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.37 60.74 0.36 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.555 2.17 . . . . 0.0 110.308 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.05 HD21 ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -133.77 170.36 15.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.019 -177.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.513 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -117.01 173.54 14.75 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.094 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 48' ' ' GLY . 8.3 p -112.6 112.1 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.324 0.583 . . . . 0.0 110.548 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.5 120.89 39.7 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.569 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.12 -37.93 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.701 ' C ' HD12 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -126.04 120.02 29.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.972 0.415 . . . . 0.0 110.72 179.352 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.646 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 2.7 tptt -130.38 108.61 10.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.464 ' HB3' ' HE3' ' A' ' 140' ' ' MET . 0.0 OUTLIER -78.68 140.56 38.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.667 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -89.38 13.45 13.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.815 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.58 -76.05 0.28 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.504 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.83 89.81 2.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.855 0.36 . . . . 0.0 110.293 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.515 ' O ' ' NE ' ' A' ' 121' ' ' ARG . . . -168.57 144.27 2.94 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.21 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 25.9 Cg_endo -62.16 105.0 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.697 2.265 . . . . 0.0 111.944 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -117.37 143.84 45.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.249 -179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.64 ' CD2' ' HB2' ' A' ' 150' ' ' ARG . 14.6 m-85 -119.59 127.18 52.72 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 120.734 0.302 . . . . 0.0 111.131 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.943 ' CE2' HG13 ' A' ' 133' ' ' VAL . 1.3 t80 -117.48 106.73 13.48 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 1.02 HG12 HD23 ' A' ' 216' ' ' LEU . 4.5 p -98.73 110.96 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.371 0.605 . . . . 0.0 111.809 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -102.96 133.63 47.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.527 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.987 ' O ' HD21 ' A' ' 246' ' ' LEU . . . -105.62 103.17 2.1 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.497 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.836 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 118.22 -154.52 16.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.834 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.029 ' CG2' HD22 ' A' ' 79' ' ' LEU . 18.8 m -107.88 -11.89 15.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.805 0.336 . . . . 0.0 111.111 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.642 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -66.92 9.72 0.91 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.545 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.665 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -78.05 4.15 13.06 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.912 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -47.34 -44.54 52.32 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.098 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 5.9 Cg_exo -73.32 -30.73 9.99 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.836 2.357 . . . . 0.0 110.104 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.012 ' O ' HG23 ' A' ' 137' ' ' VAL . 17.7 t -65.79 -49.49 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.921 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.665 HG13 ' HG ' ' A' ' 130' ' ' LEU . 19.0 m -64.54 -33.28 62.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.541 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.5 -50.65 66.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.235 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -31.82 71.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.885 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.012 HG23 ' O ' ' A' ' 133' ' ' VAL . 74.7 t -59.85 -52.9 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 134' ' ' VAL . 0.8 OUTLIER -60.76 -31.38 70.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.622 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.631 ' CG ' ' CG ' ' A' ' 45' ' ' PHE . 31.7 mt-30 -63.0 -38.55 91.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.264 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.817 ' HE1' HG23 ' A' ' 149' ' ' THR . 2.5 ptm -67.91 -42.76 80.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.268 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.612 HE22 HD22 ' A' ' 170' ' ' LEU . 21.4 mt-30 -68.5 -42.83 78.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.116 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -12.37 60.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.788 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.459 ' HB2' ' O ' ' A' ' 139' ' ' GLN . 0.8 OUTLIER -80.54 -84.34 0.1 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.455 0.645 . . . . 0.0 111.164 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.498 ' C ' ' CD ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -156.6 23.66 0.34 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.678 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 140' ' ' MET . . . -112.66 49.69 0.38 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.356 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.505 ' HA ' ' HG2' ' A' ' 175' ' ' ARG . 52.6 Cg_endo -69.31 -3.6 12.03 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.579 2.186 . . . . 0.0 111.922 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -69.97 -159.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.256 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.546 ' CB ' ' HB2' ' A' ' 176' ' ' ASN . 1.0 OUTLIER -73.03 105.28 4.43 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.62 0.724 . . . . 0.0 111.515 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.817 HG23 ' HE1' ' A' ' 140' ' ' MET . 0.5 OUTLIER -110.04 115.21 29.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.237 178.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.64 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -106.34 138.56 42.29 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.745 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.909 HD12 ' N ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -133.52 134.95 56.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.026 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.909 ' N ' HD12 ' A' ' 151' ' ' ILE . 21.8 m-30 -109.51 123.24 49.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.071 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.446 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 7.2 t80 -119.87 131.01 55.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.775 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.769 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -158.49 158.6 29.43 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 119.492 -1.337 . . . . 0.0 113.775 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.866 HG11 ' CD2' ' A' ' 161' ' ' LEU . 11.8 m -164.15 -116.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.841 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.6 OUTLIER -119.91 -164.27 1.06 Allowed 'General case' 0 C--N 1.343 0.285 0 O-C-N 122.459 -0.151 . . . . 0.0 110.895 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.811 HG23 ' HA ' ' A' ' 187' ' ' SER . 65.3 p -25.95 -41.38 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.456 0.302 . . . . 0.0 111.515 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.604 ' CB ' ' O ' ' A' ' 157' ' ' THR . 0.8 OUTLIER 107.82 -43.27 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.617 0 O-C-N 123.967 0.792 . . . . 0.0 112.402 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 157' ' ' THR . 80.3 Cg_exo -46.2 -22.02 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.199 1.933 . . . . 0.0 112.335 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -98.4 -13.96 20.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.764 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.866 ' CD2' HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -110.58 -165.69 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.756 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.49 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 0.1 OUTLIER 178.26 -154.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.903 0.382 . . . . 0.0 111.349 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.522 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 77.13 16.12 1.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.097 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 1.033 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -70.27 -39.17 76.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.246 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 1.033 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.6 OUTLIER -73.68 -27.45 61.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.097 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.458 ' O ' ' OG ' ' A' ' 169' ' ' SER . 3.5 mm-40 -64.79 -49.61 70.02 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -76.21 -31.13 58.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 165' ' ' ASP . 7.7 mttt -62.74 -36.67 83.77 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 166' ' ' GLU . 15.0 p -66.96 -32.95 74.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.808 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -63.01 -41.57 99.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.659 ' OE1' HD22 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -68.91 -36.45 78.04 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.913 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -76.21 -25.05 54.72 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.348 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 169' ' ' SER . 37.4 t -61.48 -71.06 0.16 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.707 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.02 ' O ' HD12 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -179.92 -153.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.133 0.492 . . . . 0.0 112.083 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER 42.59 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.577 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 176' ' ' ASN . 0.0 OUTLIER -13.45 73.69 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 124.433 1.083 . . . . 0.0 111.736 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.02 HD12 ' O ' ' A' ' 174' ' ' MET . 0.3 OUTLIER -94.65 148.53 22.17 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.201 -178.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.522 ' OG1' ' CZ ' ' A' ' 150' ' ' ARG . 6.8 m -137.18 115.33 11.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.03 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.482 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 7.3 p -101.22 127.77 54.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.161 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.578 ' CB ' ' CD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -95.84 135.52 37.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.539 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -101.0 104.97 16.15 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.354 0.597 . . . . 0.0 110.899 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.624 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 34.5 m -88.67 -160.76 0.68 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.108 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.841 HG21 ' O ' ' A' ' 156' ' ' ASN . 40.6 t 56.23 146.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.765 0.793 . . . . 0.0 111.815 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.718 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.3 -63.4 0.76 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.751 -178.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.563 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 1.1 t60 -168.65 51.47 0.2 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.541 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.569 ' HG2' ' CA ' ' A' ' 156' ' ' ASN . 62.6 Cg_endo -88.01 -101.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.054 2.503 . . . . 0.0 112.793 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.811 ' HA ' HG23 ' A' ' 157' ' ' THR . 0.4 OUTLIER 153.23 -8.01 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.605 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 130.34 12.11 2.35 Favored Glycine 0 C--N 1.322 -0.214 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.728 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.54 63.39 1.55 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.518 ' N ' ' OG ' ' A' ' 248' ' ' SER . 7.5 t-105 -125.86 117.53 23.54 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.21 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.404 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 10.0 mm-40 -92.01 104.18 16.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 251' ' ' ALA . . . 142.06 -120.05 1.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.438 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.656 ' O ' ' N ' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -167.09 -85.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 0.0 OUTLIER -85.82 126.78 34.29 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.636 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -25.99 106.74 0.01 OUTLIER Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.085 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 2.2 m 146.25 166.01 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 114.961 -0.619 . . . . 0.0 110.896 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.465 ' HG2' ' OD2' ' A' ' 199' ' ' ASP . 83.5 Cg_endo -81.93 44.33 1.7 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.899 2.399 . . . . 0.0 112.566 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.025 HG13 ' HB1' ' A' ' 251' ' ' ALA . 0.1 OUTLIER 65.81 17.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.297 0.57 . . . . 0.0 110.754 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.465 ' OD2' ' HG2' ' A' ' 197' ' ' PRO . 1.0 OUTLIER -58.41 -36.77 74.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.442 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.88 -43.68 94.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.685 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.883 ' HB2' HD12 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -65.8 -31.38 72.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.927 0.394 . . . . 0.0 110.527 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.576 ' HG2' HD22 ' A' ' 229' ' ' LEU . 5.7 mtm180 -58.83 -42.13 88.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.5 0.666 . . . . 0.0 110.178 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.84 -32.71 65.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.088 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -58.79 -43.2 90.41 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.758 HD11 ' HB2' ' A' ' 229' ' ' LEU . 0.0 OUTLIER -60.79 -46.06 91.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.0 -24.22 66.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.352 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 208' ' ' SER . 16.4 t -92.11 -87.96 0.21 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.885 0.374 . . . . 0.0 111.18 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 1.9 p 163.28 103.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.645 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 1.2 m-20 156.69 57.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.52 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 0.934 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 147.4 105.37 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.397 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.6 ' O ' HG23 ' A' ' 240' ' ' VAL . 56.3 t30 177.27 -56.01 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.208 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 9.6 Cg_endo -52.82 -55.69 3.51 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.953 1.769 . . . . 0.0 110.667 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.47 109.45 9.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.979 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.994 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.9 OUTLIER -121.12 125.56 74.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.677 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -117.39 126.21 52.29 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.49 0.662 . . . . 0.0 110.163 -178.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 1.02 HD23 HG12 ' A' ' 124' ' ' VAL . 34.0 mt -122.73 118.78 28.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.042 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . 0.573 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -123.42 132.31 53.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.107 178.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 245' ' ' PHE . . . 136.32 -154.78 22.16 Favored Glycine 0 C--O 1.224 -0.475 0 C-N-CA 120.333 -0.936 . . . . 0.0 112.859 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.581 ' HG3' ' HA ' ' A' ' 248' ' ' SER . 11.8 Cg_endo -53.79 161.21 4.78 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.005 2.47 . . . . 0.0 112.648 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.564 ' O ' HG22 ' A' ' 223' ' ' ILE . 50.5 Cg_endo -69.28 -8.97 25.03 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.611 2.208 . . . . 0.0 111.572 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.48 -49.17 52.94 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.282 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.775 ' O ' ' HB3' ' A' ' 226' ' ' ALA . 0.0 OUTLIER -55.7 -25.71 41.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.574 HD11 ' C ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -76.59 -42.54 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.487 178.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -74.67 -47.57 31.04 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.561 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -76.41 -48.99 17.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.911 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -59.5 -37.79 79.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.76 0.314 . . . . 0.0 110.594 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 37.9 t -69.64 -31.22 69.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.946 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 232' ' ' SER . 4.8 mt-10 -70.95 -45.13 64.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.738 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.758 ' HB2' HD11 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -60.67 -37.38 81.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.178 0.513 . . . . 0.0 110.702 -179.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 1.048 HG13 HG23 ' A' ' 235' ' ' ILE . 12.5 t -65.24 -45.63 93.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.393 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.8 -30.16 61.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.035 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 228' ' ' GLU . 0.6 OUTLIER -75.37 -44.16 46.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.391 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.54 ' HD3' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -79.65 -70.57 0.5 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.008 0.432 . . . . 0.0 111.11 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 154.9 -31.42 0.67 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.8 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 1.048 HG23 HG13 ' A' ' 230' ' ' VAL . 0.0 OUTLIER -26.33 84.59 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.394 0 C-N-CA 123.064 0.545 . . . . 0.0 112.423 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.539 ' N ' ' O ' ' A' ' 234' ' ' GLY . 5.8 Cg_exo -76.37 114.35 3.87 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 123.427 2.751 . . . . 0.0 112.232 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -106.22 161.08 14.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.931 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -117.51 -45.96 2.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.736 0.303 . . . . 0.0 110.91 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 19.3 mm-40 -105.87 40.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.354 0.597 . . . . 0.0 110.281 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.994 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.3 t -92.04 134.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.928 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.36 145.67 30.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.248 -178.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 1.004 ' CD1' HD12 ' A' ' 216' ' ' LEU . 1.5 m-85 -131.64 144.24 50.89 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.721 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . 0.521 ' O ' ' CE ' ' A' ' 222' ' ' MET . 21.2 tt0 -132.72 148.72 52.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -111.19 106.48 15.51 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.871 ' CE1' HD23 ' A' ' 246' ' ' LEU . 0.0 OUTLIER -137.0 145.28 43.93 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.557 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.987 HD21 ' O ' ' A' ' 126' ' ' GLY . 0.2 OUTLIER 51.59 171.52 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.564 ' CD ' ' HB2' ' A' ' 246' ' ' LEU . 32.2 Cg_exo -60.36 -138.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.914 3.076 . . . . 0.0 113.054 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.581 ' HA ' ' HG3' ' A' ' 219' ' ' PRO . 1.0 OUTLIER -72.75 161.15 31.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.808 0.337 . . . . 0.0 111.847 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.484 ' C ' ' HA3' ' A' ' 126' ' ' GLY . . . 143.41 -20.75 2.24 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.609 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.55 ' O ' ' OXT' ' A' ' 251' ' ' ALA . . . -105.78 153.43 21.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.903 0.383 . . . . 0.0 111.785 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 1.025 ' HB1' HG13 ' A' ' 198' ' ' ILE . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.037 -0.982 . . . . 0.0 112.614 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' FDA . . . . . 0.963 HM82 ' CZ ' ' A' ' 50' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.776 0.322 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -116.59 -70.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.771 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.8 mt -114.9 82.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.988 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 t -94.36 33.87 1.35 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 70.53 46.87 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.78 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.79 159.0 7.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.607 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.74 155.59 48.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.0 110.735 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.13 100.6 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.003 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 105' ' ' LYS . . . -105.81 20.77 35.68 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.6 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 105' ' ' LYS . 3.6 p -112.61 150.99 30.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.583 -0.308 . . . . 0.0 110.711 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.898 ' CE1' ' HB2' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -132.41 165.63 23.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.034 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.582 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 3.3 mt-10 -113.53 129.89 56.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.989 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.979 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -125.86 150.68 47.69 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 1.9 pt-20 -102.11 112.19 24.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.825 0.345 . . . . 0.0 110.303 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 100' ' ' GLN . 11.4 t -71.36 105.67 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.012 0.434 . . . . 0.0 110.715 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 17' ' ' VAL . 7.7 p -120.21 19.53 6.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.98 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -132.8 -124.75 2.57 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.558 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.719 HD12 ' C ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 74.71 95.31 0.07 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.861 0.839 . . . . 0.0 109.586 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -142.33 139.35 31.76 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.808 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.564 ' CZ2' ' HG3' ' A' ' 93' ' ' ARG . 22.3 m0 -89.47 113.31 24.65 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.485 HG12 ' ND2' ' A' ' 20' ' ' ASN . 1.5 m -86.6 -33.25 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-O 121.928 0.871 . . . . 0.0 109.265 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 160' ' ' GLU . 0.4 OUTLIER -129.85 -174.19 3.24 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.411 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.462 ' HB3' ' HG3' ' A' ' 160' ' ' GLU . 9.8 t -60.06 -40.66 90.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.433 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 8.9 m-80 -133.66 40.84 3.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.197 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.712 HG23 HG21 ' A' ' 128' ' ' THR . 17.7 m -133.92 123.42 24.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.674 ' CG2' HD13 ' A' ' 19' ' ' LEU . 6.6 p -136.72 132.63 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 111.747 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 3.1 tt0 -119.98 134.58 55.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.577 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.741 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -130.68 142.61 50.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.406 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.73 HD13 ' C ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -113.04 116.93 30.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.591 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.979 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 38.8 mt -101.57 142.93 32.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 1.3 mt-30 -146.79 134.18 20.75 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.635 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . 2.7 tmtp? -178.14 -70.67 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.66 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 8.2 mtp180 -139.84 -163.4 0.06 OUTLIER Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.66 ' CD ' ' CB ' ' A' ' 34' ' ' ARG . 41.5 Cg_exo -40.9 108.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 122.74 2.294 . . . . 0.0 113.742 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.57 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . 21.3 m-20 144.68 -179.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.638 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.864 ' HG3' HD21 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -70.68 60.73 0.23 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.564 ' C ' ' HA2' ' A' ' 74' ' ' GLY . 67.7 m -159.19 -54.61 0.06 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.403 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.507 ' O ' ' NE ' ' A' ' 41' ' ' ARG . . . -87.34 26.44 7.06 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.446 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 73' ' ' GLU . 1.8 p-10 40.56 50.03 2.78 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.533 ' HD3' ' N ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -86.16 -41.52 14.63 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.669 178.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 72' ' ' PRO . . . 154.87 109.59 0.34 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 119.776 -1.202 . . . . 0.0 116.063 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.951 HG22 ' CA ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -103.4 167.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 121.257 0.551 . . . . 0.0 110.311 176.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' O ' ' CA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -146.69 -142.2 0.12 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.962 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.01 81.24 2.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.165 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.5 mp0 -113.21 165.31 13.52 Favored Pre-proline 0 C--N 1.332 -0.194 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.522 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 14.6 Cg_endo -57.57 72.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.422 2.082 . . . . 0.0 111.484 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 41.96 73.94 0.19 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.324 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -28.28 145.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.512 0.196 . . . . 0.0 110.979 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 1.034 ' CD2' HD21 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -143.7 142.27 30.89 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.722 0.296 . . . . 0.0 111.724 -178.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.581 ' O ' ' CE1' ' A' ' 50' ' ' PHE . 3.7 mtt -141.38 -155.59 0.6 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 105' ' ' LYS . 19.9 t70 -136.5 119.11 15.98 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.041 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.81 157.21 42.66 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.93 HG23 ' C ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -95.7 154.48 17.2 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.875 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.993 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -31.49 -66.08 0.19 Allowed Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 123.309 0.381 . . . . 0.0 110.701 -179.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.993 ' HD3' HG23 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -112.36 8.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.834 3.022 . . . . 0.0 111.704 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 101.08 -6.26 56.42 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.64 -177.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.955 HG23 ' CG ' ' A' ' 56' ' ' PRO . 69.0 p -23.02 -87.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.269 0.628 . . . . 0.0 111.703 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.634 ' O ' HG12 ' A' ' 60' ' ' VAL . 4.8 m-20 -151.64 42.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.105 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.93 ' C ' HG23 ' A' ' 54' ' ' THR . 0.4 OUTLIER 80.96 125.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.874 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.851 ' N ' HG23 ' A' ' 54' ' ' THR . 27.0 t -111.23 -57.73 2.2 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.692 0.758 . . . . 0.0 110.005 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -179.9 -177.92 0.41 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.175 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.585 ' O ' " H2'" ' A' ' 252' ' ' FDA . 0.7 OUTLIER -88.62 129.65 35.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.144 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.489 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 2.1 t80 -140.65 125.76 18.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.949 0.404 . . . . 0.0 110.778 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 32.0 t -75.33 106.27 2.75 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.674 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.87 ' HB2' HD22 ' A' ' 76' ' ' LEU . 11.1 Cg_endo -91.24 154.33 3.75 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.439 2.759 . . . . 0.0 111.1 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 132' ' ' PRO . . . -144.38 128.91 18.05 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.613 ' CB ' ' HB3' ' A' ' 37' ' ' GLU . 12.0 t-20 -108.94 -67.79 0.96 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.554 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER 142.28 151.11 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 O-C-N 123.825 0.703 . . . . 0.0 109.977 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.567 ' CD ' ' HG ' ' A' ' 69' ' ' LEU . 12.0 Cg_endo -55.56 108.0 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 121.732 1.621 . . . . 0.0 109.962 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.92 ' O ' HG23 ' A' ' 43' ' ' VAL . 6.8 p30 178.0 -168.19 0.04 OUTLIER Pre-proline 0 C--O 1.217 -0.657 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.831 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.621 ' CD ' ' HB2' ' A' ' 71' ' ' ASN . 53.2 Cg_exo -53.19 -21.86 18.12 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.842 1.695 . . . . 0.0 113.295 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.951 ' CA ' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER 79.81 70.02 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 177.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.564 ' HA2' ' C ' ' A' ' 38' ' ' CYS . . . -141.61 28.1 2.32 Favored Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.143 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 59.8 mtm-85 -152.86 93.59 1.77 Allowed 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.073 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.87 HD22 ' HB2' ' A' ' 66' ' ' PRO . 8.5 mt -91.08 143.18 26.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -127.47 111.21 13.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.0 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.741 ' CD2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -108.7 142.35 39.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.776 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.019 HD12 ' HB2' ' A' ' 131' ' ' ALA . 9.2 mt -126.36 80.6 1.94 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.143 0.497 . . . . 0.0 109.768 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.622 ' HB ' ' CE2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -92.56 122.07 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.171 -178.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.736 ' O ' H52A ' A' ' 252' ' ' FDA . 0.4 OUTLIER -79.55 95.77 5.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.438 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.551 HG13 HG12 ' A' ' 27' ' ' VAL . 2.4 m -90.59 141.22 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.983 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.708 HD23 ' H4B' ' A' ' 252' ' ' FDA . 0.2 OUTLIER -87.25 167.51 21.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.591 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 83' ' ' LEU . 30.4 Cg_endo -63.8 77.7 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.593 2.195 . . . . 0.0 112.251 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.42 61.47 3.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.465 ' CA ' HD13 ' A' ' 83' ' ' LEU . . . -109.88 -39.71 1.53 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.731 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.81 -63.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 111.383 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.535 ' CD2' ' O2P' ' A' ' 252' ' ' FDA . 6.1 t80 -71.74 -39.76 69.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.004 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -69.04 -24.02 64.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.923 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 2.3 m-20 -76.11 -37.77 57.69 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.812 0.815 . . . . 0.0 109.214 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.621 ' CE1' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -73.19 -28.8 62.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.304 -1.317 . . . . 0.0 110.777 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.695 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -68.41 -43.24 77.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.302 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.564 ' HG3' ' CZ2' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -90.58 -23.75 20.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.753 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 20.2 m120 -87.26 -15.25 38.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.576 0.227 . . . . 0.0 111.325 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.509 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 1.5 t70 -127.92 -23.68 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -118.13 36.87 4.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.954 0.407 . . . . 0.0 111.078 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -70.58 -41.21 72.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.545 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 98' ' ' VAL . 2.2 t -121.8 90.45 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.203 0.525 . . . . 0.0 111.834 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.516 ' CA ' ' O ' ' A' ' 16' ' ' VAL . . . 8.77 56.7 0.01 OUTLIER Glycine 0 N--CA 1.459 0.181 0 CA-C-N 114.119 -1.4 . . . . 0.0 114.153 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.62 ' O ' HG23 ' A' ' 16' ' ' VAL . 3.6 mt-30 -68.92 -179.27 1.42 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.715 0.293 . . . . 0.0 110.852 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.0 p -92.94 133.42 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.824 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.041 HD11 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.74 120.81 25.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.798 0.332 . . . . 0.0 110.453 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.552 ' N ' HD12 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -89.66 136.5 33.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.182 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.784 HG13 ' CE1' ' A' ' 12' ' ' PHE . 1.4 m -111.11 127.55 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -129.75 117.53 20.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.497 -178.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.53 ' CA ' ' HB3' ' A' ' 51' ' ' MET . . . 164.64 71.44 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.751 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.41 58.93 1.03 Allowed 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.159 1.906 . . . . 0.0 110.228 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.034 HD21 ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -129.36 169.87 14.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.031 -178.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.548 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -116.17 173.25 14.62 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.49 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 47' ' ' PRO . 2.5 p -121.25 111.75 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.325 0.583 . . . . 0.0 110.587 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -81.14 114.25 19.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.406 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 241' ' ' PHE . . . -179.0 -48.18 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.675 HD22 HG22 ' A' ' 133' ' ' VAL . 1.1 pp -124.4 118.06 25.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.212 0.53 . . . . 0.0 110.867 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.627 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -139.46 114.13 9.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.04 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.446 ' OE1' ' HE3' ' A' ' 140' ' ' MET . 2.0 tp10 -89.59 138.25 31.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.47 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -91.34 13.66 16.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.025 0.44 . . . . 0.0 110.839 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.46 -73.8 0.43 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.461 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.54 ' HA ' ' CB ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -129.83 89.56 2.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.846 0.355 . . . . 0.0 110.409 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 121' ' ' ARG . . . -164.09 155.85 14.31 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.406 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 10.2 Cg_exo -71.36 107.65 2.19 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.077 2.518 . . . . 0.0 111.747 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.505 ' NH1' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -136.82 138.1 40.45 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.226 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.669 ' CE2' ' CD ' ' A' ' 150' ' ' ARG . 1.9 m-85 -107.62 127.29 53.52 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.141 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.588 ' CD2' ' HB2' ' A' ' 113' ' ' LEU . 1.1 m-85 -106.73 104.34 14.0 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 1.039 HG13 ' CB ' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -99.1 111.18 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.344 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -110.14 133.73 52.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.285 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -109.63 102.63 1.62 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.674 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.926 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 122.58 -152.79 16.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.992 -1.099 . . . . 0.0 112.349 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.862 ' CG2' HD22 ' A' ' 79' ' ' LEU . 2.9 m -111.55 -16.32 13.3 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.247 0.546 . . . . 0.0 110.51 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.618 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -65.58 11.21 0.4 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.857 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.686 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -74.99 4.34 6.79 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.52 0.328 . . . . 0.0 110.191 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 1.019 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -45.32 -41.93 17.29 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.29 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 7.3 Cg_exo -72.36 -31.08 11.94 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.39 2.06 . . . . 0.0 109.936 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.675 HG22 HD22 ' A' ' 113' ' ' LEU . 5.9 t -66.85 -44.31 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.41 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.686 HG13 ' HG ' ' A' ' 130' ' ' LEU . 10.5 m -70.59 -30.4 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.893 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -64.37 -51.31 63.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.3 tpt -64.19 -45.45 88.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.169 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.487 HG12 ' OE1' ' A' ' 141' ' ' GLN . 42.6 t -61.82 -30.52 48.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.227 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 135' ' ' SER . 0.0 OUTLIER -62.1 -38.0 87.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.336 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -42.18 98.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.395 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.623 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 4.7 tpp -68.66 -34.77 76.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.503 0.668 . . . . 0.0 110.732 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.766 ' OE1' HD22 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -77.77 -30.74 51.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.519 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -70.47 -44.5 67.63 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.764 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -79.04 -21.14 47.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.432 0.634 . . . . 0.0 109.828 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 141' ' ' GLN . 1.1 p 54.17 26.64 6.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.917 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.764 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -37.27 161.11 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.775 0.322 . . . . 0.0 110.586 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' ' 145' ' ' ALA . 57.7 Cg_endo -72.44 5.36 2.83 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 122.662 2.241 . . . . 0.0 112.9 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.631 ' OD1' ' HB3' ' A' ' 145' ' ' ALA . 19.0 p-10 -86.2 136.8 33.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 111.85 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 0.9 OUTLIER -73.62 113.69 11.03 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.753 0.787 . . . . 0.0 111.012 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 53.8 m -107.96 115.09 29.5 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.539 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.669 ' CD ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -103.4 140.91 36.83 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.266 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.941 HD12 ' N ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -134.54 133.96 54.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.162 0.506 . . . . 0.0 110.816 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 1.039 ' CB ' HG13 ' A' ' 124' ' ' VAL . 19.1 m-30 -114.05 110.66 20.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.497 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 154' ' ' GLY . 1.0 OUTLIER -116.45 133.42 56.04 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 122.091 -0.38 . . . . 0.0 111.064 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.866 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -158.73 158.79 29.68 Favored Glycine 0 CA--C 1.502 -0.748 0 C-N-CA 119.366 -1.397 . . . . 0.0 113.649 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 1.118 HG21 HD22 ' A' ' 161' ' ' LEU . 2.5 m -168.76 -108.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.874 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.4 OUTLIER -122.19 -169.71 1.94 Allowed 'General case' 0 C--N 1.344 0.331 0 CA-C-O 120.773 0.32 . . . . 0.0 111.517 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.765 HG23 ' N ' ' A' ' 187' ' ' SER . 76.9 p -29.51 -63.38 0.12 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.488 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.56 ' CB ' ' O ' ' A' ' 157' ' ' THR . 4.4 mm-40 153.32 -53.54 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.194 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 79.0 Cg_exo -37.65 -27.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.955 2.437 . . . . 0.0 112.732 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -86.41 -30.56 22.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.897 0.379 . . . . 0.0 110.976 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.118 HD22 HG21 ' A' ' 155' ' ' VAL . 1.0 OUTLIER -108.86 -174.66 2.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.268 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.53 ' O ' ' CB ' ' A' ' 163' ' ' TYR . 0.3 OUTLIER -171.05 -167.12 0.52 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.302 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.53 ' CB ' ' O ' ' A' ' 162' ' ' PHE . 0.2 OUTLIER 85.57 13.17 0.19 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.823 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.492 HD13 ' HA ' ' A' ' 164' ' ' ILE . 0.1 OUTLIER -65.45 -49.59 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.293 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.48 ' N ' HG22 ' A' ' 164' ' ' ILE . 0.7 OUTLIER -69.27 -33.37 73.12 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.271 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.438 ' CD ' ' CE1' ' A' ' 163' ' ' TYR . 1.6 mt-10 -72.42 -36.14 68.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.582 ' CD2' HG21 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -60.89 -32.07 71.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.05 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 171' ' ' GLU . 4.5 mtpt -63.14 -49.04 75.92 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 6.8 m -61.83 -31.54 71.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.766 HD22 ' OE1' ' A' ' 141' ' ' GLN . 0.8 OUTLIER -62.86 -34.6 77.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.783 ' HA ' HD11 ' A' ' 177' ' ' LEU . 40.6 mt-10 -63.86 -42.08 97.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.28 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 -78.21 -33.62 49.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.603 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.27 -46.29 55.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.639 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.065 ' HB2' HD23 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -77.15 -163.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.176 0.512 . . . . 0.0 111.602 -179.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER -105.08 -62.38 1.35 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.351 -179.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 176' ' ' ASN . 0.0 OUTLIER -130.28 64.02 1.54 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.795 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.065 HD23 ' HB2' ' A' ' 174' ' ' MET . 0.7 OUTLIER -105.1 154.25 20.41 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.032 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.488 ' N ' HD12 ' A' ' 177' ' ' LEU . 9.1 m -136.72 117.37 13.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.578 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.623 HG11 ' OE2' ' A' ' 171' ' ' GLU . 7.6 p -95.43 135.33 29.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.671 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.553 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 1.9 tppt? -97.95 135.95 38.94 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.852 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 194' ' ' GLN . . . -102.11 105.34 16.04 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 121.517 0.675 . . . . 0.0 111.751 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.631 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 34.7 m -87.35 -159.15 0.49 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.645 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.874 HG21 ' O ' ' A' ' 156' ' ' ASN . 28.4 t 55.93 148.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.64 0.733 . . . . 0.0 111.77 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.723 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -136.37 -62.55 0.66 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.197 -178.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.597 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 3.7 t60 -166.86 51.43 0.22 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.724 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.625 ' HG2' ' HA ' ' A' ' 156' ' ' ASN . 98.5 Cg_endo -88.97 -98.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.044 2.496 . . . . 0.0 112.704 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.765 ' N ' HG23 ' A' ' 157' ' ' THR . 13.6 t 143.11 2.28 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.603 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 123.73 12.29 4.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.453 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.27 62.72 1.58 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 249' ' ' GLY . 8.3 t-105 -130.83 120.6 23.93 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.249 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 250' ' ' ALA . 0.0 OUTLIER -98.96 104.45 16.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.341 178.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.585 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 145.18 -117.75 1.04 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.506 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 183' ' ' VAL . 18.7 mt-10 -165.04 -98.05 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -87.41 126.85 35.13 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 196' ' ' SER . . . 2.46 108.92 0.0 OUTLIER Glycine 0 C--N 1.339 0.7 0 O-C-N 124.061 0.851 . . . . 0.0 113.726 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 5.9 m 96.83 156.21 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.286 0 CA-C-O 121.06 0.457 . . . . 0.0 111.086 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 196' ' ' SER . 58.0 Cg_exo -35.75 -69.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.349 2.699 . . . . 0.0 113.638 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER 173.36 35.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 122.093 0.949 . . . . 0.0 110.636 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.516 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 0.9 OUTLIER -57.61 -37.19 72.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.859 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.81 -32.81 70.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.316 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.706 ' HB2' HD13 ' A' ' 198' ' ' ILE . 0.3 OUTLIER -69.54 -32.13 70.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 110.489 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.729 ' HG2' HD22 ' A' ' 229' ' ' LEU . 2.8 mtt180 -59.86 -52.25 66.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.533 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.11 -40.93 86.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.566 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 207' ' ' SER . 11.3 m-20 -60.18 -28.49 67.99 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.788 ' HG ' HD11 ' A' ' 235' ' ' ILE . 0.1 OUTLIER -61.79 -47.99 82.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.25 178.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -14.38 59.69 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.016 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.449 ' HB2' ' HA ' ' A' ' 204' ' ' ASP . 3.8 m -91.98 -76.59 0.45 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.803 0.335 . . . . 0.0 111.497 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.548 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 17.3 p 168.97 102.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.677 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.63 ' O ' ' HB3' ' A' ' 210' ' ' ALA . 5.0 m-20 153.32 86.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.696 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 0.766 ' CB ' HD11 ' A' ' 214' ' ' ILE . . . 101.6 109.79 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.579 ' HB2' HD13 ' A' ' 235' ' ' ILE . 1.4 t-20 -175.26 -58.51 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.437 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 11.7 Cg_endo -57.23 -83.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.043 1.829 . . . . 0.0 110.676 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.89 ' HA ' HG21 ' A' ' 240' ' ' VAL . 0.0 OUTLIER -114.38 111.59 21.7 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.766 HD11 ' CB ' ' A' ' 210' ' ' ALA . 0.8 OUTLIER -109.5 126.48 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.689 ' CE1' ' CD2' ' A' ' 241' ' ' PHE . 2.7 m-85 -116.72 134.2 55.1 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.77 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.803 HD23 ' HB ' ' A' ' 124' ' ' VAL . 1.5 mt -134.45 115.58 14.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.791 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . 0.53 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 42.3 t -123.48 107.54 11.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.851 0.357 . . . . 0.0 110.476 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.613 ' CA ' ' CD2' ' A' ' 245' ' ' PHE . . . 114.14 -36.92 3.77 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.769 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 218' ' ' GLY . 45.0 Cg_endo -92.82 79.99 0.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.812 2.341 . . . . 0.0 113.956 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.783 ' HD2' ' HB2' ' A' ' 250' ' ' ALA . 9.2 Cg_endo -51.59 -66.8 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.452 2.101 . . . . 0.0 111.074 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.844 ' N ' ' HB1' ' A' ' 250' ' ' ALA . . . -54.09 -48.77 61.91 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.012 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.571 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -55.22 -24.73 28.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.729 HD11 ' H ' ' A' ' 243' ' ' GLU . 0.1 OUTLIER -74.56 -37.07 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.111 177.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 221' ' ' GLY . 7.2 m-20 -71.85 -46.43 58.0 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.813 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.528 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -67.59 -33.14 74.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -60.13 -39.43 86.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.361 0.6 . . . . 0.0 110.055 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.436 ' HB2' ' OE1' ' A' ' 239' ' ' GLN . 31.5 t -70.49 -31.8 69.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.784 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -44.02 92.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.638 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.729 HD22 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -59.74 -37.59 79.38 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.077 0.465 . . . . 0.0 110.636 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.782 HG22 ' CG ' ' A' ' 238' ' ' GLU . 3.0 t -62.46 -46.45 96.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.424 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -74.56 -30.28 61.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.783 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 51.5 m -74.11 -42.05 60.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.303 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.499 ' HD3' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -85.11 -74.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.236 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 158.75 -56.58 0.35 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.07 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.847 ' O ' HD12 ' A' ' 235' ' ' ILE . 2.2 pp -39.36 98.69 0.18 Allowed Pre-proline 0 N--CA 1.453 -0.288 0 CA-C-O 121.255 0.55 . . . . 0.0 111.221 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.505 ' O ' ' ND2' ' A' ' 211' ' ' ASN . 57.7 Cg_endo -70.33 164.43 35.12 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 123.404 2.736 . . . . 0.0 112.646 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 211' ' ' ASN . . . 76.3 9.42 85.75 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.642 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.782 ' CG ' HG22 ' A' ' 230' ' ' VAL . 8.7 tp10 -71.53 1.02 7.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.68 0.276 . . . . 0.0 111.282 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.535 ' O ' ' O ' ' A' ' 214' ' ' ILE . 39.3 mt-30 -101.95 -76.98 0.56 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.369 0.604 . . . . 0.0 109.874 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.89 HG21 ' HA ' ' A' ' 213' ' ' ASP . 4.0 t 65.06 -83.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.46 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.788 ' CG ' HG12 ' A' ' 240' ' ' VAL . 9.5 m-85 -115.64 127.82 55.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.894 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.411 ' HB3' HG12 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -132.57 132.84 42.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.438 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . 0.729 ' H ' HD11 ' A' ' 223' ' ' ILE . 11.0 tp10 -132.56 149.04 52.38 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.281 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 220' ' ' PRO . 0.9 OUTLIER -127.74 106.23 8.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.618 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -138.58 146.11 41.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.342 179.134 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.566 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 5.7 mt 64.71 167.63 0.11 Allowed Pre-proline 0 N--CA 1.471 0.588 0 O-C-N 121.886 -0.509 . . . . 0.0 111.925 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.476 ' CD ' HD22 ' A' ' 246' ' ' LEU . 38.6 Cg_endo -88.6 -107.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.764 2.976 . . . . 0.0 112.422 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 247' ' ' PRO . 30.7 m -36.4 136.49 0.33 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 110.959 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 190' ' ' TRP . . . 125.84 -15.87 6.97 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.844 ' HB1' ' N ' ' A' ' 221' ' ' GLY . . . -106.38 119.36 39.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.81 -0.695 . . . . 0.0 111.364 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.585 ' N ' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' FDA . . . . . 0.92 " H3'" ' N1 ' ' A' ' 252' ' ' FDA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.752 0.311 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -116.65 0.83 12.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.102 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.1 mm -79.14 104.9 7.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.867 0.365 . . . . 0.0 111.079 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.0 t -61.63 156.58 19.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -67.3 138.29 56.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.98 35.3 0.78 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.548 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.68 104.45 16.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.713 0.292 . . . . 0.0 110.821 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.11 100.41 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.075 0.464 . . . . 0.0 111.096 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.06 21.02 9.66 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.602 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -118.91 152.82 35.62 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.818 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.976 ' CE1' ' HB2' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -132.45 165.19 24.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.93 0.395 . . . . 0.0 110.947 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.582 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -104.84 123.99 48.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.635 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.976 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . . . -121.44 154.2 36.87 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.536 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -118.99 116.56 26.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.569 HG12 ' CD2' ' A' ' 31' ' ' LEU . 17.3 m -71.16 125.66 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.454 . . . . 0.0 111.194 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.538 ' HA ' ' CG1' ' A' ' 98' ' ' VAL . 8.7 p -144.56 16.31 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.367 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -140.97 -135.38 3.17 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.691 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.004 HD11 HD22 ' A' ' 92' ' ' LEU . 0.2 OUTLIER 92.17 70.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.196 0.522 . . . . 0.0 110.494 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.639 HD21 HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -111.8 147.88 34.75 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.677 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -89.31 114.37 25.75 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.639 HG12 HD21 ' A' ' 20' ' ' ASN . 2.0 m -89.37 -29.19 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.523 0.677 . . . . 0.0 109.718 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.532 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 20.9 m -137.11 177.18 8.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.435 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.444 ' OG ' ' OD1' ' A' ' 25' ' ' ASN . 2.9 t -51.88 -58.37 6.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.894 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 2.5 m-20 -117.55 44.85 2.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.441 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.928 HG23 ' HG2' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -146.06 137.29 24.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.602 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.811 HG21 ' CD2' ' A' ' 19' ' ' LEU . 1.5 p -140.34 143.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.595 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -115.42 103.14 10.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.213 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.62 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 0.6 OUTLIER -91.4 121.24 32.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.676 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.604 ' N ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -102.37 116.02 31.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.375 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.677 HD22 HD23 ' A' ' 102' ' ' LEU . 6.9 mt -111.9 133.78 53.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 46.8 mt-30 -142.79 129.49 20.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.589 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.591 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -152.38 -97.48 0.05 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.163 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.554 ' HB3' ' CB ' ' A' ' 41' ' ' ARG . 2.8 mmp_? -37.75 98.0 0.15 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 57.9 Cg_endo -71.76 90.43 0.72 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.16 2.573 . . . . 0.0 115.206 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.533 ' OD2' ' CA ' ' A' ' 42' ' ' GLY . 1.8 t70 -107.96 -36.62 6.3 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 122.343 1.068 . . . . 0.0 108.426 176.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -173.27 -39.57 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.24 -1.8 . . . . 0.0 108.146 178.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' CB ' ' N ' ' A' ' 75' ' ' ARG . 86.6 m -116.67 -52.96 2.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.14 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 34' ' ' ARG . . . 154.5 52.33 0.01 OUTLIER Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.471 -0.871 . . . . 0.0 114.114 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.612 ' CB ' ' CA ' ' A' ' 74' ' ' GLY . 26.1 t-20 -144.59 6.71 1.26 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.451 0.625 . . . . 0.0 112.488 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.554 ' CB ' ' HB3' ' A' ' 34' ' ' ARG . 0.0 OUTLIER 78.84 -5.81 1.98 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 72' ' ' PRO . . . 117.12 101.6 2.18 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.752 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -94.39 163.93 2.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.807 0.337 . . . . 0.0 111.279 -179.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.678 ' N ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -166.69 22.57 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.006 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.888 ' CB ' HD12 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -103.94 -169.38 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.265 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.521 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 20.5 mm-40 -107.55 130.28 23.05 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.905 0.383 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.965 ' HA ' HD23 ' A' ' 69' ' ' LEU . 99.8 Cg_exo -41.75 -23.01 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.618 2.212 . . . . 0.0 112.219 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . -51.83 -34.35 37.12 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.961 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.492 ' NE2' ' O ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -68.44 158.91 32.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.904 0.383 . . . . 0.0 110.909 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 1.043 ' HB2' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -125.79 164.06 21.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.445 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.537 ' CA ' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -114.84 143.33 45.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.978 0.418 . . . . 0.0 111.902 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.545 ' HA ' ' CB ' ' A' ' 63' ' ' SER . 14.1 t70 -98.95 107.8 20.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.031 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -148.96 157.08 43.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.361 -178.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.937 HG22 ' HB2' ' A' ' 61' ' ' SER . 0.2 OUTLIER -93.42 151.52 19.69 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.96 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -32.72 -66.06 0.21 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.519 -178.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.96 ' HD3' HG23 ' A' ' 55' ' ' ILE . 7.5 Cg_endo -106.32 4.19 0.2 Allowed 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 123.424 2.75 . . . . 0.0 111.486 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 106.95 -3.02 35.61 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.261 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.799 HG23 ' CD ' ' A' ' 56' ' ' PRO . 31.4 p -24.52 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.178 0.513 . . . . 0.0 111.744 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.85 ' H ' HG21 ' A' ' 54' ' ' THR . 19.8 p-10 -178.06 -28.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.77 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 60' ' ' VAL . 6.2 p -147.58 109.28 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.682 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.937 ' HB2' HG22 ' A' ' 54' ' ' THR . 0.3 OUTLIER -143.15 -76.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.793 179.288 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.556 ' HG3' " H3'" ' A' ' 252' ' ' FDA . 0.4 OUTLIER 170.49 155.22 0.06 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.47 . . . . 0.0 111.901 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.712 ' CB ' HD21 ' A' ' 108' ' ' LEU . 46.6 p -89.54 131.82 35.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.382 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.547 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -120.78 119.62 33.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.404 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.562 ' HB3' ' H6 ' ' A' ' 252' ' ' FDA . 60.7 p -60.41 102.68 0.32 Allowed Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HB2' HD13 ' A' ' 76' ' ' LEU . 92.6 Cg_endo -102.9 -178.42 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.276 2.651 . . . . 0.0 113.563 -178.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 76' ' ' LEU . . . -87.21 167.37 14.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.984 ' O ' HD22 ' A' ' 69' ' ' LEU . 0.2 OUTLIER 89.63 117.55 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -177.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.984 HD22 ' O ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -167.47 -65.59 0.01 OUTLIER Pre-proline 0 C--O 1.215 -0.734 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.543 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 66.4 Cg_endo -99.07 75.26 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.379 2.053 . . . . 0.0 113.244 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.622 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.5 OUTLIER 178.9 125.33 0.21 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.718 0.294 . . . . 0.0 110.48 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.577 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 30.8 Cg_endo -64.26 56.98 0.23 Allowed 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.313 2.009 . . . . 0.0 111.675 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.575 ' HB3' ' N ' ' A' ' 38' ' ' CYS . 2.4 mt-10 -135.93 -81.44 0.4 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.017 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.612 ' CA ' ' CB ' ' A' ' 40' ' ' ASN . . . 126.77 15.25 2.66 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.854 -1.165 . . . . 0.0 114.255 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.593 ' N ' ' CB ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -61.96 85.25 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.284 0.542 . . . . 0.0 110.257 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.814 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -96.18 128.76 43.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.599 0.714 . . . . 0.0 111.197 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.708 ' N ' HD12 ' A' ' 76' ' ' LEU . 7.7 mt-10 -132.72 141.4 48.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.625 -1.171 . . . . 0.0 111.251 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.62 ' CE2' ' HB3' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -133.4 133.09 41.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.222 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.903 HD12 ' HB2' ' A' ' 131' ' ' ALA . 9.1 mt -106.78 85.6 2.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.189 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.608 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -90.48 116.57 32.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.945 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.928 ' HG2' HG23 ' A' ' 26' ' ' THR . 0.1 OUTLIER -78.12 96.07 5.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.408 0.623 . . . . 0.0 110.19 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.615 HG13 HG12 ' A' ' 27' ' ' VAL . 2.5 m -89.07 141.47 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.84 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.84 HD21 ' HB2' ' A' ' 87' ' ' ARG . 3.9 pp -74.46 169.73 18.25 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.845 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 83' ' ' LEU . 34.5 Cg_exo -61.22 63.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.804 2.336 . . . . 0.0 112.192 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER 51.15 107.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.52 ' CA ' HD11 ' A' ' 83' ' ' LEU . . . -178.55 -35.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.573 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.84 ' HB2' HD21 ' A' ' 83' ' ' LEU . 2.1 mpt_? -133.26 -81.58 0.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.752 0.311 . . . . 0.0 111.175 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.565 ' CE2' H5'1 ' A' ' 252' ' ' FDA . 2.3 t80 -74.03 -45.17 51.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.203 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.536 ' HB3' ' CG2' ' A' ' 82' ' ' VAL . 3.3 p -67.94 -23.33 65.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.513 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -75.66 -46.07 33.5 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.486 0.66 . . . . 0.0 109.493 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.408 ' HB3' HD13 ' A' ' 55' ' ' ILE . 7.8 t80 -73.35 -23.28 60.2 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.52 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.004 HD22 HD11 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -65.75 -49.37 68.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.275 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.89 -19.0 21.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.662 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 1.5 m-20 -94.38 -2.37 52.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.399 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.69 30.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.651 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.839 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . . . -151.03 25.95 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -170.02 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.87 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.538 ' CG1' ' HA ' ' A' ' 17' ' ' VAL . 1.5 t -97.9 -137.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.551 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 98' ' ' VAL . . . 31.7 53.92 0.35 Allowed Glycine 0 CA--C 1.516 0.128 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.021 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.446 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -159.68 -170.96 3.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 111.197 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 14' ' ' ALA . 2.3 t -129.04 143.61 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.882 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.031 HD11 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -128.81 153.75 47.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.016 0.436 . . . . 0.0 111.541 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.689 ' N ' HD12 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -99.14 119.17 37.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.587 178.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.835 HG23 HD12 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -113.89 143.0 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.18 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.537 ' O ' ' CA ' ' A' ' 51' ' ' MET . 5.1 mtpt -128.7 168.25 16.07 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.521 ' N ' ' HD3' ' A' ' 107' ' ' PRO . . . -153.38 49.66 0.51 Allowed Glycine 0 C--N 1.313 -0.708 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.628 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 106' ' ' GLY . 91.5 Cg_endo -86.17 27.4 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.722 2.281 . . . . 0.0 111.403 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.043 HD23 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -88.27 172.96 9.05 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 122.108 0.956 . . . . 0.0 113.01 -178.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.592 ' O ' ' CE2' ' A' ' 50' ' ' PHE . . . -110.27 174.04 17.07 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.574 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.45 107.56 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 117.911 0.856 . . . . 0.0 110.801 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 4.3 m-85 -123.11 114.84 20.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.525 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . 136.63 -82.88 0.27 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.633 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.839 HD11 ' SD ' ' A' ' 136' ' ' MET . 0.4 OUTLIER -95.53 117.97 31.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.19 0.519 . . . . 0.0 111.206 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -138.49 113.09 8.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.033 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.458 ' OE1' ' CE2' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -106.52 140.54 39.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.12 12.0 30.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.115 0.483 . . . . 0.0 110.946 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 129.18 -90.77 0.31 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.919 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.469 ' HA ' ' OD1' ' A' ' 147' ' ' ASN . 19.6 ptt? -130.52 90.98 3.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.77 0.319 . . . . 0.0 110.835 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.699 ' HB3' ' CZ ' ' A' ' 121' ' ' ARG . . . -149.29 147.29 23.03 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.984 0.421 . . . . 0.0 111.285 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 36.4 Cg_endo -65.38 110.2 1.54 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.842 2.361 . . . . 0.0 112.071 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.699 ' CZ ' ' HB3' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -136.71 146.77 46.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.884 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 150' ' ' ARG . 0.6 OUTLIER -115.08 122.2 45.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.58 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 1.15 ' CE2' HG13 ' A' ' 133' ' ' VAL . 1.0 OUTLIER -106.44 108.08 19.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.144 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.727 HG13 HD23 ' A' ' 216' ' ' LEU . 10.0 p -98.41 111.63 28.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.571 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -101.28 132.69 46.68 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.419 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.99 103.07 1.2 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.542 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.819 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 115.99 -154.88 16.6 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.134 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.76 ' CG2' HD13 ' A' ' 79' ' ' LEU . 14.5 m -105.66 -9.59 17.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.205 0.526 . . . . 0.0 110.54 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.576 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -64.66 10.01 0.36 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.537 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.873 ' O ' HG22 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -81.22 5.55 16.68 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.82 0.31 . . . . 0.0 110.632 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.903 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -47.03 -46.71 54.62 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.306 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 131' ' ' ALA . 90.0 Cg_endo -79.72 -29.92 2.61 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.653 2.235 . . . . 0.0 111.053 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.15 HG13 ' CE2' ' A' ' 123' ' ' PHE . 20.9 t -63.11 -52.4 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.566 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 130' ' ' LEU . 2.0 m -61.78 -36.56 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.659 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 139' ' ' GLN . 18.6 m -62.08 -50.35 72.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.333 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.839 ' SD ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -62.56 -36.17 81.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.469 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.073 HG23 ' O ' ' A' ' 133' ' ' VAL . 17.7 t -66.97 -53.45 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.302 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.975 ' CG ' HD21 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -63.63 -31.83 73.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.708 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -67.47 -37.34 82.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.026 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.569 ' SD ' HG21 ' A' ' 149' ' ' THR . 3.0 ptm -63.43 -43.38 97.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.736 HE22 HG12 ' A' ' 137' ' ' VAL . 2.0 mt-30 -73.06 -34.86 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.4 ' OE1' ' O ' ' A' ' 138' ' ' ARG . 1.5 mp0 -79.62 -12.84 59.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.913 0.387 . . . . 0.0 110.672 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.47 ' HB2' ' O ' ' A' ' 139' ' ' GLN . 2.8 m95 -92.23 -85.33 0.25 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.443 0.64 . . . . 0.0 111.264 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 144' ' ' THR . 0.2 OUTLIER -154.81 20.34 0.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.242 -178.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.555 ' N ' ' CD ' ' A' ' 146' ' ' PRO . . . -125.3 44.87 1.21 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.343 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 145' ' ' ALA . 73.1 Cg_endo -76.16 5.75 4.35 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.606 2.204 . . . . 0.0 112.005 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.482 ' C ' ' ND2' ' A' ' 176' ' ' ASN . 8.4 p-10 -58.46 -159.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.149 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 40.9 mt-10 -74.55 104.63 5.32 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.408 0.623 . . . . 0.0 111.273 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.569 HG21 ' SD ' ' A' ' 140' ' ' MET . 2.8 m -119.06 117.92 30.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.095 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.633 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 1.8 mmt180 -101.52 146.15 28.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.992 0.425 . . . . 0.0 110.369 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.707 HD13 ' O ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -133.47 134.11 57.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.811 -178.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.726 ' CD2' HD21 ' A' ' 201' ' ' LEU . 18.2 m-30 -112.91 110.47 20.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.238 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.496 ' HZ ' HD23 ' A' ' 161' ' ' LEU . 3.4 t80 -112.99 126.72 55.81 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.484 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.818 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -155.58 151.89 23.41 Favored Glycine 0 CA--C 1.499 -0.939 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.105 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 1.03 HG21 HD22 ' A' ' 161' ' ' LEU . 3.8 m -164.64 -111.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.776 ' O ' HG21 ' A' ' 183' ' ' VAL . 19.9 p30 -105.85 -168.05 1.39 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.369 0.604 . . . . 0.0 112.182 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.639 HG23 ' HA ' ' A' ' 187' ' ' SER . 34.1 p -33.96 -32.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.83 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.586 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.9 tt0 105.46 -52.09 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.974 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.524 ' HD2' ' C ' ' A' ' 157' ' ' THR . 86.3 Cg_exo -48.26 -21.57 3.14 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 121.994 1.796 . . . . 0.0 112.003 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -87.29 -30.75 20.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.491 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.03 HD22 HG21 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -89.23 -160.51 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.396 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 38.0 p90 177.14 -176.59 0.15 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.0 0.429 . . . . 0.0 111.501 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 162' ' ' PHE . 0.2 OUTLIER 79.84 2.46 2.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.336 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.976 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -71.28 -45.42 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.817 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.976 ' N ' HD13 ' A' ' 164' ' ' ILE . 6.8 m-20 -67.16 -35.02 78.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.24 0.543 . . . . 0.0 110.172 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -72.28 -37.03 69.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -61.05 -32.15 71.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.015 179.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.475 ' HG3' ' HA ' ' A' ' 165' ' ' ASP . 8.1 mttt -65.9 -39.3 90.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 m -62.88 -32.0 73.16 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.315 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.975 HD21 ' CG ' ' A' ' 138' ' ' ARG . 0.9 OUTLIER -63.8 -36.89 85.38 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' A' ' 177' ' ' LEU . 2.3 mm-40 -67.53 -37.66 83.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.224 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -78.76 -32.27 46.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.235 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 170' ' ' LEU . 58.4 p -75.01 -16.17 60.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.006 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.865 ' HB3' HD13 ' A' ' 177' ' ' LEU . 0.7 OUTLIER -94.95 -168.93 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.178 0.513 . . . . 0.0 111.643 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.493 ' CB ' ' O ' ' A' ' 146' ' ' PRO . 0.7 OUTLIER -81.76 -63.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.331 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.49 ' ND2' ' N ' ' A' ' 176' ' ' ASN . 0.0 OUTLIER -141.9 70.11 1.33 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.943 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.865 HD13 ' HB3' ' A' ' 174' ' ' MET . 7.3 mp -98.68 151.75 20.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.827 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.491 ' CB ' ' HD3' ' A' ' 150' ' ' ARG . 4.8 m -136.83 115.01 11.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.822 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.424 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 7.7 p -92.85 134.97 29.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.505 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -99.1 136.44 39.06 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.588 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -96.55 105.44 17.54 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.851 0.834 . . . . 0.0 111.04 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.762 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 92.3 m -95.1 -167.96 1.72 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.182 -1.372 . . . . 0.0 111.16 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.815 HG23 ' H ' ' A' ' 155' ' ' VAL . 6.2 t 56.07 148.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.785 0.802 . . . . 0.0 111.186 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.75 -49.78 0.53 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.409 -1.268 . . . . 0.0 108.238 -177.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.594 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 12.1 t-80 178.55 57.04 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.498 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 187' ' ' SER . 33.5 Cg_endo -94.02 -93.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.538 2.825 . . . . 0.0 112.886 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 27.4 t 137.22 20.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.6 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 96.79 11.05 54.55 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.585 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.432 ' C ' ' HA ' ' A' ' 251' ' ' ALA . 0.4 OUTLIER -136.96 63.31 1.57 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.553 ' O ' ' O ' ' A' ' 249' ' ' GLY . 4.9 t-105 -125.44 123.19 38.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.448 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.741 ' N ' ' HB2' ' A' ' 251' ' ' ALA . 2.5 mt-10 -84.33 105.36 15.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.51 ' C ' ' CG ' ' A' ' 193' ' ' GLU . . . 131.42 -111.15 1.05 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.092 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.548 ' CB ' ' SG ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -167.51 -71.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.615 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -102.33 150.67 23.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.176 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.645 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -37.46 107.29 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.74 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.623 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 48.0 m 127.66 143.77 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 123.658 0.783 . . . . 0.0 110.169 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 199' ' ' ASP . 27.5 Cg_endo -62.32 56.83 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.797 2.331 . . . . 0.0 112.752 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.928 HD11 ' CD1' ' A' ' 229' ' ' LEU . 0.5 OUTLIER 37.17 26.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.574 0.702 . . . . 0.0 111.961 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.553 ' HA ' ' CD ' ' A' ' 202' ' ' ARG . 5.1 m-20 -57.67 -34.77 69.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.126 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.83 89.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.543 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.866 ' HB2' HD12 ' A' ' 198' ' ' ILE . 0.4 OUTLIER -69.21 -30.86 69.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.172 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.805 ' HG2' HD13 ' A' ' 229' ' ' LEU . 11.0 mtp-105 -58.46 -48.57 80.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.513 0.673 . . . . 0.0 110.645 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.536 ' HA ' ' NH1' ' A' ' 233' ' ' ARG . 2.1 mt-10 -71.41 -33.66 69.65 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.318 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -59.87 -39.07 84.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.609 -0.436 . . . . 0.0 109.937 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.884 ' HB2' HG21 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -61.18 -49.61 76.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -64.53 -21.63 66.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.816 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.8 -85.27 0.2 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.751 0.31 . . . . 0.0 111.202 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 2.2 p 174.03 99.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.719 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.667 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 7.9 m-20 154.18 42.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.15 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 1.002 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 150.05 104.35 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.539 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.581 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 14.5 t-20 177.87 -57.32 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.06 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 8.4 Cg_endo -51.75 -55.79 3.59 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.17 1.913 . . . . 0.0 110.984 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -133.32 109.37 9.33 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 1.002 HD11 ' HB1' ' A' ' 210' ' ' ALA . 1.0 OUTLIER -116.45 125.82 73.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.58 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.4 m-85 -117.52 126.47 52.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.484 0.659 . . . . 0.0 110.533 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.727 HD23 HG13 ' A' ' 124' ' ' VAL . 0.7 OUTLIER -125.66 117.22 23.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.163 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . 0.509 ' SG ' ' CG2' ' A' ' 133' ' ' VAL . 48.8 t -124.53 107.8 11.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.978 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.577 ' HA2' ' CD2' ' A' ' 245' ' ' PHE . . . 168.57 -175.81 43.06 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.005 -1.093 . . . . 0.0 113.187 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.561 ' HB2' ' CB ' ' A' ' 250' ' ' ALA . 5.4 Cg_exo -38.18 168.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.773 2.982 . . . . 0.0 112.904 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 224' ' ' ASP . 73.3 Cg_endo -75.52 -28.12 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.888 2.392 . . . . 0.0 111.84 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.484 ' HA2' ' HB2' ' A' ' 224' ' ' ASP . . . -81.75 -46.55 6.71 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.23 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.554 ' SD ' HD12 ' A' ' 223' ' ' ILE . 1.3 tmt? -57.07 -35.49 69.43 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.712 HD11 ' HB3' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -76.97 -34.53 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.985 178.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.484 ' HB2' ' HA2' ' A' ' 221' ' ' GLY . 0.2 OUTLIER -67.59 -46.81 71.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.161 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -61.42 -47.05 87.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.808 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -68.28 -31.21 70.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.675 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 223' ' ' ILE . 49.6 t -70.32 -31.8 69.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.165 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -65.84 -44.37 85.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.867 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.928 ' CD1' HD11 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -60.49 -39.88 89.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.793 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.891 HG12 ' HG3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -66.05 -41.6 89.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 -179.219 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -72.9 -30.0 63.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.151 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.42 -29.83 19.92 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.59 ' HD3' HD12 ' A' ' 205' ' ' LEU . 1.4 mmp_? -72.91 -66.83 0.62 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.874 0.368 . . . . 0.0 111.415 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.52 ' C ' ' HD2' ' A' ' 236' ' ' PRO . . . 122.09 9.67 6.62 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.795 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.884 HG21 ' HB2' ' A' ' 205' ' ' LEU . 1.0 OUTLIER -83.3 -19.18 0.26 Allowed Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.891 ' HG3' HG12 ' A' ' 230' ' ' VAL . 66.1 Cg_exo -39.99 117.23 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.68 1.587 . . . . 0.0 112.382 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -96.49 -116.79 3.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.753 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -129.53 -32.8 1.92 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.585 0.231 . . . . 0.0 111.401 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.577 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 9.7 mm-40 -99.87 30.74 3.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.008 0.433 . . . . 0.0 111.147 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.988 HG22 ' HB ' ' A' ' 214' ' ' ILE . 1.7 t -94.52 131.87 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.041 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.645 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.66 151.4 37.19 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.65 151.27 51.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.097 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . 0.591 ' O ' HD13 ' A' ' 223' ' ' ILE . 8.8 tm-20 -132.47 149.4 52.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.269 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -117.85 107.35 14.01 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 111.674 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.577 ' CD2' ' HA2' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -136.48 148.14 47.53 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.147 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.664 ' HB2' ' N1 ' ' A' ' 252' ' ' FDA . 3.0 tt -15.72 139.99 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.57 ' O ' ' CB ' ' A' ' 248' ' ' SER . 77.7 Cg_exo -50.8 -149.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.885 3.057 . . . . 0.0 113.565 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 247' ' ' PRO . 7.4 m 97.01 -19.43 0.05 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.907 0.86 . . . . 0.0 109.871 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 190' ' ' TRP . . . -122.15 -18.5 3.44 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.085 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.561 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . . . -109.08 151.67 26.09 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.606 0.762 . . . . 0.0 110.339 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.741 ' HB2' ' N ' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.07 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' FDA . . . . . 0.94 HM72 ' CG ' ' A' ' 50' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 81.9 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.42 -54.75 1.87 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.04 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.3 mt -116.33 117.13 54.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.468 ' O ' ' CG ' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -154.85 57.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 5' ' ' SER . 2.2 m-85 179.23 91.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.43 -139.47 9.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.504 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -121.06 45.48 2.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 111.057 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.79 101.02 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.59 24.58 3.38 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.47 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -111.47 158.49 19.07 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.922 0.391 . . . . 0.0 111.055 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 34' ' ' ARG . 1.9 t80 -128.55 165.24 21.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.957 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -110.46 129.63 55.73 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.084 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -137.8 154.62 49.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.864 0.364 . . . . 0.0 111.153 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -103.52 121.38 42.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.881 HG13 ' HE1' ' A' ' 29' ' ' PHE . 24.3 t -72.1 136.03 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 17' ' ' VAL . 10.5 p -162.2 24.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.264 0.554 . . . . 0.0 109.711 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.596 ' O ' ' CE1' ' A' ' 29' ' ' PHE . . . -153.05 122.2 1.26 Allowed Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.85 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.933 ' CD2' HD22 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -170.85 90.44 0.14 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.569 -0.816 . . . . 0.0 109.665 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -140.39 144.04 36.0 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.7 178.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.415 ' HA ' ' O ' ' A' ' 26' ' ' THR . 10.1 m0 -89.94 112.6 24.03 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.579 -0.849 . . . . 0.0 108.87 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.585 HG22 ' HB ' ' A' ' 26' ' ' THR . 0.7 OUTLIER -71.41 -19.02 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.639 0.733 . . . . 0.0 109.122 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.533 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 37.9 m -153.17 -175.24 5.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.074 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.3 m -52.2 -57.86 8.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.113 0.483 . . . . 0.0 110.917 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -118.79 47.26 1.68 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.14 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.585 ' HB ' HG22 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -143.28 128.59 18.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.754 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.537 HG11 ' CD1' ' A' ' 92' ' ' LEU . 2.5 p -131.0 133.83 62.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.301 0.572 . . . . 0.0 112.476 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.487 ' HG2' HD21 ' A' ' 30' ' ' LEU . 15.2 tt0 -100.62 131.36 46.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.792 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.881 ' HE1' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -126.02 128.42 47.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.917 -178.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.862 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -121.35 115.77 23.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.213 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.078 HD13 HD21 ' A' ' 102' ' ' LEU . 2.8 mt -115.28 148.73 38.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.455 . . . . 0.0 111.753 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -124.01 108.32 12.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.523 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.65 ' HD3' HG11 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -105.35 -165.43 1.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.048 -179.091 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.628 ' N ' ' HD2' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -28.81 -55.41 0.26 Allowed Pre-proline 0 N--CA 1.463 0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.832 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 34' ' ' ARG . 9.5 Cg_endo -52.95 -153.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.019 2.479 . . . . 0.0 111.972 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.603 ' CB ' ' HB3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -129.89 -156.51 0.76 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.402 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -93.04 67.81 4.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 111.644 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.599 ' CB ' ' HB2' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -161.28 -63.2 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 179.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.647 ' CA ' HG22 ' A' ' 43' ' ' VAL . . . -164.96 99.16 0.16 Allowed Glycine 0 C--N 1.344 1.003 0 C-N-CA 120.325 -0.94 . . . . 0.0 114.151 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.786 ' N ' ' HA2' ' A' ' 74' ' ' GLY . 18.0 t30 -14.81 138.3 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 124.499 1.12 . . . . 0.0 113.334 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.457 ' C ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER 31.5 35.51 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.584 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.7 ' HA2' ' HA ' ' A' ' 72' ' ' PRO . . . 61.69 81.36 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.935 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 40' ' ' ASN . 21.9 m -94.41 170.68 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.258 0.551 . . . . 0.0 111.459 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -155.77 23.12 0.39 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.803 -178.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.643 ' CG ' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER 99.07 92.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.583 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -115.2 125.4 28.94 Favored Pre-proline 0 N--CA 1.453 -0.317 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.937 178.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.447 ' C ' ' O ' ' A' ' 46' ' ' GLU . 53.5 Cg_exo -28.13 84.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.055 2.503 . . . . 0.0 112.739 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.635 ' N ' ' CD2' ' A' ' 111' ' ' PHE . . . 40.56 75.97 0.1 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.612 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.446 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 1.6 tm0? -69.74 109.7 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 111.021 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.664 ' CE1' ' HB2' ' A' ' 65' ' ' SER . 1.5 m-30 -109.97 164.15 12.88 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.549 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.485 ' HB3' ' O ' ' A' ' 105' ' ' LYS . 5.2 mmt -135.74 -171.48 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.418 0.628 . . . . 0.0 112.414 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 9.3 t0 -131.79 102.5 5.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.665 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.01 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -134.58 157.93 45.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.451 0.643 . . . . 0.0 112.228 -177.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.866 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -109.19 151.2 26.8 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.968 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.891 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -30.45 -69.62 0.1 Allowed Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.224 0.327 . . . . 0.0 110.897 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 1.094 ' HD2' HG23 ' A' ' 58' ' ' THR . 59.9 Cg_endo -104.69 7.64 0.28 Allowed 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.451 2.767 . . . . 0.0 111.735 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.41 18.56 14.28 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.093 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 1.094 HG23 ' HD2' ' A' ' 56' ' ' PRO . 6.8 p -63.65 -110.51 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.128 -0.536 . . . . 0.0 111.4 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.866 ' N ' HG21 ' A' ' 54' ' ' THR . 0.3 OUTLIER 175.45 28.5 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.757 HG12 ' O ' ' A' ' 60' ' ' VAL . 48.3 t -140.83 31.94 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.712 0.291 . . . . 0.0 111.289 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.59 ' CB ' ' HA ' ' A' ' 54' ' ' THR . 34.0 t -103.5 -103.23 0.29 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.681 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 61' ' ' SER . 8.6 mtt180 166.99 -179.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.088 0.471 . . . . 0.0 111.569 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 2.7 t -88.76 143.01 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.591 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 1.014 ' CE2' HG22 ' A' ' 80' ' ' ILE . 1.9 t80 -141.25 130.29 23.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.664 ' HB2' ' CE1' ' A' ' 50' ' ' PHE . 22.4 p -75.9 105.63 2.34 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.533 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 72.4 Cg_endo -99.45 -169.92 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.905 2.403 . . . . 0.0 113.348 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.713 ' HB3' ' N ' ' A' ' 77' ' ' GLU . . . -86.15 176.77 7.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.721 ' O ' HD12 ' A' ' 69' ' ' LEU . 3.2 t30 106.61 123.71 0.01 OUTLIER 'General case' 0 C--N 1.343 0.31 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.952 HD13 ' CB ' ' A' ' 135' ' ' SER . 0.4 OUTLIER -170.96 -84.32 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 122.139 -0.351 . . . . 0.0 110.615 -178.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 55.3 Cg_endo -85.81 72.57 4.07 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 120.384 1.173 . . . . 0.0 112.397 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.598 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -164.51 139.09 4.4 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.586 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.7 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 60.3 Cg_endo -91.15 53.57 0.91 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.665 2.243 . . . . 0.0 116.234 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.603 ' HB3' ' CB ' ' A' ' 36' ' ' ASP . 61.6 mt-10 -158.66 -106.91 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.269 0.94 . . . . 0.0 112.558 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.786 ' HA2' ' N ' ' A' ' 40' ' ' ASN . . . -160.57 78.0 0.17 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.591 ' CG ' ' N ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -123.46 81.92 1.95 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.159 0.98 . . . . 0.0 111.332 178.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.65 HD12 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -97.48 132.14 43.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.713 ' N ' ' HB3' ' A' ' 67' ' ' ALA . 1.3 tt0 -129.99 111.69 12.77 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.443 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.868 ' CD1' HG23 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -104.78 137.18 42.96 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.226 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.864 HD22 ' CG2' ' A' ' 128' ' ' THR . 0.2 OUTLIER -122.53 75.41 1.25 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.918 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.014 HG22 ' CE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -92.61 130.4 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.121 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.79 ' HG3' HD21 ' A' ' 246' ' ' LEU . 0.3 OUTLIER -78.11 102.7 7.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.178 -178.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' CB ' ' A' ' 89' ' ' SER . 3.5 m -102.02 138.22 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.313 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.508 ' HG ' ' H4B' ' A' ' 252' ' ' FDA . 5.4 mt -68.99 129.01 92.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.738 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.23 110.14 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.666 2.244 . . . . 0.0 111.938 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.525 ' N ' ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER 47.25 43.73 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.422 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.54 -68.88 0.58 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.956 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -137.24 -68.2 0.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.662 0.268 . . . . 0.0 111.663 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -76.98 -33.57 57.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.714 0.292 . . . . 0.0 111.515 -179.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.686 ' CB ' HG23 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -78.84 -20.74 48.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.404 -179.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.414 ' O ' ' CG ' ' A' ' 94' ' ' ASN . 0.7 OUTLIER -75.68 -46.66 30.03 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.692 0.758 . . . . 0.0 109.069 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.728 ' O ' HD11 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -74.62 -24.52 58.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.498 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.933 HD22 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.78 -49.4 73.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.001 -179.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -89.05 -16.95 30.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.447 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.414 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 73.8 m-20 -95.04 -9.32 34.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.286 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.481 ' HB3' HD11 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -135.13 2.99 3.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.383 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -139.16 28.91 2.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.825 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -77.53 -49.58 14.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.467 -179.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.931 HG13 ' HG3' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -74.95 3.2 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.142 0.496 . . . . 0.0 111.796 -179.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 100' ' ' GLN . . . 54.12 36.92 57.67 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.415 -0.897 . . . . 0.0 111.722 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.931 ' HG3' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -52.8 -160.41 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.943 0.401 . . . . 0.0 111.065 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.65 143.14 12.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.775 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.078 HD21 HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -128.91 132.95 47.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.468 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.578 ' N ' HD12 ' A' ' 102' ' ' LEU . 6.8 m -92.02 123.1 35.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.088 0.471 . . . . 0.0 111.063 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.65 HG11 ' HD3' ' A' ' 33' ' ' LYS . 2.0 m -96.8 127.85 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 51' ' ' MET . 0.1 OUTLIER -127.0 170.17 12.58 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.557 -178.214 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 51' ' ' MET . . . 69.59 83.88 0.17 Allowed Glycine 0 C--N 1.312 -0.795 0 CA-C-N 114.934 -1.03 . . . . 0.0 114.05 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.22 54.03 4.49 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.427 2.084 . . . . 0.0 110.053 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.626 ' HG ' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -97.42 166.52 11.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.134 -177.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.626 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -156.9 129.32 2.37 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.485 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 110' ' ' VAL . 10.7 p -158.25 113.51 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.865 0.364 . . . . 0.0 110.769 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.635 ' CD2' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -119.24 150.26 40.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.681 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -95.09 9.41 70.12 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.948 HD11 ' HG2' ' A' ' 136' ' ' MET . 3.7 pp -116.09 119.4 35.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.278 0.561 . . . . 0.0 110.848 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.647 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.5 OUTLIER -137.5 112.92 9.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.485 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 121' ' ' ARG . 0.1 OUTLIER -87.2 140.54 29.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.54 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -94.12 14.29 20.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.2 -74.68 0.22 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.765 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -129.59 89.96 2.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.941 0.401 . . . . 0.0 110.461 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 121' ' ' ARG . . . -164.37 144.73 6.4 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.363 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 43.8 Cg_endo -67.98 116.93 4.56 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.765 2.31 . . . . 0.0 111.905 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.1 OUTLIER -130.96 158.53 40.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.999 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.647 ' CE2' ' CD ' ' A' ' 150' ' ' ARG . 3.5 m-85 -126.68 130.53 50.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.079 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.809 ' HE2' HD13 ' A' ' 113' ' ' LEU . 0.4 OUTLIER -106.46 103.71 13.23 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.631 HG13 HD23 ' A' ' 216' ' ' LEU . 0.8 OUTLIER -101.01 111.09 29.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.275 0.56 . . . . 0.0 110.843 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -114.47 133.08 56.02 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.898 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -105.82 102.7 2.01 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.841 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.968 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 124.08 -164.32 17.41 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.417 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.864 ' CG2' HD22 ' A' ' 79' ' ' LEU . 5.4 m -106.4 -10.39 16.34 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.45 0.643 . . . . 0.0 110.746 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.605 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -68.01 10.63 1.17 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.459 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.777 ' C ' HD23 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -75.75 5.14 6.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 122.894 0.478 . . . . 0.0 110.283 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.716 ' N ' HD23 ' A' ' 130' ' ' LEU . . . -44.98 -41.24 12.36 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.197 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 3.7 Cg_exo -73.53 -31.39 8.91 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.49 2.127 . . . . 0.0 110.063 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.717 HG21 ' HB2' ' A' ' 217' ' ' CYS . 21.4 t -64.86 -42.7 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.614 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.715 HG13 ' HG ' ' A' ' 130' ' ' LEU . 10.6 m -70.15 -29.78 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.533 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.952 ' CB ' HD13 ' A' ' 69' ' ' LEU . 16.7 m -66.49 -53.09 39.09 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.948 ' HG2' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -60.5 -42.4 96.3 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.511 0.672 . . . . 0.0 109.215 178.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.741 HG12 ' HG3' ' A' ' 141' ' ' GLN . 26.8 t -62.35 -32.39 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.927 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 135' ' ' SER . 5.3 mtm180 -59.6 -32.12 70.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.198 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.567 ' OE1' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -68.4 -43.03 78.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.09 178.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.626 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -71.5 -34.96 70.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.507 0.67 . . . . 0.0 111.047 179.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.926 ' CD ' HD22 ' A' ' 170' ' ' LEU . 0.4 OUTLIER -78.05 -30.45 49.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.239 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 138' ' ' ARG . 3.4 mm-40 -69.8 -44.99 68.93 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -79.24 -21.14 46.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.436 0.636 . . . . 0.0 109.736 179.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 141' ' ' GLN . 0.6 OUTLIER 52.74 28.03 5.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.735 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.857 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -33.09 153.95 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.946 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.454 ' HA ' ' HG3' ' A' ' 175' ' ' ARG . 41.8 Cg_endo -67.63 -3.58 10.52 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.667 2.245 . . . . 0.0 112.71 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.571 ' ND2' ' NH2' ' A' ' 121' ' ' ARG . 40.3 t30 -76.37 144.12 40.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 111.567 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 1.2 mt-10 -73.59 111.41 8.71 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.624 0.726 . . . . 0.0 111.072 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.646 ' HB ' HD11 ' A' ' 177' ' ' LEU . 1.1 m -108.5 115.38 29.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.892 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.647 ' CD ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -106.6 141.49 37.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.455 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.818 HD12 ' N ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -133.59 129.33 55.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.262 0.554 . . . . 0.0 111.032 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.818 ' N ' HD12 ' A' ' 151' ' ' ILE . 22.0 m-30 -108.33 115.06 29.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.47 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.466 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 37.2 t80 -120.15 132.02 55.24 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.396 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.925 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -155.06 160.67 29.9 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 119.511 -1.328 . . . . 0.0 113.288 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.977 ' CG2' HD13 ' A' ' 161' ' ' LEU . 1.2 m -170.73 -106.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.873 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.3 OUTLIER -126.17 -169.59 2.04 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 120.663 0.268 . . . . 0.0 111.287 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.829 HG23 ' CA ' ' A' ' 187' ' ' SER . 72.0 p -28.29 -62.67 0.1 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.655 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.57 ' HA ' HD21 ' A' ' 161' ' ' LEU . 0.2 OUTLIER 153.1 -54.05 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.495 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 40.7 Cg_exo -31.28 -31.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.155 2.57 . . . . 0.0 112.96 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.2 mm-40 -85.44 -60.11 2.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.016 0.436 . . . . 0.0 110.636 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.977 HD13 ' CG2' ' A' ' 155' ' ' VAL . 0.4 OUTLIER -67.3 -174.68 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.394 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 163' ' ' TYR . 0.8 OUTLIER 175.27 176.11 0.2 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.86 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 162' ' ' PHE . 0.3 OUTLIER 87.66 6.75 0.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.313 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.983 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -71.39 -45.51 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.771 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.983 ' N ' HD13 ' A' ' 164' ' ' ILE . 3.5 m-20 -66.0 -35.7 81.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.243 0.544 . . . . 0.0 110.107 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.454 ' O ' ' OG ' ' A' ' 169' ' ' SER . 0.9 OUTLIER -72.38 -36.22 68.66 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -61.61 -31.83 71.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.095 179.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 164' ' ' ILE . 24.2 mttt -62.92 -48.54 78.5 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 166' ' ' GLU . 3.9 p -61.8 -31.41 71.62 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.926 HD22 ' CD ' ' A' ' 141' ' ' GLN . 1.1 mt -63.57 -37.41 87.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.648 ' HA ' HD23 ' A' ' 177' ' ' LEU . 4.4 mm-40 -68.43 -36.07 78.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.922 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -34.53 59.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.143 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.1 t -53.7 -49.17 68.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.521 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.895 ' HB3' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -69.31 -154.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 111.588 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.454 ' HG3' ' HA ' ' A' ' 146' ' ' PRO . 0.3 OUTLIER -106.49 -54.26 2.5 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.718 -179.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -132.35 69.91 1.47 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.112 0.482 . . . . 0.0 110.706 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.895 HD13 ' HB3' ' A' ' 174' ' ' MET . 3.6 mp -98.81 150.47 21.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.888 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.513 ' OG1' ' CZ ' ' A' ' 150' ' ' ARG . 2.4 m -137.48 115.41 11.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.718 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.48 ' HB ' ' HG3' ' A' ' 171' ' ' GLU . 2.6 p -101.15 134.65 40.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.776 0.322 . . . . 0.0 111.352 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.6 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -101.69 135.28 43.49 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.562 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -100.82 105.51 16.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.491 0.663 . . . . 0.0 111.824 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.645 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 29.6 m -88.53 -161.93 0.79 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.181 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.873 HG21 ' O ' ' A' ' 156' ' ' ASN . 14.9 t 54.73 147.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-O 121.703 0.763 . . . . 0.0 111.812 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.24 -60.78 0.61 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.188 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.604 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 1.9 t-80 -164.99 51.26 0.25 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.789 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 187' ' ' SER . 86.3 Cg_endo -90.3 -98.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.21 2.607 . . . . 0.0 112.542 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.829 ' CA ' HG23 ' A' ' 157' ' ' THR . 21.7 t 137.85 6.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.596 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 120.64 12.19 6.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.259 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.16 62.62 1.59 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.469 ' HE1' ' C ' ' A' ' 193' ' ' GLU . 8.5 t-105 -132.08 121.31 23.61 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.305 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' A' ' 250' ' ' ALA . 3.9 mt-10 -95.92 104.71 16.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.52 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.564 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 140.82 -117.02 1.2 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.696 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.595 ' C ' ' HB3' ' A' ' 182' ' ' CYS . 13.6 mt-10 -162.98 -95.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.514 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -86.73 139.34 30.83 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.641 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -21.37 107.08 0.01 OUTLIER Glycine 0 C--N 1.334 0.448 0 O-C-N 123.688 0.618 . . . . 0.0 113.096 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.614 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 67.1 m 120.65 154.45 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 123.481 0.712 . . . . 0.0 110.701 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.65 -75.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 123.234 2.623 . . . . 0.0 112.728 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.703 HG23 ' O ' ' A' ' 198' ' ' ILE . 0.2 OUTLIER 174.88 32.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.985 0.897 . . . . 0.0 110.732 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.505 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 35.9 m-20 -58.61 -37.27 75.49 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.191 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.46 73.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.637 ' HB2' HD13 ' A' ' 198' ' ' ILE . 0.2 OUTLIER -69.32 -34.04 74.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.873 0.368 . . . . 0.0 110.904 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.688 ' HG2' HD22 ' A' ' 229' ' ' LEU . 5.9 mtm180 -59.84 -52.15 66.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -41.87 96.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.814 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.2 -29.16 68.53 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 1.04 ' CD2' HD11 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -62.67 -43.96 97.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.337 178.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.44 -18.07 57.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.538 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 208' ' ' SER . 59.4 m -75.79 -80.45 0.09 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.93 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 207' ' ' SER . 0.4 OUTLIER 164.99 34.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.449 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.663 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 2.0 m-20 -137.85 52.29 1.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.697 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 209' ' ' ASP . . . 151.5 102.01 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.208 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.875 ' HB2' HD13 ' A' ' 235' ' ' ILE . 13.5 t30 174.04 -56.78 0.0 OUTLIER Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.143 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 18.8 Cg_endo -59.53 -58.04 0.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.294 1.996 . . . . 0.0 111.207 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.14 109.23 9.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.309 178.493 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.933 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.5 OUTLIER -121.63 125.76 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.716 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -120.62 127.1 51.78 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.388 0.613 . . . . 0.0 111.063 -178.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.631 HD23 HG13 ' A' ' 124' ' ' VAL . 3.4 mt -125.71 116.45 21.66 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.284 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . 0.717 ' HB2' HG21 ' A' ' 133' ' ' VAL . 38.9 m -124.8 107.09 10.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.077 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.621 ' N ' ' CD ' ' A' ' 219' ' ' PRO . . . 110.44 -28.13 10.58 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.93 -1.128 . . . . 0.0 114.075 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 218' ' ' GLY . 46.3 Cg_endo -89.76 83.17 0.53 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.238 1.958 . . . . 0.0 114.72 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.799 ' CD ' ' HB2' ' A' ' 250' ' ' ALA . 11.9 Cg_endo -53.48 -71.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 111.301 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.824 ' N ' ' HB1' ' A' ' 250' ' ' ALA . . . -54.2 -48.62 62.94 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.427 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.588 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -54.77 -24.08 20.89 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.595 ' CD1' ' HB3' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -72.76 -36.81 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.942 178.132 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 221' ' ' GLY . 65.6 m-20 -73.45 -47.04 44.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.003 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -69.72 -37.02 76.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.641 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.796 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -59.4 -38.5 80.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.385 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 31.7 m -69.91 -31.19 68.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.572 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -44.5 82.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.811 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.688 HD22 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -60.76 -37.14 80.83 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.013 0.435 . . . . 0.0 110.664 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 226' ' ' ALA . 3.6 t -66.23 -45.62 89.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.392 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -72.75 -30.02 63.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 6.2 m -76.98 -44.15 32.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.557 ' NE ' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -68.21 -75.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.166 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.472 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 137.8 -36.13 1.97 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.255 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 1.04 HD11 ' CD2' ' A' ' 205' ' ' LEU . 1.6 pp -35.84 95.29 0.09 OUTLIER Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 111.005 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 18.7 Cg_endo -59.86 115.33 2.55 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.757 2.305 . . . . 0.0 112.185 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -93.85 173.72 33.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.437 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -143.71 -41.92 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 110.91 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.582 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 43.7 mm-40 -107.5 37.78 2.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.933 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.1 t -92.84 132.45 37.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.647 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -144.72 144.5 31.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.42 -178.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -130.75 140.93 50.35 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . 0.576 ' O ' HD13 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -132.79 149.12 52.31 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.75 178.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 244' ' ' LYS . 1.0 OUTLIER -127.22 108.09 10.57 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.629 ' CD1' ' HB2' ' A' ' 246' ' ' LEU . 0.4 OUTLIER -138.22 144.32 40.57 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.538 178.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.834 HD23 ' HD2' ' A' ' 247' ' ' PRO . 0.1 OUTLIER 68.31 148.55 0.12 Allowed Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 121.917 -0.49 . . . . 0.0 111.379 -179.101 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.834 ' HD2' HD23 ' A' ' 246' ' ' LEU . 97.7 Cg_endo -73.28 -104.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.959 2.439 . . . . 0.0 112.371 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 247' ' ' PRO . 52.8 p -37.66 134.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.183 0.516 . . . . 0.0 110.912 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 127.71 -15.69 6.27 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.824 ' HB1' ' N ' ' A' ' 221' ' ' GLY . . . -106.53 120.55 42.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.709 -0.745 . . . . 0.0 111.541 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.564 ' N ' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.066 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' FDA . . . . . 0.782 H52A ' O ' ' A' ' 81' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.807 0.337 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -126.11 125.61 42.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.946 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 mt -124.82 133.75 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.063 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.57 -162.89 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -134.71 37.55 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.47 39.33 4.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.433 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -108.43 44.31 1.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.846 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 t -122.56 103.62 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.154 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.05 22.5 17.37 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.81 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.558 ' CB ' ' HB3' ' A' ' 105' ' ' LYS . 0.8 OUTLIER -115.03 149.34 37.62 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.693 -0.253 . . . . 0.0 111.022 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.795 ' CE1' HG13 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -134.05 165.54 24.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -113.31 135.29 54.0 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.992 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . . . -134.53 150.35 50.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.755 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 1.1 pt-20 -96.5 116.63 29.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 110.754 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.003 HG22 ' O ' ' A' ' 100' ' ' GLN . 2.9 m -75.34 135.34 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.284 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 17' ' ' VAL . 7.4 p -149.4 20.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.168 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -106.63 -129.82 6.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.028 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.988 HD22 HD22 ' A' ' 92' ' ' LEU . 0.1 OUTLIER 74.9 80.39 0.11 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.831 -0.685 . . . . 0.0 110.445 -178.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.799 HD21 HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -123.25 139.45 54.04 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.079 178.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 7.9 m0 -90.1 113.49 25.24 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.164 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.799 HG12 HD21 ' A' ' 20' ' ' ASN . 1.3 m -96.26 -26.99 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.542 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 8.2 m -143.43 171.09 14.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.244 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.468 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -52.88 -53.83 43.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.116 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -119.46 45.47 2.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.58 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.542 ' CB ' ' HB2' ' A' ' 23' ' ' SER . 0.3 OUTLIER -148.06 140.36 24.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.426 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.863 HG11 HD13 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -140.89 141.28 31.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.26 0.552 . . . . 0.0 112.036 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.654 ' HB2' HD21 ' A' ' 79' ' ' LEU . 17.0 tt0 -121.44 110.52 16.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.895 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.961 ' CE1' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -118.74 140.52 49.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 111.446 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.834 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -117.13 143.66 45.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.347 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.973 HD22 HG12 ' A' ' 16' ' ' VAL . 0.7 OUTLIER -122.14 154.91 36.78 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.17 0.509 . . . . 0.0 111.954 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 6.0 mt-30 -116.13 104.81 11.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.491 178.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.643 ' CG ' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -60.63 -171.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.459 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.644 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 1.9 mmp_? -55.57 -90.36 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.698 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.644 ' CD ' ' CB ' ' A' ' 34' ' ' ARG . 32.4 Cg_exo -45.67 -82.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.185 0 CA-C-N 120.474 1.205 . . . . 0.0 112.333 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -104.31 -164.31 1.04 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.767 0.712 . . . . 0.0 109.725 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.631 ' HB2' ' HA ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -54.55 -26.41 31.91 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.981 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' CB ' ' CA ' ' A' ' 74' ' ' GLY . 5.0 t -110.91 -6.1 14.76 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.684 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.551 ' CA ' ' HB3' ' A' ' 33' ' ' LYS . . . 78.92 68.77 1.46 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.805 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.601 ' N ' ' HB2' ' A' ' 35' ' ' PRO . 13.0 t30 61.89 12.95 5.15 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.206 0.527 . . . . 0.0 110.261 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 1.027 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -73.84 -15.23 61.17 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.619 ' CA ' ' HA ' ' A' ' 72' ' ' PRO . . . -2.19 75.28 0.0 OUTLIER Glycine 0 C--N 1.343 0.935 0 O-C-N 124.151 0.907 . . . . 0.0 114.41 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.027 HG13 ' O ' ' A' ' 41' ' ' ARG . 18.8 m -134.0 164.39 34.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.281 0.563 . . . . 0.0 112.441 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.704 ' HA ' ' CA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.32 41.37 1.09 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.282 178.123 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.6 ' CZ ' ' O ' ' A' ' 132' ' ' PRO . 83.9 t80 71.66 143.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.064 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.594 ' O ' ' CE2' ' A' ' 45' ' ' PHE . 4.9 mt-10 -112.91 161.88 24.5 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.743 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' GLY . 5.1 Cg_endo -47.44 80.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.717 2.278 . . . . 0.0 112.326 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.59 ' O ' HG12 ' A' ' 110' ' ' VAL . . . 34.85 41.2 0.24 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.862 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.497 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 4.8 mt-30 -53.46 161.04 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.67 0.235 . . . . 0.0 110.442 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.718 ' CD2' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -152.82 160.47 43.09 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.964 0.411 . . . . 0.0 111.703 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.627 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -138.73 -172.35 3.29 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.389 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.7 108.79 17.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.084 ' CD1' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -149.64 155.92 41.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 1.008 HG23 ' C ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -106.9 155.3 19.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.792 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.968 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -29.89 -68.62 0.11 Allowed Pre-proline 0 CA--C 1.54 0.58 0 O-C-N 123.393 0.433 . . . . 0.0 110.666 -179.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.968 ' HD3' HG23 ' A' ' 55' ' ' ILE . 6.3 Cg_endo -107.89 3.69 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.434 2.756 . . . . 0.0 111.807 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 107.23 -4.35 35.42 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.132 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.893 HG21 ' OH ' ' A' ' 91' ' ' TYR . 70.5 p -25.52 -89.76 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.975 0.51 . . . . 0.0 111.864 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.622 ' O ' HG12 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -147.2 43.11 1.12 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.008 ' C ' HG23 ' A' ' 54' ' ' THR . 0.4 OUTLIER 79.25 125.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.676 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.815 ' N ' HG23 ' A' ' 54' ' ' THR . 4.1 m -101.44 -54.32 2.79 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.372 0.606 . . . . 0.0 110.493 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.451 ' HB3' " O4'" ' A' ' 252' ' ' FDA . 0.0 OUTLIER 175.2 -155.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.438 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.683 ' CB ' ' CE1' ' A' ' 50' ' ' PHE . 3.6 p -105.73 119.36 38.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.898 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.527 ' CE2' ' N3 ' ' A' ' 252' ' ' FDA . 4.2 t80 -140.72 124.51 17.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.119 0.485 . . . . 0.0 112.086 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.712 ' HB3' ' H6 ' ' A' ' 252' ' ' FDA . 1.3 t -80.85 108.25 9.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.063 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.663 ' HB2' HD13 ' A' ' 76' ' ' LEU . 87.9 Cg_endo -83.61 159.41 14.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.795 2.33 . . . . 0.0 111.667 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.722 ' HB2' ' HA ' ' A' ' 132' ' ' PRO . . . -119.48 129.51 54.76 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.603 ' O ' ' CB ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -82.21 -75.31 0.31 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.328 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.603 ' CB ' ' O ' ' A' ' 68' ' ' ASN . 10.8 tp 101.53 141.38 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.22 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.704 ' CA ' ' HA ' ' A' ' 44' ' ' LYS . 5.5 Cg_exo -36.25 86.31 0.01 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 123.001 2.467 . . . . 0.0 112.0 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -162.67 117.96 1.2 Allowed Pre-proline 0 CA--C 1.518 -0.251 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.086 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.619 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 88.7 Cg_endo -85.56 38.55 0.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.484 2.123 . . . . 0.0 112.379 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.601 ' N ' ' HA2' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -129.06 -51.47 1.21 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.594 ' O ' ' CB ' ' A' ' 37' ' ' GLU . . . 127.34 107.95 1.48 Allowed Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.81 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.631 ' HA ' ' HB2' ' A' ' 37' ' ' GLU . 5.9 mtt180 -139.53 93.55 2.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.517 0.199 . . . . 0.0 110.506 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.814 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -95.88 131.55 42.1 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.351 0.596 . . . . 0.0 111.368 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.766 ' N ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.9 150.74 30.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.138 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.703 ' CD1' ' CD2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -135.29 129.99 34.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.367 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.832 HD12 ' HB2' ' A' ' 131' ' ' ALA . 2.7 mt -135.6 103.37 5.42 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-O 120.846 0.355 . . . . 0.0 110.355 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.703 HD13 ' CZ ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -115.04 127.33 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.194 -178.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.617 ' HG3' HD11 ' A' ' 246' ' ' LEU . 1.8 mmt180 -79.69 95.57 5.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.595 ' CG2' ' CB ' ' A' ' 89' ' ' SER . 3.0 m -90.56 142.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.114 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.672 ' CD1' ' H1B' ' A' ' 252' ' ' FDA . 0.5 OUTLIER -88.15 151.35 48.96 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.612 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.481 ' HD2' ' HG ' ' A' ' 83' ' ' LEU . 55.3 Cg_endo -69.87 -8.46 23.66 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.753 2.302 . . . . 0.0 112.392 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -70.51 -25.87 63.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.503 ' CA ' ' HB2' ' A' ' 90' ' ' ASP . . . 115.43 -4.06 21.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.569 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 86' ' ' GLY . 9.3 mmm180 -36.63 -73.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 110.792 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.493 ' CB ' ' O1A' ' A' ' 252' ' ' FDA . 13.4 t80 -116.92 -21.88 8.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.595 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 1.3 p -65.75 -36.79 84.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.206 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.503 ' HB2' ' CA ' ' A' ' 86' ' ' GLY . 2.1 m-20 -75.09 -33.47 61.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.364 0.602 . . . . 0.0 109.868 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.893 ' OH ' HG21 ' A' ' 58' ' ' THR . 2.0 t80 -73.34 -31.59 64.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.702 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.988 HD22 HD22 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -68.73 -39.36 80.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.203 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.08 -19.88 21.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 9.0 m-20 -97.48 -10.97 24.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.43 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.549 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -124.73 -12.3 7.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.452 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -132.56 33.2 3.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.028 0.442 . . . . 0.0 110.909 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -52.88 61.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.682 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 99' ' ' GLY . 1.8 t -89.32 -135.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 120.737 0.303 . . . . 0.0 111.129 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 100' ' ' GLN . . . -120.97 28.07 6.24 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.995 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 1.003 ' O ' HG22 ' A' ' 16' ' ' VAL . 17.2 mp0 -39.26 163.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 110.911 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 14' ' ' ALA . 4.8 p -92.83 139.77 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.953 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.084 HD11 ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.67 125.33 35.78 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -92.38 134.55 34.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.97 0.414 . . . . 0.0 111.086 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.795 HG13 ' CE1' ' A' ' 12' ' ' PHE . 1.9 m -112.91 129.37 68.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.445 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.558 ' HB3' ' CB ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -130.55 112.97 13.67 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.759 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 151.56 73.66 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.022 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.94 53.97 4.37 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.496 2.131 . . . . 0.0 110.924 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.718 HD22 ' CD2' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -102.17 166.61 10.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.781 -178.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.58 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -108.75 172.7 16.84 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.492 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.968 HG21 HM73 ' A' ' 252' ' ' FDA . 4.4 p -152.18 113.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.201 0.524 . . . . 0.0 111.205 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.471 ' HB3' ' HB3' ' A' ' 241' ' ' PHE . 13.0 m-30 -71.01 114.74 9.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.419 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -149.99 -46.46 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.611 ' HA ' ' CG ' ' A' ' 215' ' ' TYR . 2.0 pt? -146.43 119.59 8.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.937 0.399 . . . . 0.0 110.488 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.645 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -137.9 112.83 9.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.853 -179.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -78.95 140.2 38.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.287 179.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.46 ' HD3' ' HG3' ' A' ' 239' ' ' GLN . 17.2 ttp180 -98.37 11.7 37.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.185 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.478 ' C ' ' NH2' ' A' ' 121' ' ' ARG . . . 107.27 -78.08 0.24 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.693 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.46 ' HA ' ' HB3' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -129.91 89.83 2.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.844 0.354 . . . . 0.0 110.577 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.713 ' HB3' HH12 ' A' ' 121' ' ' ARG . . . -166.86 151.93 7.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 33.0 Cg_endo -64.47 116.73 3.93 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.652 2.235 . . . . 0.0 111.606 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.713 HH12 ' HB3' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -124.76 128.24 48.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.081 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.636 ' CD2' ' CE1' ' A' ' 152' ' ' TYR . 2.5 m-30 -106.65 115.84 30.9 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 1.157 ' CE2' HG21 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -119.66 111.01 17.51 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.258 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.938 ' CG1' HD23 ' A' ' 216' ' ' LEU . 7.4 p -109.15 111.06 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.206 0.527 . . . . 0.0 110.978 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -103.7 133.58 48.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.951 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.57 ' HA3' ' N ' ' A' ' 250' ' ' ALA . . . -109.59 103.61 1.77 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.944 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.599 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 123.55 -158.91 18.21 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 119.782 -1.199 . . . . 0.0 112.757 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.737 ' CG2' HD13 ' A' ' 79' ' ' LEU . 3.2 m -110.09 -14.41 14.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.675 0.274 . . . . 0.0 111.409 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.604 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -67.67 9.36 1.35 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.355 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.839 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -77.99 3.88 13.59 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 122.491 0.316 . . . . 0.0 110.192 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.832 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -46.52 -43.34 36.5 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 120.516 -0.473 . . . . 0.0 109.998 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.722 ' HA ' ' HB2' ' A' ' 67' ' ' ALA . 2.8 Cg_exo -73.82 -35.35 4.51 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.529 2.152 . . . . 0.0 109.718 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.659 HG11 ' CE1' ' A' ' 123' ' ' PHE . 15.8 t -63.36 -42.88 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.208 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.839 HG13 ' HG ' ' A' ' 130' ' ' LEU . 20.8 m -70.48 -29.74 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.414 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.479 ' HB3' ' CG ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -63.21 -52.7 61.23 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -46.44 89.73 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.477 0.656 . . . . 0.0 109.628 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.157 HG21 ' CE2' ' A' ' 123' ' ' PHE . 0.9 OUTLIER -59.53 -33.42 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.623 178.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -34.19 71.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.224 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.443 ' CD ' ' HG3' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -65.3 -42.45 93.05 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.601 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.7 OUTLIER -70.49 -34.01 71.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.661 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 1.021 ' OE1' HD11 ' A' ' 170' ' ' LEU . 0.6 OUTLIER -77.06 -30.61 55.66 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.287 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -70.55 -44.82 66.66 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.879 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -80.66 -20.56 42.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.411 0.624 . . . . 0.0 110.192 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.514 ' O ' ' CG ' ' A' ' 175' ' ' ARG . 0.1 OUTLIER 51.21 28.75 4.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.656 178.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.879 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -31.17 150.56 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 111.1 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.42 -9.19 6.37 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.877 2.385 . . . . 0.0 113.083 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.584 ' OD1' ' HB3' ' A' ' 145' ' ' ALA . 8.4 p-10 -76.35 143.34 40.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.128 0.49 . . . . 0.0 111.861 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 9.1 mt-10 -73.75 127.38 32.65 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.827 0.822 . . . . 0.0 110.88 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.584 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 26.1 m -118.27 121.67 41.02 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.477 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.628 ' HB2' ' CD1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.46 134.77 44.05 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.062 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.708 HG22 ' HA ' ' A' ' 179' ' ' VAL . 0.5 OUTLIER -113.88 130.81 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.957 -179.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.636 ' CE1' ' CD2' ' A' ' 122' ' ' TYR . 45.4 m-85 -123.76 109.28 13.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.034 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.984 ' CE2' HD11 ' A' ' 161' ' ' LEU . 4.4 t80 -122.15 132.26 54.37 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.397 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.84 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -160.85 153.63 24.51 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 119.697 -1.239 . . . . 0.0 113.723 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 1.012 HG21 HD13 ' A' ' 161' ' ' LEU . 2.4 m -167.58 -105.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.822 ' O ' HG21 ' A' ' 183' ' ' VAL . 4.0 p30 -108.3 174.39 5.9 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.936 0.398 . . . . 0.0 111.738 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 187' ' ' SER . 0.5 OUTLIER -34.28 -41.81 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.401 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.0 OUTLIER 153.85 -41.53 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.241 0 O-C-N 123.307 0.379 . . . . 0.0 111.88 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.612 ' HD2' HG23 ' A' ' 157' ' ' THR . 62.4 Cg_exo -40.1 -30.23 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.458 2.105 . . . . 0.0 112.707 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.494 ' CB ' ' ND2' ' A' ' 156' ' ' ASN . 1.2 mp0 -103.61 -13.93 16.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.701 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.012 HD13 HG21 ' A' ' 155' ' ' VAL . 10.9 tp -94.75 171.85 8.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.846 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 1.1 p90 176.28 -163.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.977 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.6 OUTLIER 72.05 9.22 6.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.393 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 1.003 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -57.62 -41.65 79.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 109.986 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 1.003 ' N ' HD13 ' A' ' 164' ' ' ILE . 16.8 m-20 -64.24 -27.76 69.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.873 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -71.57 -47.49 54.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.88 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.54 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -62.95 -31.28 72.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.088 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -60.7 -45.93 92.34 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.6 m -61.76 -31.76 71.97 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 1.021 HD11 ' OE1' ' A' ' 141' ' ' GLN . 1.0 OUTLIER -62.75 -38.02 88.89 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.534 ' HA ' HD11 ' A' ' 177' ' ' LEU . 30.8 mt-10 -66.68 -36.22 82.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.309 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -78.65 -35.93 44.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.31 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.461 ' O ' ' C ' ' A' ' 174' ' ' MET . 0.5 OUTLIER -87.77 -79.14 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.684 0.278 . . . . 0.0 111.606 -179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.644 ' HB3' HD12 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -23.69 126.5 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.458 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' ' 144' ' ' THR . 1.7 mmp_? -38.41 -91.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.427 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.44 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -119.0 61.3 0.8 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.27 0.557 . . . . 0.0 109.894 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.07 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -103.58 157.77 16.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.622 -179.094 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 1.07 ' N ' HD22 ' A' ' 177' ' ' LEU . 3.7 m -137.1 123.13 20.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.932 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.708 ' HA ' HG22 ' A' ' 151' ' ' ILE . 64.2 t -89.18 136.57 23.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.638 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.468 ' HE2' ' OE1' ' A' ' 194' ' ' GLN . 17.8 tptt -102.63 130.31 49.48 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.642 0.258 . . . . 0.0 110.582 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' NE2' ' A' ' 194' ' ' GLN . . . -97.51 104.93 17.0 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.74 0.781 . . . . 0.0 110.798 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.736 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 97.6 m -91.16 -168.54 2.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.11 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.822 HG21 ' O ' ' A' ' 156' ' ' ASN . 19.4 t 56.47 148.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.913 0.864 . . . . 0.0 111.407 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.98 -69.27 0.54 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.979 -178.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.606 ' N ' ' CD ' ' A' ' 186' ' ' PRO . 0.2 OUTLIER -155.89 34.93 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.584 178.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.633 ' O ' ' CB ' ' A' ' 187' ' ' SER . 83.3 Cg_endo -73.47 -100.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.502 2.135 . . . . 0.0 112.791 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.711 ' HA ' HG22 ' A' ' 157' ' ' THR . 27.4 t 137.69 30.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.972 0.509 . . . . 0.0 111.707 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.618 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 94.06 12.57 56.28 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.3 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.07 63.4 1.57 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.509 ' HB2' ' HB3' ' A' ' 186' ' ' PRO . 4.0 t-105 -132.25 113.7 13.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.723 -177.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.444 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 1.3 mt-10 -84.34 103.66 13.71 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.818 ' HA2' ' HB3' ' A' ' 251' ' ' ALA . . . 146.05 -122.09 1.59 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.056 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.565 ' CB ' ' SG ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -159.21 -79.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.606 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -100.88 148.59 24.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.07 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.651 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -40.49 105.92 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.674 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.566 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 3.5 m 148.71 172.72 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 111.264 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.532 ' O ' ' HB ' ' A' ' 198' ' ' ILE . 2.6 Cg_exo -75.86 -70.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.994 2.462 . . . . 0.0 112.606 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.067 HD12 HD21 ' A' ' 201' ' ' LEU . 0.0 OUTLIER 169.13 37.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-O 122.372 1.082 . . . . 0.0 110.136 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 199' ' ' ASP . 0.5 OUTLIER -72.57 -34.24 67.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.054 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -57.81 -45.49 86.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 1.067 HD21 HD12 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -71.39 -29.73 65.28 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.175 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.516 ' O ' ' NE ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -58.06 -52.89 63.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.786 -178.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.23 -43.17 64.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.334 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.61 -29.2 67.83 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.935 ' O ' HG21 ' A' ' 235' ' ' ILE . 0.5 OUTLIER -63.31 -48.69 76.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.422 ' CD ' ' NH2' ' A' ' 233' ' ' ARG . 3.4 mt-10 -67.73 -26.93 66.39 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.666 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 208' ' ' SER . 69.9 m -75.32 -82.5 0.07 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.893 0.377 . . . . 0.0 110.789 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 209' ' ' ASP . 0.1 OUTLIER 166.08 90.31 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.691 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.677 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 0.2 OUTLIER 164.23 53.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.837 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 209' ' ' ASP . . . 151.94 99.92 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.189 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.649 ' HB2' HD13 ' A' ' 235' ' ' ILE . 13.5 t30 172.65 -56.54 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.981 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 12.9 Cg_endo -56.63 -50.97 10.17 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.412 2.075 . . . . 0.0 111.025 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -132.67 109.06 9.44 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.982 ' HB ' HG22 ' A' ' 240' ' ' VAL . 1.0 OUTLIER -122.11 125.08 72.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.611 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.3 m-85 -118.75 126.71 52.49 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.397 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.938 HD23 ' CG1' ' A' ' 124' ' ' VAL . 20.5 mt -125.16 118.81 26.9 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.829 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -122.87 131.66 53.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.658 178.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.63 ' HA3' ' HB3' ' A' ' 250' ' ' ALA . . . 144.08 -151.46 23.44 Favored Glycine 0 C--O 1.224 -0.511 0 C-N-CA 120.058 -1.067 . . . . 0.0 113.075 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 250' ' ' ALA . 56.7 Cg_endo -70.73 166.61 28.23 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.65 2.233 . . . . 0.0 112.459 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.491 ' O ' HG22 ' A' ' 223' ' ' ILE . 27.7 Cg_exo -61.1 -9.07 11.34 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.77 2.313 . . . . 0.0 112.189 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -69.32 -54.83 11.65 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.959 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.918 ' O ' ' HB3' ' A' ' 226' ' ' ALA . 0.0 OUTLIER -55.51 -25.66 38.5 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -77.07 -42.41 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.376 178.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -75.58 -48.68 21.26 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 229' ' ' LEU . . . -77.44 -48.37 17.33 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.918 ' HB3' ' O ' ' A' ' 222' ' ' MET . . . -66.36 -39.49 89.17 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.559 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 223' ' ' ILE . 49.9 t -65.32 -45.83 82.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.543 0.211 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 232' ' ' SER . 0.8 OUTLIER -66.87 -36.3 82.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.302 0.573 . . . . 0.0 109.701 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.627 HD12 HG23 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -60.15 -56.36 22.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.349 179.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.994 HG13 HD11 ' A' ' 235' ' ' ILE . 94.7 t -72.53 -42.57 63.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.242 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.47 ' HD2' ' SG ' ' A' ' 227' ' ' CYS . 30.7 mtp180 -62.38 -30.17 71.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.427 . . . . 0.0 110.074 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 228' ' ' GLU . 21.5 m -91.41 -27.11 18.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.516 ' NE ' ' O ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -57.57 -67.98 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.1 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 146.78 -54.12 0.54 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.852 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.994 HD11 HG13 ' A' ' 230' ' ' VAL . 2.1 pp -34.03 95.21 0.08 OUTLIER Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 121.151 0.5 . . . . 0.0 111.556 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.441 ' N ' ' O ' ' A' ' 234' ' ' GLY . 32.7 Cg_endo -64.48 118.16 5.15 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.855 2.37 . . . . 0.0 112.257 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.464 ' CA ' ' OD1' ' A' ' 211' ' ' ASN . . . -108.97 154.94 16.3 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.56 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -117.95 -37.26 3.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.738 0.304 . . . . 0.0 110.866 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.572 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 70.5 mm-40 -102.17 35.66 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.22 0.534 . . . . 0.0 110.359 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.982 HG22 ' HB ' ' A' ' 214' ' ' ILE . 1.8 t -89.65 128.83 41.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.365 0.602 . . . . 0.0 110.873 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.645 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.73 142.56 27.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.86 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.55 ' HB2' ' CD1' ' A' ' 223' ' ' ILE . 0.7 OUTLIER -131.32 141.1 49.88 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.912 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 216' ' ' LEU . 7.2 pt-20 -132.12 148.46 52.48 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.243 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 4.5 ptmm? -116.35 105.83 12.96 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.604 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -137.02 144.46 43.25 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.309 178.237 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.617 HD11 ' HG3' ' A' ' 81' ' ' ARG . 5.1 mt 62.43 155.73 0.12 Allowed Pre-proline 0 N--CA 1.467 0.405 0 CA-C-O 121.131 0.491 . . . . 0.0 111.993 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.763 ' HG2' ' H3B' ' A' ' 252' ' ' FDA . 22.5 Cg_exo -65.1 -141.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.628 2.886 . . . . 0.0 112.363 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.491 ' HA ' ' HG3' ' A' ' 219' ' ' PRO . 0.4 OUTLIER -52.98 151.95 4.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.144 0.497 . . . . 0.0 111.391 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 152.45 -51.61 0.49 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.818 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.63 ' HB3' ' HA3' ' A' ' 218' ' ' GLY . . . -108.19 142.03 39.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.533 -0.334 . . . . 0.0 111.272 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.818 ' HB3' ' HA2' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.837 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' FDA . . . . . 0.968 HM73 HG21 ' A' ' 110' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.799 0.333 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -123.87 32.77 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.56 125.89 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.031 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.4 m 47.94 58.22 5.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.014 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.9 t80 72.86 132.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.53 40.51 1.65 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.514 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 47.66 47.35 17.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.831 0.348 . . . . 0.0 111.093 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.39 102.37 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.8 20.5 2.17 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.7 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.511 ' HB2' ' CG ' ' A' ' 105' ' ' LYS . 2.3 t -102.74 151.52 22.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.672 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.668 ' CE2' ' HB2' ' A' ' 14' ' ' ALA . 5.0 t80 -132.1 152.76 51.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.695 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.592 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -111.13 126.11 54.49 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 110.826 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.717 ' HB1' ' CB ' ' A' ' 31' ' ' LEU . . . -131.18 154.12 48.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.154 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.562 ' N ' ' HB2' ' A' ' 33' ' ' LYS . 19.8 tt0 -98.86 124.89 44.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.018 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.935 HG22 ' O ' ' A' ' 100' ' ' GLN . 6.4 m -70.69 115.71 10.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.043 0.449 . . . . 0.0 110.561 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 17' ' ' VAL . 13.7 p -146.05 14.91 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.047 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 29' ' ' PHE . . . -150.34 117.63 0.86 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.064 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.791 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -155.74 52.82 0.58 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.654 -0.773 . . . . 0.0 109.996 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.667 HD21 HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -95.6 150.72 20.03 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.679 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 7.8 m95 -88.86 112.39 23.2 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.667 HG12 HD21 ' A' ' 20' ' ' ASN . 2.6 m -76.92 -23.13 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.569 0.7 . . . . 0.0 109.74 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.522 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 38.8 m -150.5 -175.27 5.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.3 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.97 -57.02 9.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.632 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -121.92 49.25 1.58 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.724 179.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.602 ' HB ' HG22 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -147.56 141.12 25.48 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.473 -179.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.791 HG21 ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -140.8 148.26 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.162 -178.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.568 ' HG2' HD21 ' A' ' 30' ' ' LEU . 6.7 tt0 -108.74 129.23 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.554 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.876 ' CE1' HD21 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -124.37 121.83 36.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.622 -178.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.823 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -112.3 115.5 28.87 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.887 HD12 HD21 ' A' ' 76' ' ' LEU . 3.2 mt -120.64 133.74 55.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.261 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HA ' ' HB2' ' A' ' 38' ' ' CYS . 29.6 mt-30 -145.64 110.18 5.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.601 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.562 ' HB2' ' N ' ' A' ' 15' ' ' GLU . 8.1 tmtm? -156.43 6.28 0.18 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.545 ' CD ' ' HB2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -163.0 168.72 9.9 Favored Pre-proline 0 N--CA 1.462 0.158 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.332 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.519 ' HA ' ' HB2' ' A' ' 41' ' ' ARG . 35.4 Cg_exo -59.91 78.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.899 2.399 . . . . 0.0 112.049 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.598 ' N ' ' HB3' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -170.08 -70.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.585 0.707 . . . . 0.0 110.106 179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.543 ' CB ' ' HB3' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -131.81 64.82 1.59 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.072 178.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.554 ' CA ' ' O ' ' A' ' 74' ' ' GLY . 17.4 t -161.48 -74.23 0.06 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 73' ' ' GLU . . . -81.37 -81.52 0.85 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.43 -177.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 6.7 t-20 -154.98 47.1 0.53 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.566 -0.317 . . . . 0.0 110.761 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.678 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -107.19 -28.7 9.78 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.652 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.709 ' O ' ' O ' ' A' ' 71' ' ' ASN . . . -69.98 90.48 0.34 Allowed Glycine 0 CA--C 1.491 -1.44 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.426 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.86 ' HA ' ' N ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -122.85 142.48 39.23 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.758 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 10.4 ttmt -13.85 74.0 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.854 0.861 . . . . 0.0 112.886 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.596 ' N ' ' O ' ' A' ' 43' ' ' VAL . 55.4 t80 -99.19 -103.59 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.655 0.264 . . . . 0.0 110.868 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.5 OUTLIER -113.42 155.76 44.23 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 120.771 0.319 . . . . 0.0 110.703 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 1.032 ' HD2' HG21 ' A' ' 110' ' ' VAL . 72.8 Cg_exo -49.53 80.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.665 2.243 . . . . 0.0 112.231 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 49.09 63.47 3.93 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.762 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.531 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -48.45 -179.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.576 -0.157 . . . . 0.0 110.576 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.664 ' CD1' ' CB ' ' A' ' 65' ' ' SER . 0.2 OUTLIER -131.95 163.21 28.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.947 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.535 ' O ' ' CB ' ' A' ' 63' ' ' SER . 2.6 mmt -129.9 -168.41 1.95 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.942 0.401 . . . . 0.0 111.703 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -138.47 96.34 3.15 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.957 HD12 HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -132.82 158.18 43.14 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.764 -177.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.889 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -106.85 151.13 25.62 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.983 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.01 ' CA ' ' O ' ' A' ' 103' ' ' SER 10.821 1.9 mp -53.53 102.83 0.33 Allowed Pre-proline 2 N--CA 7.684 311.237 3 C-N-CA 11.143 -44.223 . . . . 0.0 17.059 -71.011 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.824 ' HD3' ' HB ' ' A' ' 55' ' ' ILE . 7.2 Cg_endo -95.54 4.88 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 1 CA-C-N 103.419 -4.886 . . . . 0.0 111.153 72.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 105.82 2.43 39.77 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.494 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.811 HG23 ' CG ' ' A' ' 56' ' ' PRO . 27.0 p -46.43 -105.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.582 0.229 . . . . 0.0 111.345 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.889 ' N ' HG21 ' A' ' 54' ' ' THR . 6.0 p-10 172.33 29.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 60' ' ' VAL . 58.3 t -137.99 34.47 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.733 0.302 . . . . 0.0 111.223 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.598 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 38.8 t -107.82 -104.77 0.35 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.738 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 162.94 -173.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.095 0.474 . . . . 0.0 111.501 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -88.97 135.05 33.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.21 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.611 ' CE1' ' HB2' ' A' ' 78' ' ' PHE . 1.7 t80 -134.16 126.03 29.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.747 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.664 ' CB ' ' CD1' ' A' ' 50' ' ' PHE . 91.6 p -64.77 106.67 1.05 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.569 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.573 ' CB ' HD13 ' A' ' 76' ' ' LEU . 90.5 Cg_endo -92.15 171.03 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.639 2.226 . . . . 0.0 112.72 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . . . -87.2 159.36 18.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.513 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.575 ' HB3' ' O ' ' A' ' 67' ' ' ALA . 9.2 t30 82.17 138.74 0.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 124.167 0.917 . . . . 0.0 110.371 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.596 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER 151.64 -46.58 0.0 OUTLIER Pre-proline 0 CA--C 1.512 -0.512 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.758 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 97.6 Cg_endo -92.74 55.15 0.53 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.167 2.578 . . . . 0.0 111.609 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.709 ' O ' ' O ' ' A' ' 42' ' ' GLY . 4.6 p30 158.16 109.17 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.413 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.86 ' N ' ' HA ' ' A' ' 43' ' ' VAL . 6.2 Cg_endo -48.18 106.15 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.274 2.649 . . . . 0.0 113.88 -177.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 40' ' ' ASN . 10.8 mm-40 -158.71 -74.73 0.08 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.803 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.554 ' O ' ' CA ' ' A' ' 38' ' ' CYS . . . 105.36 72.56 0.86 Allowed Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.011 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 68' ' ' ASN . 9.7 mtm180 -151.98 109.25 3.57 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.887 HD21 HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -93.88 128.03 39.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.622 -178.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.707 ' N ' HD12 ' A' ' 76' ' ' LEU . 56.0 mt-10 -130.26 115.75 17.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.236 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.686 ' CD1' ' CG2' ' A' ' 80' ' ' ILE . 1.6 p90 -121.5 135.04 55.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.865 0.364 . . . . 0.0 110.996 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.921 HD22 ' HB2' ' A' ' 131' ' ' ALA . 0.6 OUTLIER -114.78 82.17 1.68 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.979 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.686 ' CG2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -92.14 129.2 43.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.108 -179.161 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.685 ' NH1' H61A ' A' ' 252' ' ' FDA . 0.3 OUTLIER -77.52 110.13 12.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.233 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.57 ' CG2' ' CB ' ' A' ' 89' ' ' SER . 4.4 m -102.5 127.81 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.293 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.724 HD12 ' HB2' ' A' ' 87' ' ' ARG . 13.5 mt -42.66 166.56 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 83' ' ' LEU . 74.7 Cg_exo -49.77 -50.01 14.37 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.654 2.236 . . . . 0.0 112.391 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 175.83 67.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 87' ' ' ARG . . . 176.27 64.25 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.575 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.724 ' HB2' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER 164.07 -93.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.676 0.274 . . . . 0.0 111.005 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.599 ' CE1' ' CG1' ' A' ' 55' ' ' ILE . 1.1 t80 -94.99 -29.96 14.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.343 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.57 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 4.8 p -81.36 -27.14 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.862 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -75.8 -43.44 46.21 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.571 0.701 . . . . 0.0 109.822 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -72.89 -25.29 61.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.934 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.7 OUTLIER -68.46 -47.49 67.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.282 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.446 ' O ' ' CD ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -90.2 -25.61 20.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 12.5 m120 -96.9 2.29 51.5 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.166 -0.213 . . . . 0.0 111.343 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.59 19.72 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.955 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . . . -146.96 27.68 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.671 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 96' ' ' ALA . 39.7 mmm-85 -45.39 173.36 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.114 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.736 HG13 ' HB ' ' A' ' 16' ' ' VAL . 0.5 OUTLIER -95.31 -144.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.44 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.37 -44.9 1.99 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.986 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.935 ' O ' HG22 ' A' ' 16' ' ' VAL . 9.3 pt20 -83.52 -158.52 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.282 0.563 . . . . 0.0 112.372 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.521 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 5.3 p -125.13 144.19 36.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.483 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.957 HD11 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -129.32 136.1 49.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.711 0.291 . . . . 0.0 110.638 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 1.01 ' O ' ' CA ' ' A' ' 55' ' ' ILE . 16.1 t -102.67 127.22 49.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.03 0.443 . . . . 0.0 111.066 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.847 ' HA ' ' CA ' ' A' ' 55' ' ' ILE . 2.0 m -101.37 122.61 53.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.978 ' HG3' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -130.18 113.01 13.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.624 -178.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 52' ' ' ASP . . . -173.56 85.14 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.972 -1.108 . . . . 0.0 113.779 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.01 64.37 1.36 Allowed 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.353 2.036 . . . . 0.0 110.786 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.44 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -88.47 173.75 8.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.231 -178.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.573 ' O ' ' CE2' ' A' ' 50' ' ' PHE . . . -108.54 174.51 18.79 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.282 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.032 HG21 ' HD2' ' A' ' 47' ' ' PRO . 18.7 m -107.46 109.2 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 121.605 0.717 . . . . 0.0 110.516 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 1.3 m-85 -121.54 132.82 54.92 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.26 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 215' ' ' TYR . . . 124.43 -86.98 0.37 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.012 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.6 ' HB3' ' CE2' ' A' ' 123' ' ' PHE . 0.4 OUTLIER -81.75 118.36 22.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.935 0.397 . . . . 0.0 110.001 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.641 ' CB ' ' CD2' ' A' ' 241' ' ' PHE . 0.9 OUTLIER -137.5 114.63 10.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.959 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.21 129.54 53.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.205 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.05 14.28 24.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.956 0.408 . . . . 0.0 111.114 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.26 -66.23 1.81 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.527 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.535 ' HA ' ' HB2' ' A' ' 147' ' ' ASN . 17.3 ttm -128.82 89.05 2.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.896 0.379 . . . . 0.0 110.376 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.66 ' HB3' ' HE ' ' A' ' 121' ' ' ARG . . . -167.15 142.92 3.5 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.597 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 97.1 Cg_endo -78.28 108.81 2.55 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 123.148 2.565 . . . . 0.0 112.219 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.66 ' HE ' ' HB3' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -136.99 153.03 50.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.949 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.616 ' CD2' ' HB2' ' A' ' 150' ' ' ARG . 2.1 m-85 -120.64 123.03 41.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.022 0.439 . . . . 0.0 110.985 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.945 ' CE1' HG11 ' A' ' 133' ' ' VAL . 45.6 t80 -108.23 111.3 23.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.181 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.834 HG23 ' HB2' ' A' ' 152' ' ' TYR . 3.2 p -98.15 112.25 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 121.473 0.654 . . . . 0.0 111.914 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.838 ' HB2' ' HE1' ' A' ' 123' ' ' PHE . . . -118.23 132.22 56.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.815 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.706 ' O ' HD21 ' A' ' 246' ' ' LEU . . . -123.98 101.97 0.7 Allowed Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.433 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.596 ' N ' HG12 ' A' ' 155' ' ' VAL . . . 142.1 -152.01 23.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.006 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.745 ' CG2' HD23 ' A' ' 79' ' ' LEU . 32.1 m -119.39 -15.82 9.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.056 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.72 ' HA3' ' HN3' ' A' ' 252' ' ' FDA . . . -66.65 9.37 0.9 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.8 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.934 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -80.4 4.72 17.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 120.875 0.369 . . . . 0.0 110.01 179.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.921 ' HB2' HD22 ' A' ' 79' ' ' LEU . . . -46.8 -52.5 31.77 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.516 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 131' ' ' ALA . 39.8 Cg_endo -65.68 -30.83 50.43 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 121.915 1.743 . . . . 0.0 109.946 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.954 ' O ' HG23 ' A' ' 137' ' ' VAL . 41.6 t -67.27 -45.75 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.403 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.934 HG13 ' HG ' ' A' ' 130' ' ' LEU . 15.5 m -70.6 -29.81 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.012 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.21 -52.56 58.21 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 109.991 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.562 ' CE ' ' CE ' ' A' ' 140' ' ' MET . 7.8 tpt -62.29 -44.12 97.25 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.312 0.577 . . . . 0.0 109.504 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 133' ' ' VAL . 61.5 t -61.61 -30.21 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.079 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -36.29 80.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.412 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -42.83 87.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 110.236 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.646 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 2.4 tpp -70.56 -33.26 70.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.002 0.906 . . . . 0.0 110.103 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.85 HE21 HD21 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -77.32 -29.81 53.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.307 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -71.7 -45.11 62.89 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.796 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -77.25 -22.41 52.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.389 0.614 . . . . 0.0 109.798 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 145' ' ' ALA . 1.2 p 58.4 26.3 13.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.229 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.796 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -37.01 160.4 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.541 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.64 14.15 1.05 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.12 2.547 . . . . 0.0 113.328 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 118' ' ' MET . 2.1 p-10 -83.14 132.3 35.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.99 0.424 . . . . 0.0 111.779 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 1.0 OUTLIER -73.94 105.12 5.05 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.626 0.727 . . . . 0.0 111.08 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.697 ' HB ' HD11 ' A' ' 177' ' ' LEU . 2.7 m -113.48 115.5 28.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.109 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.616 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -105.66 139.81 39.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.094 0.473 . . . . 0.0 110.157 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.42 HD11 ' HD1' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -133.98 126.93 51.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.51 -178.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.834 ' HB2' HG23 ' A' ' 124' ' ' VAL . 17.3 m-85 -103.15 108.7 19.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.551 ' CE1' ' CD1' ' A' ' 130' ' ' LEU . 31.9 t80 -125.92 156.36 39.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 182' ' ' CYS . . . 153.87 -172.62 32.57 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.711 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.741 HG21 HD13 ' A' ' 161' ' ' LEU . 22.4 m -161.97 -124.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.621 ' CA ' HG22 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -108.67 160.14 16.18 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 117.484 0.129 . . . . 0.0 110.978 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.68 HG22 ' N ' ' A' ' 187' ' ' SER . 0.1 OUTLIER -4.69 -65.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.66 0.784 . . . . 0.0 112.315 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 156' ' ' ASN . 1.4 mt-10 165.67 59.14 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.229 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.54 ' HG2' H62A ' A' ' 252' ' ' FDA . 26.5 Cg_exo -61.2 -16.45 46.49 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.736 1.624 . . . . 0.0 109.491 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.496 ' O ' ' O ' ' A' ' 161' ' ' LEU . 1.3 tp10 174.26 -58.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.779 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.741 HD13 HG21 ' A' ' 155' ' ' VAL . 3.5 tp 41.63 -177.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.306 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.566 ' CG ' ' O ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER 154.56 179.95 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.701 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.574 ' CE1' ' HG2' ' A' ' 166' ' ' GLU . 0.0 OUTLIER 83.01 3.41 1.0 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.695 179.323 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 1.019 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -56.84 -41.21 75.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 1.019 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.6 OUTLIER -64.9 -27.6 68.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.831 178.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.574 ' HG2' ' CE1' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -71.54 -46.61 59.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.955 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.954 ' HB2' HG21 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -59.72 -30.09 68.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.515 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.467 ' HE3' HG12 ' A' ' 164' ' ' ILE . 11.9 mttt -75.83 -24.47 55.85 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -32.75 65.96 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.745 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.982 ' HB2' HD23 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -66.89 -48.09 69.8 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.163 176.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.924 ' OE2' HG12 ' A' ' 179' ' ' VAL . 1.2 mm-40 -56.97 -39.61 74.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.284 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -29.32 40.22 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.532 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 174' ' ' MET . 49.5 m -79.63 -72.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.778 ' CB ' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -52.42 -163.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.182 0.515 . . . . 0.0 111.76 -178.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -114.24 -42.34 3.36 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.604 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.499 ' HB2' ' CB ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -132.21 64.02 1.61 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.077 -179.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.982 HD23 ' HB2' ' A' ' 170' ' ' LEU . 3.2 mp -102.69 152.74 20.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.262 0.554 . . . . 0.0 111.388 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.482 ' OG1' ' HD3' ' A' ' 150' ' ' ARG . 27.3 m -136.51 114.82 11.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.899 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.954 HG21 ' HB2' ' A' ' 167' ' ' LEU . 8.9 p -99.63 135.27 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.431 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -112.74 135.62 53.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.027 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.513 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -104.38 106.76 17.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.213 0.53 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.655 ' HB2' ' HA3' ' A' ' 154' ' ' GLY . 31.3 m -80.07 -163.7 0.58 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.334 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.621 HG22 ' CA ' ' A' ' 156' ' ' ASN . 24.1 t 66.72 149.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 122.365 1.078 . . . . 0.0 113.639 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.695 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -139.09 -84.17 0.26 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.846 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.699 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 0.2 OUTLIER -140.78 29.27 0.11 Allowed Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.43 176.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.699 ' HD3' ' N ' ' A' ' 185' ' ' HIS . 52.3 Cg_exo -53.88 -138.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 122.209 1.939 . . . . 0.0 113.714 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.68 ' N ' HG22 ' A' ' 157' ' ' THR . 47.0 t 173.24 35.59 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.402 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.498 ' H ' ' CB ' ' A' ' 156' ' ' ASN . . . 86.52 16.18 62.56 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.145 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.51 64.76 1.45 Allowed 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' A' ' 249' ' ' GLY . 13.3 t-105 -133.37 127.39 33.37 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.687 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.516 ' HG2' ' CG ' ' A' ' 219' ' ' PRO . 1.2 mt-10 -113.98 105.74 13.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.717 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.529 ' HA2' ' N ' ' A' ' 251' ' ' ALA . . . 148.44 -108.6 0.42 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.351 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.566 ' HA ' ' HB3' ' A' ' 182' ' ' CYS . 16.4 mt-10 -168.89 -95.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.513 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 64.5 mt-30 -86.95 133.95 33.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.61 ' HA2' ' CD1' ' A' ' 184' ' ' TRP . . . -22.24 106.82 0.01 OUTLIER Glycine 0 C--N 1.333 0.406 0 O-C-N 123.717 0.635 . . . . 0.0 113.214 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 5.9 m 140.11 158.98 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 O-C-N 124.245 0.615 . . . . 0.0 110.539 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.455 ' O ' ' HB ' ' A' ' 198' ' ' ILE . 49.4 Cg_exo -54.08 -70.44 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.445 2.097 . . . . 0.0 112.077 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.72 HG23 ' O ' ' A' ' 198' ' ' ILE . 0.3 OUTLIER 169.65 29.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 121.665 0.745 . . . . 0.0 111.111 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.507 ' OD1' ' NH2' ' A' ' 202' ' ' ARG . 1.4 m-20 -64.11 -36.81 85.25 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.312 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.33 -37.53 78.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.547 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -69.42 -35.22 75.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.812 0.339 . . . . 0.0 110.978 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.704 ' HG2' HD13 ' A' ' 229' ' ' LEU . 26.8 mtt180 -59.37 -49.96 75.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.421 0.629 . . . . 0.0 111.246 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -31.94 71.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.63 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.451 ' OD1' ' OD2' ' A' ' 209' ' ' ASP . 0.5 OUTLIER -58.56 -43.23 89.29 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.287 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.725 HD12 ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -61.24 -48.24 82.36 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.486 ' OE2' ' HG3' ' A' ' 233' ' ' ARG . 2.4 mt-10 -62.25 -22.15 65.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.706 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.65 -86.8 0.28 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.823 0.344 . . . . 0.0 111.623 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 0.0 OUTLIER 179.37 97.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.806 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.674 ' O ' ' HB3' ' A' ' 210' ' ' ALA . 3.9 p30 152.55 87.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.537 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 1.043 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 96.37 106.09 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.657 ' HA ' HD13 ' A' ' 235' ' ' ILE . 1.1 t30 -172.39 -58.82 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.737 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 10.0 Cg_endo -52.72 -64.47 0.18 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.218 1.945 . . . . 0.0 110.895 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.551 ' HA ' HG21 ' A' ' 240' ' ' VAL . 0.4 OUTLIER -125.34 110.19 13.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.371 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 1.043 HD11 ' HB1' ' A' ' 210' ' ' ALA . 1.0 OUTLIER -107.45 125.71 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 114' ' ' LYS . 2.3 m-85 -116.13 129.68 56.44 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.648 HD23 HG12 ' A' ' 124' ' ' VAL . 0.6 OUTLIER -139.86 123.42 17.23 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -178.055 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 123' ' ' PHE . 2.5 m -123.75 110.37 14.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.71 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.667 ' HA3' ' HB3' ' A' ' 250' ' ' ALA . . . -176.98 -156.85 16.73 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.678 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.518 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 37.3 Cg_endo -65.79 175.61 4.35 Favored 'Trans proline' 0 N--CA 1.466 -0.11 0 C-N-CA 122.326 2.017 . . . . 0.0 111.687 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 219' ' ' PRO . 26.2 Cg_endo -62.53 -8.84 13.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.457 2.105 . . . . 0.0 112.136 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -83.15 -40.36 9.3 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 120.734 -0.745 . . . . 0.0 113.127 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.56 ' HB2' ' HB1' ' A' ' 250' ' ' ALA . 0.0 OUTLIER -56.38 -33.85 66.12 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.536 ' CB ' ' HE2' ' A' ' 222' ' ' MET . 0.0 OUTLIER -77.6 -36.81 23.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.896 178.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.481 ' OD1' HG22 ' A' ' 223' ' ' ILE . 16.0 m-20 -73.94 -47.67 35.98 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 251' ' ' ALA . . . -73.22 -48.68 33.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 1.017 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -60.85 -34.07 74.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.823 0.344 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 223' ' ' ILE . 8.0 m -70.0 -32.28 70.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.029 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -71.09 -45.32 63.93 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.568 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.704 HD13 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -62.43 -46.21 89.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.112 0.482 . . . . 0.0 110.799 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 1.017 HG23 ' O ' ' A' ' 226' ' ' ALA . 13.0 t -60.01 -45.58 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.106 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -67.55 -29.82 69.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.187 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -31.37 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.945 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.725 ' HD3' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -84.22 -83.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.135 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 235' ' ' ILE . . . 140.87 -23.68 2.61 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.33 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.657 HD13 ' HA ' ' A' ' 211' ' ' ASN . 1.4 pp -31.51 105.17 0.23 Allowed Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-O 121.128 0.489 . . . . 0.0 111.681 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.486 ' O ' ' OD1' ' A' ' 211' ' ' ASN . 79.0 Cg_exo -33.15 158.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.605 2.87 . . . . 0.0 112.542 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 238' ' ' GLU . . . 68.84 6.08 49.65 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.693 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.665 ' C ' HG11 ' A' ' 230' ' ' VAL . 2.9 mp0 29.12 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.841 0.353 . . . . 0.0 111.253 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.985 ' HG2' HG21 ' A' ' 230' ' ' VAL . 7.5 mt-30 -122.68 -2.62 8.83 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.658 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.801 HG12 ' N ' ' A' ' 241' ' ' PHE . 2.3 t 52.25 -82.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.153 0.501 . . . . 0.0 111.344 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.801 ' N ' HG12 ' A' ' 240' ' ' VAL . 10.1 m-85 -119.28 125.4 49.01 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.26 129.62 37.89 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.874 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -132.21 148.26 52.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.048 178.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -125.37 106.55 9.91 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.657 ' O ' HD23 ' A' ' 246' ' ' LEU . 0.2 OUTLIER -136.94 144.9 43.67 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 178.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.706 HD21 ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER 83.29 160.8 0.12 Allowed Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.429 0.691 . . . . 0.0 112.775 179.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.807 ' HG2' ' H8A' ' A' ' 252' ' ' FDA . 37.3 Cg_exo -61.66 -138.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.67 2.913 . . . . 0.0 111.741 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.435 ' HB2' ' C ' ' A' ' 190' ' ' TRP . 10.1 p -72.84 145.84 46.67 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.298 0.571 . . . . 0.0 110.858 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 190' ' ' TRP . . . 167.98 -53.99 0.22 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.9 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.667 ' HB3' ' HA3' ' A' ' 218' ' ' GLY . . . -107.69 149.12 28.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.54 -0.33 . . . . 0.0 110.49 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.687 ' O ' ' HB3' ' A' ' 225' ' ' ALA . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.173 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' FDA . . . . . 0.807 ' H8A' ' HG2' ' A' ' 247' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.818 0.342 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 177.05 -55.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -110.07 155.57 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.62 121.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.827 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -144.6 95.72 2.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.952 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.47 94.42 1.94 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.476 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -62.03 175.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.13 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.93 99.77 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.523 0.678 . . . . 0.0 111.111 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.13 22.09 31.1 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.457 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 m -96.29 150.6 20.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.889 0.376 . . . . 0.0 111.07 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.622 ' CD1' ' HB2' ' A' ' 36' ' ' ASP . 2.6 t80 -132.09 149.02 52.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.939 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.592 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 3.9 mt-10 -108.79 119.81 40.63 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.873 0.368 . . . . 0.0 111.02 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.897 ' O ' HG13 ' A' ' 101' ' ' VAL . . . -119.74 131.78 55.46 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.965 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.544 ' CB ' ' HB2' ' A' ' 33' ' ' LYS . 1.2 tt0 -92.71 137.57 32.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.117 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.763 ' HA ' HD23 ' A' ' 31' ' ' LEU . 10.9 t -71.28 124.55 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.75 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 17' ' ' VAL . 7.6 p -154.36 22.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.126 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.496 ' HA3' ' HG ' ' A' ' 30' ' ' LEU . . . -150.55 -139.77 3.09 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.548 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.767 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER 82.57 62.71 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.174 0.512 . . . . 0.0 110.471 -179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.694 HD21 HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -101.69 148.96 24.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.589 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 12.2 m95 -89.16 114.63 25.94 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.694 HG12 HD21 ' A' ' 20' ' ' ASN . 1.5 m -95.04 -27.6 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-O 121.529 0.681 . . . . 0.0 109.301 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.543 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 13.8 m -143.9 173.68 11.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.348 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -54.27 -58.07 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.958 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 0.3 OUTLIER -112.69 39.23 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.801 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.617 ' CG2' HG21 ' A' ' 128' ' ' THR . 0.2 OUTLIER -145.92 135.53 23.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.522 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.767 HG21 ' CD2' ' A' ' 19' ' ' LEU . 1.5 p -140.6 147.19 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.084 0.469 . . . . 0.0 112.019 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -116.57 122.17 43.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.981 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.751 ' CZ ' HG13 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -114.09 121.35 43.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.797 0.332 . . . . 0.0 111.726 -178.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.822 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -108.62 116.37 31.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.883 179.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.97 HD22 HD11 ' A' ' 102' ' ' LEU . 2.3 mt -122.63 133.15 54.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.048 0.452 . . . . 0.0 111.746 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.519 ' CA ' ' HB2' ' A' ' 38' ' ' CYS . 0.5 OUTLIER -145.05 131.37 19.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.079 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.544 ' HB2' ' CB ' ' A' ' 15' ' ' GLU . 7.2 tptm -164.74 -33.38 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.508 ' CD ' ' HD2' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -147.08 177.22 1.84 Allowed Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' A' ' 36' ' ' ASP . 75.6 Cg_exo -49.18 106.59 0.12 Allowed 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.505 2.137 . . . . 0.0 111.987 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.622 ' HB2' ' CD1' ' A' ' 12' ' ' PHE . 1.5 m-20 157.37 -36.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.288 0.565 . . . . 0.0 111.475 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.524 ' HB3' ' HB2' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -169.93 51.28 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.193 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.586 ' H ' ' HA3' ' A' ' 74' ' ' GLY . 53.2 t -163.71 -58.2 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 73' ' ' GLU . . . -137.75 -66.02 0.05 OUTLIER Glycine 0 CA--C 1.51 -0.263 0 C-N-CA 119.97 -1.109 . . . . 0.0 113.69 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.528 ' CB ' ' HG3' ' A' ' 35' ' ' PRO . 0.8 OUTLIER -88.08 18.82 3.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.87 0.367 . . . . 0.0 111.259 -179.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.948 ' HG3' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -56.45 -45.52 80.77 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.47 0.652 . . . . 0.0 109.624 178.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 72' ' ' PRO . . . 60.14 78.15 0.15 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.911 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.948 HG22 ' HG3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -93.45 163.4 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.435 0.636 . . . . 0.0 111.849 -178.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HE3' ' CE1' ' A' ' 45' ' ' PHE . 4.8 tttp -154.72 -142.03 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.733 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.547 ' CE1' ' HE3' ' A' ' 44' ' ' LYS . 22.2 p90 -122.06 78.11 1.45 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.376 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 48' ' ' GLY . 28.1 mm-40 -113.04 166.55 10.86 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.579 ' HD2' HG11 ' A' ' 110' ' ' VAL . 32.1 Cg_exo -58.05 65.98 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.389 2.06 . . . . 0.0 111.616 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 40.39 62.46 1.57 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.223 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.508 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -30.32 148.98 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.716 0.258 . . . . 0.0 110.844 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.701 ' C ' HD23 ' A' ' 108' ' ' LEU . 5.3 m-85 -116.16 163.17 16.36 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.719 ' N ' HD23 ' A' ' 108' ' ' LEU . 4.7 mtt -131.41 162.56 29.89 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.962 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 105' ' ' LYS . 4.4 t0 -125.31 102.46 7.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.842 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.983 HD12 HG12 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -150.07 156.95 42.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.958 HG23 ' C ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -85.63 154.69 21.52 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.313 178.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.716 HD11 ' CZ ' ' A' ' 88' ' ' PHE . 1.3 mt -30.4 -71.91 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 123.411 0.444 . . . . 0.0 109.906 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.907 ' CG ' HG23 ' A' ' 58' ' ' THR . 9.3 Cg_endo -99.82 4.47 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.568 2.179 . . . . 0.0 111.583 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 101.41 -3.05 54.0 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.832 -178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.907 HG23 ' CG ' ' A' ' 56' ' ' PRO . 64.9 p -27.81 -87.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 122.841 0.456 . . . . 0.0 112.084 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.683 ' O ' HG12 ' A' ' 60' ' ' VAL . 43.9 p-10 -150.45 40.02 0.75 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.958 ' C ' HG23 ' A' ' 54' ' ' THR . 0.3 OUTLIER 90.68 121.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 178.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.723 ' N ' HG23 ' A' ' 54' ' ' THR . 40.3 t -120.72 -66.95 1.01 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.708 0.766 . . . . 0.0 109.931 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -170.41 157.94 6.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.227 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.895 ' HB2' HD21 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -88.73 120.7 30.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.669 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.527 ' OH ' ' N ' ' A' ' 79' ' ' LEU . 3.0 t80 -111.7 121.18 44.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.901 0.381 . . . . 0.0 111.608 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.694 ' CB ' ' CD1' ' A' ' 50' ' ' PHE . 82.4 p -55.56 98.69 0.17 Allowed Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.732 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.983 ' HB2' HD13 ' A' ' 76' ' ' LEU . 2.1 Cg_endo -82.94 155.34 15.13 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.83 2.353 . . . . 0.0 111.54 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 132' ' ' PRO . . . -144.65 130.65 19.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.846 ' ND2' HG21 ' A' ' 43' ' ' VAL . 10.0 t-20 -115.88 -63.62 1.43 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.764 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 68' ' ' ASN . 0.6 OUTLIER 144.42 154.44 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.936 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.652 ' HD2' HD23 ' A' ' 69' ' ' LEU . 18.0 Cg_endo -59.63 96.89 0.1 Allowed 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.283 1.989 . . . . 0.0 111.225 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.557 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -179.2 138.06 0.33 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.058 0.456 . . . . 0.0 111.519 -179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.459 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 85.5 Cg_endo -82.07 79.63 3.07 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.377 . . . . 0.0 111.998 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.529 ' O ' ' CA ' ' A' ' 39' ' ' GLY . 39.3 mt-10 -144.23 -72.84 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.961 0.41 . . . . 0.0 110.008 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.586 ' HA3' ' H ' ' A' ' 38' ' ' CYS . . . 122.83 97.08 1.33 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.335 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 74' ' ' GLY . 85.0 mtm-85 -162.33 83.66 0.55 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 122.633 0.373 . . . . 0.0 110.888 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.983 HD13 ' HB2' ' A' ' 66' ' ' PRO . 30.0 mt -96.91 145.94 25.42 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.61 0.719 . . . . 0.0 112.496 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 5.9 pt-20 -131.24 141.89 50.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.433 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.662 ' CE1' ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -115.95 133.76 55.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.013 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.995 HD22 ' HB2' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -101.58 82.31 2.28 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.662 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -91.22 118.01 35.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.854 -178.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.674 ' O ' H52A ' A' ' 252' ' ' FDA . 0.0 OUTLIER -78.33 95.99 5.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.584 ' CG1' ' CG2' ' A' ' 80' ' ' ILE . 2.3 m -94.0 142.12 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.999 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.534 HD13 ' C4B' ' A' ' 252' ' ' FDA . 0.1 OUTLIER -68.14 172.63 4.05 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.799 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 83' ' ' LEU . 44.6 Cg_endo -68.68 58.39 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 0.0 112.149 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 84' ' ' PRO . 0.6 OUTLIER 67.48 72.58 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 87' ' ' ARG . . . 173.12 66.58 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.691 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.475 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 163.09 -90.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 111.132 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.716 ' CZ ' HD11 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -108.6 -27.19 10.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.26 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.572 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -60.1 -32.99 71.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 111.185 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 0.8 OUTLIER -75.93 -32.0 59.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.386 0.612 . . . . 0.0 110.842 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.562 ' CG ' HD13 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -68.94 -51.26 41.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.878 -178.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.646 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -71.59 -30.75 66.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -31.04 18.07 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.662 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 2.1 t-20 -95.87 -11.29 26.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.7 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 91' ' ' TYR . 2.2 t70 -135.58 -15.28 1.87 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.646 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . . . -119.43 29.02 7.85 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.993 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 96' ' ' ALA . 1.1 mmt180 -56.58 -163.37 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.614 HG13 HG12 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -86.74 -153.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-O 121.195 0.522 . . . . 0.0 110.65 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.41 -47.26 1.38 Allowed Glycine 0 C--N 1.316 -0.548 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.469 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.756 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -96.55 179.45 5.0 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 14' ' ' ALA . 99.6 t -121.85 145.23 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.259 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.97 HD11 HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.6 120.36 40.74 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 108.57 13.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.983 HG12 HD12 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -108.49 165.43 4.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.066 0.46 . . . . 0.0 112.079 -177.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.63 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -132.24 112.49 12.29 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 51' ' ' MET . . . -103.54 44.97 1.38 Allowed Glycine 0 CA--C 1.519 0.321 0 C-N-CA 119.533 -1.318 . . . . 0.0 115.74 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.518 ' HD3' ' C ' ' A' ' 105' ' ' LYS . 82.5 Cg_endo -81.83 38.81 0.78 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.173 1.915 . . . . 0.0 111.481 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.895 HD21 ' HB2' ' A' ' 63' ' ' SER . 0.0 OUTLIER -88.33 173.19 8.89 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.813 0.816 . . . . 0.0 112.761 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.01 173.42 19.41 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.477 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.579 HG11 ' HD2' ' A' ' 47' ' ' PRO . 9.3 m -108.63 107.16 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 117.925 0.862 . . . . 0.0 110.923 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 0.3 OUTLIER -123.74 122.53 38.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.476 178.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 215' ' ' TYR . . . 123.35 -84.78 0.37 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.283 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.588 ' HB2' ' CE2' ' A' ' 123' ' ' PHE . 7.7 tp -75.88 117.87 18.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.057 0.456 . . . . 0.0 110.073 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.616 ' O ' ' CZ ' ' A' ' 215' ' ' TYR . 0.1 OUTLIER -138.7 127.3 23.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.605 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.535 ' HA ' ' CZ ' ' A' ' 121' ' ' ARG . 2.2 pp20? -112.45 134.56 53.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.624 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -110.32 6.35 22.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.974 0.416 . . . . 0.0 111.197 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.81 -75.73 0.4 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.544 ' HA ' ' CB ' ' A' ' 147' ' ' ASN . 3.7 mpp? -129.91 89.33 2.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.887 0.375 . . . . 0.0 110.524 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.49 ' O ' ' HD3' ' A' ' 121' ' ' ARG . . . -158.36 144.2 12.41 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.243 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.86 94.67 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.599 2.2 . . . . 0.0 111.613 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -127.81 150.45 49.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.257 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.745 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -124.17 144.39 49.95 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.923 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.885 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.9 t80 -128.35 115.36 18.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.746 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.76 HG21 ' CE ' ' A' ' 222' ' ' MET . 8.0 p -98.82 111.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.101 0.477 . . . . 0.0 111.33 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.564 ' HB2' HG11 ' A' ' 133' ' ' VAL . . . -111.31 132.84 54.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.784 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.454 ' HA3' ' C ' ' A' ' 249' ' ' GLY . . . -129.18 104.34 0.64 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.412 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 134.64 -166.13 24.33 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.033 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.839 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -98.84 -28.15 13.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.118 0.485 . . . . 0.0 110.56 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.63 ' HA3' ' HN3' ' A' ' 252' ' ' FDA . . . -65.5 8.24 0.8 Allowed Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.764 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.829 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -79.23 4.51 14.75 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.995 ' HB2' HD22 ' A' ' 79' ' ' LEU . . . -46.9 -44.57 47.26 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.904 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 8.9 Cg_exo -69.48 -30.89 22.86 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.425 2.084 . . . . 0.0 109.748 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.074 ' O ' HG23 ' A' ' 137' ' ' VAL . 13.7 t -68.12 -53.08 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.576 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.829 HG13 ' HG ' ' A' ' 130' ' ' LEU . 29.1 m -66.57 -30.47 49.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.625 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.3 OUTLIER -61.16 -50.73 71.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.183 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.438 ' HA ' ' CD ' ' A' ' 139' ' ' GLN . 0.5 OUTLIER -66.93 -43.03 84.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.791 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.074 HG23 ' O ' ' A' ' 133' ' ' VAL . 13.5 t -59.81 -37.59 72.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 134' ' ' VAL . 3.2 mtm-85 -69.43 -31.03 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.1 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.492 ' O ' ' HB3' ' A' ' 143' ' ' TRP . 43.7 mt-30 -63.15 -43.03 99.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.259 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.475 ' HE1' HG21 ' A' ' 149' ' ' THR . 3.9 ptp -71.38 -48.87 47.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.189 0.519 . . . . 0.0 110.6 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.529 ' NE2' ' CD2' ' A' ' 177' ' ' LEU . 0.7 OUTLIER -58.2 -30.99 66.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.716 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 138' ' ' ARG . 1.3 mt-10 -82.16 -37.31 26.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.266 0.555 . . . . 0.0 110.085 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.789 ' CD1' ' HB2' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -67.59 -9.65 44.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.651 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 143' ' ' TRP . 1.6 p 87.55 10.45 0.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.766 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.789 ' HB2' ' CD1' ' A' ' 143' ' ' TRP . . . -38.79 98.42 0.17 Allowed Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.737 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.543 ' HA ' ' HB2' ' A' ' 175' ' ' ARG . 81.0 Cg_endo -78.12 8.41 3.54 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.906 2.404 . . . . 0.0 112.679 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.583 ' OD1' ' HB1' ' A' ' 145' ' ' ALA . 14.7 p-10 -78.58 150.3 32.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.944 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 176' ' ' ASN . 0.2 OUTLIER -74.18 104.77 5.09 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.49 0.662 . . . . 0.0 110.99 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.7 OUTLIER -123.01 117.21 24.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.936 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.659 ' CB ' ' CD2' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -102.71 141.55 35.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.832 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.885 HD13 ' O ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -134.27 126.23 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.745 ' CE1' ' HB3' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -102.89 108.1 19.17 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.6 ' CD1' ' CD1' ' A' ' 130' ' ' LEU . 7.1 t80 -124.91 153.96 41.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.852 0.358 . . . . 0.0 111.949 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.686 ' O ' HG13 ' A' ' 155' ' ' VAL . . . 150.07 -168.21 30.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.711 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.91 HG21 HD13 ' A' ' 161' ' ' LEU . 16.4 m -163.52 -120.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.781 ' O ' HG21 ' A' ' 183' ' ' VAL . 2.4 p-10 -103.93 -166.01 1.21 Allowed 'General case' 0 C--N 1.35 0.613 0 C-N-CA 122.371 0.268 . . . . 0.0 111.122 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.61 ' CG2' ' HA ' ' A' ' 187' ' ' SER . 0.1 OUTLIER -28.03 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.608 0.242 . . . . 0.0 111.415 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 156' ' ' ASN . 39.6 mt-10 93.35 41.0 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.684 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 37.7 Cg_endo -66.85 -26.09 44.91 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 C-N-CA 122.137 1.891 . . . . 0.0 110.626 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -130.58 20.8 5.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.208 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.91 HD13 HG21 ' A' ' 155' ' ' VAL . 9.9 tp -88.57 165.31 14.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.063 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.478 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 0.9 OUTLIER 176.26 -160.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.998 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.3 OUTLIER 72.85 26.63 2.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.243 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 1.047 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -69.8 -35.87 67.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.912 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 1.047 ' N ' HD13 ' A' ' 164' ' ' ILE . 9.2 m-20 -62.29 -28.47 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.299 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.466 ' O ' ' CD2' ' A' ' 170' ' ' LEU . 2.3 mm-40 -72.08 -47.46 51.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.705 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -64.22 -30.25 71.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.763 178.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 172' ' ' ARG . 4.8 mtmm -72.55 -24.8 61.17 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -35.82 71.17 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.415 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -67.64 -48.52 66.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.476 ' O ' ' SD ' ' A' ' 174' ' ' MET . 3.3 mt-10 -57.65 -32.15 67.0 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.864 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 168' ' ' LYS . 1.1 mtt-85 -79.56 -41.69 26.68 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 174' ' ' MET . 6.4 t -93.1 -50.67 5.4 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.911 ' HB2' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -35.62 167.19 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.966 0.889 . . . . 0.0 112.892 -178.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.543 ' HB2' ' HA ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -99.75 -71.92 0.68 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.473 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -124.63 56.31 1.3 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.787 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.911 HD13 ' HB2' ' A' ' 174' ' ' MET . 5.8 mp -114.47 154.69 27.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.397 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.472 ' OG1' ' HG3' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -136.06 117.79 15.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.464 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.464 ' HB ' ' OE2' ' A' ' 171' ' ' GLU . 91.0 t -89.66 134.32 29.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.6 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.552 ' CB ' ' HA ' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -104.13 135.72 45.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.013 0.435 . . . . 0.0 111.676 -179.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -103.14 107.05 17.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.905 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.698 ' HB3' ' HA ' ' A' ' 193' ' ' GLU . 38.1 m -79.91 -168.26 1.55 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.311 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 155' ' ' VAL . 52.5 t 70.07 148.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.875 0.845 . . . . 0.0 112.835 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.714 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -138.53 -53.3 0.6 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.586 -177.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.547 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 4.7 p-80 167.77 62.2 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 113.623 -1.626 . . . . 0.0 108.696 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.626 ' O ' ' CB ' ' A' ' 187' ' ' SER . 67.0 Cg_endo -95.65 -96.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.797 2.998 . . . . 0.0 114.305 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.626 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 28.6 t 136.78 78.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.985 0.514 . . . . 0.0 110.34 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.509 ' O ' ' H2A' ' A' ' 252' ' ' FDA . . . 41.65 23.13 0.11 Allowed Glycine 0 C--N 1.329 0.148 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.066 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 187' ' ' SER . 0.2 OUTLIER -139.23 62.05 1.54 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.541 ' NE1' ' O ' ' A' ' 193' ' ' GLU . 19.4 t-105 -135.24 129.12 33.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 1.052 ' C ' ' HB3' ' A' ' 251' ' ' ALA . 1.6 mp0 -113.83 104.87 12.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.376 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.628 ' N ' ' HB3' ' A' ' 251' ' ' ALA . . . 147.0 -113.07 0.63 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.272 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.698 ' HA ' ' HB3' ' A' ' 182' ' ' CYS . 80.8 mt-10 -161.42 -118.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.578 ' O ' ' O ' ' A' ' 195' ' ' GLY . 2.1 tt0 -87.75 117.74 26.79 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 194' ' ' GLN . . . 31.74 104.31 0.01 OUTLIER Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.348 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.538 ' C ' ' O ' ' A' ' 195' ' ' GLY . 0.3 OUTLIER 5.86 66.68 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.2 0.6 . . . . 0.0 112.435 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.502 ' HG2' ' HB2' ' A' ' 193' ' ' GLU . 22.2 Cg_endo -97.12 22.6 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.28 2.653 . . . . 0.0 113.872 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 201' ' ' LEU . 0.2 OUTLIER -87.92 -9.44 10.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.469 -179.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.16 -36.99 83.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -61.03 -29.58 69.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.334 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.557 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -64.04 -39.64 94.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.938 0.399 . . . . 0.0 110.13 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.638 ' HG2' HD13 ' A' ' 229' ' ' LEU . 12.9 mtt180 -58.88 -48.37 81.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.514 0.673 . . . . 0.0 110.259 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.29 -32.04 68.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.013 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.76 -42.65 89.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.707 ' HB2' HG21 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -60.47 -48.05 83.47 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.428 ' OE1' ' HG3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -61.31 -21.05 63.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.019 178.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.0 t -86.31 -90.5 0.11 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.773 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 173.65 33.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.473 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.673 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 0.0 OUTLIER -145.09 58.46 1.29 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 0.851 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 148.87 101.02 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.23 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.595 ' O ' HG23 ' A' ' 240' ' ' VAL . 19.1 t30 173.84 -56.91 0.0 OUTLIER Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.175 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 12.3 Cg_endo -57.25 -53.74 4.43 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.265 1.977 . . . . 0.0 111.144 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.536 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -133.0 108.59 8.99 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.508 0.671 . . . . 0.0 109.319 178.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.93 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.8 OUTLIER -123.51 131.04 73.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.128 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.623 ' CZ ' ' HB3' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -127.89 131.96 49.38 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.302 0.572 . . . . 0.0 110.679 -178.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.747 HD12 ' HB3' ' A' ' 242' ' ' PHE . 0.2 OUTLIER -142.53 119.49 11.3 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.787 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.5 OUTLIER -122.45 109.15 14.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.871 179.467 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.548 ' HA3' ' HB3' ' A' ' 250' ' ' ALA . . . -178.57 -147.52 7.08 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.618 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 220' ' ' PRO . 58.7 Cg_endo -72.48 174.5 11.52 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.504 2.136 . . . . 0.0 111.918 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 219' ' ' PRO . 26.8 Cg_endo -62.05 -8.66 12.48 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.551 2.167 . . . . 0.0 112.215 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -72.0 -54.16 8.51 Favored Glycine 0 C--O 1.224 -0.483 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.893 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.908 ' O ' ' HB3' ' A' ' 226' ' ' ALA . 1.1 tpp -55.31 -27.96 50.42 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.538 ' O ' ' CB ' ' A' ' 227' ' ' CYS . 0.0 OUTLIER -77.17 -41.56 30.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.404 178.276 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -75.37 -49.22 19.71 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.552 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -77.13 -49.53 15.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 222' ' ' MET . . . -62.63 -35.62 80.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.948 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 223' ' ' ILE . 52.3 t -70.19 -31.96 69.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 110.306 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.5 -44.95 81.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.638 HD13 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -61.02 -38.96 87.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.979 0.419 . . . . 0.0 111.011 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 226' ' ' ALA . 2.3 t -64.45 -45.29 96.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.288 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.5 ' CZ ' ' SG ' ' A' ' 227' ' ' CYS . 19.0 mtt180 -74.22 -29.97 61.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.871 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 2.7 m -75.43 -44.41 44.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.469 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.545 ' NE ' ' HB3' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -68.4 -45.01 73.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.191 -179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 235' ' ' ILE . . . 109.18 -31.01 8.02 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.983 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.707 HG21 ' HB2' ' A' ' 205' ' ' LEU . 1.2 pp -34.27 95.99 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-O 120.829 0.347 . . . . 0.0 111.4 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 235' ' ' ILE . 11.6 Cg_endo -55.25 112.5 1.06 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.744 2.296 . . . . 0.0 111.877 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -93.75 116.59 5.25 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.699 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -88.35 -46.77 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 110.67 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 241' ' ' PHE . 6.0 mt-30 -110.31 37.56 2.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.082 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.93 HG22 ' HB ' ' A' ' 214' ' ' ILE . 1.5 t -89.89 129.41 40.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.178 0.513 . . . . 0.0 110.348 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 239' ' ' GLN . 0.8 OUTLIER -146.11 135.1 22.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.451 -178.179 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.747 ' HB3' HD12 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -131.07 140.93 50.12 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.56 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 111' ' ' PHE . 8.0 tp10 -131.42 148.66 52.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.108 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -111.51 106.73 15.69 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.593 ' CD1' ' HB2' ' A' ' 246' ' ' LEU . 0.1 OUTLIER -136.16 143.97 44.75 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.052 178.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.593 ' HB2' ' CD1' ' A' ' 245' ' ' PHE . 3.2 mt 59.42 151.12 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-O 120.95 0.405 . . . . 0.0 111.337 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.791 ' HG2' ' H3B' ' A' ' 252' ' ' FDA . 24.9 Cg_exo -64.05 -141.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.128 2.552 . . . . 0.0 112.056 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 190' ' ' TRP . 0.5 OUTLIER -43.14 148.64 0.26 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.274 0.559 . . . . 0.0 111.662 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.454 ' C ' ' HA3' ' A' ' 126' ' ' GLY . . . 157.56 -66.88 0.29 Allowed Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.207 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.548 ' HB3' ' HA3' ' A' ' 218' ' ' GLY . . . -106.82 137.11 45.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.274 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 1.052 ' HB3' ' C ' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.699 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' FDA . . . . . 0.791 ' H3B' ' HG2' ' A' ' 247' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.822 0.344 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.29 -70.44 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.512 HG22 ' N ' ' A' ' 5' ' ' SER . 3.9 mm 60.01 166.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 4' ' ' ILE . 11.7 p 171.64 118.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.843 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.428 ' CB ' ' O ' ' A' ' 5' ' ' SER . 1.0 OUTLIER 78.43 124.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.36 138.71 20.16 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.558 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -158.08 175.43 13.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.834 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.5 p -108.55 105.08 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 121.599 0.714 . . . . 0.0 111.137 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.47 18.6 5.73 Favored Glycine 0 C--N 1.315 -0.634 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.362 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -125.22 150.04 47.39 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.927 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.786 ' CZ ' HG11 ' A' ' 104' ' ' VAL . 1.5 p90 -133.79 166.73 21.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.789 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -103.77 137.33 41.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.249 0.547 . . . . 0.0 111.388 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.832 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -130.65 140.16 50.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.592 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . 2.3 tp10 -93.41 119.03 32.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.225 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 100' ' ' GLN . 9.9 m -71.34 107.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 17' ' ' VAL . 6.7 p -129.3 20.19 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.807 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -133.0 -128.73 2.92 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.639 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.878 HD21 ' CD1' ' A' ' 92' ' ' LEU . 0.1 OUTLIER 74.74 95.84 0.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.808 0.813 . . . . 0.0 109.407 -178.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -142.19 137.76 31.04 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.607 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -88.5 112.49 23.04 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.537 HG12 ' ND2' ' A' ' 20' ' ' ASN . 2.0 m -90.27 -30.65 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.712 0.768 . . . . 0.0 109.32 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.544 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 19.0 m -137.3 175.04 9.96 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.626 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.7 t -51.09 -53.41 34.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.071 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 0.8 OUTLIER -123.27 52.52 1.38 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.026 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.544 ' OG1' ' HB2' ' A' ' 23' ' ' SER . 0.2 OUTLIER -150.73 137.18 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.846 -179.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.659 HG12 HG13 ' A' ' 82' ' ' VAL . 2.0 p -141.27 147.15 22.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.119 0.485 . . . . 0.0 112.007 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.473 ' HG3' ' HG ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -119.98 113.63 20.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.154 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CB ' ' CZ ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -111.95 121.08 44.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.364 -179.259 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.561 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -102.67 119.49 38.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.329 179.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.023 HD22 HD23 ' A' ' 102' ' ' LEU . 1.2 mt -122.89 136.25 54.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 0.0 112.06 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 1.7 mt-30 -144.65 135.49 24.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.376 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.5 ' HG3' ' HB2' ' A' ' 15' ' ' GLU . 0.0 OUTLIER 166.21 -23.48 0.0 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.903 0.383 . . . . 0.0 111.962 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.621 ' HB3' ' CD1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -75.66 161.68 75.25 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.183 -179.098 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.681 ' HA ' ' HB2' ' A' ' 40' ' ' ASN . 73.9 Cg_endo -95.77 77.6 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.889 3.059 . . . . 0.0 112.953 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.485 ' N ' ' HD2' ' A' ' 34' ' ' ARG . 0.1 OUTLIER 170.35 -159.61 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 121.091 0.472 . . . . 0.0 111.807 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.748 ' HA ' HG12 ' A' ' 43' ' ' VAL . 23.3 mp0 -76.87 65.71 2.62 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.452 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.507 ' HG ' ' HZ ' ' A' ' 12' ' ' PHE . 4.8 t -174.87 -31.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.5 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 74' ' ' GLY . . . -157.88 24.78 0.42 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.217 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.681 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 64.3 t30 -132.47 39.58 3.36 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 117.822 0.811 . . . . 0.0 112.408 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.538 ' HA ' ' CA ' ' A' ' 73' ' ' GLU . 1.7 mpp_? 46.17 21.92 0.13 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.445 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.46 ' N ' ' C ' ' A' ' 40' ' ' ASN . . . -137.14 73.69 0.43 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.285 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.898 HG11 ' ND2' ' A' ' 68' ' ' ASN . 1.0 OUTLIER -118.66 165.66 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.013 0.435 . . . . 0.0 110.774 179.318 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -153.92 22.67 0.51 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.756 -178.318 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.61 ' CE1' ' HA ' ' A' ' 136' ' ' MET . 0.0 OUTLIER 58.21 127.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.538 -179.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.562 ' O ' ' N ' ' A' ' 48' ' ' GLY . 32.0 mt-10 -113.28 145.27 32.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.513 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 80.6 Cg_exo -45.11 81.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.63 2.22 . . . . 0.0 112.36 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 38.9 46.77 2.35 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.335 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.585 ' HA ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -71.88 151.18 43.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.622 0.249 . . . . 0.0 110.698 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.889 ' CG ' HM72 ' A' ' 252' ' ' FDA . 0.0 OUTLIER -133.31 163.21 29.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.96 0.409 . . . . 0.0 111.392 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.546 ' O ' ' CB ' ' A' ' 63' ' ' SER . 1.7 mtt -131.74 -167.82 1.93 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.699 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' A' ' 105' ' ' LYS . 7.9 t0 -133.39 115.32 14.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.969 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.932 HD23 ' O ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -149.6 157.39 43.21 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.872 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -109.97 150.87 27.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.737 179.319 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.808 HG23 ' HB2' ' A' ' 96' ' ' ALA . 1.5 mt -32.85 -77.12 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.828 ' HG2' HG23 ' A' ' 58' ' ' THR . 4.1 Cg_endo -96.01 9.31 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.199 1.932 . . . . 0.0 111.582 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 102.37 1.67 50.65 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.669 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.828 HG23 ' HG2' ' A' ' 56' ' ' PRO . 29.8 p -46.58 -104.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.661 0.267 . . . . 0.0 111.302 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.872 ' N ' HG21 ' A' ' 54' ' ' THR . 1.3 m-20 169.24 30.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.726 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.415 ' H ' ' CG2' ' A' ' 54' ' ' THR . 0.6 OUTLIER -140.89 34.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.684 0.278 . . . . 0.0 111.111 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.656 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 28.2 t -108.63 -104.17 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.901 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.455 ' CG ' ' O ' ' A' ' 61' ' ' SER . 0.3 OUTLIER 172.44 -169.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.42 . . . . 0.0 111.019 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 51' ' ' MET . 1.8 m -101.89 145.07 29.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.86 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.644 ' CE2' HG22 ' A' ' 80' ' ' ILE . 2.4 t80 -143.51 130.3 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -59.84 105.49 0.57 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.454 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.826 ' CB ' HD13 ' A' ' 76' ' ' LEU . 57.6 Cg_endo -90.34 131.93 1.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.648 2.232 . . . . 0.0 111.482 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 77' ' ' GLU . . . -144.28 138.61 28.07 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.898 ' ND2' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -113.21 -67.69 0.98 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.568 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER 151.03 150.5 0.0 OUTLIER Pre-proline 0 CA--C 1.521 -0.166 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.998 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.646 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 12.6 Cg_endo -56.75 96.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.719 1.613 . . . . 0.0 111.37 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.879 ' O ' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER 177.21 166.48 0.49 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-O 121.362 0.601 . . . . 0.0 112.053 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.531 ' CA ' ' O ' ' A' ' 41' ' ' ARG . 88.7 Cg_endo -90.5 73.64 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.347 2.698 . . . . 0.0 112.543 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' CA ' ' HA ' ' A' ' 41' ' ' ARG . 3.2 tp10 -129.19 -16.68 3.96 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.783 ' H ' HG13 ' A' ' 43' ' ' VAL . . . 42.46 78.78 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.23 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -155.96 112.85 3.18 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 120.738 0.304 . . . . 0.0 110.313 -178.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.826 HD13 ' CB ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -95.23 130.65 41.89 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.062 0.458 . . . . 0.0 110.275 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.746 ' N ' HD12 ' A' ' 76' ' ' LEU . 16.9 pt-20 -127.54 125.49 40.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.123 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.686 ' CD1' ' CG2' ' A' ' 80' ' ' ILE . 2.0 p90 -118.93 144.15 46.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.343 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.019 HD12 ' HB2' ' A' ' 131' ' ' ALA . 2.7 mt -112.6 74.97 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.73 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.686 ' CG2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -91.85 127.08 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.456 0.646 . . . . 0.0 111.085 -179.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.699 ' NH1' H61A ' A' ' 252' ' ' FDA . 0.7 OUTLIER -78.59 105.98 10.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.194 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.659 HG13 HG12 ' A' ' 27' ' ' VAL . 2.6 m -96.17 122.45 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.206 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.88 HD12 ' HB2' ' A' ' 87' ' ' ARG . 16.2 mt -41.28 168.52 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.98 0.419 . . . . 0.0 111.178 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 52.8 Cg_exo -54.53 -49.66 16.09 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.703 2.269 . . . . 0.0 112.361 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 84' ' ' PRO . 2.5 mt-10 176.29 61.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 87' ' ' ARG . . . -175.86 57.72 0.11 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.749 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.88 ' HB2' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER 170.34 -95.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.597 0.237 . . . . 0.0 111.135 179.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.631 ' CE1' HD11 ' A' ' 55' ' ' ILE . 2.8 t80 -93.64 -27.01 16.82 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 111.195 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 83' ' ' LEU . 80.4 p -73.16 -20.39 60.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 5.0 m-20 -74.22 -40.21 62.59 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.653 ' OH ' HG21 ' A' ' 58' ' ' THR . 0.9 OUTLIER -73.16 -21.14 60.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.867 178.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.957 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -65.76 -47.59 74.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.602 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -16.6 24.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.591 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 1.9 t-20 -99.82 1.71 43.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.561 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.511 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -171.1 22.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.957 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -138.56 28.39 2.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.235 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -51.51 -166.92 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.715 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.66 HG12 ' O ' ' A' ' 98' ' ' VAL . 2.1 t -125.21 95.96 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-O 121.463 0.649 . . . . 0.0 110.717 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 158.16 34.2 0.02 OUTLIER Glycine 0 C--N 1.316 -0.561 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.735 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.872 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -144.63 174.93 10.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.959 0.409 . . . . 0.0 111.198 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.5 p -105.59 143.74 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.466 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.023 HD23 HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -120.28 140.9 50.54 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.797 0.332 . . . . 0.0 110.986 -179.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.52 ' N ' HD12 ' A' ' 102' ' ' LEU . 4.3 m -100.34 115.2 29.41 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.876 HG23 HD12 ' A' ' 53' ' ' LEU . 1.1 t -105.26 133.72 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.626 ' O ' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -130.56 110.67 11.6 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.019 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.543 ' HA3' ' CB ' ' A' ' 51' ' ' MET . . . -123.75 84.08 0.36 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 119.597 -1.287 . . . . 0.0 114.924 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -91.72 30.05 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.126 2.551 . . . . 0.0 110.417 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -88.07 173.04 9.09 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.842 -178.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -114.59 174.71 15.62 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.317 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.793 HG23 ' HE2' ' A' ' 114' ' ' LYS . 35.9 m -107.62 107.45 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 117.91 0.855 . . . . 0.0 110.936 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.446 ' O ' ' HB2' ' A' ' 243' ' ' GLU . 55.5 m-85 -123.0 114.75 20.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.548 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 241' ' ' PHE . . . 142.85 -88.92 0.17 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.366 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.833 HD22 ' CZ ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -82.86 116.4 22.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 110.565 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.793 ' HE2' HG23 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -139.19 110.6 7.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.514 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.512 ' HB2' ' NH1' ' A' ' 121' ' ' ARG . 2.0 tt0 -95.21 138.63 32.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.67 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -103.06 9.53 38.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.453 . . . . 0.0 111.071 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.88 -79.02 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.559 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.492 ' HA ' ' HB3' ' A' ' 147' ' ' ASN . 5.9 mtp -130.18 90.14 2.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.87 0.367 . . . . 0.0 110.44 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 121' ' ' ARG . . . -159.53 146.04 12.34 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.435 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.479 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 42.7 Cg_endo -67.35 102.43 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.696 2.264 . . . . 0.0 111.24 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.544 ' HB2' ' CE2' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -124.1 147.01 48.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.353 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.653 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 3.3 m-85 -110.19 122.3 47.3 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.99 ' CE2' HG13 ' A' ' 133' ' ' VAL . 2.3 t80 -123.46 126.61 47.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.671 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -131.34 145.24 35.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.049 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.813 ' HB2' HG11 ' A' ' 133' ' ' VAL . . . -116.95 133.68 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.288 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -102.49 103.8 2.5 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.939 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.8 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 105.41 -161.81 14.56 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.875 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 79' ' ' LEU . 19.4 m -96.14 -10.4 28.3 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 110.791 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.643 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -67.25 11.34 0.75 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.393 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.826 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.8 OUTLIER -73.01 3.08 5.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 122.662 0.385 . . . . 0.0 110.279 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 1.019 ' HB2' HD12 ' A' ' 79' ' ' LEU . . . -45.96 -40.95 18.27 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.27 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 2.9 Cg_endo -78.46 -31.02 2.88 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.821 2.347 . . . . 0.0 110.279 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.008 ' O ' HG23 ' A' ' 137' ' ' VAL . 24.6 t -65.14 -43.82 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.828 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.826 HG13 ' HG ' ' A' ' 130' ' ' LEU . 33.8 m -70.26 -31.26 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.704 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -51.09 66.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.61 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -62.42 -46.91 86.45 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.172 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 133' ' ' VAL . 23.6 t -60.1 -30.63 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.108 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -62.77 -36.52 83.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.438 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.569 ' HG3' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -63.93 -42.65 97.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.448 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.635 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.0 OUTLIER -64.52 -34.25 77.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.771 0.796 . . . . 0.0 110.173 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.873 ' OE1' HD22 ' A' ' 170' ' ' LEU . 0.1 OUTLIER -79.36 -30.12 42.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.603 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -44.83 79.02 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.728 0.299 . . . . 0.0 111.356 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.802 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -82.46 -19.94 37.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.582 0.706 . . . . 0.0 109.718 179.026 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.501 ' O ' ' O ' ' A' ' 145' ' ' ALA . 5.1 m 51.61 29.45 5.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.268 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.802 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -37.22 162.3 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.824 0.345 . . . . 0.0 110.568 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.542 ' HD2' ' HB1' ' A' ' 145' ' ' ALA . 74.6 Cg_endo -78.79 13.32 1.96 Allowed 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.741 2.294 . . . . 0.0 112.955 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.492 ' HB3' ' HA ' ' A' ' 118' ' ' MET . 31.6 p-10 -91.35 136.71 32.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.153 0.502 . . . . 0.0 111.989 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 120' ' ' PRO . 3.6 pm0 -73.84 119.67 18.37 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.66 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 41.9 m -115.55 124.53 51.24 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.671 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.625 ' NE ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.4 131.17 47.63 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.845 178.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -127.19 109.08 19.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.43 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.69 ' O ' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -121.31 110.04 15.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.457 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.506 ' O ' ' SG ' ' A' ' 182' ' ' CYS . 0.3 OUTLIER -122.22 147.3 46.36 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.394 -178.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.867 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -148.82 171.4 29.13 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 119.606 -1.283 . . . . 0.0 114.224 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 1.0 HG21 HD22 ' A' ' 161' ' ' LEU . 3.0 m -167.72 -111.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.872 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.4 OUTLIER -124.36 -170.32 2.12 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 120.709 0.29 . . . . 0.0 111.414 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.782 HG23 ' N ' ' A' ' 187' ' ' SER . 49.5 p -27.04 -64.47 0.08 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.705 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 157' ' ' THR . 1.9 mt-10 152.26 -50.75 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.312 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 85.9 Cg_exo -38.85 -26.84 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.745 2.297 . . . . 0.0 112.511 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -87.93 -30.87 19.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.025 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.0 HD22 HG21 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -105.07 -172.5 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.0 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 0.5 OUTLIER 176.71 -155.56 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.071 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.553 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 77.4 9.58 2.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.632 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.985 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -57.74 -44.33 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 110.162 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.985 ' N ' HD13 ' A' ' 164' ' ' ILE . 2.4 m-20 -62.43 -28.09 69.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.111 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 163' ' ' TYR . 1.8 mt-10 -71.72 -47.41 54.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.837 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.553 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -62.34 -30.64 71.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.98 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 171' ' ' GLU . 13.2 mttm -60.41 -47.72 84.87 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -31.66 72.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.873 HD22 ' OE1' ' A' ' 141' ' ' GLN . 0.5 OUTLIER -65.15 -35.62 81.68 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.695 ' HA ' HD11 ' A' ' 177' ' ' LEU . 0.9 OUTLIER -62.96 -41.64 99.59 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.967 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.54 -37.65 59.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.397 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.5 t -65.34 -14.79 61.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.478 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.615 ' CG ' ' HB3' ' A' ' 177' ' ' LEU . 2.2 tpt -94.3 178.63 5.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.203 0.525 . . . . 0.0 111.311 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 6.0 tpp180 -96.18 -71.61 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.119 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.471 ' ND2' ' C ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -128.04 63.16 1.41 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.671 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.028 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -109.49 160.3 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.255 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 1.028 ' N ' HD22 ' A' ' 177' ' ' LEU . 1.8 m -137.55 121.95 18.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.117 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.613 HG23 ' HG2' ' A' ' 171' ' ' GLU . 53.7 t -90.06 135.71 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.167 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.539 ' CB ' ' HB3' ' A' ' 152' ' ' TYR . 3.2 tptp -108.47 130.27 55.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.687 0.28 . . . . 0.0 110.882 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.54 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -99.78 104.61 16.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 111.038 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.67 ' HB2' ' CA ' ' A' ' 154' ' ' GLY . 63.1 m -80.43 -157.87 0.17 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.956 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.872 HG21 ' O ' ' A' ' 156' ' ' ASN . 22.5 t 57.66 143.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.485 0.66 . . . . 0.0 111.166 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.737 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -130.16 -59.82 1.03 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.916 -178.005 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.579 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 0.1 OUTLIER -168.06 51.84 0.22 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.692 178.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.624 ' O ' ' CB ' ' A' ' 187' ' ' SER . 96.2 Cg_endo -89.87 -98.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.967 2.445 . . . . 0.0 112.876 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.782 ' N ' HG23 ' A' ' 157' ' ' THR . 23.6 t 139.6 3.41 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.454 0.471 . . . . 0.0 112.199 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.62 ' HA3' ' N1A' ' A' ' 252' ' ' FDA . . . 124.22 11.47 4.69 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.539 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.31 62.4 1.59 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.569 ' CE3' ' N ' ' A' ' 191' ' ' GLU . 4.5 t-105 -129.86 116.25 18.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.387 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.569 ' N ' ' CE3' ' A' ' 190' ' ' TRP . 0.9 OUTLIER -91.52 103.83 16.39 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.874 ' CA ' ' HB2' ' A' ' 251' ' ' ALA . . . 143.06 -123.82 2.2 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.344 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.869 ' OE2' HD11 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -163.1 -93.92 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.592 ' O ' ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -87.56 120.72 29.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 194' ' ' GLN . . . 5.14 107.3 0.0 OUTLIER Glycine 0 C--N 1.35 1.321 0 O-C-N 123.735 0.647 . . . . 0.0 112.748 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER 11.98 -73.11 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.7 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 196' ' ' SER . 75.3 Cg_exo -22.67 68.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.845 3.697 . . . . 0.0 114.535 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.869 HD11 ' OE2' ' A' ' 193' ' ' GLU . 0.3 OUTLIER -88.28 14.49 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.416 0.627 . . . . 0.0 110.311 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.485 ' HA ' ' HG3' ' A' ' 202' ' ' ARG . 0.2 OUTLIER -59.43 -36.24 75.53 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.911 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -58.72 -31.37 68.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.673 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.517 ' O ' ' CD2' ' A' ' 205' ' ' LEU . 0.2 OUTLIER -69.27 -34.15 74.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.154 0.502 . . . . 0.0 110.27 179.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.736 ' HG2' HD13 ' A' ' 229' ' ' LEU . 46.8 mtt180 -60.1 -45.72 92.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.325 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.74 -32.78 71.51 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.946 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 207' ' ' SER . 88.6 m-20 -58.95 -43.76 91.31 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.019 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.628 HD12 ' HD2' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -60.59 -45.86 92.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.414 ' CD ' ' HG3' ' A' ' 233' ' ' ARG . 1.1 mt-10 -62.15 -25.6 67.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.487 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 208' ' ' SER . 1.1 t -70.81 -86.71 0.02 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.157 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.41 ' N ' ' OG ' ' A' ' 207' ' ' SER . 0.5 OUTLIER 178.31 30.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.517 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.695 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 1.8 m-20 -148.87 60.98 1.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.779 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 0.789 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 155.96 97.22 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.655 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.762 ' HB2' HD13 ' A' ' 235' ' ' ILE . 17.6 t30 174.39 -56.53 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.992 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 27.5 Cg_endo -62.08 -50.49 4.86 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.477 2.118 . . . . 0.0 111.208 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.533 ' CB ' ' OH ' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -132.44 109.97 10.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.181 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.951 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.9 OUTLIER -123.26 125.42 71.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.583 ' CZ ' ' O ' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -123.06 127.5 48.84 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.76 0.791 . . . . 0.0 112.007 -177.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.486 ' O ' HD11 ' A' ' 223' ' ' ILE . 0.9 OUTLIER -134.97 115.36 13.46 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.716 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 1.8 t -124.64 112.81 17.22 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.55 ' N ' ' CD ' ' A' ' 219' ' ' PRO . . . 112.83 -40.08 2.65 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.285 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.575 ' HB2' ' CB ' ' A' ' 222' ' ' MET . 55.7 Cg_endo -91.84 83.9 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.618 2.212 . . . . 0.0 113.562 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.853 ' HD2' ' HB2' ' A' ' 250' ' ' ALA . 9.9 Cg_endo -52.03 -70.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.689 2.26 . . . . 0.0 111.587 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.84 ' H ' ' HB1' ' A' ' 250' ' ' ALA . . . -53.35 -48.17 60.46 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.836 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.575 ' CB ' ' HB2' ' A' ' 219' ' ' PRO . 0.2 OUTLIER -55.66 -25.14 37.88 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.594 HD11 ' H ' ' A' ' 243' ' ' GLU . 0.0 OUTLIER -75.84 -37.45 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.387 178.382 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -70.35 -46.67 63.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.849 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.564 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -70.18 -47.62 60.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.281 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.883 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -59.73 -39.97 86.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.329 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.3 t -70.28 -31.92 69.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.16 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -44.65 77.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.831 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.736 HD13 ' HG2' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -60.52 -35.93 77.16 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.108 0.48 . . . . 0.0 110.453 179.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 226' ' ' ALA . 2.8 t -65.68 -44.89 93.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.035 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.5 mtt85 -73.48 -30.3 63.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.0 -44.08 32.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.628 ' HD2' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -55.99 -59.69 4.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.989 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 137.65 -50.9 0.8 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.214 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.762 HD13 ' HB2' ' A' ' 211' ' ' ASN . 0.7 OUTLIER -34.99 94.84 0.08 OUTLIER Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.128 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 28.1 Cg_endo -62.7 127.47 20.71 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.825 2.35 . . . . 0.0 112.225 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -95.31 -175.33 37.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.687 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -157.47 -40.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 110.622 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.576 ' O ' ' CE2' ' A' ' 241' ' ' PHE . 8.3 mm-40 -110.73 42.38 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.336 0.589 . . . . 0.0 110.48 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.951 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.4 t -91.64 137.52 21.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.652 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -141.69 140.73 33.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.159 -178.301 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.544 ' CB ' HG12 ' A' ' 223' ' ' ILE . 5.6 p90 -131.14 139.27 49.77 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.296 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . 0.594 ' H ' HD11 ' A' ' 223' ' ' ILE . 0.8 OUTLIER -131.79 148.74 52.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.036 179.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 220' ' ' PRO . 1.9 mptt -124.03 105.71 9.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.643 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.2 OUTLIER -138.02 145.84 42.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 178.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.573 HD21 ' O2 ' ' A' ' 252' ' ' FDA . 5.2 mt 67.83 163.99 0.13 Allowed Pre-proline 0 N--CA 1.468 0.461 0 CA-C-O 120.81 0.338 . . . . 0.0 111.294 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.478 ' CD ' HD22 ' A' ' 246' ' ' LEU . 54.9 Cg_endo -86.41 -103.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.284 2.656 . . . . 0.0 112.111 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 247' ' ' PRO . 32.3 m -37.93 137.29 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.013 0.435 . . . . 0.0 110.547 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . 124.76 -15.38 7.5 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.853 ' HB2' ' HD2' ' A' ' 220' ' ' PRO . . . -107.49 110.76 22.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.957 -0.621 . . . . 0.0 111.515 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.874 ' HB2' ' CA ' ' A' ' 192' ' ' GLY . . . . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.108 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' FDA . . . . . 0.889 HM72 ' CG ' ' A' ' 50' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.3 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.828 0.346 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.97 16.31 5.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.809 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 tt -148.81 132.58 8.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.044 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.406 ' OG ' ' N ' ' A' ' 6' ' ' PHE . 29.4 t -56.86 -179.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.933 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' N ' ' OG ' ' A' ' 5' ' ' SER . 80.5 m-85 59.23 158.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.975 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.08 -81.35 1.2 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.57 26.57 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.921 0.391 . . . . 0.0 110.906 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.35 99.76 7.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.05 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.454 ' C ' ' HG3' ' A' ' 105' ' ' LYS . . . -157.17 20.29 0.41 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.637 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.529 ' CB ' ' HB2' ' A' ' 105' ' ' LYS . 25.4 t -123.48 150.04 44.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.845 0.355 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.789 ' CZ ' ' HB2' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -133.01 165.37 24.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.15 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.515 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 2.0 mp0 -105.98 133.08 51.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.134 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.791 ' HB1' ' HB3' ' A' ' 31' ' ' LEU . . . -123.23 144.29 49.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.727 0.299 . . . . 0.0 111.012 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 32' ' ' GLN . 1.2 pt-20 -93.58 120.75 34.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.811 0.338 . . . . 0.0 110.123 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.961 HG22 ' O ' ' A' ' 100' ' ' GLN . 3.9 m -71.67 105.74 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.252 0.549 . . . . 0.0 111.06 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.93 -33.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.018 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 19' ' ' LEU . . . -79.18 -129.02 0.61 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.03 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.785 HD23 ' CB ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER 71.39 95.53 0.07 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.978 0.894 . . . . 0.0 109.747 -179.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.722 HD21 HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -142.32 143.22 32.67 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.858 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.535 ' NE1' ' HD3' ' A' ' 93' ' ' ARG . 3.3 m0 -88.43 113.16 23.74 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.722 HG12 HD21 ' A' ' 20' ' ' ASN . 2.0 m -92.05 -29.9 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-O 121.747 0.784 . . . . 0.0 108.963 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.552 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 12.0 m -137.6 173.83 11.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.471 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.535 ' CB ' ' HG2' ' A' ' 160' ' ' GLU . 18.6 t -53.51 -53.34 52.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.095 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 82' ' ' VAL . 98.6 m-20 -119.19 47.6 1.65 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.397 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 1.008 ' CG2' HG21 ' A' ' 128' ' ' THR . 0.2 OUTLIER -149.02 140.97 23.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.735 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.591 ' CG2' HD13 ' A' ' 19' ' ' LEU . 1.4 p -140.34 147.4 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.144 0.497 . . . . 0.0 112.087 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.496 ' HG3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -113.8 105.26 13.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.932 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -100.07 128.69 46.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.882 -178.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 6.9 mp -118.35 116.86 27.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.899 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.791 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 5.1 mt -114.03 133.84 55.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.029 0.442 . . . . 0.0 112.054 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.516 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -144.27 136.71 26.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.648 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -170.43 -94.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.707 0.289 . . . . 0.0 111.586 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.565 ' N ' ' CD ' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -48.01 -47.53 64.49 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 121.118 0.485 . . . . 0.0 110.185 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.638 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 91.2 Cg_endo -80.89 -142.1 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.015 2.477 . . . . 0.0 111.531 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 74' ' ' GLY . 0.2 OUTLIER -138.17 -162.64 1.33 Allowed 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.879 -0.513 . . . . 0.0 110.182 179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.504 ' C ' ' CG ' ' A' ' 75' ' ' ARG . 5.1 pt-20 -98.06 65.01 1.72 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.589 ' N ' ' CG ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -170.55 1.93 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -178.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.827 ' CA ' HG22 ' A' ' 43' ' ' VAL . . . 163.53 90.6 0.08 OUTLIER Glycine 0 C--O 1.218 -0.897 0 C-N-CA 118.544 -1.789 . . . . 0.0 115.127 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.604 ' CA ' ' HA2' ' A' ' 74' ' ' GLY . 60.5 t-20 -25.35 115.2 0.05 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 49.09 27.62 1.8 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.955 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.672 ' HA2' ' HA ' ' A' ' 72' ' ' PRO . . . 76.01 86.38 0.34 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.698 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.921 HG21 ' CG ' ' A' ' 68' ' ' ASN . 0.6 OUTLIER -94.75 170.46 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.356 0.598 . . . . 0.0 111.66 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.542 ' HG2' ' CD1' ' A' ' 45' ' ' PHE . 5.9 ttpt -148.57 -141.63 0.11 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.689 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.542 ' CD1' ' HG2' ' A' ' 44' ' ' LYS . 48.6 p90 -95.06 56.46 1.94 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.282 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.6 OUTLIER -114.21 127.61 26.65 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 48' ' ' GLY . 63.3 Cg_exo -32.01 84.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.842 2.361 . . . . 0.0 112.111 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 33.32 73.06 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.889 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.504 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -32.66 154.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.906 0.353 . . . . 0.0 110.851 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 1.031 ' CD2' HM72 ' A' ' 252' ' ' FDA . 1.3 m-85 -122.92 163.23 20.74 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.561 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -133.06 162.82 30.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.47 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 105' ' ' LYS . 2.8 t0 -122.66 109.29 14.09 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 110.249 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.73 ' CD1' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -150.16 158.9 44.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.53 0.681 . . . . 0.0 112.225 -178.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.772 HG21 ' N ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -103.09 151.0 23.06 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.455 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.983 HG23 ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -32.32 -68.62 0.15 Allowed Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.72 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.983 ' HD3' HG23 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -103.89 2.27 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.926 2.417 . . . . 0.0 111.144 177.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 58' ' ' THR . . . 109.9 -0.07 30.26 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.084 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.828 HG23 ' CD ' ' A' ' 56' ' ' PRO . 30.4 p -31.16 -98.47 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.515 0.326 . . . . 0.0 111.449 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.772 ' N ' HG21 ' A' ' 54' ' ' THR . 10.1 p-10 160.5 31.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.71 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 59' ' ' ASP . 2.7 t -158.8 40.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.044 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.698 ' HB3' ' HA ' ' A' ' 54' ' ' THR . 45.4 t -107.66 -103.34 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 53' ' ' LEU . 4.7 mtm180 172.77 -174.36 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.99 0.424 . . . . 0.0 111.037 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 51' ' ' MET . 0.5 OUTLIER -105.33 123.95 48.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.636 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 78' ' ' PHE . 1.2 t80 -107.36 126.14 52.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.819 0.343 . . . . 0.0 110.633 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.671 ' CB ' ' CD2' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -63.78 104.94 0.57 Allowed Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.791 -179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.942 ' HB3' HD13 ' A' ' 76' ' ' LEU . 7.2 Cg_exo -73.25 152.74 50.52 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.528 2.152 . . . . 0.0 110.861 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.4 128.53 52.3 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.921 ' CG ' HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -135.71 -81.11 0.41 Allowed 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.631 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.66 HD22 ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER 146.59 171.65 0.0 OUTLIER Pre-proline 0 C--N 1.339 0.134 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.156 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 69' ' ' LEU . 29.4 Cg_endo -63.63 88.26 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 121.654 1.569 . . . . 0.0 111.858 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.559 ' ND2' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -170.41 139.29 1.42 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 111.173 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.672 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 91.5 Cg_endo -86.8 67.13 4.48 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.942 2.428 . . . . 0.0 114.541 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.638 ' O ' ' HB2' ' A' ' 35' ' ' PRO . 37.2 mp0 -136.77 -116.26 0.17 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.636 ' HA3' ' HB2' ' A' ' 35' ' ' PRO . . . -166.69 71.61 0.17 Allowed Glycine 0 CA--C 1.543 1.829 0 N-CA-C 116.114 1.206 . . . . 0.0 116.114 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.589 ' CG ' ' N ' ' A' ' 38' ' ' CYS . 0.1 OUTLIER -121.72 82.0 1.89 Allowed 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.275 1.537 . . . . 0.0 110.296 178.345 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.942 HD13 ' HB3' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -97.17 129.3 44.55 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.333 0.587 . . . . 0.0 111.447 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.718 ' N ' HD12 ' A' ' 76' ' ' LEU . 3.5 mt-10 -130.77 121.17 24.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.739 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 29' ' ' PHE . 1.3 p90 -114.86 140.55 48.87 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.968 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.103 HD22 ' HB2' ' A' ' 131' ' ' ALA . 0.7 OUTLIER -102.44 84.1 2.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.613 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -90.37 139.94 16.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.728 -177.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.684 ' HB3' ' H8A' ' A' ' 252' ' ' FDA . 0.0 OUTLIER -78.05 112.03 14.56 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG23 ' N ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -105.9 138.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.783 -178.277 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.729 HD11 ' H4B' ' A' ' 252' ' ' FDA . 9.0 mt -101.4 158.55 31.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.768 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 83' ' ' LEU . 26.2 Cg_endo -62.06 67.71 0.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.673 2.249 . . . . 0.0 112.023 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 83' ' ' LEU . 29.2 mm-40 75.63 53.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.647 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.14 -97.19 1.35 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.665 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -125.57 -48.46 1.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.67 0.271 . . . . 0.0 111.157 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.592 ' CZ ' ' HA ' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -85.52 -32.95 21.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 0.0 110.859 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.582 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 3.3 p -70.01 -20.58 63.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.28 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 9.9 m-20 -77.25 -34.12 55.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.31 0.576 . . . . 0.0 110.867 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.961 ' HB2' HD11 ' A' ' 55' ' ' ILE . 35.0 t80 -73.51 -51.41 17.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.93 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.968 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -70.97 -29.63 65.68 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.074 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.535 ' HD3' ' NE1' ' A' ' 21' ' ' TRP . 8.4 mtm180 -90.55 -27.46 19.13 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.81 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 1.9 t-20 -102.56 -5.45 23.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.702 0.287 . . . . 0.0 110.845 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 91' ' ' TYR . 2.9 t70 -130.22 -23.47 2.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.968 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -96.51 28.67 3.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.15 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 7.2 mmm180 -97.03 -47.4 5.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.045 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.795 HG13 ' CG ' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -72.95 -1.17 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.864 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.662 ' HA2' HG23 ' A' ' 16' ' ' VAL . . . 77.05 20.41 75.82 Favored Glycine 0 C--N 1.32 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.047 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.961 ' O ' HG22 ' A' ' 16' ' ' VAL . 25.0 mt-30 -47.96 179.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 111.186 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.439 ' CG1' ' O ' ' A' ' 14' ' ' ALA . 2.1 t -109.54 139.77 31.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.977 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.73 HD11 ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -130.09 126.21 37.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.298 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.483 ' HB2' ' HG3' ' A' ' 13' ' ' GLU . 1.5 t -94.78 140.47 29.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 111.915 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.716 HG22 ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -115.91 142.22 30.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.901 178.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 25.6 ttpp -131.63 113.23 13.36 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.192 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 50' ' ' PHE . . . 162.49 98.38 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 118.921 -1.609 . . . . 0.0 114.592 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -92.9 29.95 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.414 2.743 . . . . 0.0 110.014 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -88.61 166.74 13.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.466 -177.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.59 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -146.07 171.78 26.89 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.354 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.869 HG12 ' CZ ' ' A' ' 50' ' ' PHE . 3.5 p -158.05 121.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.222 0.534 . . . . 0.0 111.067 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -70.1 135.93 49.72 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.508 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -146.66 -41.09 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.942 HD13 ' CE2' ' A' ' 123' ' ' PHE . 1.4 pt? -133.27 119.51 19.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.166 0.508 . . . . 0.0 110.432 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.651 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.4 OUTLIER -137.93 114.79 10.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.452 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.47 ' HA ' ' OH ' ' A' ' 215' ' ' TYR . 7.5 pm0 -83.62 140.62 32.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.693 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.41 15.01 5.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.746 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.82 -78.06 0.25 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.9 mtt -130.04 89.92 2.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.85 0.357 . . . . 0.0 110.153 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 121' ' ' ARG . . . -165.6 150.84 8.03 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.455 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 47.6 Cg_endo -68.75 104.83 1.21 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.806 2.337 . . . . 0.0 112.078 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.657 HH12 HG23 ' A' ' 149' ' ' THR . 0.0 OUTLIER -120.81 146.66 46.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.692 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.673 ' HB3' ' CZ ' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -115.52 141.05 48.58 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.168 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 1.123 ' CE2' HG13 ' A' ' 133' ' ' VAL . 1.1 t80 -122.42 117.16 25.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.866 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.745 HG23 ' CD1' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -106.2 113.29 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.365 0.602 . . . . 0.0 111.943 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.577 ' HB2' HG11 ' A' ' 133' ' ' VAL . . . -100.83 133.12 45.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.201 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.526 ' O ' HD11 ' A' ' 246' ' ' LEU . . . -112.47 103.62 1.48 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.643 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.861 ' HA3' HD21 ' A' ' 246' ' ' LEU . . . 106.31 -156.57 16.24 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.621 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.008 HG21 ' CG2' ' A' ' 26' ' ' THR . 8.6 m -100.35 -17.01 17.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.955 0.407 . . . . 0.0 111.132 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -63.71 10.1 0.23 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.098 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.565 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -77.86 3.62 13.95 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.895 0.348 . . . . 0.0 110.08 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 1.103 ' HB2' HD22 ' A' ' 79' ' ' LEU . . . -46.75 -43.96 42.25 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.966 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 2.8 Cg_exo -74.02 -30.74 8.68 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.933 2.422 . . . . 0.0 110.399 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.123 HG13 ' CE2' ' A' ' 123' ' ' PHE . 10.7 t -64.64 -46.82 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.601 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.565 HG13 ' HG ' ' A' ' 130' ' ' LEU . 19.3 m -66.86 -30.75 50.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.21 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -66.72 -50.82 61.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.859 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.782 ' HG3' HD21 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -63.88 -39.07 93.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.029 178.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 133' ' ' VAL . 27.7 t -62.61 -44.8 99.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.333 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -60.9 -31.04 70.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.229 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 136' ' ' MET . 75.2 mt-30 -63.47 -41.74 98.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.485 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.809 ' HG3' ' HB3' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -57.68 -51.98 67.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.687 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.57 ' OE1' HD21 ' A' ' 170' ' ' LEU . 1.7 mp0 -69.23 -33.46 73.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.701 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -80.89 -12.25 59.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.983 0.42 . . . . 0.0 111.012 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.671 ' C ' HG22 ' A' ' 144' ' ' THR . 3.8 m95 -89.21 -85.05 0.21 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.303 0.573 . . . . 0.0 111.554 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.671 HG22 ' C ' ' A' ' 143' ' ' TRP . 0.6 OUTLIER -174.69 26.52 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.652 -178.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.809 ' HB3' ' HG3' ' A' ' 140' ' ' MET . . . -111.81 54.39 0.42 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.388 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.526 ' O ' ' CB ' ' A' ' 175' ' ' ARG . 57.7 Cg_endo -70.75 -1.56 9.48 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.663 2.242 . . . . 0.0 112.132 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.501 ' C ' ' ND2' ' A' ' 176' ' ' ASN . 0.7 OUTLIER -50.43 -169.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.07 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 120' ' ' PRO . 1.2 mt-10 -71.87 105.2 3.72 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.586 0.707 . . . . 0.0 110.294 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.657 HG23 HH12 ' A' ' 121' ' ' ARG . 98.8 m -117.43 117.38 29.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.595 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.657 ' CD ' ' CZ ' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -102.73 135.72 43.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.091 0.472 . . . . 0.0 110.493 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.658 HD13 ' O ' ' A' ' 123' ' ' PHE . 0.3 OUTLIER -133.19 109.72 14.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.033 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.745 ' CD1' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -107.1 109.27 21.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.646 ' HZ ' HD11 ' A' ' 161' ' ' LEU . 2.1 t80 -111.91 145.39 39.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.586 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.717 ' O ' HG13 ' A' ' 155' ' ' VAL . . . -162.0 167.01 36.52 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.63 -1.748 . . . . 0.0 114.717 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 1.078 HG21 HD13 ' A' ' 161' ' ' LEU . 17.0 m -164.95 -119.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 114.471 -0.865 . . . . 0.0 110.998 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.864 ' O ' HG21 ' A' ' 183' ' ' VAL . 1.4 p30 -112.55 -171.38 1.85 Allowed 'General case' 0 C--N 1.343 0.284 0 O-C-N 122.243 -0.285 . . . . 0.0 111.118 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.573 ' CG2' ' HA ' ' A' ' 187' ' ' SER . 0.2 OUTLIER -32.01 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.768 0.318 . . . . 0.0 111.071 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 19.5 mt-10 89.05 39.1 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.305 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 24.8 Cg_endo -62.22 -25.97 77.25 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 C-N-CA 122.296 1.997 . . . . 0.0 110.698 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.535 ' HG2' ' CB ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -121.73 -28.15 4.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.045 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.078 HD13 HG21 ' A' ' 155' ' ' VAL . 5.3 tp -40.41 165.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.783 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 163' ' ' TYR . 0.0 OUTLIER 177.38 -153.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.926 0.393 . . . . 0.0 111.079 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.524 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER 72.33 7.68 5.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.361 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.976 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -59.72 -41.81 86.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.976 ' N ' HD13 ' A' ' 164' ' ' ILE . 18.5 m-20 -61.88 -27.84 69.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.179 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.509 ' HG3' ' CD1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -72.33 -41.85 66.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.994 179.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -71.5 -31.53 67.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.075 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.505 ' HD3' ' HA ' ' A' ' 165' ' ' ASP . 14.1 mtpp -61.3 -46.36 90.65 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 6.0 m -63.0 -31.87 73.11 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.57 HD21 ' OE1' ' A' ' 141' ' ' GLN . 1.0 OUTLIER -62.9 -36.67 84.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 1.01 ' HG2' HD11 ' A' ' 177' ' ' LEU . 3.6 mt-10 -63.04 -41.0 99.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.203 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -33.98 47.73 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.09 -6.59 53.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.022 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.694 ' CB ' HD23 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -106.29 -168.64 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.032 0.444 . . . . 0.0 111.242 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' A' ' 146' ' ' PRO . 6.9 ttt-85 -103.26 -64.43 1.08 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.901 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.501 ' ND2' ' C ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -139.91 66.37 1.4 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.431 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.01 HD11 ' HG2' ' A' ' 171' ' ' GLU . 0.6 OUTLIER -106.65 153.68 22.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.6 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.506 ' HB ' ' HG3' ' A' ' 150' ' ' ARG . 40.9 m -136.08 115.12 12.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.278 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 151' ' ' ILE . 8.8 p -89.66 135.1 26.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.658 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.38 133.92 47.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.101 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.551 ' O ' ' CG ' ' A' ' 194' ' ' GLN . . . -98.66 104.26 16.28 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.463 0.649 . . . . 0.0 110.541 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.631 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 95.6 m -80.71 -167.44 1.38 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.186 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.864 HG21 ' O ' ' A' ' 156' ' ' ASN . 77.2 t 64.33 148.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.689 0.757 . . . . 0.0 111.822 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.717 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -133.45 -61.12 0.82 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.288 -178.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.539 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 2.6 m170 -174.95 53.38 0.12 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.728 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.581 ' HG2' ' HA ' ' A' ' 156' ' ' ASN . 91.3 Cg_endo -86.88 -98.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.922 2.414 . . . . 0.0 112.632 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.573 ' HA ' ' CG2' ' A' ' 157' ' ' THR . 0.4 OUTLIER 156.35 -0.63 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.613 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 124.04 11.18 4.89 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.356 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.8 63.26 1.55 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.507 ' CE3' ' N ' ' A' ' 191' ' ' GLU . 1.8 t-105 -127.46 108.81 11.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.455 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.703 ' C ' ' HB3' ' A' ' 251' ' ' ALA . 0.2 OUTLIER -98.55 104.86 16.94 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.56 178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.673 ' CA ' ' HB3' ' A' ' 251' ' ' ALA . . . 164.84 -76.28 0.15 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.734 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.835 ' OE2' ' HB1' ' A' ' 250' ' ' ALA . 1.1 mt-10 148.03 -100.14 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.551 ' CG ' ' O ' ' A' ' 181' ' ' ALA . 0.0 OUTLIER -87.09 131.91 33.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.656 ' CA ' ' CD1' ' A' ' 184' ' ' TRP . . . -31.02 105.28 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 C-N-CA 119.888 -1.148 . . . . 0.0 111.962 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.525 ' CB ' ' CD ' ' A' ' 197' ' ' PRO . 0.3 OUTLIER 162.57 -178.44 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.305 -0.447 . . . . 0.0 111.301 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.525 ' CD ' ' CB ' ' A' ' 196' ' ' SER . 69.7 Cg_endo -91.3 -1.15 4.73 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.168 2.579 . . . . 0.0 114.05 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.137 HD12 HD21 ' A' ' 201' ' ' LEU . 0.2 OUTLIER 75.64 33.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 122.669 1.223 . . . . 0.0 109.522 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.498 ' OD1' ' NE ' ' A' ' 202' ' ' ARG . 0.2 OUTLIER -78.29 -33.54 49.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.579 -1.192 . . . . 0.0 112.492 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -56.61 -44.78 81.49 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 1.137 HD21 HD12 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -65.79 -31.2 72.03 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.399 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.773 ' CD ' HD22 ' A' ' 229' ' ' LEU . 18.6 mtm180 -57.71 -48.71 78.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.429 0.633 . . . . 0.0 110.265 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.19 -32.66 67.01 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.313 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -59.4 -40.92 88.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.598 ' CB ' HD11 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -60.69 -47.75 84.85 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -20.67 66.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.946 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.97 12.35 27.1 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.677 0.275 . . . . 0.0 111.425 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 209' ' ' ASP . 0.7 OUTLIER 72.24 100.11 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.87 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.661 ' O ' ' HB3' ' A' ' 210' ' ' ALA . 0.9 OUTLIER 155.47 86.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 0.775 ' HB1' HD11 ' A' ' 214' ' ' ILE . . . 96.32 102.17 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.281 0.562 . . . . 0.0 110.381 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.674 ' O ' HG23 ' A' ' 240' ' ' VAL . 4.5 t-20 174.45 -55.53 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.888 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 10.0 Cg_endo -51.01 -48.0 23.04 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.199 1.933 . . . . 0.0 110.58 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.68 108.41 8.52 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.893 ' HB ' HG22 ' A' ' 240' ' ' VAL . 1.0 OUTLIER -121.26 125.43 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.67 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -121.03 127.16 51.47 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.804 -178.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.557 HD22 HG11 ' A' ' 124' ' ' VAL . 3.0 mt -138.44 115.88 11.23 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.622 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . 0.531 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 1.0 OUTLIER -125.84 119.66 28.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.582 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.594 ' HA2' ' CG ' ' A' ' 245' ' ' PHE . . . 115.29 -48.8 0.9 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.779 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.861 ' CB ' ' HB3' ' A' ' 250' ' ' ALA . 97.8 Cg_endo -80.51 110.01 2.37 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.424 2.083 . . . . 0.0 113.549 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.488 ' O ' ' HB ' ' A' ' 223' ' ' ILE . 16.0 Cg_exo -66.72 -45.35 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.718 2.279 . . . . 0.0 110.825 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.49 -38.35 90.65 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.589 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.828 ' O ' ' HB3' ' A' ' 226' ' ' ALA . 3.6 tpt -56.08 -25.27 44.7 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.577 HG13 ' CB ' ' A' ' 242' ' ' PHE . 0.0 OUTLIER -69.09 -45.49 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.12 178.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 223' ' ' ILE . 69.8 m-20 -75.04 -47.78 27.25 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.531 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.557 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -77.34 -50.24 13.24 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.842 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -59.84 -40.1 87.38 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.436 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 223' ' ' ILE . 42.5 t -69.95 -30.86 68.33 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 232' ' ' SER . 3.5 mm-40 -69.61 -44.62 70.31 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.578 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.773 HD22 ' CD ' ' A' ' 202' ' ' ARG . 0.0 OUTLIER -60.06 -37.92 81.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.002 0.429 . . . . 0.0 110.658 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 226' ' ' ALA . 2.3 t -64.19 -45.34 96.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.181 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -30.19 61.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.059 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.506 ' OG ' ' NH1' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -75.48 -46.22 33.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.181 0.515 . . . . 0.0 111.258 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.563 ' CG ' HD12 ' A' ' 205' ' ' LEU . 0.0 OUTLIER -58.91 -51.1 71.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.026 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 236' ' ' PRO . . . 125.34 -52.48 0.8 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.098 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.598 HD11 ' CB ' ' A' ' 205' ' ' LEU . 0.9 OUTLIER -36.04 95.73 0.1 OUTLIER Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-O 121.08 0.467 . . . . 0.0 111.128 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 234' ' ' GLY . 31.8 Cg_endo -64.16 119.61 6.7 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.897 2.398 . . . . 0.0 112.47 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -90.75 176.71 41.38 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.45 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.7 -40.25 0.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 0.0 111.081 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.581 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 21.0 mm100 -105.64 36.03 2.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.017 0.437 . . . . 0.0 110.67 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.893 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.1 t -89.19 136.5 23.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.322 0.582 . . . . 0.0 111.062 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.651 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.6 OUTLIER -144.92 138.02 26.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.94 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.577 ' CB ' HG13 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -129.52 130.39 45.73 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.081 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . 0.489 ' CA ' HD11 ' A' ' 223' ' ' ILE . 0.3 OUTLIER -132.65 149.39 52.3 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.543 179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 244' ' ' LYS . 1.7 ptmm? -129.08 115.0 17.07 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.594 ' CG ' ' HA2' ' A' ' 218' ' ' GLY . 0.5 OUTLIER -137.42 146.86 44.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.171 179.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.861 HD21 ' HA3' ' A' ' 127' ' ' GLY . 0.2 OUTLIER 57.61 174.3 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.477 0 C-N-CA 122.922 0.489 . . . . 0.0 111.731 -178.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 246' ' ' LEU . 75.9 Cg_exo -52.78 -141.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.371 2.714 . . . . 0.0 113.643 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 190' ' ' TRP . 2.4 p -81.4 177.25 9.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.485 0.66 . . . . 0.0 112.085 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 163.2 -71.0 0.21 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.578 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.861 ' HB3' ' CB ' ' A' ' 219' ' ' PRO . . . -107.74 149.64 27.92 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.703 ' HB3' ' C ' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.46 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' FDA . . . . . 1.031 HM72 ' CD2' ' A' ' 50' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.782 0.325 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.711 ' O ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -141.87 144.58 33.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.797 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.711 HD13 ' O ' ' A' ' 3' ' ' ARG . 20.4 mm -149.82 46.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.198 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.13 173.75 8.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.782 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.45 147.64 30.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.976 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.96 -167.35 11.04 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.467 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.8 mp0 -66.14 128.61 36.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 110.947 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 t -121.99 101.14 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.102 0.477 . . . . 0.0 110.982 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.11 25.23 29.06 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.443 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.521 ' CB ' ' HB2' ' A' ' 105' ' ' LYS . 83.9 p -95.71 153.87 17.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.821 0.343 . . . . 0.0 110.892 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.939 ' CE2' ' HB2' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -132.05 156.88 45.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.916 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.61 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 1.6 mt-10 -106.04 121.79 44.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.939 ' HB2' ' CE2' ' A' ' 12' ' ' PHE . . . -126.73 127.69 45.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.183 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.487 ' OE1' HG22 ' A' ' 101' ' ' VAL . 4.2 tp10 -93.41 128.08 39.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.899 0.38 . . . . 0.0 110.697 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.061 HG22 ' O ' ' A' ' 100' ' ' GLN . 28.0 m -71.88 106.14 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.091 0.472 . . . . 0.0 111.096 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 17' ' ' VAL . 2.4 p -127.2 2.31 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.314 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -120.14 -128.86 3.71 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.526 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.885 ' CD2' HG21 ' A' ' 27' ' ' VAL . 0.2 OUTLIER 82.49 58.77 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.329 0.585 . . . . 0.0 110.063 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.543 ' ND2' HG12 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -95.63 145.42 25.27 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.669 -179.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -88.69 113.86 24.69 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG12 ' ND2' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -97.3 -27.59 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.554 ' HB2' ' CB ' ' A' ' 26' ' ' THR . 13.2 m -141.44 173.62 11.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.133 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.404 ' CB ' ' HG2' ' A' ' 160' ' ' GLU . 14.9 t -52.19 -57.06 10.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.692 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.519 ' CA ' ' O ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -118.07 44.45 2.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.553 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.907 HG23 ' HG2' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -148.34 138.66 22.66 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.311 0.577 . . . . 0.0 110.886 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.885 HG21 ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -141.34 148.35 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.138 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -114.55 103.54 11.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.367 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.729 ' C ' HD13 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -99.26 127.51 45.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.886 -178.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -113.28 116.65 30.07 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.027 HD22 HD11 ' A' ' 102' ' ' LEU . 4.6 mt -112.37 131.57 55.47 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.025 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.535 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -144.77 109.86 5.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.72 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.607 ' HB2' ' CA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -114.92 -49.17 2.81 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.613 ' HB3' ' HD2' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -63.68 -164.68 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 34' ' ' ARG . 88.1 Cg_exo -44.54 -74.46 0.04 OUTLIER 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 121.645 1.563 . . . . 0.0 113.546 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.639 ' O ' ' N ' ' A' ' 38' ' ' CYS . 2.4 m-20 153.81 -169.83 0.0 OUTLIER 'General case' 0 C--N 1.345 0.372 0 CA-C-N 118.089 0.404 . . . . 0.0 110.784 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.592 ' CA ' ' HB3' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -58.0 59.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.592 0.558 . . . . 0.0 111.391 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER 166.56 -16.04 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.596 ' HA3' ' HB2' ' A' ' 35' ' ' PRO . . . -103.87 -84.33 1.77 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 119.578 -1.296 . . . . 0.0 114.991 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.715 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 8.0 t-20 -157.47 88.26 0.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.789 HH12 HD12 ' A' ' 76' ' ' LEU . 1.1 ptt85 -177.26 -29.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.612 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.601 ' C ' ' HA ' ' A' ' 72' ' ' PRO . . . -57.64 -166.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.689 -0.767 . . . . 0.0 114.293 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.105 HG13 HD23 ' A' ' 76' ' ' LEU . 20.4 m -134.4 167.4 26.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 C-N-CA 123.793 0.837 . . . . 0.0 111.029 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.695 ' HA ' ' N ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -112.76 84.02 1.91 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.131 0.973 . . . . 0.0 111.14 178.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER 7.06 61.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.171 0.919 . . . . 0.0 112.572 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -84.92 160.94 54.43 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.816 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.976 ' O ' HG23 ' A' ' 110' ' ' VAL . 37.1 Cg_exo -57.99 68.53 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.589 2.193 . . . . 0.0 111.837 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.736 ' O ' HG21 ' A' ' 110' ' ' VAL . . . 59.39 37.74 92.43 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.003 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 65' ' ' SER . 4.8 tt0 -52.95 158.12 1.51 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.064 0.432 . . . . 0.0 110.077 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.84 ' CE2' HD21 ' A' ' 108' ' ' LEU . 28.7 p90 -151.96 163.47 39.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 63' ' ' SER . 2.0 mmt -121.14 175.36 6.14 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.705 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.54 108.09 15.07 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.907 HD23 ' O ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -150.49 156.69 41.92 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.973 HG23 ' C ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -96.6 154.15 17.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.602 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.028 ' O ' HD23 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -29.45 -68.14 0.12 Allowed Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 123.443 0.464 . . . . 0.0 110.601 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.96 ' HD3' HG23 ' A' ' 55' ' ' ILE . 4.4 Cg_endo -110.05 6.26 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.719 2.946 . . . . 0.0 111.733 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 58' ' ' THR . . . 104.51 -5.88 44.76 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.019 -178.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.812 HG23 ' CG ' ' A' ' 56' ' ' PRO . 67.6 p -24.34 -88.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.127 0.571 . . . . 0.0 111.814 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.667 ' O ' HG12 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -154.12 42.84 0.53 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.973 ' C ' HG23 ' A' ' 54' ' ' THR . 0.3 OUTLIER 88.19 125.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.783 ' N ' HG23 ' A' ' 54' ' ' THR . 28.8 t -117.41 -72.42 0.69 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.502 0.668 . . . . 0.0 110.268 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HB3' " H4'" ' A' ' 252' ' ' FDA . 0.0 OUTLIER -167.63 171.14 10.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.597 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.648 ' CB ' ' CE1' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -101.54 118.96 38.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.903 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.542 ' C ' ' HB2' ' A' ' 50' ' ' PHE . 1.6 t80 -118.57 127.34 53.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.994 0.426 . . . . 0.0 111.94 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.586 ' HA ' ' CB ' ' A' ' 50' ' ' PHE . 92.4 p -72.18 109.54 6.04 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.741 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.545 ' CD ' ' HA ' ' A' ' 50' ' ' PHE . 88.6 Cg_endo -85.67 169.65 9.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.956 2.438 . . . . 0.0 112.694 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.4 130.53 19.55 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.964 0.412 . . . . 0.0 111.655 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 1.0 ' HB3' HG22 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -129.68 -56.09 1.14 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.555 0.693 . . . . 0.0 109.844 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.575 ' HB3' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER 164.61 -164.93 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 96.6 Cg_endo -91.31 63.16 1.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.102 1.201 . . . . 0.0 112.372 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.695 ' N ' ' HA ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -174.46 109.74 0.29 Allowed Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.601 ' HA ' ' C ' ' A' ' 42' ' ' GLY . 4.1 Cg_exo -74.17 40.85 0.62 Allowed 'Trans proline' 0 CA--C 1.515 -0.429 0 C-N-CA 122.336 2.024 . . . . 0.0 112.409 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.715 ' HA ' ' HA ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -138.14 6.79 2.62 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.579 178.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.612 ' O ' ' CG ' ' A' ' 41' ' ' ARG . . . -90.29 -116.05 1.74 Allowed Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.912 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.592 ' HB3' ' CA ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -152.34 119.49 5.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.875 -0.662 . . . . 0.0 110.012 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.105 HD23 HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -96.8 148.33 23.03 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 122.22 1.009 . . . . 0.0 113.169 -178.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.73 ' CB ' HD12 ' A' ' 30' ' ' LEU . 1.8 pt-20 -131.07 150.56 52.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.972 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.773 ' HE2' HD11 ' A' ' 31' ' ' LEU . 1.9 p90 -126.37 139.8 52.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.938 0.399 . . . . 0.0 111.549 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.921 HD22 HG21 ' A' ' 128' ' ' THR . 1.3 mt -104.4 91.56 3.95 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.604 ' O ' HG13 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -92.36 118.61 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.197 -178.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.907 ' HG2' HG23 ' A' ' 26' ' ' THR . 0.8 OUTLIER -79.34 96.25 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.978 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.971 HG11 HD11 ' A' ' 92' ' ' LEU . 2.9 m -92.69 141.5 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.006 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.53 ' HG ' ' CD ' ' A' ' 84' ' ' PRO . 1.1 mp -60.73 -179.97 0.21 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.747 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.53 ' CD ' ' HG ' ' A' ' 83' ' ' LEU . 37.4 Cg_exo -56.8 -32.35 91.38 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.593 2.195 . . . . 0.0 112.182 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER 157.94 100.7 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.831 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 155.04 -16.91 0.53 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.645 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.481 ' CG ' HD22 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -102.72 -98.19 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.881 -0.188 . . . . 0.0 110.975 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.535 ' O ' ' CD2' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -97.07 -30.17 13.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.717 0.294 . . . . 0.0 111.204 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.706 ' HB2' HG21 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -60.47 -27.31 67.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.99 0.424 . . . . 0.0 110.921 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -76.24 -32.47 58.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.555 0.693 . . . . 0.0 109.819 179.469 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.814 ' CD1' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -73.43 -45.31 55.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.129 -179.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.971 HD11 HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -67.73 -34.72 77.4 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -29.68 15.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 90' ' ' ASP . 2.4 t-20 -95.2 -5.14 44.56 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.384 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.49 15.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.911 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . . . -153.61 30.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.668 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -47.49 -102.1 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 98' ' ' VAL . 2.5 t -148.01 103.14 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.115 0.484 . . . . 0.0 110.98 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.58 ' H ' HG23 ' A' ' 16' ' ' VAL . . . 150.7 -12.65 0.87 Allowed Glycine 0 C--N 1.32 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.021 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 1.061 ' O ' HG22 ' A' ' 16' ' ' VAL . 27.1 mp0 -91.29 162.46 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 111.133 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.487 HG22 ' OE1' ' A' ' 15' ' ' GLU . 40.9 t -129.62 142.22 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.581 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.028 HD23 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -118.94 153.4 34.67 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.089 0.471 . . . . 0.0 111.415 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.6 t -105.95 97.56 7.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.815 HG12 ' CD1' ' A' ' 53' ' ' LEU . 2.0 m -90.88 118.54 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.521 ' HB2' ' CB ' ' A' ' 11' ' ' SER . 3.7 tttt -129.52 123.08 30.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.496 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 51' ' ' MET . . . 161.79 65.66 0.02 OUTLIER Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.732 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.44 57.4 1.33 Allowed 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.422 2.081 . . . . 0.0 110.883 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.84 HD21 ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -100.55 170.03 8.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.864 -178.543 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.654 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -118.83 172.09 14.41 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.987 HG11 ' C7M' ' A' ' 252' ' ' FDA . 0.2 OUTLIER -157.13 115.33 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.564 0.682 . . . . 0.0 111.683 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -69.67 113.81 7.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.539 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 215' ' ' TYR . . . -147.02 -40.5 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.849 HD11 ' HB3' ' A' ' 136' ' ' MET . 0.9 OUTLIER -146.14 119.14 8.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.431 178.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.652 ' CB ' ' CE2' ' A' ' 241' ' ' PHE . 0.1 OUTLIER -138.28 117.48 12.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.294 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -92.29 140.62 29.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.435 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -90.05 15.89 9.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.018 0.437 . . . . 0.0 110.98 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.46 -77.39 0.23 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.69 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.56 89.87 2.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.939 0.4 . . . . 0.0 110.37 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -163.59 149.94 9.97 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.16 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.462 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 32.2 Cg_endo -64.24 115.22 3.03 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.569 2.179 . . . . 0.0 111.69 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.581 ' NE ' HG23 ' A' ' 149' ' ' THR . 0.0 OUTLIER -124.77 146.31 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.393 -179.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.642 ' CD2' ' HB3' ' A' ' 150' ' ' ARG . 39.5 m-85 -126.09 122.78 36.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 110.63 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 1.11 ' CZ ' HG22 ' A' ' 133' ' ' VAL . 0.9 OUTLIER -111.93 106.05 14.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.418 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.735 HG22 ' HE1' ' A' ' 222' ' ' MET . 6.9 p -99.11 111.0 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 121.233 0.539 . . . . 0.0 111.125 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 217' ' ' CYS . . . -109.79 133.68 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.143 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.439 ' C ' ' HA3' ' A' ' 249' ' ' GLY . . . -107.82 103.08 1.86 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.047 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.769 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . 118.86 -167.94 13.2 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.372 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.921 HG21 HD22 ' A' ' 79' ' ' LEU . 6.1 m -91.74 -13.42 31.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.024 0.44 . . . . 0.0 110.847 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.577 ' HA3' ' CE1' ' A' ' 245' ' ' PHE . . . -64.72 10.02 0.36 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 116.111 -0.495 . . . . 0.0 113.409 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.734 ' HG ' HG13 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -79.97 3.68 19.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 117.177 0.489 . . . . 0.0 110.033 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.584 ' N ' ' CD ' ' A' ' 132' ' ' PRO . . . -47.55 -43.43 49.41 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.917 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 131' ' ' ALA . 6.7 Cg_exo -71.35 -30.87 14.93 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.525 2.15 . . . . 0.0 109.655 177.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.11 HG22 ' CZ ' ' A' ' 123' ' ' PHE . 17.9 t -66.07 -44.33 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.208 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.734 HG13 ' HG ' ' A' ' 130' ' ' LEU . 14.4 m -70.44 -29.91 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.532 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.14 -52.69 57.88 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.849 ' HB3' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -62.13 -44.95 95.5 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.389 0.614 . . . . 0.0 109.46 178.312 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.464 HG13 ' NE2' ' A' ' 141' ' ' GLN . 5.3 t -60.17 -30.16 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.846 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.82 -37.99 83.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.254 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.552 ' OE1' ' CE2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -63.61 -42.66 98.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.065 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.611 ' O ' ' CD1' ' A' ' 143' ' ' TRP . 0.6 OUTLIER -70.05 -33.31 71.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.664 0.745 . . . . 0.0 110.366 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 1.019 ' CG ' HD21 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -76.4 -30.38 57.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.51 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -73.11 -44.67 60.01 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.798 ' CE2' ' HB2' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -78.14 -21.26 50.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.335 0.588 . . . . 0.0 110.115 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER 53.57 27.84 7.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.761 178.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.798 ' HB2' ' CE2' ' A' ' 143' ' ' TRP . . . -36.6 160.32 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 0.0 110.693 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.514 ' HD2' ' HB1' ' A' ' 145' ' ' ALA . 60.2 Cg_endo -73.23 4.27 3.96 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.691 2.26 . . . . 0.0 112.728 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 148' ' ' GLU . 10.8 t30 -81.48 135.83 35.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.984 0.421 . . . . 0.0 111.522 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.555 ' CB ' ' HB2' ' A' ' 176' ' ' ASN . 4.6 pt-20 -73.78 112.7 10.14 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.437 0.637 . . . . 0.0 110.957 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.581 HG23 ' NE ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -111.74 116.35 30.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.052 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.642 ' HB3' ' CD2' ' A' ' 122' ' ' TYR . 0.8 OUTLIER -107.12 142.82 36.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.76 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.945 HD12 ' N ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -134.05 136.2 53.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.152 0.501 . . . . 0.0 110.697 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.945 ' N ' HD12 ' A' ' 151' ' ' ILE . 18.2 m-30 -110.5 112.02 23.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.881 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.82 ' HZ ' HD11 ' A' ' 161' ' ' LEU . 8.6 t80 -113.9 130.34 56.51 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 122.199 -0.313 . . . . 0.0 111.364 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.683 ' HA2' ' HB2' ' A' ' 182' ' ' CYS . . . -154.12 161.19 29.89 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 119.535 -1.316 . . . . 0.0 113.865 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.939 HG21 HD13 ' A' ' 161' ' ' LEU . 21.0 m -164.05 -122.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.379 -0.411 . . . . 0.0 111.265 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.827 ' O ' HG21 ' A' ' 183' ' ' VAL . 44.7 p-10 -103.45 -174.34 2.52 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-O 120.557 0.218 . . . . 0.0 110.783 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.621 HG23 ' HD3' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -42.95 -25.31 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.323 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.668 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 40.1 mt-10 94.16 22.41 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.711 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 158' ' ' GLU . 77.9 Cg_exo -46.78 -23.82 2.65 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.28 1.32 . . . . 0.0 111.252 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -131.59 -28.85 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.674 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.939 HD13 HG21 ' A' ' 155' ' ' VAL . 13.3 tp -35.76 158.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.71 -157.99 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.564 ' CE1' ' HG2' ' A' ' 166' ' ' GLU . 0.1 OUTLIER 74.15 27.61 1.52 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.1 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 1.024 HD13 ' N ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -70.23 -39.07 76.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.071 0.462 . . . . 0.0 110.306 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 1.024 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.2 OUTLIER -73.7 -27.2 61.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.825 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.564 ' HG2' ' CE1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -64.17 -49.16 73.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 -179.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -75.19 -30.84 60.77 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 164' ' ' ILE . 1.8 mttm -61.64 -41.26 97.25 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.16 -32.4 73.01 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 1.019 HD21 ' CG ' ' A' ' 141' ' ' GLN . 0.3 OUTLIER -61.72 -48.58 80.08 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.468 ' O ' ' SD ' ' A' ' 174' ' ' MET . 36.2 mt-10 -56.58 -32.65 65.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.89 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -39.94 30.85 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 m -112.13 28.8 8.44 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.633 ' HB2' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -113.65 167.05 10.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.164 0.507 . . . . 0.0 111.615 179.365 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -84.85 -80.05 0.21 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.373 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.565 ' C ' HD12 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -130.61 63.48 1.57 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.245 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.633 HD13 ' HB2' ' A' ' 174' ' ' MET . 4.5 mp -112.27 149.65 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.077 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.465 ' HB ' ' HG2' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -137.08 126.9 25.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.283 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 151' ' ' ILE . 72.6 t -100.99 135.8 35.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.314 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.625 ' CG ' ' CD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -99.79 136.69 39.34 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.196 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -98.22 105.89 18.1 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.68 0.752 . . . . 0.0 111.389 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.683 ' HB2' ' HA2' ' A' ' 154' ' ' GLY . 64.4 m -86.06 -164.75 1.08 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.358 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.827 HG21 ' O ' ' A' ' 156' ' ' ASN . 37.3 t 54.17 147.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 122.151 0.977 . . . . 0.0 112.646 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.729 ' CD1' ' N ' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -137.18 -62.94 0.61 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.523 -1.672 . . . . 0.0 108.484 -178.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.538 ' N ' ' HD3' ' A' ' 186' ' ' PRO . 50.8 m-70 -167.64 49.45 0.18 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.698 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.574 ' O ' ' CB ' ' A' ' 187' ' ' SER . 40.7 Cg_endo -85.95 -104.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.384 2.723 . . . . 0.0 112.895 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 186' ' ' PRO . 9.6 t 150.81 21.78 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.618 ' N ' ' CB ' ' A' ' 156' ' ' ASN . . . 97.84 10.4 52.62 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.636 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 251' ' ' ALA . 0.4 OUTLIER -138.07 63.88 1.52 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 178.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' TRP . . . . . 0.523 ' O ' ' O ' ' A' ' 249' ' ' GLY . 5.6 t-105 -122.81 123.63 41.46 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.778 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.52 ' HG3' ' HA ' ' A' ' 251' ' ' ALA . 0.3 OUTLIER -83.84 105.57 14.84 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.856 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.501 ' C ' ' CG ' ' A' ' 193' ' ' GLU . . . 127.33 -108.8 1.0 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.256 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.576 ' C ' ' HB3' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -168.9 -74.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.583 ' CB ' ' HA ' ' A' ' 182' ' ' CYS . 0.0 OUTLIER -99.35 153.31 19.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 179.466 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.639 ' N ' ' CD1' ' A' ' 184' ' ' TRP . . . -28.22 108.95 0.02 OUTLIER Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.465 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 195' ' ' GLY . 8.2 m 95.4 155.61 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.268 -0.466 . . . . 0.0 110.418 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.471 ' O ' ' C ' ' A' ' 198' ' ' ILE . 32.5 Cg_exo -59.79 58.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.998 2.466 . . . . 0.0 112.634 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.987 HG13 HD23 ' A' ' 201' ' ' LEU . 0.1 OUTLIER 30.16 92.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 122.031 0.92 . . . . 0.0 110.066 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.89 -33.69 59.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.534 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -57.73 -31.56 66.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.987 HD23 HG13 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -69.52 -41.76 75.59 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.806 0.336 . . . . 0.0 110.672 -178.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.506 ' O ' ' HG ' ' A' ' 205' ' ' LEU . 13.6 mtm180 -57.19 -49.23 76.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.367 0.603 . . . . 0.0 110.257 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -71.78 -32.66 67.89 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.575 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.974 ' HB3' ' HB3' ' A' ' 210' ' ' ALA . 1.5 m-20 -59.44 -41.68 90.19 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.669 HD12 ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -60.73 -47.13 87.69 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.401 ' CG ' ' HG2' ' A' ' 233' ' ' ARG . 1.8 mm-40 -65.15 -19.06 65.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.674 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 208' ' ' SER . 16.2 t -90.8 -79.53 0.36 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.457 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 207' ' ' SER . 3.0 t 155.59 -11.68 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.87 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 210' ' ' ALA . 6.8 m-20 -88.97 40.07 0.96 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.212 0.529 . . . . 0.0 110.412 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 0.974 ' HB3' ' HB3' ' A' ' 204' ' ' ASP . . . 161.96 99.75 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.78 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.693 ' HA ' HD11 ' A' ' 235' ' ' ILE . 6.0 t30 173.25 -55.42 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.215 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 211' ' ' ASN . 1.5 Cg_endo -45.81 -55.24 3.75 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.272 1.981 . . . . 0.0 110.889 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -133.03 108.85 9.13 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 1.007 ' HB ' HG22 ' A' ' 240' ' ' VAL . 0.9 OUTLIER -117.5 124.71 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.649 ' CG ' ' HA ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -113.18 127.3 56.14 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.551 -178.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.565 ' CD1' ' CG1' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -131.94 123.61 27.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.71 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . 0.558 ' HB2' ' CE1' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -122.71 107.27 11.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.8 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 244' ' ' LYS . . . 176.22 166.14 33.06 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.571 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.768 ' HG2' ' HB3' ' A' ' 250' ' ' ALA . 24.3 Cg_exo -55.45 -170.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.721 2.281 . . . . 0.0 112.594 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 219' ' ' PRO . 23.6 Cg_exo -64.72 -19.69 64.68 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 123.192 2.595 . . . . 0.0 113.002 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -83.09 -54.61 3.14 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.839 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . 0.735 ' HE1' HG22 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -57.13 -34.39 68.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 242' ' ' PHE . 0.1 OUTLIER -76.66 -34.14 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.452 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.473 ' HA ' ' SG ' ' A' ' 227' ' ' CYS . 12.3 m-20 -72.96 -47.0 49.25 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.851 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.538 ' O ' ' CD2' ' A' ' 229' ' ' LEU . . . -61.43 -48.12 82.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.724 0.297 . . . . 0.0 111.74 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.793 ' O ' HG23 ' A' ' 230' ' ' VAL . . . -69.57 -34.87 74.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.566 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 223' ' ' ILE . 8.2 p -70.05 -31.93 69.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 110.263 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.99 -44.82 95.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.551 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.653 HD11 HD11 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -62.11 -39.62 93.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.093 0.473 . . . . 0.0 110.847 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.881 HG13 ' CG2' ' A' ' 235' ' ' ILE . 3.8 t -65.88 -45.68 90.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.456 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 23.5 mtt-85 -72.76 -30.25 63.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.782 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 33.3 m -69.08 -43.63 74.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.348 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.669 ' HD3' HD12 ' A' ' 205' ' ' LEU . 1.0 OUTLIER -80.99 -74.35 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.967 0.413 . . . . 0.0 111.354 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 236' ' ' PRO . . . 148.76 -18.64 1.26 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.865 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.881 ' CG2' HG13 ' A' ' 230' ' ' VAL . 0.0 OUTLIER -22.86 82.41 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.533 ' N ' ' O ' ' A' ' 234' ' ' GLY . 6.0 Cg_exo -75.82 113.05 3.64 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.156 2.571 . . . . 0.0 111.811 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -119.84 -174.54 15.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.827 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.2 -35.92 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.621 0.248 . . . . 0.0 111.277 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.59 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . 5.7 mm-40 -101.81 32.52 3.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.493 . . . . 0.0 110.834 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 1.007 HG22 ' HB ' ' A' ' 214' ' ' ILE . 2.2 t -94.6 134.67 31.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.248 0.547 . . . . 0.0 110.451 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.652 ' CE2' ' CB ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -146.24 149.36 33.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.947 -177.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.568 ' HB2' HD11 ' A' ' 223' ' ' ILE . 5.7 p90 -131.55 148.68 52.64 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.247 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . 0.467 ' N ' HD11 ' A' ' 223' ' ' ILE . 2.2 tt0 -132.8 148.81 52.32 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -106.61 111.43 23.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.328 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.577 ' CE1' ' HA3' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -136.97 147.64 46.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 1.046 HD21 H51A ' A' ' 252' ' ' FDA . 0.4 OUTLIER -20.34 146.09 0.01 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.61 ' HA ' ' HG2' ' A' ' 219' ' ' PRO . 71.9 Cg_exo -50.28 -155.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.69 2.927 . . . . 0.0 113.122 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 247' ' ' PRO . 5.6 m 92.72 -19.29 0.1 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.816 0.817 . . . . 0.0 110.428 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 190' ' ' TRP . . . -128.45 -24.14 1.16 Allowed Glycine 0 C--N 1.309 -0.921 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.569 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.768 ' HB3' ' HG2' ' A' ' 219' ' ' PRO . . . -108.38 150.27 27.59 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 122.747 0.419 . . . . 0.0 110.52 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.52 ' HA ' ' HG3' ' A' ' 191' ' ' GLU . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.229 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' FDA . . . . . 1.046 H51A HD21 ' A' ' 246' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_